Citrus Sinensis ID: 012219
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.927 | 0.415 | 0.425 | 1e-103 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.910 | 0.380 | 0.432 | 4e-97 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.910 | 0.386 | 0.372 | 3e-74 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.916 | 0.389 | 0.359 | 4e-68 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.901 | 0.337 | 0.342 | 4e-66 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.905 | 0.338 | 0.331 | 1e-65 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.914 | 0.422 | 0.343 | 1e-64 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.895 | 0.347 | 0.348 | 1e-62 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.876 | 0.412 | 0.370 | 2e-62 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.897 | 0.347 | 0.343 | 3e-62 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 374 bits (961), Expect = e-103, Method: Compositional matrix adjust.
Identities = 203/477 (42%), Positives = 299/477 (62%), Gaps = 43/477 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N +L + L N L +IP + KL +L L+LS+N ++G+I SQ + ++ +DLS
Sbjct: 572 NLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSH 631
Query: 62 NNLSGSIPESVRK---VPHLYVYGKNFDVEIPNTS--ENSPPPHHK-------------- 102
NNLSG IP S + + H+ V N IP+ + N+PP +
Sbjct: 632 NNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQG 691
Query: 103 -------------KIATRLVAIILPMVA---LLALIFGILFVRRRRDKRVEPAETGEITK 146
K ++ I++P++ +L++ GI R+R K++E E +
Sbjct: 692 LKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIE--EHTDSES 749
Query: 147 CADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSE 206
+ +I+++DG++ +Q++I+AT +F KY IGTGG+G VY+A+LP+ ++A+KKL+ +
Sbjct: 750 GGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETT 808
Query: 207 TEELA---SLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD 263
++ + + F NE R L++IRHRN+VKL+GFC HR+ FL+YEYME GSL VL D
Sbjct: 809 DSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLEND 868
Query: 264 EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
+EA LDW KR+NVVKG+ HALSY+HHD +P IVHRDISS N+LL + EA ++DFG A+
Sbjct: 869 DEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAK 928
Query: 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSS-SS 382
LL DSSN + +AGTYGY+APELAY M VTEKCDVYSFGV+ LEV+ G+HPG+L+S+ SS
Sbjct: 929 LLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSS 988
Query: 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
D + L + D RL P + I+++++ + VA CL S P++RPTM +S F
Sbjct: 989 SPPDATLSLKSISDHRLPEPTPE-IKEEVLEILKVALLCLHSDPQARPTMLSISTAF 1044
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (912), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 205/474 (43%), Positives = 292/474 (61%), Gaps = 48/474 (10%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
KL + L N GSIP ++KL +L L+LSHN ++G+I SQL + +D +DLS NNL
Sbjct: 655 KLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNL 713
Query: 65 SGSIP---ESVRKVPHLYVYGKNFDVEIPNT-----------SEN----SPPPHH----- 101
SG IP E + + ++ + + +P+T EN S P
Sbjct: 714 SGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPC 773
Query: 102 ------KKIATRLVAIILPMVALLALI------FGILFVRRR-RDKRVEPAETGEITKCA 148
KK +V I++P++ +L ++ F +R+ ++ R ETGE
Sbjct: 774 RELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGE----- 828
Query: 149 DEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE 208
+I++ DG+ +QD+IE+T +F + IGTGGY VYRA L ++A+K+LH + E
Sbjct: 829 -NMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDE 886
Query: 209 ELAS---LESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE 265
E++ + F NE + L++IRHRN+VKL+GFC HR+ FLIYEYME GSL +L DEE
Sbjct: 887 EISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEE 946
Query: 266 AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325
A L W KR+NVVKG+ HALSY+HHD PIVHRDISS N+LL+++ A ++DFG A+LL
Sbjct: 947 AKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLL 1006
Query: 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385
DSSN + +AGTYGY+APE AYTM VTEKCDVYSFGV+ LE+++GKHPG+L+SS S S
Sbjct: 1007 KTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSP 1066
Query: 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+ + L + D R+ P Q R+ ++ + +A CL++ P+SRPTM +S F
Sbjct: 1067 GEALSLRSISDERVLEPRGQN-REKLLKMVEMALLCLQANPESRPTMLSISTTF 1119
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (714), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 179/480 (37%), Positives = 258/480 (53%), Gaps = 54/480 (11%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNY-LNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
++L L+LG NLLS +IP E+ KL L LN+SHN+++G I LG + ++ + L+ N
Sbjct: 595 TRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDN 654
Query: 63 NLSGSIPESVRKVPHLYV---YGKNFDVEIPNTSE----------------NSPPPH--- 100
LSG IP S+ + L + N +P+T+ NS H
Sbjct: 655 KLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQP 714
Query: 101 -----------------HKKIATRLVAIILPMVALLALIFGILFVRRRRDKRVEPAETGE 143
+KI T + I++ V L+ + G+ + +RR+ E
Sbjct: 715 LVPHSDSKLNWLINGSQRQKILT-ITCIVIGSVFLITFL-GLCWTIKRREPAFVALEDQT 772
Query: 144 ITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLH 203
D + + T+Q +++AT +F +G G G+VY+A + G+V+A+KKL+
Sbjct: 773 KPDVMDSY--YFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN 830
Query: 204 RSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD 263
S E +S SF E L +IRHRNIVKLYGFC H+ L+YEYM GSL L+
Sbjct: 831 -SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRG 889
Query: 264 EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
E+ LDW R + G L YLHHDC P IVHRDI SNN+LL+ +A V DFG+A+
Sbjct: 890 EKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAK 949
Query: 324 LLNFD-SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP-------G 375
L++ S + + +AG+YGYIAPE AYTM VTEKCD+YSFGVV LE++ GK P G
Sbjct: 950 LIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG 1009
Query: 376 ELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
+L++ S+ I I++ D RL D++ ++ LV +A C + P SRPTM+ V
Sbjct: 1010 DLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 4e-68, Method: Compositional matrix adjust.
Identities = 173/481 (35%), Positives = 262/481 (54%), Gaps = 52/481 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNY-LNLSHNSINGKILSQLGEIPRIDTVDLS 60
N S+L L++G NL +GSIP E+ L L LNLS+N + G+I +L + ++ + L+
Sbjct: 599 NLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLN 658
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDV---EIP---NTSENS--------PPPHHKKIAT 106
NNLSG IP S + L Y +++ IP N S +S PP ++ I T
Sbjct: 659 NNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQT 718
Query: 107 R---------------------LVAIILPMVALLALIFGILFVRRRRDKRVEPAETGEIT 145
+ + A ++ V+L+ + + +RR A+ G+ +
Sbjct: 719 QPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPS 778
Query: 146 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL--- 202
+ + + +G TFQD++ AT++F + +G G G+VY+A LP+G +A+KKL
Sbjct: 779 EMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASN 837
Query: 203 HRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT 262
H SF E L IRHRNIVKL+GFC H+ L+YEYM GSL +L
Sbjct: 838 HEGGNNNNVD-NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH- 895
Query: 263 DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322
+ + LDW+KR + G L+YLHHDC P I HRDI SNN+LL+ + EA V DFG+A
Sbjct: 896 -DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 954
Query: 323 RLLNF-DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP------- 374
++++ S + + +AG+YGYIAPE AYTM VTEK D+YS+GVV LE+L GK P
Sbjct: 955 KVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQG 1014
Query: 375 GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQL 434
G++++ + ++ +LD RL+ D++I ++ V +A C P +RP+M+
Sbjct: 1015 GDVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSPVARPSMRQ 1073
Query: 435 V 435
V
Sbjct: 1074 V 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 168/491 (34%), Positives = 263/491 (53%), Gaps = 69/491 (14%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQEL-NYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
SKL L L N L+G IP EI +LQ+L + L+LS+N+ G I S +G + +++T+DLS N
Sbjct: 743 SKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHN 802
Query: 63 NLSGSIPESVRKVPHLYVYGKNF----------------DVEIPNTSENSPP-------- 98
L+G +P SV + L +F D + NT P
Sbjct: 803 QLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVR 862
Query: 99 --PHHKKIATRLVAIILPMVALLALIFGIL----FVRRRRD--KRVEPAETGEITKCADE 150
+ ++ R V II + AL A+ IL F ++R D K+V T + +
Sbjct: 863 SNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSS 922
Query: 151 -------FAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLH 203
F I ++D++EAT + ++ IG+GG G VY+A L +G+ VA+KK+
Sbjct: 923 QATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL 982
Query: 204 RSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVLR 261
+ +L S +SF E + L +IRHR++VKL G+C + LIYEYM+ GS++ L
Sbjct: 983 WKD--DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLH 1040
Query: 262 TDEEAVG-----LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316
D+ + LDW R+ + G+ + YLHHDC PPIVHRDI S+NVLL+S +EA +
Sbjct: 1041 EDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHL 1100
Query: 317 ADFGVARLL----NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK 372
DFG+A++L + ++ + T A +YGYIAPE AY++ TEK DVYS G+V +E++ GK
Sbjct: 1101 GDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGK 1160
Query: 373 HP-----GELLSSSSWSLDKNIKLI-----DLLDPRLSP--PVDQKIRQDIILVSTVAFS 420
P G + W ++ ++++ L+DP+L P P ++ ++ +A
Sbjct: 1161 MPTDSVFGAEMDMVRW-VETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVL---EIALQ 1216
Query: 421 CLRSQPKSRPT 431
C ++ P+ RP+
Sbjct: 1217 CTKTSPQERPS 1227
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 164/495 (33%), Positives = 260/495 (52%), Gaps = 71/495 (14%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQEL-NYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
SKL L L N L+G IP EI +LQ+L + L+LS+N+ G+I S + +P+++++DLS N
Sbjct: 744 SKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHN 803
Query: 63 NLSGSIPESVRKVPHLYVYGKNF----------------DVEIPNTSENSPPPHH----- 101
L G +P + + L ++ D + N P H
Sbjct: 804 QLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAG 863
Query: 102 ----KKIATRLVAII-----LPMVALLALIFGILFVRRRRD--KRVEPAETGEITKC--- 147
+ ++ + V II L +AL+ L+ ILF ++ D K+V + +
Sbjct: 864 SKNQRSLSPKTVVIISAISSLAAIALMVLVI-ILFFKQNHDLFKKVRGGNSAFSSNSSSS 922
Query: 148 -ADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSE 206
A F+ I + D++EAT + ++ IG+GG G VY+A L +G+ +A+KK+ +
Sbjct: 923 QAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKD 982
Query: 207 TEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVLRTDE 264
+L S +SF E + L IRHR++VKL G+C + LIYEYM GS++ L +E
Sbjct: 983 --DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANE 1040
Query: 265 EAVG---LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321
L W R+ + G+ + YLH+DC PPIVHRDI S+NVLL+S +EA + DFG+
Sbjct: 1041 NTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGL 1100
Query: 322 ARLL--NFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377
A++L N+D++ + T+ AG+YGYIAPE AY++ TEK DVYS G+V +E++ GK P E
Sbjct: 1101 AKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA 1160
Query: 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII----------------LVSTVAFSC 421
+ D+ ++ ++ L P + R+ +I V +A C
Sbjct: 1161 M------FDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQC 1214
Query: 422 LRSQPKSRPTMQLVS 436
+S P+ RP+ + S
Sbjct: 1215 TKSYPQERPSSRQAS 1229
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 165/481 (34%), Positives = 258/481 (53%), Gaps = 53/481 (11%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+C L L+L +N L+G+IPS I ++L LNL +N++ G+I Q+ + + +DLS
Sbjct: 498 DCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSN 557
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFD--------------VEIPNTSENS-------PPPH 100
N+L+G +PES+ P L + +++ + + NS PP
Sbjct: 558 NSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCS 617
Query: 101 HKKIAT---------RLVA-IILPMVALLALIFGILFVRRRRDKRVEPAETGEITKCADE 150
+ AT R+VA ++ + ++LAL + R K G+ T E
Sbjct: 618 KFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGE 677
Query: 151 FAIWNYDG--RITF--QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRS 205
+ W R+ F D++ ++ ++ IG G G VY+A + S V+A+KKL RS
Sbjct: 678 WP-WRLMAFHRLGFTASDILACIKESNM---IGMGATGIVYKAEMSRSSTVLAVKKLWRS 733
Query: 206 ETE-ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 264
+ E + F E LL ++RHRNIV+L GF + K M ++YE+M G+L +
Sbjct: 734 AADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKN 793
Query: 265 EAVGL--DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322
A L DW R N+ G+ H L+YLHHDC PP++HRDI SNN+LL++ L+A +ADFG+A
Sbjct: 794 AAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLA 853
Query: 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP-----GEL 377
R++ +++AG+YGYIAPE YT+ V EK D+YS+GVV LE+L G+ P GE
Sbjct: 854 RMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES 913
Query: 378 LSSSSW---SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQL 434
+ W + NI L + LDP + + ++++++LV +A C PK RP+M+
Sbjct: 914 VDIVEWVRRKIRDNISLEEALDPNVGNC--RYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971
Query: 435 V 435
V
Sbjct: 972 V 972
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 165/473 (34%), Positives = 249/473 (52%), Gaps = 54/473 (11%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L +L LG+N LSG IP ++ L+ + L+LS+N NG I + L + + +DLS NNLS
Sbjct: 689 LSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLS 748
Query: 66 GSIPESV--RKVPHLYVYGKN----FDVEIPNTS-----ENSPPPHHKKIATRLVAIILP 114
G IPES P Y + N + + IP +S N H++ A+ ++ +
Sbjct: 749 GMIPESAPFDTFPD-YRFANNSLCGYPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMG 807
Query: 115 MVALLALIFGILFV-------RRRRDKRVEPAETGEITKCADEFAIWNYDG--------- 158
++ L IFG++ V RR+++ +E G + A + W +
Sbjct: 808 LLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANSAWKFTSAREALSINL 866
Query: 159 --------RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL-HRSETEE 209
++TF D++EAT FH +G+GG+G VY+A+L G VVA+KKL H S +
Sbjct: 867 AAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD 926
Query: 210 LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG- 268
F E + +I+HRN+V L G+C + L+YEYM+ GSL VL D + +G
Sbjct: 927 ----REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLH-DRKKIGI 981
Query: 269 -LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
L+W R + G L++LHH+C P I+HRD+ S+NVLL+ LEA V+DFG+ARL++
Sbjct: 982 KLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSA 1041
Query: 328 DSSNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS---- 381
++ ++ LAGT GY+ PE + + K DVYS+GVV LE+L GK P +
Sbjct: 1042 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNL 1101
Query: 382 -SW-SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM 432
W L K+ D+ D L D I +++ VA +CL + RPTM
Sbjct: 1102 VGWVKLHAKGKITDVFDRELLKE-DASIEIELLQHLKVACACLDDRHWKRPTM 1153
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 183/494 (37%), Positives = 261/494 (52%), Gaps = 84/494 (17%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L +E+ N+L G IPS ++ EL LNLS+N + G I +LG++P ++ +DLS N L+
Sbjct: 509 LERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLT 568
Query: 66 GSIPESVRK-------VPHLYVYGK---NFDVEI--------PN-TSENSPP--PHHKKI 104
G IP + + V +YGK F +I PN + N P P K
Sbjct: 569 GEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKR 628
Query: 105 ATR--LVAIILPMVALL-ALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRIT 161
TR L IL +VAL AL++ LF++ + + +P T +IT I+ G T
Sbjct: 629 ETRYILPISILCIVALTGALVW--LFIKTKPLFKRKPKRTNKIT-------IFQRVG-FT 678
Query: 162 FQDMI-EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEA 220
+D+ + TED IG+GG G VYR +L SG+ +A+KKL ++ S F +E
Sbjct: 679 EEDIYPQLTED----NIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEV 734
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--AVG-LDWAKRVNV 277
L ++RH NIVKL C + FL+YE+ME GSL VL +++E AV LDW R ++
Sbjct: 735 ETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSI 794
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN------ 331
G LSYLHHD PPIVHRD+ SNN+LL+ E++ VADFG+A+ L + ++
Sbjct: 795 AVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVS 854
Query: 332 RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI-- 389
+ +AG+YGYIAPE YT V EK DVYSFGVV LE++ GK P + SS+ +K+I
Sbjct: 855 MSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPND----SSFGENKDIVK 910
Query: 390 ----------------------------KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSC 421
L L+DP++ + + ++I V VA C
Sbjct: 911 FAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMK--LSTREYEEIEKVLDVALLC 968
Query: 422 LRSQPKSRPTMQLV 435
S P +RPTM+ V
Sbjct: 969 TSSFPINRPTMRKV 982
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 162/472 (34%), Positives = 248/472 (52%), Gaps = 52/472 (11%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L +L LG+N LSG IP ++ L+ + L+LS+N NG I + L + + +DLS NNLS
Sbjct: 689 LSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLS 748
Query: 66 GSIPESV--RKVPHLYVYGKN----FDVEIPNTS-----ENSPPPHHKKIATRLVAIILP 114
G IPES P Y + N + + +P +S N H++ A+ ++ +
Sbjct: 749 GMIPESAPFDTFPD-YRFANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMG 807
Query: 115 MVALLALIFGILFV-------RRRRDKRVEPAETGEITKCADEFAIWNYDG--------- 158
++ L IFG++ V RR+++ +E G + A + W +
Sbjct: 808 LLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANSAWKFTSAREALSINL 866
Query: 159 --------RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL-HRSETEE 209
++TF D++EAT FH +G+GG+G VY+A+L G VVA+KKL H S +
Sbjct: 867 AAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD 926
Query: 210 LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE-AVG 268
F E + +I+HRN+V L G+C + L+YEYM+ GSL VL ++ +
Sbjct: 927 ----REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK 982
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
L+W R + G L++LHH+C P I+HRD+ S+NVLL+ LEA V+DFG+ARL++
Sbjct: 983 LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1042
Query: 329 SSNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS----- 381
++ ++ LAGT GY+ PE + + K DVYS+GVV LE+L GK P +
Sbjct: 1043 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLV 1102
Query: 382 SW-SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM 432
W L K+ D+ D L D I +++ VA +CL + RPTM
Sbjct: 1103 GWVKLHAKGKITDVFDRELLKE-DASIEIELLQHLKVACACLDDRHWKRPTM 1153
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.523 | 0.521 | 1e-135 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.970 | 0.519 | 0.521 | 1e-135 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.959 | 0.592 | 0.524 | 1e-134 | |
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.967 | 0.574 | 0.535 | 1e-133 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.967 | 0.537 | 0.535 | 1e-133 | |
| 225466223 | 736 | PREDICTED: probable leucine-rich repeat | 0.980 | 0.623 | 0.523 | 1e-133 | |
| 359488981 | 757 | PREDICTED: probable LRR receptor-like se | 0.961 | 0.594 | 0.533 | 1e-133 | |
| 224110024 | 827 | predicted protein [Populus trichocarpa] | 0.963 | 0.545 | 0.522 | 1e-133 | |
| 225452698 | 727 | PREDICTED: probable LRR receptor-like se | 0.978 | 0.629 | 0.520 | 1e-133 | |
| 224108669 | 811 | predicted protein [Populus trichocarpa] | 0.967 | 0.558 | 0.523 | 1e-133 |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1255), Expect = e-135, Method: Compositional matrix adjust.
Identities = 242/464 (52%), Positives = 330/464 (71%), Gaps = 10/464 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L+L +NL+ G IPS++ L+ L LNLSHN ++G I I + ++D S
Sbjct: 414 NLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSH 473
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRLVAIILPMVALLAL 121
N+ G IP ++ V V+G N + E PH K+ ++ I L + L+
Sbjct: 474 NDFEGHIPHELQFVYPPRVFGHNKGL----CGEREGLPHCKRGHKTILIISLSTILFLSF 529
Query: 122 I-FGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGT 180
+ GIL + R+ + A + TK D F++WNYDG+I ++D+IEATEDF IKYCIGT
Sbjct: 530 VALGILLLSRKTRRNQTKATS---TKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGT 586
Query: 181 GGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240
GGYGSVY+A+LP+G VVALKKLH E +E L+SF NE ++LS+I+HRNI+KL+G+CLH
Sbjct: 587 GGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLH 646
Query: 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300
++CMFLIY+YME GSL+CVL + EA+ LDW KRVNV+K + HAL Y+HHD TPPI+HRD
Sbjct: 647 KRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRD 706
Query: 301 ISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYS 360
+SSNN+LL+ +L+AF++DFG ARLL+ DSSN+TLLAGTYGYIAPELAYTM VTEKCDVYS
Sbjct: 707 VSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYS 766
Query: 361 FGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFS 420
FGVVALE +MG+HP EL + S S +NI L D+LD RL P D+++ +D++LV +A
Sbjct: 767 FGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALK 826
Query: 421 CLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
C+ S P+SRPTMQ +S++ + ++P +PFH IS+ +L QE+
Sbjct: 827 CIHSNPRSRPTMQHISSKLLI--QSPFLEPFHGISLWQLNIQEI 868
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 242/464 (52%), Positives = 330/464 (71%), Gaps = 10/464 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L+L +NL+ G IPS++ L+ L LNLSHN ++G I I + ++D S
Sbjct: 420 NLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSH 479
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRLVAIILPMVALLAL 121
N+ G IP ++ V V+G N + E PH K+ ++ I L + L+
Sbjct: 480 NDFEGHIPHELQFVYPPRVFGHNKGL----CGEREGLPHCKRGHKTILIISLSTILFLSF 535
Query: 122 I-FGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGT 180
+ GIL + R+ + A + TK D F++WNYDG+I ++D+IEATEDF IKYCIGT
Sbjct: 536 VALGILLLSRKTRRNQTKATS---TKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGT 592
Query: 181 GGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240
GGYGSVY+A+LP+G VVALKKLH E +E L+SF NE ++LS+I+HRNI+KL+G+CLH
Sbjct: 593 GGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLH 652
Query: 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300
++CMFLIY+YME GSL+CVL + EA+ LDW KRVNV+K + HAL Y+HHD TPPI+HRD
Sbjct: 653 KRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRD 712
Query: 301 ISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYS 360
+SSNN+LL+ +L+AF++DFG ARLL+ DSSN+TLLAGTYGYIAPELAYTM VTEKCDVYS
Sbjct: 713 VSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYS 772
Query: 361 FGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFS 420
FGVVALE +MG+HP EL + S S +NI L D+LD RL P D+++ +D++LV +A
Sbjct: 773 FGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALK 832
Query: 421 CLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
C+ S P+SRPTMQ +S++ + ++P +PFH IS+ +L QE+
Sbjct: 833 CIHSNPRSRPTMQHISSKLLI--QSPFLEPFHGISLWQLNIQEI 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1244), Expect = e-134, Method: Compositional matrix adjust.
Identities = 251/479 (52%), Positives = 335/479 (69%), Gaps = 30/479 (6%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L L+L N +SG IP EI L++L++L++S+N I+GKI SQLG + + +LS NNLS
Sbjct: 286 LSYLDLSENQISGFIPEEIVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLS 345
Query: 66 GSIPESV---------------------RKVPHLYVYGKNFDVEIPNTSENSPPPHHKKI 104
G+IP S+ R + + K EI + P +
Sbjct: 346 GTIPYSISSNYNKWTLIDLSNNRLEGQTRAPVEAFGHNKGLCGEI----KGRPRCKKRHQ 401
Query: 105 ATRLVAIILPMVALLAL-IFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQ 163
T ++ + L LL++ I G LF +RR ++ + ET ++ K D F+IW+YDG I +Q
Sbjct: 402 ITLIIVVSLSTTLLLSIAILGFLF-HKRRIRKNQLLETTKV-KNGDLFSIWDYDGVIAYQ 459
Query: 164 DMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLL 223
D+I+ATEDF IKYCIGTGGYGSVYRA+LPSGKVVALKKLH E + L+SF NE ++L
Sbjct: 460 DIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFENEVQML 519
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
++IRHRNIVKL+GFCLH++CMFL+Y+YME GSL+C+LR + EAV LDW KRVNVVK + +
Sbjct: 520 TRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIAN 579
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
ALSY+HHDC PI+HRDISSNN+LL+S+LEAFV+DFG ARLL+ DSSNRTLL GTYGYIA
Sbjct: 580 ALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIA 639
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
PELAYTMVVTEKCD+YSFG+VALE +MG HPGE ++S S S +N L D+LD RLS P
Sbjct: 640 PELAYTMVVTEKCDIYSFGMVALETMMGMHPGEFVTSLSSSSTQNTTLKDVLDSRLSSPK 699
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQ 462
++ +I L+ ++A CL S P+ RP+MQ VS++ ++ P +P IS+L+L+++
Sbjct: 700 STQVANNIALIVSLALKCLHSNPQFRPSMQEVSSKLVSTRSFP--QPISTISLLQLKDE 756
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1240), Expect = e-133, Method: Compositional matrix adjust.
Identities = 250/467 (53%), Positives = 332/467 (71%), Gaps = 14/467 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L+L NL+ G IPS++ L+ L YLNLSHN ++G I + L ++DLS
Sbjct: 333 NLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSH 392
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKK--IATRLVAIILPM-VAL 118
N+L G IP ++ + G +FD + PH K+ TR++ I L + L
Sbjct: 393 NDLEGHIPFELQSK---FSQG-SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFL 448
Query: 119 LALIFGILFVRRRRDKRVEPAETGEI-TKCADEFAIWNYDGRITFQDMIEATEDFHIKYC 177
++ G L + R+ K +T EI TK D F++WNYDG+I ++D+I+ATEDF IKYC
Sbjct: 449 FFVVLGFLLLSRKTRK----IQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYC 504
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IGTGGYGSVY+A+LP+G VVALKKLH E +E L+SF NE ++LS+IRHRNIVKL G+
Sbjct: 505 IGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGY 564
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
CLH++CMFLIY YM GSL+CVL + EA+ LDW KRVNVVK + HA+ Y+HHDCTPPI+
Sbjct: 565 CLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPII 624
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCD 357
HRDISSNN+LL+S+L+AF++DFG ARLL+ DSSN+TLLAGTYGYIAPELAYTMVVTEKCD
Sbjct: 625 HRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCD 684
Query: 358 VYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTV 417
VYSFGVVALE +MGKHPGEL + S S +NI L ++LD RL P DQ++ +D++LV +
Sbjct: 685 VYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWL 744
Query: 418 AFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
A C+ S P+SRPTMQ + ++ + ++P PF+ IS+ +L E+
Sbjct: 745 ALKCIHSNPRSRPTMQHILSKLLT--QSPFLGPFNWISLCQLTALEI 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 250/467 (53%), Positives = 332/467 (71%), Gaps = 14/467 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L+L NL+ G IPS++ L+ L YLNLSHN ++G I + L ++DLS
Sbjct: 387 NLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSH 446
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKK--IATRLVAIILPM-VAL 118
N+L G IP ++ + G +FD + PH K+ TR++ I L + L
Sbjct: 447 NDLEGHIPFELQSK---FSQG-SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFL 502
Query: 119 LALIFGILFVRRRRDKRVEPAETGEI-TKCADEFAIWNYDGRITFQDMIEATEDFHIKYC 177
++ G L + R+ K +T EI TK D F++WNYDG+I ++D+I+ATEDF IKYC
Sbjct: 503 FFVVLGFLLLSRKTRK----IQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYC 558
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IGTGGYGSVY+A+LP+G VVALKKLH E +E L+SF NE ++LS+IRHRNIVKL G+
Sbjct: 559 IGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGY 618
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
CLH++CMFLIY YM GSL+CVL + EA+ LDW KRVNVVK + HA+ Y+HHDCTPPI+
Sbjct: 619 CLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPII 678
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCD 357
HRDISSNN+LL+S+L+AF++DFG ARLL+ DSSN+TLLAGTYGYIAPELAYTMVVTEKCD
Sbjct: 679 HRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCD 738
Query: 358 VYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTV 417
VYSFGVVALE +MGKHPGEL + S S +NI L ++LD RL P DQ++ +D++LV +
Sbjct: 739 VYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWL 798
Query: 418 AFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
A C+ S P+SRPTMQ + ++ + ++P PF+ IS+ +L E+
Sbjct: 799 ALKCIHSNPRSRPTMQHILSKLLT--QSPFLGPFNWISLCQLTALEI 843
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 244/466 (52%), Positives = 331/466 (71%), Gaps = 7/466 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
NC LR L + N L+GSIPSEI L L L+LS N+I+G I Q ++ +DLS
Sbjct: 275 NCHSLRYLSMKFNRLNGSIPSEIGGLVALRKLDLSVNNISGTIPLQFQNFNSLEYLDLSY 334
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRLVAIILPMVALL-- 119
N L G +P + +P L+ ++ +T PP + T ++ +++ + + L
Sbjct: 335 NYLEGYVPFELH-LPSLFRAFEHNKGLCGDTKFGIPPCRKRNRITIIIIVVICLCSALLI 393
Query: 120 -ALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCI 178
++IFG+L + RR+ ++++P E T+ D F+IW+YDG+I ++D+IEATEDF IKYCI
Sbjct: 394 SSIIFGVLLIWRRKTRKLQPEE-ATTTQNGDIFSIWDYDGKIAYEDIIEATEDFDIKYCI 452
Query: 179 GTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFC 238
GTGGYGSVYRA+L +GK VALKKLH E++ ++SF NE R+LS+IRHRNIVKLYGFC
Sbjct: 453 GTGGYGSVYRAKLTNGKEVALKKLHTLESQNPTYMKSFTNEVRVLSKIRHRNIVKLYGFC 512
Query: 239 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVH 298
LH++CMFL+YEYME GSL CVL + EA+ DW KRVNVVK + +ALSY+H+DC PP++H
Sbjct: 513 LHKRCMFLVYEYMERGSLHCVLSDEIEALEFDWIKRVNVVKSIANALSYMHNDCIPPLLH 572
Query: 299 RDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDV 358
RDISS N+LL+SE A V+DFG ARLL+ DSSN+TLLAGTYGY+APELAYTMVVTEKCDV
Sbjct: 573 RDISSGNILLDSEFRAVVSDFGTARLLDPDSSNQTLLAGTYGYVAPELAYTMVVTEKCDV 632
Query: 359 YSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVA 418
YSFGV+ LE++MGKHP EL++ S S +NI L+D+LDPRL+P +D ++ +++L+ +A
Sbjct: 633 YSFGVLTLEIMMGKHPRELVTILSTSSSQNIMLVDILDPRLAPHIDPEVIDNVVLIIRLA 692
Query: 419 FSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
C+ P SRPTMQ V EF P PFH IS+ + ++QE+
Sbjct: 693 LKCINLNPTSRPTMQHVCKEF--ETCTPFPIPFHAISLGQSKDQEV 736
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1238), Expect = e-133, Method: Compositional matrix adjust.
Identities = 247/463 (53%), Positives = 327/463 (70%), Gaps = 13/463 (2%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+N KL L++ NNL+SG IPS++ L+E+ Y NLSHN+++G I + R +DLS
Sbjct: 305 VNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYRWTLIDLS 364
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRLVAIILPMVALLA 120
N L G V H K EI + + T ++ + L LL+
Sbjct: 365 NNRLEGQARAPVEAFGH----NKGLCGEIKGWAR----CKKRHQITLIIVVSLSTTLLLS 416
Query: 121 L-IFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIG 179
+ I G LF +RR ++ + ET ++ K D F+IW++DG I +QD+I+ATEDF IKYCIG
Sbjct: 417 VAILGFLF-HKRRIRKNQLLETTKV-KNGDLFSIWDFDGVIAYQDIIQATEDFDIKYCIG 474
Query: 180 TGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL 239
TGGYGSVYRA+LPSGKVVALKKLH E E+ L+SF NE ++L++IRHRNIVKL+GFCL
Sbjct: 475 TGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRNIVKLHGFCL 534
Query: 240 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHR 299
H++CMFL+Y+YME GSL+C+LR + EAV LDW KRVNVVK + +ALSY+HHDC PI+HR
Sbjct: 535 HKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIHR 594
Query: 300 DISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVY 359
DISSNN+LL+S+LEAFV+DFG ARLL+ DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVY
Sbjct: 595 DISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVY 654
Query: 360 SFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAF 419
SFG+VALE +MG HPGE ++S S S +N L D+LD RLS P ++ +I L+ ++A
Sbjct: 655 SFGMVALETMMGMHPGEFITSLSSSSTQNTTLKDVLDSRLSSPKSTRVANNIALIVSLAL 714
Query: 420 SCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQ 462
CL P+ P+MQ VS++ ++ P +P IS+L+L+++
Sbjct: 715 KCLHFNPQFCPSMQEVSSKLVSTRSFP--QPISAISLLQLKDE 755
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110024|ref|XP_002333161.1| predicted protein [Populus trichocarpa] gi|222835014|gb|EEE73463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1237), Expect = e-133, Method: Compositional matrix adjust.
Identities = 253/484 (52%), Positives = 327/484 (67%), Gaps = 33/484 (6%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
L L+L NN ++GSI S + + L YL+LS+N+++G+I SQL +P + V+ NNL
Sbjct: 344 NLAFLDLSNNQINGSIASSLKNCKYLTYLDLSYNNLSGQIPSQLHNLPSLSYVNFRYNNL 403
Query: 65 SGSIPESVRK-----------------VPHLY---VYGKNFDVEIPNTSENSP---PPHH 101
SG +P + + P ++ V+ N D+ P+ S S PP
Sbjct: 404 SGFVPLQLPQPFDVSFTCDSLHGQRTNSPEIFQATVFEGNKDLH-PDFSRCSSIYSPPSK 462
Query: 102 KKIATRLVAIILPMVALLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRIT 161
+ I LP+ + + + R K +P T K D F+IWNYDGRI
Sbjct: 463 DNRIIHSIKIFLPITTISLCLLCLGCCYLSRCKATQPEATS--LKNGDLFSIWNYDGRIA 520
Query: 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEAR 221
++D+I ATE+F ++YCIG+GGYGSVYRA+LPSGK+VALKKLH E EE A +S NE
Sbjct: 521 YEDIIAATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSLKNEVE 580
Query: 222 LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM 281
LL+QIRHR+IVKLYGFCLH++CMFL+YEYME GSLFC LR D AV L W KR +++K +
Sbjct: 581 LLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDI 640
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
HALSYLHHDC PPIVHRDISS+NVLLNSE ++FVADFGVARLL+ DSSN T+LAGTYGY
Sbjct: 641 AHALSYLHHDCNPPIVHRDISSSNVLLNSEFKSFVADFGVARLLDPDSSNHTVLAGTYGY 700
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
IAPELAYTM VTEKCDVYSFGVVALE LMG+HPG++LSSS+ + I L ++LDPRL P
Sbjct: 701 IAPELAYTMAVTEKCDVYSFGVVALETLMGRHPGDILSSSAQA----ITLKEVLDPRLPP 756
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRN 461
P ++ + Q+I ++++ FSCL S PK RP+M+ VS EF++ + EIS LELRN
Sbjct: 757 PTNEIVIQNICTIASLIFSCLHSNPKYRPSMKFVSQEFLSPKRLLGGL---EISFLELRN 813
Query: 462 QEMY 465
M+
Sbjct: 814 LGMH 817
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-133, Method: Compositional matrix adjust.
Identities = 252/484 (52%), Positives = 338/484 (69%), Gaps = 26/484 (5%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S L L L NN ++G IP +I L++L L+LS NSI+GKI SQ+ + R++ ++LS N
Sbjct: 243 SNLISLCLNNNQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQNLKRLENLNLSRNK 302
Query: 64 LSGSIPESVR---KVPHLYVYGKNFDVEIPNTSE-NSPP----------------PHHKK 103
LSG+IP S+ K + + + + IP + SPP PH KK
Sbjct: 303 LSGAIPPSLTYDYKWTSIDLSYNDLEGHIPFELQFESPPGVFEHNKHLCGEIRHWPHCKK 362
Query: 104 IATRLVAIILPMVALLALIFG----ILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGR 159
+ +++ ++A L + F +L R+ R R A E T+ D F++W+YDG
Sbjct: 363 GQKITLILVISLLATLCIAFAFLKFLLLPRKMRKMRHMSASAAE-TRRGDLFSVWDYDGT 421
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNE 219
I +QD+I++TE+F IKYC+G GGYGSVYRA+LP GKVVALKKLH E EE L+SF NE
Sbjct: 422 IAYQDIIQSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENE 481
Query: 220 ARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK 279
A++LS+IRHRNIVKL+GFCLHR+ MFL+Y++ME GSLFC+L + EA+ LDW KR+NVVK
Sbjct: 482 AQILSKIRHRNIVKLHGFCLHRRSMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVK 541
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ HALSY+HHDC+PPI+HRDISSNNVLLNS+LEAFV+DFG ARLL+ DSS +TLL GTY
Sbjct: 542 SIAHALSYMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTY 601
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399
GYIAPELAYTM VT+KCDVYSFGVVALE +MGKHP E+++S S S ++I L D+LDPRL
Sbjct: 602 GYIAPELAYTMTVTKKCDVYSFGVVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRL 661
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILEL 459
+ P + ++ +DI+ V +A C+ S P+SRPTMQ +S + + P + PF+ IS+ L
Sbjct: 662 ALPENPQVAKDIVFVVLLALKCIHSNPQSRPTMQQISYKLLGDIPFP-KLPFYAISLYGL 720
Query: 460 RNQE 463
++E
Sbjct: 721 NHEE 724
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108669|ref|XP_002333361.1| predicted protein [Populus trichocarpa] gi|222836312|gb|EEE74733.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-133, Method: Compositional matrix adjust.
Identities = 252/481 (52%), Positives = 331/481 (68%), Gaps = 28/481 (5%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ LR+L L NN ++G IPS + L L+LS N+++ +I S+L ++P + V+ S NN
Sbjct: 330 TSLRLLFLSNNQINGPIPSSLKYCNNLTSLDLSFNNLSEEIPSKLYDLPSLQYVNFSYNN 389
Query: 64 LSGSIPESVRKVPHLYV------YGK--NFDVEIPNTS-----------ENSPPPHHKKI 104
LSG +P ++ Y+ +G+ N V T+ N P
Sbjct: 390 LSGPVPLNLPPPFDFYLTCDLPLHGQITNDSVTFKATAFEGNKDLHPDLSNCTLPSKTNR 449
Query: 105 ATRLVAIILPMVALLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQD 164
+ I LP+ + + + R K +P T K D F+IWNYDGRI ++D
Sbjct: 450 MIHSIKIFLPISTISLCLLCLGCCYLSRCKATQPEPTS--LKNGDLFSIWNYDGRIAYED 507
Query: 165 MIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLS 224
+I ATE+F ++YCIG+GGYGSVYRA+LPSGK+VALKKLH E EE A +SF NE LL+
Sbjct: 508 IIAATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLT 567
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
QIRHR+IV+LYGFCLH++CMFL+YEYME GSLFC LR D EAV L W KR +++K + HA
Sbjct: 568 QIRHRSIVRLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVEAVELKWMKRAHIIKDIAHA 627
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
LSYLHH+C PPIVHRDISS+NVLLNSE ++FVADFGVARLL+ DSSN T+LAGTYGYIAP
Sbjct: 628 LSYLHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAP 687
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
ELAYTMVVTEKCDVYSFGVVALE LMGKHPG++LSSS+ ++ L ++LDPRL PP +
Sbjct: 688 ELAYTMVVTEKCDVYSFGVVALETLMGKHPGDILSSSARAM----TLKEVLDPRLPPPTN 743
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
+ + Q+I +++++AFSCL S PKSRP+M+ VS EF++ + EIS+LELRN +
Sbjct: 744 EIVIQNICIIASLAFSCLHSNPKSRPSMKFVSQEFLSPKRLLGGL---EISLLELRNLGL 800
Query: 465 Y 465
+
Sbjct: 801 H 801
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.923 | 0.413 | 0.434 | 7.8e-94 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.905 | 0.378 | 0.435 | 2.5e-88 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.589 | 0.245 | 0.432 | 1.8e-72 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.897 | 0.381 | 0.370 | 4.3e-65 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.675 | 0.253 | 0.357 | 2.6e-63 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.897 | 0.381 | 0.356 | 1.3e-61 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.760 | 0.358 | 0.416 | 4.7e-61 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.893 | 0.432 | 0.368 | 7.1e-61 | |
| TAIR|locus:2024432 | 977 | LRR XI-23 [Arabidopsis thalian | 0.899 | 0.430 | 0.338 | 1.3e-59 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.905 | 0.418 | 0.345 | 2.7e-59 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
Identities = 196/451 (43%), Positives = 286/451 (63%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S+L++L+L N L G I S+ LQ L L+LSHN+++G+I ++ + VD+S NN
Sbjct: 598 SQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNN 657
Query: 64 LSGSIPESV--RKVPHLYVYGKNFDVEIPNTSENSPP-------PHHKKIATRLVAIILP 114
L G IP++ R P G NT++ P HK ++ I++P
Sbjct: 658 LQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKD-RNLIIYILVP 716
Query: 115 MVA---LLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATED 171
++ +L++ GI R+R K++E E + +I+++DG++ +Q++I+AT +
Sbjct: 717 IIGAIIILSVCAGIFICFRKRTKQIEEHTDSE--SGGETLSIFSFDGKVRYQEIIKATGE 774
Query: 172 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS---LESFGNEARLLSQIRH 228
F KY IGTGG+G VY+A+LP+ ++A+KKL+ + +++ + F NE R L++IRH
Sbjct: 775 FDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRH 833
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
RN+VKL+GFC HR+ FL+YEYME GSL VL D+EA LDW KR+NVVKG+ HALSY+
Sbjct: 834 RNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYM 893
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
HHD +P IVHRDISS N+LL + EA ++DFG A+LL DSSN + +AGTYGY+APELAY
Sbjct: 894 HHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAY 953
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSXXXXXXXXXXXXPRLSPPVDQKIR 408
M VTEKCDVYSFGV+ LEV+ G+HPG+L+S+ S S P +I+
Sbjct: 954 AMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIK 1013
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
++++ + VA CL S P++RPTM +S F
Sbjct: 1014 EEVLEILKVALLCLHSDPQARPTMLSISTAF 1044
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
Identities = 198/455 (43%), Positives = 285/455 (62%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
++L L+L +N L G IPS+++ LQ L+ L+LSHN+++G I + + + VD+S N
Sbjct: 677 TQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNK 736
Query: 64 LSGSIPES--VRKVPHLYVYGKNFDV--EIPNTSENSPPPHH----KKIATRLVAIILPM 115
L G +P++ RK +N + IP + P KK +V I++P+
Sbjct: 737 LEGPLPDTPTFRKAT-ADALEENIGLCSNIPK--QRLKPCRELKKPKKNGNLVVWILVPI 793
Query: 116 VALLAL--IFGILF---VRRRR---DKRVEPAETGEITKCADEFAIWNYDGRITFQDMIE 167
+ +L + I F +R+R+ + +P ETGE +I++ DG+ +QD+IE
Sbjct: 794 LGVLVILSICANTFTYCIRKRKLQNGRNTDP-ETGE------NMSIFSVDGKFKYQDIIE 846
Query: 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS---LESFGNEARLLS 224
+T +F + IGTGGY VYRA L ++A+K+LH + EE++ + F NE + L+
Sbjct: 847 STNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALT 905
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+IRHRN+VKL+GFC HR+ FLIYEYME GSL +L DEEA L W KR+NVVKG+ HA
Sbjct: 906 EIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHA 965
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
LSY+HHD PIVHRDISS N+LL+++ A ++DFG A+LL DSSN + +AGTYGY+AP
Sbjct: 966 LSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP 1025
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSXXXXXXXXXXXXPRLSPPVD 404
E AYTM VTEKCDVYSFGV+ LE+++GKHPG+L+SS S S R+ P
Sbjct: 1026 EFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRG 1085
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
Q R+ ++ + +A CL++ P+SRPTM +S F
Sbjct: 1086 QN-REKLLKMVEMALLCLQANPESRPTMLSISTTF 1119
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 1.8e-72, Sum P(2) = 1.8e-72
Identities = 126/291 (43%), Positives = 173/291 (59%)
Query: 159 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL--HRSETEELASL--E 214
R T +D++EAT+ FH Y +G G G+VY+A +PSGK +A+KKL +R ++
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 215 SFGNEARLLSQIRHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 272
SF E L +IRHRNIV+LY FC H+ L+YEYM GSL +L + +DW
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSH-SMDWP 924
Query: 273 KRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSN 331
R + G L+YLHHDC P I+HRDI SNN+L++ EA V DFG+A++++ S +
Sbjct: 925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984
Query: 332 RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSS----SSWSXXX 387
+ +AG+YGYIAPE AYTM VTEKCD+YSFGVV LE+L GK P + L ++W+
Sbjct: 985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044
Query: 388 XXXXXXXXX---PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
P L+ D I +I V+ +A C +S P RPTM+ V
Sbjct: 1045 IRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 4.3e-65, P = 4.3e-65
Identities = 167/451 (37%), Positives = 244/451 (54%)
Query: 9 LELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI 68
L + +N LSG+IP + LQ L L L+ N ++G+I + +G + + ++S NNL G++
Sbjct: 625 LNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTV 684
Query: 69 PESV--RKVPHLYVYGKNFDVEIPNTSENSP-PPH-------------HKKIATRLVAII 112
P++ +++ G N + S P PH +KI T + I+
Sbjct: 685 PDTAVFQRMDSSNFAG-NHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILT-ITCIV 742
Query: 113 LPMVALLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDF 172
+ V L+ + G+ + +RR+ E D + + G T+Q +++AT +F
Sbjct: 743 IGSVFLITFL-GLCWTIKRREPAFVALEDQTKPDVMDSY-YFPKKG-FTYQGLVDATRNF 799
Query: 173 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G G G+VY+A + G+V+A+KKL+ S E +S SF E L +IRHRNIV
Sbjct: 800 SEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIV 858
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
KLYGFC H+ L+YEYM GSL L+ E+ LDW R + G L YLHHDC
Sbjct: 859 KLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDC 918
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMV 351
P IVHRDI SNN+LL+ +A V DFG+A+L++ S + + +AG+YGYIAPE AYTM
Sbjct: 919 RPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMK 978
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSS----SW---SXXXXXXXXXXXXPRLSPPVD 404
VTEKCD+YSFGVV LE++ GK P + L +W S RL D
Sbjct: 979 VTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-D 1037
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
++ ++ LV +A C + P SRPTM+ V
Sbjct: 1038 KRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 2.6e-63, Sum P(2) = 2.6e-63
Identities = 124/347 (35%), Positives = 191/347 (55%)
Query: 113 LPMVALLALIFGILFVRRRRD--KRVEPAETGEITKCADEFAIWN---YDGR----ITFQ 163
L + L+ L+ LF ++R D K+V T + + A +G I ++
Sbjct: 884 LTAIGLMILVIA-LFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942
Query: 164 DMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLL 223
D++EAT + ++ IG+GG G VY+A L +G+ VA+KK+ + +L S +SF E + L
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD--DLMSNKSFSREVKTL 1000
Query: 224 SQIRHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVN 276
+IRHR++VKL G+C + LIYEYM+ GS++ L D+ + LDW R+
Sbjct: 1001 GRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLR 1060
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDSS--NR 332
+ G+ + YLHHDC PPIVHRDI S+NVLL+S +EA + DFG+A++L N D++ +
Sbjct: 1061 IAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSN 1120
Query: 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP-----GELLSSSSWSXXX 387
T A +YGYIAPE AY++ TEK DVYS G+V +E++ GK P G + W
Sbjct: 1121 TWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETH 1180
Query: 388 XXXXXXXXXPRLSPPVDQKI--RQDIIL-VSTVAFSCLRSQPKSRPT 431
+ P + + +D V +A C ++ P+ RP+
Sbjct: 1181 LEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPS 1227
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 161/451 (35%), Positives = 244/451 (54%)
Query: 9 LELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI 68
L L N L+G IP E++ L L +L L++N+++G+I S + + + S N+L+G I
Sbjct: 631 LNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPI 690
Query: 69 PESVRKVPHLYVYGK--------NFDVEI----PNTSENSPPPHHKKIATRLVAIILPMV 116
P +R + G N ++ P+ S P + A ++ V
Sbjct: 691 P-LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGV 749
Query: 117 ALLALIFGILFVRRRRDKRV-EPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIK 175
+L+ LI I+++ RR + V A+ G+ ++ + + +G TFQD++ AT++F
Sbjct: 750 SLM-LIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDES 807
Query: 176 YCIGTGGYGSVYRARLPSGKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIV 232
+ +G G G+VY+A LP+G +A+KKL H SF E L IRHRNIV
Sbjct: 808 FVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVD-NSFRAEILTLGNIRHRNIV 866
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
KL+GFC H+ L+YEYM GSL +L + + LDW+KR + G L+YLHHDC
Sbjct: 867 KLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDC 924
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTMV 351
P I HRDI SNN+LL+ + EA V DFG+A++++ S + + +AG+YGYIAPE AYTM
Sbjct: 925 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMK 984
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSS----SWSXXXXXXXXXXXX---PRLSPPVD 404
VTEK D+YS+GVV LE+L GK P + + +W RL+ D
Sbjct: 985 VTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE-D 1043
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
++I ++ V +A C P +RP+M+ V
Sbjct: 1044 ERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 4.7e-61, Sum P(2) = 4.7e-61
Identities = 169/406 (41%), Positives = 235/406 (57%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L +E+ N+L G IPS ++ EL LNLS+N + G I +LG++P ++ +DLS N L+
Sbjct: 509 LERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLT 568
Query: 66 GSIP-ESVR-KVPHLYV-----YGK---NFDVEI--------PNT-SENSPP--PHHKKI 104
G IP E +R K+ V YGK F +I PN + N P P K
Sbjct: 569 GEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKR 628
Query: 105 ATRLVA--IILPMVALL-ALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRIT 161
TR + IL +VAL AL++ LF++ + + +P T +IT I+ G T
Sbjct: 629 ETRYILPISILCIVALTGALVW--LFIKTKPLFKRKPKRTNKIT-------IFQRVG-FT 678
Query: 162 FQDMI-EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES-FGNE 219
+D+ + TED +I IG+GG G VYR +L SG+ +A+KKL ET + ES F +E
Sbjct: 679 EEDIYPQLTED-NI---IGSGGSGLVYRVKLKSGQTLAVKKLW-GETGQKTESESVFRSE 733
Query: 220 ARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--AVG-LDWAKRVN 276
L ++RH NIVKL C + FL+YE+ME GSL VL +++E AV LDW R +
Sbjct: 734 VETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFS 793
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN----- 331
+ G LSYLHHD PPIVHRD+ SNN+LL+ E++ VADFG+A+ L + ++
Sbjct: 794 IAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDV 853
Query: 332 -RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGE 376
+ +AG+YGYIAPE YT V EK DVYSFGVV LE++ GK P +
Sbjct: 854 SMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPND 899
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 7.1e-61, P = 7.1e-61
Identities = 169/458 (36%), Positives = 241/458 (52%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEI-PRIDTVDLSMNN 63
KL +L L N L SIP ++ L+ LN L+LS N + G+I L E+ P +++ S N
Sbjct: 485 KLNLLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENLSELLPT--SINFSSNR 542
Query: 64 LSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSP---P----PHHKKIATRLVAIILPMV 116
LSG IP S+ + + + N ++ IP T+ +S P PH KK + + AI+ V
Sbjct: 543 LSGPIPVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAIL---V 599
Query: 117 ALLALIFGIL--FVRRRRDKRVEPAETGEITKCADEFAIWNYD----GRITFQDMIEATE 170
++ L+ G++ ++R+R K E E A F ++YD RI+F D E E
Sbjct: 600 SVFILVLGVIMFYLRQRMSKNRAVIEQDETL--ASSF--FSYDVKSFHRISF-DQREILE 654
Query: 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFG------NEARLLS 224
K +G GG G+VYR L SG+VVA+KKL ++ AS + E L
Sbjct: 655 SLVDKNIVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASEDKMHLNKELKTEVETLG 714
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
IRH+NIVKL+ + C L+YEYM G+L+ L + V L+W R + G+
Sbjct: 715 SIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALH--KGFVHLEWRTRHQIAVGVAQG 772
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF--DSSNRTLLAGTYGYI 342
L+YLHHD +PPI+HRDI S N+LL+ + VADFG+A++L S T++AGTYGY+
Sbjct: 773 LAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMAGTYGYL 832
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP-----GELLSSSSWSXXXXXXXXXXXXP 397
APE AY+ T KCDVYSFGVV +E++ GK P GE + +W
Sbjct: 833 APEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIVNW-VSTKIDTKEGLIE 891
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
L + + + D+I VA C P RPTM V
Sbjct: 892 TLDKRLSESSKADMINALRVAIRCTSRTPTIRPTMNEV 929
|
|
| TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 1.3e-59, Sum P(2) = 1.3e-59
Identities = 155/458 (33%), Positives = 231/458 (50%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+CS L + + N +SG IP + L LN LNLS N ++G+I L + R+ +DLS
Sbjct: 504 SCSMLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSL-RLSLLDLSN 562
Query: 62 NNLSGSIPESVRKVPHLYVYGKNF---DVEIPNTSENSPPPHHKKIATRLVAIILPMVAL 118
N LSG IP S+ + ++ N N P H ++ I+ ++ L
Sbjct: 563 NRLSGRIPLSLSSYNGSFNGNPGLCSTTIKSFNRCIN-PSRSHGDTRVFVLCIVFGLLIL 621
Query: 119 LALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGR-ITFQDMIEATEDFHIKYC 177
LA + L++ K+ E E G K + ++I ++ T D+I++ ++ ++
Sbjct: 622 LASLVFFLYL-----KKTEKKE-GRSLK-HESWSIKSFRKMSFTEDDIIDSIKEENL--- 671
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEE--------LASLES----FGNEARLLSQ 225
IG GG G VYR L GK VA+K + S T++ L E F E + LS
Sbjct: 672 IGRGGCGDVYRVVLGDGKEVAVKHIRCSSTQKNFSSAMPILTEREGRSKEFETEVQTLSS 731
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
IRH N+VKLY L+YEY+ GSL+ +L + +++ L W R ++ G L
Sbjct: 732 IRHLNVVKLYCSITSDDSSLLVYEYLPNGSLWDMLHSCKKS-NLGWETRYDIALGAAKGL 790
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDSSNRTLLAGTYGYI 342
YLHH P++HRD+ S+N+LL+ L+ +ADFG+A++L N + ++AGTYGYI
Sbjct: 791 EYLHHGYERPVIHRDVKSSNILLDEFLKPRIADFGLAKILQASNGGPESTHVVAGTYGYI 850
Query: 343 AP-ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSXXXXXXXXXXXXPRLSP 401
AP E Y VTEKCDVYSFGVV +E++ GK P E S +
Sbjct: 851 APAEYGYASKVTEKCDVYSFGVVLMELVTGKKPIEAEFGESKDIVNWVSNNLKSKESVME 910
Query: 402 PVDQKI----RQDIILVSTVAFSCLRSQPKSRPTMQLV 435
VD+KI R+D + + +A C P RPTM+ V
Sbjct: 911 IVDKKIGEMYREDAVKMLRIAIICTARLPGLRPTMRSV 948
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 2.7e-59, P = 2.7e-59
Identities = 158/457 (34%), Positives = 249/457 (54%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+C KL L L NN L+G IP +I + L L+LS+NS+ G + +G P ++ +++S
Sbjct: 522 SCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSY 581
Query: 62 NNLSGSIPES--VRKVPHLYVYGKN--FDVEIPNTS--ENSPPPHHKKIATRLVA-IILP 114
N L+G +P + ++ + + G + +P S + + H R+VA ++
Sbjct: 582 NKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIG 641
Query: 115 MVALLALIFGILFVRRRR--DKRVEPAETGEITKCADEFAIWNYDG--RITF--QDMIEA 168
+ ++LAL GIL + R K G+ T E+ W R+ F D++
Sbjct: 642 IASVLAL--GILTIVTRTLYKKWYSNGFCGDETASKGEWP-WRLMAFHRLGFTASDILAC 698
Query: 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETE-ELASLESFGNEARLLSQI 226
++ ++ IG G G VY+A + S V+A+KKL RS + E + F E LL ++
Sbjct: 699 IKESNM---IGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKL 755
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG---LDWAKRVNVVKGMCH 283
RHRNIV+L GF + K M ++YE+M G+L + + A G +DW R N+ G+ H
Sbjct: 756 RHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIH-GKNAAGRLLVDWVSRYNIALGVAH 814
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
L+YLHHDC PP++HRDI SNN+LL++ L+A +ADFG+AR++ +++AG+YGYIA
Sbjct: 815 GLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIA 874
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHP-----GELLSSSSWSXXXXXXXXXXXXPR 398
PE YT+ V EK D+YS+GVV LE+L G+ P GE + W
Sbjct: 875 PEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEW-VRRKIRDNISLEEA 933
Query: 399 LSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
L P V + ++++++LV +A C PK RP+M+
Sbjct: 934 LDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMR 970
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-49
Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 23/273 (8%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ I +G G +G VY AR +GK+VA+K + + + ++ E E ++L +++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
IV+LY ++L+ EY E G LF +L+ + D A+ ++ + AL YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF--YLRQILSALEYLHS 115
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
IVHRD+ N+LL+ + +ADFG+AR L+ T GT Y+APE+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGK 171
Query: 351 VVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+ D++S GV+ E+L GK P G+ L + K I P PP
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD------QLLELFKKIGKPKPPFPPPEWDISP 225
Query: 409 QDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
+ L+ L P+ R T + + + F
Sbjct: 226 EAKDLIR----KLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 15/272 (5%)
Query: 172 FHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ + +G+G +G+VY+A+ GK+VA+K L + + ++ E R+L ++ H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
IV+L + ++L+ EY E G LF L L + + + L YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYT 349
+ I+HRD+ N+LL+ +ADFG+A+ L SS+ T GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409
K DV+S GV+ E+L GK P S LD+ + +L P L +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEFDEPKWSSG 229
Query: 410 DIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
+ CL P RPT +++ + +
Sbjct: 230 SEEAKDLIK-KCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 9e-47
Identities = 70/193 (36%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G+VY AR +GK VA+K + + ++ L LE E +L ++ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
++L+ EY E GSL +L+ E L + + ++ + L YLH + I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 297 VHRDISSNNVLLNS-ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTE 354
+HRD+ N+LL+S + +ADFG+++LL D S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 355 KCDVYSFGVVALE 367
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 85/278 (30%), Positives = 129/278 (46%), Gaps = 34/278 (12%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
F I IG GG+G VY+AR +GK VA+K + E E NE ++L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
NIVK YG L + ++++ E+ GSL E + V K +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKG 110
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L YLH + I+HRDI + N+LL S+ E + DFG++ L+ D+ R + GT ++AP
Sbjct: 111 LEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAP 166
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP-GELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
E+ K D++S G+ A+E+ GK P EL K + I PP
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKI----ATNGPPG 216
Query: 404 DQKIRQ-DIILVSTVAFSCLRSQPKSRPTM-QLVSNEF 439
+ + + CL+ P+ RPT QL+ + F
Sbjct: 217 LRNPEKWSDEFKDFLK-KCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 41/275 (14%)
Query: 178 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G G +G VY+ L + VA+K L +EE E F EA ++ ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HD 291
+L G C + ++++ EYM G L LR E + L + + + + YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKN 122
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APEL 346
VHRD+++ N L+ L ++DFG++R + D R G + APE
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPES 175
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD--PRLSPPVD 404
T K DV+SFGV+ E+ L + N ++++LL+ RL P +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT-------LGEQPYPGMSNEEVLELLEDGYRLPRPEN 228
Query: 405 --QKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVS 436
++ +++L C P+ RPT +LV
Sbjct: 229 CPDEL-YELML------QCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-41
Identities = 133/476 (27%), Positives = 223/476 (46%), Gaps = 78/476 (16%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ S+L L+L N LSG IP E++ ++L L+LSHN ++G+I + E+P + +DLS
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 61 MNNLSGSIP------ESVRKV--PHLYVYGK-----------------NFDVEIPNTSEN 95
N LSG IP ES+ +V H +++G N D+ +T+
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615
Query: 96 SPPPHH-KKIATRLVAIILPMVALLALI---FGILFVRRRRD---KRVEPAETGEITKCA 148
PP +K + I + A L L FG +F+R R + KRVE
Sbjct: 616 LPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE----------- 664
Query: 149 DEFAIWN---YDGR----ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKK 201
+E W +D + IT D++ + ++ ++ I G G+ Y+ + + + K
Sbjct: 665 NEDGTWELQFFDSKVSKSITINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVK 721
Query: 202 LHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR 261
E ++ S+ S +E + +++H NIVKL G C K +LI+EY+E +L VLR
Sbjct: 722 ----EINDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775
Query: 262 TDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321
L W +R + G+ AL +LH C+P +V ++S ++++ + E + +
Sbjct: 776 ------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828
Query: 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS 381
LL D+ A Y+APE T +TEK D+Y FG++ +E+L GK P +
Sbjct: 829 PGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 382 SWSLDK-------NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP 430
S+ + + L +DP + V + I+ V +A C + P +RP
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE-IVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 4e-41
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 38/278 (13%)
Query: 177 CIGTGGYGSVYRARLP-SGKVVALKK--LHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +GSVY A +G+++A+K L EEL +LE E R+LS ++H NIV+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE---REIRILSSLQHPNIVR 63
Query: 234 LYGFCLHR-KCMFLIY-EYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYL 288
YG K I+ EY+ GSL +L+ E V + +++ ++G L+YL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEG----LAYL 117
Query: 289 H-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDSSNRTLLAGTYGYIAPE 345
H + IVHRDI N+L++S+ +ADFG A+ L + GT ++APE
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--NIKLIDLLDPRLSPPV 403
+ D++S G +E+ GK P L + +L K + + LS
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
+D + CLR PK RPT +L+ + F+
Sbjct: 234 -----KDFLR------KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 178 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G G +G VY+ L VA+K L +E+ +E F EAR++ ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIV 64
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
KL G C + + ++ EYM G L LR + L + ++ + + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK- 122
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMV 351
+HRD+++ N L+ L ++DFG++R L D + ++APE
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 352 VTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVD--QK 406
T K DV+SFGV+ E+ +G+ P + N ++++ L RL P + +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP--------YPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ + + C P+ RPT
Sbjct: 233 LYK-------LMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-40
Identities = 73/265 (27%), Positives = 122/265 (46%), Gaps = 29/265 (10%)
Query: 178 IGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G G +G VY+ +L GK VA+K L +E+ +E F EAR++ ++ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
KL G C + ++++ EYME G L LR + L + ++ + + YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLESK- 121
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTMV 351
+HRD+++ N L+ L ++DFG++R L D R ++APE
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 352 VTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVDQKIR 408
T K DV+SFGV+ E+ +G+ P + N ++++ L RL P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEEVLEYLKNGYRLPQP--PNCP 229
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQ 433
++ + C P+ RPT
Sbjct: 230 PELY---DLMLQCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
D +G G G VY+ R P+GK+ ALKK+H EE E + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCES 58
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHA 284
+VK YG + ++ EYM+ GSL +L+ E + + + +
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKG 111
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L YLH I+HRDI +N+L+NS+ E +ADFG++++L GT Y++P
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
Query: 345 EL----AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL----- 395
E +Y+ D++S G+ LE +GK P S+ +L+
Sbjct: 170 ERIQGESYSY----AADIWSLGLTLLECALGKFPFLPPGQPSF--------FELMQAICD 217
Query: 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
P S P ++ + +S CL+ PK RP+ +L+ + FI
Sbjct: 218 GPPPSLPAEEFSPEFRDFISA----CLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 41/281 (14%)
Query: 178 IGTGGYGSVYRARL---PSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G VY+ +L VA+K L +EE + F EAR++ ++ H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNVVKGMCHALSY 287
L G C + ++L+ EYME G L LR E L ++ + + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---AP 344
L VHRD+++ N L+ +L ++DFG++R + +D G I AP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAP 176
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVL-MGKHP-GELLSSSSWSLDKNIKLIDLL--DPRLS 400
E + T K DV+SFGV+ E+ +G P L N ++++ L RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---------SNEEVLEYLRKGYRLP 227
Query: 401 PP--VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
P ++ + + SC + P+ RPT +
Sbjct: 228 KPEYCPDELYE-------LMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 1e-34
Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 18/284 (6%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-R 229
+ I +G G +G VY AR K+VALK L + + +E F E ++L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NIVKLY F ++L+ EY++ GSL +L+ L ++ + ++ + AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFV-ADFGVARLLNFDSSNRTLLA------GTYGYI 342
I+HRDI N+LL+ + DFG+A+LL S ++ A GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 343 APELAYTMV---VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399
APE+ + + D++S G+ E+L G P E +SS + +++L P L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 400 SPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPTM-QLVSNEFIA 441
+ P+ + I S + L PK+R + +S++ +A
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 35/286 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
E F + CIG G +G VY+A + +VVA+K + E E+ +E E + LSQ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRS 58
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNVVKGMCHAL 285
I K YG L +++I EY GS +L+ DE + +++ + L
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGL 111
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
YLH + +HRDI + N+LL+ E + +ADFGV+ L S R GT ++APE
Sbjct: 112 EYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--KNIKLIDLLDPRLSPPV 403
+ EK D++S G+ A+E+ G+ P LS L + + LI P+ +PP
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP---LSD----LHPMRVLFLI----PKNNPP- 216
Query: 404 DQKIRQDIILVSTVAF--SCLRSQPKSRPTM-QLVSNEFIARNKAP 446
+ + F CL PK RP+ +L+ ++FI + K
Sbjct: 217 --SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 3e-32
Identities = 84/289 (29%), Positives = 132/289 (45%), Gaps = 50/289 (17%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLSQI 226
+ I IG G +G VY R GK+ LK++ + SE E +L NE ++L ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKL 56
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNVV 278
H NI+K Y + + ++ EY + G L ++ EE + LDW V
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDW-----FV 110
Query: 279 KGMCHALSYLH--HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
+ +C AL YLH I+HRDI N+ L S + DFG++++L+ +
Sbjct: 111 Q-LCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 337 GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392
GT Y++PEL Y K D++S G V E+ KHP E + L I +
Sbjct: 165 GTPYYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFE--GENLLELALKI--L 216
Query: 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
P + ++R LVS S L+ P+ RP++ Q++ + FI
Sbjct: 217 KGQYPPIPSQYSSELRN---LVS----SLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-32
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ + IG G +G VY+ L +G VA+K++ + +E +L+S E LL ++H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHP 59
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHAL 285
NIVK G +++I EY E GSL +++ E V V + L
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGL 112
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+YLH ++HRDI + N+L + +ADFGVA LN S + + GT ++APE
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ + D++S G +E+L G P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 40/277 (14%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLH-RSETEELASLESFGNEARLLSQIRHRNIVKLY 235
IG G G VY+A +GK VA+KK+ R + +EL NE ++ +H NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI-----INEILIMKDCKHPNIVDYY 81
Query: 236 GFCLHRKCMFLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
L ++++ EYM+ GSL +R +E + V + + L YLH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLH- 133
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
+ ++HRDI S+N+LL+ + +ADFG A L + S R + GT ++APE+
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 351 VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD----KNIKLIDLLDPRLSPPVDQK 406
K D++S G++ +E+ G+ P L + + LI PP+
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP---------YLREPPLRALFLITTKGI---PPLKNP 239
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTMQ-LVSNEFIAR 442
+ + CL P+ RP+ + L+ + F+ +
Sbjct: 240 EKWSPEFKDFLNK-CLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
DF I IG G +G V++ R +V A+K++ S+ E+ +EAR+L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNVVKGMCH 283
I++ Y L + + ++ EY E G L +L+ E+ V W + ++ G
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLG--- 113
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
L++LH + I+HRDI S N+ L++ + D GVA+LL+ +++ + GT Y++
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
PEL EK DV++ GVV E GKHP + + LI + + PPV
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHP--------FDANNQGALILKIIRGVFPPV 221
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRP-TMQLVSN 437
Q Q + + CL + RP T QL+ N
Sbjct: 222 SQMYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 45/279 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLH-RSETEELASLESFGNEARLLSQIRH---RNIV 232
IG G YG+VYR + +P+G+VVALK ++ + ++++ ++ E LLSQ+R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQPPNIT 65
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNVVKGMCHALSYLH 289
K YG L +++I EY E GS+ +++ E+ + + +++ + AL Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIH 118
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349
++HRDI + N+L+ + + DFGVA LLN +SS R+ GT ++APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE---- 171
Query: 350 MVVTE------KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI-DLLDPRLSPP 402
V+TE K D++S G+ E+ G P S + + LI PRL
Sbjct: 172 -VITEGKYYDTKADIWSLGITIYEMATGNPP-----YSDVDAFRAMMLIPKSKPPRLEDN 225
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSR-PTMQLVSNEFI 440
K+ ++ + +CL +PK R +L+ +++I
Sbjct: 226 GYSKLLREFVA------ACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 47/291 (16%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLH-----RSETEELASLESFGNEARLLS 224
D+ + IG G +G+V + R GK++ K++ E ++L +E +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV------SEVNILR 54
Query: 225 QIRHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVL--------RTDEEAVGLDWAKR 274
+++H NIV+ Y + R + ++++ EY E G L ++ +EE + W
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W--- 108
Query: 275 VNVVKGMCHALSYLHH--DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332
++ + AL H+ D ++HRD+ N+ L++ + DFG+A++L DSS
Sbjct: 109 -RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK-- 390
GT Y++PE M EK D++S G + E+ P + + L IK
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT--ARNQLQLASKIKEG 225
Query: 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFI 440
+ R S +++ I+ S L P RP T +L+ I
Sbjct: 226 KFRRIPYRYSSELNEVIK-----------SMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-29
Identities = 86/270 (31%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 178 IGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
IG G +G V R RL P K VA+K L +++ F EA ++ Q H NI++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
L G + + +I EYME GSL LR ++ + V +++G+ + YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG--YIAPE-LAYTM 350
VHRD+++ N+L+NS L V+DFG++R L + T G + APE +AY
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR- 183
Query: 351 VVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD--QKI 407
T DV+SFG+V EV+ G+ P S IK ++ RL PP+D +
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYW-----DMSNQDVIKAVE-DGYRLPPPMDCPSAL 237
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTM-QLVS 436
Q + C + RPT Q+VS
Sbjct: 238 YQ-------LMLDCWQKDRNERPTFSQIVS 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 47/286 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
E F I +G G YGSVY+A +G+VVA+K + E+L + E +L Q
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEII---KEISILKQCDS 57
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMCH 283
IVK YG ++++ EY GS+ +++ EE + ++
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLK 110
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
L YLH + +HRDI + N+LLN E +A +ADFGV+ L + R + GT ++A
Sbjct: 111 GLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 344 PELAYTMVVTE-----KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398
PE V+ E K D++S G+ A+E+ GK P + + I +I P
Sbjct: 168 PE-----VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----RAIFMI----PN 213
Query: 399 LSPP---VDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
PP +K + V CL P+ RP+ +QL+ + FI
Sbjct: 214 KPPPTLSDPEKWSPE--FNDFVK-KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 27/265 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G+G +G V+ + VA+K + E S + F EA+++ ++ H N+V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
C ++ +F++ EYM G L LR + +G +W +++ +C A+ YL + +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLL---NFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
HRD+++ N L+ + V+DFG+AR + + SS T + PE+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA--PPEVFDYSRFSS 180
Query: 355 KCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413
K DV+SFGV+ EV GK P E S+S ++ L P+L+P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAPTE---------- 229
Query: 414 VSTVAFSCLRSQPKSRPT-MQLVSN 437
V T+ +SC +P+ RP +L+S
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 26/216 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED+ + IG+G YG VY+AR + +G++VA+K + ++ ++ E +L + RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRH 59
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSL---FCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
NIV +G L R ++++ EY GSL + V R + + + R +KG L
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG----L 114
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+YLH +HRDI N+LL + + +ADFGV+ L + R GT ++APE
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171
Query: 346 LA-------YTMVVTEKCDVYSFGVVALEVLMGKHP 374
+A Y KCD+++ G+ A+E+ + P
Sbjct: 172 VAAVERKGGY----DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+D+ + IG G VY A LP+ + VA+K++ + + S++ E + +SQ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNH 58
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+VK Y + ++L+ Y+ GSL ++++ GLD A V+K + L YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDSSN--RTLLAGTYGYIAP 344
H + +HRDI + N+LL + +ADFGV+ L D + R GT ++AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 345 EL-----AYTMVVTEKCDVYSFGVVALEVLMGKHPG 375
E+ Y K D++SFG+ A+E+ G P
Sbjct: 176 EVMEQVHGY----DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 48/284 (16%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G VY A L +G+++A+K++ R + + +++ +E ++L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+HR+ +++ EY G+L +L DE + + + L+YLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-------YTLQLLEGLAYLH--- 116
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-------LAGTYGYIAPE 345
+ IVHRDI N+ L+ + DFG A L +N T LAGT Y+APE
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 346 LAYTMVVTEK---CDVYSFGVVALEVLMGKHPGELLSSSSWS-LDKNIKLIDLLDPRLSP 401
+ D++S G V LE+ GK P WS LD +++ + P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--------WSELDNEFQIMFHVGAGHKP 225
Query: 402 PVDQKIRQDIILVSTVAFS----CLRSQPKSRPT-MQLVSNEFI 440
P+ D + +S CL S PK RPT +L+ + F+
Sbjct: 226 PI-----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ + IG G +G V G+ VA+K L + + ++F EA +++ +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHP 60
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
N+V+L G L ++++ EYM GSL LR+ AV + A+++ +C + YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELA 347
VHRD+++ NVL++ +L A V+DFG+A+ +++ +G + APE
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171
Query: 348 YTMVVTEKCDVYSFGVVALEV 368
+ K DV+SFG++ E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G G V + P+GK++A+K + E + + E +L + IV YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFYG 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+ + + EYM+ GSL +L+ + + ++ V + L+YLH I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--I 122
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRD+ +N+L+NS + + DFGV+ L +S +T GT Y+APE + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGNDYSVKS 180
Query: 357 DVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD-------PRLSPPVDQKIRQ 409
D++S G+ +E+ G+ P + D + +LL PRL Q
Sbjct: 181 DIWSLGLSLIELATGRFP-----YPPEN-DPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234
Query: 410 DIILVSTVAFSCLRSQPKSRPTMQ-LVSNEFIAR 442
D + + CL P+ RP+ + L+ + FI +
Sbjct: 235 DFVNL------CLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G G +G V R +GK+ A+K L + + + +E E +LS+I H IVKL Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTP 294
F K ++L+ EY G LF L E + A+ + AL YLH
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLS-KEGRFSEERARFY--AAEIVLALEYLHSLG--- 113
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTM 350
I++RD+ N+LL+++ + DFG+A+ L+ + S GT Y+APE+ Y
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 351 VVTEKCDVYSFGVVALEVLMGKHP 374
V D +S GV+ E+L GK P
Sbjct: 173 AV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 34/211 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE----LASLESFGNEARLLSQIRHRNIV 232
IG G YG VY+AR +G++VALKK+ R E E+ + ++ E +LL ++RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR----EIKLLQKLRHPNIV 61
Query: 233 KLYGFCLHRKC--MFLIYEYME---MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+L + +++++EYM+ G +L + E K +K + L Y
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKCY--MKQLLEGLQY 115
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPEL 346
LH + I+HRDI +N+L+N++ +ADFG+AR +S T T Y PEL
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 347 -----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y + D++S G + E+ +GK
Sbjct: 173 LLGATRY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 36/269 (13%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIVK 233
+GTG + S Y+AR + +G ++A+K++ + +E+ +E+ E RL++++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLHH 290
+ G L E+M GS+ +L +EAV +N + + LSYLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV------IINYTEQLLRGLSYLHE 121
Query: 291 DCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTL----LAGTYGYIAPE 345
+ I+HRD+ N+L++S + +ADFG A L + L GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS----P 401
+ CDV+S G V +E+ K P W+ +K+ + L+ S P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP--------WNAEKHSNHLALIFKIASATTAP 230
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRP 430
+ + + + V CL QP+ RP
Sbjct: 231 SIPEHLSPG---LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 80/243 (32%), Positives = 123/243 (50%), Gaps = 27/243 (11%)
Query: 174 IKYCIGTGGYGSVYRARL-PSGK---VVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
I+ IG G +G V R RL GK VA+K L TE+ F +EA ++ Q H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHP 65
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NI+ L G + + +I E+ME G+L LR ++ + + V +++G+ + YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLS 123
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----AP 344
VHRD+++ N+L+NS L V+DFG++R L D+S+ T + G I AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLL--DPRLSP 401
E T DV+S+G+V EV+ G+ P W + N +I+ + D RL P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDM-SNQDVINAIEQDYRLPP 232
Query: 402 PVD 404
P+D
Sbjct: 233 PMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 42/263 (15%)
Query: 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
F + IG G +G V + + K+ A+K +++ + E S+ + NE R+L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 231 IVKL-YGFCLHRKCMFLIYEYMEMGSL-FCVLRT---DEEAVGLDWAKRVNVVKGMCHAL 285
+V L Y F + M+L+ + + G L + + + EE V W + AL
Sbjct: 62 LVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEI------VLAL 113
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
YLH + I+HRDI +N+LL+ + + DF +A + + T +GT GY+APE
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPE 169
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHP------------------GELLSSSSWSLDK 387
+ + D +S GV A E L GK P ++L ++WS +
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA 229
Query: 388 NIKLIDLL---DP--RLSPPVDQ 405
I I+ L DP RL +
Sbjct: 230 -IDAINKLLERDPQKRLGDNLKD 251
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIVK 233
IG G YG VY+AR +G++VA+KK+ SE +L E +LL ++ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HDC 292
L H+ ++L++E+M+ L+ +++ GL + + + + L++ H H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-V 351
I+HRD+ N+L+N+E +ADFG+AR T T Y APEL
Sbjct: 119 ---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 352 VTEKCDVYSFGVVALEVLMGK 372
+ D++S G + E+L +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 8e-24
Identities = 69/263 (26%), Positives = 131/263 (49%), Gaps = 23/263 (8%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+GTG +G V + VA+K + E + F EA+++ ++ H +V+LYG
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
C ++ ++++ EYM G L LR E ++ + + K +C ++YL + +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG-TYGYIAPELAYTMVVTEKC 356
HRD+++ N L++ + V+DFG++R + D ++ + + PE+ + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 357 DVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVS 415
DV++FGV+ EV +GK P E ++S +++K + + L P L+ V
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSE-TVEKVSQGLRLYRPHLASEK----------VY 231
Query: 416 TVAFSCLRSQPKSRPTMQ-LVSN 437
+ +SC + + RPT Q L+S+
Sbjct: 232 AIMYSCWHEKAEERPTFQQLLSS 254
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G V++ + KVVA+K + E E+ +E E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +++I EY+ GS +L E LD + +++ + L YLH +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KK 122
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI + NVLL+ E +ADFGVA L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 357 DVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416
D++S G+ A+E+ G+ P L +K++ L+ P+ +PP + +
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHP--------MKVLFLI-PKNNPPTLEGNYSKPL--KE 231
Query: 417 VAFSCLRSQPKSRPTM-QLVSNEFIARN 443
+CL +P RPT +L+ ++FI R
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 35/282 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG+G G+VY+ P+G++ ALK ++ + + E +L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHD 139
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
H + ++ E+M+ GSL DE+ + +V + + ++YLH I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHRR---HI 189
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTYGYIAPE-----LAYT 349
VHRDI +N+L+NS +ADFGV+R+L D N ++ GT Y++PE L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW-SLDKNIKLIDLLDPRLSPP-VDQKI 407
D++S GV LE +G+ P + W SL + I + P +P ++
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMSQPPEAPATASREF 304
Query: 408 RQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNKAPMQ 448
R I CL+ +P R + MQL+ + FI R +
Sbjct: 305 RHFISC-------CLQREPAKRWSAMQLLQHPFILRAQPGQG 339
|
Length = 353 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 74/266 (27%), Positives = 135/266 (50%), Gaps = 25/266 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E+F ++ +G+G +G V+ + VA+K L ++L + F E + L ++RH+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHK 62
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+++ L+ C + +++I E ME GSL LR+ E V L A +++ + ++YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPEL 346
+HRD+++ N+L+ +L VADFG+ARL+ D SS++ + Y + APE
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEA 175
Query: 347 AYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
A + K DV+SFG++ E+ G+ P ++ N ++ D + P
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYRMPCPA 227
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPT 431
K Q+I + C ++P+ RP+
Sbjct: 228 KCPQEI---YKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 45/279 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G+G +G+VY+ +P G+ VA+K L E + + +EA +++ + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHVV 72
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGMCHALSYL 288
+L G CL + LI + M +G L +R ++ +G L+W V + KGM SYL
Sbjct: 73 RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYL 125
Query: 289 --HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAP 344
+VHRD+++ NVL+ + + DFG+A+LL+ D G ++A
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLI-DLLD--PRLS 400
E + T K DV+S+GV E++ G P E I DLL+ RL
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE---------GIPAVEIPDLLEKGERLP 231
Query: 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
P I ++LV C +SRPT + + NEF
Sbjct: 232 QPPICTIDVYMVLV-----KCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 3e-23
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------EARLLS 224
+ +G G YG VY+AR +G++VALKK+ EE G E LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-------GIPSTALREISLLK 53
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+++H NIVKL + ++L++EY +M L L + + K ++ +
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRG 110
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+Y H I+HRD+ N+L+N + +ADFG+AR T T Y AP
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 345 EL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
E+ Y+ V D++S G + E++ GK
Sbjct: 168 EILLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-23
Identities = 71/257 (27%), Positives = 127/257 (49%), Gaps = 24/257 (9%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G+G +G V+ + + VA+K ++ E E F EA+++ ++ H +V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
C +K ++++ E+ME G L LR + + D +++ + +C + YL + +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG-TYGYIAPELAYTMVVTEKC 356
HRD+++ N L++S V+DFG+ R + D + A + PE+ + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 357 DVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLID-LLDPRLSPPVDQKIRQDIILV 414
DV+SFGV+ EV GK P E S++ + + I L P+L+ + V
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE--KKSNYEVVEMISRGFRLYRPKLAS----------MTV 230
Query: 415 STVAFSCLRSQPKSRPT 431
V +SC +P+ RPT
Sbjct: 231 YEVMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 73/213 (34%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +GTG +G V R SGK ALK L +++ +L +E NE R+L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNVVKGMCHALS 286
+V LYG ++L+ EY+ G LF LR A+ VV AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVL----ALE 115
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPE 345
YLH IV+RD+ N+LL+S+ + DFG A+ + RT L GT Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168
Query: 346 L----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ Y V D ++ G++ E+L G P
Sbjct: 169 IILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 178 IGTGGYGSVYRA--RLPSGK--VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
IG G +G V+R ++P K VA+K L TE+ + F +EA ++ Q H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIR 70
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
L G K +I EYME G+L LR D E + V +++G+ + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYLSD-- 125
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG---TYGYIAPELAYT 349
VHRD+++ N+L+NS LE V+DFG++R+L D +G + APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 350 MVVTEKCDVYSFGVVALEVL-MGKHP 374
T DV+SFG+V EV+ G+ P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 30/276 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G VY+A+ + A K + E LE F E +LS+ +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK--IIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
+ ++++ E+ + G+L ++ E GL + V + M AL++LH ++
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE--- 354
HRD+ + N+LL + + +ADFGV+ R GT ++APE+ V E
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VACETFK 181
Query: 355 ------KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
K D++S G+ +E+ + P L+ ++++ + P +DQ +
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEPPTLDQPSK 233
Query: 409 QDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARN 443
+ SCL P RPT +L+ + F++
Sbjct: 234 WSSSFNDFLK-SCLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-22
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G VY+ + +VVA+K + E E+ +E E +LSQ I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYG 69
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +++I EY+ GS +L+ L+ +++ + L YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERK--- 122
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI + NVLL+ + + +ADFGVA L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 357 DVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416
D++S G+ A+E+ G+ P D + + L P+ SPP + Q
Sbjct: 183 DIWSLGITAIELAKGEPPNS---------DLHPMRVLFLIPKNSPPTLEG--QYSKPFKE 231
Query: 417 VAFSCLRSQPKSRPTM-QLVSNEFIAR 442
+CL P+ RPT +L+ ++FI R
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G V++ + +VVA+K + E E+ +E E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +++I EY+ GS +LR A D + ++K + L YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI + NVLL+ + + +ADFGVA L R GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 357 DVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416
D++S G+ A+E+ G+ P D + + L P+ +PP + +
Sbjct: 183 DIWSLGITAIELAKGEPPNS---------DMHPMRVLFLIPKNNPPT-------LTGEFS 226
Query: 417 VAF-----SCLRSQPKSRPTM-QLVSNEFIARN 443
F +CL P RPT +L+ ++FI +N
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 29/268 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IG G +G VY+ L VA+K + +L F EA +L Q H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
C+ ++ ++++ E + GSL LR + L K + + + YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT----YGYIAPELAYTMVVT 353
HRD+++ N L+ ++DFG++R + T+ G + APE T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 354 EKCDVYSFGVVALEVLM---GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410
+ DV+S+G++ E +PG + ++ R+ P Q ++
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAP--QLCPEE 223
Query: 411 IILVSTVAFSCLRSQPKSRPTMQLVSNE 438
I + C P++RP+ + NE
Sbjct: 224 I---YRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 34/257 (13%)
Query: 170 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARL 222
E H+K+ +G G +G V R +G+ VA+K L+ S E F E +
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEI 59
Query: 223 LSQIRHRNIVKLYGFC--LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
L + H NIVK G C + + LI EY+ GSL L+ ++ + +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ--RHRDQINLKRLLLFSSQ 117
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------SNRTL 334
+C + YL + +HRD+++ N+L+ SE ++DFG+A++L D
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKH----PGELLSSSSWSLDKNI 389
Y APE T + DV+SFGV E+ G P E L + + I
Sbjct: 175 PIFWY---APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 390 --KLIDLLDP--RLSPP 402
+L++LL RL P
Sbjct: 232 VTRLLELLKEGERLPRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 34/270 (12%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IG+G +G V+ + VA+K + E S E F EA+++ ++ H +V+LYG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC----HALSYLHHDCT 293
C R + L++E+ME G L LR G + + GMC ++YL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQR---GKFSQE---TLLGMCLDVCEGMAYLESSN- 120
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDSSNRTLLAGTYGYIAPELAYTM 350
++HRD+++ N L+ V+DFG+ R + + SS T + +PE+
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFS 176
Query: 351 VVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409
+ K DV+SFGV+ EV GK P E S+S N L PRL+ ++ Q
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKPRLASQSVYELMQ 235
Query: 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
C + +P+ RP+ L+ ++
Sbjct: 236 ----------HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 83/303 (27%), Positives = 124/303 (40%), Gaps = 59/303 (19%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
+ T F + IG G YG VY+AR +G++VA+K + E EE E + N R S
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY-NILRKYSN 61
Query: 226 IRHRNIVKLYGFCL------HRKCMFLIYEYMEMGS--------LFCVLRTDEEAVGLDW 271
H NI YG + + ++L+ E GS R EE +
Sbjct: 62 --HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331
+++ L+YLH + ++HRDI N+LL E + DFGV+ L+
Sbjct: 118 -----ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 332 RTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK------HPGELLSS 380
R GT ++APE+ + DV+S G+ A+E+ GK HP L
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-- 227
Query: 381 SSWSLDKNIKLIDLLDPRLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSN 437
K+ P L P + +K D I CL + RP M +L+ +
Sbjct: 228 --------FKIPRNPPPTLKSPENWSKKF-NDFIS------ECLIKNYEQRPFMEELLEH 272
Query: 438 EFI 440
FI
Sbjct: 273 PFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 34/203 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETE---------ELASLESFGNEARLLSQIR 227
IG G YG+VY+AR L +G+ VALKK+ +E E+A L + L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALL-------KQLESFE 59
Query: 228 HRNIVKLYGFC----LHRKC-MFLIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNVVK 279
H NIV+L C R+ + L++E+++ L T GL ++++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMR 114
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ + +LH IVHRD+ N+L+ S+ + +ADFG+AR+ +F+ + T + T
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTL 170
Query: 340 GYIAPELAYTMVVTEKCDVYSFG 362
Y APE+ D++S G
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-22
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 36/279 (12%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
D +K+ +G G YG VY VA+K L E+ +E F EA ++ +I+H
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G C ++I E+M G+L LR + + ++ + + + A+ YL
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYL 120
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT---YGYIAPE 345
+HRD+++ N L+ VADFG++RL+ D+ T AG + APE
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPE 175
Query: 346 -LAYTMVVTEKCDVYSFGVVALEVL---MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
LAY K DV++FGV+ E+ M +PG LS L+K + + P P
Sbjct: 176 SLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCP 231
Query: 402 P-VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
P V + +R C + P RP+ + F
Sbjct: 232 PKVYELMRA-----------CWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 72/212 (33%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE----LASLESFGNEARLLSQIRHRNIV 232
IG G YG VYRAR SG++VALKK+ R + E ++SL E LL +RH NIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR----EITLLLNLRHPNIV 69
Query: 233 KLYGFCL--HRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKR---VNVVKGMC--- 282
+L + H +FL+ EY E + SL LD + VK +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASL------------LDNMPTPFSESQVKCLMLQL 117
Query: 283 -HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
L YLH + I+HRD+ +N+LL + +ADFG+AR + T T Y
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 342 IAPELAYTMVV-TEKCDVYSFGVVALEVLMGK 372
APEL T D+++ G + E+L K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 85/276 (30%), Positives = 129/276 (46%), Gaps = 45/276 (16%)
Query: 178 IGTGGYGSVYRA--RLPSGKV--VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +GSV + + SGK VA+K L + A + F EA +++Q+ H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD---WAKRVNVVKGMCHALSYLHH 290
L G C M L+ E +G L L+ E D A +V + GM L H
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM--GM-AYLESKH- 115
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPE 345
VHRD+++ NVLL + +A ++DFG++R L S A T G + APE
Sbjct: 116 -----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168
Query: 346 LAYTMVVTEKCDVYSFGVVALEVL-MGKHP-GELLSSSSWSLDKNIKLIDLLDP--RLSP 401
+ K DV+S+GV E G P GE+ K ++I +L+ RL
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---------KGAEVIAMLESGERLPR 219
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVS 436
P ++ Q+I ++ SC + +P+ RPT +L S
Sbjct: 220 P--EECPQEIY---SIMLSCWKYRPEDRPTFSELES 250
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 58/295 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFGNEARLL 223
+ +K +G G +G V+ + +VA+K L + + + + F EA LL
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKR-------- 274
+ +H NIVK YG C +++EYME G L LR+ +A L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 275 ------VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--- 325
V + GM + L+ H VHRD+++ N L+ +L + DFG++R +
Sbjct: 123 QLLQIAVQIASGMVY-LASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
Query: 326 -NFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSS 382
+ T+L ++ PE + Y TE DV+SFGVV E+ GK P LS+
Sbjct: 176 DYYRVGGHTMLP--IRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNE- 231
Query: 383 WSLDKNIKLID----LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ I+ I L PR P V + C + P+ R ++
Sbjct: 232 ----EVIECITQGRLLQRPRTCPSE----------VYDIMLGCWKRDPQQRINIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+D +GTG +G V+ R S ALK + E L + NE R+L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
I++L+ ++ ++++ EY+ G LF LR + GL +A + +C AL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-----VC-AL 114
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAP 344
YLH + IV+RD+ N+LL+ E + DFG A+ L +RT L GT Y+AP
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAP 167
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
E+ + + D ++ G++ E+L+G P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 83/290 (28%), Positives = 127/290 (43%), Gaps = 56/290 (19%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG V + R +G++VA+KK SE +E ++ E ++L Q+RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKE 67
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTPP 295
+ ++L++EY+E +L +L + GL + + + A++Y H H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSHN---- 120
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPEL-----AYT 349
I+HRDI N+L++ + DFG AR L ++ T T Y APEL Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 350 MVVTEKCDVYSFGVVALEVLMGK--HPGE---------------LLSSSSWSLDKNIKLI 392
V DV++ G + E+L G+ PG+ L S N
Sbjct: 181 KPV----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN---- 232
Query: 393 DLLDPRLS----PPVDQKI---RQDIILVSTVAF----SCLRSQPKSRPT 431
PR + P Q R+ VS+ A +CLR PK R T
Sbjct: 233 ----PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G V++A+ +G+ VALKK+ E ++ E + L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL-REIKALQACQHPYVVKLLD 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
H L+ EYM L VLR +E + K ++ + ++Y+H + I
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN---GI 120
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELAY-TMVVTE 354
+HRD+ N+L++++ +ADFG+ARL + + + T Y APEL Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 355 KCDVYSFGVVALEVLMGK--HPGE 376
D+++ G + E+L G PGE
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 178 IGTGGYGSVYRARL--PSGKVVALKKLH-------RSETEELASLESFGNEARLL-SQIR 227
+G+G +G VY+ R ++ALK+++ + + E S+ +E ++ Q+R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NVVKGMCHALS 286
H NIV+ Y L ++++ + +E L + +E +R+ N+ M AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
YLH + IVHRD++ NN++L + + + DFG+A+ S T + GT Y PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSCPEI 184
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
EK DV++FG + ++ + P S++ SL I ++ P +
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKI-----VEAVYEPLPEGM 237
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436
+D+ V T SCL ++RP + VS
Sbjct: 238 YSEDVTDVIT---SCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 35/290 (12%)
Query: 162 FQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA 220
F D+ E IG G +G+VY AR + + +VVA+KK+ S + + E
Sbjct: 17 FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
R L Q+RH N ++ G L +L+ EY +GS +L ++ L + + G
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKK--PLQEVEIAAICHG 123
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
L+YLH +HRDI + N+LL +ADFG A L++ +S GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPY 176
Query: 341 YIAPELAYTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397
++APE+ M K DV+S G+ +E+ K P L + ++ S +I D
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQND---- 230
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAP 446
P + V SCL+ P+ RP+ +L+ + F+ R + P
Sbjct: 231 ---SPTLSSNDWSDYFRNFVD-SCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLH---RSETEELASLESFGNEARLLSQI 226
DF + +G G YGSVY+ RL + ALK++ S+ E ++ NE R+L+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASV 56
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNVV 278
H NI+ L + ++ EY G L + E+ + W + ++
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQLL 113
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 338
+G L LH I+HRD+ S N+LL + + D G++++L + + + GT
Sbjct: 114 RG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GT 164
Query: 339 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398
Y+APE+ + K D++S G + E+ P E S D K+ P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRYKVQRGKYPP 220
Query: 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ P Q ++ I S L+ +PK RP
Sbjct: 221 IPPIYSQDLQNFIR-------SMLQVKPKLRPNCD 248
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 75/241 (31%), Positives = 116/241 (48%), Gaps = 25/241 (10%)
Query: 174 IKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
I+ IG G +G V R +LP + VA+K L TE+ F +EA ++ Q H
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHP 65
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NI+ L G K + ++ EYME GSL LR + + + V +++G+ + YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL- 122
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG---TYGYIAPEL 346
VHRD+++ N+L+NS L V+DFG++R+L D G + APE
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 347 AYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPV 403
T DV+S+G+V EV+ G+ P W + N +I ++ RL P+
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWEM-SNQDVIKAIEEGYRLPAPM 232
Query: 404 D 404
D
Sbjct: 233 D 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 74/276 (26%), Positives = 132/276 (47%), Gaps = 31/276 (11%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKK--LHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
IG G G V A +G+ VA+KK L + + EL NE ++ +H NIV++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHPNIVEM 81
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
Y L ++++ E++E G+L ++ R +EE + V + ALS+LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLAVLKALSFLH-- 132
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
++HRDI S+++LL S+ ++DFG ++ + R L GT ++APE+ +
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411
+ D++S G++ +E++ G+ P + K I+ D L P+L R
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP--YFNEPPLQAMKRIR--DNLPPKLKNLHKVSPR--- 244
Query: 412 ILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNKAP 446
+ + L P R T +L+++ F+A+ P
Sbjct: 245 --LRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-R 227
+DF IG G + +V A+ + K A+K L + + + ++ E +L+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
H I+KLY + ++ + EY G L +R LD + AL Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEY 117
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA----------- 336
LH + I+HRD+ N+LL+ ++ + DFG A++L+ +SS +
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 337 ---------GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387
GT Y++PEL + D+++ G + ++L GK P S+ + +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR--GSNEYLTFQ 232
Query: 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQL 434
I ++ P PP +D+I L P+ R +
Sbjct: 233 KILKLEYSFPPNFPPD----AKDLIE------KLLVLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 170 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARL 222
E+ H+K+ +G G +GSV R +G+VVA+KKL S E L F E +
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEI 58
Query: 223 LSQIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
L ++H NIVK G C R+ + L+ EY+ GSL L+ E LD K +
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQ 116
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+C + YL + VHRD+++ N+L+ SE + DFG+ ++L D +
Sbjct: 117 ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 341 YI---APELAYTMVVTEKCDVYSFGVVALEV 368
I APE + DV+SFGVV E+
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
I G YG V+ A+ S G + A+K + +++ ++ E +LSQ + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+K ++L+ EY+ G L +L DE D A+ + + AL YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVAR--IYIAEIVLALEYLHSN- 112
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARL--------LNFDSSNRTLLAGTYGYIAP 344
I+HRD+ +N+L++S + DFG++++ LN D + GT YIAP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
E+ ++ D +S G + E L+G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLH------RSETEELASLESFGNEARLLSQIRHRN 230
IG+G +GSVY SG+++A+K++ S+ + + L++ E LL +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNVVKGMCHALSY 287
IV+ G L + + EY+ GS+ +L EE + N V+ + L+Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL------VRNFVRQILKGLNY 121
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------SNRTLLAGTYGY 341
LH I+HRDI N+L++++ ++DFG+++ L +S R L G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+APE+ T K D++S G + +E+L GKHP
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRSETEELASLESFGNEARLL 223
D +K+ +G G +G V+ A LP +VA+K L E E A + F EA LL
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQD-FQREAELL 61
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRV------- 275
+ ++H++IV+ YG C + + +++EYM G L LR+ +A L + V
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 276 --------NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL-- 325
+ GM + L+ LH VHRD+++ N L+ L + DFG++R +
Sbjct: 122 GQMLAIASQIASGMVY-LASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174
Query: 326 --NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSS 382
+ RT+L ++ PE T + D++SFGVV E+ GK P LS++
Sbjct: 175 TDYYRVGGRTMLP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
Query: 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+++ + +L PR PP I Q C + +P+ R ++
Sbjct: 233 -AIECITQGRELERPRTCPPEVYAIMQ----------GCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 68/261 (26%), Positives = 121/261 (46%), Gaps = 27/261 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V+ + VA+K L + T + F EA+++ ++RH +++LY
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
C + ++++ E M+ GSL L+ L + +++ + ++YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKC 356
HRD+++ NVL+ VADFG+AR++ D R + APE A + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 357 DVYSFGVVALE-VLMGKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVD-QKIRQDII 412
DV+SFG++ E V G+ P ++ N +++ +D R+ P K DI+
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMT--------NAEVLQQVDQGYRMPCPPGCPKELYDIM 237
Query: 413 LVSTVAFSCLRSQPKSRPTMQ 433
L C + P RPT +
Sbjct: 238 L------DCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 75/285 (26%), Positives = 146/285 (51%), Gaps = 43/285 (15%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLH-------RSETEELASLESFGNEARLLSQIRHR 229
IG G YG VY A + +G+++A+K++ R ++ + +++ +E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHAL 285
NIV+ GF + + + EY+ GS+ LRT +E+ V + + L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGL 121
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTYGYIA 343
+YLH + I+HRD+ ++N+L++++ ++DFG+++ + +D+ + G+ ++A
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 344 PEL--AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK-LIDLLDPRLS 400
PE+ +Y+ + K D++S G V LE+ G+ P WS ++ I + L + R +
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------WSDEEAIAAMFKLGNKRSA 230
Query: 401 PPVDQKIRQDIILVSTVA----FSCLRSQPKSRPTM-QLVSNEFI 440
PP+ + + +S VA +C P +RPT +L+ + FI
Sbjct: 231 PPIPPDV---SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 77/265 (29%), Positives = 117/265 (44%), Gaps = 31/265 (11%)
Query: 178 IGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G V R GKV VA+K L + ++ ++ F EA ++ + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA---VGLDWAKRVNVVKGMCHALSYLHH 290
LYG L M ++ E +GSL LR D + V + GM YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM----RYLE- 114
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPELA 347
+ +HRD+++ N+LL S+ + + DFG+ R L + + + L + + APE
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 348 YTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
T + DV+ FGV E+ G+ P LS S + +K ID RL P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGERLERPEA-- 225
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPT 431
QDI V C P RPT
Sbjct: 226 CPQDIY---NVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ VA+K L S E+F EA+++ ++RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHD 61
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE-EAVGL----DWAKRVNVVKGMCHA 284
+V+LY C + ++++ EYM GSL L++ E + + L D A + + +GM
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ--IAEGM--- 116
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-- 342
+YL +HRD+++ N+L+ L +ADFG+ARL+ D T G I
Sbjct: 117 -AYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKW 170
Query: 343 -APELAYTMVVTEKCDVYSFGVVALEV 368
APE A T K DV+SFG++ E+
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 40/279 (14%)
Query: 178 IGTGGYGSVYRARLPSG------KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G V+ A+ +V +K L +T++ F E + ++ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG------LDWAKRVNVVKGMCHAL 285
V+L G C + ++I EY ++G L LR + L ++V + + +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN------RTLLAGTY 339
+L VHRD+++ N L++S+ E V+ +++ D N R L
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALI-PL 182
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPR 398
++APE + K DV+SFGV+ EV G+ P LS ++L P
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242
Query: 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVS 436
P K+ C PK RP+ +LVS
Sbjct: 243 GCPSRLYKLMT----------RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 36/285 (12%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHR 229
F + +G G YG VY+ R + +G++ A+K + +E EE E E +L + HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73
Query: 230 NIVKLYGFCL------HRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRV--NVVKG 280
NI YG + H ++L+ E+ GS+ V T A+ DW + +++G
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+ H + H ++HRDI NVLL E + DFGV+ L+ R GT
Sbjct: 134 LAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 341 YIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395
++APE+ + D++S G+ A+E+ G P D + L
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---------LCDMHPMRALFL 237
Query: 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440
PR PP + + + + +++ T QL+ + FI
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 46/222 (20%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G Y VY+AR +G++VA+KK+ R E ++ + + E +LL +++H NI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV----------KGMCH 283
L H+ + L++E+ME TD E V K ++V
Sbjct: 67 LLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYMLMTLR 113
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGY 341
L YLH + I+HRD+ NN+L+ S+ +ADFG+AR +F S NR T T Y
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWY 168
Query: 342 IAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKH--PGE 376
APEL Y + V D++S G + E+L+ PG+
Sbjct: 169 RAPELLFGARHYGVGV----DMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 39/282 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED +G G GSV + +P+G V+A K +H + + E +++ + R
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRS 62
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
IV YG L+ + + E+M+ GSL + + E +G + +
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEG 115
Query: 285 LSYL---HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTYG 340
L+YL H I+HRDI +N+L+NS + + DFGV+ L+N S GT
Sbjct: 116 LTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTST 167
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD---- 396
Y++PE T K DV+S G+ +E+ +GK P + D + ++DLL
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 397 ---PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
PRL + +D + CL P RPT Q +
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDA------CLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G GSV + RL +G + ALK + +L + E + + IVK YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 237 FCL--HRKCMFLIYEYMEMGSLFCVL--------RTDEEAVGLDWAKRV--NVVKGMCHA 284
L + + EY E GSL + R E+ +G ++ +V+KG
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKG---- 117
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTYGYIA 343
LSYLH + I+HRDI +N+LL + + + DFGV+ L+N + T GT Y+A
Sbjct: 118 LSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMA 171
Query: 344 PE----LAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
PE Y++ DV+S G+ LEV + P
Sbjct: 172 PERIQGKPYSI----TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 28/269 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V+ + VA+K L S+++F EA L+ ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
+ +++I EYM GSL L++DE + K ++ + ++Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYI 125
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKC 356
HRD+ + NVL++ L +ADFG+AR++ + + R + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 357 DVYSFGVVALEVLM-GK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413
DV+SFG++ E++ GK +PG S +L + ++ PR+ D+
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-----PRMENCPDE-------- 232
Query: 414 VSTVAFSCLRSQPKSRPT---MQLVSNEF 439
+ + +C + + + RPT +Q V ++F
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 29/276 (10%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G+VY A + +VVA+KK+ S + + E + L Q++H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +L+ EY +GS +L ++ L + + G L+YLH +
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE-- 354
+HRDI + N+LL + +ADFG A SS GT ++APE+ M +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 355 -KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413
K DV+S G+ +E+ K P L + ++ S +I D SP + D
Sbjct: 199 GKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQND------SPTLQSNEWTD--- 247
Query: 414 VSTVAFS--CLRSQPKSRPT-MQLVSNEFIARNKAP 446
S F CL+ P+ RP +L+ ++F+ R++
Sbjct: 248 -SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 170 EDFHIKYCIGTGGYGSV----YRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
++ + IG G +G V YR G VA+K + A+ ++F EA +++Q
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 226 IRHRNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+RH N+V+L G + K ++++ EYM GSL LR+ +V L + +C A
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 114
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
+ YL + VHRD+++ NVL++ + A V+DFG+ + SS + + AP
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP 168
Query: 345 ELAYTMVVTEKCDVYSFGVVALEV 368
E + K DV+SFG++ E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 5e-18
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G G+V+ A + +G+ VA+K+++ ++ E NE ++ ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +F++ EY+ GSL V+ +D A+ V + AL +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI S+NVLL + + DFG + + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 357 DVYSFGVVALEVLMGKHP 374
D++S G++A+E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 47/288 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
D+ + +G+G YG VY+AR L +G++ A+K + ++ + ++ E ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NIV +G L R+ +++ EY GSL + L A V + L+YL
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYL 122
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + +HRDI N+LL + +ADFGVA + + R GT ++APE+A
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA- 178
Query: 349 TMVVTEK-------CDVYSFGVVALEV------LMGKHPGE---LLSSSSWSLDKNIKLI 392
EK CD+++ G+ A+E+ + HP L+S S++
Sbjct: 179 ---AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-------- 227
Query: 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ-LVSNEF 439
P + K + + V S L PK RPT + L+++ F
Sbjct: 228 -------PPKLKDKTKWSSTFHNFVKIS-LTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 50/288 (17%)
Query: 178 IGTGGYGSVYRARL--PSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY+ L P+ + VA+K L E E + F EA L+S ++H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNVV 278
V L G C + +++EY+ G L F V + VG LD + +++
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 279 KGMCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNR 332
+ + YL HH VHRD+++ N L+ L ++DFG++R + + ++
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKL 391
+LL ++ PE T + D++SFGVV E+ G P S N ++
Sbjct: 186 SLLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------NQEV 235
Query: 392 IDLLDPR--LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437
I+++ R L P D R V + C P RP + +
Sbjct: 236 IEMIRSRQLLPCPEDCPAR-----VYALMIECWNEIPARRPRFKDIHT 278
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 57/297 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYR---ARLPSGKV---VALKKLHRSETEELASLESFGNEARLL 223
E + +G G +G VY + G+ VA+K ++ E + F NEA ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVM 63
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLD--------- 270
+ ++V+L G + ++ E M G L LR+ E GL
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
A + GM +YL VHRD+++ N ++ +L + DFG+ R +
Sbjct: 124 MA--AEIADGM----AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174
Query: 331 NRTLLAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWS 384
R G G ++APE V T K DV+SFGVV E+ + + P + LS+
Sbjct: 175 YRK---GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---- 227
Query: 385 LDKNIKLI---DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN 437
++ +K + LD + P +++ + C + PK RPT +++VS+
Sbjct: 228 -EEVLKFVIDGGHLDLPENCPD---KLLELMRM------CWQYNPKMRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS---LESFGNEARLLSQIRHRNIVKL 234
+G G YG+VY G+++A+K++ + LA+ E E LL ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
G CL + + E++ GS+ +L + K K + ++YLH++C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT------LLAGTYGYIAPELAY 348
+VHRDI NNV+L + DFG AR L + + T + GT ++APE+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW-SLDKNIKLIDLLDPR-LSPPVDQK 406
K D++S G E+ GK P S+D+ + + R L P +
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP--------LASMDRLAAMFYIGAHRGLMPRLPDS 233
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
I T SCL RP+ +QL+ ++F+
Sbjct: 234 FSAAAIDFVT---SCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 68/259 (26%), Positives = 126/259 (48%), Gaps = 30/259 (11%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IG G +G+V + +G+ VA+K + T + +F E +++++ H+N+V+L G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
LH ++++ E M G+L LRT A+ + + + + + YL + +V
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCD 357
HRD+++ N+L++ + A V+DFG+AR + + + L + APE + K D
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179
Query: 358 VYSFGVVALEVL-MGK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414
V+S+GV+ EV G+ +P L ++K + ++P P D V
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----MEPPEGCPAD---------V 226
Query: 415 STVAFSCLRSQPKSRPTMQ 433
+ SC ++PK RP+
Sbjct: 227 YVLMTSCWETEPKKRPSFH 245
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 33/271 (12%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V+ VA+K L + S E+F EA L+ Q++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA- 68
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
+ ++ +++I EYME GSL L+T E + L K +++ + ++++ +
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT---YGYIAPELAYTMVVTE 354
HRD+ + N+L++ L +ADFG+ARL+ + + T G + APE T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 355 KCDVYSFGVVALE-VLMGK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411
K DV+SFG++ E V G+ +PG N ++I L+ P +++
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGM----------TNPEVIQNLERGYRMPRPDNCPEEL 232
Query: 412 ILVSTVAFSCLRSQPKSRPT---MQLVSNEF 439
+ C + +P+ RPT ++ V +F
Sbjct: 233 Y---ELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 22/258 (8%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V+ VA+K L S ESF EA+++ ++RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYA- 68
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
+ + ++++ EYM GSL L+ D E L V++ + ++Y+ +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
HRD+ S N+L+ L +ADFG+ARL+ + + + R + APE A T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 357 DVYSFGVVALE-VLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVS 415
DV+SFG++ E V G+ P +++ L++ + + P+ P +
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNRE-VLEQVERGYRMPCPQDCPIS----------LH 233
Query: 416 TVAFSCLRSQPKSRPTMQ 433
+ C + P+ RPT +
Sbjct: 234 ELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALK--KLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G +GSVY L G A+K L +++ E LLS+++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHALSYLHH 290
G +++ E + GSL +L+ E + + + L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI-------RLYTRQILLGLEYLHD 120
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL---- 346
VHRDI N+L+++ +ADFG+A+ + S ++ G+ ++APE+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQ 176
Query: 347 -AYTMVVTEKCDVYSFGVVALEVLMGKHP-GELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
Y + D++S G LE+ GK P +L ++ K + + LS
Sbjct: 177 GGYGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK 232
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
I + CL+ P RPT +L+ + F+
Sbjct: 233 DFILK-----------CLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 26/268 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ VA+K L S E+F EA+++ ++RH
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 61
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LY + + ++++ EYM GSL L+ E L + V++ + ++Y+
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAY 348
VHRD+ + N+L+ L VADFG+ARL+ + + + R + APE A
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 349 TMVVTEKCDVYSFGVVALEVLM-GK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
T K DV+SFG++ E+ G+ +PG + N +++D ++ P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------NREVLDQVERGYRMPCPP 226
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ + + + C R +P+ RPT +
Sbjct: 227 ECPESL---HDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G G+VY A + +G+ VA+K+++ + + E NE ++ + +H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L ++++ EY+ GSL V+ +D + V + AL +LH + +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI S+N+LL + + DFG + + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 357 DVYSFGVVALEVLMGKHP 374
D++S G++A+E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YGSVY+ P+G +A+K++ R E +E + E +L + IV YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDE-SKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+++ EYM+ GSL + G+ + + L +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE----------L 346
+HRD+ NVL+N + + DFGV+ N +S G Y+APE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
YT+ + DV+S G+ LE+ +G++P + + ++ + I DP P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGDPPTLPSGYSD 236
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAP 446
QD + CL P RPT QL+ + ++ + K
Sbjct: 237 DAQDFVA------KCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALK--KLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
IG G G V AR SG+ VA+K L + + EL NE ++ +H+N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQHQNVVEM 83
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
Y L + ++++ E+++ G+L ++ R +EE + V + + AL YLH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-------TVCESVLQALCYLH-- 134
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
+ ++HRDI S+++LL + ++DFG ++ D R L GT ++APE+
Sbjct: 135 -SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193
Query: 352 VTEKCDVYSFGVVALEVLMGKHP 374
+ D++S G++ +E++ G+ P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 43/225 (19%)
Query: 172 FHIKYCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ I+ CIG G YG VY+A+ GK A+KK + + +S E LL +++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 229 RNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC---- 282
N+V L L K ++L+++Y E L+ +++ + AKRV++ M
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQ------AKRVSIPPSMVKSLL 114
Query: 283 ----HALSYLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTL 334
+ + YLH + ++HRD+ N+L+ E + D G+ARL F++ + L
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLKPL 169
Query: 335 LAG-----TYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVL 369
T Y APEL YT + D+++ G + E+L
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFGNEARLLSQIR 227
D IK IG G G V A + SGK+VA+KK L + + EL NE ++ +
Sbjct: 23 DNFIK--IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQ 75
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHA 284
H N+V++Y L ++++ E++E G+L ++ R +EE + V + A
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKA 128
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
LS LH ++HRDI S+++LL + ++DFG ++ + R L GT ++AP
Sbjct: 129 LSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
EL + + D++S G++ +E++ G+ P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG VY+AR +G++VALKK+ R ETE+ + E LL ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG----MCHALSYLHHDC 292
++L++E++++ L+ ++ L ++K + ++Y H
Sbjct: 66 VVHSENKLYLVFEFLDLD-----LKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCH--- 116
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----A 347
+ ++HRD+ N+L++ E +ADFG+AR T T Y APE+
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGK 372
Y+ V D++S G + E++ +
Sbjct: 177 YSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G V ++ + ALK + + E E +E +L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+K ++++ EY G L+ +LR + D + + A YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEK 355
++RD+ N+LL+S + DFG A+ L S +T GT Y+APE ++ K
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPE-----IILNK 167
Query: 356 -----CDVYSFGVVALEVLMGKHP 374
D +S G++ E+L G+ P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 63/293 (21%)
Query: 178 IGTGGYGSVYRARLP------SGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+G+G +G VY SG + VA+K L + T++ F EA L+S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR--------------TDEEAVGLDWAKRVN 276
IVKL G CL + ++I E ME G L LR + + LD
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD------ 114
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-----VADFGVARLLNFDSSN 331
V KG C L +H +HRD+++ N L++ + + DFG+AR +
Sbjct: 115 VAKG-CVYLEQMH------FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 332 RTLLAGTYG--YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKN 388
R G ++APE T + DV+SFGV+ E+L +G+ P L+ N
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------N 219
Query: 389 IKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437
+++ + RL P + KI Q + C P RPT +
Sbjct: 220 QEVLQHVTAGGRLQKPENCPDKIYQLMTN-------CWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 25/272 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G+VY AR + + +VVA+KK+ S + + E + L +I+H N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L +L+ EY +GS +L ++ L + + G L+YLH + +
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLH---SHNM 146
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE-- 354
+HRDI + N+LL + +ADFG A + + +S GT ++APE+ M +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQYD 202
Query: 355 -KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413
K DV+S G+ +E+ K P L + ++ S +I + SP + D
Sbjct: 203 GKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNE------SPTLQSNEWSDYF- 253
Query: 414 VSTVAFSCLRSQPKSRPTM-QLVSNEFIARNK 444
SCL+ P+ RPT +L+ + F+ R +
Sbjct: 254 -RNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF + IG+G YG VY+AR + +G++ A+K + E+ A ++ E ++ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NIV +G L R +++ E+ GSL + L ++ V + L YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYL 122
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H +HRDI N+LL +ADFGV+ + + R GT ++APE+A
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA- 178
Query: 349 TMVVTEK------CDVYSFGVVALEV 368
V K CD+++ G+ A+E+
Sbjct: 179 --AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 178 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G V+ RL + VA+K + +L + F EAR+L Q H NIV+L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVRLIG 60
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
C ++ ++++ E ++ G LRT E L + + +V+ + YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG-------YIAPE-LAY 348
+HRD+++ N L+ + ++DFG++R + A T G + APE L Y
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 349 TMVVTEKCDVYSFGVVALEVL-MGKHPGELLSS--SSWSLDKNIKLIDLLDPRLSPPVDQ 405
+E DV+SFG++ E +G P LS+ + ++++ ++ L P L P
Sbjct: 171 GRYSSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDA-- 224
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441
V + C P RP+ V E +
Sbjct: 225 --------VYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 65/267 (24%), Positives = 133/267 (49%), Gaps = 25/267 (9%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V+ A VA+K + S+E+F EA ++ ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
+ ++ +++I E+M GSL L++DE K ++ + ++++ +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
HRD+ + N+L+++ L +ADFG+AR++ + + + R + APE T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 357 DVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVS 415
DV+SFG++ +E++ G+ P +S+ ++I L+ P + +++
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPRPENCPEELY--- 233
Query: 416 TVAFSCLRSQPKSRPT---MQLVSNEF 439
+ C +++P+ RPT +Q V ++F
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 172 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+ I IG G +G +Y A+ S + K + E+ E LL++++H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNVVKGMCHALS 286
V + +F++ EY + G L + E L W V + G+ H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLGLKHI-- 117
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
HD I+HRDI S N+ L+ + A + DFG+AR LN GT Y++PE
Sbjct: 118 ---HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHPGE 376
+ K D++S G V E+ KHP E
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 8e-17
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE---LASLESFGNEARLLSQ 225
+++ I G YG VYRAR +G++VALKKL + +E + SL E +L +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLK 60
Query: 226 IRHRNIVKL----YGFCLHRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNVVK 279
++H NIV + G L + ++++ EY+E L++ + ++ ++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDK--IYMVMEYVEHD-----LKSLMETMKQPFLQSEVKCLML 113
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ +++LH + I+HRD+ ++N+LLN+ + DFG+AR T L T
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170
Query: 340 GYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGK 372
Y APEL + D++S G + E+L K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 76/279 (27%), Positives = 117/279 (41%), Gaps = 46/279 (16%)
Query: 178 IGTGGYGSVYRA------RLPSGKVVALKKL----HRSETEELASLESFGNEARLLSQI- 226
+G G +G V A + + VA+K L H SE E L S E +++S +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS------ELKIMSHLG 96
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW---AKRVNVVKGMCH 283
H NIV L G C + +I EY G L LR E+ + V KGM
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY---G 340
S +C +HRD+++ NVLL + DFG+AR + D SN +
Sbjct: 157 LAS---KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVK 208
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVL---MGKHPGELLSSSSWSLDKNIKLIDLLDP 397
++APE + V T + DV+S+G++ E+ +PG + S + L K + P
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMAQP 266
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436
+P I + +C + P RPT + +
Sbjct: 267 EHAPAEIYDIMK----------TCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 45/292 (15%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG V + + +G++VA+KK SE +++ + E R+L Q+RH N+V L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRHENLVNLIE 67
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+K ++L++E+++ VL E+ GLD ++ + + + + H
Sbjct: 68 VFRRKKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTM 350
I+HRDI N+L++ + DFG AR L T T Y APEL Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 351 VVTEKCDVYSFGVVALEVLMGK--HPGELLSSSSWSLDKNIKLIDLLDPRL------SP- 401
V D+++ G + E+L G+ PG S L IK + L PR +P
Sbjct: 181 AV----DIWAVGCLVTEMLTGEPLFPG---DSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 402 -------------PVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEF 439
P++++ + LV +A CLR P RP+ QL+ +EF
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 1e-16
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G G+VY A + +G+ VA+K+++ ++ E NE ++ + ++ NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L ++++ EY+ GSL V+ +D + V + AL +LH + +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI S+N+LL + + DFG + + S R+ + GT ++APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 357 DVYSFGVVALEVLMGKHP 374
D++S G++A+E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRA--RLPSGKV--VALKKLHRSETEELASLESFGNEARLLSQ 225
ED + CIG G +G VY+ P + VA+K + + E F EA ++ Q
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
H +IVKL G ++++ E +G L L+ ++ + LD A + + AL
Sbjct: 64 FDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTAL 120
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS---SNRTLLAGTYGYI 342
+YL + VHRDI++ NVL++S + DFG++R L +S +++ L ++
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWM 175
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
APE T DV+ FGV E+LM G P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKK--LHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
IG G G V A +GK VA+KK L + + EL NE ++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL-----LFNEVVIMRDYHHENVVDM 84
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
Y L ++++ E++E G+L ++ R +EE + V + ALSYLH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH-- 135
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
++HRDI S+++LL S+ ++DFG ++ + R L GT ++APE+ +
Sbjct: 136 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 352 VTEKCDVYSFGVVALEVLMGKHP 374
+ D++S G++ +E++ G+ P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 83/296 (28%), Positives = 141/296 (47%), Gaps = 40/296 (13%)
Query: 165 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFGNE 219
+++ TE IK +G+G +G+VY+ +P G+ VA+K+L R T A+ E +E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 59
Query: 220 ARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 275
A +++ + + ++ +L G CL LI + M G L +R ++ +G L+W V
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 116
Query: 276 NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 335
+ KGM +YL +VHRD+++ NVL+ + + DFG+A+LL D
Sbjct: 117 QIAKGM----NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 336 AGTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWS--LDKNIK 390
G ++A E + T + DV+S+GV E++ G P + + +S S L+K +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 229
Query: 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446
L P+ PP+ I V + C SRP + + EF + P
Sbjct: 230 L-----PQ--PPICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 27/273 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G+VY AR + + +VVA+KK+ S + + E R L ++RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTPP 295
L +L+ EY +GS +L ++ L + V G L+YLH H+
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHN---- 135
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE- 354
++HRD+ + N+LL+ + DFG A ++ + GT ++APE+ M +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQY 191
Query: 355 --KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII 412
K DV+S G+ +E+ K P L + ++ S +I + P Q
Sbjct: 192 DGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIA-------QNESPALQSGHWSEY 242
Query: 413 LVSTVAFSCLRSQPKSRPTMQ-LVSNEFIARNK 444
+ V SCL+ P+ RPT + L+ + F+ R +
Sbjct: 243 FRNFVD-SCLQKIPQDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 71/237 (29%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN---------EAR 221
+ I +G G YG V++A + +VVALKK+ ++F N E
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIM 58
Query: 222 LLSQIR-HRNIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 276
L ++ H NIVKL + + K ++L++EYME TD AV R N
Sbjct: 59 FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYME---------TDLHAV-----IRAN 102
Query: 277 VVKGMCH----------ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
+++ + H AL Y+H + ++HRD+ +N+LLNS+ +ADFG+AR L+
Sbjct: 103 ILEDV-HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 327 FDSSNRTLLAGTYGYIA------PEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
N T Y+A PE+ YT V D++S G + E+L+GK
Sbjct: 159 ELEENPENPVLTD-YVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 178 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG VY AR S +V +A+K++ ++ + L E L S ++HRNIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+ E + GSL +LR+ + + + K + L YLH + I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 297 VHRDISSNNVLLNSELEAF-VADFGVA-RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
VHRDI +NVL+N+ ++DFG + RL + T GT Y+APE V +
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPE------VID 182
Query: 355 K--------CDVYSFGVVALEVLMGKHP 374
K D++S G +E+ GK P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 177 CIGTGGYGSVYRAR-LPSGKVVALKKLH--RSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G VY + +G+ +A+K++ E + + E +LL ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLHH 290
YG + + + EYM GS+ L+ E V + +++ + YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH- 121
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTYGYIAPELA 347
+ IVHRDI N+L +S + DFG ++ L S+ T + GT +++PE+
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP 374
K DV+S G +E+L K P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 82/303 (27%), Positives = 140/303 (46%), Gaps = 51/303 (16%)
Query: 171 DFHIKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRSETEELASLESFGNEARLLS 224
D +K +G G +G V+ A P+ +VA+K L + LA+ + F EA LL+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 62
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------------EEAVG-LDW 271
++H +IVK YG C + +++EYM+ G L LR +A G L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331
++ +++ + + YL + VHRD+++ N L+ + L + DFG++R + S++
Sbjct: 123 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTD 177
Query: 332 RTLLAG----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD 386
+ G ++ PE T + DV+SFGV+ E+ GK P LS++
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----- 232
Query: 387 KNIKLID----LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442
+ I+ I L PR+ P K DI+L C + +P+ R ++ + A
Sbjct: 233 EVIECITQGRVLERPRVCP----KEVYDIML------GCWQREPQQRLNIKEIYKILHAL 282
Query: 443 NKA 445
KA
Sbjct: 283 GKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 32/253 (12%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G VY+A+ +A K+ +++EE LE + E +L+ H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297
++++ E+ G++ ++ E GL + + + M AL YLH + I+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLH---SMKII 132
Query: 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE--- 354
HRD+ + NVLL + + +ADFGV+ R GT ++APE+ + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 355 --KCDVYSFGVVALEV------------------LMGKHPGELLSSSSWSLDKNIKLIDL 394
K D++S G+ +E+ + P L S WS++ L
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252
Query: 395 LD--PRLSPPVDQ 405
LD P P Q
Sbjct: 253 LDKHPETRPSAAQ 265
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARL--LSQIRHRNIVKL 234
IG G YG+VY+AR P SG VALK + E+ L + A L L H NIV+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 235 YGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNVVKGMCHALS 286
C + + L++E+++ LRT + V GL ++++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-----LRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
+LH +C IVHRD+ N+L+ S + +ADFG+AR+ + + T + T Y APE+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEV 178
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGK 372
D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G G+VY A + +G+ VA+++++ ++ E NE ++ + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
L ++++ EY+ GSL V+ +D + V + AL +LH + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRDI S+N+LL + + DFG + + S R+ + GT ++APE+ K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 357 DVYSFGVVALEVLMGKHP 374
D++S G++A+E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
DF + +GTG +G V A+ +G+ A+K L + E ++ ++ E +L ++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 230 NIVKLY-GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH----- 283
IV + F + FL+ E++ G LF LR + N V H
Sbjct: 79 FIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVL 129
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYI 342
A YL H I++RD+ N+LL+++ V DFG A+ + +RT L GT Y+
Sbjct: 130 AFEYL-HSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYL 182
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
APE+ + + D ++ GV+ E + G P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG V++ R +G++VA+KK SE + + + E R+L Q++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-REIRMLKQLKHPNLVNLIE 67
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTP 294
++ + L++EY + VL ++ G+ ++ A+++ H H+C
Sbjct: 68 VFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC-- 121
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYT 349
+HRD+ N+L+ + + + DFG AR+L + T T Y APEL Y
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 350 MVVTEKCDVYSFGVVALEVLMG-----------------KHPGELL--SSSSWSLDKNIK 390
V DV++ G V E+L G K G+L+ +S ++ K
Sbjct: 180 PPV----DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFS----CLRSQPKSRPT 431
+ + +P P++ K +S+ A S CL+ P R +
Sbjct: 236 GLSIPEPETREPLESKFPN----ISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 178 IGTGGYGSVYRAR------LPSGKVVALKKLHR-SETEELASLESFGNEARLLSQIRHRN 230
+G G +G V +A VA+K L + + EL L S E LL Q+ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS---EFNLLKQVNHPH 64
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----------------------DEEAV 267
++KLYG C + LI EY + GSL LR DE A+
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 268 GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
+ ++ + + YL +VHRD+++ NVL+ + ++DFG++R +
Sbjct: 125 TM--GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 328 DSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM---GKHPGELLSSSS 382
+ S R+ ++A E + + T + DV+SFGV+ E++ +PG +
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPERL 238
Query: 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
++L K ++ + S + + C + +P RPT +S E
Sbjct: 239 FNLLKTGYRMERPE-NCSEEMYNLMLT-----------CWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+D + +G G G+VY+A L + +++A+K + T EL + +E +L +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
I+ YG + + E+M+ GSL + E +G V VVKG L+YL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---RIAVAVVKG----LTYL 111
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
+ I+HRD+ +N+L+N+ + + DFGV+ L +S GT Y+APE
Sbjct: 112 ---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERIS 166
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL----IDLLDPRLSPPVD 404
DV+S G+ +E+ +G+ P + + SL ++L +D P L PV
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVL--PVG 223
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQ-LVSNEFI 440
Q + + ++ C+R QPK RP + L+ + FI
Sbjct: 224 QFSEKFVHFIT----QCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G V++ L VA+K +EL F +EAR+L Q H NIVKL G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--VNVVKGMCHALSYLHHDCTPP 295
C R+ ++++ E + G LR ++ + + ++ GM + S +C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNC--- 114
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTYGYIAPELAYTMVV 352
+HRD+++ N L+ ++DFG++R + + SS L + APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG--LKQIPIKWTAPEALNYGRY 171
Query: 353 TEKCDVYSFGVVALEVL---MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409
+ + DV+S+G++ E + +PG + ++K R+S P QK
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------RMSCP--QKCPD 221
Query: 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441
D+ V C +P++RP + E A
Sbjct: 222 DV---YKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 71/227 (31%), Positives = 107/227 (47%), Gaps = 58/227 (25%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFG----NEARLLSQIRHRNIV 232
IG G YG VY+AR +G++VALKK+ R + E+ E F E ++L Q+ HRNIV
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNEK----EGFPITAIREIKILRQLNHRNIV 69
Query: 233 KLY----------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------ 276
L F + +L++EYM D + +GL + V+
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYM-----------DHDLMGLLESGLVHFSEDHI 118
Query: 277 --VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS---- 330
+K + L+Y H +HRDI +N+LLN++ + +ADFG+ARL N + S
Sbjct: 119 KSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 331 NRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
N+ + T Y PEL Y + DV+S G + E+ K
Sbjct: 176 NKVI---TLWYRPPELLLGEERYGPAI----DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +K +G G +G V R +G + A+K + +S ++ F E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 229 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMC 282
I +L Y F + ++L+ EY G L +L DE+ A+ V + +
Sbjct: 61 PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV- 118
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-NRTLLAGTYGY 341
H + Y VHRDI NVL++ +ADFG A L + N L GT Y
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 342 IAPELAYTMVVTEK------CDVYSFGVVALEVLMGKHP 374
IAPE+ TM K CD +S GV+A E++ G+ P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 178 IGTGGYGS--VYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235
+G G +G +YR R +V K+++ + E ++ NE +LS ++H NI+ Y
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPNIIAYY 65
Query: 236 GFCLHRKCMFLIYEYMEMGSLF-CVLRT-----DEEAVGLDWAKRVNVVKGMCHALSYLH 289
+ + + EY G+L+ ++R +EE V W + + A+SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL--W-----YLFQIVSAVSYIH 118
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349
I+HRDI + N+ L + DFG++++L + S + GT Y++PEL
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 350 MVVTEKCDVYSFGVVALEVL 369
+ K D+++ G V E+L
Sbjct: 176 VKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKLY 235
I G +GSVY A+ +G A+K L +S+ + + E ++ Q + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ ++L+ EY+ G +++T + DWAK + + + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVAR--LLNFDSSNRTLLAGTYGYIAPELAYTMVVT 353
I+HRDI N+L++ + DFG++R L N GT Y+APE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDD 171
Query: 354 EKCDVYSFGVVALEVLMGKHP 374
+ D +S G V E L G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 40/298 (13%)
Query: 165 MIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFGNEA 220
+++ TE +K +G+G +G+VY+ +P G+ V + K+ T A++E F +EA
Sbjct: 3 ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 60
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVN 276
+++ + H ++V+L G CL + L+ + M G L + ++ +G L+W V
Sbjct: 61 LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQ 117
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
+ KGM YL +VHRD+++ NVL+ S + DFG+ARLL D
Sbjct: 118 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 337 GTY--GYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLID 393
G ++A E + T + DV+S+GV E++ G P + + + ++ D
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPD 222
Query: 394 LLDP--RL-SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQ 448
LL+ RL PP+ I V V C SRP + ++ EF + P +
Sbjct: 223 LLEKGERLPQPPICT------IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 7e-16
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 34/284 (11%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHR 229
F + +G G YG VY+ R + +G++ A+K + + EE E E +L + HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63
Query: 230 NIVKLYGFCLHRKC------MFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNVVKGMC 282
NI YG + + ++L+ E+ GS+ +++ T + +W + + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
LS+LH ++HRDI NVLL E + DFGV+ L+ R GT ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 343 APELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397
APE+ K D++S G+ A+E+ G P D + L P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---------LCDMHPMRALFLIP 229
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFI 440
R P + + S + SCL RP T QL+ + FI
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIE-SCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 53/197 (26%), Positives = 79/197 (40%), Gaps = 41/197 (20%)
Query: 197 VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256
VA+K L ++ E F E ++LS++ NI +L G C + +I EYME G L
Sbjct: 49 VAVKVLRPDASDNA--REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 257 FCVLRTDE-EAVGLDWAKR-----------VNVVKGMCHALSYLHHDCTPPIVHRDISSN 304
L+ E GL + + GM + L L+ VHRD+++
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLN------FVHRDLATR 159
Query: 305 NVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----------APELAYTMVVT 353
N L+ +ADFG +R L + Y + A E T
Sbjct: 160 NCLVGKNYTIKIADFG---------MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT 210
Query: 354 EKCDVYSFGVVALEVLM 370
K DV++FGV E+L
Sbjct: 211 TKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 13/267 (4%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+F I+ IG G + VYRA L G VALKK+ + + + E LL Q+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NVVKGMCHALSYL 288
N++K Y + + ++ E + G L +++ ++ L K V +C AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + ++HRDI NV + + + D G+ R + ++ L GT Y++PE +
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
K D++S G + E+ + P + +SL K I+ D P S +++R
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELR 238
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLV 435
Q + + C+ P+ RP + V
Sbjct: 239 QLVNM-------CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+F I+ IG G + VY+A L G+VVALKK+ E + + + E LL Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR--------TDEEAVGLDWAKRVNVVK 279
H N++K + + ++ E + G L +++ E + W V +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI---WKYFVQL-- 115
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
C AL ++H + I+HRDI NV + + + D G+ R + ++ L GT
Sbjct: 116 --CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399
Y++PE + K D++S G + E+ + P + +SL K I+ D
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----- 225
Query: 400 SPPV-----DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437
PP+ +++R LVS C+ P+ RP + V
Sbjct: 226 -PPLPADHYSEELRD---LVSR----CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G V+ R K+V +K++ ++ E LA+ NE ++L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ----NECQVLKLLSHPNIIE 63
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLF------CVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
Y L K + ++ EY G+L C DE+ + L + ++ L
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI-LHFFVQI---------LLA 113
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
LHH T I+HRD+ + N+LL+ + DFG++++L+ S T++ GT YI+PEL
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPEL 172
Query: 347 AYTMVVTEKCDVYSFGVVALEVL 369
+K D+++ G V E+
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 34/235 (14%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHR-SETEELASLESFG 217
+ + + + T+ + I IG G YG VY+ G + A+K L S+ +E +E+
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEY 69
Query: 218 NEARLLSQIRHRNIVKLYG-FCLHRKC----MFLIYEYMEMGS--------LFCVLRTDE 264
N + L H N+VK YG F K ++L+ E GS L C R DE
Sbjct: 70 NILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 265 EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
+ ++ G L +LH++ I+HRD+ NN+LL +E + DFGV+
Sbjct: 128 AMISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 325 LNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
L R GT ++APE+ Y +CDV+S G+ A+E+ G P
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG+G YG V A +G+ VA+KK+ + + + E +LL +RH NI+ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLLD 66
Query: 237 FCLHRKCM-----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
+++ E ME L V+++ + L + + L YLH
Sbjct: 67 ILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFLYQILRGLKYLH-- 120
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG---TYGYIAPELAY 348
+ ++HRD+ +N+L+NS + + DFG+AR ++ D + L T Y APEL
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL-- 177
Query: 349 TMVVTEKC----DVYSFGVVALEVLMGKH--PGE 376
++ + + D++S G + E+L K PG
Sbjct: 178 -LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG VY+AR +G+VVALKK+ R +TE + E LL ++ H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
++L++E++ + + + L K + + + L++ H + +
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH---SHRV 121
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEK 355
+HRD+ N+L+N+E +ADFG+AR T T Y APE L +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 356 CDVYSFGVVALEVLMGK--HPGE 376
D++S G + E++ + PG+
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G+G +G+VY+ +P G+ V + K+ R T A+ E +EA +++ + + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL-DEAYVMAGVGSPYVCR 73
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGMCHALSYLH 289
L G CL L+ + M G L +R +++ +G L+W V + KGM SYL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYLE 126
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY--GYIAPELA 347
+VHRD+++ NVL+ S + DFG+ARLL+ D + G ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 348 YTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVD 404
T + DV+S+GV E++ G P + + + ++ DLL+ RL P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQPPI 235
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446
I +I+V C + RP + + +EF + P
Sbjct: 236 CTIDVYMIMV-----KCWMIDSECRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV--VALKKLHRSETEELASLESFGNEARLLSQIR 227
EDF+ +GTG +G V A + VA+K+ +S+ + ++ +E ++L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE---AVGLDWAKRVNVVKGMCHA 284
H V LYG ++L+ E++ G F LR ++ VG +A ++ ++ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+ IV+RD+ N+LL+ + + DFG A+++ D+ T L GT YIAP
Sbjct: 150 LN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAP 197
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
E+ + + D ++ G+ E+L+G P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 178 IGTGGYGSV-YRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G+G YG+V +G VA+KKL+R EL + ++ E RLL ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81
Query: 237 FCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+ +L+ +M ++G L + E+ + +V M L Y+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H I+HRD+ N+ +N + E + DFG+AR + S T T Y APE+
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD---SEMTGYVVTRWYRAPEVIL 188
Query: 349 T-MVVTEKCDVYSFGVVALEVLMGK 372
M T+ D++S G + E+L GK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG VY+AR + + +ALKK+ R E E+ + E LL +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG----MCHALSYLHHDC 292
K ++L++EY+++ L+ ++ D+AK ++K + ++Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 293 TPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPEL----- 346
+ ++HRD+ N+L++ A +ADFG+AR T T Y APE+
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGK--HPGE 376
Y+ V D++S G + E++ K PG+
Sbjct: 180 HYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I IG G +G V ++ +G+V A+K L++ E + A F E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
R I L+ ++L+ +Y G L +L E+ + D A+ + M A+ +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDSV 118
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELA 347
H VHRDI +NVLL+ +ADFG L D + ++ +A GT YI+PE+
Sbjct: 119 HQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 348 YTM-----VVTEKCDVYSFGVVALEVLMGKHP 374
M +CD +S GV E+L G+ P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 57/311 (18%)
Query: 172 FHIKYC-----IGTGGYGSV--YR---ARLPSGKVVALKKLHRSETEELASLESFGNEAR 221
FH +Y +G G +G V Y A +G++VA+K L R ++ S + E
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTS--GWKKEIN 58
Query: 222 LLSQIRHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK 279
+L + H NIVK G C + K + LI EY+ +GSL L + + L A+ + +
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQ 114
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---------NFDSS 330
+C ++YLH + +HRD+++ NVLL+++ + DFG+A+ + D
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG--------ELLSSSS 382
+ + A E + DV+SFGV E+L E++
Sbjct: 172 SPVF------WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225
Query: 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442
+ ++LI+LL+ + P + Q++ ++ +C ++ K RPT R
Sbjct: 226 GQMTV-VRLIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTF---------R 272
Query: 443 NKAPMQKPFHE 453
+ P+ K H
Sbjct: 273 SLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 65/272 (23%), Positives = 125/272 (45%), Gaps = 26/272 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E + +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHD 61
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V LY + + ++++ E+M GSL L+ + + L + V++ + ++Y+
Sbjct: 62 KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPELAY 348
+HRD+ + N+L+ L +ADFG+ARL+ + + + R + APE A
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 349 TMVVTEKCDVYSFGVVALE-VLMGK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
T K DV+SFG++ E V G+ +PG + N ++++ ++ P Q
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMV----------NREVLEQVERGYRMPCPQ 226
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437
+ + + C + P RPT + + +
Sbjct: 227 GCPESL---HELMKLCWKKDPDERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 33/267 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G + GK +K+++ S+ ES E +LS ++H NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQE 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNVVKGMCHALSYLHH 290
++++ +Y E G L+ + E+ + LDW ++ C AL ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQI------CLALKHVHD 119
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
I+HRDI S N+ L + + DFG+AR+LN GT Y++PE+
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 351 VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS-PPVDQKIRQ 409
K D+++ G V E+ KH E N+K + L R S PPV
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA---------GNMKNLVLKIIRGSYPPVSSHYSY 227
Query: 410 DI-ILVSTVAFSCLRSQPKSRPTMQLV 435
D+ LVS + + P+ RP++ +
Sbjct: 228 DLRNLVSQL----FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 178 IGTGGYGSVY------RARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY R VA+K L S +E+ F EA ++S+ H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNI 71
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-------LDWAKRVNVVKGMCHA 284
V+L G R F++ E M G L LR + D V C
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADFGVARLL----NFDSSNRTLLAG 337
L H +HRDI++ N LL + A +ADFG+AR + + R +L
Sbjct: 132 LEENH------FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP- 184
Query: 338 TYGYIAPELAYTMVVTEKCDVYSFGVVALEV 368
++ PE + T K DV+SFGV+ E+
Sbjct: 185 -IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G +G VY+A+ V+A K+ +++EE LE + E +L+ H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV-KGMCHALSYLHHDCTPPI 296
+ ++++ E+ G++ V+ E + ++ VV K AL+YLH + I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KI 124
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE-- 354
+HRD+ + N+L + + +ADFGV+ R GT ++APE+ +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 355 ---KCDVYSFGVVALEV 368
K DV+S G+ +E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI 226
D+ I +G G +G VY+AR + +G+VVALKK+ ++ + + E ++L ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKL 64
Query: 227 RHRNIVKLYGFCLHR--------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
+H N+V L + R ++++ YM+ L +L + +V L ++ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLL--ENPSVKLTESQIKCYM 121
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 338
+ ++YLH + I+HRDI + N+L++++ +ADFG+AR + N
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN-----PK 173
Query: 339 YGYIAPELAYT-MVVT 353
G YT +VVT
Sbjct: 174 GGGGGGTRKYTNLVVT 189
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 42/223 (18%)
Query: 178 IGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLE---SFGNEARLLSQIRH 228
IG G +G V++AR P +VA+K L +E AS + F EA L+++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQREAALMAEFDH 67
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------------------DEEAVGL 269
NIVKL G C K M L++EYM G L LR + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 270 DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329
+++ + K + ++YL VHRD+++ N L+ + +ADFG++R N S
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR--NIYS 182
Query: 330 SNRTLLAGT----YGYIAPELAYTMVVTEKCDVYSFGVVALEV 368
++ + ++ PE + T + DV+++GVV E+
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 34/266 (12%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKL---HRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G YG V R + GK +KKL + S E A+ + EA+LLSQ++H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ----EAQLLSQLKHPNIVA 63
Query: 234 LYGFCLHRKCM-FLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNVVKGMCHALSY 287
+ +++ + E G L+ L+ + E ++W ++ + AL Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM------ALQY 117
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH I+HRD+ + NV L V D G+AR+L + L GT Y++PEL
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
K DV++ G E+ KH + D N + +++ +L P
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFN-------AKDMNSLVYRIIEGKLPPMPKDYS 227
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ L++T+ L +P+ RP+++
Sbjct: 228 PELGELIATM----LSKRPEKRPSVK 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 54/289 (18%)
Query: 178 IGTGGYGSVYRARL-----PSGKV-VALKKLHRSETE-ELASLESFGNEARLLSQI-RHR 229
+G G +G V +A P+ VA+K L TE +L+ L S E ++ I +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS---EMEMMKMIGKHK 76
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------------- 276
NI+ L G C ++++ EY G+L LR G +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 277 -----VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331
V +GM +L + +HRD+++ NVL+ + +ADFG+AR ++
Sbjct: 136 SFAYQVARGM----EFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 332 RTLLAG--TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI 389
R G ++APE + V T + DV+SFGV+ E+ L S +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------LGGSPYPGIPVE 241
Query: 390 KLIDLLDP--RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLV 435
+L LL R+ P Q Q+ + + C P RPT QLV
Sbjct: 242 ELFKLLKEGYRMEKP--QNCTQE---LYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G GG+G V ++ +GK+ A KKL++ ++ E E R+L+++ R IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 236 GFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
F + + L+ M G L + + DEE G + + L +LH
Sbjct: 61 AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----AYTM 350
I++RD+ NVLL+++ ++D G+A L S AGT G++APEL Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 351 VVTEKCDVYSFGVVALEVLMGKHP 374
V D ++ GV E++ + P
Sbjct: 177 SV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G+G YGSV A +G+ VA+KKL R E+ + ++ E LL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL-- 79
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAV-GLDWA--KRVNVVKGMCHALSYLHH 290
L + + E + V+ +TD + + G + K +V M L Y+H
Sbjct: 80 --LDVFTSAVSGD--EFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT- 349
+ I+HRD+ N+ +N + E + DFG+AR + + + + T Y APE+
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVILNW 189
Query: 350 MVVTEKCDVYSFGVVALEVLMGK 372
M + D++S G + E+L GK
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 177 CIGTGGYGSVYRAR-LPSGKVVALKKLHR--SETEELASLESFGNEARLLSQI-RHRNIV 232
+G G +GSVY AR +G++VA+KK+ + EE +L E + L ++ H NIV
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL----REVKSLRKLNEHPNIV 61
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV---NVVKGMCH----AL 285
KL ++ ++EYME G+L+ +++ + + +V++ + + L
Sbjct: 62 KLKEVFRENDELYFVFEYME-GNLYQLMKDRK--------GKPFSESVIRSIIYQILQGL 112
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR---TLLAGTYGYI 342
+++H HRD+ N+L++ +ADFG+AR + +R T T Y
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYR 165
Query: 343 APEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
APE+ +Y+ V D+++ G + E+ +
Sbjct: 166 APEILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 29/229 (12%)
Query: 174 IKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRSETEELASLESFGNEARLLSQIR 227
+K +G G +G V+ A P +VA+K L + + + F EA LL+ ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQ 65
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAV---------GLDWAKRVNV 277
H +IVK YG C+ + +++EYM+ G L LR +AV L ++ +++
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 337
+ + + YL + VHRD+++ N L+ L + DFG++R + S++ + G
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGG 180
Query: 338 ----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSS 381
++ PE T + DV+S GVV E+ GK P LS++
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 26/222 (11%)
Query: 171 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQI 226
+++ +G G +G RA L S + A+K++ ++ +++E EA LL+++
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKM 55
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNVVKGM 281
+H NIV ++++ EY + G L ++ E L W + M
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------M 109
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
C + ++H ++HRDI S N+ L + + DFG ARLL + GT Y
Sbjct: 110 CLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW 383
+ PE+ M K D++S G + E+ KHP ++SW
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQANSW 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 69/258 (26%), Positives = 123/258 (47%), Gaps = 24/258 (9%)
Query: 178 IGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFGNEA--RLLSQIRHRNIVK 233
IG G YG V++AR G+ VALK++ EE L + A R L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 234 LYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
L+ C + + L++E+++ + + E V + K +++ + L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + +VHRD+ N+L+ S + +ADFG+AR+ +F + +++ T Y APE+
Sbjct: 127 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
D++S G + E+ K L SS +D+ K++D+ + P ++
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK---PLFRGSS-DVDQLGKILDV----IGLPGEEDWP 234
Query: 409 QDIILVSTVAFSCLRSQP 426
+D+ L AF +QP
Sbjct: 235 RDVALPRQ-AFHSKSAQP 251
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 83/280 (29%), Positives = 123/280 (43%), Gaps = 49/280 (17%)
Query: 178 IGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
IG G +G VY L A+K L+R +L +E F E ++ H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 234 LYGFCLHRKCMFLI-YEYMEMGSLFCVLR------TDEEAVGLDWAKRVNVVKGMCHALS 286
L G CL + L+ YM+ G L +R T ++ +G + V KGM
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG----LQVAKGME---- 112
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS-SNRTLLAGTYGYI 342
YL + VHRD+++ N +L+ VADFG+AR + + S N T ++
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLID---LLDPR 398
A E T T K DV+SFGV+ E++ G P + S D + L+ LL P
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRRLLQPE 225
Query: 399 LSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVS 436
P P+ + V SC +P+ RPT +LVS
Sbjct: 226 YCPDPLYE-----------VMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I IG G +G V ++ ++ A+K L++ E + A F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK-RVNVVKGMCHALSY 287
+ I L+ ++L+ +Y G L +L E+ + D A+ + + H++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPEL 346
LH+ VHRDI +NVLL+ +ADFG +N D + ++ +A GT YI+PE+
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 347 AYTM-----VVTEKCDVYSFGVVALEVLMGKHP 374
M +CD +S GV E+L G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
DF I +G GGYG V+ A+ +G++VALK++ +S +L + E +L+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 230 NIVKL-YGFCLHRKCMFLIYEYMEMG---SLFCVLRT-DEEAVGLDWAKRVNVVKGMCHA 284
+VKL Y F + ++L EY+ G +L L E+ A+ V H
Sbjct: 62 WLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA-LHE 119
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGTYGYIA 343
L Y+H D P N L+++ + DFG+++ ++ + +S + G+ Y+A
Sbjct: 120 LGYIHRDLKP---------ENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMA 166
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
PE+ D +S G + E L G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 13/267 (4%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+F I+ IG G + VYRA L K VALKK+ E + + + E LL Q+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NVVKGMCHALSYL 288
N++K + + ++ E + G L +++ ++ L + V +C A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + ++HRDI NV + + + D G+ R + ++ L GT Y++PE +
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
K D++S G + E+ + P + +SL + I+ D P + +K+R
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-YPPLPTEHYSEKLR 238
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLV 435
+ LVS C+ P RP + V
Sbjct: 239 E---LVSM----CIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF I IG G +G V +L + KV A+K L++ E + A F E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK----RVNVVKGMCHA 284
+ I L+ ++L+ +Y G L +L E+ + D A+ + + H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIA 343
L Y VHRDI +N+L++ +ADFG L D + ++ +A GT YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 344 PELAYTMV-----VTEKCDVYSFGVVALEVLMGKHP 374
PE+ M +CD +S GV E+L G+ P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 8/197 (4%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +VY+ R +G++VALK++H E S E L+ +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI--REISLMKELKHENIVRLHD 65
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+ L++EYM+ L + T LD + + +++ H + +
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEK 355
+HRD+ N+L+N E +ADFG+AR + + T Y AP+ L + +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 356 CDVYSFGVVALEVLMGK 372
D++S G + E++ G+
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 178 IGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +GSV A+L S + VA+K L +++ + +E F EA + + H N++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 234 LYGFCLHRKCM------FLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHA 284
L G L + +I +M+ G L L R EE L V + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY--GYI 342
+ YL + +HRD+++ N +LN + VADFG+++ + R A ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLL--DPRL 399
A E V T DV++FGV E++ G+ P ++ +N ++ + L RL
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--------YAGVENSEIYNYLIKGNRL 234
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
P D +D+ + C +PK RP+ Q + ++
Sbjct: 235 KQPPD--CLEDVY---ELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLH-----RSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY + +G+ +A K++ ++E+++LE E +LL ++H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC---EIQLLKNLQHERI 66
Query: 232 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
V+ YG CL K + + EYM GS+ L+ E+V + +++ ++GM
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI--LEGM---- 119
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTYGYI 342
SYLH + IVHRDI N+L +S + DFG ++ L + + GT ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+PE+ K DV+S G +E+L K P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 40/227 (17%)
Query: 178 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RH 228
+G G +G V A + VA+K L TE+ L +E ++ I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 80
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG-------- 280
+NI+ L G C +++I EY G+L LR G++++ + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 281 ------MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRT 333
+ + YL + +HRD+++ NVL+ +ADFG+AR + N D +T
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 334 LLAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
T G ++APE + V T + DV+SFGV+ E+ +G P
Sbjct: 197 ----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 81/309 (26%), Positives = 125/309 (40%), Gaps = 55/309 (17%)
Query: 158 GRITFQDMIEAT--EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLE 214
G +T D IG+G G VY+ R +G V+A+K++ R+ +E
Sbjct: 1 GYLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----- 55
Query: 215 SFGNEARLLSQIR-----HR--NIVKLYGFCLHRKCMFLIYEYME-MGSLFCVLRT---- 262
R+L + H IVK YG I ME M + L
Sbjct: 56 ---ENKRILMDLDVVLKSHDCPYIVKCYG-YFITDSDVFIC--MELMSTCLDKLLKRIQG 109
Query: 263 --DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320
E+ +G V +VK AL YL ++HRD+ +N+LL++ + DFG
Sbjct: 110 PIPEDILG---KMTVAIVK----ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG 160
Query: 321 VA-RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK----CDVYSFGVVALEVLMGKHPG 375
++ RL+ DS +T AG Y+APE K DV+S G+ +E+ G+ P
Sbjct: 161 ISGRLV--DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
Query: 376 ELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPTM-Q 433
+ + L K++ P L P ++ D V CL + RP +
Sbjct: 219 KNCKTEFEVLT---KILQEEPPSLPP--NEGFSPDFCSFVD----LCLTKDHRKRPKYRE 269
Query: 434 LVSNEFIAR 442
L+ + FI R
Sbjct: 270 LLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
F + +G G YG V + R + ++VA+KK SE E E+ E ++L ++ N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTLKQEN 61
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
IV+L R ++L++EY+E L + +E G+ K + + + A+ + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS-SNRTLLAGTYGYIAPELAYT 349
+ IVHRDI N+L++ + DFG AR L+ S +N T T Y +PEL
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 350 MVVTEKCDVYSFGVVALEVLMGK--HPGE 376
+ D++S G + E+ G+ PGE
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 178 IGTGGYGSVYRA-RLPSGKV----VALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G+G +G+V++ +P G VA+K + + + + + + + H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ--TFQEITDHMLAMGSLDHAYIV 72
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGMCHALSYL 288
+L G C + L+ + +GSL +R +++ L+W V + KGM YL
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YYL 125
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD------SSNRTLLAGTYGYI 342
+VHR++++ N+LL S+ +ADFGVA LL D S ++T + ++
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WM 178
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDP--RL 399
A E T + DV+S+GV E++ G P ++ + ++ DLL+ RL
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP--------YAGMRPHEVPDLLEKGERL 230
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446
+ P + I V V C RPT + ++NEF + P
Sbjct: 231 AQP-----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG VY+ R +G++VA+KK+ R E+EE + E LL +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+ ++LI+E++ M L L + + +D + + + + + H + +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMV 351
+HRD+ N+L++++ +ADFG+AR T T Y APE+ Y+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 352 VTEKCDVYSFGVVALEVLMGK 372
V D++S G + E+ K
Sbjct: 183 V----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 6e-13
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 178 IGTGGYGSVY---------RARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+G G +G+VY RL K + + +L+ +ET + A+ E A+LLS++ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQE-----AQLLSKLDH 61
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
IVK + L R +I EY E L C L + G ++ V + L +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-GKTLSEN-QVCEWFIQLLLGV 119
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H+ I+HRD+ + N+ L + L + DFGV+RLL T GT Y++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKH 373
K D++S G + E+ H
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 33/70 (47%), Positives = 46/70 (65%)
Query: 9 LELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI 68
L L N L G IP++I+KL+ L +NLS NSI G I LG I ++ +DLS N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 69 PESVRKVPHL 78
PES+ ++ L
Sbjct: 483 PESLGQLTSL 492
|
Length = 623 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 45/277 (16%)
Query: 178 IGTGGYGSVYRARLPSGKVVALK---KLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G G +GSV +L LK K + + + +E F +EA + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 235 YGFCLHRKCM------FLIYEYMEMGSLFCVL---RTDEEAVGLDWAK----RVNVVKGM 281
G C + +I +M+ G L L R L V++ GM
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGT-Y 339
YL +HRD+++ N +L ++ VADFG+++ + + D + +A
Sbjct: 127 ----EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVL---MGKHPGELLSSSSWSLDKNIKLIDLL- 395
+IA E V T K DV++FGV E+ +PG +N ++ D L
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV----------ENHEIYDYLR 229
Query: 396 -DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
RL P D + + +SC R+ PK RPT
Sbjct: 230 HGNRLKQPEDCLDE-----LYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 81/313 (25%), Positives = 132/313 (42%), Gaps = 53/313 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +G G G V + PSG ++A K +H E + A E ++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKP-AIRNQIIRELKVLHECNS 58
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHA 284
IV YG + + E+M+ GSL VL R E +G + V++G
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG---KISIAVLRG---- 111
Query: 285 LSYLH--HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
L+YL H I+HRD+ +N+L+NS E + DFGV+ L DS + + GT Y+
Sbjct: 112 LTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYM 165
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP-------------------------GEL 377
+PE T + D++S G+ +E+ +G++P
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 378 LSSSSWSLDKNIKLIDLLDPRL-SPPVDQKIRQDIILVSTVAF--SCLRSQPKSRPTM-Q 433
+S + + + +LLD + PP K+ F CL+ PK R + +
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
Query: 434 LVSNEFIARNKAP 446
L + FI R +
Sbjct: 284 LTKHPFIKRAELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 44/284 (15%)
Query: 178 IGTGGYGSVYRARLPSGKV---VALKKLH-----RSETEELASLESFGNEARLLSQIRHR 229
+G G +GSV +L VA+K + RSE +E F +EA + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHP 60
Query: 230 NIVKLYGFCLHRK------CMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKG 280
N+++L G CL +I +M+ G L L R + L V +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGT- 338
+ + YL + +HRD+++ N +LN + VADFG++ ++ N D + +A
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 339 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397
+IA E V T K DV+SFGV E+ G+ P + +N ++ D L
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--------YPGVENSEIYDYLRQ 229
Query: 398 --RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
RL P D + + ++ SC PK RP+ + + E
Sbjct: 230 GNRLKQPPDC-----LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKL---HRSETEELASLES 215
I F + ++ + I IG G YG V++ +G A+K L H + E +E+
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEA 63
Query: 216 FGNEARLLSQIRHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLD 270
N + LS H N+VK YG + ++L+ E GS+ TD L
Sbjct: 64 EYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLK 116
Query: 271 WAKRVN--VVKGMCH-ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
+R+ ++ + H AL L H +HRD+ NN+LL +E + DFGV+ L
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 328 DSSNRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
R GT ++APE+ +CDV+S G+ A+E+ G P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 44/229 (19%)
Query: 178 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETE-ELASLESFGNEARLLSQI-R 227
+G G +G V RA R VA+K L + T+ +LA L S E L+ I +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS---EMELMKLIGK 76
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSL---------------FCVLRTDEEAVGLDWA 272
H+NI+ L G C +++I EY G+L F + + EE L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ--LSFK 134
Query: 273 KRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSN 331
V+ + + YL + +HRD+++ NVL+ + +ADFG+AR + + D
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 332 RTLLAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+T + G ++APE + V T + DV+SFG++ E+ +G P
Sbjct: 192 KT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLS-QIRHRNIVKLY 235
+G G +G V+ A L + + A+K L + +E E R+LS H + LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
++ +F + EY+ G L +++ + D + + L +LH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKG 116
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
IV+RD+ +N+LL+++ +ADFG+ + + GT YIAPE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 356 CDVYSFGVVALEVLMGKHP 374
D +SFGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQI 226
ED + IG G +G V RA + + A+K L +E F E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKL 59
Query: 227 -RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR------TD-----EEAVGLDWAKR 274
H NI+ L G C +R +++ EY G+L LR TD E +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
+++ + + + +HRD+++ NVL+ L + +ADFG++R
Sbjct: 120 -QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVY 172
Query: 335 LAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ T G ++A E V T K DV+SFGV+ E++ +G P
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 43/281 (15%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLES-FGNEARLLSQIRHRNIVKLY 235
IG GG G VY A P + VALKK+ R + E L+ F EA++ + + H IV +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNV------VKGMCHALSY 287
C ++ Y+E +L +L++ +E++ + A++ +V +C + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---------------SSNR 332
+H + ++HRD+ +N+LL E + D+G A + S+
Sbjct: 129 VH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 333 TL---LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI 389
T+ + GT Y+APE + +E D+Y+ GV+ ++L P + K
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--------YRRKKGR 237
Query: 390 KLIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSR 429
K+ + P++ ++I +S +A L P R
Sbjct: 238 KISY--RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQI- 226
D + IG G +G V +AR+ + A+K++ +++ F E +L ++
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 65
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR------TD-------EEAVGLDWAK 273
H NI+ L G C HR ++L EY G+L LR TD A L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 274 RVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333
++ + + YL +HRD+++ N+L+ A +ADFG++R
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEV 176
Query: 334 LLAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ T G ++A E V T DV+S+GV+ E++ +G P
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLY 235
+G G +G V ARL SG++ A+K L + + +E E R+LS R H + +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 236 GFCLHR-KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
C +F + E++ G L ++ D A+ + AL +LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLH---DK 115
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
I++RD+ +NVLL+ E +ADFG+ + F+ + GT YIAPE+ M+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 355 KCDVYSFGVVALEVLMGKHPGE 376
D ++ GV+ E+L G P E
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 29/94 (30%), Positives = 56/94 (59%), Gaps = 3/94 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L L +N L G IP E+ +++ L ++ L +N+++G+I ++G + ++ +DL
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 62 NNLSGSIPES---VRKVPHLYVYGKNFDVEIPNT 92
NNL+G IP S ++ + +L++Y IP +
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
|
Length = 968 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 34/160 (21%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFG-NEARLLSQIRHRNIVKLY 235
IG G YG+V++A+ + ++VALK++ + +E + S E LL +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLY 65
Query: 236 GFCLHRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNVVK----------GMCH 283
K + L++EY + + F D + +VK CH
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCH 116
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
+ H+ ++HRD+ N+L+N E +ADFG+AR
Sbjct: 117 S----HN-----VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 55/225 (24%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQ----IRHRN-- 230
IG G +G+V + PSG ++A+K++ RS +E + RLL +R +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEK-------EQKRLLMDLDVVMRSSDCP 63
Query: 231 -IVKLYGFCLHRK----CMFLIYEYMEMGSL-------FCVLRT--DEEAVGLDWAKRVN 276
IVK YG CM E M++ SL + VL++ EE +G V
Sbjct: 64 YIVKFYGALFREGDCWICM----ELMDI-SLDKFYKYVYEVLKSVIPEEILG---KIAVA 115
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
VK AL+YL + I+HRD+ +N+LL+ + DFG++ L DS +T A
Sbjct: 116 TVK----ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDA 168
Query: 337 GTYGYIAPEL-------AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
G Y+APE Y + + DV+S G+ EV GK P
Sbjct: 169 GCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 25/264 (9%)
Query: 117 ALLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKY 176
L AL++ + F R++K + D F D +D+ ED+ +
Sbjct: 2 GLDALVYDLDFPALRKNKNI------------DNFLNRYKDTINKIRDLRMKAEDYEVVK 49
Query: 177 CIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235
IG G +G V R S KV A+K L + E + + F E +++ +V+L+
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ ++++ EYM G L ++ + V WA+ + AL +H +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTA--EVVLALDAIH---SMG 162
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELAYTM---- 350
+HRD+ +N+LL+ +ADFG +N + R A GT YI+PE+ +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 351 VVTEKCDVYSFGVVALEVLMGKHP 374
+CD +S GV E+L+G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G GG+G V ++ +GK+ A KKL + ++ + NE ++L ++ R IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 236 GFCLHRKC-MFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
F K + L+ M G L + + E G A+ + + L +LH
Sbjct: 61 AF--ETKDDLCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 353
IV+RD+ NVLL+ ++D G+A L AGT GY+APE+ V
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 354 EKCDVYSFGVVALEVLMGKHP 374
D ++ G E++ G+ P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 37/236 (15%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELA-SLESFGNEARLLSQ 225
+F + +GTG YG V+ R GK+ A+K L ++ + A + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 226 IRHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVK 279
+R +V L Y F K + LI +Y+ G LF L E V RV +
Sbjct: 61 VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV------RV-YIA 112
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGT 338
+ AL +LH I++RDI N+LL+SE + DFG+++ + R GT
Sbjct: 113 EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 339 YGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGKHP----GELLSSSSWS 384
Y+APE+ + V D +S GV+ E+L G P GE S S S
Sbjct: 170 IEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 178 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G +G VY+ L + VA+K L + E E F +EA + S+++H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNVV 278
V L G + + +I+ Y L F V+R+ VG L+ A V++V
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 279 KGMCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
+ + +L HH +VH+D+++ NVL+ +L ++D G+ R + + + L+
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREV-YAADYYKLMG 184
Query: 337 GTY---GYIAPELAYTMVVTEKCDVYSFGVVALEVL 369
+ +++PE + D++S+GVV EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 178 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G +G+V + S K VA+K L +++ + A + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK-GMCHALSYLHHDCT 293
G C M L+ E E+G L L+ ++ + + V+ V GM YL
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGM----KYLEET-- 114
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG-----YIAPELAY 348
VHRD+++ NVLL ++ A ++DFG+++ L D + A T+G + APE
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMN 171
Query: 349 TMVVTEKCDVYSFGVVALE 367
+ K DV+SFGV+ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 178 IGTGGYGSVYRAR----LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G V+ R +G++ A+K L ++ T ++ E +L+++ H IVK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 234 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHALSYL 288
L Y F K ++LI +++ G LF L + EE V A+ + AL +L
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELA 347
H + I++RD+ N+LL+ E + DFG+++ + D + GT Y+APE+
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVV 170
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP 374
T+ D +SFGV+ E+L G P
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF + IG G +G V R S +V A+K L + E + + F E +++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNVVKGMCHALS 286
IV+L+ K ++++ EYM G L ++ + + WA+ VV AL
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVL----ALD 156
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPE 345
+H + +HRD+ +N+LL+ +ADFG ++ + R A GT YI+PE
Sbjct: 157 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 346 LAYTMVVT----EKCDVYSFGVVALEVLMGKHP 374
+ + +CD +S GV E+L+G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +G G G V + + PSG ++A K +H + + E ++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS 62
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHA 284
IV YG + + E+M+ GSL VL R EE +G + V++G
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIAVLRG---- 115
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+YL I+HRD+ +N+L+NS E + DFGV+ L DS + + GT Y++P
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSP 171
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
E + + D++S G+ +E+ +G++P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 23/154 (14%)
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ N +KLY K LI +Y++ G LF +L+ + + L A+ +++ + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124
Query: 288 LH-HDCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
LH H+ I+H DI NVL + ++ ++ D+G+ +++ S GT Y +PE
Sbjct: 125 LHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE 176
Query: 346 LAYTMVVTEKCDVYSF-----GVVALEVLMGKHP 374
+ D SF GV+ E+L GKHP
Sbjct: 177 ----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 34/227 (14%)
Query: 163 QDMIEATEDFHIKY----CIGTGGYGSVYRARLPSGKV-VALKKLHRS-ETEELASLESF 216
Q++ + + +Y +G+G YG V A VA+KKL R ++ A ++
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK-RTY 62
Query: 217 GNEARLLSQIRHRNIVKLYG-FCLHRKCM-----FLIYEYMEMGSLFCVLR----TDEEA 266
E RLL + H N++ L F +L+ M L +++ +D+
Sbjct: 63 -RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHI 120
Query: 267 VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
L V + L Y+H + I+HRD+ +N+ +N + E + DFG+AR +
Sbjct: 121 QFL--------VYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 327 FDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK 372
+ T T Y APE+ M + D++S G + E+L GK
Sbjct: 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +VY+ + +GK+VALK + R + EE + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAI-REASLLKGLKHANIVLLHD 70
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
++ + L++EY+ C D+ GL + + LSY+H I
Sbjct: 71 IIHTKETLTLVFEYVHTD--LCQY-MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKC 356
+HRD+ N+L++ E +ADFG+AR + S + T Y P++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 357 -DVYSFGVVALEVLMG 371
D++ G + +E++ G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 174 IKYCIGTGGYGSVYRA--RLPSGK--VVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
I+ +GTG +G + R +LPS + VA+ L +++ F EA L Q H
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHS 66
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NIV+L G M ++ EYM G+L LR E L + + ++ G+ + YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLS 124
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG-YIAPELAY 348
VH+ ++++ VL+NS+L ++ F + ++ T+ + + APE
Sbjct: 125 E---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 349 TMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ DV+SFG+V EV+ G+ P
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELA-SLESFGNEARLLSQ 225
+F + +GTG YG V+ R SG K+ A+K L ++ + A + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 226 IRHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVK 279
IR +V L Y F K + LI +Y+ G LF L R E+ V +
Sbjct: 61 IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKEQEVQI-------YSG 112
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGT 338
+ AL +LH I++RDI N+LL+S + DFG+++ + D R GT
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 339 YGYIAPELAYTMVV--TEKCDVYSFGVVALEVLMGKHP 374
Y+AP++ + D +S GV+ E+L G P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSE-TEELASLESFGNEARLLSQ 225
+F + +GTG YG V+ R +G K+ A+K L ++ ++ ++E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 226 IRHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
+R +V L Y F K + LI +Y+ G +F L E+ V R +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEV------RFYSGE 113
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGT 338
+ AL +LH IV+RDI N+LL+SE + DFG+++ + RT GT
Sbjct: 114 -IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 339 YGYIAPELAYTMVVTEKC-DVYSFGVVALEVLMGKHP----GELLSSSSWSLDKNIKLID 393
Y+APE+ K D +S G++ E+L G P GE + S S + I
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-----RRIL 224
Query: 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR 429
DP P QD++ LR PK R
Sbjct: 225 KCDPPF-PSFIGPEAQDLL------HKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 44/232 (18%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSE-----TEELASLESFG------NEARLLSQ 225
+G G YG V +A +GK+VA+KK+ E T++ + G E +++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
I+H NI+ L + + L+ + M L V+ + + L ++ ++ + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG----- 340
+ LH +HRD+S N+ +NS+ +ADFG+AR + + TL
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 341 ---------YIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK--HPGE 376
Y APEL Y D++S G + E+L GK PGE
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 40/227 (17%)
Query: 178 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RH 228
+G G +G V A + VA+K L T++ L +E ++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DLSDLVSEMEMMKMIGKH 77
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA--------------KR 274
+NI+ L G C ++++ EY G+L LR G+D++
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRA-RRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRT 333
V+ + + YL + +HRD+++ NVL+ + +ADFG+AR + N D +T
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 334 LLAGTYG-----YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
T G ++APE + V T + DV+SFGV+ E+ +G P
Sbjct: 194 ----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 59/251 (23%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
+DF IG G +G V RL +G + A+KKL +SE E + E +L++
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-RTD---EEAVGLDWAKRVNVVKGM 281
+ +VKLY ++LI EY+ G + +L + D EE A+ + + +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV------------ARLL---- 325
H L Y +HRDI +N+LL+++ ++DFG+ R+L
Sbjct: 118 -HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 326 ----------NFDSS--------NRTLLA----GTYGYIAPELAYTMVVTEKCDVYSFGV 363
S NR LA GT YIAPE+ ++CD +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 364 VALEVLMGKHP 374
+ E+L+G P
Sbjct: 228 IMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 171 DFHIKY----CIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
D +Y IG+G YG V A SGK VA+KK+ + + + E ++L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRH 60
Query: 226 IRHRNIVKLYGFCL----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NVVK 279
+H NI+ + K ++++ + ME L ++ +D+ + + + +++
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLR 118
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR----TLL 335
G L Y+H ++HRD+ +N+L+N + E + DFG+AR L+ + T
Sbjct: 119 G----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 336 AGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKH--PG 375
T Y APEL ++ T D++S G + E+L + PG
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 178 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVK 233
IG G +G V +AR+ + A+K++ +++ F E +L ++ H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIIN 60
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLR------TD-----EEAVGLDWAKRVNVVKGMC 282
L G C HR ++L EY G+L LR TD + + + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ-QLLHFAA 119
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG-- 340
+ + +HRD+++ N+L+ A +ADFG++R + T G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRL 173
Query: 341 ---YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
++A E V T DV+S+GV+ E++ +G P
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED+ + IG G +G V R S KV A+K L + E + + F E +++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+V+L+ K ++++ EYM G L ++ + V WAK + AL +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTA--EVVLALDAI 158
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPELA 347
H + ++HRD+ +N+LL+ +ADFG ++ R A GT YI+PE+
Sbjct: 159 H---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 348 YTM----VVTEKCDVYSFGVVALEVLMGKHP 374
+ +CD +S GV E+L+G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235
+G G +G V A L + ++ A+K L + + +E E R+L+ +H + +L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLH-HD 291
+ +F + EY+ G L ++ +E +A + + L +LH
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL------GLQFLHERG 116
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVAR--LLNFDSSNRTLLAGTYGYIAPELAYT 349
I++RD+ +NVLL+SE +ADFG+ + +L +++ GT YIAPE+
Sbjct: 117 ----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAPEILSY 170
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHPGE 376
D ++ GV+ E+L G+ P E
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 178 IGTGGYGSVYRARLP-----SGKVVALKKLH-RSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G V R +G+ VA+K L S +A L+ E +L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK---KEIEILRNLYHENI 68
Query: 232 VKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
VK G C + LI E++ GSL L ++ + L +++ +C + YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDYLG 126
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTYGYIAPEL 346
+ VHRD+++ NVL+ SE + + DFG+ + + D T+ L + APE
Sbjct: 127 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 347 AYTMVVTEKCDVYSFGVVALEVL 369
DV+SFGV E+L
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ I+ IG G YG V A +G+ VA+KK++ E ++ E +LL +RH +
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60
Query: 231 IVKLYGFCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
IV++ L K +++++E ME L V++ +++ L + + AL
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRAL 116
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTYGYI 342
Y+H T + HRD+ N+L N++ + + DFG+AR+ D+ T Y
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 343 APEL--AYTMVVTEKCDVYSFGVVALEVLMGK 372
APEL ++ T D++S G + EVL GK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 57/226 (25%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ--IRHR----- 229
+G G YG V + R +P+G ++A+K++ A++ S + RLL I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR-------ATVNS-QEQKRLLMDLDISMRSVDCP 60
Query: 230 NIVKLYGFCLHRK-----CMFLIYEYMEMGSLFCV--------LRTDEEAVGLDWAKRVN 276
V YG L R+ CM E M+ SL L E+ +G V+
Sbjct: 61 YTVTFYG-ALFREGDVWICM----EVMDT-SLDKFYKKVYDKGLTIPEDILG---KIAVS 111
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
+VK AL YLH + ++HRD+ +NVL+N + + DFG++ L DS +T+ A
Sbjct: 112 IVK----ALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA 164
Query: 337 GTYGYIAPEL--------AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
G Y+APE Y + K DV+S G+ +E+ G+ P
Sbjct: 165 GCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G V ++ +GK+ A KKL + ++ NE ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 237 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ + L+ M G L F + E G + + V +C L LH +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
IV+RD+ N+LL+ ++D G+A + + + + GT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 356 CDVYSFGVVALEVLMGKHP 374
D ++ G + E++ G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +V++ R + +VALK++ R E EE A + E LL ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAI-REVSLLKNLKHANIVTLHD 70
Query: 237 FCLHRKCMFLIYEYME---------MGSLFCVLRTDEEAVGLDWAKRVNVVK-GMCHALS 286
+C+ L++EY++ G+L + V + + LS
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM-------------HNVKIFMFQLLRGLS 117
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE- 345
Y H I+HRD+ N+L+N + E +ADFG+AR + + + T Y P+
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGK 372
L + + D++ G + E+ G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 168 ATEDFHIKYCIGTGGYGSVYR--ARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
AT +++ +G G Y +VY+ +R+ +G++VALK + +TEE + EA LL
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRI-NGQLVALKVISM-KTEEGVPFTAI-REASLLKG 59
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNVVK 279
++H NIV L+ ++ + ++EYM TD + GL +
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMH---------TDLAQYMIQHPGGLHPYNVRLFMF 110
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ L+Y+H I+HRD+ N+L++ E +ADFG+AR + S + T
Sbjct: 111 QLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL 167
Query: 340 GYIAPE--LAYTMVVTEKCDVYSFGVVALEVLMGK 372
Y P+ L T + D++ G + +E+L G+
Sbjct: 168 WYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 41/202 (20%)
Query: 196 VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255
+VA+K L + + F E ++LS+++ NI++L G C+ + +I EYME G
Sbjct: 48 LVAVKILRPDANKNARN--DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 256 LFCVLRT----DEEAVGLD------------WAKRVNVVKGMCHALSYLHHDCTPPIVHR 299
L L + D+E G D ++ ++V + + YL + VHR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162
Query: 300 DISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY-----------GYIAPELAY 348
D+++ N L+ L +ADFG++ R L AG Y ++A E
Sbjct: 163 DLATRNCLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECIL 213
Query: 349 TMVVTEKCDVYSFGVVALEVLM 370
T DV++FGV E+LM
Sbjct: 214 MGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 193 SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY--GFCLHRKCMFLIYEY 250
+G VA+K L EE F E L +++ H NIV L G +F ++EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 251 MEMGSLFCVLRTD-----EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNN 305
+ +L VL D E L + V+ + A H+ IVHRD+ N
Sbjct: 61 VPGRTLREVLAADGALPAGETGRL----MLQVLDALACA-----HNQG--IVHRDLKPQN 109
Query: 306 VLLNS---ELEAFVADFGVARLL-NFDSSNRTLLA------GTYGYIAPELAYTMVVTEK 355
++++ A V DFG+ LL ++ L GT Y APE VT
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 356 CDVYSFGVVALEVLMGK 372
D+Y++G++ LE L G+
Sbjct: 170 SDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKL-----HRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY +G+ +A+K++ + ++E+ +LE E +LL +RH I
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC---EIQLLKNLRHDRI 66
Query: 232 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK----GMCHA 284
V+ YG CL K + + EYM GS+ + +A G A NV + +
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSI----KDQLKAYG---ALTENVTRRYTRQILQG 118
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTYGY 341
+SYLH + IVHRDI N+L +S + DFG ++ + + + GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
++PE+ K DV+S +E+L K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 24/71 (33%), Positives = 43/71 (60%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
C LR + L +N SG +PSE KL + +L++S+N++ G+I S+ ++P + + L+ N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 63 NLSGSIPESVR 73
G +P+S
Sbjct: 463 KFFGGLPDSFG 473
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +G G G V++ + PSG ++A K +H + + E ++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNS 62
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHA 284
IV YG + + E+M+ GSL VL R E+ +G + V+KG
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG---- 115
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+YL I+HRD+ +N+L+NS E + DFGV+ L DS + + GT Y++P
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMSP 171
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
E + + D++S G+ +E+ +G++P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 178 IGTGGYGSVYRA--RLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G +G V + ++ ++ VA+K L ++E E+ + + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEK-SVRDEMMREAEIMHQLDNPYIVRM 60
Query: 235 YGFCLHRKCMFLIYEYMEMGS-----LFCVLRTDEEAVGLDWAKRVNVVKGMCHALS--- 286
G C M + MEM S F + DE V NVV+ M H +S
Sbjct: 61 IGVCEAEALMLV----MEMASGGPLNKFLSGKKDEITVS-------NVVELM-HQVSMGM 108
Query: 287 -YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG----- 340
YL VHRD+++ NVLL ++ A ++DFG+++ L D S A + G
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLK 163
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ APE + + DV+S+G+ E G+ P
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLH----RSET-EELASLESFGNEARLLSQIRHRNI 231
+G G +G VY +G+ +A+K++ ET +E+ +LE E +LL + H I
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC---EIQLLKNLLHERI 66
Query: 232 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
V+ YG CL + + + E+M GS+ L++ E V + +++ +
Sbjct: 67 VQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTYGYI 342
SYLH + IVHRDI N+L +S + DFG ++ L + + GT ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+PE+ K D++S G +E+L K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 30/199 (15%)
Query: 197 VALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255
VA+K L TE+ L +E ++ I +H+NI+ L G C +++I EY G+
Sbjct: 53 VAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 256 L-------------FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS 302
L +C T L + V+ + + YL + +HRD++
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 303 SNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGTYG-----YIAPELAYTMVVTEKC 356
+ NVL+ + +ADFG+AR + + D +T T G ++APE + + T +
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKT----TNGRLPVKWMAPEALFDRIYTHQS 223
Query: 357 DVYSFGVVALEVL-MGKHP 374
DV+SFGV+ E+ +G P
Sbjct: 224 DVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 42/238 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF + IG G +G V+ R +G+V A+K L +S+ + + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
IVKLY + ++L+ EYM G L +L ++ + A+ + + AL +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARF--YIAELVLALDSV 117
Query: 289 H---HDCTPPIVHRDISSNNVLLNSELEAFVADFGVA----------------------- 322
H +HRDI +N+L++++ +ADFG+
Sbjct: 118 HKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 323 ------RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
R GT YIAPE+ +CD +S GV+ E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 23/154 (14%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +VY+ R +G++VALK++ R E EE A + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAI-REASLLKDLKHANIVTLHD 70
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV----NVVKGM---CHALSYLH 289
+K + L++EY++ TD + +D NV + L+Y H
Sbjct: 71 IIHTKKTLTLVFEYLD---------TDLKQY-MDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
++HRD+ N+L++ E +ADFG+AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLS-QIRHRNIVKLY 235
+G G +G V A L + + A+K L + E +E E R+L+ H + L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLF----CVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
++ +F + EY+ G L R DE A+ + L +LH
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC-------GLQFLH-- 113
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
I++RD+ +NVLL+ + +ADFG+ + + GT YIAPE+
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 352 VTEKCDVYSFGVVALEVLMGKHP 374
E D +SFGV+ E+L+G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ IG G YG V A P+G VA+KK+ E + + E ++L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTL-REIKILRRFKH 62
Query: 229 RNIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC 282
NI+ + F ++++ E ME L+ +++T + D + + +
Sbjct: 63 ENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQH--LSNDHIQYF--LYQIL 116
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTY 339
L Y+H + ++HRD+ +N+LLN+ + + DFG+AR+ + + + L T
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 340 GYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y APE+ YT + D++S G + E+L +
Sbjct: 174 WYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G G +G V R SGK A+K L + + E+R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
F + F++ EY+ G LF L + E D + + AL YLH +
Sbjct: 63 SFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYGA--EIVSALDYLH---SGK 115
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
IV+RD+ N++L+ + + DFG+ + D++ GT Y+APE+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 356 CDVYSFGVVALEVLMGKHP 374
D + GVV E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 178 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232
+G +G +Y+ L ++VA+K L + F EA L++++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--QWGEFQQEASLMAELHHPNIV 70
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG------------LDWAKRVNVV 278
L G + + +++EY+ G L F ++R+ VG LD +++
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNRTL 334
+ + YL + VH+D+++ N+L+ +L ++D G++R + + ++L
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369
L ++ PE + D++SFGVV E+
Sbjct: 188 LP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 33/113 (29%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 199 LKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFC 258
L K HR+ +E SF A ++SQ+ H+++V YG C+ ++ EY++ GSL
Sbjct: 35 LDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 259 VLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311
L+ ++ + + W ++ V K + AL +L + H ++ + NVLL E
Sbjct: 89 YLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 36/190 (18%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKK-LHRSETE--ELASLESFGNEARLLSQIRHRNIVK 233
IG G +G V++AR + ++VALKK L +E E + +L E ++L ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 234 LYGFCLHRKCMF-----LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------VVKG 280
L C + + Y E FC + + GL K V V+K
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFE----FC----EHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF---DSSNR-TLLA 336
+ + L Y+H I+HRD+ + N+L+ + +ADFG+AR + NR T
Sbjct: 128 LLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 337 GTYGYIAPEL 346
T Y PEL
Sbjct: 185 VTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 23/260 (8%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235
IG G Y V RL + ++ A+K + + + ++ E + Q H +V L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+F + EY+ G L + R E ++ +++ AL+YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER- 115
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV 352
I++RD+ +NVLL+SE + D+G+ + + GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 353 TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK---LIDLLDPRLSPPVDQKIRQ 409
D ++ GV+ E++ G+ P +++ SS + D+N + +L+ ++ P ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSD-NPDQNTEDYLFQVILEKQIRIPRSLSVK- 231
Query: 410 DIILVSTVAFSCLRSQPKSR 429
++V S L PK R
Sbjct: 232 ----AASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 26/244 (10%)
Query: 178 IGTGGYGSVYRARL----PSGKVVALKKLHRS----ETEELASLESFGNEARLLSQIRHR 229
+G GGYG V++ R +GK+ A+K L ++ ++ A ++ E +L ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNILEAVKHP 60
Query: 230 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL-DWAKRVNVVKGMCHALSY 287
IV L Y F K ++LI EY+ G LF L + E + + D A + + AL +
Sbjct: 61 FIVDLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFY--LSEISLALEH 115
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH I++RD+ N+LL+++ + DFG+ + + + GT Y+APE+
Sbjct: 116 LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
+ D +S G + ++L G P E + ++DK +K L P L+P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAE---NRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 406 KIRQ 409
+++
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK--- 233
IG G +G V+ P GK VALKK+ + L S + E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 234 -----LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNVVKGMCHALS 286
++++ E M+ L ++ + + D K +++G L
Sbjct: 67 ILQPPHIDPFEE---IYVVTELMQ-SDLHKII-VSPQPLSSDHVKVFLYQILRG----LK 117
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-NRTLLAGTYGYIAPE 345
YLH + I+HRDI N+L+NS + DFG+AR+ D S + T T Y APE
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 346 LA-----YTMVVTEKCDVYSFGVVALEVLMGK 372
+ YT V D++S G + E+L +
Sbjct: 175 ILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 196 VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255
+VA+K L R++ + A F E +++S++++ NI++L G C+ + +I EYME G
Sbjct: 46 LVAVKML-RADVTKTAR-NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 256 LFCVLRTDE------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN 309
L L E A + N++ S + + + VHRD+++ N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 310 SELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV----TEKCDVYSFGVVA 365
+ +ADFG++R N S + + G +A+ ++ T DV++FGV
Sbjct: 164 NHYTIKIADFGMSR--NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 366 LEV--LMGKHPGELLS 379
E+ L + P LLS
Sbjct: 222 WEMFTLCKEQPYSLLS 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLS-QIRHRNIVKLY 235
+G G +G V A L G+ A+K L + +E E R+L+ + + LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
++ +F + E++ G L + ++ D + + L +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
I++RD+ +NV+L+ + +ADFG+ + F + + GT YIAPE+ + T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 356 CDVYSFGVVALEVLMGKHP 374
D +SFGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S L+VL+LG N+L G IP+ + L L +L L+ N + G+I +LG++ + + L NN
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 64 LSGSIPESVRKVP---HLYVYGKNFDVEIP 90
LSG IP + + HL + N IP
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLS-QIRH 228
DF+ +G G +G V A R + ++ A+K L + + +E E R+L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
+ +L+ ++ + EY+ G L ++ +E + +A + + L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI------GL 114
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+LH + I++RD+ +NV+L++E +ADFG+ + F GT YIAPE
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPE 171
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ + D ++FGV+ E+L G+ P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 38/161 (23%), Positives = 63/161 (39%), Gaps = 27/161 (16%)
Query: 219 EARLLSQIRHRNIVKL-----YG--FCL---HRKCMFLIYEYMEMGSLFCVLRTDEEAVG 268
EA LL + H +++++ G C+ H Y L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL------------ 154
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
+ + + K + L YLH I+HRD+ + N+ +N + + D G A+
Sbjct: 155 -PIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVV 209
Query: 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369
+ LAGT APE+ K D++S G+V E+L
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 50/245 (20%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF IG G +G V + +G V A+K L +++ E + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHA 284
+VK++ + ++LI E++ G + +L EE A+ V + + H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL------------------- 325
L + +HRDI +N+LL+S+ ++DFG+ L
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 326 ----NFDSS--------NRTLLA----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369
N +S NR LA GT YIAPE+ + CD +S GV+ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 370 MGKHP 374
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 45/300 (15%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V AR +G+ VA+KK+ + + + + ++ E +LL +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 237 -FCLHRKCMFLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
F + ++ + E + ++ L +++ + + +++G L Y+H +
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ---ILRG----LKYVH---S 126
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVV 352
+VHRD+ +N+L+N + + DFG+AR+ T T Y APE+ T
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 353 TEKCDVYSFGVVALEVLMGK--HPG-----------ELLSSSSWSLDKNI------KLID 393
+ D++S G + E+L GK PG +LL + + I + +
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHE 453
L R P +K + A L P ++ + E +A P P+H+
Sbjct: 244 SLPKREPVPFSEKFKN----ADPSAIDLLEKMLVFDPQKRISAAEALAH---PYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G G +G V R +G+ A+K L + + E+R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
F H + F++ EY G LF L + E + A+ + AL YLH +
Sbjct: 63 AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA--EIVSALEYLH---SRD 115
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
+V+RDI N++L+ + + DFG+ + D + GT Y+APE+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 356 CDVYSFGVVALEVLMGKHP 374
D + GVV E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +VY+ R + +VALK++ R E EE A + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNV--VK----GMCHALSYLHH 290
K + L++EY++ D + D +N+ VK + L+Y H
Sbjct: 72 IIHTEKSLTLVFEYLD---------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYT 349
++HRD+ N+L+N E +ADFG+AR + + + T Y P+ L +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 350 MVVTEKCDVYSFGVVALEVLMGK 372
+ + D++ G + E+ G+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G V ++ +GK+ A KKL + ++ NE R+L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 237 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ + L+ M G L F + G D + + +C L L +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRE---R 122
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
IV+RD+ N+LL+ ++D G+A + + R + GT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181
Query: 356 CDVYSFGVVALEVLMGKHP 374
D + G + E++ G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G+G YGSV A +G VA+KKL R + + ++ E RLL ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 237 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ + +L+ M ++ ++ C TD+ L + +++G L Y
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 135
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
+H + I+HRD+ +N+ +N + E + DFG+AR T T Y APE+
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 189
Query: 348 YT-MVVTEKCDVYSFGVVALEVLMGK 372
M + D++S G + E+L G+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 178 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G YGSV Y RL + VA+KKL R + + ++ E RLL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 235 YGFCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS 286
+ +L+ M ++ ++ + +E V ++ + L
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLK 132
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
Y+H + I+HRD+ +NV +N + E + DFG+AR + T T Y APE+
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVATRWYRAPEI 186
Query: 347 AYT-MVVTEKCDVYSFGVVALEVLMGK 372
M + D++S G + E+L GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 50/245 (20%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF IG G +G V + +G + A+K L +++ E + E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
+VK++ ++ ++LI E++ G + +L EEA A+ V + + H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL------------------- 325
L + +HRDI +N+LL+++ ++DFG+ L
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 326 ----NFDS--------SNRTLLA----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369
N +S NR LA GT YIAPE+ + CD +S GV+ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 370 MGKHP 374
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 178 IGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKL- 234
IG G +G V AR + K A+K L + + + +E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
+ F K ++ + +Y+ G LF L+ E L+ R + + AL YLH +
Sbjct: 63 FSFQTADK-LYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAE-IASALGYLH---SL 115
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
IV+RD+ N+LL+S+ + DFG+ + + + GT Y+APE+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 355 KCDVYSFGVVALEVLMGKHP 374
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 30/67 (44%), Positives = 41/67 (61%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
L+ + LG N LSG IP EI L LN+L+L +N++ G I S LG + + + L N LS
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273
Query: 66 GSIPESV 72
G IP S+
Sbjct: 274 GPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLY 235
+G G +G V A L + +V A+K L + + ++ E R+L+ H + L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYLH-HD 291
+ +F + EY+ G L + R +E +A V + AL +LH H
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHRHG 116
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
+++RD+ +N+LL++E +ADFG+ + + T GT YIAPE+ +
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGE 376
D ++ GV+ E++ G+ P E
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLL---SQIRHRNIVK 233
+G G +G V A +G++ A+K L + + +ES E R+ + RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 234 LYGFCLHRKC-MFLIYEYMEMGSLFCVLRTD--EEAVGLDWAKRVNVVKGMCHALSYLHH 290
L+ C + + + EY G L + TD E + +A V L YLH
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV------VLGLQYLHE 119
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTYGYIAPEL--- 346
+ IV+RD+ +N+LL++E +ADFG+ + + F T GT ++APE+
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTE 175
Query: 347 -AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+YT V D + GV+ E+L+G+ P
Sbjct: 176 TSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKL------HRSETEELASLESFGNEARLLSQIRHRN 230
IG G +G V A R GK A+K L +R E + + + + LL ++H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-----LLKNVKHPF 57
Query: 231 IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNVVKGMCHALS 286
+V L Y F K ++ + +++ G LF L R+ E +A + AL
Sbjct: 58 LVGLHYSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE------IASALG 110
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
YLH + IV+RD+ N+LL+S+ + DFG+ + S T GT Y+APE+
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
D + G V E+L G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
DF+ +G G +G V A R + ++ A+K L + + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 230 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
+ C ++ + EY+ G L ++ +E + +A ++V L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GL 114
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+LH I++RD+ +NV+L+SE +ADFG+ + D GT YIAPE
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE 171
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ + D +++GV+ E+L G+ P
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKL--HRSETEELASLESFGNEARLLSQIR-HRNIVK 233
IG G + V +A+ +GK A+K + H E++ +L E + L ++ H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSPHPNILR 62
Query: 234 LYGFCLHRK--CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NVVKGMCHALSYLHH 290
L RK + L++E M+M +L+ +++ + + KRV + + + +L ++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMHR 118
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
+ I HRDI N+L+ ++ +ADFG R + + T T Y APE T
Sbjct: 119 N---GIFHRDIKPENILIKDDILK-LADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTD 173
Query: 351 -VVTEKCDVYSFGVVALEVL 369
K D+++ G V E+L
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N L+ L L N LSG IP I LQ+L L+LS NS++G+I + ++ ++ + L
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 62 NNLSGSIPESVRKVPHLYV---YGKNFDVEIP 90
NN +G IP ++ +P L V + F EIP
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 177 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235
IG G YG V A+ + + VA+KK+ + + + + E +LL + H N++ +
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAIK 70
Query: 236 GFCL--HR---KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
HR ++++YE M+ L ++R+ + + D + + + L Y+H
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQ-TLSDDHCQYF--LYQLLRGLKYIH- 125
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL---- 346
+ ++HRD+ +N+LLN+ + + DFG+AR + T T Y APEL
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 347 -AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
YT + DV+S G + E L+G+ P
Sbjct: 184 SEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 39/259 (15%)
Query: 196 VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255
+VA+K L R + + A F E +++S+++ NI++L C+ + +I EYME G
Sbjct: 48 LVAVKML-REDANKNAR-NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 256 L---FCVLR-----TDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVL 307
L + V + ++ + + + + YL + VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCL 162
Query: 308 LNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV----TEKCDVYSFGV 363
+ +ADFG++R N S + + G +++ ++ T DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSR--NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 364 VALEVLM--GKHPGELLS-------SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414
E+L + P LS + + D+ + + L P L P +
Sbjct: 221 TLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG-RQVYLPKPALCPD----------SL 269
Query: 415 STVAFSCLRSQPKSRPTMQ 433
+ SC R K RP+ Q
Sbjct: 270 YKLMLSCWRRNAKERPSFQ 288
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G V ++ +GK+ A K+L + ++ NE ++L ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 237 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ + L+ M G L F + G + + + + L LH +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFEEERALFYAAEILCGLEDLHRE---N 122
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
V+RD+ N+LL+ ++D G+A + S R + GT GY+APE+ T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181
Query: 356 CDVYSFGVVALEVLMGKHP 374
D + G + E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G Y +V++ R + +VALK++ R E EE A + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71
Query: 237 FCLHRKCMFLIYEYME------MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
K + L++EY++ M ++ + L +++G L+Y H
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQILRG----LAYCHR 122
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYT 349
++HRD+ N+L+N E +ADFG+AR + + + T Y P+ L +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 350 MVVTEKCDVYSFGVVALEVLMGK 372
+ + D++ G + E+ G+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 33/135 (24%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
L+ + L N + G+IP + + L L+LS+NS NG I LG++ + ++L+ N+L
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 65 SGSIPESVRKVPHLYVYGKNFDVE-------IPNTSENSPPPHHKKIATRL-VAIILPMV 116
SG +P ++ ++ +F+ IP P H + ++ +A + +
Sbjct: 503 SGRVPAALGGRL---LHRASFNFTDNAGLCGIPGLRACGP---HLSVGAKIGIAFGVSVA 556
Query: 117 ALLALIFGILFVRRR 131
L +I + + +RR
Sbjct: 557 FLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
IG G +G V + R + ++ ALK + ++ + + E +L+Q+ IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
F K ++L+ ++ G LF L+ E R + +C AL LH
Sbjct: 61 SFQSPEK-LYLVLAFINGGELFHHLQ--REGRFDLSRARFYTAELLC-ALENLH---KFN 113
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTE 354
+++RD+ N+LL+ + + DFG+ +L N ++T GT Y+APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 355 KCDVYSFGVVALEVLMGKHP 374
D ++ GV+ E+L G P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-Y 235
+G G +G V + +G+ A+K L + + E R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHALSYLHHD 291
F H + F++ EY G LF L + E+ A+ V+ AL YLH +
Sbjct: 63 SFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------ALDYLHSE 114
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
+V+RD+ N++L+ + + DFG+ + D + GT Y+APE+
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 352 VTEKCDVYSFGVVALEVLMGKHP 374
D + GVV E++ G+ P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 178 IGTGGYGSVYRARLPSGKVVA---LKKLHRSET--EELASLESFGNEARLLSQIRHRNIV 232
IG G +G V G A +K+L S T E+L L+ E + ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+ G C+ L+ E+ +G L LR++ V K V + + C S L
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV-LQRMACEVASGLLWLH 117
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVA----RLLNFDSSNRTLLAGTYGYIAPELA- 347
+H D++ N L ++L + D+G+A + + + A ++APEL
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC--HAVPLRWLAPELVE 175
Query: 348 ------YTMVVTEKCDVYSFGVVALEV 368
T+K +++S GV E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 171 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
DF+ +G G +G V A R + ++ A+K L + + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 230 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
+ C ++ + EY+ G L ++ +E + +A + + L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+LH + I++RD+ +NV+L+SE +ADFG+ + +D GT YIAPE
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLMGKHPGE 376
+ + D ++FGV+ E+L G+ P E
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 3/98 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ KL L+L +N LSG IP + +LQ L L+L N+ GKI L +PR+ + L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 62 NNLSGSIPESVRKVPHLYVYG---KNFDVEIPNTSENS 96
N SG IP+++ K +L V N EIP +S
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
L L+L NN+LSG IP++I L L+L N + GKI + L + ++ + L+ N
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 64 LSGSIPESVRKVPHL---YVYGKNFDVEIPN 91
L G IP + ++ L Y+ N EIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
|
Length = 968 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 65/257 (25%), Positives = 107/257 (41%), Gaps = 62/257 (24%)
Query: 170 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDFH IG G +G V + +GK+ A+K L +SE + L E +L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-RTD---EEAVGLDWAKRVNVVKGMCHA 284
+V LY + ++LI E++ G L +L + D E+ A+ V ++ + H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV-HK 119
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-------------RLLNFDSS- 330
L + +HRDI +N+L++ ++DFG++ +LL S+
Sbjct: 120 LGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 331 -----------------------------NRTLLA----GTYGYIAPELAYTMVVTEKCD 357
NR L+A GT YIAPE+ ++CD
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 358 VYSFGVVALEVLMGKHP 374
+S G + E L+G P
Sbjct: 231 WWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 10/200 (5%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKL- 234
IG G +G V A+ S G A+K L + + E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
Y F K ++ + +Y+ G LF E L+ R + A+ YLH +
Sbjct: 63 YSFQTAEK-LYFVLDYVNGGELF--FHLQRERCFLEPRARFYAAEVAS-AIGYLH---SL 115
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
I++RD+ N+LL+S+ + DFG+ + + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 355 KCDVYSFGVVALEVLMGKHP 374
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG+G G V A G VA+KKL R + + ++ E LL + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87
Query: 237 FCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
+K + +L+ E M+ +L V+ + LD + ++ M + +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH- 140
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
+ I+HRD+ +N+++ S+ + DFG+AR + + Y Y APE+ M
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGM 197
Query: 351 VVTEKCDVYSFGVVALEVLMG 371
E D++S G + E++ G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 40/94 (42%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 6 LRVLELGNNLLSGSIPSEINKL-QELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
++ + L NN LSG IP +I L YLNLS+N+ G I G IP ++T+DLS N L
Sbjct: 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNML 152
Query: 65 SGSIPESVRKVPHLYV--YGKNFDV-EIPNTSEN 95
SG IP + L V G N V +IPN+ N
Sbjct: 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 52/243 (21%)
Query: 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
F +G G G V+ RL +GK+ ALK L + E + ++ E +L+ + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNVVKGMCHA 284
+ LY + L+ +Y G LF +L+ E V +A V + A
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL------A 115
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF-------------------GVARLL 325
L YLH IV+RD+ N+LL+ ++DF G R
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 326 NFDSSNRTLLA----------GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMG 371
+ T GT YIAPE+ + V D ++ G++ E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYG 228
Query: 372 KHP 374
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G VY+ R + ++ A+K L + E + E +L + + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 237 FCLHRKC---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNV-VKGMCHALSYLH-HD 291
+ ++L+ +YM G LF L+ + G R + + AL +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----- 346
IV+RD+ N+LL++ + DFG+++ D+ GT Y+APE+
Sbjct: 117 ----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
YT V D +S GV+ E+ G P
Sbjct: 173 GYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN-IVKLY 235
IG G YG VY+AR +GK+VALKK R E +E + E LL + IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 236 GFCLH-------RKCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ + ++L++EY++ F L + + + +++
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
H ++HRD+ N+L++ + +AD G+ R + + T T Y APE+
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182
Query: 347 -----AYTMVVTEKCDVYSFGVVALEVLMGK--HPGE 376
Y+ V D++S G + E+ + PG+
Sbjct: 183 LLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 185 SVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF----CLH 240
S+Y+ + K V ++ + ++ NE + L +I NI+K+YGF
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTPPIVHR 299
+ LI EY G L VL +++ L + ++++ C L L+ + P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 300 DISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV--VTEKCD 357
+++S + L+ + + G+ ++L+ Y + ++ + T K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDD 204
Query: 358 VYSFGVVALEVLMGKHPGELLSSSS 382
+YS GVV E+ GK P E L++
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 178 IGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+G G +G VY + G V VA+K + +E + F NEA ++ + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHH 70
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGL----DWAKRVNVVKGMCH 283
+V+L G + +I E M G L LR+ + E + K + + +
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG--Y 341
++YL+ + VHRD+++ N ++ + + DFG+ R + R G +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEV 368
++PE V T DV+SFGVV E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 21/142 (14%)
Query: 178 IGTGGYGSVYRARL---PSGKV--------VALKKLHRSETEELASLESFGNEARLLSQI 226
+G G + ++Y+ L + V LK L + LA E+ A L+SQ+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET----ASLMSQL 58
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS 286
H+++VKLYG C+ + + ++ EY++ G L L ++ V L W +++V K + AL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115
Query: 287 YLHHDCTPPIVHRDISSNNVLL 308
YL +VH ++ N+L+
Sbjct: 116 YLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTYGYIAP 344
+HH + ++HRDI S N+LL S + DFG +++ D RT GT Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAP 214
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIK-LIDLLDPRLSP 401
E+ ++K D++S GV+ E+L K P GE + + K + D L P +SP
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMHKTLAGRYDPLPPSISP 271
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
+ + + L S PK RP+
Sbjct: 272 E-----------MQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 49/161 (30%), Positives = 70/161 (43%), Gaps = 36/161 (22%)
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFC----VLRTDEEAVGLDWAKRVNVVKGMCHAL 285
N+V L+ + + +FL+ ++ E G L+ L EE V WA M AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVAL 98
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-------DSSNRTLLAGT 338
LH + IV RD++ NN+LL+ D G +L F DS + +
Sbjct: 99 DALHRE---GIVCRDLNPNNILLD--------DRGHIQLTYFSRWSEVEDSCDGEAVENM 147
Query: 339 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK-----HP 374
Y APE+ TE CD +S G + E+L GK HP
Sbjct: 148 Y--CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 27/186 (14%)
Query: 217 GNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY-------MEMGSLFCVLRTDEEAVG- 268
G E +L I HR I+ L I+ Y M M C L T + G
Sbjct: 134 GREIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF- 327
L + + + + + AL+YLH I+HRD+ + N+ L+ A + DFG A L+
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 328 -DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWS 384
D+ +GT +PEL K D++S G+V E+ + G+ + SSS
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298
Query: 385 LDKNIK 390
L I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG+G V ++ +GK+ A KKL + ++ NE ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 237 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
+ + L+ M G L F + G D + V + L LH +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFDEERAVFYAAEITCGLEDLHRE---R 122
Query: 296 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEK 355
IV+RD+ N+LL+ ++D G+A + + R + GT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFS 181
Query: 356 CDVYSFGVVALEVLMGKHP 374
D + G + E++ GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 178 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
IG+G G V Y A L + VA+KKL R + + ++ E L+ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 235 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+K + +L+ E M+ +L V++ + LD + ++ M + +L
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 135
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + I+HRD+ +N+++ S+ + DFG+AR S T T Y APE+
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 191
Query: 349 TMVVTEKCDVYSFGVVALEVLMGK 372
M E D++S G + E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSET-----EELASLESFGNEARLLSQIRHRNI 231
+G GG+G V ++ +GK+ A KKL + E++A LE +L ++ I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEK-----EILEKVNSPFI 55
Query: 232 VKL-YGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
V L Y F + + L+ M G L + + E GL+ + ++ + + +LH
Sbjct: 56 VNLAYAF-ESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH 112
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349
+ IV+RD+ NVLL+ + ++D G+A L D T AGT GY+APE+
Sbjct: 113 ---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMAPEILKE 168
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHP 374
+ D ++ G E++ G+ P
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 3/90 (3%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ L L+L N L+G IPS + L+ L YL L N ++G I + + ++ ++DLS N+
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 64 LSGSIPESVRKVPH---LYVYGKNFDVEIP 90
LSG IPE V ++ + L+++ NF +IP
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRS---ETEELASLESFGNEARLLSQIRHRNIVK 233
+G G +G V R +GK A+K L + +E+A + E+R+L RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRHPFLTA 59
Query: 234 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHALSYL 288
L Y F H + F++ EY G LF L + E+ A+ V+ AL YL
Sbjct: 60 LKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------ALGYL 111
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + +V+RD+ N++L+ + + DFG+ + D + GT Y+APE+
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHP 374
D + GVV E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-----NRTLLAGTYGYIAPELAYTMV 351
+HRD+++ NVLL A + DFG+AR + DS+ N L ++APE + V
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIFDCV 290
Query: 352 VTEKCDVYSFGVVALEVL-MGK--HPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
T + DV+S+G++ E+ +GK +PG L++S + + K + P +PP I
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIM 348
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442
+ C +P RPT +S + I R
Sbjct: 349 K----------MCWNLEPTERPTFSQIS-QLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF I G YG+VY R + A+KK+++ ++ E +L+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
+V ++ ++ + ++ EY+E G +L+ + + +A+ V A
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV-------LA 113
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR--LLNF---------DSSNRT 333
L YLH IVHRD+ +N+L+ S + DFG+++ L++ + R
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 334 LL----AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
L GT YIAPE+ + D ++ G++ E L+G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 178 IGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G Y V RL ++ A+K + + + ++ E + Q +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 237 FCLHRKC-MFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKGMCHALSYLHHD 291
C +FL+ EY+ G L ++ EE A+ +C AL++LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE-------ICIALNFLHER 115
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
I++RD+ +NVLL+++ + D+G+ + + GT YIAPE+
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSS 381
D ++ GV+ E++ G+ P ++++ +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 23/247 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFG-NEARLLSQIRHRN----I 231
IG GG+G VY R +GK+ A+K L + + + E+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
Y F K F I + M G L L + V + R + + L ++H+
Sbjct: 61 CMTYAFHTPDKLCF-ILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHMHNR 116
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTM 350
+V+RD+ N+LL+ ++D G+A +F GT+GY+APE L
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGT 171
Query: 351 VVTEKCDVYSFGVVALEVLMGKHPGELLSSSS------WSLDKNIKLIDLLDPRLSPPVD 404
D +S G + ++L G P + +L N++L D P L ++
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231
Query: 405 QKIRQDI 411
+++D+
Sbjct: 232 GLLQRDV 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 32/181 (17%)
Query: 218 NEARLLSQIRHRNIVKL--------YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL 269
NE L ++ H NI+K+ + + +K F +Y +M + D + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 270 DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329
R ++K + A+ Y+H ++HRDI N+ LN + + + DFG A + F+
Sbjct: 266 LKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA--MPFEK 319
Query: 330 SNRTLLAGTYGYIA---PELAYTMVVTEKCDVYSFGVVALEVLM---------GKHPGEL 377
G G +A PE+ E D++S G++ L++L G PG+
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379
Query: 378 L 378
L
Sbjct: 380 L 380
|
Length = 501 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
S LR L L NN +GSIP + L L+LS+N ++G+I + +G + +DL N
Sbjct: 117 SSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
Query: 63 NLSGSIPESVRKVPHL 78
L G IP S+ + L
Sbjct: 175 VLVGKIPNSLTNLTSL 190
|
Length = 968 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKLH------RSETEELASLESFGNEARLLSQIRHRN 230
IG G +G V A+ + GK A+K L + E + + + + LL ++H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-----LLKNVKHPF 57
Query: 231 IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V L Y F K F++ +Y+ G LF L+ E + R + AL YLH
Sbjct: 58 LVGLHYSFQTADKLYFVL-DYVNGGELFFHLQ--RERSFPEPRARFYAAEIAS-ALGYLH 113
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349
+ I++RD+ N+LL+S+ + DFG+ + S + GT Y+APE+
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHP 374
D + G V E+L G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 178 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
IG+G G V Y A L + VA+KKL R + + ++ E L+ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 235 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+K + +++ E M+ +L V++ + LD + ++ M + +L
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H + I+HRD+ +N+++ S+ + DFG+AR + Y Y APE+
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 198
Query: 349 TMVVTEKCDVYSFGVVALEVLMGK 372
M E D++S G + E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 197 VALKKLHRSETE-ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255
V LK L S + LA E+ A ++ Q+ H++IV LYG C+ ++ E++E G
Sbjct: 35 VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 256 LFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311
L + + + W + V K + ALSYL +VH ++ + N+LL E
Sbjct: 91 LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 219 EARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
EA +L I H +I++L G + K LI + L+C L D + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI---LAIE 188
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAG 337
+ + A+ YLH + I+HRDI + N+ +N + + DFG A ++N+ AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 338 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP---GELLSSSSWSLDKNIKLIDL 394
T APEL D++S G+V E+ + L S D+ IKLI +
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS-DRQIKLI-I 303
Query: 395 LDPRLSP---PVDQKIRQDIILVSTVAFSCLRS--QPKSRPT 431
P P+D + D I + +S +P SRP
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGL----AKKSSRKPGSRPL 341
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 50/229 (21%), Positives = 106/229 (46%), Gaps = 39/229 (17%)
Query: 178 IGTGGYGSVYRARLPSG------KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
IG G +G V+ + K ++ + L E +L E ++ +++H+NI
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI------EVNVMRELKHKNI 74
Query: 232 VKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNVVKGMCHALSYL 288
V+ L++ + ++++ E+ + G L ++ + G ++ V++ + + HAL+Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 289 HHDCTPP----IVHRDISSNNVLLNSELE-----------------AFVADFGVARLLNF 327
H+ P ++HRD+ N+ L++ + A + DFG+++ +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 328 DSSNRTLLAGTYGYIAPELAY--TMVVTEKCDVYSFGVVALEVLMGKHP 374
+S + + GT Y +PEL T +K D+++ G + E+ GK P
Sbjct: 195 ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 45/224 (20%)
Query: 176 YCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G G G V+ A K VA+KK+ ++ + S++ E +++ ++ H NIVK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKV 67
Query: 235 Y--------------GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNV 277
Y G ++++ EYME L VL EE L
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-------F 119
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA 336
+ + L Y+H + ++HRD+ NV +N+E L + DFG+AR+++ S++ L+
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 337 ---GTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGK 372
T Y +P L YT + D+++ G + E+L GK
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 156 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-ELASLE 214
YDGR+ + E ED G + R V LK L S + LA E
Sbjct: 12 YDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELR------VVLKVLDPSHRDIALAFFE 65
Query: 215 SFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR 274
+ A L+SQ+ H ++ ++G C+ ++ E++E G L LR ++ V + W +
Sbjct: 66 T----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL-------NSELEAFVADFGVARLLNF 327
+ V + + ALSYL +VH ++ + N+LL + ++D GV+ F
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS----F 172
Query: 328 DSSNRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEV-------LMGKHPGE 376
+ +R +IAPE + ++ D +SFG LE+ L + P E
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 62/297 (20%), Positives = 119/297 (40%), Gaps = 42/297 (14%)
Query: 177 CIGTGGYGSVYRARLPSGKVVALKK--LHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
C + + + P+ +VA+KK L E+L L+ E Q++H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ---QEIITSRQLQHPNILPY 64
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
+ ++++ M GS +L+T GL ++K + +AL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSK--- 120
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGTYG------YIAPELA 347
+HR + ++++LL+ + + ++ + ++ R + +++PE+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 348 YTMV--VTEKCDVYSFGVVALEVLMGKHP----------GELLSSSSWS-LDKNIKLIDL 394
+ EK D+YS G+ A E+ G P E + + LDK+ +
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 395 LD--PRLSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPTM-QLVSNEF 439
S R + T FS CL+ P+SRP+ QL+++ F
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 178 IGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G G YG VY+A+ G + ALK++ + A E LL +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELKHPNVISL 63
Query: 235 YGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY----- 287
L + ++L+++Y E L+ +++ + K V + +GM +L Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK--KPVQLPRGMVKSLLYQILDG 120
Query: 288 LHHDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTL-----LAGT 338
+H+ ++HRD+ N+L+ E +AD G ARL F+S + L + T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVT 178
Query: 339 YGYIAPELAY-TMVVTEKCDVYSFGVVALEVL 369
+ Y APEL T+ D+++ G + E+L
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 178 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG+G G V A +G+ VA+KKL R + ++ E L+ + H+NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82
Query: 237 -FCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
F + ++L+ E M+ +L V++ D LD + ++ M + +LH
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH- 135
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
+ I+HRD+ +N+++ S+ + DFG+AR S T T Y APE+ M
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGM 192
Query: 351 VVTEKCDVYSFGVVALEVLMGK 372
E D++S G + E++ G
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 66/258 (25%), Positives = 112/258 (43%), Gaps = 41/258 (15%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALK-------KLHRSETEELASLESFGNEARLLSQIRHR 229
IG GG+G VY R +GK+ A+K K+ + ET L NE +LS +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-------NERIMLSLVSTG 54
Query: 230 N---IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR---VNVVKGMC 282
+ IV + Y F K F I + M G L L + V + R ++ G+
Sbjct: 55 DCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLE 111
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
H +H+ +V+RD+ N+LL+ ++D G+A +F GT+GY+
Sbjct: 112 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 162
Query: 343 APE-LAYTMVVTEKCDVYSFGVVALEVLMGKHPG-ELLSSSSWSLDK-----NIKLIDLL 395
APE L + D +S G + ++L G P + + +D+ ++L D
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222
Query: 396 DPRLSPPVDQKIRQDIIL 413
P L ++ +++D+
Sbjct: 223 SPELRSLLEGLLQRDVNR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 38/187 (20%)
Query: 263 DEEAVGLDWAKRVN----VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318
+E+ + LD ++ V KGM S +C +HRD+++ N+LL + D
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLAS---KNC----IHRDLAARNILLTHGRITKICD 257
Query: 319 FGVARLLNFDSS-----NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGK 372
FG+AR + DS+ N L ++APE + V T + DV+S+G++ E+ +G
Sbjct: 258 FGLARDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 314
Query: 373 HPGELLSSSSWSLDKNIKLID----LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKS 428
P + S K K+I +L P +P I + SC + P
Sbjct: 315 SPYPGMPVDS----KFYKMIKEGYRMLSPECAPSEMYDIMK----------SCWDADPLK 360
Query: 429 RPTMQLV 435
RPT + +
Sbjct: 361 RPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
+G G YG VY+A+ GK K+ + E S E LL +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 238 CLHR--KCMFLIYEYMEMGSLFCVL------RTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
L + ++L+++Y E L+ ++ + +++ + L + +++ + + YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 290 HDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTL-----LAGTYG 340
+ ++HRD+ N+L+ E +AD G ARL F+S + L + T+
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVTFW 180
Query: 341 YIAPELAY-TMVVTEKCDVYSFGVVALEVL 369
Y APEL T+ D+++ G + E+L
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
E+F I I G +G VY R + K+ A+K + +++ + E L+ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
IV LY ++L+ EY+ G + +L DEE V + + A
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALA 116
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
L YLH I+HRD+ +N+L+++E + DFG++++
Sbjct: 117 LDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 56/244 (22%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G V R + + + A+K L +++ E +L++ + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 237 FCLHRKCMFLIYEYM---EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
+ ++ + +Y+ +M SL L EE D A R + + C A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE----DLA-RFYIAELTC-AIESVHK--- 119
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGV------------------ARLLNFDSSNR--- 332
+HRDI +N+L++ + + DFG+ R + + S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 333 -------TL---------------LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 370
L L GT YIAPE+ T+ CD +S GV+ E+L+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 371 GKHP 374
G+ P
Sbjct: 240 GQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 21/148 (14%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPELAYTMVV 352
VHRD+++ NVLL + DFG+AR + N+ S T L ++APE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP--VKWMAPESIFDNLY 316
Query: 353 TEKCDVYSFGVVALEVL-MG--KHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409
T DV+S+G++ E+ +G +PG ++ S+ ++ K+ R++ P D ++
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-------GYRMAKP-DHATQE 368
Query: 410 DIILVSTVAFSCLRSQPKSRPTMQLVSN 437
V + C S+P+ RP+ +S+
Sbjct: 369 ----VYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 48/300 (16%)
Query: 178 IGTGGYGSVYRA---RLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY + G+ VA+K + +E+ L F NEA ++ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 71
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH-------A 284
V+L G + ++ E M G L LR+ + + ++ M
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNRTLLAGTYG 340
++YL+ VHRD+++ N ++ + + DFG+ R + + + LL
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VR 186
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEV-LMGKHPGELLSSSSWSLDKNIKLI---DLLD 396
++APE V T D++SFGVV E+ + + P + LS+ ++ +K + LD
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMDGGYLD 241
Query: 397 -PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEIS 455
P P + + C + PK RPT E + K + F E+S
Sbjct: 242 QPDNCPERVTDLMR----------MCWQFNPKMRPTFL----EIVNLLKDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 52/248 (20%), Positives = 97/248 (39%), Gaps = 60/248 (24%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V A + + + A+K L + + + E +L++ + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 237 FCLHRKCMFLIYEYM---EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
+ ++ + +Y+ +M SL + E + + + + H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-------------------------D 328
+HRDI +N+L++ + + DFG+ + D
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 329 SSN-------RTL---------------LAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 366
SN +TL L GT YIAPE+ T+ CD +S GV+
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 367 EVLMGKHP 374
E+L+G+ P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 172 FHIKYCIGTGGYGSVYRARLPS---GKVVALKKLHRSETEELASLESFGNEARLLSQIR- 227
+ + +G G YG V AR + VA+KK+ ++++ + + E +LL R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRG 60
Query: 228 HRNIVKLYGFCLHRKCMF-LIYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
H+NI LY + F +Y Y E+ L ++R+ + L A + + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP---LTDAHFQSFIYQILCG 117
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD----SSNRTLLAGTYG 340
L Y+H + ++HRD+ N+L+N++ E + DFG+AR + + + T T
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 341 YIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y APE+ +YT + DV+S G + E+L K
Sbjct: 175 YRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 24/99 (24%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL---------------- 48
+L+VL+L +N SG IP + K L L+LS N++ G+I L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 49 -GEIPR-------IDTVDLSMNNLSGSIPESVRKVPHLY 79
GEIP+ + V L N+ SG +P K+P +Y
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
|
Length = 968 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 178 IGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235
IG G Y V L ++ A+K + + + ++ E + H +V L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
+F + E++ G L + + EE A+ + AL++LH
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLALNFLHER 115
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
I++RD+ +NVLL++E + D+G+ + + GT YIAPE+
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN 388
D ++ GV+ E++ G+ P +++ S D+N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-DQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 53/248 (21%), Positives = 97/248 (39%), Gaps = 60/248 (24%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V AR + + + A+K L + + + E +L++ + +V+LY
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 237 FCLHRKCMFLIYEYM---EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
+ ++ + +Y+ +M SL + E + + + H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF------ 122
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVA------------------RLLNFDSSN---- 331
+HRDI +N+L++ + + DFG+ R + D SN
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 332 ----------------------RTL---LAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 366
R L L GT YIAPE+ T+ CD +S GV+
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 367 EVLMGKHP 374
E+L+G+ P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 35/210 (16%)
Query: 185 SVYRAR-LPSGKVVALK--KLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241
SVY AR P+G +V ++ L E L +L+ NE L RH NI+ +
Sbjct: 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQ---NEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI 301
+++I +M GS +L+T G+ A N++ G L+YLH + +HR+I
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQN---GYIHRNI 127
Query: 302 SSNNVLLN----------SELEAFVADFGVARLL-NFDSSNRTLLAGTYGYIAPEL---- 346
++++L++ S L + V + A+++ +F + ++L +++PEL
Sbjct: 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP----WLSPELLRQD 183
Query: 347 --AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y + K D+YS G+ A E+ G+ P
Sbjct: 184 LYGYNV----KSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ------IRHRNI 231
IG G +G V + + + VA R +EL + S + L Q ++H NI
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA-----RVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
++ G C+ L++EY E+G L L ++ ++ + + + C + + H
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN--SQLLLLQRMACEIAAGVTHM 115
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGV 321
+H D++ N L S+L V D+G+
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 45/247 (18%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL-- 234
IG G +G VY A + + + VA+KK+ L + E ++ + H NI+ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 235 --YGFCLHR--KCMFL----------IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
Y C + K +FL +++YM+ + + A+ L K +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA------RNNHALPLFLVKLYSY--Q 178
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTY 339
+C AL+Y+H + I HRD+ N+L++ + DFG A+ L + + + +
Sbjct: 179 LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 340 GYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398
Y APEL T D++S G + E+++G +P + S S+D+ +++I +L
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP---IFSGQSSVDQLVRIIQVLG-- 288
Query: 399 LSPPVDQ 405
+P DQ
Sbjct: 289 -TPTEDQ 294
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 19/51 (37%), Positives = 31/51 (60%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIP 52
+ + L VL+L N +GSIP + +L L LNL+ NS++G++ + LG
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 350
+HRD+++ N+LL+ + DFG+AR + D S R L ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK----WMAPESIFDK 251
Query: 351 VVTEKCDVYSFGVVALEVL-MGKHP 374
V T + DV+SFGV+ E+ +G P
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 178 IGTGGYGSVYRARLPSG---KVVALKKLHRSET--EELASLESFGNEARLLSQIRHRNIV 232
IG G +G V + SG V +K+L S + E++ LE EA+ ++H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM-CHALSYLHHD 291
+ G C L+ E+ +G L LR+ +A + ++ M C L H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHL 116
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPEL- 346
+H D++ N LL ++L + D+G++ + + ++ + +IAPEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP--LRWIAPELV 174
Query: 347 ----AYTMVV--TEKCDVYSFGVVALEVL-MGKHP 374
+VV T++ +V+S GV E+ +G P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 181 GGYGSVYRARLPSGKV-----VALKKL--HRSETEELASLESFGNEARLLSQIRHRNIVK 233
G +G ++ L K V +K + H SE + + E+ LL + H+NI+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQNILP 72
Query: 234 LYGFC--LHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNVVKGMCHALS 286
+ C F++Y YM G+L L+ L + V++ + +S
Sbjct: 73 ILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF--------DSSNRTLLAGT 338
YLH ++H+DI++ N +++ EL+ + D ++R L F D+ NR +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRPV---- 183
Query: 339 YGYIAPELAYTMVVTEKCDVYSFGVVALE-VLMGKHP 374
++A E + DV+SFGV+ E + +G+ P
Sbjct: 184 -KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 30/179 (16%)
Query: 215 SFGNEARLLSQIRHRNIVKLYGFCLHR----KCMFL------IYEYMEMGSLFCVLRTDE 264
S +EARLL ++ H ++ L + C+ L +Y Y+
Sbjct: 206 SSVHEARLLRRLSHPAVLALLD--VRVVGGLTCLVLPKYRSDLYTYL-----------GA 252
Query: 265 EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
L A+ V + + A+ Y+H + I+HRDI + NVL+N + + DFG A
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACF 309
Query: 325 LNFDSSNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS 381
S +AGT APE+ T D++S G+V E + H L S+S
Sbjct: 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV--HTASLFSAS 366
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 4/65 (6%)
Query: 33 LNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV----RKVPHLYVYGKNFDVE 88
++LS +I+GKI S + +P I T++LS N LSG IP+ + + +L + NF
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 89 IPNTS 93
IP S
Sbjct: 134 IPRGS 138
|
Length = 968 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 56/201 (27%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 188 RARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247
R P KVVA K + ++ + A S E L+ H IVK + + LI
Sbjct: 88 RGSDPKEKVVA-KFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 248 YEYMEMGSLFCVLRT--------DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHR 299
EY G L ++ E VGL + + V AL +H ++HR
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV-------LALDEVHSRK---MMHR 193
Query: 300 DISSNNVLLNSELEAFVADFGVARL------LNFDSSNRTLLAGTYGYIAPELAYTMVVT 353
D+ S N+ L + DFG ++ L+ SS GT Y+APEL +
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCGTPYYLAPELWERKRYS 249
Query: 354 EKCDVYSFGVVALEVLMGKHP 374
+K D++S GV+ E+L P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 350
+HRD+++ N+LL+ + DFG+AR + D R L ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPESIFDK 250
Query: 351 VVTEKCDVYSFGVVALEVL-MGKHP 374
V T + DV+SFGV+ E+ +G P
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 1e-04
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 5 KLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
L+ L+L NN L+ IP L L L+LS N++ +P + ++DLS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 64 L 64
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFD------SSNRTLLAGTYGYIAPELAYTM 350
+HRD+++ N+LL+ + DFG+AR + D R L ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPETIFDR 256
Query: 351 VVTEKCDVYSFGVVALEVL-MGKHP 374
V T + DV+SFGV+ E+ +G P
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLL----NFDSSNRTLLAGTYGYIAPELAYTMVV 352
VHRD+++ NVL+ + DFG+AR + N+ S T L ++APE + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP--LKWMAPESIFNNLY 318
Query: 353 TEKCDVYSFGVVALEVL-MGKHP 374
T DV+SFG++ E+ +G P
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 23/70 (32%), Positives = 37/70 (52%)
Query: 9 LELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI 68
L L +N L G IP + + L + L NS +G++ S+ ++P + +D+S NNL G I
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
Query: 69 PESVRKVPHL 78
+P L
Sbjct: 445 NSRKWDMPSL 454
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 33/100 (33%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 178 IGTGGYGSVYRA------RLPSGKVVALKKL----HRSETEELASLESFGNEARLLSQI- 226
+G G +G V A + + VA+K L H E E L S E ++LS +
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS------ELKILSHLG 99
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA 266
+H+NIV L G C H + +I EY G L LR E
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 20/64 (31%), Positives = 36/64 (56%), Gaps = 2/64 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L L+L NN + + S ++ L+ L+ L LS+N + + +G + ++T+DLS
Sbjct: 207 LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264
Query: 62 NNLS 65
N +S
Sbjct: 265 NQIS 268
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.002
Identities = 13/39 (33%), Positives = 20/39 (51%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSI 40
L+VL+L N L+ P + L L L+LS N++
Sbjct: 22 GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.15 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.0 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.6 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.59 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.59 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.58 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.52 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.49 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.47 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.46 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.38 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.35 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.17 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.16 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.11 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.08 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.02 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.91 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.83 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=489.89 Aligned_cols=419 Identities=28% Similarity=0.482 Sum_probs=297.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
++++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..+. .|..|
T Consensus 497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l 576 (968)
T PLN00113 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576 (968)
T ss_pred hhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEE
Confidence 567889999999999999999999999999999999999999999999999999999999999999998654 45667
Q ss_pred ecccccccccCCCCCC-----------C-----------CCCCCCCccc-cc--eehhhhHHHHHHHHHHHHhhheeccC
Q 012219 79 YVYGKNFDVEIPNTSE-----------N-----------SPPPHHKKIA-TR--LVAIILPMVALLALIFGILFVRRRRD 133 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~-----------~-----------~~~~~~~~~~-~~--i~~i~~~~~~l~~l~~~~~~~~~~~~ 133 (468)
++++|++.+.+|.... + .++|...... .. ++++++++++++++++.+++++++++
T Consensus 577 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (968)
T PLN00113 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656 (968)
T ss_pred eccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhh
Confidence 8999999887775311 0 0112111011 11 11112222222222222222222222
Q ss_pred -CccCCCCccccccccccchhcc--CCCCcCHHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhh
Q 012219 134 -KRVEPAETGEITKCADEFAIWN--YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE 209 (468)
Q Consensus 134 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~ 209 (468)
.+.+..+.... .-+..... ....++++++ ...+...+.||+|+||.||+|.. .++..||||++......
T Consensus 657 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~- 729 (968)
T PLN00113 657 NLELKRVENEDG---TWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI- 729 (968)
T ss_pred cccccccccccc---cccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-
Confidence 11111110000 00000000 0112344443 34577788999999999999975 57899999998754321
Q ss_pred hhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHH
Q 012219 210 LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289 (468)
Q Consensus 210 ~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 289 (468)
...|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++. ++|.++.+++.|+|+|++|||
T Consensus 730 ------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH 797 (968)
T PLN00113 730 ------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLH 797 (968)
T ss_pred ------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhc
Confidence 12468889999999999999999999999999999999999999963 889999999999999999999
Q ss_pred hcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHH
Q 012219 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369 (468)
Q Consensus 290 ~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~ 369 (468)
+.++++|+||||||+||+++.++.+++. ||....... .....+++.|+|||++.+..++.++|||||||++|||+
T Consensus 798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872 (968)
T ss_pred cCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence 8778899999999999999999988875 665543321 12236789999999999999999999999999999999
Q ss_pred hCCCCCCcccccc-----hhh--hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 370 MGKHPGELLSSSS-----WSL--DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 370 tg~~p~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
||+.||+...... |.. .........+|+.+...... ..+++..+.+++.+||+.||++||||.+|++.|+++
T Consensus 873 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 873 TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV-NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred hCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc-cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999986432111 110 01112233445544332211 224556688999999999999999999999999987
Q ss_pred CCC
Q 012219 443 NKA 445 (468)
Q Consensus 443 ~~~ 445 (468)
...
T Consensus 952 ~~~ 954 (968)
T PLN00113 952 SRS 954 (968)
T ss_pred hcc
Confidence 654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=431.45 Aligned_cols=282 Identities=39% Similarity=0.686 Sum_probs=240.3
Q ss_pred CCCCcCHHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEE
Q 012219 156 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235 (468)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 235 (468)
....|++.++..||++|...+.||+|+||.||+|.+++|+.||||++....... .++|.+|++++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 345689999999999999999999999999999999999999999887765431 35699999999999999999999
Q ss_pred EEEeeCC-EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 236 GFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 236 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
|||.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.+.|+||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999988 599999999999999999986654 68999999999999999999999888899999999999999999999
Q ss_pred EEeeccccccccCCCCCceec-cccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc------ccch--hh
Q 012219 315 FVADFGVARLLNFDSSNRTLL-AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS------SSSW--SL 385 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~------~~~~--~~ 385 (468)
||+|||+|+............ .||.+|+|||+...+..++|+|||||||+++||+||+.|.+... ...| ..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996654312222222 79999999999999999999999999999999999998876432 1122 22
Q ss_pred hcccccccccCCCCCC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 386 DKNIKLIDLLDPRLSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.......+++|+.+.. ..... +++..+.+++..|++.+|++||+|.+|++.|+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCcchhheeCCCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 2334788899999873 32211 56666999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=388.43 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=212.1
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-EEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-CMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 249 (468)
++.+.+.||+|+||+||+|.+++...||||++......... .+.|.+|+.+|.+++|||||+++|+|.++. ..++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34445669999999999999976666999999876654433 779999999999999999999999999987 7999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceeeCCCC-CeEEeeccccccccC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP-IVHRDISSNNVLLNSEL-EAFVADFGVARLLNF 327 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~ 327 (468)
|+++|+|..+++.. ....+++..+++++.|||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999874 3445999999999999999999999 566 99999999999999997 999999999988754
Q ss_pred CCCCceecccccccccccccc--CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 328 DSSNRTLLAGTYGYIAPELAY--TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
.....+...||+.|||||++. ...|+.|+|||||||++|||+||+.||........... .......+.+.....
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~---v~~~~~Rp~~p~~~~- 272 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA---VVVGGLRPPIPKECP- 272 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhcCCCCCCCccCC-
Confidence 334444478999999999999 56999999999999999999999999987764211111 111112222222222
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
..+..++.+||+.||+.||++.+++..|..+..
T Consensus 273 ------~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 273 ------PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 226678889999999999999999999986643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=386.96 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=211.6
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+.+...+.||+|.||.||.|+++....||+|.++..... .++|.+|+++|++|+|+|||+++|+|..++.++||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 445667889999999999999988889999999876543 3689999999999999999999999999889999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
||+.|+|.++|+.. ....+...+.+.++.|||+|++||+ ++++|||||.++|||++++..|||+|||+|+....+.
T Consensus 282 ~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999873 3345889999999999999999999 8899999999999999999999999999999654333
Q ss_pred CCcee-ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SNRTL-LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
+.... ..-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+... ...+.++...+.+.+...
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRLPRPEGC 429 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcCCCCCCC
Confidence 32222 223558999999999999999999999999999999 99998876543 222333333333333322
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+ ..+.+++..||+.+|++|||++.+...+....
T Consensus 430 P---~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 430 P---DEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred C---HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2 23778999999999999999998888777653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=379.63 Aligned_cols=264 Identities=27% Similarity=0.462 Sum_probs=221.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|...+.||+|||+.+|.++. ..|..||+|++.+.........+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999976 889999999998866665566778889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+|.+++|..+++.. ..+++.++..++.||+.||.||| +.+|+|||||-.|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999843 34999999999999999999999 889999999999999999999999999999999888
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.+.....+|||-|.|||++....++..+||||+||+||-|+.|++||+...- .........-+-.++......
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----kety~~Ik~~~Y~~P~~ls~~-- 244 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----KETYNKIKLNEYSMPSHLSAE-- 244 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----HHHHHHHHhcCcccccccCHH--
Confidence 8888889999999999999999999999999999999999999999985421 111111111222222222211
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhcCCCCCCCCc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIARNKAPMQKPF 451 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~~~~~~~~~~ 451 (468)
-.++|.++|+.||.+|||+++|+ +.|+....-|...|.
T Consensus 245 -----A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 245 -----AKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS 283 (592)
T ss_pred -----HHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence 34688899999999999999999 445544444444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=357.76 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=205.5
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-EEEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-CMFLIYE 249 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 249 (468)
++..+.||+|..|+||++++ ++++.+|+|++...... ...+++.+|+++++..+||+||.++|.|..+. ...++||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~--~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP--ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH--HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 44467799999999999976 47889999999554433 34578999999999999999999999999988 5999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
||++|||++.+...+. +++...-+|+.+|++||.|||+ .++||||||||+|||++..|++||+|||.++.+...
T Consensus 159 YMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999986533 8999999999999999999995 479999999999999999999999999999887533
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccc-cchhhhcccccccccCCCCCCccchhHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSS-SSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ..........+..-..|.++.. .+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~f- 307 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG---EF- 307 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc---cC-
Confidence 55667899999999999999999999999999999999999999875311 0011111111222222333332 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..++..++..||++||.+|||+++++++=
T Consensus 308 --S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 308 --SPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred --CHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 12277799999999999999999998543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=353.94 Aligned_cols=203 Identities=30% Similarity=0.499 Sum_probs=181.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..+|.....||+|+||+||+|++ .++..||||.+...... ....+....|+.+|+.++|||||++++++..++..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45788888899999999999976 46899999999876532 23456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC------CCeEEeeccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE------LEAFVADFGV 321 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfg~ 321 (468)
||||.||+|.++++..+. +++.....++.|+|.||++|| +++||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999997653 899999999999999999999 8899999999999999875 4579999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
|+.+. ........+|++-|||||++..++|+.|+|+||.|+|+||+++|+.||+...
T Consensus 162 AR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99987 4455566799999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=359.95 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=206.5
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhh----hHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA----SLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.+.|.+.+.||+|+||.|-+|. .++|+.||||.++........ ......+|+++|++|+|||||++.+++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3567888999999999999995 568999999999876543311 22335699999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEeecc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVADFG 320 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg 320 (468)
.|||+||++||.|.+.+-.++. +.+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999976654 666677889999999999999 8899999999999999776 789999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCC---CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+|+..+ ........+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||..........++...- .-
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G----~y 399 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG----RY 399 (475)
T ss_pred hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC----cc
Confidence 999876 566677789999999999998654 3348899999999999999999997543322111110000 01
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhc
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIAR 442 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~ 442 (468)
.+.++.+..+.+ +..++|.+||..||++|||++|++ +.|.+.
T Consensus 400 ~f~p~~w~~Ise---ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 400 AFGPLQWDRISE---EALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred cccChhhhhhhH---HHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 112222333333 467899999999999999998888 556653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=345.57 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=207.3
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEE-EeeCCE-EEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF-CLHRKC-MFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~l 246 (468)
.+|.+.++||+|.||+||++. ..+|..||.|.++-.... ....++...|+.+|++|+|||||+++++ +.++.. .+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 458888999999999999994 679999999999854443 3456788899999999999999999983 344444 899
Q ss_pred EEEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 247 IYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
|||||..|+|..+++.. .....+++..+|+++.|++.||.++|+...+ -|+||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999998653 3345689999999999999999999953222 388999999999999999999999999999
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
+..........+|||.||+||.+.+..|+.||||||+||++|||+.-++||....- ..... ++.+- .+++...
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~~--KI~qg---d~~~~p~ 250 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLCK--KIEQG---DYPPLPD 250 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHHH--HHHcC---CCCCCcH
Confidence 98777777788999999999999999999999999999999999999999986421 11111 11111 1111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
...+. .+.+|+..|+..||+.||+.-.++..+.
T Consensus 251 ~~YS~---~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 EHYST---DLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHhhh---HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 22222 2677899999999999999544444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.93 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=208.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||+|+||+||.++. ++++.+|+|++++....+....+....|..++.+++||.||.++-.+++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999964 56899999999988776666778889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+.||.|..+|+..+. +++..+.-++..|+.||.||| +.+||||||||+|||+|.+|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999986554 888888889999999999999 88999999999999999999999999999997655
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.+......+||+.|||||++....|+..+|.||+|+++|||++|.+||........... +....+. ..+..+
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~-------I~~~k~~-~~p~~l 249 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK-------ILKGKLP-LPPGYL 249 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH-------HhcCcCC-CCCccC
Confidence 55666668999999999999999999999999999999999999999975443221110 0000100 011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC----CHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP----TMQLVS 436 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP----s~~~v~ 436 (468)
..+ ..+++.+.+..||++|. ++.++.
T Consensus 250 s~~---ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 250 SEE---ARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CHH---HHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 111 45688899999999996 455554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=375.41 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=213.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
..+....+.||+|+||+||+|... +...||||.++..... ...++|++|++++..++|||||+++|.|.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 455666788999999999999742 4567999999876654 35689999999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
..++|+|||..|+|.+||+.... ..+++..+.+.||.|||.|+.||- ++.+|||||..+|+|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence 99999999999999999975321 234889999999999999999999 7789999999999999999
Q ss_pred CCeEEeeccccccccCCCCCce--eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcc
Q 012219 312 LEAFVADFGVARLLNFDSSNRT--LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKN 388 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 388 (468)
..|||+|||+++.+....+... ...-..+|||||.+..+++|++||||||||+|||+++ |+.||...........-
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i- 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI- 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-
Confidence 9999999999998754333221 1233569999999999999999999999999999999 99999876653322111
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+ +..+ -+. .+.+..++++|+..||+..|++||++.||-..|+....+
T Consensus 719 -~-----~g~l-L~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 -R-----AGQL-LSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -H-----cCCc-ccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 0 1111 111 113334488899999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=333.87 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=205.4
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|+....+|+|+||+||+++.+ +|+.||||++...... ....+-.++|++++++++|+|+|.++++|...+..+||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 35777788999999999999865 6999999999765432 233455679999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||+. ++.+-|..... .++...+.+++.|++.|+.|+| +.+++||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99987 44444544433 3888999999999999999999 789999999999999999999999999999999877
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-----------------hcccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-----------------DKNIK 390 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-----------------~~~~~ 390 (468)
....+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|...+...... .....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 777888899999999999887 689999999999999999999999886544321110 00000
Q ss_pred ccc--ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 391 LID--LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 391 ~~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
... +.++.-..+...........+.+++..|++.||.+|++.+++++
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 001 11111111111112222234789999999999999999999884
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.32 Aligned_cols=273 Identities=30% Similarity=0.469 Sum_probs=223.8
Q ss_pred CCCCcCHHHHHHHhhC---------ccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHH
Q 012219 156 YDGRITFQDMIEATED---------FHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARL 222 (468)
Q Consensus 156 ~~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~ 222 (468)
+...++|+|...+... ..+.+.||.|.||.||+|+++ ....||||.++....+ .+..+|+.|+.+
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsI 683 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASI 683 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhh
Confidence 4445667665555443 466789999999999999864 2457999999987665 356899999999
Q ss_pred HhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 012219 223 LSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS 302 (468)
Q Consensus 223 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 302 (468)
|.++.||||++|-|+....+..+||+|||++|+|+.||+.+... +.+.+...++.+||.|+.||- +.++|||||.
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA 758 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA 758 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence 99999999999999999999999999999999999999987643 999999999999999999999 8899999999
Q ss_pred CCceeeCCCCCeEEeeccccccccCCCCCce-eccc--cccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcc
Q 012219 303 SNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAG--TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELL 378 (468)
Q Consensus 303 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~ 378 (468)
++|||++.+..+|++|||+++.+..+..... ...| ..+|.|||.+...+++.+||||||||+|||.++ |..||-++
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 9999999999999999999998865543322 2223 458999999999999999999999999999998 99998776
Q ss_pred cccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
........ +. .+-+++++. ++...|.+|++.||++|-.+||.+.+++..|.+....|
T Consensus 839 SNQdVIka----Ie--~gyRLPpPm-----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 839 SNQDVIKA----IE--QGYRLPPPM-----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred chHHHHHH----HH--hccCCCCCC-----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 54322111 00 122333332 23344889999999999999999999999998876554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=337.23 Aligned_cols=267 Identities=26% Similarity=0.381 Sum_probs=212.9
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||.|..++||+|+ .+.+..||||++..++... .++.+.+|+..|+.++||||++++..|..++.+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4679999999999999999996 5678999999999887764 378899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|.||.+||+.+.+...... .+++..+..|++++++||.||| ..|.||||+|+.|||++.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999875543 3899999999999999999999 77999999999999999999999999998766643
Q ss_pred CCCCc----eeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 328 DSSNR----TLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 328 ~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.+... ...+||++|||||++.. ..|+.|+|||||||...||.+|..||..++........-.......+ ...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--t~~ 256 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--TSG 256 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--ccc
Confidence 33222 34589999999999654 47999999999999999999999999877654332221111111000 000
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARN 443 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~ 443 (468)
.........-..+.+++..|++.||.+|||++++++ .|++..
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 001111112235788999999999999999999884 444443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.51 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=212.7
Q ss_pred HHhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
+...+|.+++.||+|+|++|++|+ ...++.+|||++.+.-.-.....+....|-+.|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999996 457899999999876554444556677899999999 899999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
|.|+||+++|+|.++++..+. +++.-...++.+|+.||+||| +.|||||||||+|||+|.|+++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999987654 899999999999999999999 88999999999999999999999999999998
Q ss_pred ccCCCCC-------------ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccc
Q 012219 325 LNFDSSN-------------RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 325 ~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 391 (468)
+...... ...++||..|.+||++.....+..+|+|+||||+|+|+.|++||.....-.. +.+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-FqkI--- 299 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-FQKI--- 299 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-HHHH---
Confidence 8532111 1457899999999999999999999999999999999999999986442111 1111
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
-.++-.+.+.++.. ..+|+.+.|..||.+|+|.+++.++-+
T Consensus 300 -~~l~y~fp~~fp~~-------a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 300 -QALDYEFPEGFPED-------ARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred -HHhcccCCCCCCHH-------HHHHHHHHHccCccccccHHHHhhCcc
Confidence 11233344433322 456888999999999999999986643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=351.97 Aligned_cols=269 Identities=25% Similarity=0.438 Sum_probs=216.4
Q ss_pred CcCHHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEE
Q 012219 159 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFC 238 (468)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 238 (468)
+.+.++|....+++.+.+.||+|.||+||+|++.+ .||||++.-..... ...+.|.+|+..+++-+|.||+-+.|||
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 34456777777888889999999999999999853 59999998776654 3789999999999999999999999999
Q ss_pred eeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 239 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 239 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
..+.. .||+.+|+|.+|+.+++..+. .++..+.+.||.|||+|+.||| .++|||||||..||++.++++|||+|
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence 98887 999999999999999997664 4889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccC--CCCCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc
Q 012219 319 FGVARLLNF--DSSNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 319 fg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
||++..... .........|...|||||+++. ..|+..+|||||||++|||+||..||. ...... +.-
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq-------Iif 603 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ-------IIF 603 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh-------eEE
Confidence 999865432 1222334568889999999874 479999999999999999999999998 322111 111
Q ss_pred ccCCC-CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 394 LLDPR-LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 394 ~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
++... +.+........+...+.+|+..||..++++||.+.+++..|+...+
T Consensus 604 mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111 1111111122333447788999999999999999999998877655
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=353.70 Aligned_cols=273 Identities=26% Similarity=0.415 Sum_probs=215.9
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEcC--CC--CE-EEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLP--SG--KV-VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 235 (468)
.-+.|+...++..+.++||+|+||.||+|++. ++ .. ||||..+..........++|++|+++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 34455556677778899999999999999753 23 23 899999874444446788999999999999999999999
Q ss_pred EEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 236 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
|++.....+++|||+|.||+|.++|+..+. .++..+++.++.+.|.||+||| +.+++||||.++|+|++.++.+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999998765 4899999999999999999999 88999999999999999999999
Q ss_pred EeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccc
Q 012219 316 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|+|||+++.-..-........-+.+|+|||.+....++.++|||||||++||+++ |..||.......... . +
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~----k---I 375 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA----K---I 375 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH----H---H
Confidence 9999998764311111111123568999999999999999999999999999999 899998765431111 1 1
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQ 448 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~ 448 (468)
.....+...+..... .+..++.+||..+|++||+|.++.+.+.........
T Consensus 376 ~~~~~r~~~~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HhcCccCCCCCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011111111111112 255677899999999999999999999888765443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.64 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=203.2
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC--EEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 246 (468)
.++...+.||+|+||+||++... +|...|||......... .+.+.+|+.+|.+++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 34667788999999999999754 58999999998764332 567889999999999999999999855444 6899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeeccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLL 325 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~ 325 (468)
.|||+++|+|.+++...+. .+++..+..++.||++||+||| ++||+||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999987664 4999999999999999999999 889999999999999999 799999999999876
Q ss_pred cC---CCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcc-cccchhhhcccccccccCCCCC
Q 012219 326 NF---DSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELL-SSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 326 ~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.. .........||+.|||||++..+ ....++||||+||++.||+||+.||... ....+..... . +..-|.++
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig-~--~~~~P~ip 245 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG-R--EDSLPEIP 245 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-c--cCCCCCCC
Confidence 53 11223346899999999999864 3345999999999999999999998763 2111111100 0 00112222
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
...+ ++ ..+++.+|+..||++|||+++++++.+.....
T Consensus 246 ~~ls----~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 246 DSLS----DE---AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cccC----HH---HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 2222 22 45688899999999999999999887765443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.09 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=201.6
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++..+ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46799999999999999999963 23568999999754332 2346788999999999 899999999998764
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcc-------------------------------------------------------
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------- 265 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 265 (468)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 458899999999999999875321
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC--Cceeccccc
Q 012219 266 ----AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTY 339 (468)
Q Consensus 266 ----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~ 339 (468)
...+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124778889999999999999999 78999999999999999999999999999986532211 112234567
Q ss_pred cccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHH
Q 012219 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVA 418 (468)
Q Consensus 340 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 418 (468)
.|+|||++.+..++.++|||||||++|||++ |+.||............ .............. ..+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~l~~li 310 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR---LKDGTRMRAPENAT-------PEIYRIM 310 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HhcCCCCCCCCCCC-------HHHHHHH
Confidence 8999999999999999999999999999997 99998764322111110 00000111111111 2267899
Q ss_pred HhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 419 FSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 419 ~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.+||+.||++|||+.++++.|++..
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=342.00 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=209.3
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
..|....+||+|+.|.||.++ ..+++.||||++....... .+-..+|+.+|+..+|+|||.+++.|...+..++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 457777889999999999995 5678999999998765442 345779999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|.+.+.... +++.++..|+.++++||+||| ..+|+|||||.+|||++.++.+||+|||+|..+...
T Consensus 350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999987543 899999999999999999999 889999999999999999999999999999998877
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||+.|||||+.....|++|+||||||++++||+-|.+||-....... ...+...-.|.+....
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA----lyLIa~ng~P~lk~~~----- 493 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPKLKNPE----- 493 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH----HHHHhhcCCCCcCCcc-----
Confidence 7677788999999999999999999999999999999999999999864222111 1111111222222211
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.-...+.+++.+||+.||++||++.|++++=
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 1112377889999999999999999999543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=308.38 Aligned_cols=276 Identities=25% Similarity=0.363 Sum_probs=212.3
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|...+.+|+|.||.||+|+ ..+|+.||||+++.....+.-. ....+|++.|+.++|+||+.+++++...+...||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 457778899999999999996 5689999999998776554332 35669999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||+. +|...++... ..++..++..++.++.+|++||| .+.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99974 8988887543 45889999999999999999999 889999999999999999999999999999999877
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCccccc----------------chhh----hc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSS----------------SWSL----DK 387 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~----------------~~~~----~~ 387 (468)
.......+-|..|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|....+. .|.. ..
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 666666688999999998876 57999999999999999999998766543321 1110 00
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcCCCCCCCCcccccHhh
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARNKAPMQKPFHEISILE 458 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~~~~~~~~~~~~~~~~ 458 (468)
.........+.... .+........+++.+++..||.+|++++|+++ ..+.. .|.+.+-.+++...
T Consensus 235 Y~~~~~~P~~~~~~----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN----LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPPSKLPIPS 300 (318)
T ss_pred HHHHhcCCCCcccc----ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCChhhCcCCc
Confidence 00111111111111 11112223578999999999999999988874 44443 34444444554443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.94 Aligned_cols=265 Identities=27% Similarity=0.373 Sum_probs=205.5
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 245 (468)
.+.|+..++||+|.||.||+|+ ..+|+.||+|++..+...+ .......+||.+|++|+||||+++.+...+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3567778889999999999996 5789999999998766433 2345567999999999999999999998876 6899
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
||+|||+. +|.-++.... ..++..++..++.|++.||+||| ++||.|||||.+|||+|.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999986 8888887543 45899999999999999999999 899999999999999999999999999999988
Q ss_pred cCCCCC-ceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-----------hccc--c
Q 012219 326 NFDSSN-RTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-----------DKNI--K 390 (468)
Q Consensus 326 ~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-----------~~~~--~ 390 (468)
...... .+..+-|.+|+|||++.+. .|+.++|+||.||||.||++|++.|.........- ..+. +
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 655433 6667889999999988764 79999999999999999999999987543321100 0000 1
Q ss_pred cccccCCCCCCccchhHHHHH----HHHHHHHHhcccCCCCCCCCHHHHH-HHHH
Q 012219 391 LIDLLDPRLSPPVDQKIRQDI----ILVSTVAFSCLRSQPKSRPTMQLVS-NEFI 440 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~----~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~ 440 (468)
+..........+....+.+.. ...++|+..+|..||.+|.|+.+++ ..++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 110000011111122222221 2367888999999999999997777 4555
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=367.20 Aligned_cols=264 Identities=29% Similarity=0.454 Sum_probs=210.9
Q ss_pred hCccccceeeeeCCceEEEEEcCC--CC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS--GK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
...+....||+|+||.||.|...+ |. .||||.+.+.... ....+|.+|..+|+.++|||||+++|+|.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 456667889999999999997532 33 4899999876543 456899999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
.+|++|||++|+|..+|+... ....+...+.+.++.|||+|+.||+ +.++|||||.++|+|++....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999998752 2345889999999999999999999 889999999999999999999999999
Q ss_pred cccccccCCCCCcee-c-cccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccC
Q 012219 320 GVARLLNFDSSNRTL-L-AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 320 g~~~~~~~~~~~~~~-~-~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|+|+.+....+.... . .-..+|||||.+..+.++.|+|||||||++||++| |..||............. -+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EG 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hC
Confidence 999965433332221 1 23468999999999999999999999999999999 999998665432221100 01
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQK 449 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~ 449 (468)
-++.++. .+...+++++..||+.+|++||++..+++.+..+....-..
T Consensus 921 gRL~~P~-----~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 921 GRLDPPS-----YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred CccCCCC-----CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 1222221 11223778999999999999999999999887766543333
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=330.24 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=199.0
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 251 (468)
..||+|++|.||+|.+ +|+.||||++...........+.|.+|++++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 688999999987654443446788899999999999999999999877 34689999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
++|+|.+++.... .+++...+.++.+++.||.|||. ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 9999999997643 38899999999999999999993 247889999999999999999999999999865422
Q ss_pred ceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 332 RTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 332 ~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||............ ......+......+
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~----- 248 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI---INKNNSLKLPLDCP----- 248 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhcCCCCCCCCcCc-----
Confidence 123457889999999876 68999999999999999999999999865322111100 00001111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||+.||++|||++++++.|...
T Consensus 249 --~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 249 --LEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1367899999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=342.60 Aligned_cols=251 Identities=28% Similarity=0.499 Sum_probs=205.2
Q ss_pred CCcCHHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 158 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
..+.|+++.+ .+-||.|+.|.||.|++ .++.||||+++.-+. .+|+-|++|+|+||+.+.|+
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE----------TdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE----------TDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhhh----------hhHHHHHhccCcceeeEeee
Confidence 4566766544 45599999999999999 468899998864322 57889999999999999999
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
|.....+|||||||..|-|...|+.... +.......+..+||.|+.||| .+.|||||||.-|||++.+..|||+
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEec
Confidence 9999999999999999999999986543 777888899999999999999 6799999999999999999999999
Q ss_pred eccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
|||-++..... .....++||..|||||++.....++|+|||||||+||||+||..||.+............+...+
T Consensus 255 DFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L--- 330 (904)
T KOG4721|consen 255 DFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL--- 330 (904)
T ss_pred cccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc---
Confidence 99999877533 55556899999999999999999999999999999999999999998766542221111111111
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.++...+.+ +.-|++.||+..|..||++++++.+|.-..
T Consensus 331 pvPstcP~G-------fklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 331 PVPSTCPDG-------FKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cCcccCchH-------HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 112222222 334778999999999999999999997543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.64 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=206.8
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchh-h-hhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETE-E-LASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKC 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 243 (468)
..+.|.+.+.||+|+||+|+.|. ..++..||+|++.+.... . ....+...+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34689999999999999999995 457899999977764221 1 123445668999999999 9999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~ 322 (468)
.++||||+.+|+|.+++...+ .+.+.++..++.|++.|++||| +.||+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999998733 3788999999999999999999 8899999999999999999 99999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCC-CC-ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMV-VT-EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.............+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||++......... ....+ ..++
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~~---~~~p 243 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKGE---FKIP 243 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcCC---ccCC
Confidence 88743445566789999999999999877 75 789999999999999999999997332111111 11111 1111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhc
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIAR 442 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~ 442 (468)
.... ...+..++.+|+..||.+|+++.+++ +.|.+.
T Consensus 244 ~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLL------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCcC------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1110 11266789999999999999999988 445554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.73 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=207.4
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCC-EEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRK-CMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 245 (468)
.++|...++||.|.||+||+|+ ..+|..||||++++....- + .-.=.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-E-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-H-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4678899999999999999996 5678999999998654331 1 112348999999999 999999999999887 899
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|||||+ .+|.++++.. .+.+++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence 9999997 4999999875 456999999999999999999999 889999999999999999999999999999987
Q ss_pred cCCCCCceeccccccccccccc-cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------cccc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------KNIK 390 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------~~~~ 390 (468)
. .....+..+.|.+|+|||++ ++..|+.+.||||+|||++|+.+-++-|........... ....
T Consensus 161 ~-SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 161 R-SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred c-cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 6 34556667899999999976 467899999999999999999999988765433211000 0011
Q ss_pred cccccCCCCCC----ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 391 LIDLLDPRLSP----PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 391 ~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+...+.-.++. ..............+++..|+..||.+|||+.+.+++-.-..
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 11111111111 111122223344778999999999999999999997654433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.13 Aligned_cols=249 Identities=30% Similarity=0.434 Sum_probs=209.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+....+ ..++...+|+++++.++|||||.++++|+...+.++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4678888999999999999964 568999999998766554 45788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.| +|..++..++. +++..+..|+.++..||.||| +.+|.|||+||+|||++..+.+|++|||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99987 99999987665 899999999999999999999 889999999999999999999999999999999877
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
....+...||+-|||||+..++.|+..+|.||+|||+||+.+|++||....- ....+.. .-|+...+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I----~~d~v~~p~------ 221 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSI----LKDPVKPPS------ 221 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHH----hcCCCCCcc------
Confidence 7777888999999999999999999999999999999999999999863221 0111000 012222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+..++...+.+||.+|.|-.+++.+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111126678889999999999999888744
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.17 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=199.8
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|...+.||+|+||.||+|.. .+++.||+|.+.............+.+|++++.+++|+|++++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999975 57899999998765443333345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence 99999988876432 234889999999999999999999 789999999999999999999999999999775322 2
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.................. .......... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s----~- 230 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-DQEEYSEKFS----E- 230 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-ccccCCccCC----H-
Confidence 223456899999999999999999999999999999999999999754321110000000000 0011111111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 411 IILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
.+.+++.+||+.||++||+ +++++++
T Consensus 231 --~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 231 --DAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 2667999999999999997 7888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=336.75 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=212.2
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+...+.++||+|.||.|..+....+..||||.++...... ..++|..|+++|.+++||||++++|+|..++.+++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34567889999999999999999888999999999876653 4689999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|..++..+.... .......+|+.|||.|++||. +.++|||||.++|+|++.++++||+|||.++-+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998775433 566677889999999999999 789999999999999999999999999999865433
Q ss_pred CCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh--CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 329 SSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 329 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.+.. ...+-+.+|||||.+.-++++++||||+||+.+||+++ ...||+.+....... +..++++..-.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve----n~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE----NAGEFFRDQGRQVVL 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH----hhhhhcCCCCcceec
Confidence 2222 22345679999999999999999999999999999986 888998766533221 112222111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
....-+...+++++.+||+.|-++||+++++...|+..
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111223377899999999999999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.11 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=202.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+....||.|+||.|..++.+ +|..+|+|++.........+.+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999754 68899999999988888888888999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++||.|..++++.+. +++..+.-+|.+|+.||+||| +.+|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999987654 899999999999999999999 88999999999999999999999999999998652
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....+||+.|+|||.+.+..+..++|.|||||++|||+.|.+||...... .........+ -.++......
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--~iY~KI~~~~---v~fP~~fs~~-- 267 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--QIYEKILEGK---VKFPSYFSSD-- 267 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--HHHHHHHhCc---ccCCcccCHH--
Confidence 355679999999999999999999999999999999999999999754331 1111111111 1122222221
Q ss_pred HHHHHHHHHHHhcccCCCCCC
Q 012219 409 QDIILVSTVAFSCLRSQPKSR 429 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~R 429 (468)
+.+|+.+.++.|-.+|
T Consensus 268 -----~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 268 -----AKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----HHHHHHHHHhhhhHhh
Confidence 4567778888888888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.88 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=198.3
Q ss_pred hCccccceeeeeCCceEEEEEcCC-----------------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCcee
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 232 (468)
++|.+.+.||+|+||.||+|.+++ +..||+|.+...... .....|.+|++++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCee
Confidence 578889999999999999997532 346999998765432 2356789999999999999999
Q ss_pred eEEEEEeeCCEEEEEEEeccCCChhhhhhcCc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012219 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296 (468)
Q Consensus 233 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 296 (468)
++++++...+..++||||+++|+|.+++.... ....+++..+++++.||+.||.||| +.+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 99999999999999999999999999886421 1124688899999999999999999 7899
Q ss_pred EecCCCCCceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh--CC
Q 012219 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GK 372 (468)
Q Consensus 297 vH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t--g~ 372 (468)
+||||||+||+++.++.+||+|||+++........ .....++..|+|||++....++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999765322211 112345778999999988899999999999999999997 56
Q ss_pred CCCCcccccchhhhcccccc---cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 373 HPGELLSSSSWSLDKNIKLI---DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 373 ~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.||................. ........+..+ ..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP-------QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCC-------HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67765432211100000000 000000111111 22678999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.49 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=197.7
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.||+|+||.||+++. .+|+.||+|++.............+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999975 578999999998654433344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987543 3889999999999999999999 789999999999999999999999999999764333333444
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
..|++.|+|||++.+..++.++|||||||++|||+||+.||........... ...-+..+..... . .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-----~~~~~~~~p~~~~----~---~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEEIRFPRTLS----P---EA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCC----H---HH
Confidence 6799999999999999999999999999999999999999865332111000 0000111222111 1 26
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 6789999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.44 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=203.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999764 58999999998654433344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 3788999999999999999999 78999999999999999999999999999976532
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC-CCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD-PRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 407 (468)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+. +.......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~--- 227 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKETLQRPVYDDPRF--- 227 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-HHHhccccccCCCCCcccc---
Confidence 2334568999999999999899999999999999999999999997543221100 0000011111 11110000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+|+..+|.+||++++++++
T Consensus 228 -~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 -NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111226678999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=338.52 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=201.7
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|++.+.||+|+||.||+|.. .++..||||+++..... ...+.+.+|++++..+ +||||++++++|...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45789999999999999999963 34668999999754432 2346788999999999 899999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc--------------------------------------------------------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------- 265 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 265 (468)
...++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 266 ----------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 266 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
...+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 124788899999999999999999 7899999999999999999999999999998664322
Q ss_pred CC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 330 SN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 330 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||............. .....+......
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~--- 342 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI---KEGYRMLSPECA--- 342 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH---HhCccCCCCCCC---
Confidence 21 112234567999999999999999999999999999998 899987543221111100 000000011111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+||+.||++|||+.+|++.|++
T Consensus 343 ----~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 343 ----PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1137789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.02 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=201.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 68999999997654433344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 3888999999999999999999 789999999999999999999999999999765422
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........... . .. -...+.....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-i---~~-~~~~~~~~~~---- 222 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-I---LA-GKLEFPRHLD---- 222 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H---Hh-CCcCCCccCC----
Confidence 2234689999999999988899999999999999999999999875432111100 0 00 0011111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
..+.+++.+||+.||.+||+ +++++++
T Consensus 223 ---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 223 ---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12667999999999999995 8888755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.45 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=209.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
..|+..+.||+|.||.||+|.. ..++.||+|++..+...+ .+++..+|+.++.+++++||.+++|.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 3466678899999999999964 578999999998776553 4678889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||.||++.+.++...- +++....-|+.++..|+.||| ..+.+|||||+.||++..+|.+|++|||.+-.+...
T Consensus 91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999986543 467777788999999999999 789999999999999999999999999999888766
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
......++||+.|||||++....|+.|+||||||++.+||.+|.+|+......+..+ .+.+-..|.+...+..
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----lIpk~~PP~L~~~~S~--- 237 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----LIPKSAPPRLDGDFSP--- 237 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----eccCCCCCccccccCH---
Confidence 666677899999999999998899999999999999999999999987665422211 1122222333332222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.+.+++..|+++||+.||++.+++.+=
T Consensus 238 ----~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 238 ----PFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred ----HHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 266788999999999999999998543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=300.03 Aligned_cols=253 Identities=31% Similarity=0.440 Sum_probs=213.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||+|.||.||.|+. +++-.||+|++.+.........+++.+|+++.+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46899999999999999999975 56889999999887766656678899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||..+|++...|..... ..+++.....++.|+|.||.|+| .++|+||||||+|+|++.++..||+|||-+..-
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 999999999999985432 34888889999999999999999 899999999999999999999999999988653
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
+.......+||..|.|||...+..++..+|+|++|++.||++.|.+||+.... ....+...-.+..+ +......
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--~etYkrI~k~~~~~---p~~is~~- 248 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--SETYKRIRKVDLKF---PSTISGG- 248 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--HHHHHHHHHccccC---CcccChh-
Confidence 25556677999999999999999999999999999999999999999986542 11111222222222 2333322
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..+++..|+..+|.+|.+..|++.+.
T Consensus 249 ------a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 249 ------AADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ------HHHHHHHHhccCccccccHHHHhhhH
Confidence 45688899999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=336.98 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=202.0
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|.. .++..||+|+++...... ....+.+|+++++.+ +|+||++++++|...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45789999999999999999863 234579999997654332 346788999999999 899999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc--------------------------------------------------------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------- 265 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 265 (468)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998854211
Q ss_pred -----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC--c
Q 012219 266 -----------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--R 332 (468)
Q Consensus 266 -----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 332 (468)
...+++.++++++.||+.||.||| +.+|+||||||+||++++++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 124788899999999999999999 789999999999999999999999999999765432211 1
Q ss_pred eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 333 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
....++..|+|||++....++.++|||||||++|||++ |+.||............. .....+......+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~------- 341 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRGYQMSRPDFAP------- 341 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---HcccCccCCCCCC-------
Confidence 12234567999999988899999999999999999997 999987543221111100 0001111111111
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 412 ILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1267799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.59 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=194.3
Q ss_pred eeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||.||+|+.. +++.||+|++.............+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999754 6889999999765433334456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecc
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 336 (468)
.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997643 3889999999999999999999 78999999999999999999999999999976433333334457
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHH
Q 012219 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416 (468)
Q Consensus 337 g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 416 (468)
||+.|+|||++.+..++.++|||||||++|||+||+.||........... ... -...+..... . .+.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-~~~----~~~~~~~~~~----~---~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-ILQ----EPLRFPDGFD----R---DAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-HHc----CCCCCCCcCC----H---HHHH
Confidence 99999999999999999999999999999999999999975432211110 000 0111111111 1 2667
Q ss_pred HHHhcccCCCCCCCC---HHHHHH
Q 012219 417 VAFSCLRSQPKSRPT---MQLVSN 437 (468)
Q Consensus 417 l~~~cl~~dP~~RPs---~~~v~~ 437 (468)
++.+||+.||++||+ +.+++.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc
Confidence 899999999999985 566664
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.55 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=201.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999764 68999999997654433345567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997643 3788888999999999999999 789999999999999999999999999999865422
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||......... . .+.+. ...++...+
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~---~i~~~-~~~~p~~~~---- 239 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-E---KILAG-RLKFPNWFD---- 239 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-H---HHhcC-CcCCCCCCC----
Confidence 22357899999999999999999999999999999999999998653321110 0 00000 011111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
. .+.+++.+||+.||++||+ +++++++
T Consensus 240 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 240 G---RARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred H---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 2567999999999999997 6777744
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=331.29 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=196.6
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.||+|+||.||++.. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999975 578999999998654333334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998886543 3889999999999999999999 789999999999999999999999999998764333333344
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........... . ...+..+..... . .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~--~---~~~~~~~p~~~~----~---~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--I---LMEEIRFPRTLS----P---EA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--H---hcCCCCCCCCCC----H---HH
Confidence 5789999999999999999999999999999999999999865432111000 0 000111122121 1 25
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 6789999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=330.95 Aligned_cols=245 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.||+|+||.||+++. .+++.||+|++.............+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999975 568999999998654333344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
+|..++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9998886543 3889999999999999999999 789999999999999999999999999998764333333344
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
..|++.|+|||++.+..++.++|||||||++|||++|+.||......... .. ....+..+..... . .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~----~~~~~~~~p~~~~----~---~~ 222 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL----ILMEDIKFPRTLS----A---DA 222 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HH----hccCCccCCCCCC----H---HH
Confidence 57999999999999889999999999999999999999999653321111 00 0001111222221 1 26
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+++.+||+.||++|| ++.+++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 6789999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=327.05 Aligned_cols=199 Identities=28% Similarity=0.358 Sum_probs=173.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+++.. ++..+|+|.+...... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 67899999999999999999754 6888999998764322 23467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 9999999999997643 37889999999999999999994 24699999999999999999999999999976532
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
.......|+..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 222345689999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=332.76 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=200.7
Q ss_pred hCccccceeeeeCCceEEEEEcCC--CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|.... +..||+|++...........+.+.+|++++..++||||+++++++...+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568999999999999999997533 368999999765433334456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999997654 3889999999999999999999 78999999999999999999999999999987542
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +... ...++....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~---i~~~-~~~~p~~~~--- 252 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQK---ILEG-IIYFPKFLD--- 252 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHH---HhcC-CCCCCCCCC---
Confidence 22345789999999999988899999999999999999999999975432111 010 0000 011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
. .+.+++.+|++.||++|+ ++++++++
T Consensus 253 -~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 253 -N---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -H---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 156789999999999995 88888765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=316.83 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=214.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..+|++.+.||+|.||.|-+++. ..|+.||||.++++...+...+-.+.+|+++|+.|+||||+.++++|...+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788899999999999999964 78999999999998887777778899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||..+|.|.+++...+. +++.+...++.||..|+.|+| ..+++|||||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 999999999999987654 999999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCceeccccccccccccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
+......++|++-|.+||...+..|. +.+|-||+||+||-|+.|..||+..+..... +.........|.-+. .
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv--rQIs~GaYrEP~~PS----d 278 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV--RQISRGAYREPETPS----D 278 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH--HHhhcccccCCCCCc----h
Confidence 55667778999999999999998874 6899999999999999999999865432111 111112222222221 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
-.-+|.+||..+|++|-|+.+|..+|
T Consensus 279 -------A~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 279 -------ASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------HHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12378899999999999999999887
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=317.21 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred hCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|.+. .+..||+|.++..... .....|.+|+..+.+++||||++++|++...+..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 56888999999999999999642 4668999999865433 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999997643 24889999999999999999999 789999999999999999999999999987654
Q ss_pred cCCCCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 326 NFDSSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 326 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||........... ..+..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 233 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----VEDGFRLPAPRNC 233 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HHCCCCCCCCCCC
Confidence 221111 112234578999999999999999999999999999875 9999875433211111 0111111111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+||+.+|++||+++++.+.|.+
T Consensus 234 -------~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 234 -------PNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1236779999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=318.11 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=196.2
Q ss_pred eeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||+||++.. .+++.+|+|.+...........+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999965 47889999999765444333456778899999999999999999999999999999999999999
Q ss_pred hhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceec
Q 012219 257 FCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 335 (468)
Q Consensus 257 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 335 (468)
..++... .....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9887542 22345899999999999999999999 7899999999999999999999999999997765433333345
Q ss_pred cccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHH
Q 012219 336 AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVS 415 (468)
Q Consensus 336 ~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 415 (468)
.|++.|+|||++.+..++.++|||||||++|||++|+.||............. ......... .... ....+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~--~~~~---~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRILNDSVT--YPDK---FSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---HhhcccCCC--Cccc---CCHHHH
Confidence 78999999999999999999999999999999999999997543211110000 001111111 0011 112266
Q ss_pred HHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 416 TVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 416 ~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
+++.+||+.||++|| ++++++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 789999999999999 67777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=320.94 Aligned_cols=249 Identities=33% Similarity=0.502 Sum_probs=190.0
Q ss_pred ccceeeeeCCceEEEEEcC-----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 174 IKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.+.||.|.||.||+|.+. .+..|+||.++..... ...+.|.+|++.+++++||||++++|+|...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE--EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH--HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc--ccceeeeecccccccccccccccccccccccccccccc
Confidence 4578999999999999765 3678999999654333 23678999999999999999999999999888899999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ...+++..++.|+.||+.||+||| +.+++|+||+++||+++.++.+||+|||+++.....
T Consensus 81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999998762 234899999999999999999999 678999999999999999999999999999876322
Q ss_pred CCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... .........|+|||.+....++.++||||||+++|||++ |+.||........... . .+..........+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~-~---~~~~~~~~~~~~~- 231 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK-L---KQGQRLPIPDNCP- 231 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH-H---HTTEETTSBTTSB-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c---cccccceeccchh-
Confidence 111 122346778999999999989999999999999999999 7899876533221111 0 0000011111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
. .+.+++..||+.||++|||++++++.|
T Consensus 232 ---~---~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 ---K---DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---H---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---H---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 266799999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.79 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=211.1
Q ss_pred hhCccccceeeeeCCceEEEEEcCCC-CEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEE-EEee-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYG-FCLH----- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~----- 240 (468)
..++++.+.|.+|||+.||.|....+ ..+|+|++-..+. ..++...+|+++|+.|+ |+|||.+++ ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34677889999999999999986555 9999999976643 45788899999999997 999999999 3322
Q ss_pred -CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
..+++|.||||.||.|.+++...-... |++.++++|+.|+|+|+++||.. .++|||||||.+|||++.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 235899999999999999998654443 99999999999999999999976 788999999999999999999999999
Q ss_pred cccccccCCCCCce---------eccccccccccccc---cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 320 GVARLLNFDSSNRT---------LLAGTYGYIAPELA---YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 320 g~~~~~~~~~~~~~---------~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
|.+........... ...-|+.|+|||++ .+..+++|+|||++||+||-|+....||+.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 99865432221110 12358999999976 4678999999999999999999999999854321
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCCCccc
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHE 453 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~~~~~ 453 (468)
.++.-.+.-+... .....+..||..||++||.+||++.+|++.+.++...+.+.+...
T Consensus 265 -----aIlng~Y~~P~~p---~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 -----AILNGNYSFPPFP---NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -----eEEeccccCCCCc---cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 1222222221111 223347789999999999999999999999999887666544433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.36 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=197.3
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+.. +++.||+|++....... ....+.+|+++++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 367999999999999999999764 68899999987543321 234567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+. ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 68888776543 23788899999999999999999 78999999999999999999999999999976543
Q ss_pred CCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccc------------cc-
Q 012219 328 DSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL------------ID- 393 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~------------~~- 393 (468)
.........+++.|+|||++.+ ..++.++||||+||++|||++|+.||................ ..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 3333344568899999998765 458889999999999999999999997543221111100000 00
Q ss_pred -ccCC-CCCCccchhHHH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 394 -LLDP-RLSPPVDQKIRQ------DIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 394 -~~~~-~~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..++ ...........+ ....+.+++.+|++.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000000000000 0123668999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=329.43 Aligned_cols=204 Identities=26% Similarity=0.391 Sum_probs=176.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||++.. .+++.||+|++.............+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999965 468999999997654433344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 3889999999999999999999 789999999999999999999999999998754321
Q ss_pred CC-----------------------------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCC
Q 012219 329 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKH 373 (468)
Q Consensus 329 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~ 373 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 0123469999999999999999999999999999999999999
Q ss_pred CCCccc
Q 012219 374 PGELLS 379 (468)
Q Consensus 374 p~~~~~ 379 (468)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.26 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=196.0
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+++. .+++.||+|+++..........+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999975 46889999999865444434456788999999988 799999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99998886543 3899999999999999999999 78999999999999999999999999999875332333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-ccccc-cccC--CCCCCccchhHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-NIKLI-DLLD--PRLSPPVDQKIRQ 409 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-~~~~~-~~~~--~~~~~~~~~~~~~ 409 (468)
...||+.|+|||++.+..++.++|||||||++|||+||+.||+........... ..... .... ..++....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----- 229 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS----- 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC-----
Confidence 567899999999999999999999999999999999999999743221100000 00000 0111 11111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCC------HHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPT------MQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs------~~~v~~~ 438 (468)
..+.+++.+|++.||.+||+ +++++++
T Consensus 230 --~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 230 --VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 12667999999999999997 6777643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=314.65 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=207.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+. .+++.||+|.+......+......|.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999975 478999999886543333344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 2234788899999999999999999 78999999999999999999999999999887653
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||............. ......+... ..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~---~~-- 231 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK--IEQCDYPPLP---TE-- 231 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH--HhcCCCCCCC---hh--
Confidence 3333334568889999999988889999999999999999999999986432211111110 1111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.....+.+++.+||+.+|++||++.+|++.++..
T Consensus 232 -~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 232 -HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112377899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.30 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=194.6
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+. .+++.+|+|+++..........+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999975 46889999999865443334456678899888776 799999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99998886543 3889999999999999999999 78999999999999999999999999999976433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-cccccc-cc--CCCCCCccchhHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-NIKLID-LL--DPRLSPPVDQKIRQ 409 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~-~~--~~~~~~~~~~~~~~ 409 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....+ .. ...++....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~----- 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS----- 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC-----
Confidence 567899999999999999999999999999999999999999643211100000 000000 01 111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCC------HHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPT------MQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs------~~~v~~~ 438 (468)
..+.+++.+||+.||++||+ +.+++++
T Consensus 230 --~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 230 --VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 12567899999999999998 4676644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.56 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=196.3
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.||+|+||.||++.. .+++.||+|++.............+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999974 578999999998654333334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
+|..++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9998886543 38899999999999999999993 269999999999999999999999999998754333333344
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
..|++.|+|||++.+..++.++|||||||++|||+||+.||........... .......+...... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~-----i~~~~~~~p~~~~~-------~~ 223 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILMEEIRFPRTLSP-------EA 223 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH-----HhcCCCCCCCCCCH-------HH
Confidence 5799999999999999999999999999999999999999965332111000 00011111211111 26
Q ss_pred HHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+++.+||+.||++|| ++.+++++
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 6789999999999997 89888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=327.14 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=212.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE-EEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC-MFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 247 (468)
++|...+++|+|+||.++.++. .+++.+++|.+......+.. .+...+|+.++++++|||||.+.+.+..++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 5688889999999999999965 46789999999876655433 3467899999999999999999999999888 9999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|+|++||++.+.+...+ ...+++.+++.++.|++.|+.||| +..|+|||||+.|||++.+..|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998766 455899999999999999999999 78999999999999999999999999999999987
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
+.......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|............ ....-..++..
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki----~~~~~~Plp~~----- 229 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI----NRGLYSPLPSM----- 229 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH----hhccCCCCCcc-----
Confidence 766777789999999999999999999999999999999999999999865443222111 11111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+..++..|+..+|+.||++.+++..
T Consensus 230 --ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 --YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11226778999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=330.39 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=207.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.-|.+++.||.|+.|.|-.|++ .+|+.+|||++.....-.........+|+-+|+-+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999975 579999999998764333333456778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|-|++++...+. +.+.++.+++.||..|+.|+| ..+|+||||||+|+|+|..+++||+|||.|..- .+
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VP 164 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc-cC
Confidence 99999999999987554 899999999999999999999 789999999999999999999999999999653 35
Q ss_pred CCCceeccccccccccccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
+......+|++.|.|||++.+..|+ .++||||.|||||.|+||+.||++...............++ +.....
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M-----Ps~Is~-- 237 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM-----PSNISS-- 237 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC-----CCcCCH--
Confidence 5566677999999999999998874 68999999999999999999998543221111111111121 121221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+|+.+|+..||++|.|++||.++-.-
T Consensus 238 -----eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 238 -----EAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -----HHHHHHHHHhccCccccccHHHHhhCchh
Confidence 15568899999999999999999976543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=318.35 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=202.2
Q ss_pred hCccccceeeeeCCceEEEEEcCC------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|++.+.||+|+||.||+|.... ...||+|.+...... .....|.+|++++.+++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468889999999999999997532 257999998755432 234678899999999999999999999999889
Q ss_pred EEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
.+++|||+++|+|.+++..... ...+++...+.++.|++.||+||| +.+++|+||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcC
Confidence 9999999999999999875321 134788999999999999999999 789999999999999999
Q ss_pred CCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~--- 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI--- 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence 99999999999976532221 1223346788999999988899999999999999999998 99998754321110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.......... .....+.+++.+||+.||.+||++++|.+.|+.
T Consensus 237 -----~~i~~~~~~~~~~---~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -----EMIRSRQLLPCPE---DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----HHHHcCCcCCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111111111 112237789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=329.39 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=192.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+..+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3466678899999999999975 46899999999654332 23467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.... ...+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986532 2456778889999999999999 789999999999999999999999999999876533
Q ss_pred CCCceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
........|+..|+|||++.. ...+.++|||||||++|||++|+.||.......+..... .......+......
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-AICMSQPPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-HHhccCCCCCCCcc
Confidence 333344578999999998743 234568999999999999999999997432222211100 00000011111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
. ..+.+++.+||+.||++||++.|++++-
T Consensus 301 ~-------~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 301 S-------REFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred C-------HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1 2267899999999999999999998653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=320.30 Aligned_cols=261 Identities=22% Similarity=0.264 Sum_probs=196.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|+++..... .....+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 5688899999999999999975 46899999998754322 12346778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++ +|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99975 89888865432 3788899999999999999999 789999999999999999999999999999765433
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-----------------cccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-----------------KNIK 390 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-----------------~~~~ 390 (468)
........+++.|+|||++.+ ..++.++||||+||++|||+||+.||........... ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 333344568899999998865 5689999999999999999999999864332110000 0000
Q ss_pred cccccCCCCCCc-cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 LIDLLDPRLSPP-VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 ~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+..... .............+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011110000 000000001125689999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=313.24 Aligned_cols=250 Identities=27% Similarity=0.450 Sum_probs=200.0
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|++.+.||+|+||.||++++.++..+|+|.+...... .+.|.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 468888999999999999999888889999988754332 3568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.++++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999999875432 3889999999999999999999 7799999999999999999999999999987653221
Q ss_pred CC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. .....++..|+|||+..+..++.++||||||+++|||++ |+.||........... .........+.. .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~---~---- 226 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM-ISRGFRLYRPKL---A---- 226 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCCCCCC---C----
Confidence 11 112234568999999988889999999999999999999 9999875432211111 000000001111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
...+.+++.+||+.+|++||+++++++.|
T Consensus 227 ---~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 ---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12367899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.80 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=203.1
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+.. +++.||+|++.............+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999764 78999999998654433345567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 34889999999999999999999 789999999999999999999999999999876433
Q ss_pred C-----------------------------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 329 S-----------------------------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 329 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12233568999999999999999999999999999999999999997544
Q ss_pred ccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 012219 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNE 438 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~v~~~ 438 (468)
...... .+.... .....+....... .+.+++.+|+. ||.+||+ +++++++
T Consensus 235 ~~~~~~----~i~~~~-~~~~~p~~~~~~~---~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYN----KIINWK-ESLRFPPDPPVSP---EAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHH----HHhccC-CcccCCCCCCCCH---HHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211110 001100 0000000000111 26678889997 9999999 9999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=325.80 Aligned_cols=245 Identities=25% Similarity=0.366 Sum_probs=194.8
Q ss_pred ceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 176 YCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
+.||+|+||.||+++. .+++.||+|+++..... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 36789999999764321 122345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++|+|.+++.... .+.+..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987543 3778888899999999999999 78999999999999999999999999999875433333
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...... ....+..... .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-~~~~~~----~~~~~~~~~~----~- 225 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK----GKLNLPPYLT----P- 225 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-HHHHHc----CCCCCCCCCC----H-
Confidence 33445789999999999988899999999999999999999999975432111 110000 0111111111 1
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 411 IILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+.+++.+||+.||++|| ++++++++
T Consensus 226 --~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 226 --EARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --HHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 266799999999999999 78888753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=322.90 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=201.1
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.+|+..+.||+|+||.||+|.+. ++. .||+|+++..... ...+.|.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46889999999999999999753 333 4899998754322 2346788999999999999999999999875 46
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++|+|.+++..... .+++...+.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence 799999999999999986542 3788999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCCce--eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSNRT--LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
......... ...++..|+|||++....++.++|||||||++|||++ |+.||+............ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~ 234 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----KGERLPQPP 234 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----CCCCCCCCC
Confidence 653322211 1234568999999999999999999999999999998 999987543322111000 000000111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.. ...+.+++.+||+.+|++||++.+++..+......
T Consensus 235 ~~-------~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 235 IC-------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CC-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11 12267799999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=325.83 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=194.5
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHH---hhccCCceeeEEEEEeeCCEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLL---SQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999999975 46899999999865433333345566666654 567899999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|...+... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999887642 3899999999999999999999 78999999999999999999999999999875433
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||........... . .. .........+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-i---~~-~~~~~p~~~~--- 225 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-I---VN-DEVRYPRFLS--- 225 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-H---Hh-CCCCCCCCCC---
Confidence 33334456789999999999999999999999999999999999999975432111100 0 00 0111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
. .+.+++.+||+.||++|| ++.+++++
T Consensus 226 -~---~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 226 -R---EAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -H---HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 256789999999999999 46666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=313.77 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=203.7
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.++++++|+||+++++++...+..++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 3578999999999999999999888889999998754332 467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999987543 234788999999999999999999 789999999999999999999999999999876432
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. ......++..|+|||+.....++.++|||||||++|+|+| |+.||........... .............+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~-- 230 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQRGYRMPRMENCP-- 230 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC--
Confidence 21 1122335678999999988889999999999999999998 9999864332111110 00111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.+++.+|++.+|++||+++++.+.|++
T Consensus 231 -----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 231 -----DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 226789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=325.27 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=197.2
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC-ceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR-NIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 248 (468)
+|++.+.||+|+||.||+|... +++.||+|++...........+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999754 5789999999865433333456788899999999765 6888999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999987543 3788999999999999999999 789999999999999999999999999998754333
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||++.+..++.++|||||||++|||+||+.||........... ... ....+.....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~~-~~~~~~~~~~---- 225 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IME-HNVSYPKSLS---- 225 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCC----
Confidence 3334456799999999999999999999999999999999999999975432111100 000 0111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTM-----QLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~-----~~v~~ 437 (468)
. .+.+++.+||+.||++||+. +++.+
T Consensus 226 ~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 226 K---EAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred H---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 25678999999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.60 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=209.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||++.. .+++.+|||.+......+....+.+.+|+++++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999974 588999999887654444445578899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++++|.+++.... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999 78999999999999999999999999999877654
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........++..|+|||+..+..++.++||||||+++|+|++|..||............ .......+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~---~~- 232 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYPPLPS---DH- 232 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--hhhcCCCCCCCc---cc-
Confidence 333333456888999999998888999999999999999999999998643322111111 111111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
....+.+++.+||+.||++||||.+|++.+.+.
T Consensus 233 --~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 233 --YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112377899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=294.43 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=205.3
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|.+.+.||+|||+-||.+. ..++..+|+|++...... ..+..++|++..++++|||++++++++..+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4689999999999999999996 678899999999877643 3567789999999999999999999886543
Q ss_pred EEEEEEEeccCCChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
+.|++++|...|+|.+.+..... ...+++.+.+.|+.+|++||++||.. .++++||||||.||++++++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999876432 33589999999999999999999943 34599999999999999999999999999
Q ss_pred cccccCCCCC---------ceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc
Q 012219 322 ARLLNFDSSN---------RTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI 389 (468)
Q Consensus 322 ~~~~~~~~~~---------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 389 (468)
++...-.-.. ......|..|+|||.+. +...++++|||||||++|+|+.|..||+..-....+.....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 8765321111 11234688999999885 45688999999999999999999999986543322222111
Q ss_pred ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 390 KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
. .+.+..+......+ .+.+++.+|++.||.+||++.+++..+..
T Consensus 256 ~-----n~q~s~P~~~~yse---~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 256 Q-----NAQISIPNSSRYSE---ALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred e-----ccccccCCCCCccH---HHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1 11222111111222 27789999999999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=314.10 Aligned_cols=263 Identities=25% Similarity=0.446 Sum_probs=198.6
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh--ccCCceeeEEEEEeeCC----E
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ--IRHRNIVKLYGFCLHRK----C 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~ 243 (468)
....+.+.||+|+||.||||.+. ++.||||++.... .+.|.+|-++.+. ++|+||+++++.-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 44556778999999999999994 5999999997543 4578888888875 58999999999876554 7
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD------CTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
++||+||.+.|+|.++|..+- ++|....+|+..+++||+|||.+ ++++|+|||||++|||+.+|+++.|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999999999999998654 89999999999999999999964 36789999999999999999999999
Q ss_pred eccccccccCCCCC--ceeccccccccccccccCCC-C-----CccchhhHHHHHHHHHHhCCCCCCc--cc------cc
Q 012219 318 DFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMV-V-----TEKCDVYSFGVVALEVLMGKHPGEL--LS------SS 381 (468)
Q Consensus 318 Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dv~s~Gvil~el~tg~~p~~~--~~------~~ 381 (468)
|||+|..+...... ....+||.+|||||++.+.. + -.+.||||+|.+||||+++-.-++. .+ ..
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999887643322 22368999999999997642 2 2368999999999999986543321 00 00
Q ss_pred ----chhhh--cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 382 ----SWSLD--KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 382 ----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.-..+ +.....+...|.++...... ..+..+.+.+..||..||+.|.|+.=|.+.+.+....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 00000 01111122223333222222 3445588999999999999999998888777666543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.22 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=209.6
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999765 78999999887544333334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++|+|..++.... ....+++.+++.++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2345889999999999999999999 78999999999999999999999999999876644
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .......+.... .
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~---~-- 231 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEKCDYPPLPA---D-- 231 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh--hhhcCCCCCCCh---h--
Confidence 333334456888999999998888999999999999999999999998643321111110 000000011110 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.....+.+++.+||..+|++|||+.++++.|..+.
T Consensus 232 -~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 232 -HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11123678999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.22 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=207.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
...+|++.+.||+|+||.||+|...+++.+++|.+...... ....+..|+.+++.++|+||+++++++......++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 34678889999999999999999888999999999765542 245688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... ...+++.+++.++.|++.||.||| +.+++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999997643 234899999999999999999999 78999999999999999999999999999977643
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.........++..|+|||......++.++||||||+++|+|++ |+.||......... .. ..............
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~-- 230 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY-DQ---ITAGYRMPCPAKCP-- 230 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH-HH---HHhCCcCCCCCCCC--
Confidence 3222233345678999999988889999999999999999998 89998754321111 10 00111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 231 -----~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 231 -----QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 226789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=325.70 Aligned_cols=239 Identities=26% Similarity=0.371 Sum_probs=191.3
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|... +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999754 6889999999765433333456677888888876 699999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999887543 3889999999999999999999 78999999999999999999999999999876433333444
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||........... ... . ......... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~-i~~-~---~~~~~~~~~----~---~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-ILN-D---EVVYPTWLS----Q---D 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-Hhc-C---CCCCCCCCC----H---H
Confidence 56799999999999988999999999999999999999999975432211100 000 0 011111111 1 2
Q ss_pred HHHHHHhcccCCCCCCCCH
Q 012219 414 VSTVAFSCLRSQPKSRPTM 432 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~ 432 (468)
+.+++.+|++.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 5678999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.65 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=200.3
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|++.+.||+|+||.||++.. .+++.||+|++.............+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999999975 4689999999976544333334567789999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 999999998886533 234899999999999999999999 779999999999999999999999999999775422
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||.................. .........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~------ 228 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE-DQEEYSEKF------ 228 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh-cccccCccc------
Confidence 2223346899999999999888999999999999999999999999754321110000000000 011111111
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
...+.+++.+||+.||++|| ++++++++
T Consensus 229 -~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 229 -SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 12266799999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=324.18 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=197.2
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+|.+.+.||+|+||.||+|... +++.||+|++...........+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999754 5789999999865433333445667788888777 5899999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+.+.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 3889999999999999999999 789999999999999999999999999999764433
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.......... . +.+ ....+.....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~-~---i~~-~~~~~p~~~s---- 225 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-S---IME-HNVAYPKSMS---- 225 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH-H---HHh-CCCCCCCcCC----
Confidence 333445678999999999999999999999999999999999999997543221110 0 000 0111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTM-----QLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~-----~~v~~ 437 (468)
. .+.+++.+|++.||++|++. .++.+
T Consensus 226 ~---~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 226 K---EAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred H---HHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1 25678999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=330.37 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=195.9
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|...+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999964 5688999999976554433456778999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 3788888999999999999999 7899999999999999999999999999975431100
Q ss_pred C-----------------------------------------------CceeccccccccccccccCCCCCccchhhHHH
Q 012219 330 S-----------------------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFG 362 (468)
Q Consensus 330 ~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G 362 (468)
. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 01124689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHh--cccCCCCCCCCHHHHHHH
Q 012219 363 VVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFS--CLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 363 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~~v~~~ 438 (468)
|++|||+||+.||............ ..... ....... ..... .+.+++.+ |+..+|..||++++++++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i-~~~~~--~~~~~~~--~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKV-INWEN--TLHIPPQ--VKLSP---EAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHH-Hcccc--ccCCCCC--CCCCH---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999754321111100 00000 0011110 00111 14456655 556677779999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.89 Aligned_cols=260 Identities=28% Similarity=0.376 Sum_probs=193.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----CEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----KCM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 244 (468)
+|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|++++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 477889999999999999975 47899999998743221 12345688999999999999999999988643 247
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999995 68988886543 3899999999999999999999 78999999999999999999999999999976
Q ss_pred ccCCCC---CceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh--------------
Q 012219 325 LNFDSS---NRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-------------- 385 (468)
Q Consensus 325 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-------------- 385 (468)
...... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||..........
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532211 1233568999999999865 678999999999999999999999986433210000
Q ss_pred -----hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 -----DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.........+..................+.+++.+||+.||++|||+++++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000001110000000111236789999999999999999999944
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=319.21 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|++...||+|+||.||.|+. .+|..+|+|++++...-...+++....|-.+|...++|.||+++-.|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999964 5799999999999988888888899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||++||++..+|...+. +++..+...+.+++-|+..+| ..|||||||||+|+|+|..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999976543 888888999999999999999 7899999999999999999999999999985431
Q ss_pred C-----------------------CCC-----Cc-------------------eeccccccccccccccCCCCCccchhh
Q 012219 327 F-----------------------DSS-----NR-------------------TLLAGTYGYIAPELAYTMVVTEKCDVY 359 (468)
Q Consensus 327 ~-----------------------~~~-----~~-------------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~ 359 (468)
. +.. .. ...+|||-|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 00 124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHH
Q 012219 360 SFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT---MQLVS 436 (468)
Q Consensus 360 s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~v~ 436 (468)
|+|||+|||+.|.+||........- .........+...-..... .+-.++|.+|+. ||++|.. ++||.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l~fP~~~~~s-------~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETLKFPEEVDLS-------DEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhccCCCcCccc-------HHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999999754322110 0111111111111111111 224568888998 9999975 67777
Q ss_pred H
Q 012219 437 N 437 (468)
Q Consensus 437 ~ 437 (468)
.
T Consensus 444 ~ 444 (550)
T KOG0605|consen 444 K 444 (550)
T ss_pred c
Confidence 4
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.09 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=203.5
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|++|.||+|...+++.||+|.++..... .+.|.+|++++++++|+||+++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 4568889999999999999998878889999998764432 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ...+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999997644 334899999999999999999999 789999999999999999999999999999876522
Q ss_pred CCCce-eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSNRT-LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
..... ....+..|+|||+..+..++.++||||||+++|||+| |+.||........... . ............
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~---~~~~~~~~~~~~--- 229 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-V---DQGYRMPCPPGC--- 229 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-H---HcCCCCCCCCcC---
Confidence 21111 1123457999999998899999999999999999999 9999875432111110 0 000001111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+|++.+|++||+++++...|+.
T Consensus 230 ----~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 ----PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1237789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=330.66 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|+. .+++.||||++.............+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688899999999999999975 468999999997654333344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 3899999999999999999999 789999999999999999999999999998754321
Q ss_pred CC--------------------------------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh
Q 012219 329 SS--------------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM 370 (468)
Q Consensus 329 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t 370 (468)
.. ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999999999999999999999999999
Q ss_pred CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 012219 371 GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT---MQLVSNE 438 (468)
Q Consensus 371 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~v~~~ 438 (468)
|+.||........... .... ...+..+......+ .+.+++.+|+. +|.+|++ +.+++.+
T Consensus 235 G~~Pf~~~~~~~~~~~----i~~~-~~~~~~~~~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQETYRK----IINW-KETLQFPDEVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHHHHH----HHcC-CCccCCCCCCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999975432211100 0000 00011000001111 25567888886 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.55 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=202.8
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|... .+..||||++...... ...+.|.+|+++++++. ||||++++++|...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 568889999999999999999742 2346999999754432 23467899999999996 99999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc--------------------------------------------------------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------- 265 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 265 (468)
...++||||+++|+|.++++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998864311
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 266 -------------------------------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 266 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
...+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence 124778888999999999999999 7899999999999999
Q ss_pred CCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhh
Q 012219 309 NSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSL 385 (468)
Q Consensus 309 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~ 385 (468)
+.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999986543221 1122346778999999998899999999999999999997 999987543211111
Q ss_pred hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.. ............. ...+.+++.+||+.||++||++.+|.+.|.+.-
T Consensus 351 ~~---~~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NK---IKSGYRMAKPDHA-------TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH---HhcCCCCCCCccC-------CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 10 0000111111111 123678999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.07 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=195.1
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999754 5789999999765433333456677889988866 799999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|...+.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99998887543 3889999999999999999999 78999999999999999999999999999876433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||+||+.||......... ... ...+ ...+.... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-~~i-~~~~---~~~p~~~~----~---~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-ESI-LHDD---VLYPVWLS----K---E 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-HHH-HcCC---CCCCCCCC----H---H
Confidence 457899999999999989999999999999999999999999754322111 000 0000 11111111 1 2
Q ss_pred HHHHHHhcccCCCCCCC-------CHHHHHHH
Q 012219 414 VSTVAFSCLRSQPKSRP-------TMQLVSNE 438 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RP-------s~~~v~~~ 438 (468)
+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 66789999999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.42 Aligned_cols=266 Identities=24% Similarity=0.255 Sum_probs=203.8
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 245 (468)
.++|+..+.|++|+||.||+|+. +++..||+|+++-+...+.-.+ ...+|+.++.+++|||||.+..+..- -+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 35678889999999999999975 5789999999987664433333 34599999999999999999887764 35699
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|||||+. +|...++...+ ++...++.-++.|+++|++||| ...|+|||||++|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999986 89999987653 4888999999999999999999 789999999999999999999999999999999
Q ss_pred cCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccch----------------hhhcc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW----------------SLDKN 388 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~----------------~~~~~ 388 (468)
+......+..+-|.+|+|||++.+. .|+++.|+||+|||+.||+++++-|........ .-...
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 8887778888899999999988764 799999999999999999999998765432111 00000
Q ss_pred ccc---cccc---CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhcC
Q 012219 389 IKL---IDLL---DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIARN 443 (468)
Q Consensus 389 ~~~---~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~~ 443 (468)
... ..+. -..+...+.... -...=++++...+..||.+|.|++|.+ +.++...
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cchhhccccCCCCchhhhhhccccc--cchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 000 0000 000000000000 001245688889999999999998777 5555543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=318.96 Aligned_cols=262 Identities=26% Similarity=0.321 Sum_probs=198.5
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 36888999999999999999764 68899999997653322 23466789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++++.+..+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999987776554332 24888999999999999999999 789999999999999999999999999999876432
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--c---------------ccc
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--K---------------NIK 390 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~---------------~~~ 390 (468)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||........... . ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 22335689999999999988899999999999999999999999975432111000 0 000
Q ss_pred cccccCCCCCCccc---hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 LIDLLDPRLSPPVD---QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+....... .........+.+++.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0000011237889999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.73 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=202.3
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.|.+|+++++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 56888899999999999999753 3478999999765443 234688999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE-----------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
.++||||+++++|.+++.... ....+++..+..++.|++.|+.||| +.+++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCC
Confidence 999999999999999997542 1234788999999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccc
Q 012219 313 EAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNI 389 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 389 (468)
.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.............
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~- 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 999999999976532221 1122345678999999999999999999999999999999 999986543321111100
Q ss_pred ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 390 KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
....+...... ...+.+++.+||+.||++||+++||++.|.
T Consensus 239 ---~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ---QGRLLQRPRTC-------PSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---cCCcCCCCCCC-------CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000111111 123678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.33 Aligned_cols=199 Identities=27% Similarity=0.361 Sum_probs=173.2
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+.+|++++++++|+||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 67899999999999999999764 6888999988765322 23457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.....++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999997543 37888999999999999999994 247999999999999999999999999998765321
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22334688999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=318.25 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=192.5
Q ss_pred hCccccceeeeeCCceEEEEEc--CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEee----
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCLH---- 240 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 240 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 3688899999999999999975 346889999987544322 1223455677776665 69999999999852
Q ss_pred -CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
....++|+||+. ++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345899999996 689988875432 34889999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--------cccc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--------NIKL 391 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~--------~~~~ 391 (468)
|+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||............ ....
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 999876433 2333456899999999998889999999999999999999999999754321110000 0000
Q ss_pred -------ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 392 -------IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 392 -------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.....+................+.+++.+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000000000011123668999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.33 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=200.3
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+.+.||+|+||.||+|+..++..+|+|.+...... .+.|.+|+.++.+++||||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 467888999999999999998877778999998754332 3568899999999999999999999998888999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++..... .+++..++.++.||+.||+||| +.+++|+||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999876433 4899999999999999999999 7899999999999999999999999999987654322
Q ss_pred CCc-eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SNR-TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
... ....++..|+|||+..+..++.++|||||||++|||+| |+.||........... .............
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~---- 226 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQGLRLYRPHLA---- 226 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HhcCCCCCCCCCC----
Confidence 111 11235568999999988889999999999999999999 9999875443211110 0110011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
...+.+++.+||+.+|++||++.++++.+
T Consensus 227 ---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 227 ---SEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---CHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 12377899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.31 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=200.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
..++|++.+.||+|+||.||+|... .+..||+|++...... .....|.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4578999999999999999998643 3567999998654322 2345688999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
...++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 999999999999999999865322 223678889999999999999999 7899999999999999999999
Q ss_pred EEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccc
Q 012219 315 FVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 391 (468)
+|+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||............ ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--~~ 236 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--ME 236 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--Hc
Confidence 999999987653221111 12235678999999998889999999999999999999 78898654322111000 00
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
... +..... ....+.+++.+|++.+|++|||+.++++.|+
T Consensus 237 ~~~--~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGL--LDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCc--CCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 011111 1123778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.42 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=191.6
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh-ccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQ-IRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|.. .+++.||+|+++..........+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999975 4578999999986543332334556667777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999887543 3888999999999999999999 78999999999999999999999999999976543333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +. ...+.+..... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-~~---i~-~~~~~~~~~~~----~---~ 222 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-DS---IL-NDRPHFPRWIS----K---E 222 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-HH---HH-cCCCCCCCCCC----H---H
Confidence 567999999999999889999999999999999999999999754321111 00 00 01111111111 1 2
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQ-LVSN 437 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~-~v~~ 437 (468)
+.+++.+||+.||++||++. ++.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 56788999999999999974 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=310.19 Aligned_cols=256 Identities=28% Similarity=0.392 Sum_probs=203.2
Q ss_pred hhCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|++.+.||+|+||.||+|.+. +...||+|.+...... .....|.+|+.++.+++|+||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 357889999999999999999764 2457999998755432 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+++|||+++++|.+++..... .+++..++.++.|++.|++||| +.+|+||||||+||++++++.++|+|||+++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999976433 4899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCCce--eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSNRT--LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
......... ...++..|+|||...+..++.++||||||+++|||++ |..||.......... ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 231 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK----AVEDGYRLPPPM 231 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH----HHHcCCCCCCCC
Confidence 642221111 1234578999999998899999999999999999998 999986543221110 000000000111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.. ...+.+++.+|++.+|++||++.++++.|.+.
T Consensus 232 ~~-------~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 232 DC-------PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 12367899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=322.65 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=195.7
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+.. +++.||+|++.............+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 5789999999865433333456677899999888 699999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99999887543 3899999999999999999999 78999999999999999999999999999875433333333
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||........... ... .......... ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~--i~~---~~~~~~~~~~-------~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS--ILE---DEVRYPRWLS-------KE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH--HHc---CCCCCCCcCC-------HH
Confidence 45689999999999999999999999999999999999999975432211100 000 0111111111 12
Q ss_pred HHHHHHhcccCCCCCCCCH-----HHHHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTM-----QLVSNE 438 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~-----~~v~~~ 438 (468)
+.+++.+||+.||++||++ .+++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 6679999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.45 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=195.3
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999975 46789999999876544444566788999999888 699999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99998886543 3899999999999999999999 78999999999999999999999999999875433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC--CCCCCccchhHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD--PRLSPPVDQKIRQDI 411 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 411 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.................... ..++...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------- 227 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS------- 227 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC-------
Confidence 567999999999999999999999999999999999999999643221100000000000001 11111111
Q ss_pred HHHHHHHHhcccCCCCCCCCH------HHHHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRPTM------QLVSNE 438 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RPs~------~~v~~~ 438 (468)
..+.+++.+||+.||++||++ +++.++
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 125678999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=327.43 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=215.5
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
++|+....+....++||-|.||.||.|.|+. .-.||||.++.+.. .+++|..|..+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4555555677888999999999999998754 56799999987654 468999999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
..+|||+|||.+|+|.++|+..... .++....+.++.||+.|++||. .+.+|||||.++|+|+.++..|||+|||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999876543 3666778899999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCceeccc---cccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCC
Q 012219 322 ARLLNFDSSNRTLLAG---TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++++..+.+. ...| ...|.|||-+....++.|+|||+|||+|||+.| |..||..+... +..+++..
T Consensus 412 sRlMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLEk 481 (1157)
T KOG4278|consen 412 SRLMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLEK 481 (1157)
T ss_pred hhhhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHhc
Confidence 9998654433 2333 458999999999999999999999999999999 99998865432 22233334
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.++...++.. ...+++|++.||+.+|.+||++.|+-..|+.+-
T Consensus 482 gyRM~~PeGC---PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 GYRMDGPEGC---PPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cccccCCCCC---CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4433333322 234788999999999999999999988887653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.56 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=192.0
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+.. +|+.||+|.++..........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999764 6889999999765432222345566788887754 899999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999887543 3788999999999999999999 78999999999999999999999999999875433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... .. .....+....... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-~~----~~~~~~~~~~~~~----~---~ 222 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-ES----IRVDTPHYPRWIT----K---E 222 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HH----HHhCCCCCCCCCC----H---H
Confidence 567899999999999999999999999999999999999999754321110 00 0011111221111 1 2
Q ss_pred HHHHHHhcccCCCCCCCCH-HHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTM-QLVS 436 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~-~~v~ 436 (468)
+.+++.+||+.||++||++ +++.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 5678999999999999998 5666
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.44 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=199.6
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356799999999999999999975 4688999999975443333344567899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998643 3778888899999999999999 7899999999999999999999999999998764
Q ss_pred CCCC-CceeccccccccccccccCC----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 327 FDSS-NRTLLAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 327 ~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........ ......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~~~~--~~~~~~ 270 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SKIMDHKN--SLTFPD 270 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-HHHHcCCC--cCCCCC
Confidence 3222 22345699999999988653 4788999999999999999999999754321110 10000000 001111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
. .... ..+.+++.+|++.+|++ ||++++++++
T Consensus 271 ~--~~~s---~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 D--IEIS---KQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c--CCCC---HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0011 12667899999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.79 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=201.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|.+.+.||+|+||.||+|.. +.++.||+|.+..... ..+.+.+|++++.+++|+||+++++++......+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4578889999999999999975 4588999999875432 2467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999875432 34889999999999999999999 789999999999999999999999999999775432
Q ss_pred CCCc-eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSNR-TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......... .......+......+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~-- 231 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKGYRMERPEGCP-- 231 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHCCCCCCCCCCCC--
Confidence 2111 11223567999999998899999999999999999998 999986533211100 011111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||+.+|++||++.++.+.|...
T Consensus 232 -----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 232 -----PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2267799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=312.94 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=192.5
Q ss_pred eeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||.||+++. .+|+.+|+|.+...........+.+..|++++++++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999975 46899999999754333222334566799999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecc
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 336 (468)
.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 98886543 234889999999999999999999 789999999999999999999999999998765422 2223356
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHH
Q 012219 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416 (468)
Q Consensus 337 g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 416 (468)
|+..|+|||++.+..++.++||||+||++|||++|+.||............ .............. .. ...+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~---~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVKFEHQ-NF---TEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHhhccccccccc-cC---CHHHHH
Confidence 899999999999888999999999999999999999998643221110000 00011111110000 11 112678
Q ss_pred HHHhcccCCCCCCCCHHHHHHHH
Q 012219 417 VAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 417 l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
++.+||+.||++||++.|+++..
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHhccCHhhCCCCccchhhh
Confidence 99999999999999996655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=319.40 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=192.2
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh-ccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQ-IRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|... +++.||+|+++..........+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 578999999976543222234556678888876 4899999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999987543 3788999999999999999999 78999999999999999999999999999875433333334
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. . .....+....... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~-~---i~~~~~~~~~~~~----~---~ 222 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQ-S---IRMDNPCYPRWLT----R---E 222 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HH-H---HHhCCCCCCccCC----H---H
Confidence 45789999999999988999999999999999999999999975432111 00 0 0111111221111 1 2
Q ss_pred HHHHHHhcccCCCCCCCCHH-HHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQ-LVSN 437 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~-~v~~ 437 (468)
+.+++.+||+.||++||++. ++..
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 56789999999999999996 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=310.35 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=199.6
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++...||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++.+++||||+++++++...+..++|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 5789999999999999999975 57889999999754332 2346778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.++++... .+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999987543 3789999999999999999999 789999999999999999999999999999866433
Q ss_pred CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
........++..|+|||.+. ...++.++|||||||++|||++|+.||............ .......+..... .
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~--~ 235 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPPKLKDK--T 235 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCCCCCCCccc--c
Confidence 33333456888999999874 345788999999999999999999998643321111000 0000111111100 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.....+.+++.+||+.+|++||+++++++++
T Consensus 236 ---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 236 ---KWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112377899999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.97 Aligned_cols=250 Identities=23% Similarity=0.249 Sum_probs=197.7
Q ss_pred CccccceeeeeCCceEEEEEcC-C-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-S-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.|.+.+.||+|+||.||+|... + +..||+|.+...... ....+.+|+++++.++||||+++++++...+..++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER---QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4888999999999999999643 3 677888877554332 3356778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++|+|.+++... .....+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988643 22345889999999999999999999 78999999999999999999999999999987643
Q ss_pred CCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 328 DSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 328 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............ .....++ ......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~-~~~~~s- 296 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV---LYGKYDP-FPCPVS- 296 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCC-CCccCC-
Confidence 221 223456899999999999999999999999999999999999998753321110000 0000010 111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+.+++.+||+.||++||++.++++
T Consensus 297 ------~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 297 ------SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12677999999999999999988864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=323.08 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=188.8
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHH-HHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||+||+|.. .+|+.||+|++...........+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999976 478999999997654332233345555554 56789999999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999887543 3888999999999999999999 78999999999999999999999999999876433333334
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... .. ... ....+.+... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~---i~~-~~~~~~~~~~-------~~ 222 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-DN---ILN-KPLRLKPNIS-------VS 222 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-HH---HHc-CCCCCCCCCC-------HH
Confidence 457899999999999999999999999999999999999999754321110 00 000 0011112111 12
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQ 433 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~ 433 (468)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 66789999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=304.41 Aligned_cols=263 Identities=23% Similarity=0.392 Sum_probs=205.0
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh--ccCCceeeEEEEEeeC----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ--IRHRNIVKLYGFCLHR----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~ 242 (468)
..+..+.+.||+|.||.||+|+++ |..||||++...+ .+.+.+|.++.+. |+|+||+.+++.-..+ .
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 356788899999999999999994 7889999997543 2567788888876 4999999999876543 2
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH-----DCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
+++||++|.+.|||+|+|... .++....++++..+|.||++||. +.++.|+|||||+.|||+..++++.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 589999999999999999863 38889999999999999999995 347889999999999999999999999
Q ss_pred eccccccccCCCC----CceeccccccccccccccCCC------CCccchhhHHHHHHHHHHhC----------CCCCCc
Q 012219 318 DFGVARLLNFDSS----NRTLLAGTYGYIAPELAYTMV------VTEKCDVYSFGVVALEVLMG----------KHPGEL 377 (468)
Q Consensus 318 Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~el~tg----------~~p~~~ 377 (468)
|+|+|........ .....+||.+|||||++...- --..+||||||.++||+.-+ +.||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999976543321 233468999999999987542 22468999999999999742 257766
Q ss_pred ccccchhhhc--ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 378 LSSSSWSLDK--NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 378 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
......+.++ ..-..+.+.|.++..... .+.+..+.+++..||..+|..|-|+--+.+.|.++.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s--~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKS--DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCccccc--CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5443333332 222333344444433322 2566679999999999999999999988888877654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=308.54 Aligned_cols=252 Identities=28% Similarity=0.400 Sum_probs=203.2
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|++|.||+|.. .+++.|++|.+...... ....+.+.+|++++++++|||++++++++...+..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477788999999999999975 46899999998754332 2345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.++++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999997642 235889999999999999999999 7899999999999999999999999999998765443
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||........... .....-+......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~------ 225 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK----IIRGVFPPVSQMY------ 225 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCcccc------
Confidence 333445688999999999998899999999999999999999999875432111100 0000001111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 -~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 -SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1237789999999999999999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.30 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=196.9
Q ss_pred CccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
+|++.+.||+|+||.||+++. .+++.||+|++...... .....+.+..|++++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999964 36889999999754322 222345678899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 3889999999999999999999 78999999999999999999999999999976
Q ss_pred ccCCC-CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 325 LNFDS-SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 325 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||................ ...++.+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSF 233 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCC
Confidence 53222 222345789999999998765 47889999999999999999999996432211100000000 0112222222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
... .+.+++.+||+.||++|| ++++++++
T Consensus 234 ~~~-------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 234 IGP-------EAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCH-------HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 221 256789999999999999 67787754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.64 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=194.2
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|...+.||+|+||.||+|+. .+++.||+|++...........+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999975 5688999999976544333456678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987543 3788888899999999999999 7899999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCceeccccccccccccccCCCCCccchhhHHH
Q 012219 330 -----------------------------------------------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFG 362 (468)
Q Consensus 330 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G 362 (468)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 012219 363 VVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT---MQLVSNE 438 (468)
Q Consensus 363 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~v~~~ 438 (468)
|++|||++|+.||........... .... ......+.......+ ..+++.+|+ .+|++|++ +++++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~----i~~~-~~~~~~p~~~~~s~~---~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMK----VINW-QTSLHIPPQAKLSPE---ASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHH----HHcc-CCCcCCCCcccCCHH---HHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999975432111110 0000 011111111111111 445566655 59999997 8887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=313.53 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=204.4
Q ss_pred hCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.+|.+.+.||+|+||.||+|.. .++..+++|.+...... ..+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 4578889999999999999964 23566899988755432 34678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
.++||||+++++|.+++..... ...+++..++.++.||+.|++||| +.+++||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence 9999999999999999975321 234789999999999999999999 789999999999999999
Q ss_pred CCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.++|+|||+++....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...........
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~- 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC- 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 99999999999976543221 1122346788999999998899999999999999999999 9999865432111000
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
......+..... ....+.+++.+||+.+|++||++++|++.|.+..+.
T Consensus 238 ---~~~~~~~~~~~~-------~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ---ITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HhCCCCCCCCcc-------CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 000000001111 112377899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.36 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=196.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999964 578999999997654433345677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 3788888999999999999999 789999999999999999999999999998633110
Q ss_pred CC-----------------------------------------------CceeccccccccccccccCCCCCccchhhHH
Q 012219 329 SS-----------------------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSF 361 (468)
Q Consensus 329 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~ 361 (468)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 012219 362 GVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR---PTMQLVSNE 438 (468)
Q Consensus 362 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~v~~~ 438 (468)
||++|||+||+.||........ ..........+ .+... .... ..+.+++.+|+. +|.+| |++.+++.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~--~~p~~--~~~s---~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET-YRKIINWRETL--YFPDD--IHLS---VEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH-HHHHHccCCcc--CCCCC--CCCC---HHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999975432111 11000000000 01110 0011 125678888997 66665 599998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.69 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=200.7
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+..|++++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 457899999999999999999532 3578999999754432 2346678899999999 899999999988754
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcc-------------------------------------------------------
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------- 265 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 265 (468)
...++++||+++|+|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 568899999999999998864221
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC--Cceecccccc
Q 012219 266 ---AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYG 340 (468)
Q Consensus 266 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~ 340 (468)
...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||+++.+..... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125789999999999999999999 78999999999999999999999999999987633221 1122345678
Q ss_pred ccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHH
Q 012219 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAF 419 (468)
Q Consensus 341 y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 419 (468)
|+|||++.+..++.++|||||||++|||++ |+.||............ ......+..... ....+.+++.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~l~~ 310 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR---LKEGTRMRAPEY-------ATPEIYSIML 310 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH---HhccCCCCCCcc-------CCHHHHHHHH
Confidence 999999999999999999999999999998 99998653221111000 000000011111 1123778999
Q ss_pred hcccCCCCCCCCHHHHHHHHHhcC
Q 012219 420 SCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 420 ~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+||+.+|++||++.+++++|.+..
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=313.32 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=203.8
Q ss_pred hCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||.||++.. .++..+|+|.+...... ..+.+.+|++++.+++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5688899999999999999974 23456899988754432 34678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE 313 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~ 313 (468)
.++|+||+++++|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999999987532 1234899999999999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccc
Q 012219 314 AFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIK 390 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~ 390 (468)
++|+|||+++....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||........ ...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-~~~--- 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IEC--- 234 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---
Confidence 99999999976532221 1122335678999999998899999999999999999998 9999865432111 000
Q ss_pred cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+............+ ..+.+++.+||+.+|.+|||++++...|+++.+.
T Consensus 235 i~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRPRTCP-------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCCCCCC-------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000011111111 1277899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=308.44 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=199.4
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.+|++.+.||+|+||.||+|...++..+|+|.+...... ...|.+|++++++++|+||+++++++...+..++|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 357788999999999999998877888999998754332 2468889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999999975433 4889999999999999999999 7899999999999999999999999999987653221
Q ss_pred CCc-eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SNR-TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
... ....++..|+|||...+..++.++||||||+++||+++ |+.||+......... ..............
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~---- 226 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVSAGYRLYRPKLA---- 226 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHHcCCcCCCCCCC----
Confidence 111 11123457999999998899999999999999999999 899987543221111 11111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
...+.+++.+||+.+|++|||+.++++.|
T Consensus 227 ---~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 ---PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12377899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.88 Aligned_cols=264 Identities=24% Similarity=0.290 Sum_probs=202.5
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc-eeeEEEEEeeCC-----
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN-IVKLYGFCLHRK----- 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 242 (468)
..|...++||+|+||+||+|+ ..+|+.||+|++......+. ......+|+.+++.++|+| ||++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 346667779999999999996 45789999999987655322 2345569999999999999 999999999877
Q ss_pred -EEEEEEEeccCCChhhhhhcCccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 243 -CMFLIYEYMEMGSLFCVLRTDEEA-VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 243 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
..++|+||++. +|..++...... ..++...+..++.||++||+||| +++|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78999999974 899998765532 34677888999999999999999 8899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCccccc----------------ch
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSS----------------SW 383 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~----------------~~ 383 (468)
+|+....+....+..++|..|+|||++.+. .|+...||||+|||++||++++.-|...... .|
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999887666667777899999999998876 7999999999999999999999888654331 11
Q ss_pred hhhcccccccccCCCCC--CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 384 SLDKNIKLIDLLDPRLS--PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.........+..-+... ...............+++.+|++.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11000000000000000 00000001111236678999999999999999988876
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.39 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=195.5
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999975 4689999999976544333345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997643 3788888899999999999999 7899999999999999999999999999975321000
Q ss_pred -------------------------------------------CCceeccccccccccccccCCCCCccchhhHHHHHHH
Q 012219 330 -------------------------------------------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL 366 (468)
Q Consensus 330 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ 366 (468)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 012219 367 EVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP---TMQLVSNE 438 (468)
Q Consensus 367 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~~v~~~ 438 (468)
||++|+.||............ .... .....+....... .+.+++.+|+ .+|++|+ ++.+++++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i-~~~~----~~~~~~~~~~~s~---~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKV-INWE----TTLHIPSQAKLSR---EASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHH-hccC----ccccCCCCCCCCH---HHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999754322111110 0000 0000000000111 1445666765 5999999 88998855
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=312.57 Aligned_cols=256 Identities=21% Similarity=0.384 Sum_probs=199.8
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|++.+.||+|+||.||+|.. .++..+++|.+...... .....|.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4678889999999999999973 35678999999754332 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcc--------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 245 FLIYEYMEMGSLFCVLRTDEE--------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
+++|||+++++|.+++..... ...+++.+.+.++.|++.||+||| +.+++||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence 999999999999999853211 234788899999999999999999 779999999999999999
Q ss_pred CCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||........ ...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence 99999999999976532221 1222345678999999988889999999999999999998 9999864332111 000
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...... ........ ..+.+++.+||+.||++||++.++.+.|..
T Consensus 239 -~~~~~~--~~~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 -VRKRQL--LPCSEDCP-------PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHcCCc--CCCCCCCC-------HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000000 01111111 226678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=324.84 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=194.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|.+.+.||+|+||.||++.. .+++.||+|.... +.+.+|++++++++||||+++++++......++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 5799999999999999999965 5788999997532 34568999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC-
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF- 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~- 327 (468)
|++. ++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9995 68888886543 3889999999999999999999 77999999999999999999999999999975422
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc------hhhhcc-------------
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS------WSLDKN------------- 388 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~------~~~~~~------------- 388 (468)
.........||+.|+|||++.+..++.++|||||||++|||+||+.|+-...... ......
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1122334579999999999999899999999999999999999998753211100 000000
Q ss_pred ---ccccc---------ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 389 ---IKLID---------LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 389 ---~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
..... ...+...+ ...........+.+++.+||+.||++|||++|+++ .++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRP-LWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCC-CHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 00000 00000000 01111122234778999999999999999999984 4443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=324.47 Aligned_cols=255 Identities=26% Similarity=0.337 Sum_probs=200.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++.. .+++.||+|+++..........+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999975 478999999998655433345567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976532 4889999999999999999999 789999999999999999999999999999876433
Q ss_pred CCC-ceecccccccccccccc------CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 329 SSN-RTLLAGTYGYIAPELAY------TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......... ................
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-NNIMNFQRFLKFPEDP 234 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-HHHHcCCCccCCCCCC
Confidence 222 22346899999999986 456788999999999999999999999754322111 1000001111100001
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... . .+.+++.+|++ +|++||++++++.+
T Consensus 235 ~~~----~---~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 235 KVS----S---DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC----H---HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111 1 25668888997 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=313.27 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=195.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhh-----------hhhHHHHHHHHHHHhhccCCceeeEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE-----------LASLESFGNEARLLSQIRHRNIVKLYG 236 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~l~~ 236 (468)
.++|++...||+|.||.|-+|+. .+++.||+|++.+..... ....+...+|+.+|++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46899999999999999999974 579999999997543221 123457889999999999999999999
Q ss_pred EEeeC--CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 237 FCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 237 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
+..++ +..|||+|||..|.+...=. ....++..++++++.++..||+||| .+|||||||||+|+|++++|+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 98764 56999999999888754322 1122899999999999999999999 7799999999999999999999
Q ss_pred EEeeccccccccCC-----CCCceeccccccccccccccCCC----CCccchhhHHHHHHHHHHhCCCCCCcccccchhh
Q 012219 315 FVADFGVARLLNFD-----SSNRTLLAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385 (468)
Q Consensus 315 kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~ 385 (468)
||+|||.+...... .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 99999999766321 11122368999999999887632 356789999999999999999998643211
Q ss_pred hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.... +++...+.-+... +.-..+.+++.++|++||++|.+..+|..+..
T Consensus 326 ~l~~---KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELFD---KIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHH---HHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1111 1111122211111 11122668999999999999999999885553
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=310.87 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=198.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|.+ .+++ .+++|.+...... ....++..|+..+++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 4678889999999999999975 3444 4778887543221 234577788889999999999999999864 456
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 78999999999999997543 24899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||........... .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~-- 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERLAQPQI-- 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCCCCC--
Confidence 543221 1223446778999999998899999999999999999998 9999875432211000 000000001111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
. ...+.+++.+||..+|++|||+.++.+.|..+..++
T Consensus 236 -~-------~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 236 -C-------TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -C-------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1 112567889999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.36 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK---- 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 242 (468)
..++|.+.+.||+|+||+||+|+ ..+++.||||++....... .....+.+|+..+..++|+|++++.+.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34689999999999999999996 4579999999997654322 23466889999999999999999987765322
Q ss_pred ----EEEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 243 ----CMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 243 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999986532 2345889999999999999999999 7899999999999999999999999
Q ss_pred eccccccccCC--CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 318 DFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 318 Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|||+++.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~---~~~~~ 262 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT---LAGRY 262 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---hcCCC
Confidence 99999875432 12223457899999999999999999999999999999999999999754321111000 00001
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+ .+..... ..+.+++.+||+.||++||++.+++++
T Consensus 263 ~-~~~~~~~-------~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 D-PLPPSIS-------PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-CCCCCCC-------HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111111 126679999999999999999999864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=318.69 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=193.9
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 248 (468)
+|+..+.||+|+||.||+|.. .+++.||+|++...........+.+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999999975 468999999998654433334567788999988886 577888999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 3899999999999999999999 789999999999999999999999999998764333
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||++.+..++.++|||||||++|||+||+.||......... .. +.. ..........
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-~~---i~~-~~~~~p~~~~---- 225 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-QS---IME-HNVSYPKSLS---- 225 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HH---HHh-CCCCCCccCC----
Confidence 33334456899999999999889999999999999999999999999754321110 00 000 0111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTM 432 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~ 432 (468)
. .+.+++.+|++.+|.+|++.
T Consensus 226 ~---~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 226 K---EAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred H---HHHHHHHHHcccCHhhCCCC
Confidence 1 25678999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=342.85 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=203.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.|.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788999999999999999975 468999999997654333334567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 249 EYMEMGSLFCVLRTDE--------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
||+++|+|.+++.... .....++..++.++.||+.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1223567788999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCC------------------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc
Q 012219 321 VARLLNFDS------------------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS 382 (468)
Q Consensus 321 ~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~ 382 (468)
+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662110 01112468999999999999999999999999999999999999986532211
Q ss_pred hhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHhcCC
Q 012219 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNK 444 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~v~~~l~~~~~ 444 (468)
.... ....++....+.. .....+.+++.+|++.||++||+ ++++.+.|+....
T Consensus 239 i~~~-----~~i~~P~~~~p~~----~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-----DVILSPIEVAPYR----EIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-----hhccChhhccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 0111111000000 11123667899999999999965 5778887776543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.12 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=202.1
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|+||.||+|...+++.||+|.+...... ...|.+|+.++++++|+|++++++++. .+..++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3578889999999999999999888999999999765432 357889999999999999999999874 45689999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999987543 235899999999999999999999 789999999999999999999999999999765422
Q ss_pred C-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 S-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .......++..|+|||++....++.++||||||+++||+++ |+.||........... .............
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~--- 228 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----LERGYRMPRPDNC--- 228 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----HHcCCCCCCCCCC---
Confidence 1 11222345678999999988889999999999999999999 9999975432211110 0010111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 ----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 229 ----PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1237789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=306.05 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=193.7
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.||+|+||.||+|.. .+++.+|+|.+...... .....|.+|++++++++||||+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3589999999999976 47889999988654322 23467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc--
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-- 332 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 332 (468)
+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999987543 24789999999999999999999 7899999999999999999999999999987543211111
Q ss_pred eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 333 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||.......... .............. .
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----~~~~~~~~~~~~~~-------~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE----AIEQGVRLPCPELC-------P 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH----HHHcCCCCCCcccC-------C
Confidence 11123457999999998889999999999999999998 889986543211100 00000111111111 1
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
..+.+++.+|++.+|++|||++++.+.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=312.48 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=201.4
Q ss_pred CccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
+|.+.+.||+|+||.||+|... ....+++|.+...... ...+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4677889999999999999642 3357899988755432 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 012219 245 FLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISS 303 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 303 (468)
++++||+.+|+|.+++.... ....+++..++.++.|++.||.||| +.+++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence 99999999999999886421 1234789999999999999999999 78999999999
Q ss_pred CceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccc
Q 012219 304 NNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSS 380 (468)
Q Consensus 304 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~ 380 (468)
+||++++++.+||+|||+++........ .....++..|+|||+..+..++.++||||||+++|||+| |+.||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999765322211 122345678999999988889999999999999999999 9999865432
Q ss_pred cchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.... +.............. ...+.+++.+|++.+|++||++.+++..|+++..
T Consensus 236 ~~~~--------~~~~~~~~~~~~~~~---~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLF--------NLLKTGYRMERPENC---SEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH--------HHHhCCCCCCCCCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2111 111111111111111 1236789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=323.02 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=191.4
Q ss_pred ceeeeeCCceEEEEEc----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.||+|+||.||+++. .+|+.+|+|++....... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5699999999999864 468899999997644322 23345778999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999986543 3899999999999999999999 789999999999999999999999999999765433333
Q ss_pred ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 332 RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 332 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
.....|++.|+|||++....++.++|||||||++|||++|+.||........... +.. ....+..... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----i~~-~~~~~p~~~~----~-- 223 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----ILK-AKLGMPQFLS----P-- 223 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCC----H--
Confidence 3446789999999999988899999999999999999999999975432111100 000 0011111111 1
Q ss_pred HHHHHHHHhcccCCCCCCCCHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRPTMQL 434 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RPs~~~ 434 (468)
.+.+++.+||+.||++||++.+
T Consensus 224 -~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 224 -EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -HHHHHHHHHhhcCHhHcCCCCC
Confidence 2567899999999999999533
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.72 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=196.7
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|++.+.||+|+||.||+++.. +++.+|+|++...........+.+.+|+.+++.++||||+++++++..+...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3568999999999999999999764 688999999975433333344568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998643 3788889999999999999999 7899999999999999999999999999998764
Q ss_pred CCCC-CceeccccccccccccccCC----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 327 FDSS-NRTLLAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 327 ~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ......||+.|+|||++... .++.++||||+||++|||++|+.||........ .. .+... ...+..
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~---~i~~~-~~~~~~ 268 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YS---KIMDH-KNSLNF 268 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HH---HHHhC-CcccCC
Confidence 3222 22345799999999998654 378899999999999999999999975432111 01 00000 000111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
+....... .+.+++.+|+..++.+ ||++.+++++
T Consensus 269 p~~~~~s~---~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PEDVEISK---HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcccCCH---HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111 2456777888755543 8899999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.73 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=198.4
Q ss_pred ccccceeeeeCCceEEEEE-----cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEE
Q 012219 172 FHIKYCIGTGGYGSVYRAR-----LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCM 244 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 244 (468)
|...+.||+|+||+||.+. ..+++.||+|.+...... .....|.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3778899999999998864 246788999999765432 2346788999999999999999999988753 458
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+++|||+++|+|.+++... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999998653 3899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-------cccccccc
Q 012219 325 LNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-------KNIKLIDL 394 (468)
Q Consensus 325 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-------~~~~~~~~ 394 (468)
....... .....++..|+|||......++.++||||||+++|||+||+.|+........... ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6432211 1122356679999999888899999999999999999999999864332111000 00011111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+.....+.... ....+.+++..||+.+|++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKN---CPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCC---CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111111111 112477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.88 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=189.1
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHH-HHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|.. .+|+.+|+|++...........+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999964 578999999997654333233445556655 46779999999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998887543 3889999999999999999999 78999999999999999999999999999875433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ....+.+... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~~~~----~~~~~~~~~~-------~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-DNILH----KPLVLRPGAS-------LT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-HHHHc----CCccCCCCCC-------HH
Confidence 567999999999999999999999999999999999999999754321110 10000 0011111111 12
Q ss_pred HHHHHHhcccCCCCCCCCHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQL 434 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~ 434 (468)
+.+++.+|++.+|.+||++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCC
Confidence 567899999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=313.96 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=200.0
Q ss_pred hCccccceeeeeCCceEEEEEcCC-C--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-G--KVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||.||+|...+ + ..+++|.++..... ...+.|.+|++++.++ +||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 468889999999999999997643 3 34788888743322 2346788999999999 7999999999999988999
Q ss_pred EEEEeccCCChhhhhhcCc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 246 LIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
+++||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+++||||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence 9999999999999996532 1124788999999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 391 (468)
.+||+|||++...... ........+..|+|||+.....++.++|||||||++|||++ |+.||........... .
T Consensus 157 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~ 231 (297)
T cd05089 157 ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----L 231 (297)
T ss_pred eEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H
Confidence 9999999998643211 11111223457999999988889999999999999999998 9999875432211110 1
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
.....+....... ..+.+++.+||+.+|.+||+++++++.|..+....
T Consensus 232 ~~~~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRMEKPRNCD-------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1101111111111 12678999999999999999999998887776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.39 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=203.7
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 245 (468)
..++|.+..+||+|.||+|+.+.. .+++.+|||++++...-....++..+.|.+++...+ ||.++.++..++..++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 346899999999999999999975 468899999999887766667788889999988875 999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
.||||+.||++..+.+. ..+++..+.-++..|+.||.||| .++||+||||-+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999994443332 33899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
-......+.++||+.|||||++.+..|+.++|.|||||+||||+.|..||...+.+.. .+. .. .-++.++...+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-Fds-I~---~d~~~yP~~ls- 592 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDS-IV---NDEVRYPRFLS- 592 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH-Hh---cCCCCCCCccc-
Confidence 5556677789999999999999999999999999999999999999999985432211 111 11 11222222221
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTM 432 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 432 (468)
.+ ...|+.+++.++|++|.-+
T Consensus 593 ---~e---a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 ---KE---AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---HH---HHHHHHHHhccCcccccCC
Confidence 22 4568889999999999866
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.33 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=187.9
Q ss_pred ceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHH-HHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEA-RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+.. +++.||+|++.............+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999754 6788999999764432222233444444 456788999999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... .+.+.....++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999987543 3778888889999999999999 78999999999999999999999999999976433333344
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... .. .... .....+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~---i~~~-~~~~~~~~~~-------~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DN---ILNK-PLQLKPNITN-------S 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-HH---HHhC-CcCCCCCCCH-------H
Confidence 567999999999999999999999999999999999999999754322110 00 0000 0111111111 2
Q ss_pred HHHHHHhcccCCCCCCCCHHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQLV 435 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~v 435 (468)
+.+++.+|++.||.+||++.+.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCC
Confidence 5678899999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=306.45 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=200.0
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+.+.||+|+||.||+|...++..+|+|.+...... .+.|.+|+.++++++|+|++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence 568889999999999999999888889999999765432 3568899999999999999999998854 45789999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++.... ...+++..++.++.|++.||.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999987543 234789999999999999999999 7799999999999999999999999999997654322
Q ss_pred CC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. .....++..|+|||+..+..++.++||||||+++|||++ |+.||........ ... +......+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~~-------~~~~~~~~~~~-- 226 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-LEQ-------VERGYRMPCPQ-- 226 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HHH-------HHcCCCCCCCC--
Confidence 11 112234567999999988889999999999999999999 8999865432111 110 11111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
.....+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 -DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111237789999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=306.12 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=193.1
Q ss_pred eeeeeCCceEEEEEc---CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.||+|+||.||+|.+ .++..+|+|+++..... ....+.+.+|+.+++.++|+||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999964 46788999998754432 2345678899999999999999999999864 457899999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc-
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR- 332 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 332 (468)
|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999987543 3889999999999999999999 7899999999999999999999999999998764332211
Q ss_pred --eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 333 --TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 333 --~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
....++..|+|||.+....++.++|||||||++|||++ |+.||........... ......+..+...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----i~~~~~~~~~~~~~----- 224 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM----IESGERMECPQRCP----- 224 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCCCCCCCCCCCC-----
Confidence 11234578999999988889999999999999999998 9999975432211110 00000111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.+++.+||+.||++||++++|...|.+
T Consensus 225 --~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 --PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 126679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.17 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=187.7
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHH-HHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|+. .+++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 468899999997654333333445555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|...+.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998886533 3788888999999999999999 78999999999999999999999999999875432333334
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... .. ... -...+..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~---i~~-~~~~~~~~~~-------~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-DN---ILH-KPLQLPGGKT-------VA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-HH---Hhc-CCCCCCCCCC-------HH
Confidence 457899999999999889999999999999999999999999754321110 00 000 0011111111 12
Q ss_pred HHHHHHhcccCCCCCCCCHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQ 433 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~ 433 (468)
+.+++.+|++.||.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 66789999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=312.01 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=197.9
Q ss_pred hCccccceeeeeCCceEEEEEcCC---------------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS---------------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 234 (468)
++|.+.+.||+|+||.||+++..+ ...||+|.++..... .....|.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCcCeE
Confidence 578899999999999999986532 235899998765332 234578899999999999999999
Q ss_pred EEEEeeCCEEEEEEEeccCCChhhhhhcCcc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 012219 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE---------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNN 305 (468)
Q Consensus 235 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 305 (468)
++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence 9999999999999999999999999864321 123688999999999999999999 7899999999999
Q ss_pred eeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh--CCCCCCccccc
Q 012219 306 VLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GKHPGELLSSS 381 (468)
Q Consensus 306 Ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t--g~~p~~~~~~~ 381 (468)
|+++.++.+||+|||++......... .....++..|+|||+.....++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999765322111 112234678999999988889999999999999999998 66777654322
Q ss_pred chhhhccc---ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 382 SWSLDKNI---KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 382 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
........ ......-....+..+ ..+.+++.+||+.||++|||+++|.+.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCP-------SPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11100000 000000000011111 23778999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=312.78 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=202.8
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|++.+.||+|+||.||++... +...+|+|.+...... .....+.+|++++.++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 457888999999999999999753 3467999998765433 2346688999999999 799999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcC-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
+..+++|||+++|+|.++++.. .....+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999998642 22345889999999999999999999 7899999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhh
Q 012219 309 NSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSL 385 (468)
Q Consensus 309 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~ 385 (468)
+.++.+||+|||+++.+...... .....++..|+|||+..+..++.++|||||||++|||++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999876432211 111234567999999988899999999999999999998 999986543221110
Q ss_pred hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
. ......+...... ...+.+++.+|+..+|++|||+.++++.|..+
T Consensus 246 ~----~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 246 L----LKEGYRMEKPQNC-------TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H----HHcCCcCCCCCCC-------CHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0 0000001111111 12377899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.96 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=200.3
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|...++..||+|.+...... .+.|.+|++++++++|+||+++++++.. ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 3568999999999999999998877778999999754432 3568899999999999999999998754 4578999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999997543 234789999999999999999999 789999999999999999999999999999766432
Q ss_pred CCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
... .....++..|+|||+.....++.++||||||+++|||+| |+.||......... .. ...........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-~~---~~~~~~~~~~~----- 226 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQ---VERGYRMPCPP----- 226 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-HH---HhcCCCCCCcc-----
Confidence 221 112345678999999988899999999999999999999 88898654321111 00 00000011111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
.....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 --~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 227 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 112237789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=322.88 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=195.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+..+.||+|+||.||++.. .+++.||+|++.............+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999975 468999999997654433345567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987543 3889999999999999999999 889999999999999999999999999998754211
Q ss_pred CC-----------------------------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCC
Q 012219 329 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKH 373 (468)
Q Consensus 329 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~ 373 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113468999999999999999999999999999999999999
Q ss_pred CCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 012219 374 PGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT---MQLVSNE 438 (468)
Q Consensus 374 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~v~~~ 438 (468)
||........... .......+ ...... ...+. +.+++.+|+ .||++|++ +++++++
T Consensus 235 Pf~~~~~~~~~~~-i~~~~~~~--~~p~~~--~~s~~---~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRK-VMNWKETL--VFPPEV--PISEK---AKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHH-HHcCCCce--ecCCCC--CCCHH---HHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9975432211110 00000000 011110 01111 445666666 49999985 6777754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.71 Aligned_cols=274 Identities=26% Similarity=0.353 Sum_probs=203.2
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-----CC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-----RK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 242 (468)
...|...+.||+|+||.|+++. ..+|+.||+|++....... ...+.-.+|+++++.++|+||+.+.+.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4556667889999999999996 4578999999998543332 335667799999999999999999998865 34
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..|+|+|+|+ .+|...++.+.. ++......++.|+++||+|+| +.+|+||||||+|++++.+...||+|||+|
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 5899999994 589999887554 888899999999999999999 899999999999999999999999999999
Q ss_pred ccccCC--CCCceecccccccccccccc-CCCCCccchhhHHHHHHHHHHhCCCCCCcccccch--------------hh
Q 012219 323 RLLNFD--SSNRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW--------------SL 385 (468)
Q Consensus 323 ~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~--------------~~ 385 (468)
+..... ....+..+-|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+...... ..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987532 33345567899999999765 56899999999999999999999998865432110 00
Q ss_pred h--cccccccc---cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcCCCCCCCC
Q 012219 386 D--KNIKLIDL---LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARNKAPMQKP 450 (468)
Q Consensus 386 ~--~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~~~~~~~~ 450 (468)
. ........ +.+....++...+...-..-.+++.+||..||.+|+|++|.++ .....-..+..+|
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 0 00000011 1111111111112122223567899999999999999988774 4444443333333
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=323.24 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=203.2
Q ss_pred HHhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEe
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCL 239 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 239 (468)
...++|.+.+.||+|+||.||+|++. .++.||+|+++...... ..+.+.+|++++.++. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34467888899999999999999753 34689999998654332 2357889999999997 999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc------------------------------------------------------
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------ 265 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 265 (468)
..+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999865321
Q ss_pred -----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 012219 266 -----------------------------------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSN 304 (468)
Q Consensus 266 -----------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 304 (468)
...+++...+.++.|++.||.||| +.+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 123677888999999999999999 789999999999
Q ss_pred ceeeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCccccc
Q 012219 305 NVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSS 381 (468)
Q Consensus 305 NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~ 381 (468)
||++++++.+||+|||+++....... ......++..|+|||.+....++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976532211 1122346788999999998889999999999999999998 89998654322
Q ss_pred chhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 382 SWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
....... ..-..+....... ..+.+++.+||+.+|++||+++++++.|++.
T Consensus 349 ~~~~~~~---~~~~~~~~p~~~~-------~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQFYNAI---KRGYRMAKPAHAS-------DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHH---HcCCCCCCCCCCC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111100 0000111111111 2377899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.53 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=196.0
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... ...+.|.+|++++.+++||||+++++++...+..++|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 577888999999999999964 57899999998755322 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 99999997553 2678888999999999999999 789999999999999999999999999999765322
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc---ccccccccCCCCCCccchh
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK---NIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 406 (468)
......++..|+|||++.+..++.++||||||+++|+|++|+.||............ .........+......
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 224 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ--- 224 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc---
Confidence 233356899999999999889999999999999999999999998653321110000 0000000111111100
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
....+.+++.+|++.+|++||++++++++-
T Consensus 225 ---~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 225 ---FSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred ---CCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111267899999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.65 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=201.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.++|++.+.||+|+||.||+|.+ .++. .||+|++...... ...+.+.+|+.++..++|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 35788899999999999999974 3444 4899998755433 2346788999999999999999999999764 4
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++++||+++|+|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 678999999999999997643 23889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCC
Q 012219 324 LLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 324 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
......... ....++..|+|||...+..++.++|||||||++|||++ |..||+........ .. ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~--~~~~~~~~~~ 233 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP--DL--LEKGERLPQP 233 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HH--HHCCCcCCCC
Confidence 764322211 11234668999999988899999999999999999998 99998754321110 00 0000000111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
... ...+.+++.+||+.||++||++.++++.|.+....+
T Consensus 234 ~~~-------~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 PIC-------TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ccC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111 123677999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=306.30 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=195.1
Q ss_pred ccccceeeeeCCceEEEEEcCCC-C--EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------C
Q 012219 172 FHIKYCIGTGGYGSVYRARLPSG-K--VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------K 242 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 242 (468)
|.+.+.||+|+||.||+|...+. . .+|+|.++..... ....+.|.+|+++++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 34678899999999999986543 2 6899988764322 23356788999999999999999999988542 2
Q ss_pred EEEEEEEeccCCChhhhhhcC---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 243 CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
..++++||+++|+|.+++... .....+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCC
Confidence 468999999999999887432 12334889999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccC
Q 012219 320 GVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 320 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|+++........ .....+++.|+|||+..+..++.++||||||+++|||++ |+.||......... ... .... .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~-~~~~--~ 232 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-DYL-RQGN--R 232 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHH-HcCC--C
Confidence 999876432211 122345678999999999999999999999999999999 88998654321110 000 0000 0
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
........ ..+.+++.+||+.||++|||++++++.|.+
T Consensus 233 ~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 233 LKQPPDCL-------DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01111111 126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=307.64 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=198.5
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|+..+.||+|+||+||+|.. .+++.+|+|.+.............+.+|++++++++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999965 57899999999765443333345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++++|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence 99999998886533 234899999999999999999999 789999999999999999999999999998765322 2
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......|+..|+|||++.+..++.++|||||||++|||++|+.||................... .........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------ 229 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-EEVYSAKFS------ 229 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-ccccCccCC------
Confidence 2233468999999999988899999999999999999999999997543211111000000000 111111111
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 411 IILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
..+.+++.+|++.||++||+ +.+++++
T Consensus 230 -~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 230 -EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 12567899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.68 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=200.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch--hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET--EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
++|.+.+.||+|++|.||++.. .+++.+|+|.+..... ......+.+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999975 5689999999875432 222345678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
++||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987543 3788899999999999999999 7899999999999999999999999999987653
Q ss_pred CCCCCc---eeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 327 FDSSNR---TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 327 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||............ ......+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPTNPQLPSHV 232 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH---hccCCCCCCCccC
Confidence 221111 2345778999999999988999999999999999999999998654322111110 0000111111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ..+.+++.+||..+|++|||+.+++++
T Consensus 233 ~-------~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 233 S-------PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C-------HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 126678999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.35 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=201.0
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||++.. .+++.+|+|.+...... ...+.+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 477889999999999999975 46889999998654332 235678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... ...++....+.++.|++.||.||| +.+++|+||||+||++++++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999886532 234788999999999999999999 7899999999999999999999999999998765443
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||.............. .... .......
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~~~~~~~----- 225 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ---GSYK-PLPSHYS----- 225 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---CCCC-CCCcccC-----
Confidence 333445688999999999988899999999999999999999999975432111111000 0000 1111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+||+.||++||++.+++..
T Consensus 226 --~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 --YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 126678999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.78 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=204.8
Q ss_pred hhCccccceeeeeCCceEEEEEcCC-----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 242 (468)
.++|.+.+.||+|+||.||+|...+ +..|++|++...... ...+.+.+|+.++++++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678899999999999999998655 788999998754332 345678899999999999999999999876 46
Q ss_pred EEEEEEEeccCCChhhhhhcCccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEA-----VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
..++++||+++|+|.+++...... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764322 45899999999999999999999 7899999999999999999999999
Q ss_pred eccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccc
Q 012219 318 DFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 318 Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||........... ....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~ 235 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY----LKDG 235 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH----HHcC
Confidence 99999865322211 112345678999999988889999999999999999999 9999875432211110 0000
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.........+ ..+.+++.+||+.||++|||+.++++.|....+
T Consensus 236 ~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQPINCP-------DELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCCCCcCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111111111 236789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.79 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=195.8
Q ss_pred eeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 177 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
.||+|+||.||+|...+++.+|+|.+....... ....|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 689999999999998889999999987654332 234688999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC-ceec
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLL 335 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 335 (468)
.+++.... ..+++..++.++.|++.||.|+| +.+++||||||+||+++.++.+||+|||++......... ....
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99986543 23789999999999999999999 789999999999999999999999999998754322111 1122
Q ss_pred cccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 336 AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 336 ~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
.++..|+|||+..+..++.++||||||+++||+++ |..||........... ............. ...+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~ 223 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ----VEKGYRMSCPQKC-------PDDV 223 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCC-------CHHH
Confidence 34567999999998889999999999999999998 9999875432211110 0011111111111 1237
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.+++.+|++.+|++||++.++...|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.18 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=200.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|...+.||+|+||.||+|.. .+++.|++|.+....... .+.+.+|+.+++.++|+|++++++++......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 5788889999999999999974 578999999987654432 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999998643 3788999999999999999999 789999999999999999999999999998765433
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........+++.|+|||.+.+..++.++|||||||++|+|++|+.||............. ....+.... ..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~--~~--- 240 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----TNGTPELQN--PE--- 240 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----cCCCCCCCC--cc---
Confidence 333334568899999999988889999999999999999999999996543211111000 000011110 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+||..+|++||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111236679999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.56 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=192.2
Q ss_pred eeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.||+|+||.||+|.+. .+..||+|++...... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999653 3557999998765432 234678999999999999999999999864 467999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999987533 24899999999999999999999 77999999999999999999999999999976543322111
Q ss_pred ---eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 334 ---LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 334 ---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
...++..|+|||+.....++.++|||||||++||+++ |+.||............ .....+.......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~----- 224 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI----EQGKRLDCPAECP----- 224 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----HCCCCCCCCCCCC-----
Confidence 1223568999999988889999999999999999996 99999765432211100 0000111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||..+|++||++.+|.+.|++.
T Consensus 225 --~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 --PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2266799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.73 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=198.2
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|+..+.||+|+||.||++.. .+++.+|+|.+...........+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778899999999999965 46889999998755433323345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-Q 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-c
Confidence 999999998865332 34889999999999999999999 789999999999999999999999999998765322 2
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... .................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------ 229 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEVQEEYSEKFS------ 229 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhhhhhhcCccCC------
Confidence 22334689999999999988999999999999999999999999975332110000 00000001111111111
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 411 IILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
..+.+++.+||+.||++||| ++++++
T Consensus 230 -~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 230 -PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12667899999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.61 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=198.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-----------------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCcee
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-----------------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV 232 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 232 (468)
++|++.+.||+|+||.||++... ++..+|+|++...... ...+.|.+|+++++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence 56889999999999999998532 2346899998754322 2346788999999999999999
Q ss_pred eEEEEEeeCCEEEEEEEeccCCChhhhhhcCcc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 012219 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSN 304 (468)
Q Consensus 233 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 304 (468)
++++++...+..+++|||+++|+|.+++..... ...+++...+.++.|++.||+||| +.+++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence 999999999999999999999999999875321 124778899999999999999999 789999999999
Q ss_pred ceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh--CCCCCCcccc
Q 012219 305 NVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GKHPGELLSS 380 (468)
Q Consensus 305 NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t--g~~p~~~~~~ 380 (468)
||+++.++.++|+|||+++.+...... .....++..|+|||+...+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999765322211 112234578999999888889999999999999999998 7788865432
Q ss_pred cchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
...... ..............+... .....+.+++.+||+.||++||++.+|.+.|+
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIEN-TGEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHH-HHHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211110 000000000000000000 01123778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=321.44 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=199.7
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
.++....++|++.+.||+|+||.||+++.. +++.+|+|++...........+.+.+|+.+++.++||||+++++.+...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 334445688999999999999999999754 6889999998754433333445678999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
...++||||+++|+|.+++... .++...+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998643 2788888899999999999999 78999999999999999999999999999
Q ss_pred cccccCCCC-CceeccccccccccccccCC----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC
Q 012219 322 ARLLNFDSS-NRTLLAGTYGYIAPELAYTM----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 322 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++....... ......||+.|+|||++... .++.++|||||||++|||++|+.||........ .. .+....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~---~i~~~~- 263 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YS---KIMNHK- 263 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-HH---HHHcCC-
Confidence 987643222 22345799999999998654 378899999999999999999999975432111 01 010000
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNEF 439 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~l 439 (468)
..+..+....... .+.+++.+|+..++.+ ||++++++++.
T Consensus 264 ~~~~~~~~~~~s~---~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NSLTFPDDNDISK---EAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CcccCCCcCCCCH---HHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0011010111111 2556888899744433 78999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.38 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=201.3
Q ss_pred hhCccccceeeeeCCceEEEEEcCC-----------------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 231 (468)
.++|.+.+.||+|+||.||++...+ +..||+|.+...... ...+.|.+|++++++++|||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 3578899999999999999986532 346899998765433 345688899999999999999
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISS 303 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 303 (468)
+++++++......++++||+++++|.+++..... ...+++..++.++.|++.||+||| +.+++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccch
Confidence 9999999998999999999999999999876431 224899999999999999999999 78999999999
Q ss_pred CceeeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh--CCCCCCccc
Q 012219 304 NNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM--GKHPGELLS 379 (468)
Q Consensus 304 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t--g~~p~~~~~ 379 (468)
+||+++.++.++|+|||+++....... ......++..|+|||++....++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999876532221 1223345778999999988889999999999999999998 677876443
Q ss_pred ccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.... ...................... ....+.+++.+|++.||++|||+.++.+.|+
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQV-IENAGHFFRDDGRQIYLPRPPN---CPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHH-HHHHHhccccccccccCCCccC---CCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2111 1100000000000000000001 1123778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=310.12 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=199.0
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.+|.+.+.||+|+||.||+|... .++.||+|++...... ...+.|.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 34677888999999999999753 3578999999855432 234568899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
.++++||+.+++|.+++.... ....+++..++.++.|++.||.||| +.+++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence 999999999999999985321 1234788899999999999999999 789999999999999999
Q ss_pred CCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.+||+|||+++........ .....+++.|+|||.+....++.++|||||||++|||++ |..||...........
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~- 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM- 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence 999999999998765322211 122345678999999988889999999999999999998 8888865432211110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.......... ...+.+++.+||+.+|++||++++++..|+.
T Consensus 239 ---i~~~~~~~~~~~~-------~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 ---IRNRQVLPCPDDC-------PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHcCCcCCCCCCC-------CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0000000111111 1226789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.66 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=198.8
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
+++|.+.+.||+|++|.||+|.+. .+..|++|.+...... .....|.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 467889999999999999999764 3567899988654332 23357889999999999999999999999888
Q ss_pred EEEEEEEeccCCChhhhhhcCcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAF 315 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 315 (468)
..++||||+++++|.+++..... ...+++..++.++.||+.||+||| +.+++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence 89999999999999999876432 234899999999999999999999 77999999999999998764 589
Q ss_pred EeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+.......... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~ 235 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF----VT 235 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH
Confidence 9999999866322111 111223567999999998899999999999999999997 9999875432211100 00
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
........... ...+.+++.+|++.+|++||++.+|+++|.
T Consensus 236 ~~~~~~~~~~~-------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRLDPPKGC-------PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcCCCCCCC-------CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00001111111 123678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.93 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=198.7
Q ss_pred ccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE----
Q 012219 172 FHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC---- 243 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 243 (468)
|.+.+.||+|+||.||+|.... +..||+|.++..... ......+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 4677889999999999997532 467999998764332 2335678999999999999999999999876544
Q ss_pred --EEEEEEeccCCChhhhhhcCc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 244 --MFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 244 --~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
.++++||+++|+|..++.... ....+++.....++.|++.||.||| +.+++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999885432 2235889999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccccccc
Q 012219 319 FGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 319 fg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++........ .....++..|+|||++....++.++|||||||++|||++ |..||........... .....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~ 232 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHGN 232 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCC
Confidence 9999876432221 112234678999999988899999999999999999999 8999865443211110 00001
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
........ ...+.+++.+||+.||++||++.++++.|.+.
T Consensus 233 ~~~~~~~~-------~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLKQPEDC-------LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCcCC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 12377899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=309.62 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=201.7
Q ss_pred HhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
..++|++.+.||+|+||.||+|... .+..||+|.+...... .....+.+|+..++.++|+||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4578999999999999999999643 2457999988754432 2234688999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
...++||||+++|+|.+++..... ....++..+..++.|++.||.||| +++|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 223567788899999999999999 7899999999999999999999
Q ss_pred EEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccc
Q 012219 315 FVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 391 (468)
+|+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||........... .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~----~ 234 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF----V 234 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H
Confidence 99999998765322211 112234678999999998899999999999999999999 7889865432211100 0
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.+.......... ...+.+++.+|++.||++|||+.++++.|.+..
T Consensus 235 ~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQPDNC-------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCCCCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000000111111 123778999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.68 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=199.4
Q ss_pred hCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.++...+.||+|+||.||++.. .++..+++|.+...... ..+.|.+|+++++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4677889999999999999953 24568899988754432 34678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
.++++||+++|+|.+++..... ...+++..++.++.|++.|++||| +.+++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCC
Confidence 9999999999999999875432 124789999999999999999999 7899999999999999999
Q ss_pred CCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcc
Q 012219 312 LEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKN 388 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 388 (468)
+.+||+|||+++....... ......+++.|+|||+..+..++.++|||||||++|||++ |+.||...........
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-- 236 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-- 236 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH--
Confidence 9999999999976532211 1112234678999999998899999999999999999998 9999865432211100
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.............+ ..+.+++.+||+.||++||++++|.+.|+
T Consensus 237 --~~~~~~~~~~~~~~-------~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 --ITQGRELERPRTCP-------PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHcCccCCCCCCCC-------HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000111111111 12668999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=309.76 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=202.6
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||++.. ..+..||+|.++..... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 35799999999999999999963 23557999998765432 2346788999999999 799999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
+..++++||+.+|+|.++++.... ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999975432 23799999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCC
Q 012219 322 ARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 322 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
++........ .....++..|+|||.+.+..++.++|||||||++|||++ |+.||........... .....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-------~~~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-------LIKEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-------HHHcC
Confidence 9765432211 112345678999999998889999999999999999998 9999875432211100 01111
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
......... ...+.+++.+|++.+|++|||+.+++..|.+.
T Consensus 261 ~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMAQPEHA---PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111000111 11377899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.41 Aligned_cols=263 Identities=23% Similarity=0.261 Sum_probs=197.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|++|.||+|+. .++..||+|++....... ...+.+.+|+.++++++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 477889999999999999976 468999999987543221 233567889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|++ ++|.+++........+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 689888876544456899999999999999999999 7899999999999999999999999999997654333
Q ss_pred CCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc--------------ccccc-
Q 012219 330 SNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN--------------IKLID- 393 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~--------------~~~~~- 393 (468)
.......+++.|+|||++.+ ..++.++|||||||++|||+||+.||............. ....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 33333457889999998765 457889999999999999999999986432211000000 00000
Q ss_pred --ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 --LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 --~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.................+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000011236689999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=313.73 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=211.3
Q ss_pred hhCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 246 (468)
...|.+.+.||+|.||.||++..+. |+.+|+|.+.+.............+|+++|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3568888999999999999997654 9999999998776654345568889999999998 9999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC----CCeEEeecccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVA 322 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~ 322 (468)
|||++.||.|.+.+... .+++..+..++.|++.++.||| +.||+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999765 2899999999999999999999 7899999999999999644 47999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........-.. .+..+..+
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-----~~~~f~~~ 260 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-----GDFDFTSE 260 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-----CCCCCCCC
Confidence 98875 5667778999999999999999999999999999999999999999986654322221100 11122222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+. ..+++..|+..||.+|+|+.+++++
T Consensus 261 ~w~~is~~---akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PWDDISES---AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CccccCHH---HHHHHHHhcccCcccCCCHHHHhcC
Confidence 22222222 5568999999999999999999974
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.30 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=202.4
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++..++|+|++++++++......++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 357888999999999999999874 78999999986643 3467889999999999999999999999888999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999976442 24899999999999999999999 789999999999999999999999999999766322
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. ....+..|+|||++....++.++||||||+++||+++ |+.||............ ............
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~---- 224 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEAPEGC---- 224 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hcCCCCCCccCC----
Confidence 11 2334567999999988889999999999999999997 99998654322111000 000011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+||..+|++|||+.+++..|..
T Consensus 225 ---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 ---PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1236779999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.09 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=197.3
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR---- 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---- 241 (468)
+.+.|++.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456788889999999999999975 46889999998754322 35677899999998 699999999998753
Q ss_pred --CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 242 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 242 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
...+++|||+.+|+|.+++.... ...+++..+..++.|++.|++||| +.+|+|+||||+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence 46899999999999999987643 234889999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|++..............|+..|+|||++. ...++.++|||||||++|||++|+.||............ ...
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~ 231 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRN 231 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcC
Confidence 99976543333334456889999999886 345788999999999999999999998654322111110 000
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+..... .. ...+.+++.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~~~---~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSK---KW---SKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCC---Cc---CHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 01111110 11 1126789999999999999999998753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.06 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=201.5
Q ss_pred hhCccccceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... .+..+|+|.+...... .....+.+|++++..+ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357899999999999999999642 2357999999865332 2345788899999999 7999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
..+..++|+||+++|+|.+++..... ...+++.+++.++.|++.||+||| +.+++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence 99999999999999999999975421 134889999999999999999999 78999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999987653211111 11224468999999988889999999999999999998 8899865432111
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
... ............. ...+.+++.+|++.+|++|||+.+|++.|.++.
T Consensus 252 ~~~----~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 252 FKL----LKEGHRMDKPSNC-------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHH----HHcCCCCCCCCcC-------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 100 0000001111111 123667999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=302.98 Aligned_cols=250 Identities=30% Similarity=0.437 Sum_probs=202.0
Q ss_pred hCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+|++++++++......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578889999999999999998754 78999999875432 468899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ..+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999986533 34899999999999999999999 779999999999999999999999999999876543
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........++..|+|||++.+..++.++||||||+++|+|++|+.||........... ......+.... ....
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~--~~~~- 225 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----IPNKPPPTLSD--PEKW- 225 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----hccCCCCCCCc--hhhc-
Confidence 3333445688899999999888999999999999999999999999875432211110 00000011111 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+||+.+|++|||+.+++.+
T Consensus 226 --~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 226 --SPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1236789999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=302.52 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=199.3
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+...||+|++|.||+|...++..+|+|.+...... .+.|.+|++++++++|+|++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 468888999999999999998877778999988654332 3568899999999999999999998854 55789999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999997543 234789999999999999999999 7899999999999999999999999999997654322
Q ss_pred C-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 S-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. ......++..|+|||...+..++.++||||||+++|||+| |+.||......... .. ......+....
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~---~~~~~~~~~~~------ 226 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQ---VERGYRMPCPQ------ 226 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---HHcCCCCCCCc------
Confidence 1 1112345678999999988889999999999999999999 99998754322111 00 00101111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
.....+.+++.+||+.||++||+++++.+.|++
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 -GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111237789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=293.86 Aligned_cols=275 Identities=23% Similarity=0.325 Sum_probs=210.6
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.+.|++.+.||+|.|+.||++. .++|+.+|+|.+....... ...+.+.+|+++-+.|+||||+++.+.+.+....++|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3568888899999999999994 5678889988876544432 2456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~ 324 (468)
+|+|+|++|..-+-.. .-+++..+-..+.||+.||.|+| ..+|||||+||+|+++.. ..-+|++|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997665433 22677888899999999999999 889999999999999943 34689999999998
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
++ ++......+|||+|||||++...+|+..+|||+-|||||-|+.|.+||.+.+.......-..... .+.++..
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y-----d~~~~~w 236 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY-----DYPSPEW 236 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc-----CCCCccc
Confidence 87 66666678899999999999999999999999999999999999999986443221111011111 1222222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhcCCCCCCCCcccccHhhh
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIARNKAPMQKPFHEISILEL 459 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~~~~~~~~~~~~~~~~~~ 459 (468)
..+.++ -.+++.+||..||.+|.|+.|.+ +.|...........+...+.+++
T Consensus 237 ~~is~~---Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~l 289 (355)
T KOG0033|consen 237 DTVTPE---AKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCL 289 (355)
T ss_pred CcCCHH---HHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHH
Confidence 222232 44688999999999999998777 44544433333334444444443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.10 Aligned_cols=257 Identities=26% Similarity=0.331 Sum_probs=194.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+++. .+++.||+|++...........+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999975 468999999997544333344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999996532 23788999999999999999999 789999999999999999999999999998765432
Q ss_pred CC-CceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 329 SS-NRTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ......... .+...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-~i~~~~~~~--~~~~~ 232 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-KIMNHKEHF--QFPPD 232 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH-HHHcCCCcc--cCCCc
Confidence 22 2223468999999999863 457889999999999999999999997543211100 000000000 01111
Q ss_pred cchhHHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRS--QPKSRPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~~v~~~ 438 (468)
.. ...+ .+.+++.+|+.. ++..||++++++++
T Consensus 233 ~~-~~~~---~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VT-DVSE---EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCCH---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0111 245567776654 33448899999866
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=306.04 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=197.8
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RK 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 242 (468)
.+|.+.+.||+|+||.||++.. .++..||+|++...... ..+.|.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4688889999999999999964 35789999998765432 34678899999999999999999998754 34
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 6899999999999999987543 23889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCCc---eeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc--------cc
Q 012219 323 RLLNFDSSNR---TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI--------KL 391 (468)
Q Consensus 323 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------~~ 391 (468)
+......... ....++..|+|||+..+..++.++|||||||++|||++|..|+.............. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8764322211 111234469999999888899999999999999999998877543221100000000 00
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+.+......+..... ...+.+++.+||..+|++|||+++|++.|..+
T Consensus 236 ~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111111010001111 12377899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.22 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|... .+..||+|.+...... .....+.+|+.++..++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 357888999999999999999753 3468999998755432 23457889999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 99999999999999999865321 224788999999999999999999 78999999999999999999999
Q ss_pred EeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++....... ......++..|+|||.+.+..++.++|||||||++||++| |+.||........... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~----~~ 235 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF----VI 235 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH----Hh
Confidence 999999976543221 1122346788999999988889999999999999999998 9999865432211110 00
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
....+...... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLDLPENC-------PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCCCCCCC-------CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 10011111111 123778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=306.58 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=200.0
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|++.+.||+|+||+||+++.. +++.+|+|.+......... .....+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 567889999999999999754 5678999999987665432 23345699999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++++|.+++.. ...+++..++.++.|++.||++|| +.+++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999983 234899999999999999999999 67999999999999999999999999999976433334
Q ss_pred Cceecccccccccccccc-CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 331 NRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
......++..|+|||+.. +..++.++||||+|+++|+|++|..||............................ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 228 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR-----E 228 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT-----T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc-----h
Confidence 444567899999999998 8889999999999999999999999988652111000000000000000000000 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+||+.||++||++.+++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01348889999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.83 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=199.3
Q ss_pred HHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 166 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 166 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
+.+++.+.....||+|+||.||+|.. .++..|++|.+...... ..+.+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 34456666778899999999999974 46788999988765433 346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeeccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADFGVAR 323 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~ 323 (468)
++++||+++++|.+++.........++..+..++.||+.||+||| +.+|+||||||+||+++. ++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999976433222378888899999999999999 789999999999999976 6799999999987
Q ss_pred cccCCCCCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.............++..|+|||++... .++.++||||||+++|+|++|+.||............. . .....+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~ 235 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-G-MFKIHPEIPE 235 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-h-hhccCCCCCc
Confidence 654333333334678999999998654 37889999999999999999999986433211111000 0 0001111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... ..+.+++.+||+.+|++|||+.+++.+
T Consensus 236 ~~~-------~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 SLS-------AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccC-------HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111 226678999999999999999998864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.99 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=201.0
Q ss_pred hCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|... .+..+|+|.++..... ...+.|.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56888999999999999999753 2347999998754432 23567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++++|.+++.... ..+++.+++.++.|++.|+.||| +.+++||||||+||+++.++.++++|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999997643 24789999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCce---eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNRT---LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
........ ...++..|+|||++.+..++.++||||||+++||+++ |+.||........ .. ...+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~---~~~~~~~~~~~~ 232 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IK---AIEEGYRLPAPM 232 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-HH---HHhCCCcCCCCC
Confidence 43222111 1123467999999998889999999999999999887 9999865432111 11 011111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.. ...+.+++.+|++.+|++||+|.++++.|.+.
T Consensus 233 ~~-------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 233 DC-------PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC-------CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 12266899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=300.31 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=194.6
Q ss_pred ceeeeeCCceEEEEEcC--C--CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLP--S--GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.||+|+||.||+|... + +..+|+|.+...... ...+.+.+|+++++++.|+|++++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 36999999999999642 2 368999999866543 234678899999999999999999998864 4579999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
++|+|.+++.... .+++..++.++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999997654 4899999999999999999999 789999999999999999999999999999876433222
Q ss_pred cee---ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 332 RTL---LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 332 ~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
... ..++..|+|||...+..++.++||||||+++|||++ |+.||............ . ...........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~---~~~~~~~~~~~---- 223 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-E---SGERLPRPEEC---- 223 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-H---cCCcCCCCCCC----
Confidence 111 123467999999998899999999999999999998 99998754432111110 0 00000011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
...+.+++.+||..+|++||++.++.+.|.+.
T Consensus 224 ---~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 ---PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 12367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.06 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=196.9
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe-eCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL-HRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++... |..+|+|.+..... .+.|.+|+.++++++|+|++++++++. ..+..++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46888999999999999999774 77899999865432 357889999999999999999999765 456789999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999876433 34789999999999999999999 789999999999999999999999999998764322
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. ....++..|+|||+.....++.++|||||||++|||++ |+.||............ .....+......
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~---- 224 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGC---- 224 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCCCCCCCCCC----
Confidence 1 22334568999999988889999999999999999998 99998644321111100 000011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+|++.+|++|||+.++.+.|..
T Consensus 225 ---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 225 ---PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1236779999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=302.35 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=203.4
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|..++++.+|+|.+...... .+.+.+|+.++++++|+|++++++++......+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4678999999999999999999888889999999765432 357889999999999999999999999888899999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ...+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++++|||+++.....
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999997643 234899999999999999999999 779999999999999999999999999998765421
Q ss_pred CCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
... .....++..|+|||.+.+..++.++||||||+++||++| |+.||........ ... .............
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~---~~~~~~~~~~~~~--- 229 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-LEQ---VERGYRMPRPPNC--- 229 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---HHcCCCCCCCCCC---
Confidence 111 112234568999999998889999999999999999999 9999865432111 111 0110111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 230 ----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 ----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1237789999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=310.69 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=199.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCC--EEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGK--VVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||.||+|... ++. .+++|.+...... ...+.|.+|++++.++ +|+||+++++++...+..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 56888999999999999999753 444 4577777643322 2346788999999999 8999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 246 LIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
+|+||+++|+|.++++.... ...+++.+++.++.|++.|++||| +.+++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 99999999999999975421 224789999999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 391 (468)
.+||+|||+++..... .......++..|+|||+..+..++.++|||||||++|||+| |..||........... .
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L 236 (303)
T ss_pred cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH----H
Confidence 9999999998643211 11111234567999999988889999999999999999998 9999865432211110 0
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
............. ..+.+++.+||+.+|++||++++++..+.++...
T Consensus 237 ~~~~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 PQGYRLEKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hcCCcCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000011111111 1267899999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.42 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=195.6
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+.. +++.||+|.+....... ....+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56888999999999999999754 67889999987544321 2345778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99975 8888776543 23788899999999999999999 789999999999999999999999999999765433
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--c------------cccccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--K------------NIKLID 393 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~------------~~~~~~ 393 (468)
........+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........... . .....+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 333334567899999998765 5688999999999999999999999965432110000 0 000000
Q ss_pred ccC---CCCCC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 394 LLD---PRLSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 394 ~~~---~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+ +.... ............+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 00000 000000001123668999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.90 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=198.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++...+..++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 4678888999999999999975 56889999998765432 2356778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++.+.+.++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999987543 3889999999999999999999 779999999999999999999999999998766433
Q ss_pred CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
........|+..|+|||++. ...++.++|||||||++|+|++|+.||............ .......+......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~-- 235 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQPPKLKDKM-- 235 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCCCCCcccccC--
Confidence 33334457899999999874 456889999999999999999999998543321111100 00000111111100
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... ..+.+++.+|+..+|++||++++++++
T Consensus 236 ~~~---~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 KWS---NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCC---HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011 126679999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=308.87 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=202.1
Q ss_pred hhCccccceeeeeCCceEEEEEc--------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+...||+|+||.||+|+. .++..||+|.+...... ...+.+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 46788899999999999999963 13457999998754322 2356788999999999 8999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
.....+++|||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 99999999999999999999975321 234788899999999999999999 78999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999999876432221 112235678999999988889999999999999999998 8888865432211
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.... ........... ....+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 249 ~~~~----~~~~~~~~~~~-------~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 249 FKLL----KEGHRMDKPAN-------CTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHH----HcCCcCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1100 00000001111 1123667999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=301.33 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=197.0
Q ss_pred ceeeeeCCceEEEEEcCC--C--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLPS--G--KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.|.+|++.+++++|+||+++++++.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 358999999999997533 3 36899999876653 346789999999999999999999999988 8899999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
++|+|.+++..... ..+++...+.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999976543 45899999999999999999999 789999999999999999999999999999876432211
Q ss_pred ---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 332 ---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 332 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||............ .. . ......+ .
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~---~-~~~~~~~--~-- 224 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DK---E-GERLERP--E-- 224 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hh---c-CCcCCCC--c--
Confidence 112346778999999998899999999999999999999 99998654322111110 00 0 0001100 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.....+.+++.+|++.+|++||++.++++.|.
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01123778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=302.61 Aligned_cols=255 Identities=30% Similarity=0.414 Sum_probs=199.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CC---CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SG---KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|+..+.||+|+||.||+|... ++ ..+|+|.+...... ...+.+..|++++.+++|+|++++.+++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 56888899999999999999764 23 37999988754322 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999987543 34899999999999999999999 789999999999999999999999999999765
Q ss_pred cCCCCCce---eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNRT---LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
........ ....+..|+|||++....++.++|||||||++||+++ |+.||........... +... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~----i~~~----~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA----INDG----FRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----HhcC----CCC
Confidence 43221111 1123457999999988889999999999999999998 9999864432111110 0000 010
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
+... .....+.+++.+||+.+|++||++.+|++.|.++
T Consensus 230 ~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 1112367899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=314.71 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=199.1
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..... ...+.+.+|+.++.++ +|+||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 36799999999999999999963 35788999999764432 2346788999999999 689999999988654
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcc-------------------------------------------------------
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------- 265 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 265 (468)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999999864311
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC--Ccee
Q 012219 266 ---------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTL 334 (468)
Q Consensus 266 ---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 334 (468)
...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 123678888999999999999999 78999999999999999999999999999976532211 1112
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
..++..|+|||.+.+..++.++||||||+++|||++ |..||............ .............. ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~ 310 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEGTRMRAPDYTT-------PE 310 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH---HhccCCCCCCCCCC-------HH
Confidence 235667999999988899999999999999999997 99998654322111110 00000011111111 12
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 414 VSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+.+++..||+.||++|||+.+++++|....
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=319.09 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=187.2
Q ss_pred eeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 178 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
||+|+||+||+|+. .+++.||+|++.............+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999975 46899999999754433323344556677777665 699999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99999887543 3889999999999999999999 78999999999999999999999999999876433333344
Q ss_pred eccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII 412 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
...||..|+|||++.+. .++.++|||||||++|||+||+.||........... .. .-...+.... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~--i~---~~~~~~~~~~---~~~--- 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN--IA---FGKVRFPKNV---LSD--- 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH--HH---cCCCCCCCcc---CCH---
Confidence 56799999999988754 588999999999999999999999865332111000 00 0011111110 111
Q ss_pred HHHHHHHhcccCCCCCCC----CHHHHHH
Q 012219 413 LVSTVAFSCLRSQPKSRP----TMQLVSN 437 (468)
Q Consensus 413 ~l~~l~~~cl~~dP~~RP----s~~~v~~ 437 (468)
.+.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 256789999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=306.80 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=201.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|++...||+|+||.||+|... ++..||+|.+...... ...+.|.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357889999999999999999753 4678999998755432 23467889999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDE-------------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISS 303 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 303 (468)
..++++||+++|+|.+++.... ....+++..++.++.|++.||+||| ..+++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence 9999999999999999986421 1234788899999999999999999 78999999999
Q ss_pred CceeeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccc
Q 012219 304 NNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSS 380 (468)
Q Consensus 304 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~ 380 (468)
+||+++.++.++|+|||+++....... .......+..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876532221 1112234567999999988899999999999999999998 8888864432
Q ss_pred cchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...... ....+. ...... ....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ~~~~~~--~~~~~~--~~~~~~-------~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYY--VRDGNV--LSCPDN-------CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH--HhcCCC--CCCCCC-------CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 211110 000000 001111 11237789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=306.08 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=203.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|+..+.||.|++|.||+|.. .+++.|++|.+...... ..+.+.+|+++++.++|+|++++++++...+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4688899999999999999964 67899999998754332 2456789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999988643 3889999999999999999999 789999999999999999999999999998876544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .....+.+..+ .
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~~~~~~~~~~--~--- 239 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNGTPELQNP--E--- 239 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcCCcccCCc--c---
Confidence 33333456888999999999888999999999999999999999998754322111100 00000111111 0
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhcCC
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIARNK 444 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~~~ 444 (468)
.....+.+++.+||..||++||++.+++ +.|.+...
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0111266789999999999999998888 45555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=300.38 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=200.8
Q ss_pred ceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.||+|+||.||+|.... +..+++|.+....... ..+.+.+|++.+..++|+|++++++++......++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 369999999999997643 8889999998765443 4578889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCcc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 252 EMGSLFCVLRTDEE------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 252 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
++++|.+++..... ...+++.+++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999987521 245899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 326 NFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 326 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... .......++..|+|||.+....++.++||||+|+++|||++ |..||........... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~ 231 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRKGYRLPKPEY 231 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCCCcc
Confidence 5432 12233457889999999988889999999999999999999 6999876532211111 111111111111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
. ...+.+++.+|++.+|++|||+.++++.|+
T Consensus 232 ~-------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 232 C-------PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C-------ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 123778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.36 Aligned_cols=200 Identities=28% Similarity=0.337 Sum_probs=168.1
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK---- 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 242 (468)
..++|.+.+.||+|+||.||++.. .+|+.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 357899999999999999999975 468999999997543221 23456779999999999999999999986543
Q ss_pred --EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 243 --CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 243 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
..++||||+++ +|...+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 56666542 2778888999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
+++.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 169 LARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred Ccccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9976432 22233456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=303.88 Aligned_cols=249 Identities=31% Similarity=0.456 Sum_probs=202.0
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||.|++|.||+|... +++.||+|.+...... .....+.+|+++++.++|+|++++++++......++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 5778889999999999999754 6889999998765422 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999998754 4899999999999999999999 7899999999999999999999999999998876443
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||++.+..++.++||||||+++|+|+||+.||.......... .......+..... . .
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~--~-~-- 223 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF----LIPKNNPPSLEGN--K-F-- 223 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH----HhhhcCCCCCccc--c-c--
Confidence 33444568889999999998889999999999999999999999987543211110 0111111111111 0 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+||..+|++|||+++++++
T Consensus 224 -~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 -SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1126678999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.98 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=202.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|.. .+++.+++|.+...... ..+.+.+|++++++++||||+++++++......+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5788899999999999999975 46788999999765433 3567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999987642 24889999999999999999999 779999999999999999999999999999766433
Q ss_pred CCCceeccccccccccccccCC---CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
........++..|+|||..... .++.++||||||+++|||+||+.||............ .......+....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~---- 228 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKSNFPPPKLKD---- 228 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCCCccccc----
Confidence 3233345688899999998776 8899999999999999999999998754322111110 000000111110
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.......+.+++.+||..+|.+|||+.+++.
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 -KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112234778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=300.39 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=200.0
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcch---hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET---EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
+|...+.||+|+||.||+|...+++.+|+|.+..... ......+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888899999998875432 1223346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997543 3788999999999999999999 77999999999999999999999999999876532
Q ss_pred CC------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 328 DS------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 328 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.. .......++..|+|||+..+..++.++||||||+++|+|++|+.||........... . .......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~~ 232 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-I-GAHRGLMPRLPD 232 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-h-hhccCCCCCCCC
Confidence 11 111234578899999999988899999999999999999999999975432211110 0 000011112222
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
... ..+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~-------~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 233 SFS-------AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC-------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 12667999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.80 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=198.5
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+....||+|++|.||+|+.. +++.||+|++....... ...+.+.+|++++++++|+|++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 36888899999999999999765 68999999986543211 22356789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|..++.... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887765433 3899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc-----------------
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK----------------- 390 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~----------------- 390 (468)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||...............
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 323334457889999998865 56788999999999999999999998754321110000000
Q ss_pred --cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 --LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 --~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....++....+...........+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000000000111337789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=298.86 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=203.0
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|+||.||.++. .+++.+++|.+....... ...+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 477889999999999999964 568899999987554332 335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... ...+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999997653 234889999999999999999999 7799999999999999999999999999998765443
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||........... .......... . .
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~-------~~~~~~~~~~-~---~ 224 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK-------IVQGNYTPVV-S---V 224 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHcCCCCCCc-c---c
Confidence 333445689999999999888889999999999999999999999875332111100 0011111110 1 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
....+.+++.+||+.+|++||++.++++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112266789999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=303.86 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=196.6
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|++.+.||+|+||.||+|... ++..+++|.+...... ..+.+.+|+++++.++|+|++++++++...+..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 567788999999999999765 5778899988654432 356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++++|..++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999998876532 34899999999999999999999 78999999999999999999999999999876543333
Q ss_pred Cceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 331 NRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
......++..|+|||++. ...++.++|||||||++|||++|+.||............ .....+.... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~--~~ 232 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI----AKSEPPTLAQ--PS 232 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH----hhcCCCCCCC--cc
Confidence 333456889999999874 345778999999999999999999998754322111110 0001111111 01
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
... ..+.+++.+||+.+|++||++.+++++-
T Consensus 233 ~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 233 RWS---SEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccC---HHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111 2267899999999999999999988543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.87 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=198.6
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|++.+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+++++.++|+|++++++++..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 56888999999999999999764 5889999998765432 3567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|..++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999988876533 23889999999999999999999 789999999999999999999999999998764333
Q ss_pred CCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 SSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
........++..|+|||++. ...++.++|||||||++|||++|+.||........... ......+....+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~- 238 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEPPTLSQP- 238 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH----HhcCCCccCCCC-
Confidence 33334456888999999885 34568899999999999999999999865432111110 011111111110
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... ...+.+++.+||+.+|++||++.+++++
T Consensus 239 -~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 -SKW---SMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -ccc---CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011 1126678999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=308.74 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=202.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... ....+|+|.+...... .....+..|+++++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 467889999999999999999642 3457899998754332 2356788999999999 6999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
.....++++||+++|+|.+++..... ...+++.++..++.|++.||.||| +.+++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence 98999999999999999999965321 234889999999999999999999 78999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999997654221111 11224467999999988889999999999999999999 8999865432111
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
... ............. ...+.+++.+||+.+|++|||+.++++.|.+...
T Consensus 246 ~~~----~~~~~~~~~~~~~-------~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKL----LREGHRMDKPSNC-------THELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH----HHcCCCCCCCCCC-------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 100 0000001111111 1126679999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=305.77 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=201.7
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFC 238 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 238 (468)
.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|++...... ...+.+|+.++..+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 3455556778999999999999999999965 46889999988653322 24677899999999 699999999988
Q ss_pred e-----eCCEEEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 239 L-----HRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 239 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
. ..+..++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence 4 3456899999999999999876421 2234788999999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
.++|+|||+++.............|+..|+|||++.. ..++.++|||||||++|||++|+.||...........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~- 240 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK- 240 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-
Confidence 9999999999876543333344568999999998753 4578899999999999999999999875432111110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
......+....+ ... ...+.+++.+||+.||++|||+.+++++.
T Consensus 241 ---~~~~~~~~~~~~--~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 ---IPRNPPPTLHQP--ELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---ccccCCCcccCC--CCc---CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000011111100 000 11266799999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.01 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=189.1
Q ss_pred eeeeeCCceEEEEEcCC---CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGSVYRARLPS---GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.||+|+||.||+|...+ +..+|+|.+...... .....|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999999999997543 457999988765432 2335788999999999999999999999998889999999999
Q ss_pred CChhhhhhcCcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC-
Q 012219 254 GSLFCVLRTDEE--AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS- 330 (468)
Q Consensus 254 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 330 (468)
|+|.+++..... ....++..+..++.|++.|+.||| +.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975332 234677788899999999999999 78999999999999999999999999999875432221
Q ss_pred -CceeccccccccccccccCC-------CCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhh-cccccccccCCCCC
Q 012219 331 -NRTLLAGTYGYIAPELAYTM-------VVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD-KNIKLIDLLDPRLS 400 (468)
Q Consensus 331 -~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 400 (468)
......++..|+|||++... .++.++||||||+++|||++ |+.||........... .........++...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 11223567889999988642 35789999999999999996 9999975433211111 00111111122222
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.... + .+.+++..|+ .+|++|||+++|...|.
T Consensus 237 ~~~~----~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLS----D---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC----h---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 1 2556888898 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=297.91 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=208.6
Q ss_pred hCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||.|.-|+||.+++.+ +..+|+|++.+........+.....|-++|+.++||.+..+|+.+..++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467778899999999999998765 5899999999888776677788889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC-
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF- 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~- 327 (468)
|||+||+|....+++.. ..+++..+.-++..|.-||+||| -.|||.|||||+|||+.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999887654 44899999999999999999999 88999999999999999999999999998744310
Q ss_pred --------------------------------C-C----------------------CCceeccccccccccccccCCCC
Q 012219 328 --------------------------------D-S----------------------SNRTLLAGTYGYIAPELAYTMVV 352 (468)
Q Consensus 328 --------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~~~ 352 (468)
. . .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00112468999999999999999
Q ss_pred CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC-
Q 012219 353 TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT- 431 (468)
Q Consensus 353 ~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs- 431 (468)
+.++|.|+|||++|||+.|+.||.......- ...++...+.-+... .......+||.+.|.+||++|..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999986543221 112222222211111 12233778999999999999998
Q ss_pred ---HHHHHHH
Q 012219 432 ---MQLVSNE 438 (468)
Q Consensus 432 ---~~~v~~~ 438 (468)
+.||.++
T Consensus 383 ~rGA~eIK~H 392 (459)
T KOG0610|consen 383 KRGAAEIKRH 392 (459)
T ss_pred ccchHHhhcC
Confidence 8888854
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=301.99 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=191.9
Q ss_pred ceeeeeCCceEEEEEcCC-CC--EEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLPS-GK--VVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.||+|+||.||+|...+ +. .+++|.++..... ...+.+.+|++++.++ +||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999998643 43 4688888743322 2345788999999999 7999999999999999999999999
Q ss_pred cCCChhhhhhcCc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 252 EMGSLFCVLRTDE-------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 252 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECC
Confidence 9999999987532 1224789999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCC
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
||++...... ........+..|+|||++....++.++|||||||++|||++ |..||........... .......
T Consensus 156 fgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~ 230 (270)
T cd05047 156 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LPQGYRL 230 (270)
T ss_pred CCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----HhCCCCC
Confidence 9998532211 11111223567999999988889999999999999999997 9999865432111100 0000000
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
....... ..+.+++.+|++.+|.+|||+.+++..|.++
T Consensus 231 ~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 231 EKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCcCC-------HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111111 1267899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=300.79 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=199.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh------hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE------ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
+|.+...||+|++|.||+|.. .+++.+|+|.+...... .....+.+.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999965 46889999988654322 12234678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++++||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997643 3788899999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC
Q 012219 324 LLNFDSS------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 324 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~ 230 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGENASP 230 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhccCCC
Confidence 7642211 1122357889999999998889999999999999999999999997543221111 11111122
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
....... ..+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 EIPSNIS-------SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCcccC-------HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 2222111 22667899999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=311.62 Aligned_cols=257 Identities=25% Similarity=0.299 Sum_probs=194.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++... +++.+|+|++.............|.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999764 57889999997544333334556889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976332 3788899999999999999999 789999999999999999999999999998765332
Q ss_pred CCC-ceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 329 SSN-RTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||........... ... ..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~-i~~--~~~~~~~p~~ 232 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMN--HKERFQFPAQ 232 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH-HhC--CCccccCCCc
Confidence 222 22356999999999886 34678899999999999999999999975432111100 000 0000011111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
.. .... .+.+++.+|+..++.+ ||++++++++
T Consensus 233 ~~-~~s~---~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 VT-DVSE---DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-cCCH---HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 1111 2556777877554444 7899999866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.51 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=201.6
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|+..+.||+|+||.||+|.. .++..||+|.+...... ...+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 466778899999999999975 46889999998754432 235678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++... .+++.+...++.|++.||+||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999998643 3788899999999999999999 7899999999999999999999999999997764433
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||++.+..++.++|||||||++|||+||+.||.......... .......+.... .
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~---~ 224 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------LIPKNNPPTLTG---E 224 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------hhhcCCCCCCch---h
Confidence 33334567889999999988889999999999999999999999987543211111 111111111111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
....+.+++.+||+.+|++||++.+++.+-.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 2234778999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=311.36 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=203.3
Q ss_pred hhCccccceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
..+|.+.+.||+|+||.||+++.. .+..||+|.+...... ...+.+.+|++++.++ +|+||++++++|.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 356889999999999999999642 1236899988754322 2356788999999999 7999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
..+..++++||+++|+|.+++.... ....+++.+++.++.|++.||+||| +.+++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence 9999999999999999999987532 1234788999999999999999999 78999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999997654322111 11233567999999999999999999999999999998 8899865432221
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
.... ............ ...+.+++.+||+.+|++||++.++++.|.++....
T Consensus 246 ~~~~----~~~~~~~~~~~~-------~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FKLL----KEGHRMDKPANC-------THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHH----HcCCCCCCCCCC-------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1110 000001111111 123678999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=305.87 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=202.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++...+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 6788999999999999999975 57999999999754433 2356789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999998643 3788999999999999999999 789999999999999999999999999999776544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........+++.|+|||...+..++.++|||||||++|++++|+.||........... ....-.+.... ..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~~~~~~~--~~--- 239 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGTPELQN--PE--- 239 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCCCCCCCC--cc---
Confidence 3333445688899999999988899999999999999999999999864322111000 00000011110 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
.....+.+++.+||+.+|++||++.++++ .|.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 273 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence 11122667899999999999999999985 3443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.89 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=204.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||.|+||.||+|.. .++..+++|++....... ..+.+.+|++.++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 3688899999999999999974 468899999997554332 4577899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|++++++|.++++.......+++.....++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999976443345899999999999999999999 789999999999999999999999999999776543
Q ss_pred CCC----ceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 SSN----RTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... .....++..|+|||++... .++.++|||||||++|||++|+.||............. ....+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~ 231 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QNDPPSLETGA 231 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cCCCCCcCCcc
Confidence 222 1334688899999998876 78999999999999999999999997554321111100 00111111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .......+.+++.+|++.||++||++.+++.+
T Consensus 232 ~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 232 D--YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred c--cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00111236789999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=314.46 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=205.8
Q ss_pred hhCccccceeeeeCCceEEEEEcC---CC--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP---SG--KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.+......+||+|.||.||+|.+. .| -.||||.-+.+...+ ..+.|..|..+|+.++||||++++|+|.+. .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 344556678999999999999642 23 358899888766554 357899999999999999999999999875 5
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++|||.++.|.|..+|+.++.. ++......++.||+.||+||| +..+|||||.++|||+....-||++|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 79999999999999999887654 788888999999999999999 8899999999999999999999999999999
Q ss_pred cccCCCCCcee-ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 324 LLNFDSSNRTL-LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 324 ~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.+..+.+.... ..-+..|||||.+.-.+++.+||||-|||.+||++. |..||........ .-.+...-+.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I~~iEnGeRl 611 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------IGHIENGERL 611 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------EEEecCCCCC
Confidence 98765554433 223568999999999999999999999999999997 9999986543211 1111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+.+. .+...++.++.+||..||.+||++.++...|..+.
T Consensus 612 P~P~---nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 612 PCPP---NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCC---CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1111 22334778999999999999999999988776553
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=312.03 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=196.4
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+++.. +++.||+|++.............+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999754 67889999997644333344566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976332 3788899999999999999999 789999999999999999999999999999776433
Q ss_pred CCC-ceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 329 SSN-RTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||......... ....... ....+...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~i~~~~--~~~~~p~~ 232 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKIMNHE--ERFQFPSH 232 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-HHHHcCC--CcccCCCc
Confidence 222 223569999999998875 46788999999999999999999999754321110 0000000 00011111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
... . ...+.+++.+|+..++.+ |+++++++++
T Consensus 233 ~~~-~---~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 ITD-V---SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccc-C---CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 110 1 122566888888765544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=305.82 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=198.8
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|+..+.||+|+||.||+|.. .++..||+|.+...... ...+.+.+|++++++++|+||+++++++......++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 355667899999999999965 46788999998754433 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++++|||++.......
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999988642 3789999999999999999999 7899999999999999999999999999997765333
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||++.+..++.++|||||||++|||+||+.|+........... ......+.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~------- 224 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPKNSPPTLEGQ------- 224 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhcCCCCCCCcc-------
Confidence 233334678899999999988899999999999999999999999864332111110 001111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11236789999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=298.74 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=199.4
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.+|++.+.||+|+||.||++.+.++..+|+|.+...... ...|.+|++++++++|||++++++++......++++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 467888999999999999998877889999998754432 3568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++..... .+++..+..++.+++.|++||| +.+++|+||||+||+++.++.++|+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999999875432 3788999999999999999999 7799999999999999999999999999987653221
Q ss_pred CC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 SN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||........... .........+...
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~------- 226 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRLYKPRLA------- 226 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCCCCCCCC-------
Confidence 11 112234568999999998889999999999999999998 9999875332111110 0000111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
...+.+++.+||+.+|++|||+.++++.|
T Consensus 227 ---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 ---SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 12377899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=299.74 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=200.9
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||++...++..+|+|.+..... ..+.|.+|++++++++|+|++++.+++.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 357889999999999999999987888899998875432 24578899999999999999999999887 6789999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999997643 234788999999999999999999 779999999999999999999999999999765422
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. ......++..|+|||++....++.++|||||||++|+++| |+.||........... ............
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~---- 227 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LERGYRMPRPEN---- 227 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HhCCCCCCCccc----
Confidence 21 1112335677999999988889999999999999999999 9999875432211100 000000001111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
....+.+++.+|++.+|++||++.++...|..
T Consensus 228 ---~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 228 ---CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11236789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=298.46 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=199.4
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 248 (468)
.|++.+.||+|++|.||++.. .+++.+|+|++....... ...+.+.+|++++++++|+|++++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 477889999999999999975 457899999987543322 234568899999999999999999998764 44679999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ...+++.+++.++.+++.|+++|| +.+++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999997543 234899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........+++.|+|||+..+..++.++||||||+++++|++|+.||........... .....-+......+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---- 227 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKLPPMPKDYS---- 227 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCCCCCccccC----
Confidence 3333445688999999999999999999999999999999999999874332111100 00000011111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+|++.+|++||++.+++++
T Consensus 228 ---~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 228 ---PELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 237789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=301.77 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=200.4
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.+|++.. .+|+.||+|.+....... ...+++.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 477889999999999999964 578999999987543222 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++..... ..+++.+++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999998875332 24788999999999999999999 7899999999999999999999999999997664333
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......|++.|+|||+..+..++.++|||||||++++|++|+.||........... ......+......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~~~~~~~------ 225 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSYPPVSSHY------ 225 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCCCCCcccC------
Confidence 333334578899999999988899999999999999999999999864322111000 0000001111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+||+.+|++||++.+|+++
T Consensus 226 -~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 -SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1226789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=305.63 Aligned_cols=261 Identities=26% Similarity=0.326 Sum_probs=190.6
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEee-----C
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCLH-----R 241 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 241 (468)
+|.+.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 477889999999999999975 468899999987543221 1123455677766655 79999999998864 3
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
...++++||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 45799999997 488888865432 34889999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--------cccc--
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--------NIKL-- 391 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~--------~~~~-- 391 (468)
++..... .......++..|+|||++.+..++.++||||+||++|||++|++||............ ....
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 9876422 2223346789999999999889999999999999999999999998643321100000 0000
Q ss_pred -c----cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 392 -I----DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 392 -~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ....+................+.+++.+|++.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000000000001111236789999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.27 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=209.3
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|.+..+||+|+||+||++-+ .+|+.+|+|.+.-+. .+++...|+.+|++.+.+++|++||.+.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 66778899999999999954 579999999987543 357888999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
|..|+..+.++.... ++.+.++..++...++||+||| ...-+|||||+.|||++.+|.+|++|||.|-.+...-.
T Consensus 110 CGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999986543 4899999999999999999999 66789999999999999999999999999987765444
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......||+.|||||++..-.|+.++||||+|+...||..|++||.++...+..+. +.....|.+..+ . .-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----IPT~PPPTF~KP--E---~W 255 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----IPTKPPPTFKKP--E---EW 255 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe----ccCCCCCCCCCh--H---hh
Confidence 55667899999999999999999999999999999999999999987654332221 111112222221 1 22
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 411 IILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
...+.+++.+|+-+.|++|-|+.+++++-+-.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 23478899999999999999998888765543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=300.88 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=199.1
Q ss_pred hCccccceeeeeCCceEEEEEcCC-C---CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
.+|.+.+.||+|+||.||+|.... + ..||+|.+...... ...+.|..|+.+++.++||||+++++++......+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 357888999999999999997642 3 36999998764322 23568999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|+||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++++|||+++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999987643 24889999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCCc---eecc--ccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCC
Q 012219 326 NFDSSNR---TLLA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 326 ~~~~~~~---~~~~--g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
....... .... .+..|+|||++....++.++|||||||++||+++ |..||.......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i~~~~~~~~ 232 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AIEQDYRLPP 232 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HHHcCCcCCC
Confidence 4322111 1111 2357999999998899999999999999999987 999986543221110 0001111011
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.... ...+.+++.+||+.+|.+||++++++..|.+.
T Consensus 233 ~~~~-------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 PMDC-------PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cccC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 12366799999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.73 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=199.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||++.. .++..+|+|.+...... .....+.+|++++.+++||||+++++++..++..++|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 3688899999999999999975 46788999988754322 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++..+..++.|+++||.|||+ ..+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999997643 37889999999999999999994 258999999999999999999999999998765321
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC-----------
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP----------- 397 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 397 (468)
......++..|+|||+..+..++.++||||||+++|||++|+.||.....................+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2233568899999999988889999999999999999999999986432111100000000000000
Q ss_pred -----------------CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 398 -----------------RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 398 -----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
...+..... .....+.+++.+||..+|++|||+.+++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSG--AFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000000000 01123778999999999999999999996643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=303.64 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=198.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||++... +++.||+|.+...... .....+.+|++++++++|+||+++++++...+..++|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 35788899999999999999764 7899999988754322 23467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|..++........+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999988764333458999999999999999999994 358999999999999999999999999998765322
Q ss_pred CCCceeccccccccccccccCC------CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 329 SSNRTLLAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......... ...........+.....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDPPTLPSG 233 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCCCCCCcc
Confidence 22234578899999988554 3578999999999999999999998653321111 10001111111122221
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ...+.+++.+|++.+|++||++++++++
T Consensus 234 ~-------~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 234 Y-------SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred c-------CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 1226679999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.28 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=192.3
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----EE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-----CM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 244 (468)
.|...+.+|.|+||.||+|... ++..||||+...+.... .+|+++|+.++|||||++.-++.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 4666789999999999999764 46899999987665432 27999999999999999988886532 24
Q ss_pred EEEEEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeecccc
Q 012219 245 FLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA 322 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~ 322 (468)
.+|||||+. +|...++.. .....++...+.-+..||++||+||| +.+|+||||||+|+|+|.+ |.+||+|||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 589999986 898888742 12234777777889999999999999 7899999999999999988 99999999999
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------c
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------K 387 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------~ 387 (468)
+.+...... .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|...+....... .
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 998654444 55567899999998876 4799999999999999999999998875433211000 0
Q ss_pred -ccccccccCCCCCCccch--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhc
Q 012219 388 -NIKLIDLLDPRLSPPVDQ--KIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIAR 442 (468)
Q Consensus 388 -~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~ 442 (468)
.....+.-.+.+...... ..........+++.+++..+|.+|.++.|++ +.++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 000011111222211110 0011112367899999999999999997777 444443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.60 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=188.1
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------ 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 241 (468)
..+|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 45799999999999999999975 4688999998864321 234799999999999999999876432
Q ss_pred --CEEEEEEEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEe
Q 012219 242 --KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVA 317 (468)
Q Consensus 242 --~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~ 317 (468)
...++||||+++ ++.+++... .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 246799999985 777666432 22345889999999999999999999 78999999999999999664 79999
Q ss_pred eccccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc-------
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------- 389 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------- 389 (468)
|||+++.+.... ......|++.|+|||++.+ ..++.++|||||||++|||+||++||..............
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998764322 2233568999999998765 4689999999999999999999999975432111000000
Q ss_pred -cc----ccccCCCCCCccchhHHH-----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 -KL----IDLLDPRLSPPVDQKIRQ-----DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 -~~----~~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. ....+..+.......... ....+.+++.+||+.||.+|||+.+++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000000000000000000 11237789999999999999999998843
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=309.75 Aligned_cols=201 Identities=19% Similarity=0.315 Sum_probs=165.8
Q ss_pred ccceeeee--CCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 174 IKYCIGTG--GYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 174 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
+.+.||+| +|++||++.. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45679999 6889999965 578999999997654322 2345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999865432 23889999999999999999999 78999999999999999999999999986544321111
Q ss_pred -------CceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 331 -------NRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 331 -------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 1112346778999999875 468899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.84 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=201.5
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.+|.+.+.||+|+||.||+|... +|. .+|+|.+...... .....+.+|+.++++++|+|+++++++|.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 56888899999999999999753 232 5899988765432 234678899999999999999999999987 678
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+++|+|.+++..... .+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999976433 3889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCCcee--ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.......... ..++..|+|||......++.++||||||+++||+++ |+.||+........... .. .. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~-~~--~~~~~~ 234 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-EK-GE--RLPQPP 234 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hC-CC--CCCCCC
Confidence 6432221111 123567999999988889999999999999999999 99998764432111100 00 00 000111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
... ..+.+++.+||..+|++||++.++++.|.+..+.
T Consensus 235 ~~~-------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 235 ICT-------IDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 1266789999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.52 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=199.0
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--C
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--K 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 242 (468)
..|.+.+.||+|+||.||.+.. .++..||+|.++..... .....+.+|++++++++|||++++.+++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3467888999999999999963 35788999998755432 2346789999999999999999999998875 5
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++++|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 68999999999999999865432 4799999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh----cc---cccc
Q 012219 323 RLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD----KN---IKLI 392 (468)
Q Consensus 323 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~----~~---~~~~ 392 (468)
+........ .....++..|+|||+..+..++.++||||||+++|||+|++.|............ .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876432221 1223466789999999888899999999999999999998876432111000000 00 0000
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+......+.... ....+.+++.+|++.+|++|||+.++++.++++
T Consensus 237 ~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLPRPPN---CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCCCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000000011 112377899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.61 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=200.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||++.. .+++.+|+|++...... ...+.+.+|+++++.++||||+++++++......++|+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 5678889999999999999975 46889999988754332 23467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++...+ .+++.....++.+++.||.|||+ ..+++||||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999887543 38899999999999999999994 358999999999999999999999999998654321
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc----ccccccc---CCCCCC
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN----IKLIDLL---DPRLSP 401 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~---~~~~~~ 401 (468)
......|+..|+|||++.+..++.++|||||||++|+++||+.||............. ....... .+.+..
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 1223468999999999988889999999999999999999999997543210000000 0001111 111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
. .....+.+++.+|++.||++|||+.+++++.
T Consensus 236 ~------~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 236 S------DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred h------hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 1112377899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.63 Aligned_cols=200 Identities=26% Similarity=0.322 Sum_probs=168.5
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR----- 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 241 (468)
..++|.+.+.||+|+||.||++.. ..++.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 457899999999999999999975 468899999997643322 2345677899999999999999999988643
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
...++||||+++ ++.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 347999999975 66666642 2788889999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
+++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765422 2223456899999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.39 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=200.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .++..+|+|.+...... ..+.|.+|++++++++|+|++++++++..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 45688899999999999999976 46889999998755432 346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++..... .+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999999999875432 4889999999999999999999 78999999999999999999999999999876544
Q ss_pred CCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 328 DSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.........++..|+|||++. ...++.++||||||+++|||++|+.||.......... .......+.+..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~- 230 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL----KILKSEPPTLDQ- 230 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH----HHhcCCCCCcCC-
Confidence 333344456889999999874 3457789999999999999999999987543221111 011111111111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ..+.+++.+||+.+|.+||++.+++++
T Consensus 231 -~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 -PSKWS---SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -cccCC---HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01111 126678999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=303.29 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=203.1
Q ss_pred hCccccceeeeeCCceEEEEEcC-----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RK 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 242 (468)
++|.+.+.||+|+||.||+|.+. ++..+|||++...... ...+.|.+|+++++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 45777889999999999999753 4688999999866543 345689999999999999999999999887 55
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++++||+++++|.+++..... .+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 78999999999999999976543 4899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCCce---eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-------hcccccc
Q 012219 323 RLLNFDSSNRT---LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-------DKNIKLI 392 (468)
Q Consensus 323 ~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-------~~~~~~~ 392 (468)
........... ...++..|+|||...+..++.++||||||+++|||+||+.|+.......... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 87652222111 1234567999999988899999999999999999999999976432211000 0000011
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
+.+......+... .....+.+++.+||+.+|++|||+.+|+++|.++
T Consensus 237 ~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPP---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCc---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111111 1113477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=297.16 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=185.5
Q ss_pred ceeeeeCCceEEEEEcCC-------------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 176 YCIGTGGYGSVYRARLPS-------------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
+.||+|+||.||+|.+.+ ...|++|++..... .....|.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 358999999999997532 23588898765432 23457889999999999999999999999988
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-------eE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-------AF 315 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-------~k 315 (468)
..+++|||+++|+|..++.... ..+++..++.++.||+.||+||| +.+|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 8999999999999998886543 23889999999999999999999 889999999999999987664 89
Q ss_pred EeeccccccccCCCCCceecccccccccccccc-CCCCCccchhhHHHHHHHHHH-hCCCCCCcccccchhhhccccccc
Q 012219 316 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
++|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+........... ..
T Consensus 153 l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-----~~ 223 (262)
T cd05077 153 LSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-----YE 223 (262)
T ss_pred eCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-----Hh
Confidence 999999865432 12245788899999886 467899999999999999998 58888764321111000 00
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
. ......+. ...+.+++.+||+.||.+||++.++++.+
T Consensus 224 ~-~~~~~~~~-------~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 G-QCMLVTPS-------CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c-CccCCCCC-------hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00111111 12367899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.64 Aligned_cols=259 Identities=24% Similarity=0.262 Sum_probs=193.9
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----EE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-----CM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 244 (468)
+|++.+.||+|+||.||++.. .+++.||+|++...... ....+.+.+|+++++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 477889999999999999975 57899999998654222 123467889999999999999999999998776 78
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+. ++|.+.+.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 57887775433 3899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCC-CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc-------------
Q 012219 325 LNFDS-SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------------- 389 (468)
Q Consensus 325 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------------- 389 (468)
..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHH
Confidence 54322 122334578899999998764 5789999999999999999999999754321100 0000
Q ss_pred ---cccccc-CCCCCCccchh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 ---KLIDLL-DPRLSPPVDQK----IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 ---~~~~~~-~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+ ......+.... .......+.+++.+|++.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 00000000000 00001236789999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.16 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=189.1
Q ss_pred ceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEEEEEEEe
Q 012219 176 YCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCMFLIYEY 250 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 250 (468)
+.||+|+||.||+|... +...+|+|.+...... ...+.+.+|+.+++.++|||++++++++.. ++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 35899999999999753 2457999988643322 235678899999999999999999998764 5567899999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+.+|+|.+++..... ..++..++.++.|++.||+||| ..+++||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999975432 2677888999999999999999 77999999999999999999999999999976532111
Q ss_pred ----CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhC-CCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 331 ----NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMG-KHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 331 ----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
......++..|+|||+..+..++.++|||||||++|||++| .+||.......... .......+....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~---- 225 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV----YLLQGRRLLQPE---- 225 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhcCCCCCCCC----
Confidence 11123456789999999888999999999999999999995 55665432211100 000000011111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.. ...+.+++.+||+.+|++||++.+++..|++.
T Consensus 226 ~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 226 YC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred cC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 11367899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.88 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=201.6
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFC 238 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 238 (468)
+..++..++++|.+.+.||+|+||.||++.. .+++.+|+|++...... ...+.+|+.++.++ +|||++++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 4455556678999999999999999999975 57889999998654322 24567899999998 899999999998
Q ss_pred eeC-----CEEEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 239 LHR-----KCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 239 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
... +..++|+||+++|+|.++++... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 753 35899999999999999886421 2234889999999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCC-----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
.+||+|||++..............++..|+|||++... .++.++|||||||++|||++|+.||...........
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~- 244 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK- 244 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH-
Confidence 99999999998764333333345688899999987643 368899999999999999999999875432211111
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+.+..+ . +....+.+++.+||+.+|++||++.+++++
T Consensus 245 ---~~~~~~~~~~~~--~---~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 ---IPRNPPPTLLHP--E---KWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HhcCCCCCCCcc--c---ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000111110 0 111237789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=306.80 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=195.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+.. +++.||+|.+...... .....+.+|+++++.++|+||+++++++...+..++|+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 56889999999999999999754 6889999998754332 12345778999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++ ++|.+++..... .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 589888865432 3788999999999999999999 789999999999999999999999999999765433
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--c------cccccc------
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--K------NIKLID------ 393 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~------~~~~~~------ 393 (468)
........+++.|+|||.+.+ ..++.++|||||||++|||+||+.||........... . ......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 333334457889999998765 4578899999999999999999999875432110000 0 000000
Q ss_pred ccC---CCCCCccchhH-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 394 LLD---PRLSPPVDQKI-RQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 394 ~~~---~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
... +.......... ......+.+++.+|++.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000000000 000113678999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=315.27 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=208.7
Q ss_pred ccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|.-...||.|+||.||-++ ..+...||||++.....+.....+++..|+..|.+++|||++.+.|+|....+.||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445679999999999996 467889999999877766556667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
|- ||-.|.+...++ ++.+.++..|..+.+.||+||| +.+.||||||+.|||+++.|.|||+|||.|....+
T Consensus 108 Cl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred Hh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 95 688888876554 4888899999999999999999 78999999999999999999999999999977643
Q ss_pred Cceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 331 NRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
...++|||.|||||++. .+.|+-++||||+||+..||.-.++|+-.+....... .+.+.-.|.+.... +
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY----HIAQNesPtLqs~e---W 250 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPTLQSNE---W 250 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH----HHHhcCCCCCCCch---h
Confidence 34578999999999875 5689999999999999999999999965443322211 11122234444332 2
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
.. .+.+++.+||++-|.+|||.++++.+-+-....|
T Consensus 251 S~---~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 251 SD---YFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HH---HHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 22 2778999999999999999999998877665543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.44 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=186.2
Q ss_pred eeeeeCCceEEEEEcCC---CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGSVYRARLPS---GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.||+|+||.||+|...+ ...+++|.+...... .....|.+|++.++.++|+||+++++++......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996433 456888877654332 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 254 GSLFCVLRTDEE--AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 254 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
|+|.+++..... ....++...+.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 223467788899999999999999 789999999999999999999999999998654322111
Q ss_pred --ceeccccccccccccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc-ccccccccCCCCC
Q 012219 332 --RTLLAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK-NIKLIDLLDPRLS 400 (468)
Q Consensus 332 --~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 400 (468)
.....++..|+|||+... ..++.++|||||||++|||++ |..||............ .........+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 122345678999998643 356889999999999999999 88888654322111110 1111111122222
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.... ..+.+++..|+ .||++|||+++|++.|
T Consensus 237 ~~~~-------~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 237 LKYS-------DRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCC-------HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2211 12445777888 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.59 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=202.0
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchh-----hhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETE-----ELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
-+.|.-.+.||.|..++|-++. ..+|+.+|+|++...... .....++-.+|+++++++ .||+|+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3567778899999999998885 457889999988643221 122345667899999998 599999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
...++|+|.|+.|.|.++|... ..+++.+..+|+.|+..|++||| ...||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999754 34899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccccccccc------CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAY------TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++.+. .+......+||++|+|||.+. ...|+..+|+||.|||||-|+.|.+||...........-...-
T Consensus 170 a~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk---- 244 (411)
T KOG0599|consen 170 ACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK---- 244 (411)
T ss_pred eeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc----
Confidence 99886 445566779999999999875 2368889999999999999999999986432211100000011
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
-.+..+.+. +......+++.+|++.||.+|.|++|++.+
T Consensus 245 -yqF~speWa---dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 -YQFRSPEWA---DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -cccCCcchh---hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 112222222 222336679999999999999999888843
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.81 Aligned_cols=238 Identities=26% Similarity=0.349 Sum_probs=184.2
Q ss_pred eeeeeCCceEEEEEcC-------------------------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce
Q 012219 177 CIGTGGYGSVYRARLP-------------------------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 231 (468)
.||+|+||.||+|.+. ....|++|++..... .....|.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999642 123588998865432 234578899999999999999
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
++++++|......++||||+++|+|..++..... .+++..++.++.||++||+||| +.+|+||||||+||+++.+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 9999999999999999999999999999865332 4788999999999999999999 7899999999999999765
Q ss_pred C-------CeEEeeccccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHH-hCCCCCCcccccc
Q 012219 312 L-------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSS 382 (468)
Q Consensus 312 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~-tg~~p~~~~~~~~ 382 (468)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3 3799999988643211 22356788999998865 56899999999999999995 6999986543211
Q ss_pred hhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.... .. .......+.. ..+.+++.+||+.+|++|||+.++++.|
T Consensus 230 ~~~~-----~~-~~~~~~~~~~-------~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERF-----YE-KKHRLPEPSC-------KELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH-----HH-hccCCCCCCC-------hHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1000 00 0011111111 1267799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.61 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=196.6
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCM 244 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 244 (468)
..++|.+.+.||+|+||+||++.. .++..+|+|.+....... .....|..|+.++.+++|||||++++++.. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 456899999999999999999975 457789999887543322 234678899999999999999999998854 4568
Q ss_pred EEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCceeeCCC--------
Q 012219 245 FLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDC----TPPIVHRDISSNNVLLNSE-------- 311 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~ivH~dlk~~NIll~~~-------- 311 (468)
++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||... ..+|+||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987532 2235899999999999999999999532 1469999999999999642
Q ss_pred ---------CCeEEeeccccccccCCCCCceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccc
Q 012219 312 ---------LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSS 380 (468)
Q Consensus 312 ---------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~ 380 (468)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 358999999998764322 2234578999999998854 4588999999999999999999999975432
Q ss_pred cchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
........ ... +.+.. ... ...+.+++..||+.+|.+||++.+++.
T Consensus 249 ~~qli~~l---k~~--p~lpi--~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQLISEL---KRG--PDLPI--KGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHH---hcC--CCCCc--CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21111110 000 11111 000 122678999999999999999999984
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.26 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=194.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch--hhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET--EELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 244 (468)
.+|...+.||+|+||.||+|.. .+++.|++|++..... ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999975 4689999998864421 122345678899999999999999999998875 3568
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++++|.+++.... .+++...+.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997543 3788999999999999999999 78999999999999999999999999999876
Q ss_pred ccCCC---CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||............ ......+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 232 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTNPQLPS 232 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH---hcCCCCCCCch
Confidence 53211 1122345788999999999888999999999999999999999999754322111110 01111122221
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
... +. +..++ +||..+|++||+++++++
T Consensus 233 ~~~----~~---~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 233 HIS----EH---ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcC----HH---HHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 21 33444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.26 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=196.0
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCC
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGS 255 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 255 (468)
+.||+|+||.||++...+++.||+|.+...... ...+.|.+|++++++++|+||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999998777999999998765443 234678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc--e
Q 012219 256 LFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR--T 333 (468)
Q Consensus 256 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~ 333 (468)
|.+++..... .+++..++.++.+++.||.||| +.+++||||+|+||+++.++.++|+|||+++......... .
T Consensus 79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999875432 3788999999999999999999 7799999999999999999999999999997653211111 1
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII 412 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (468)
....+..|+|||.+.+..++.++||||||+++|||+| |..||........... +........... ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~--------~~~~~~~~~~~~---~~~ 222 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER--------IESGYRMPAPQL---CPE 222 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH--------HhcCCCCCCCcc---CCH
Confidence 1223567999999988889999999999999999999 8888865432111110 000000001111 112
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 413 LVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 413 ~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.35 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=201.1
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+...||+|+||.||+|+.. +.+.+++|.+...... ...+.|.+|++++++++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 56888899999999999999753 3567999988754432 235678899999999999999999999999889
Q ss_pred EEEEEEeccCCChhhhhhcCccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEA------VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
.++||||+++|+|.+++...... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999765422 15899999999999999999999 7799999999999999999999999
Q ss_pred eccccccccCCC-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccccccc
Q 012219 318 DFGVARLLNFDS-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 318 Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||................ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~---~ 236 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK---L 236 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC---c
Confidence 999986543211 11222345678999999988888999999999999999999 888986543322111110000 0
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
........+ ..+.+++.+||+.+|++|||+.+++..|.
T Consensus 237 ~~~~~~~~~-------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPVPEGCP-------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCC-------HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111111 13778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=296.42 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=202.0
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 247 (468)
+|++.+.||.|+||.||++.. .+++.+|+|.+....... ...+.+..|++++++++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 477889999999999999964 578899999987544322 334678899999999999999999998764 4568999
Q ss_pred EEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDC--TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+||+++++|.+++.... ....+++..++.++.|++.||.|||..+ +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999986532 2345899999999999999999999543 56899999999999999999999999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
............++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . .......+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~--~~~~~~~~~~~~~-- 233 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA--S--KIKEGKFRRIPYR-- 233 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH--H--HHhcCCCCCCccc--
Confidence 754443234456899999999999888999999999999999999999998754321111 0 0011111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+|++.+|++||++.+|+++
T Consensus 234 -----~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 234 -----YSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----cCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11236789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.00 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=202.9
Q ss_pred ccccceeeeeCCceEEEEEcC--CCC--EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARLP--SGK--VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
....+.||+|.||.|++|.|. +|+ .||||.+..+.... ...+|.+|+.+|.+|+|+|++++||+..+ ....+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344577999999999999763 454 58999998766542 57899999999999999999999999987 567899
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+|.++.|||.+.|+. .....+-......++.|||.|+.||. ++++|||||.++|+++-....|||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998 33445788889999999999999999 88999999999999999999999999999998865
Q ss_pred CCCCcee---ccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 328 DSSNRTL---LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 328 ~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
....... ..-...|+|||.+....++.+||||+|||.+|||+| |..||-.... ..+.+.+|..-.-+-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLPR 336 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCCC
Confidence 4333322 122457999999999999999999999999999999 8889865432 122222332111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.....+. +++++..||...|++|||+.++.+.+....
T Consensus 337 Pk~csed---IY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 337 PKYCSED---IYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred CCCChHH---HHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 1222233 778999999999999999999986665443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.71 Aligned_cols=200 Identities=26% Similarity=0.320 Sum_probs=168.4
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR----- 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 241 (468)
..++|.+.+.||+|+||.||++.. ..++.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 357899999999999999999975 46889999999754322 12345677999999999999999999987543
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 67776642 2788889999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
+++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99765422 2223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.81 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=200.7
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFC 238 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 238 (468)
++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+..... ....+..|+.++.++ +|+|++++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 4556666778899999999999999999975 5688999999865432 235677899999998 699999999998
Q ss_pred ee------CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 239 LH------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 239 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
.. ....+++|||+++|+|.+++..... ..+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 53 4578999999999999999875432 34788888999999999999999 78999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
.++|+|||++..............|+..|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 999999999876543333334456889999999875 3467889999999999999999999986543211110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.......+.... . .....+.+++.+||+.||.+|||+.++++
T Consensus 237 --~~~~~~~~~~~~---~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --LIPRNPPPKLKS---K---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hHhhCCCCCCcc---c---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000111111110 0 11123778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=296.93 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=199.6
Q ss_pred CccccceeeeeCCceEEEEEcCC--CCEEEEEEecCcch-------hhhhhHHHHHHHHHHHhh-ccCCceeeEEEEEee
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRSET-------EELASLESFGNEARLLSQ-IRHRNIVKLYGFCLH 240 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 240 (468)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... ........+.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999998654 78899998864321 112344567788888865 799999999999999
Q ss_pred CCEEEEEEEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999888542 223358899999999999999999993 358999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
|.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||........... ..+...
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~-------~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK-------IVEAVY 230 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH-------HhhccC
Confidence 9998754332 33445688899999999988899999999999999999999999864332111100 001111
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.+...... ...+.+++.+||+.||++||++.++..++.
T Consensus 231 ~~~~~~~~---~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPEGMY---SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCcccC---CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11001001 123678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.96 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=195.6
Q ss_pred HHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC----
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR---- 241 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 241 (468)
...++|.+.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 4457899999999999999999964 578899999997643322 2345677899999999999999999887542
Q ss_pred --CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 242 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 242 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
...++++|++ +++|.+++... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence 3478999988 77898877532 3899999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc----cccccc-
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK----NIKLID- 393 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~----~~~~~~- 393 (468)
|+++.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .....+
T Consensus 163 g~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 163 GLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99986542 2233468999999999876 56889999999999999999999998643221000000 000000
Q ss_pred -----------ccC--CCCCCc-cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhc
Q 012219 394 -----------LLD--PRLSPP-VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIAR 442 (468)
Q Consensus 394 -----------~~~--~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~ 442 (468)
... +..... ...........+.+++.+|++.||++|||+.+++++ +...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 000 000000 000000001125689999999999999999999954 4433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.92 Aligned_cols=237 Identities=26% Similarity=0.401 Sum_probs=187.7
Q ss_pred ceeeeeCCceEEEEEcCCCC-----------EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 176 YCIGTGGYGSVYRARLPSGK-----------VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 35899999999999875433 5778877654322 4678899999999999999999999988 678
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-------CeEEe
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-------EAFVA 317 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~ 317 (468)
++|+||+++|+|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999999976543 4889999999999999999999 78999999999999999888 79999
Q ss_pred eccccccccCCCCCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccc
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+............. .
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-----~ 221 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-----D 221 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-----c
Confidence 9999976542 2233467789999998876 78999999999999999999 577776543221111000 0
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
......+.. ..+.+++.+||..+|.+|||+.++++.|
T Consensus 222 -~~~~~~~~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 -QHRLPMPDC-------AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -CCCCCCCCc-------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 001111111 2377899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=297.11 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=199.6
Q ss_pred hCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|...+ ...|++|........ ...+.|.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence 457888999999999999997533 346899988765432 2346788999999999999999999998764 468
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999976432 4899999999999999999999 789999999999999999999999999999766
Q ss_pred cCCCCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 326 NFDSSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 326 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.||........... .............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~ 233 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENGERLPMPPNC 233 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcCCcCCCCCCC
Confidence 433211 112234567999999988889999999999999999996 9999875543211110 0000001111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
...+.+++.+|+..+|++|||+.+++..|.+...
T Consensus 234 -------~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 234 -------PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1237779999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=296.83 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=199.5
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
-|...+.||+|+||.||+|.. .++..+|+|.+...... ...+.+.+|+..+.+++||||+++++++..+...++|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 366778899999999999965 56889999998654432 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999998643 3789999999999999999999 7899999999999999999999999999987664333
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||........... ......+.+.....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~----- 226 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL----IPKNNPPTLEGNYS----- 226 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH----HhcCCCCCCCcccC-----
Confidence 233334678899999999888889999999999999999999999865332111110 00000111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+|++.+|++||++.+++.+
T Consensus 227 --~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 --KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 226678999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.07 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=196.1
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+.+.||+|+||.||++.. +++.+|+|.+..... .+.+.+|+.++.+++|||++++++++.... .+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEE
Confidence 4688899999999999999975 678899999875432 257889999999999999999999987654 789999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++..... ..+++..++.++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999976432 34789999999999999999999 789999999999999999999999999998754321
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
......+..|+|||++.+..++.++||||||+++|||++ |+.||........... +...........
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~-- 221 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC--------VEKGYRMEPPEG-- 221 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------HhCCCCCCCCCc--
Confidence 112234567999999988899999999999999999998 9999875433211110 000111100111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
....+.+++.+||+.+|++||+++++++.|++
T Consensus 222 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 -CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11236689999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=305.03 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=198.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36788899999999999999864 58999999987544332 23457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|..+..... .+++.+++.++.||+.||+||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999888765432 3899999999999999999999 779999999999999999999999999999876443
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh----------cccc---cc--
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD----------KNIK---LI-- 392 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~----------~~~~---~~-- 392 (468)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||........... .... ..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 333334567889999998865 4578899999999999999999999864322100000 0000 00
Q ss_pred --cccCCCCCCc--cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 --DLLDPRLSPP--VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 --~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+..... ...........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 000000112237789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=294.20 Aligned_cols=252 Identities=29% Similarity=0.414 Sum_probs=200.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|...+.||+|+||.||+|.. .+++.|++|.++..... ....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 477889999999999999975 47899999999866543 2356789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++.... .+++..+..++.+++.|++||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999987543 3788899999999999999999 7899999999999999999999999999998764332
Q ss_pred CCce----eccccccccccccccCCC---CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 330 SNRT----LLAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 330 ~~~~----~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... ...++..|+|||++.... .+.++||||||+++||+++|+.||............ ......+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH---VGAGHKPPIPDS 230 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH---HhcCCCCCCCcc
Confidence 2211 245788999999988766 889999999999999999999999754321111100 011111112111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
. .....+.+++.+||+.+|++||++.+++.
T Consensus 231 ~-----~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 L-----QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-----ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 00112567899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=300.17 Aligned_cols=247 Identities=29% Similarity=0.388 Sum_probs=200.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||++... +++.+|+|++...........+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999754 68999999997655443345577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 3889999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||........ ... .. .....+....+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~---~~-~~~~~~~~~~~---- 222 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-YEK---IL-EGKVRFPSFFS---- 222 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---Hh-cCCccCCccCC----
Confidence 2334688999999999888889999999999999999999999875432110 110 00 00111222111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRP-----TMQLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~ 437 (468)
..+.+++.+||..||.+|| +++++++
T Consensus 223 ---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 223 ---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1266789999999999999 6666663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.36 Aligned_cols=194 Identities=26% Similarity=0.424 Sum_probs=159.1
Q ss_pred cceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEEEEEE
Q 012219 175 KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMFLIYE 249 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 249 (468)
...||+|+||.||+|+.. +++.+|+|.+...... ..+.+|++++++++||||+++++++.. ....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999754 5678999998754322 346789999999999999999998854 456899999
Q ss_pred eccCCChhhhhhcCc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEeec
Q 012219 250 YMEMGSLFCVLRTDE------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL----NSELEAFVADF 319 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Df 319 (468)
|+. ++|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 58887775321 2234888999999999999999999 7899999999999999 45678999999
Q ss_pred cccccccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 320 GVARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 320 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
|+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987643221 2234568999999998876 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=293.55 Aligned_cols=252 Identities=29% Similarity=0.414 Sum_probs=204.7
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|++|.||+|... +++.|++|++...... ...+.+.+|++.+.+++|+|++++++++...+..++|+|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 6788899999999999999765 5999999999766542 235678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++... ..+++..++.++.|++.|++||| + .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999999764 34899999999999999999999 7 89999999999999999999999999999876544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc-hhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS-WSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
........++..|+|||...+..++.++||||||+++|+|+||+.||....... .... ........+......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---- 227 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM--QAICDGPPPSLPAEE---- 227 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH--HHHhcCCCCCCCccc----
Confidence 433334568889999999998899999999999999999999999987654211 1111 011111111111110
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+|++.+|++||++.+++++
T Consensus 228 --~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 --FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11237779999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.81 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=194.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|++|.||+|... +++.||+|.+....... ....+.+|++++++++|+||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57888999999999999999764 68999999987543221 2245678999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.+ +|.+++..... .+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99985 89988875433 4789999999999999999999 789999999999999999999999999998765332
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc---------------cc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK---------------LI 392 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~---------------~~ 392 (468)
........++..|+|||+..+ ..++.++||||+|+++|||++|+.||............... ..
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 222223346788999998865 45889999999999999999999998654311110000000 00
Q ss_pred cccCCCCCCccchhHH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 393 DLLDPRLSPPVDQKIR------QDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
................ .....+.+++.+|++.+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000000 00123668999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.27 Aligned_cols=194 Identities=26% Similarity=0.423 Sum_probs=158.5
Q ss_pred cceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEEEEEE
Q 012219 175 KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMFLIYE 249 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 249 (468)
...||+|+||.||+|+.. ++..||+|.+...... ..+.+|+++++.++||||+++++++.. +...++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 357999999999999854 4578999998754322 356789999999999999999998854 567899999
Q ss_pred eccCCChhhhhhcC------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEeec
Q 012219 250 YMEMGSLFCVLRTD------EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL----NSELEAFVADF 319 (468)
Q Consensus 250 ~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Df 319 (468)
|+.+ +|.+++... .....+++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 777776432 12234788999999999999999999 7899999999999999 56678999999
Q ss_pred cccccccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 320 GVARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 320 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
|+++....... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987643221 1233468899999998876 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.76 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=201.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|+..+.||+|++|.||+|... +++.+|+|.+...........+.+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999764 58999999998765443345567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.+++|.+++.... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987542 235899999999999999999999 789999999999999999999999999998765321
Q ss_pred CC-----------------------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 329 SS-----------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 329 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1112357889999999998889999999999999999999999987543
Q ss_pred ccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC----HHHHHHH
Q 012219 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT----MQLVSNE 438 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~~v~~~ 438 (468)
..... ....+.....+... .....+.+++.+|++.||++||+ +++++.+
T Consensus 237 ~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETF-------SNILKKEVTFPGSP---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHH-------HHHhcCCccCCCcc---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 22111 11111111111110 01223778999999999999999 7777753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=294.56 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=198.5
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchh--hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETE--ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
+|...+.||+|++|.||+|... +++.|++|.+...... .....+.+.+|+++++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999765 7899999998654321 123456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 3789999999999999999999 78999999999999999999999999999876543
Q ss_pred CCCCceeccccccccccccccCCC-CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||............ ... ...+.......
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~--~~~~~~~~~~~-- 228 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-GRS--KELPPIPDHLS-- 228 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH-Hhc--ccCCCcCCCcC--
Confidence 22 233456888999999987766 899999999999999999999998754421111110 000 00011111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+.+++.+||+.+|++||++.+++.
T Consensus 229 -----~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 229 -----DEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12567899999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=302.89 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=198.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|...+.||+|+||.||+|.. .++. .+|+|.+...... .....+.+|+.+++.++||||++++|+|.... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSPT-I 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-c
Confidence 5677888999999999999975 3443 5788888754432 22346889999999999999999999997654 6
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence 789999999999999875432 3788999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......... ....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~--~~~~~~~--~~~~~ 234 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD--LLEKGER--LPQPP 234 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHCCCC--CCCCC
Confidence 6432221 112335678999999998899999999999999999998 999986543211100 0000000 00011
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.. ...+.+++.+||..+|++||++.+++..|.+...+
T Consensus 235 ~~-------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 235 IC-------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 12367789999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=314.59 Aligned_cols=191 Identities=27% Similarity=0.330 Sum_probs=164.4
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
..|.+...||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36888999999999999999764 578899996432 23568999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|++. ++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9995 68888886533 24899999999999999999999 789999999999999999999999999999875432
Q ss_pred CC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 012219 329 SS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 329 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 21 122356899999999999999999999999999999999987654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.79 Aligned_cols=201 Identities=18% Similarity=0.261 Sum_probs=163.0
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC------CceeeEEEE
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH------RNIVKLYGF 237 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~ 237 (468)
+...+++|.+.+.||+|+||+||+|.. ..++.||||+++..... ...+..|+++++.++| .++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----TRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334567899999999999999999975 46788999999643221 2344567777666654 558899998
Q ss_pred EeeC-CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----
Q 012219 238 CLHR-KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---- 312 (468)
Q Consensus 238 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---- 312 (468)
+... ...++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccc
Confidence 8764 5688999988 678988886543 38999999999999999999993 25999999999999998765
Q ss_pred ------------CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 313 ------------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 313 ------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886432 2233467999999999999999999999999999999999999999754
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=300.82 Aligned_cols=262 Identities=26% Similarity=0.290 Sum_probs=198.5
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh--hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
+|++.+.||+|++|.||+|.. .+++.||+|.+...... .......+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467788999999999999975 46899999999765433 112235567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+ +|+|.+++.... ..+++..++.++.||++||.||| +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997644 24899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--------------ccccc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--------------NIKLI 392 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~--------------~~~~~ 392 (468)
.........++..|+|||.+.+ ..++.++|||||||++|||++|.+||............ .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 3333333456788999998864 46788999999999999999998877643321100000 00000
Q ss_pred cccCCCCCC--ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 DLLDPRLSP--PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......... ............+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 0000011112347789999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.11 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=192.8
Q ss_pred eeeeeCCceEEEEEcCC-------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 177 CIGTGGYGSVYRARLPS-------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.||+|+||.||+|...+ +..+|+|.+...... .....|.+|+++++.++||||+++++++......++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 58999999999997542 357999988654322 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-----CeEEeecc
Q 012219 250 YMEMGSLFCVLRTDE----EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-----EAFVADFG 320 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfg 320 (468)
|+++++|.+++.... ....+++.+++.++.|++.||.||| +.+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999997532 2234788999999999999999999 78999999999999999887 89999999
Q ss_pred ccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCC
Q 012219 321 VARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 321 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||........... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~--------~~~ 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH--------VTA 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH--------Hhc
Confidence 9876532211 1112245678999999999999999999999999999998 9999864432111100 000
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
........... ..+.+++.+||..+|++||+++++.+.|+
T Consensus 229 ~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GGRLQKPENCP---DKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCccCCcccch---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00000011111 23678999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.60 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=199.5
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|.....||+|+||.||++.. .++..||+|.+...... ..+.+.+|+..++.++|+|++++++.+...+..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 33346699999999999975 46889999998654332 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++++|.+++... .+++.++..++.||+.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999988542 3788999999999999999999 77999999999999999999999999999876543333
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
......++..|+|||+..+..++.++||||||+++|||++|+.||........ .. .......+...... ..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~---~~~~~~~~~~~~~~-----~~ 244 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MR---RIRDNLPPRVKDSH-----KV 244 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HHHhcCCCcccccc-----cc
Confidence 33345688999999999888899999999999999999999999864332111 00 01111111111110 01
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCCC
Q 012219 411 IILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNKA 445 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~~ 445 (468)
...+..++.+|+..||++|||+++++++ |.+....
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 1126678889999999999999999954 5554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=299.10 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++.. .+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5788899999999999999964 46889999998644332 2356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... .+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998653 3788899999999999999999 789999999999999999999999999998766544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........+++.|+|||.+....++.++||||||+++|++++|+.||........... ....-.+.... ..
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~--~~--- 239 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGTPELQN--PE--- 239 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCCCCCCC--cc---
Confidence 3333445688899999999888899999999999999999999999975432111000 00000011110 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCC
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNK 444 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~ 444 (468)
.....+.+++.+||..+|++||++.+++.+ |++...
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 111236789999999999999999999965 555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.35 Aligned_cols=194 Identities=24% Similarity=0.403 Sum_probs=169.8
Q ss_pred CccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-C-----CceeeEEEEEeeCCE
Q 012219 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-H-----RNIVKLYGFCLHRKC 243 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~ 243 (468)
+|.+.+.||+|+||.|.+|. ..+++.||||+++..... ..+-..|+.+|..|+ | -|+|++++|+..+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 78999999999999999995 567999999999876543 345568999999997 3 489999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC--CCeEEeeccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE--LEAFVADFGV 321 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~ 321 (468)
.|||+|.+. -+|.++++.+.- .+++...+..|+.||+.||.+|| ..+|||+||||+||||.+- ..+||+|||.
T Consensus 263 lciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999996 599999987654 44999999999999999999999 7899999999999999765 4689999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~ 376 (468)
++..... ......+..|+|||++.+.+|+.+.||||||||++||++|.+.|.
T Consensus 338 Sc~~~q~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 338 SCFESQR---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccccCCc---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9876432 225567889999999999999999999999999999999987664
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.44 Aligned_cols=190 Identities=23% Similarity=0.334 Sum_probs=162.6
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..+|.+.+.||+|+||.||+|... +++.||+|+..... ...|+.++++++|+||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999764 56789999754322 23689999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+|++. ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99995 68888886533 34899999999999999999999 78999999999999999999999999999975432
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
........||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 2222345689999999999999999999999999999999985544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=295.32 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=186.5
Q ss_pred eeeeeCCceEEEEEcCCC---CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.||+|+||.||+|...++ ..+++|.+...... ...+.|.+|+.+++.++||||++++++|......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999965333 34667766544322 2356899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC--C
Q 012219 254 GSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--S 330 (468)
Q Consensus 254 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 330 (468)
|+|.++++.... ....++.....++.||+.||+||| +.+++||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999976432 233566778899999999999999 7899999999999999999999999999986432111 1
Q ss_pred CceeccccccccccccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhh-cccccccccCCCCCC
Q 012219 331 NRTLLAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD-KNIKLIDLLDPRLSP 401 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 401 (468)
......++..|+|||+... ..++.++|||||||++|||++ |..||........... .........++.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1223457889999998743 245789999999999999997 5778764432211110 011112223333333
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.... .+.+++..|| .+|++||++++|++.|.
T Consensus 237 ~~~~-------~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSE-------RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcH-------HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 2556788899 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.62 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=194.3
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.+.+.||+|+||.||+|.. .+|+.+|+|++....... .....+.+|++++++++|+|++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 477788999999999999975 468999999987543221 223467789999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|++ ++|.+++.... ..+++..++.++.||++||.||| +.+++||||||+||+++.++.++|+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 997 57888776432 23899999999999999999999 7899999999999999999999999999998664433
Q ss_pred CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc------------ccccccC
Q 012219 330 SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------------KLIDLLD 396 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------------~~~~~~~ 396 (468)
.......++..|+|||++.+. .++.++|||||||++|||+||+.|+.............. ...+..+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 333344678899999988764 478999999999999999999988643222111000000 0000000
Q ss_pred CCCCCccc------hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 397 PRLSPPVD------QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 397 ~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
........ .........+.+++.+||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 0000111236789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.29 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=200.2
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|++|.||++... +++.+++|.+...... ...+.+.+|++++++++||||+++++++...+..++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5777889999999999999765 6899999998765433 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++.... ..+++.....++.|++.|++||| + .+++|+||||+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999997643 34888999999999999999999 6 89999999999999999999999999998765322
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-hcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-DKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...........+.....
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 227 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG----- 227 (265)
T ss_pred Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-----
Confidence 111 1568889999999998899999999999999999999999986542111100 00000111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+||..+|++|||+.+++.+
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 -KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011226789999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=293.75 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=194.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch--hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET--EELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 244 (468)
.+|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999975 4689999998864321 1223456788999999999999999999988763 467
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++++|.+++.... .+++...+.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 2788889999999999999999 78999999999999999999999999999876
Q ss_pred ccCC---CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||........... .......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPTNPVLPP 232 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH---HhcCCCCCCCch
Confidence 5321 1112234588899999999888899999999999999999999999875432211110 000111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+|+. +|++||++++++.+
T Consensus 233 -------~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 233 -------HVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111235667888884 99999999998853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=300.27 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=196.3
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||++.. ..++.|++|.+...........+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 688889999999999999975 4578999999876654333445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999997543 3889999999999999999999 7799999999999999999999999999986421100
Q ss_pred C---------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 330 S---------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 330 ~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
. ......++..|+|||.+....++.++|||||||++|||++|+.||........... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~--~~~~~~ 233 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--VISDDI 233 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccc
Confidence 0 01123567889999999888899999999999999999999999864322111110 000111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..+......+ ..+.+++.+||+.||++||++.++.+.+
T Consensus 234 ~~~~~~~~~~-------~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 234 EWPEGDEALP-------ADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CCCCccccCC-------HHHHHHHHHHhccChhhccCccCHHHHH
Confidence 1111111111 1267899999999999999954443333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.28 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=193.7
Q ss_pred hhCccccceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
..+|.+.+.||+|+||.||++... .+..||+|.+.... .+.+|++++++++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999643 46789999886532 3457999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
++||++. ++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999996 6888888433 34899999999999999999999 789999999999999999999999999999765
Q ss_pred cCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccch--hhhccccccc--------
Q 012219 326 NFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW--SLDKNIKLID-------- 393 (468)
Q Consensus 326 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~--~~~~~~~~~~-------- 393 (468)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||........ ..........
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43222 12235689999999999999999999999999999999999999864332110 0000000000
Q ss_pred -----------ccCCCCCCc--cchhHH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 394 -----------LLDPRLSPP--VDQKIR--QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 394 -----------~~~~~~~~~--~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.......+. ....+. .....+.+++.+|+..||++|||+.+++.+-
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000 000000 0012366789999999999999999988553
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=292.08 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=198.8
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|+||.||++.. .+++.+|+|.+....... ...+.+.+|++++++++|||++++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 477889999999999999965 478899999987654322 235678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++.... ...+++..+..++.+++.|++||| +.+++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999997643 234789999999999999999999 7899999999999999865 45799999999876432
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||............. ............
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~---- 226 (256)
T cd08220 156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM----SGTFAPISDRYS---- 226 (256)
T ss_pred c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH----hcCCCCCCCCcC----
Confidence 2 2223467889999999998889999999999999999999999987543221111100 000011111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+||+.+|++|||+.+++.+
T Consensus 227 ---~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 ---PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 126679999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=299.54 Aligned_cols=262 Identities=25% Similarity=0.285 Sum_probs=195.2
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
++++|.+.+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+++++.++|+||+++.+++......++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 356899999999999999999965 56889999998754322 122456789999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|+||+. +++.+++.... ..+.+..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999996 67777665432 23678888899999999999999 7799999999999999999999999999987654
Q ss_pred CCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc---------------c
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI---------------K 390 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~---------------~ 390 (468)
..........+++.|+|||++.+. .++.++|||||||++|||++|+.||+............. .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 333333344578899999988754 578899999999999999999999975432111100000 0
Q ss_pred cccccCCCCCCccchhHH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 391 LIDLLDPRLSPPVDQKIR------QDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.................. .....+.+++.+|+..||++|||+++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 01123678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.99 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=196.7
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh-------hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-------ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
+|...+.||+|+||.||+|.. .+++.+|+|.+...... .....+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366788999999999999964 46899999988643221 1123457888999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++|+||+++++|.++++... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 4888999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCC--CCceeccccccccccccccCCC--CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC
Q 012219 323 RLLNFDS--SNRTLLAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 323 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+...... .......++..|+|||.+.... ++.++||||||+++||+++|+.||.............. ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 232 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRSAPP 232 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cccCCc
Confidence 7653211 1122345788999999987654 78999999999999999999999864332211111000 000111
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....... .....+.+++.+||+.+|++||++++|+++
T Consensus 233 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPDVSM---NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCccccc---cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111100 111237778999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=293.75 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=197.9
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch---hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET---EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
+|+..+.||+|++|.||++.. .+++.+|+|++..... ......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999974 6789999999875432 112235678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeeccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLL 325 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~ 325 (468)
|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999987543 4789999999999999999999 78999999999999998776 5899999998776
Q ss_pred cCCCC----CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSS----NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... ...........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA----LIFKIASATTAP 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH----HHHHHhccCCCC
Confidence 43211 1123457889999999988889999999999999999999999986433211100 000000000111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
...... ...+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHL---SPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhh---CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111 123667999999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=300.90 Aligned_cols=260 Identities=26% Similarity=0.345 Sum_probs=197.4
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 6888999999999999999765 5889999998754332 1234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|++++.+..+.... ..+++.++..++.||+.||.||| ..+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776665443 23889999999999999999999 7799999999999999999999999999998765433
Q ss_pred C-CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--c-----------------c
Q 012219 330 S-NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--K-----------------N 388 (468)
Q Consensus 330 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~-----------------~ 388 (468)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... . .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 23345678899999999887 889999999999999999999999864322110000 0 0
Q ss_pred cccccccCCCCCCccchhHH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 389 IKLIDLLDPRLSPPVDQKIR-QDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.......+............ .....+.+++.+||..+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000000000000000 01234788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.59 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=199.6
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||+|... +|..+|+|.+....... ...+.+.+|+++++.++|+|++++++++......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778899999999999999764 58899999987643221 234577899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-eEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-AFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++. ++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999875432 34789999999999999999999 779999999999999998864 699999999876543
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||+..+..++.++||||||+++|||++|+.||............ ...... ...+...
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-~~~~~~~---- 227 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI---CQGYFA-PISPNFS---- 227 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hcccCC-CCCCCCC----
Confidence 33333456888999999998888999999999999999999999998744322111111 011111 1111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+|+..+|++|||+.+++.+
T Consensus 228 ---~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 228 ---RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 126678999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.39 Aligned_cols=249 Identities=30% Similarity=0.474 Sum_probs=198.4
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc---CCceeeEEEEEeeCCEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR---HRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 246 (468)
.|+..+.||+|+||.||+|.. .+++.+|+|.+...... ...+.+.+|++++++++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 466778899999999999975 57899999998754322 23457888999999997 9999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++++|.++++.. .+++...+.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998653 4889999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
..........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.......... .......+.+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~--- 225 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLEDN--- 225 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCCcc---
Confidence 443333445688899999988654 56889999999999999999999997543221111 0001111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+||+.||++||++.+++.+
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011237789999999999999999998854
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.20 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=197.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|...+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+++++.++|||++++.++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999975 468999999987544333334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+. |++.+.+..... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 577777654332 3899999999999999999999 789999999999999999999999999998765322
Q ss_pred CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
....++..|+|||++. ...++.++||||||+++|||+||+.||............ .....+.... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~---~ 237 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNDSPTLSS---N 237 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH----hcCCCCCCCc---h
Confidence 2345788999999874 456888999999999999999999998654321111100 0000111111 1
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.....+.+++.+||+.+|++||++.+++.+..-.
T Consensus 238 ---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 238 ---DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred ---hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 1112377899999999999999999999765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=295.67 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=198.7
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCC---
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRK--- 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--- 242 (468)
++++|++.+.||+|++|.||+|... +++.+++|++...... .+.|.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4678999999999999999999764 6789999998765432 35788999999999 6999999999997644
Q ss_pred ---EEEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 243 ---CMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 243 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
..++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999886532 2345889999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCCCceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
||++..............++..|+|||++.. ..++.++|||||||++|+|++|+.||........... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~ 232 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----IPR 232 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----hhc
Confidence 9998765433333344568889999998753 3467899999999999999999999874332111110 111
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
...+..... . .....+.+++.+||..||++|||+.+++.
T Consensus 233 ~~~~~~~~~--~---~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTLKSP--E---NWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCCCch--h---hcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111110 0 11123678999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=290.75 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=197.6
Q ss_pred ccccceeeeeCCceEEEEEcCC-----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
+++.+.||+|+||.||++...+ +..||+|++....... ..+.+..|++++..++|+||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3567889999999999997643 4889999997654332 35688899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
+|||+++++|.+++...... .+++.++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus 79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999998764321 2799999999999999999999 7899999999999999999999999999997764
Q ss_pred CCCCCce-eccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 327 FDSSNRT-LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 327 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
....... ...+++.|+|||...+..++.++||||+|+++++|++ |+.||........... ............
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~-- 228 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKGYRLPKPEN-- 228 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCCCCCCCCc--
Confidence 3322111 1236789999999988889999999999999999998 8888865322111100 000000011111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
....+.+++.+|+..+|++|||+.++++.|
T Consensus 229 -----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 -----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112377799999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.79 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=200.9
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.+.+.||.|+||.||+|... +++.+|+|.+...........+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999764 689999999986544333456789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+.+++|.+++... ..+++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999764 34889999999999999999999 7799999999999999999999999999987764322
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........... ........+......+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----- 226 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI--RAKQETADVLYPATWS----- 226 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH--HHHhccccccCcccCc-----
Confidence 23345688899999999888899999999999999999999999876543111000 0000001111111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTM--QLVS 436 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~--~~v~ 436 (468)
..+.+++.+||+.||.+||++ +|++
T Consensus 227 --~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 227 --TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 236789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.53 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=197.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 246 (468)
++|...+.||.|++|.||++.. .+++.+|+|.+...... .....+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3577889999999999999976 46889999998755432 234678899999999999999999999865 346899
Q ss_pred EEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
||||+++++|.+++.... ....++......++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998875421 2344788899999999999999999 789999999999999999999999999998755
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc-hhhhcccccccccCCCCCCccc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS-WSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ..............+.+.....
T Consensus 156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 3221 123457889999999998899999999999999999999999987542210 0000000000100111111100
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. ......+.+++.+||+.+|++|||+.|++.+
T Consensus 234 ~~-~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 NG-IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC-CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 0111237789999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=300.28 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=194.7
Q ss_pred cceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 175 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
...||+|+||.||++.. .+++.||+|.+...... ..+.+.+|+.++..++|||++++++++...+..++++||+++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44699999999999975 47899999998654332 235678999999999999999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
++|..++.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999988754 23789999999999999999999 78999999999999999999999999999976544333334
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...++..|+|||++.+..++.++|||||||++|||++|+.||........... ......+..... ... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~--~~~---~~~ 246 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNA--HKI---SPV 246 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCCCcccc--CCC---CHH
Confidence 45688999999999988899999999999999999999999864332111100 000000000000 000 112
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+.+++.+|++.+|++||++++++.+
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 6678999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=316.40 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=208.3
Q ss_pred ccccceeeeeCCceEEEEE-cCCC----CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRAR-LPSG----KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~-~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
....++||+|+||+||+|. .++| -+||+|++...... ...+++.+|+-.|.+++|||+++++|+|.... ..|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3446789999999999995 4444 46899988765443 34578999999999999999999999998776 789
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|++||+.|+|.++++.++.. +.....+.|..|||+|+.||| .+++|||||.++|||+..-..+||.|||+++.+.
T Consensus 775 vtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999999986554 777889999999999999999 8899999999999999999999999999999987
Q ss_pred CCCCCceecc--ccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 327 FDSSNRTLLA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 327 ~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.+........ -.+.|||=|.+....|+.++|||||||.+||++| |..|++.++..... ...+.-+. +..+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-----dlle~geR-LsqPp 923 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-----DLLEKGER-LSQPP 923 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-----HHHhcccc-CCCCC
Confidence 6655544433 3568999999999999999999999999999999 99999876643221 11111111 22211
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
. ...-+..++.+||..|+..||+++++.+.|.++...|.
T Consensus 924 i-----CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 924 I-----CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred C-----ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 1 11226678899999999999999999999998876543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.83 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=195.6
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|++|.||+|+. .+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 477889999999999999975 468999999887543221 223568899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+. ++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 689888865432 34899999999999999999999 7899999999999999999999999999997664333
Q ss_pred CCceeccccccccccccccCCC-CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc---cccc------------
Q 012219 330 SNRTLLAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI---KLID------------ 393 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~---~~~~------------ 393 (468)
.......++..|+|||+..+.. ++.++||||||+++|||+||+.||.............. ....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 3333345688999999887644 68899999999999999999999864332111000000 0000
Q ss_pred --ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 --LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 --~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....................+.+++.+|++.||++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000001236679999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.82 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=185.9
Q ss_pred ceeeeeCCceEEEEEcCC--------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 176 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
+.||+|+||.||+|.... ...+++|.+..... ...+.|.+|+.+++.++|||++++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 358999999999996532 23488888754332 2346788999999999999999999999998889999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--------eEEeec
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE--------AFVADF 319 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Df 319 (468)
|||+++|+|.++++.... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999976543 4789999999999999999999 789999999999999988765 589999
Q ss_pred cccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCC-CCCCcccccchhhhcccccccccCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK-HPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
|++..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+............ .. ..
T Consensus 153 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~-----~~ 222 (258)
T cd05078 153 GISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED-----RH 222 (258)
T ss_pred ccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc-----cc
Confidence 98865432 223457889999999876 45789999999999999999985 665543321111000 00 11
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.+..... ..+.+++.+||+.||++|||++++++.|
T Consensus 223 ~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 QLPAPKW-------TELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cCCCCCc-------HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111111 1267899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.52 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=202.9
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
.++.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++.++|+|++++++++......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 3456888889999999999999765 688999999976543 24578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
++||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999998654 34899999999999999999999 7899999999999999999999999999987654
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.||............. .... +..... ..
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~-~~~~~~--~~ 241 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGI-PPLKNP--EK 241 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCC-CCCcch--hh
Confidence 33323333457889999999988889999999999999999999999987543221111000 0000 001110 00
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ...+.+++.+|++.+|.+||++.+++++
T Consensus 242 ~---~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 242 W---SPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C---CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 1236779999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=310.59 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=201.9
Q ss_pred ceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
-.||+|.||+||.|+..+ ...+|||-+...... ..+-+.+|+.+-++++|.|||+++|.|.+++..-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 369999999999998654 567899998765543 2456789999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEeeccccccccCCCCCce
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
||.++++..=....-.+...-.+..||++||.||| ...|||||||-.|||++ -.|.+||+|||-++.+..-.....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 99999987544333366677778899999999999 77899999999999995 568999999999998876666667
Q ss_pred eccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 334 LLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
.+.||..|||||++..+ .|+.++|||||||.+.||.||++||..+........+.. . ....++.+....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-m-----yKvHP~iPeels--- 805 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-M-----YKVHPPIPEELS--- 805 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-c-----eecCCCCcHHHH---
Confidence 78899999999999865 589999999999999999999999987665433222110 0 112233333222
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.+...++.+|..+||.+||++.+++..-+
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcc
Confidence 23567899999999999999999985443
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.91 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=195.8
Q ss_pred ccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 172 FHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
|.+.+.||+|+||.||+|.+. .++.||+|++....... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 556788999999999999743 46889999997654322 23567889999999999999999999886532
Q ss_pred -EEEEEEEeccCCChhhhhhcC---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 243 -CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 243 -~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
..++++||+.+|+|.+++... .....+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 247889999999998887532 12234788999999999999999999 78999999999999999999999999
Q ss_pred ccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccccccc
Q 012219 319 FGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 319 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... ......++..|++||.+....++.++|||||||++|||++ |+.||........... .....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~ 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----LIKGN 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH----HHcCC
Confidence 999986532221 1122335678999999988889999999999999999999 8899865432111000 00000
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
........ ...+.+++.+|++.+|++||++.+++..|+.+
T Consensus 233 ~~~~~~~~-------~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLKQPPDC-------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCCCCCC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 12377899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=292.47 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=192.5
Q ss_pred eeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||+||++.. .+|+.+|+|.+...........+.+..|++++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999964 46899999998764433333445677899999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecc
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 336 (468)
.+++..... ..+++.++..++.|++.||.||| ..+++||||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 999876543 34899999999999999999999 78999999999999999999999999999876543 22223345
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHH
Q 012219 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416 (468)
Q Consensus 337 g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 416 (468)
++..|+|||+..+..++.++|||||||++|+|++|+.||...........-...... .........+ ..+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFS-------PEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-ccccCCccCC-------HHHHH
Confidence 788999999998888999999999999999999999998654321110000000000 0111111111 12667
Q ss_pred HHHhcccCCCCCCC-----CHHHHHH
Q 012219 417 VAFSCLRSQPKSRP-----TMQLVSN 437 (468)
Q Consensus 417 l~~~cl~~dP~~RP-----s~~~v~~ 437 (468)
++.+||+.||++|| ++.+++.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.15 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=198.0
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|++|.||+|+.. +|+.||+|++...... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4778899999999999999864 6889999999765432 223567789999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++ +|.+++........+++..+..++.|++.||.||| +.+++||||||+||++++++.++++|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 88888876554455899999999999999999999 7799999999999999999999999999997654333
Q ss_pred CCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-----------ccccc--ccc
Q 012219 330 SNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-----------NIKLI--DLL 395 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-----------~~~~~--~~~ 395 (468)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||............ ..... ...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 33333457889999998765 45788999999999999999999998754322110000 00000 000
Q ss_pred CCCCCCccchh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 396 DPRLSPPVDQK----IRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 396 ~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
........... .......+.+++.+|++.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 0011123678999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=293.42 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=199.0
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|...+.||+|++|.||++.. .+++.+++|++...... ..+.+.+|+.+++.++|+|++++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 344457899999999999974 57889999998654332 23567899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++.. ..+++.++..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999875 23789999999999999999999 7899999999999999999999999999887654333
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......|+..|+|||...+..++.++||||||+++|||++|+.||.......... .......+..... . .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~-~----~ 240 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNL-H----K 240 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCccc-c----c
Confidence 33334568899999999988889999999999999999999999986533211110 0111111111111 0 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
....+.+++.+||+.+|++||++.++++ .|.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 273 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence 1123778999999999999999999995 4443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=296.46 Aligned_cols=260 Identities=24% Similarity=0.252 Sum_probs=196.5
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 246 (468)
++|++.+.||+|+||.||+|... +++.+++|.++...... .....+.+|++++.+++||||+++++++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 56888899999999999999765 68899999997554332 2234567899999999999999999998877 88999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|+||++ ++|.+++..... .+++..++.++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999997 489888875432 4899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-------------------
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD------------------- 386 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~------------------- 386 (468)
..........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 433333344578899999988754 468899999999999999999999864332110000
Q ss_pred ---cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 387 ---KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 387 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
............+....... .....+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000001100 001236689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.33 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=206.2
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.-|.+.+.||+|.|..|-.++ .-.|..||||++.+.+..+.. ...+.+|++.|+-++|||||++|++......+|||.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 457778889999999999996 458999999999988766543 356779999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-CCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfg~~~~~~~ 327 (468)
|.=++|+|++++-+.... +.+....+++.||..|+.|+| ...+|||||||+||.+ ..-|-|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 999999999999876654 888889999999999999999 6689999999999866 455899999999998775
Q ss_pred CCCCceeccccccccccccccCCCCCc-cchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTE-KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
++......+|+..|-|||++.+..|+. ++||||+|||||-|++|++||+..... .-+.-++|-.+..+ ..
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------ETLTmImDCKYtvP--sh 241 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------ETLTMIMDCKYTVP--SH 241 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------hhhhhhhcccccCc--hh
Confidence 445566779999999999999988874 789999999999999999999854432 11222333333221 22
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.. .++.++|.+||..||++|-+.++++.
T Consensus 242 vS---~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 242 VS---KECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hh---HHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22 23778999999999999999999983
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=296.56 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=195.3
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|++.+.||+|++|.||+|.. .+|+.||+|++....... .....+.+|+++++.++|+|++++++++...+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 56678899999999999975 479999999987553221 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
++ ++|.+++..... ..+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||+++.......
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 689998876442 34899999999999999999999 77999999999999999999999999999976543332
Q ss_pred CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc--------------ccccccc
Q 012219 331 NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN--------------IKLIDLL 395 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~--------------~~~~~~~ 395 (468)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||............. ....+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 22334568899999987654 57889999999999999999999986433211000000 0000000
Q ss_pred C--CCCC-CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 D--PRLS-PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~--~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. +... .............+.+++.+|++.||++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 00000000011236789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=285.55 Aligned_cols=250 Identities=32% Similarity=0.468 Sum_probs=201.9
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|+++++.++|+|++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4677889999999999999764 688999999977654 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++.... ..+++..+..++.|++.||.+|| ..+++||||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999987643 34899999999999999999999 7899999999999999999999999999997765432
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............. ...+...... .
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~--~--- 222 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPE--K--- 222 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCccc--c---
Confidence 2 3345688899999999888899999999999999999999999875532211111100 0001111110 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+|++.||++|||+.+++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01237789999999999999999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.65 Aligned_cols=261 Identities=25% Similarity=0.290 Sum_probs=198.3
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.+.+.||+|++|.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++|+|++++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 477889999999999999975 478999999997654322 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+ +++|.+++.... ..+++.+++.++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999987543 34899999999999999999999 7899999999999999999999999999998764332
Q ss_pred C-CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchh---hhccc--------------c
Q 012219 330 S-NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS---LDKNI--------------K 390 (468)
Q Consensus 330 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~---~~~~~--------------~ 390 (468)
. ......++..|+|||++.+. .++.++||||+|+++|||+||++||......... ..... .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1 12334688899999988654 4688999999999999999998887543211000 00000 0
Q ss_pred cccccCCCC-CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 LIDLLDPRL-SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 ~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+.. .........+....+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000000000112347889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=293.05 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=192.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHH-HhhccCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARL-LSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
++|++.+.||+|+||.||++.. .+|+.||+|++....... ....+..|+.. ++.++|||++++++++...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3688899999999999999975 469999999987653322 12345556654 5667899999999999999999999
Q ss_pred EEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||++ |+|.+++... .....+++..++.++.||+.||+||| +. +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99997 6888877542 22345899999999999999999999 54 8999999999999999999999999999765
Q ss_pred cCCCCCceeccccccccccccccC----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYT----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .......+....
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (283)
T cd06617 155 VDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---QVVEEPSPQLPA 230 (283)
T ss_pred ccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH---HHHhcCCCCCCc
Confidence 322 22233467889999998864 4568899999999999999999999864332111111 111111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
. ... ..+.+++.+||..+|++||++.++++ .|..
T Consensus 231 ~---~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 265 (283)
T cd06617 231 E---KFS---PEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265 (283)
T ss_pred c---ccC---HHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence 1 111 12677999999999999999999984 4443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=295.04 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=197.7
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|...+.||+|+||.||+|+. .++..+|+|.+...........+.+.+|++++++++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778899999999999975 46889999998755433333456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+. |++.+.+.... ..+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 97 57877775432 34899999999999999999999 78999999999999999999999999999865432
Q ss_pred Cceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 331 NRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.....++..|+|||++. ...++.++|||||||++|||++|+.||........... ......+.... ..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~---~~- 248 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQS---NE- 248 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCC---cc-
Confidence 22345788999999874 45688999999999999999999999865322111110 00000011111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
....+.+++.+|++.+|.+||++.+++++.......
T Consensus 249 --~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 249 --WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 112367899999999999999999999876654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.34 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=194.6
Q ss_pred eeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||.|++|.||+++.. +++.+|+|++...........+.+.+|+++++.++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999764 5899999999765544334457799999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecc
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 336 (468)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997643 2788999999999999999999 7899999999999999999999999999998764322 223346
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHH
Q 012219 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416 (468)
Q Consensus 337 g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 416 (468)
++..|+|||.+....++.++|+||||+++|+|++|+.||............ ...+........... ...+.+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~ 225 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN-----DILKGNGKLEFPNYI---DKAAKD 225 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH-----HHhccCCCCCCCccc---CHHHHH
Confidence 788999999998888999999999999999999999998754421111110 011000001111111 123778
Q ss_pred HHHhcccCCCCCCCC-----HHHHHH
Q 012219 417 VAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 417 l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
++.+||+.+|++||+ +.|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 666664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=285.97 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=203.1
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 247 (468)
+|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++.+++++|+||+++++++... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4677889999999999999765 7899999999766532 23457888999999999999999999999988 889999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... .+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999997654 4899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 328 DSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 328 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... ......++..|+|||.......+.++||||||+++++|++|+.||............... ....+.+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 229 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHL-- 229 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCccc--
Confidence 332 133456888999999998888999999999999999999999998765421111111000 00001111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+|++.+|++||++.+++.+
T Consensus 230 -----~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 230 -----SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1237789999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.86 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=192.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 248 (468)
+|...+.||+|+||.||++.. .+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...++++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 455667899999999999975 46899999998755433 23467889999999996 999999999999988999999
Q ss_pred EeccCCChhhhhhc--CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 249 EYMEMGSLFCVLRT--DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 249 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||+.. ++.++... ......+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||+++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99864 55544321 1112348899999999999999999994 3589999999999999999999999999997654
Q ss_pred CCCCCceeccccccccccccccCC---CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... ......|+..|+|||++... .++.++|||||||++|||++|+.||........... .......+.+....
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT---QVVKGDPPILSNSE 235 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHh---hhcCCCCCcCCCcC
Confidence 222 22233578899999998766 689999999999999999999999875431111100 11111111221111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. .....+.+++.+||+.+|++|||+++|+.+
T Consensus 236 ~~---~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 ER---EFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 112237789999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.46 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=194.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCE----
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKC---- 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~---- 243 (468)
++|++.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3688889999999999999975 468999999987543321 22356788999999995 6999999999887655
Q ss_pred -EEEEEEeccCCChhhhhhcCcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeec
Q 012219 244 -MFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADF 319 (468)
Q Consensus 244 -~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Df 319 (468)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.||| +.+++||||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999985 88888765332 245899999999999999999999 789999999999999998 889999999
Q ss_pred cccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc---------
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI--------- 389 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------- 389 (468)
|+++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||..............
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999865433333333456888999998765 4578999999999999999999999865332111100000
Q ss_pred --ccccccC----CCCCCc-cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 --KLIDLLD----PRLSPP-VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 --~~~~~~~----~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+..+ +...+. ...........+.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 000000 000000112237789999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=306.43 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=195.8
Q ss_pred cccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch-hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC--EEEEEE
Q 012219 173 HIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET-EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFLIY 248 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 248 (468)
.....||+|+|-+||+|.+ .+|..||--.++..+. .....++.|..|+++|+.|+|+||+++++++.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456799999999999965 3566666443332222 22235688999999999999999999999998754 478999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~ 327 (468)
|.+..|+|..|+.+.+. .+.....+|+.||++||.|||++ .++|+|||||-.|||++.+ |.|||+|+|+|..+..
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999987665 78888999999999999999987 7899999999999999877 8999999999998753
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC-CCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 406 (468)
. ......|||.|||||+.. ..|++.+||||||+.++||+|+..||..-........+ ...-+.|. +.....
T Consensus 199 s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK---V~SGiKP~sl~kV~d-- 270 (632)
T KOG0584|consen 199 S--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK---VTSGIKPAALSKVKD-- 270 (632)
T ss_pred c--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH---HHcCCCHHHhhccCC--
Confidence 3 333478999999999876 78999999999999999999999999755443222211 11111111 111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
.++.++|.+|+.. .++|||+.|++. .|+..
T Consensus 271 -----Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 -----PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1277899999999 899999999884 44444
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=294.84 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=193.5
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|++++++++|+||+++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888999999999999999764 68899999986543321 23356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~ 327 (468)
||++ ++|.+++..... ..+++.....++.||+.||+||| +.+++|+||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 578877754332 23678888899999999999999 789999999999999985 56789999999976543
Q ss_pred CCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc----cc----------cc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN----IK----------LI 392 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~----~~----------~~ 392 (468)
.........+++.|+|||++.+ ..++.++|||||||++|+|+||+.||............. .. ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 3322333457889999998865 457899999999999999999999986543211100000 00 00
Q ss_pred cc--cCCCCCCcc-chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 393 DL--LDPRLSPPV-DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 393 ~~--~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
+. ..+...... ..........+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000000 0000011123678999999999999999999885
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=290.64 Aligned_cols=246 Identities=22% Similarity=0.247 Sum_probs=186.8
Q ss_pred eeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHh---hccCCceeeEEEEEeeCCEEEEEEEecc
Q 012219 177 CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLS---QIRHRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
.||+|+||.||++.. .+++.+|+|.+.............+.+|..++. ..+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 468999999987654322222233444544333 3479999999999999999999999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 332 (468)
+|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence 999999887543 3899999999999999999999 789999999999999999999999999998755322 22
Q ss_pred eeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 333 TLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 333 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
....|+..|+|||.... ..++.++|||||||++|||++|+.||............ .........+.....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~------- 223 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTVNVELPDSFS------- 223 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH--HHhhcCCcCCccccC-------
Confidence 23468999999998864 56889999999999999999999999754322111110 000011112222221
Q ss_pred HHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRP-----TMQLVSNEF 439 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RP-----s~~~v~~~l 439 (468)
..+.+++.+|++.||++|| ++++++++-
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 1266789999999999999 599998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=284.84 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=202.1
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|++|.||++... +++.+++|.+....... ...+.+.+|++++.+++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4778899999999999999654 67899999998765422 345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998765 34899999999999999999999 7899999999999999999999999999998775443
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||............ .....+.......
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~----- 224 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----VQDDHPPLPEGIS----- 224 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----hccCCCCCCCCCC-----
Confidence 3334456888999999988888899999999999999999999998754321111110 0011111221111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+.+++.+||..+|++||++.+++.
T Consensus 225 --~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 225 --PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12667899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=297.09 Aligned_cols=205 Identities=27% Similarity=0.430 Sum_probs=167.9
Q ss_pred CccccceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMF 245 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 245 (468)
.|.+.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777889999999999999764 4789999999874322222335677899999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhhcCcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC----CCCeEEeec
Q 012219 246 LIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS----ELEAFVADF 319 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Df 319 (468)
+||||+++ ++.+.+..... ...++...++.++.|++.||.||| +.+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666643221 235888999999999999999999 789999999999999999 899999999
Q ss_pred cccccccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 320 GVARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 320 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
|+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643222 1223457889999998766 457899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=297.47 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=203.8
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 248 (468)
..|++.++||+||.+.||++...+.+.+|+|++...... ...+..|.+|+.+|.+|+ |.+|+++++|-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 568889999999999999999888899999988655443 346788999999999995 999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||=+ .+|..+|....... ..| .+..+..|++.|+.++| ..||||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus 440 E~Gd-~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred eccc-ccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 9864 58999998655432 334 67788999999999999 679999999999999876 68999999999988654
Q ss_pred CCC--ceeccccccccccccccCC-----------CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 329 SSN--RTLLAGTYGYIAPELAYTM-----------VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 329 ~~~--~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
... ....+||+.||+||.+... +++++|||||+|||||+|+.|+.||..... ...++..+.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aKl~aI~ 586 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAKLHAIT 586 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHHHHhhc
Confidence 432 2345899999999988543 256789999999999999999999985432 123344455
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+|...-+++..... .++.+++..||..||++|||+.+++++-+-..
T Consensus 587 ~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 587 DPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55433222222111 11677899999999999999999997655443
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.79 Aligned_cols=271 Identities=23% Similarity=0.291 Sum_probs=199.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 243 (468)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++.+++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 36788999999999999999974 46999999998764322 1234567789999999999999999988753 346
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++|+||+. |+|.+++.... .+++..+..++.||+.||.||| ..+++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999996 68988886543 3899999999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCC----CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh---h---------
Q 012219 324 LLNFDSS----NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL---D--------- 386 (468)
Q Consensus 324 ~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~---~--------- 386 (468)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 6543221 1123468889999998765 468899999999999999999999996543211000 0
Q ss_pred ----cccccc---cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcCCCCC
Q 012219 387 ----KNIKLI---DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARNKAPM 447 (468)
Q Consensus 387 ----~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~~~~~ 447 (468)
...... +....................+.+++.+||+.+|++||++.+++. .|.+..+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 000000 000000000000001111234788999999999999999988875 5555544444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=289.50 Aligned_cols=257 Identities=21% Similarity=0.226 Sum_probs=190.1
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeC--CEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHR--KCMFLI 247 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 247 (468)
|++.+.||+|+||.||+|.. .+++.+|+|+++...... ......+|+.++.++. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56678899999999999974 568999999987643221 1123457888888885 99999999999987 889999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||++ |++.+.+.... ..+++.+++.++.|++.||.||| +.+++||||+|+||+++. +.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99997 58888776533 24899999999999999999999 779999999999999999 9999999999987643
Q ss_pred CCCCceecccccccccccccc-CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-------------ccccccc
Q 012219 328 DSSNRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-------------KNIKLID 393 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~ 393 (468)
... .....++..|+|||+.. +..++.++|||||||++|||++|+.||........... .......
T Consensus 152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 222 22345788999999764 45678899999999999999999999965332110000 0000000
Q ss_pred ccCCCCCCc----cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 LLDPRLSPP----VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 ~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+...... ...........+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 000011123458889999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=283.33 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=203.2
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.+.+.||+|+||.||++... +++.+++|++...... ....+.+.+|+++++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4778889999999999999764 6899999999765432 1335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++.... ....+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997642 1245899999999999999999999 779999999999999999999999999999876544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||...+..++.++||||+|+++++|++|+.||............ .....+.+.....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~---- 228 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI----LKGQYPPIPSQYS---- 228 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH----hcCCCCCCCCCCC----
Confidence 33334456888999999998888999999999999999999999998654321111110 0000111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+||..+|++|||+.+++++
T Consensus 229 ---~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 229 ---SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 226779999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.20 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=207.8
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEE
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 235 (468)
++...++..+.+.||+|.||.|++|... ....||||.++..... ...+.+..|+++|+.+ +|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 3444455666779999999999999632 1457999999876654 4568899999999998 599999999
Q ss_pred EEEeeCCEEEEEEEeccCCChhhhhhcCc-----cc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 012219 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDE-----EA--------VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS 302 (468)
Q Consensus 236 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 302 (468)
|+|..++..++|.||+..|+|..+++..+ .. ..+...+.+.++.|||.|++||+ +.+++||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhh
Confidence 99999999999999999999999998765 00 13888999999999999999999 8899999999
Q ss_pred CCceeeCCCCCeEEeeccccccccCCCCCc-eeccc--cccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcc
Q 012219 303 SNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAG--TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELL 378 (468)
Q Consensus 303 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~ 378 (468)
++|||++.+..+||+|||+|+......... ....+ ...|||||.+....|+.+||||||||+||||+| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999765433332 21222 346999999999999999999999999999999 99998763
Q ss_pred cccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
...... .+.+........+..... ++++++..||+.+|++||++.++.+.|...
T Consensus 526 ~~~~~l-------~~~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEEL-------LEFLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcHHHH-------HHHHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 311111 112222222111222112 266899999999999999999999999884
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.15 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=185.5
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHH-HhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARL-LSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.||+|+||.||+|.. .+++.||+|.+.............+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999975 4689999999976543322233344455544 4455899999999999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997543 3788999999999999999999 78999999999999999999999999999875432 22
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
...++..|+|||...+..++.++||||||+++|||+||..||......... ..... . ........... ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~---~~~~~~~~~~~---~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-DNILS-R---RINWPEEVKEF---CSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHh-c---ccCCCCccccc---CCHH
Confidence 345788999999998888899999999999999999999999654322111 00000 0 00011111101 1122
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 012219 414 VSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
+.+++.+||+.+|++||++.++.+
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHH
Confidence 678999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.64 Aligned_cols=259 Identities=25% Similarity=0.305 Sum_probs=193.4
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEeeCCE----
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCLHRKC---- 243 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~---- 243 (468)
|++.+.||+|+||.||+|... +++.+|+|++....... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 566788999999999999875 48999999997543322 1234566787777666 59999999999988766
Q ss_pred -EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 244 -MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 244 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 489888865432 24899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc------c-----c
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------K-----L 391 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------~-----~ 391 (468)
....... ......++..|+|||++.+..++.++|||||||++|||++|+.||.............. . .
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 7764332 22233578899999999988999999999999999999999999875432111000000 0 0
Q ss_pred ----ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 392 ----IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 392 ----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
......................+.+++.+||+.||++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000111111111111122234778999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.47 Aligned_cols=263 Identities=28% Similarity=0.294 Sum_probs=194.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 245 (468)
.++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|++++++++|+|++++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 46799999999999999999975 468999999987543221 1123456899999999999999999998754 5689
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+.+ +|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999974 8888876543 34899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--cc-----cccc-cc--
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--KN-----IKLI-DL-- 394 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~~-----~~~~-~~-- 394 (468)
...........++..|+|||.+.+ ..++.++||||+||++|||++|+.||........... .. .... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 543333333445788999998865 4578999999999999999999999864432111000 00 0000 00
Q ss_pred ----cCCCCCCc----cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 ----LDPRLSPP----VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ----~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
-....... ...........+.+++.+|++.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000000012236689999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=298.36 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=194.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
+++|.+.+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999964 57899999998643222 2345678899999999999999999987653 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++++||+.+ +|...+... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 57999999974 787777542 3899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCC---ceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh---h-----cccc
Q 012219 323 RLLNFDSSN---RTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL---D-----KNIK 390 (468)
Q Consensus 323 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~---~-----~~~~ 390 (468)
+........ .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... . ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 765432211 122467889999998654 568899999999999999999999986432110000 0 0000
Q ss_pred cccccC-----------CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCC
Q 012219 391 LIDLLD-----------PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNK 444 (468)
Q Consensus 391 ~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~ 444 (468)
.....+ .................+.+++.+||+.||++|||+.+++++ +.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 000000000001112347789999999999999999999965 433333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=283.65 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=195.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcc--hhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSE--TEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 244 (468)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999975 468999999875432 11223456888999999999999999999998764 468
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+++++|.+++.... .+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 2788889999999999999999 77999999999999999999999999999976
Q ss_pred ccCC---CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFD---SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ........++..|+|||++.+..++.++|||||||++|+|++|+.||........... .......+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~p~ 232 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK---IATQPTKPMLPD 232 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH---HHcCCCCCCCCc
Confidence 5321 1112234588899999999988899999999999999999999999875432211110 000001111222
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... ..+.+++.+|+. +|..||+..+++++
T Consensus 233 ~~~-------~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 233 GVS-------DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ccC-------HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 126678889998 57999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=289.90 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=196.1
Q ss_pred ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
..||+|+||.||++.. .+++.||+|++...... ..+.+.+|+.+++.++|+|++++++++...+..+++|||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 5699999999999976 57899999998644322 3467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
+|.+++... .+++.....++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++............
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999987532 3788999999999999999999 779999999999999999999999999998765433333334
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
..++..|+|||+..+..++.++||||||+++|||++|+.||........... ......+..... . .....+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~-~----~~~~~l 246 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IRDNLPPKLKNL-H----KVSPSL 246 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhhCCcccCCc-c----cCCHHH
Confidence 5688999999999888889999999999999999999999864332111000 001111111110 0 011126
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH-HHHhcCC
Q 012219 415 STVAFSCLRSQPKSRPTMQLVSN-EFIARNK 444 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~~ 444 (468)
.+++.+||+.+|.+||++.+++. .|.....
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 67899999999999999999885 3544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.17 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=194.8
Q ss_pred eeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||.||++... +|+.+++|.+...........+.+.+|++++++++|+|++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999875 4899999999766554344567888999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC------
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS------ 330 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~------ 330 (468)
.+++.... .+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997644 4899999999999999999999 78999999999999999999999999999876533211
Q ss_pred --CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 331 --NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 331 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
......++..|+|||.......+.++||||||+++|++++|+.||............ .. .........
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~----- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI----LN-GKIEWPEDV----- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hc-CCcCCCccc-----
Confidence 223345788999999998888999999999999999999999998754322111100 00 000111110
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.....+.+++.+|++.+|++|||+..+.+.+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0012367899999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=283.08 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=190.0
Q ss_pred HHHHHHHhhCcccccee--eeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEE
Q 012219 162 FQDMIEATEDFHIKYCI--GTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGF 237 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 237 (468)
..+.....++|.+.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +|+|+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEE
Confidence 34455556677777776 9999999999975 568889999986543221 122222222 79999999999
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEE
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFV 316 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl 316 (468)
+...+..++||||+++++|.+++.... .+++.++..++.|+++||.||| +.+++||||||+||+++.++ .++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999999997653 4899999999999999999999 78999999999999999998 9999
Q ss_pred eeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC
Q 012219 317 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 317 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||................ ..
T Consensus 152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~ 224 (267)
T PHA03390 152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR---QQ 224 (267)
T ss_pred ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh---hc
Confidence 999998765422 22357889999999998889999999999999999999999997443221111110000 01
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN 437 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~v~~ 437 (468)
..... .. .....+.+++.+||+.+|.+||+ ++++++
T Consensus 225 ~~~~~--~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPF--IK---NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCc--cc---ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11100 00 11122677899999999999996 588873
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.37 Aligned_cols=259 Identities=27% Similarity=0.338 Sum_probs=194.6
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMFLIY 248 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 248 (468)
|++.+.||+|++|.||+|... +++.+|+|++..... .....+.+.+|+++++.++|+|++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567788999999999999765 588999999986641 112345688999999999999999999999987 7899999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++ +|.+++.... ..+++..++.++.||+.||+||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99975 8888886542 34899999999999999999999 779999999999999999999999999999876433
Q ss_pred CC-CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-----------ccccccc-
Q 012219 329 SS-NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-----------NIKLIDL- 394 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-----------~~~~~~~- 394 (468)
.. ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+........... .....+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 1223356788999997764 46789999999999999999999998754321110000 0000000
Q ss_pred --cCCCCCCccch----hHHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 395 --LDPRLSPPVDQ----KIRQ-DIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 395 --~~~~~~~~~~~----~~~~-~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
........... .... ....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 0001 1234788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.94 Aligned_cols=257 Identities=18% Similarity=0.257 Sum_probs=181.2
Q ss_pred hCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhh--------HHHHHHHHHHHhhccCCceeeEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELAS--------LESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
++|.+.+.||+|+||.||+|...+ +..+|+|+........... ......+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998654 3456666543322110000 0112233445566789999999997
Q ss_pred EeeCC----EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 012219 238 CLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE 313 (468)
Q Consensus 238 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~ 313 (468)
+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 76543 3467777764 35666554322 2567788899999999999999 789999999999999999999
Q ss_pred eEEeeccccccccCCC-------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh
Q 012219 314 AFVADFGVARLLNFDS-------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD 386 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~ 386 (468)
++|+|||+++.+.... .......||+.|+|||+..+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998763221 112234699999999999999999999999999999999999999986532211110
Q ss_pred -cccc-cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 387 -KNIK-LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 387 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.... ...+........ .....+.+++..|+..+|++||+++++.+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIK------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccC------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 011111111111 1112367899999999999999999999876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.52 Aligned_cols=261 Identities=28% Similarity=0.356 Sum_probs=193.5
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC--CEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR--KCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 244 (468)
.++|++.+.||+|+||.||+|... +++.+|+|++....... .....+.+|+.++.++ +|+||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467888999999999999999764 68899999886432211 2234577899999999 999999999998653 468
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||++ ++|..++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 4789999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCC-----CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---cc-------
Q 012219 325 LNFDSS-----NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD---KN------- 388 (468)
Q Consensus 325 ~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~---~~------- 388 (468)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||........... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643221 1223457889999998754 5678899999999999999999999864332110000 00
Q ss_pred ------cccccccC---CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 389 ------IKLIDLLD---PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 389 ------~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....++++ ..-..............+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 000000000000112347789999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.26 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=201.1
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|++.+.||+|+||.||++.. .+++.+++|.+....... .....+.+|++++++++|+||+++.+++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 477889999999999999964 478899999987654332 234677889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++.... ....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+|++|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999986532 2245889999999999999999999 889999999999999999999999999999876543
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
......++..|+|||...+..++.++|+||||+++|||++|+.||........... ... .... ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~---~~~~-~~~~--- 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK----VQR---GKYP-PIPP--- 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hhc---CCCC-CCch---
Confidence 22334578899999999988899999999999999999999999875432211110 000 1111 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+++.+|++.+|++||++.+++.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111237789999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=290.29 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=197.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
..|...+.||+|+||.||+|+. .++..+|+|.+...........+.+.+|+++++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466678899999999999975 467889999986533222234467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+. |++.+.+.... ..+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68877775433 23788999999999999999999 789999999999999999999999999998765422
Q ss_pred CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
....++..|+|||.+. ...++.++|||||||++|||++|+.||............ .....+.... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~---~ 237 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQS---G 237 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCc---c
Confidence 2345788999999874 356788999999999999999999998654321111100 0000111111 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.....+.+++.+||+.+|++||++++++++.......
T Consensus 238 ---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 238 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred ---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 1112266799999999999999999999776655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=292.26 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=191.2
Q ss_pred ceeeee--CCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEecc
Q 012219 176 YCIGTG--GYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 176 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
..||+| +||+||++.. .+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 8999999975 579999999987654332 345788899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 332 (468)
++++.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999999876432 24888999999999999999999 7899999999999999999999999998654332111111
Q ss_pred -------eeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc-------------
Q 012219 333 -------TLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK------------- 390 (468)
Q Consensus 333 -------~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~------------- 390 (468)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 112345679999998763 4789999999999999999999999754321110000000
Q ss_pred -------------------------cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHh
Q 012219 391 -------------------------LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIA 441 (468)
Q Consensus 391 -------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~ 441 (468)
.....+..+..+.. ......+.+++.+||+.||++|||+.+++ +.|.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS---KTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhh---hhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00000001111111 11223478899999999999999999988 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=287.87 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=197.6
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|...+.||+|++|.||++... +++.+++|.+....... .....+.+|++++++++|+||+++++++..+...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 456788999999999999764 78899999987654332 2345778899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+++ ++.+++.... ..+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 975 8888876533 34899999999999999999999 78999999999999999999999999999977654432
Q ss_pred CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-----------cccccc---cc
Q 012219 331 NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-----------NIKLID---LL 395 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-----------~~~~~~---~~ 395 (468)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||............ .....+ ..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 23334578889999998776 7899999999999999999999998654321110000 000000 00
Q ss_pred CCCC----CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRL----SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.... ..............+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 000001111122347899999999999999999998853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=296.33 Aligned_cols=200 Identities=27% Similarity=0.353 Sum_probs=168.2
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR----- 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 241 (468)
..++|...+.||+|+||.||+|.. .+++.||+|.+....... ...+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 347899999999999999999975 478999999986543221 2335677899999999999999999988643
Q ss_pred -CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 242 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 242 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
...++|+||+. ++|.+.+... ++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34799999996 5888877532 788889999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 998764322 223345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=287.81 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=191.9
Q ss_pred hCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|...+ ++.||||.++...... ....+..|+.++.+.. |+||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 568889999999999999998764 8999999997654322 2345667777776665 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+. +++.+++..... .+++..+..++.|++.|++|||+ ..+|+||||+|+||++++++.+||+|||++..+..
T Consensus 93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99985 477776654322 58899999999999999999994 25899999999999999999999999999876542
Q ss_pred CCCCceeccccccccccccccCCC----CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.. ......++..|+|||++.+.. ++.++||||||+++|||++|+.||............ ......+.....
T Consensus 168 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~- 242 (296)
T cd06618 168 SK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK---ILQEEPPSLPPN- 242 (296)
T ss_pred CC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH---HhcCCCCCCCCC-
Confidence 22 222335778999999987553 788999999999999999999998653221111110 000001111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
. .....+.+++.+||+.||++||++++++.+-
T Consensus 243 -~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 243 -E---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -C---CCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0112367899999999999999999998554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=293.61 Aligned_cols=274 Identities=23% Similarity=0.273 Sum_probs=199.7
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 240 (468)
..++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++.+++|+||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 355667789999999999999999999964 578999999997643222 234567789999999999999999998864
Q ss_pred C------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 241 R------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 241 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
. ...+++++++ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 3 3467888877 78998887542 3889999999999999999999 7899999999999999999999
Q ss_pred EEeeccccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---c-cc
Q 012219 315 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD---K-NI 389 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~---~-~~ 389 (468)
||+|||+++.... ......++..|+|||...+ ..++.++|||||||++|||++|+.||........... . ..
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876432 2223467889999998765 5688899999999999999999999864332110000 0 00
Q ss_pred ---ccc------------cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHhcCCCCC
Q 012219 390 ---KLI------------DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIARNKAPM 447 (468)
Q Consensus 390 ---~~~------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~~~~~~~ 447 (468)
... ..++.................+.+++.+|++.||.+||++.+++ +.+......+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 000 00000000000000000112367899999999999999998888 44444333333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=294.80 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=204.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
...|.+...||+|.|+.|..|+. .++..||+|.+++....... .+.+.+|+++|..++|||||+++.+...+..+++|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45788999999999999999975 46899999999887665433 34488999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+.+|.+++++..+.. .....+..++.|+.+|++||| ++.|+|||||++|||++.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999988765 455788889999999999999 8899999999999999999999999999999887
Q ss_pred CCCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+.-...... ...+...+.-+..-.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------~rvl~gk~rIp~~ms 279 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------PRVLRGKYRIPFYMS 279 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------chheeeeecccceee
Confidence 4445566789999999999998765 57899999999999999999999843211000 000111111111100
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .+.+++.+++-.+|.+|++++++..+
T Consensus 280 --~---dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 280 --C---DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --c---hhHHHHHHhhccCccccCCHHHhhhh
Confidence 0 14568889999999999999999854
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=290.62 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=189.4
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
.+.+|.|+++.||++.. +++.||+|++...... ....+.+.+|+++++.++|+||+++++++...+..+++|||+++|
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34455555555555555 7899999999765322 234578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC----
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS---- 330 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 330 (468)
+|.+++..... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999975432 24788899999999999999999 78999999999999999999999999998875532211
Q ss_pred ---CceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc-cccc-----------
Q 012219 331 ---NRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI-KLID----------- 393 (468)
Q Consensus 331 ---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~----------- 393 (468)
......++..|+|||++.. ..++.++|||||||++|||++|+.||.............. ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1122346778999999875 3588999999999999999999999975432211110000 0000
Q ss_pred ---------ccCCCCCCcc-chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 394 ---------LLDPRLSPPV-DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 394 ---------~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..++...... ..........+.+++.+||+.||++|||+++++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000000000 000001112477899999999999999999999543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.16 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=190.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|++.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 45799999999999999999975 468999999886543221 12234568999999999999999999987643
Q ss_pred ---EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 243 ---CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 243 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
..++|+||+. ++|.+.+.... ..+++.+++.++.||+.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 47887776532 24899999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCCCC----ceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc--
Q 012219 320 GVARLLNFDSSN----RTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI-- 392 (468)
Q Consensus 320 g~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-- 392 (468)
|++......... .....++..|+|||++.+. .++.++||||||+++|||+||+.||........ ........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 999766432211 1223567889999987664 478899999999999999999999864322100 00000000
Q ss_pred ------------cccCC-CCCCccchhHHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 ------------DLLDP-RLSPPVDQKIRQ------DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ------------~~~~~-~~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+..+. ............ ....+.+++.+||+.||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000000000 01235689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=289.10 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=199.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|.+++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999754 78999999997643332233467889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997654 4899999999999999999999 78999999999999999999999999999876643
Q ss_pred CCC--------------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 328 DSS--------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 328 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
... ......++..|+|||......++.++||||||++++++++|+.||........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHH
Confidence 221 11224578899999999888899999999999999999999999875432111 110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM----QLVSN 437 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~~v~~ 437 (468)
.. .....+....+ ..+.+++.+||+.+|++||++ +++++
T Consensus 234 ~~----~~~~~~~~~~~-------~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL----KLEYSFPPNFP-------PDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH----hcCCCCCCccC-------HHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 01111111111 126789999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.34 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=194.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
.++|.+.+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35788899999999999999974 578999999987542221 2245677899999999999999999987643 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++++||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999996 68888886543 3899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchh----------------h
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS----------------L 385 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~----------------~ 385 (468)
+.............++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876433233334467889999998764 46889999999999999999999998643211000 0
Q ss_pred hcccccccc---cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 DKNIKLIDL---LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......... ...................+.+++.+||+.+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 00000000000000112336789999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.58 Aligned_cols=263 Identities=24% Similarity=0.236 Sum_probs=192.3
Q ss_pred hCcc-ccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhh-----------hHHHHHHHHHHHhhccCCceeeEEE
Q 012219 170 EDFH-IKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELA-----------SLESFGNEARLLSQIRHRNIVKLYG 236 (468)
Q Consensus 170 ~~~~-~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 236 (468)
++|. +.+.||+|+||.||+|.. .+++.||+|++......... ....+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 356799999999999975 47899999998654322100 0124678999999999999999999
Q ss_pred EEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 237 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 68988886432 3888999999999999999999 789999999999999999999999
Q ss_pred eeccccccccCC--------------CCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCccccc
Q 012219 317 ADFGVARLLNFD--------------SSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSS 381 (468)
Q Consensus 317 ~Dfg~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~ 381 (468)
+|||.++..... ........++..|+|||++.+. .++.++|||||||++|||+||+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999765411 1111223467889999988764 4688999999999999999999998654321
Q ss_pred chhhhc------c--c--------ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 382 SWSLDK------N--I--------KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 382 ~~~~~~------~--~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
...... . . ........................+.+++.+|++.+|++||++++++.+-
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 100000 0 0 00000000000000000011123377899999999999999999998543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=289.66 Aligned_cols=264 Identities=28% Similarity=0.364 Sum_probs=194.1
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK---- 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 242 (468)
..++|++.+.||+|+||.||+|... +++.||+|+++...... .....+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4578999999999999999999764 68899999997543221 22346778999999999999999999987654
Q ss_pred ------EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 243 ------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 243 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
..++|+||+++ ++...+... ...+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence 78999999986 777776543 234899999999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCC-CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh--hc--ccc
Q 012219 317 ADFGVARLLNFDSS-NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL--DK--NIK 390 (468)
Q Consensus 317 ~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~--~~~ 390 (468)
+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .. ...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999987643321 1122345778999998764 457889999999999999999999987433211000 00 000
Q ss_pred ----cccc--------cCCCC--CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 ----LIDL--------LDPRL--SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 ----~~~~--------~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..++ .++.. ..............+.+++..||+.||++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00000 000000000011247789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=282.60 Aligned_cols=244 Identities=22% Similarity=0.236 Sum_probs=185.7
Q ss_pred eeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHH---HHhhccCCceeeEEEEEeeCCEEEEEEEecc
Q 012219 177 CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEAR---LLSQIRHRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
.||+|+||.||++.. .+++.||+|.+.............+..|.. .++...||+|+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999975 468899999987543321111122334433 4445679999999999999999999999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 332 (468)
+|+|.+++.... .+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence 999999886543 4899999999999999999999 789999999999999999999999999998765322 22
Q ss_pred eeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHH
Q 012219 333 TLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411 (468)
Q Consensus 333 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (468)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||........... ........+.+....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~s------- 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTMAVELPDSFS------- 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--HHHhhccCCCCCCcCC-------
Confidence 234689999999998754 688999999999999999999999975432111100 0001111122222111
Q ss_pred HHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 012219 412 ILVSTVAFSCLRSQPKSRP-----TMQLVSN 437 (468)
Q Consensus 412 ~~l~~l~~~cl~~dP~~RP-----s~~~v~~ 437 (468)
..+.+++.+|+..+|.+|| ++.++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2266789999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.10 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=202.1
Q ss_pred hCccccceeeeeCCceEEEEEcCCCC-EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|.+...||.|+||.||++..++.. ..|.|++..... ..+++|+-|+++|..+.||+||++++.|...+.++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 44667778999999999999766544 456677754433 45789999999999999999999999999899999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||.||.....+-.-+ +.+.+.++..++.|++.||.||| +..|||||||+.|||++-+|.++|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999988776543 34889999999999999999999 789999999999999999999999999998665544
Q ss_pred CCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 SSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
......+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-......+.... +..--.|.+..+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK----iaKSePPTLlqP- 258 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEPPTLLQP- 258 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH----HhhcCCCcccCc-
Confidence 45566789999999999864 56899999999999999999999999665443322211 111112222211
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+. ..+.+++.+||.++|..||++.+++++-+-
T Consensus 259 -S~Ws---~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 259 -SHWS---RSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred -chhh---hHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 1111 126678899999999999999998866543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.92 Aligned_cols=268 Identities=25% Similarity=0.314 Sum_probs=200.8
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----EE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-----CM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 244 (468)
+|.+.+.||+|++|.||+|... +++.+|+|++...... ....+.+.+|+++++.++|+||+++.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4778899999999999999864 5899999999764321 233467889999999999999999999988765 78
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+++|||++ ++|.+++.... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999998 48888886543 5899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCC---CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------
Q 012219 325 LNFDS---SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-------------- 386 (468)
Q Consensus 325 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-------------- 386 (468)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65432 123334578899999999887 889999999999999999999999865432110000
Q ss_pred --ccccccccc---CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCCCC
Q 012219 387 --KNIKLIDLL---DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNKAP 446 (468)
Q Consensus 387 --~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~~~ 446 (468)
......+.+ ..................+.+++.+||+.+|++||++++++.+ |.+..+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000000000 0000000000000112236789999999999999999999864 44333333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=286.63 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=192.5
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|...+.||+|+||.||+|+. .+++.|++|++...........+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567799999999999975 46889999998755433333456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
+. |++.+++.... ..+++.+++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 57777775433 34889999999999999999999 7799999999999999999999999999986432
Q ss_pred Cceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 331 NRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
......|+..|+|||++. ...++.++|||||||++|||++|..||............ .....+.... ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~---~~~ 245 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNDSPTLQS---NEW 245 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCc---ccc
Confidence 222346888999999874 456888999999999999999999998654322111110 0000011111 001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+.+++.+||+.+|.+||++.+++++
T Consensus 246 ---~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 ---TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1126678999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.81 Aligned_cols=275 Identities=23% Similarity=0.309 Sum_probs=199.7
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CC
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RK 242 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 242 (468)
+...+++|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|++++..++|||++++.+++.. ..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 344678899999999999999999964 478999999886532221 234567789999999999999999998875 45
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++++||+ +++|.+++... .+++.....++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 56888887642 3778888899999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-------------hc-
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-------------DK- 387 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-------------~~- 387 (468)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......... ..
T Consensus 156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 75432 1223456888999998765 568999999999999999999999986432210000 00
Q ss_pred --cccccccc---CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCCCCCCCCc
Q 012219 388 --NIKLIDLL---DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNKAPMQKPF 451 (468)
Q Consensus 388 --~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~~~~~~~~ 451 (468)
.....+.. ......+...........+.+++.+|++.+|++||++.+++.+ +......+...+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~ 302 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence 00000000 0000000000000111347789999999999999999998854 4444444433333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=288.11 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=201.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|..-..||+|+||.||-++. .+|+.+|.|++.+..........-..+|-.++.+++.+.||.+--.+...+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577778999999999999965 469999999987665554444456678999999999999999988889999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
..|.||+|.-+|...+. ..+++..++-++.+|+.||++|| +.+||.|||||+|||+|+.|+++|+|+|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 99999999999977654 45999999999999999999999 88999999999999999999999999999998763
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||.+|||||++.+..|+...|.||+||++|||+.|+.||.....-. ....+...+- ......+..+.
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k~eEvdrr~~-~~~~ey~~kFS 414 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----KREEVDRRTL-EDPEEYSDKFS 414 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----hHHHHHHHHh-cchhhcccccC
Confidence 344444589999999999999999999999999999999999999996432110 0100000000 00111112222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
++ ...+....|.+||++|.. +++|.+
T Consensus 415 ~e---akslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 415 EE---AKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HH---HHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 33 445666789999999975 456664
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=285.15 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=196.4
Q ss_pred CccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
+|++.+.||+|++|.||++.. .+++.||||+++..... .....+.+.+|++++.++ +|+||+++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999964 35788999998754322 223346788999999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... .+++..+..++.|+++||.||| ..+++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 3788999999999999999999 78999999999999999999999999999876
Q ss_pred ccCCCCC-ceeccccccccccccccCCC--CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSN-RTLLAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|..||.................. ..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPK 233 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCc
Confidence 5433221 22345788999999987654 788999999999999999999998632211110000000000 1111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
... ..+.+++.+||+.||++|||+.++...|.
T Consensus 234 ~~~-------~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 234 TMS-------AEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ccC-------HHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 111 12667899999999999999888876654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=284.05 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=193.5
Q ss_pred CccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchhh-hhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEE-LASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
+|++.+.||+|+||.||+++. .+|+.||+|++....... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999975 478999999997543321 12345678899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987543 3788888999999999999999 78999999999999999999999999999976
Q ss_pred ccCCC-CCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDS-SNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......|+..|+|||..... .++.++||||||+++|+|++|+.||................ ....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQ 233 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh-hccCCCCCc
Confidence 54322 122234588899999998753 46789999999999999999999986322111100000000 001111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
... ..+.+++.+|++.||++|| ++++++.+
T Consensus 234 ~~~-------~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 234 EMS-------ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cCC-------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111 2266789999999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.52 Aligned_cols=203 Identities=19% Similarity=0.285 Sum_probs=158.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcCC--CCEEEEEE--------------ecCcchhhhhhHHHHHHHHHHHhhccCCce
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPS--GKVVALKK--------------LHRSETEELASLESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 231 (468)
..++|.+.+.||+|+||+||++..+. +...++|. +.............+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999986432 22222221 111001111234568899999999999999
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN 309 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~ 309 (468)
+++++++...+..++++|++. ++|.+++..... .......+...++.||+.||.||| +.+|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 577777654221 112345667789999999999999 78999999999999999
Q ss_pred CCCCeEEeeccccccccCCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 012219 310 SELEAFVADFGVARLLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 310 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
.++.+||+|||+++.+..... ......|+..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999987643322 22235789999999999999999999999999999999998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=313.31 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=189.7
Q ss_pred HHHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----
Q 012219 166 IEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH---- 240 (468)
Q Consensus 166 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---- 240 (468)
.+...+|+....||+||||.||+++.+ ||+.+|||++.... . ........+|+..+++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s-~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S-DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H-HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 455678999999999999999999754 89999999998765 2 2344567799999999999999999732100
Q ss_pred --------------------------------------------------------------------------------
Q 012219 241 -------------------------------------------------------------------------------- 240 (468)
Q Consensus 241 -------------------------------------------------------------------------------- 240 (468)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHH
Q 012219 241 ---------------------------R--------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285 (468)
Q Consensus 241 ---------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l 285 (468)
. ...||-||||+..++.++++.+.-.. .....++++.+|+.||
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHH
Confidence 0 12567889998888888887654211 3567889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc------------------CCCCCceeccccccccccccc
Q 012219 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN------------------FDSSNRTLLAGTYGYIAPELA 347 (468)
Q Consensus 286 ~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~ 347 (468)
+|+| +.|+|||||||.||++|++..|||+|||+|+... ......+..+||.-|+|||++
T Consensus 711 aYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999 8899999999999999999999999999998721 111234557899999999998
Q ss_pred cCC---CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccC
Q 012219 348 YTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRS 424 (468)
Q Consensus 348 ~~~---~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 424 (468)
.+. .|+.|+|+||+|||++||+. ||...... . ..+..+-+..++.+ .....+....=.+++.++++.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a-----~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-A-----SILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHH-H-----HHHHhcccCCCCCC-cccccccchHHHHHHHHHhcC
Confidence 764 59999999999999999995 45432211 1 11111112222222 111112222244688999999
Q ss_pred CCCCCCCHHHHHH
Q 012219 425 QPKSRPTMQLVSN 437 (468)
Q Consensus 425 dP~~RPs~~~v~~ 437 (468)
||.+|||+.|+++
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999884
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=292.30 Aligned_cols=256 Identities=25% Similarity=0.307 Sum_probs=189.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------C
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------K 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 242 (468)
++|.....||+|+||.||+|.. .+|+.||+|++......+ .....+.+|+++++.++|+||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 6888999999999999999975 578999999987543221 2235678999999999999999999988654 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++|+||+.. +|..+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 6766542 23788999999999999999999 779999999999999999999999999998
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--c------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--K------------ 387 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~------------ 387 (468)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .
T Consensus 165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 76432 1223457888999998876 4688999999999999999999999975331110000 0
Q ss_pred --ccccccccC--CCC-CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 --NIKLIDLLD--PRL-SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 --~~~~~~~~~--~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......... +.. ..............+.+++.+||+.||++||++++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 000000000111236789999999999999999999943
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=283.93 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=193.6
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 249 (468)
|++.+.||+|++|+||+|... +++.|++|++....... ......+|+..+.+++ |+|++++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567788999999999999865 57889999987543321 1223457899999999 9999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+ +|+|.+++.... ...+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 789998887654 234899999999999999999999 7799999999999999999999999999997654322
Q ss_pred CCceecccccccccccccc-CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------cccccccc
Q 012219 330 SNRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------KNIKLIDL 394 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------~~~~~~~~ 394 (468)
......++..|+|||++. ...++.++||||||+++|||++|+.||........... ........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223345788999999875 45678999999999999999999999864432111000 00000000
Q ss_pred cCCCCCCcc----chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPV----DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+....... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 111111000 00000112347789999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=284.88 Aligned_cols=260 Identities=25% Similarity=0.310 Sum_probs=196.8
Q ss_pred ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|+..+.||+|++|.||+|... +++.+|+|.+...... ....+.+..|++++++++|+|++++++++......++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 456678999999999999764 5899999999865422 12345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
++ ++|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 58999997643 24899999999999999999999 77999999999999999999999999999987654333
Q ss_pred CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-----------cccccccc--cC
Q 012219 331 NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-----------KNIKLIDL--LD 396 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~~--~~ 396 (468)
......++..|+|||.+.+. .++.++|||||||++||+++|+.||........... ......+. .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33334567789999998766 789999999999999999999999864332110000 00000000 00
Q ss_pred CCCCC----ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 397 PRLSP----PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 397 ~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ............+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0000000112247889999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=289.48 Aligned_cols=263 Identities=24% Similarity=0.283 Sum_probs=191.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------ 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 241 (468)
.++|++.+.||+|+||.||+|.. .+++.+|+|++......+. ....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 46899999999999999999975 4689999998865433221 123567899999999999999999987543
Q ss_pred --CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 242 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 242 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
...++|+||+.+ ++...+.... ..+++..+..++.|+++||.||| +.+++|+||||+||++++++.++|+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 6777665432 34899999999999999999999 789999999999999999999999999
Q ss_pred cccccccCCCCC-----------ceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-
Q 012219 320 GVARLLNFDSSN-----------RTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD- 386 (468)
Q Consensus 320 g~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~- 386 (468)
|+++........ .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 112346788999998765 4588999999999999999999999864332110000
Q ss_pred -------------ccccccc----ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 387 -------------KNIKLID----LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 387 -------------~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....... ....................+.+++.+|++.||++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 000011111000011111347789999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=282.42 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=193.2
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhh--hhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEE--LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
+|.+.+.||+|+||.||++... .+..+++|.++.....+ ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999754 34456666655422211 11223566789999999999999999999998899999
Q ss_pred EEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 248 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
+||+++++|.+++... .....+++.+++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 22345899999999999999999999 789999999999999976 569999999997764
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
..........++..|+|||......++.++||||||+++|+|++|..||.......... .......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~---- 228 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL----RIVEGPTPSLPET---- 228 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHHcCCCCCCcch----
Confidence 43333334567889999999888888999999999999999999999986432211110 1111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+||+.+|++||++.+++++
T Consensus 229 ---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 229 ---YSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11236779999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=277.81 Aligned_cols=239 Identities=27% Similarity=0.371 Sum_probs=193.4
Q ss_pred eeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|+||.||++... +++.+|+|.+.............+..|++++++++|+|++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999764 5899999998776544334556788999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecc
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 336 (468)
.+++.... .+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997653 3889999999999999999999 78999999999999999999999999999977644323334456
Q ss_pred ccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHH
Q 012219 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVST 416 (468)
Q Consensus 337 g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 416 (468)
++..|+|||...+...+.++|+||||+++|++++|+.||........ ... ... ....+....+ ..+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~---~~~-~~~~~~~~~~-------~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEK---ILK-DPLRFPEFLS-------PEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH---Hhc-CCCCCCCCCC-------HHHHH
Confidence 88899999999888889999999999999999999999865432111 000 000 1111111111 22667
Q ss_pred HHHhcccCCCCCCCCHHH
Q 012219 417 VAFSCLRSQPKSRPTMQL 434 (468)
Q Consensus 417 l~~~cl~~dP~~RPs~~~ 434 (468)
++.+||..||++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=298.67 Aligned_cols=203 Identities=33% Similarity=0.499 Sum_probs=176.5
Q ss_pred ccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------CEE
Q 012219 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------KCM 244 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 244 (468)
+...+.||+|+||.||+|+ ..+|+.||||.++.... ....+...+|++++++++|+|||+++++-... +..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3445679999999999998 56799999999987542 23457788999999999999999999876543 357
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCC--CeEEeecc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN--SEL--EAFVADFG 320 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfg 320 (468)
.+|||||.+|||+..+....+..++++.+.+.++.+++.||.||| ..+|+||||||.||++- .+| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999999998899999999999999999999999 77999999999999983 333 35899999
Q ss_pred ccccccCCCCCceecccccccccccccc-CCCCCccchhhHHHHHHHHHHhCCCCCCcccc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAY-TMVVTEKCDVYSFGVVALEVLMGKHPGELLSS 380 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~ 380 (468)
.|+.++. .......+||..|.+||+.. ...|+..+|.|||||++|+..||..||.....
T Consensus 170 ~Arel~d-~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 170 AARELDD-NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccccCCC-CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9999874 44667789999999999998 48899999999999999999999999975443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=269.77 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=199.1
Q ss_pred hhCcccc-ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee----C
Q 012219 169 TEDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH----R 241 (468)
Q Consensus 169 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~ 241 (468)
+++|.+. ++||-|-.|.|-.+.. .+++.+|+|++.... ..++|+++--.. .|||||.+++++.. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4566554 5699999999999954 578999999997543 234788765555 59999999998864 4
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEee
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVAD 318 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D 318 (468)
..+++|||.|+||.|+..++..+. ..+.+.++-.|+.||+.|+.||| +..|.||||||+|+|.+. |..+||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecc
Confidence 568899999999999999987553 34899999999999999999999 889999999999999965 45789999
Q ss_pred ccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
||+|+.-.. .......+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||........+..- ......-.-.
T Consensus 208 fGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM-k~rI~~gqy~ 285 (400)
T KOG0604|consen 208 FGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KRRIRTGQYE 285 (400)
T ss_pred cccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH-HhHhhccCcc
Confidence 999987542 34455668899999999999999999999999999999999999999755432222111 1111111223
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcC
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARN 443 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~ 443 (468)
++.+.+..+++. ..++|+.+|..+|.+|.|++++++ .|-...
T Consensus 286 FP~pEWs~VSe~---aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEA---AKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHH---HHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 344444444443 456888999999999999999984 454443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=264.13 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=194.4
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.+....||.|..|.|++++.+ .|..+|||.+.+....+ +.+.+...++++..-+ +|.||+.+|||..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3444566999999999999765 58999999998876543 4577778888776664 899999999999998889999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|.|.. .+..++..-.. ++++.-.-++...+.+||.||.. +++|+|||+||+|||+|+.|++|++|||.+-.+- +
T Consensus 171 elMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv-d 244 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-D 244 (391)
T ss_pred HHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee-c
Confidence 98853 45555554333 36777777888999999999986 6799999999999999999999999999997764 3
Q ss_pred CCCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
+...+...|-+.|||||.+.. ..|+-++||||||+.++||.||+.||..-...-..... +.+-..|.++....
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk---vln~ePP~L~~~~g- 320 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK---VLNEEPPLLPGHMG- 320 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH---HHhcCCCCCCcccC-
Confidence 444555678899999998864 36889999999999999999999999865443222211 11112233333221
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
+.. .+.+++..||++|+.+||...+++++=
T Consensus 321 -FSp---~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 321 -FSP---DFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred -cCH---HHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 111 266789999999999999999888553
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.02 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=192.0
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK---- 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 242 (468)
..++|.+.+.||+|+||.||++. ..++..||||++...... ....+.+.+|++++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45789999999999999999996 457899999998654322 123356779999999999999999999887543
Q ss_pred --EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 243 --CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 243 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 6789888753 23889999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc---cc----ccc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK---NI----KLI 392 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---~~----~~~ 392 (468)
++...... .....+++.|+|||.+.+ ..++.++||||||+++|++++|+.||............ .. ...
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99765322 223457889999998875 45889999999999999999999999754321110000 00 000
Q ss_pred cccC-----------CCCCC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 393 DLLD-----------PRLSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 393 ~~~~-----------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
+.+. +.... ............+.+++.+|++.||++|||+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000 00000 00000001112367899999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=291.89 Aligned_cols=272 Identities=23% Similarity=0.290 Sum_probs=198.8
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE---
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC--- 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 243 (468)
..++|.+...||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.+++.++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567999999999999999999764 68899999987543221 233567789999999999999999987765544
Q ss_pred ---EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 244 ---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 244 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5799988864 23899999999999999999999 7899999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc---cc-c-----
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK---NI-K----- 390 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---~~-~----- 390 (468)
++...... .....++..|+|||...+ ..++.++|||||||++||++||+.||............ .. .
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99765422 233457889999998765 46788999999999999999999998643321110000 00 0
Q ss_pred -------cccc---cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcCCCCCCCCc
Q 012219 391 -------LIDL---LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARNKAPMQKPF 451 (468)
Q Consensus 391 -------~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~~~~~~~~~ 451 (468)
.... +..................+.+++.+|++.+|++|||+.+++. .|......+...+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~ 312 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV 312 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc
Confidence 0000 0000000000000011234778999999999999999999974 34443344334443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.39 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=202.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|...+.||+|.||+|..++- .+++.+|+|++++...-.......-..|-++++..+||.+..+.-.++..+.+|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788899999999999999974 57999999999887655555566677899999999999999998888899999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||..||.|.-+|.... .+++....-.-..|..||.||| +.+||.||||.+|.|+|.||++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998887543 3788888888899999999999 78999999999999999999999999999986544
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc---CCCCCCccc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL---DPRLSPPVD 404 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 404 (468)
.......++||+.|+|||++....|+.++|.|.+||++|||++|+.||...... ++.+++ |-+++....
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------kLFeLIl~ed~kFPr~ls 392 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------KLFELILMEDLKFPRTLS 392 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------HHHHHHHhhhccCCccCC
Confidence 555667789999999999999999999999999999999999999999754322 112211 222222222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
. + -..+....+.+||.+|.. +.||.+
T Consensus 393 ~----e---AktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 393 P----E---AKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred H----H---HHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1 1 223556789999999963 556653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.95 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=201.9
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
-++.....||.|.||.||.|. ..+|...|+|-++..... ....+...+|+.++..++|||+|+++|+-.+++..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 456667889999999999995 667999999988765544 456678889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|.+.++.... .++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999975433 566666678899999999999 789999999999999999999999999999887543
Q ss_pred CC----CceeccccccccccccccCC---CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 329 SS----NRTLLAGTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 329 ~~----~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.. ......||+.|||||++.+. ....+.||||+||+..||+||+.||..++.. |......... -.|.++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~g--h~Pq~P~ 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAG--HKPQIPE 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhcc--CCCCCch
Confidence 21 12235799999999999754 3567899999999999999999999765542 3332221111 1122222
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
. +.. +=.+++..|++.||++|-++.|++++=+.
T Consensus 1465 ~----ls~---~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1465 R----LSS---EGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred h----hhH---hHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 1 111 14468889999999999888888766554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.91 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=189.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-------
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------- 241 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 241 (468)
.+|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5788999999999999999975 56899999998765432 346788999999999999999999776543
Q ss_pred -------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCC
Q 012219 242 -------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELE 313 (468)
Q Consensus 242 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~ 313 (468)
...++|+||++ ++|.+++... .+++.....++.||+.||.||| +.+++||||||+||+++. ++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence 35789999997 5888877532 3889999999999999999999 779999999999999974 567
Q ss_pred eEEeeccccccccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--
Q 012219 314 AFVADFGVARLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-- 387 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-- 387 (468)
++++|||.++....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 89999999976532211 1122357888999997654 56888999999999999999999999644321110000
Q ss_pred ---------ccccc----cccC---CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHHh
Q 012219 388 ---------NIKLI----DLLD---PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFIA 441 (468)
Q Consensus 388 ---------~~~~~----~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~~ 441 (468)
..... .... .....+...........+.+++.+|++.||++|||+.+++ +.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 00000 0000 0000000000001112367899999999999999999998 34443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=304.72 Aligned_cols=148 Identities=27% Similarity=0.417 Sum_probs=132.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||+|++.............+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999764 68999999997654433344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
||+.+++|.+++.... .+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 3788889999999999999999 7799999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=283.72 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=187.3
Q ss_pred CccccceeeeeCCceEEEEEcC-C--CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC----C
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-S--GKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR----K 242 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~ 242 (468)
+|++.+.||+|+||.||+++.. + +..||+|++...... ....+.+.+|++++.++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4777889999999999999754 3 788999998643221 12245678899999999 599999999875432 4
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++++||+. ++|.+++.... .+++..+..++.||+.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5788899886 68988886533 3889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCC----CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-----------
Q 012219 323 RLLNFDSS----NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD----------- 386 (468)
Q Consensus 323 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~----------- 386 (468)
+....... ......|+..|+|||+..+ ..++.++|||||||++|+|++|+.||...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 76542211 1223468899999998765 4688999999999999999999999875331100000
Q ss_pred ---c--ccccccc---cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 387 ---K--NIKLIDL---LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 387 ---~--~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
. ....... ...................+.+++.+|++.||++|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 0000000 000000000000000112377899999999999999998887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=266.54 Aligned_cols=203 Identities=27% Similarity=0.364 Sum_probs=168.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-C--C--CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-P--S--GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 242 (468)
...|+....||+|.||.||+|.- + + .+.+|+|+++..+..+.- -....+|+.+++.++|||++.+..++.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 45688899999999999999942 2 2 347899999877544322 2455699999999999999999998877 78
Q ss_pred EEEEEEEeccCCChhhhhhcC--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC----CCeEE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTD--EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE----LEAFV 316 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl 316 (468)
..++++||.+. +|...++.. .....++...+.+|+.||+.|+.||| +.=|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 89999999986 888877543 33456888899999999999999999 6679999999999999988 99999
Q ss_pred eeccccccccCCCCC---ceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCC
Q 012219 317 ADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 317 ~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~ 376 (468)
+|+|+++.+...-.. ....+-|..|+|||++.+. .||.+.||||.|||+.||+|-++-|.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999998643332 2335678999999998875 58999999999999999999887764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.70 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=199.4
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFC 238 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 238 (468)
+|+|+.+.|+ +.||+|+|+.|--+. ..+|..+|||++.+... .......+|++++.+.+ |+||+.+++|+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 4777777775 559999999999884 67899999999987643 34567779999999985 99999999999
Q ss_pred eeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeE
Q 012219 239 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAF 315 (468)
Q Consensus 239 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 315 (468)
+++...|||||-|.||+|..+++.... +++.++.++..+|+.||.||| .+||.||||||+|||-.... -+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence 999999999999999999999987554 899999999999999999999 89999999999999996654 479
Q ss_pred EeeccccccccCCC-------CCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCccc--cc
Q 012219 316 VADFGVARLLNFDS-------SNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLS--SS 381 (468)
Q Consensus 316 l~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~--~~ 381 (468)
|+||.++.-+.... ......+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||...= .-
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99999875442211 1223457899999999763 3468999999999999999999999996431 11
Q ss_pred chhhhc-----ccccccccCC---CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 382 SWSLDK-----NIKLIDLLDP---RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 382 ~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.|.... ...+.+-+.. .++...+..+..+ -.+++...+..|+.+|.++.++++
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~e---akdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSE---AKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHH---HHHHHHHHHhccHHhhhhhhhccC
Confidence 222111 1111121211 1222222233333 345677788899999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=269.02 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=209.1
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEE
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 235 (468)
.+++.....++.....+-+|.||.||.|-+. +.+.|-||.++....+ -+...|..|.-++..+.|||+.++.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCcccee
Confidence 4556666678888889999999999999543 4456778887765443 3456788999999999999999999
Q ss_pred EEEeeC-CEEEEEEEeccCCChhhhhh-----cCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 012219 236 GFCLHR-KCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN 309 (468)
Q Consensus 236 ~~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~ 309 (468)
+++.+. ...+++|.++.-|+|..++. .......+...+...++.|++.|++||| +.++||.||.++|.++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceeh
Confidence 998764 56789999999999999998 4444556788899999999999999999 88999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhh
Q 012219 310 SELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD 386 (468)
Q Consensus 310 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~ 386 (468)
+..++||+|=.+++.+.+..+.. .....+..||+||.+....|+.++|||||||+||||+| |+.|+-..+.......
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 99999999999999875433321 12235678999999999999999999999999999999 9999876543221111
Q ss_pred cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
- .+ ..++..+. ++..+++.++..||..+|++||++++++.-|.+-
T Consensus 511 l----kd--GyRlaQP~-----NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 L----KD--GYRLAQPF-----NCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred H----hc--cceecCCC-----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 0 00 01122222 2333488899999999999999999999888654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.18 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=207.7
Q ss_pred HHhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee----
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH---- 240 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 240 (468)
..++-|++.+.||.|.+|.||+++ .++++.+|+|++......+ ++...|.++++.. .|||++.++|++..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 345678999999999999999996 5678999999998766543 3455788888887 69999999999864
Q ss_pred -CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
++.++||||||.+||..|++.... ...+.|..+..|+..++.|+.+|| ...++|||+|-.|||++.++.||+.||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence 568999999999999999998766 556999999999999999999999 778999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccccccccccCC-----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|.+..+...........||+.|||||++... .|+..+|+||+|++..||--|.+|+-++......+.. ...
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I----pRN 243 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRN 243 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----CCC
Confidence 9999887766777778999999999998643 4778999999999999999999998766543332211 111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..|.+.. +..+ ..++.++|..|+.+|.++||++.+++++
T Consensus 244 PPPkLkr--p~kW---s~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 PPPKLKR--PKKW---SKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCccccc--hhhH---HHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1122221 1222 2347789999999999999999888754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=263.08 Aligned_cols=219 Identities=23% Similarity=0.203 Sum_probs=173.4
Q ss_pred eCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhh
Q 012219 181 GGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV 259 (468)
Q Consensus 181 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 259 (468)
|.+|.||++.. .+++.+|+|++..... +.+|...+....|||++++++++...+..+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 88999999965 5789999999976432 22455555566799999999999999999999999999999999
Q ss_pred hhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccc
Q 012219 260 LRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339 (468)
Q Consensus 260 l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 339 (468)
+.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 87543 3889999999999999999999 789999999999999999999999999988665422 12234567
Q ss_pred cccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHH
Q 012219 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAF 419 (468)
Q Consensus 340 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 419 (468)
.|+|||......++.++||||+|+++|||++|+.|+....... .......++.... ..+.+++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~~~~~~~-------~~~~~li~ 210 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTLNIPEWVS-------EEARSLLQ 210 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccccCCcccCC-------HHHHHHHH
Confidence 8999999988889999999999999999999998865322110 0000011111111 12667899
Q ss_pred hcccCCCCCCCCH
Q 012219 420 SCLRSQPKSRPTM 432 (468)
Q Consensus 420 ~cl~~dP~~RPs~ 432 (468)
+|++.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=282.94 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=192.7
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
.++.|.+...+|.|+|+.|-.+. ..+++..+||++...... -.+|+.++... +||||+++.+.+.+....+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 36788888999999999998885 567888999999876222 22567666555 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-CCCCCeEEeecccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL-NSELEAFVADFGVARL 324 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfg~~~~ 324 (468)
+|||.+.++-+.+.+...+. .. .++..|+.+|+.|+.||| .+|++||||||+|||+ ++.++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999998888876543 22 677789999999999999 7899999999999999 5889999999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... ....+-|..|.|||++....|++++|+||||++||+|++|+.||..-+.... +...+ ..+.++
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-------i~~~i---~~~~~s 532 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-------IHTRI---QMPKFS 532 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-------HHHhh---cCCccc
Confidence 6543 2334568899999999999999999999999999999999999975544311 11111 111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS-NEFI 440 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~-~~l~ 440 (468)
..+++. -.+++..||+.||.+||+|.++. +.|.
T Consensus 533 ~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ECVSDE---AKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccCHH---HHHHHHHhccCChhhCcChhhhccCcch
Confidence 222222 44688899999999999999887 4454
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=237.95 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=195.3
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|...++||+|.||+||+|+. .+++.||+|.+..+...+. ......+|+-+++.++|.|||++++....++..-+|+||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 44557799999999999974 5688999999987665443 234567999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
|. .+|..+...-.. .++.....+++.|+.+||.|+| ++.+.||||||+|.+++.+|+.|++|||+++.++-+-.
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 96 478777765433 3888889999999999999999 78999999999999999999999999999998876555
Q ss_pred CceeccccccccccccccCC-CCCccchhhHHHHHHHHHHh-CCCCCCcccccchh-----------hhcccccccccCC
Q 012219 331 NRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWS-----------LDKNIKLIDLLDP 397 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~-----------~~~~~~~~~~~~~ 397 (468)
..+..+-|..|.+|.++.+. -|++..|+||.|||+.|+.. |++.|...+-.... .+++-.+....|-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 55556789999999998876 58889999999999999997 77666533211100 0011111111221
Q ss_pred CCCCccc--hhHHHH----HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 398 RLSPPVD--QKIRQD----IILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 398 ~~~~~~~--~~~~~~----~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..-+.+. ..+.+. ...=.++..+.+.-+|.+|.++++.+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111 111111 1223467777888899999999887653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=262.44 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=189.3
Q ss_pred ccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh-ccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 174 IKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQ-IRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
....||.|+||+|+|..+ +.|+..|||++...... ...+++..|.+...+ =+.||||+++|.+..++..++.||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 345699999999999965 57999999999876653 345778888876554 47999999999999999999999999
Q ss_pred cCCChhhhhhc--CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 252 EMGSLFCVLRT--DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 252 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
. -|+..+... .-....+++.-.-.|......||.||-. ...|+|||+||+|||++..|.+||+|||.+-.+. ++
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-~S 221 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-DS 221 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH-HH
Confidence 6 476654432 1122347777777888889999999986 5689999999999999999999999999987653 33
Q ss_pred CCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC-CCCCccchh
Q 012219 330 SNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP-RLSPPVDQK 406 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 406 (468)
...+...|-..|||||.+... .|+-+|||||+|+.|||+.||+.||..-.+.-..... .-.-|| .+..+. .
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~----Vv~gdpp~l~~~~-~- 295 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ----VVIGDPPILLFDK-E- 295 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH----HHcCCCCeecCcc-c-
Confidence 344556788899999988643 5899999999999999999999998754331111110 001111 111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.......+..++..|+.+|-..||...++.++
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 01122337788999999999999999998854
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.53 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=196.8
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcch--hh--hhhHHHHHHHHHHHhhccCCceeeEEEEEe-eCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSET--EE--LASLESFGNEARLLSQIRHRNIVKLYGFCL-HRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~ 243 (468)
++|-+..+||+|+|+.||++. +.+.+.||||+-...+. .+ ....+...+|.++-+.|.||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457777899999999999994 66788999997654322 11 123456678999999999999999999986 4567
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeecc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADFG 320 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg 320 (468)
+|-|.|||+|.+|.-+|..++. +++.++..|+.||..||.||... +++|||-||||.|||+-+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 8999999999999999987654 89999999999999999999966 789999999999999954 3789999999
Q ss_pred ccccccCCCCC-------ceeccccccccccccccC----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc
Q 012219 321 VARLLNFDSSN-------RTLLAGTYGYIAPELAYT----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI 389 (468)
Q Consensus 321 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 389 (468)
+++.+..+... .+...||.+|++||.+.- ..++.|+||||.|||+|+.+.|+.||.........+...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN- 697 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN- 697 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-
Confidence 99998765443 233579999999998753 368899999999999999999999998655433322221
Q ss_pred ccccccCCCC--CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 390 KLIDLLDPRL--SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 390 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.+.....-.+ .+.... + ...+|.+||...-++|.+..++..
T Consensus 698 TIlkAtEVqFP~KPvVss---e----AkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSS---E----AKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred chhcceeccCCCCCccCH---H----HHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111111 111111 1 345888999999999998877763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=258.83 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=193.2
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--------C
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--------R 241 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 241 (468)
.|.-..+||+|.||.||+|+. ++|+.||+|+..-+...+.-. ....+|++++..++|+|++.+++.|.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 455567899999999999975 467888998765433222222 234589999999999999999998864 3
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
.+.++|+++|+. +|...+.... ..++..++.+++.++..||.|+| ...|+|||+||.|+|++.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 458999999985 8888886543 34888999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCC----CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCccccc---------------
Q 012219 322 ARLLNFDSS----NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSS--------------- 381 (468)
Q Consensus 322 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~--------------- 381 (468)
++.+..... ..+..+-|..|++||.+.+ ..|+++.|||..|||+.||+||.+-++.....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643222 2333456899999998775 57999999999999999999999887643321
Q ss_pred -chhhhcccccccccCCC-CCCccchhHHHHHH------HHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 382 -SWSLDKNIKLIDLLDPR-LSPPVDQKIRQDII------LVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 382 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~------~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.|.......+.+.+... +.......+.+.+. .-.+++.+++..||.+||++++++++-.-.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 22211111111111100 11111111112221 356788899999999999999999665443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.66 Aligned_cols=259 Identities=26% Similarity=0.340 Sum_probs=204.3
Q ss_pred HHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 164 DMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
++.-..++|.+.+.||+|+||.|..++. .+++.+|+|++.+...-.......|..|-++|..-+.+-|+.+.-.|.+.+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3444467899999999999999999986 468899999998866555556678999999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
.+|+|||||+||+|..++.... .+++..+.-++..|.-||.-+| +.|+|||||||.|||+|..|++||+|||.|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998765 3777777888899999999999 899999999999999999999999999999
Q ss_pred ccccCCCCCc-eeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchh--hhcccccccc
Q 012219 323 RLLNFDSSNR-TLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS--LDKNIKLIDL 394 (468)
Q Consensus 323 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~ 394 (468)
-.+..++... ...+|||-|.+||++.. +.|++.+|.||+||++|||+.|..||.......-. .........+
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 8887655544 44689999999999863 56899999999999999999999999743321110 0111111111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT---MQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~~v~~~l 439 (468)
.+ . ..++++ ..+||.+.+ -+|+.|.. ++++..+-
T Consensus 303 P~-----~--~~VSee---akdLI~~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 303 PD-----E--TDVSEE---AKDLIEALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred Cc-----c--cccCHH---HHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence 10 0 112222 334555544 47888888 89988654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.14 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=191.7
Q ss_pred cceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 175 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.+.||+|.||+||-|.. ++|+.||||++.+....... ..++++|+.+|+.++||.||.+--.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999964 58999999999877665433 36789999999999999999999999999999999999965
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEeeccccccccCCCC
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 330 (468)
+..+++-.... ..+++....-++.||+.||.||| -.+|+|+||||+|||+.+. -++||+|||+|++++ +..
T Consensus 648 -DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg-Eks 721 (888)
T KOG4236|consen 648 -DMLEMILSSEK-GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG-EKS 721 (888)
T ss_pred -hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc-hhh
Confidence 55555544333 23788777888999999999999 7899999999999999654 468999999999986 445
Q ss_pred CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHH
Q 012219 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410 (468)
Q Consensus 331 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (468)
.....+||+.|+|||++....|...-|+||.|||+|--++|..||......... .+...++ +++..+..+...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----IQNAaFM---yPp~PW~eis~~ 794 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----IQNAAFM---YPPNPWSEISPE 794 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----hhccccc---cCCCchhhcCHH
Confidence 566778999999999999999999999999999999999999999743321111 1112222 222222222222
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 411 IILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 411 ~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
-.++|...++..=.+|-|.++-+
T Consensus 795 ---AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 795 ---AIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---HHHHHHHHHHHHHHHhcchHhhc
Confidence 44677778888878888765543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=263.89 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=197.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--C----ceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--R----NIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~ 241 (468)
+++|.+...+|+|.||.|..+.. ..+..||||+++.-... .++.+-|+++++++.+ | -+|.+.+|+...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 67899999999999999999964 34789999999865543 3456679999999942 2 277788899999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS----------- 310 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~----------- 310 (468)
++.|+|+|.+ |-|+.+++..+.. .+++...+..++.|++++++||| +.+++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence 9999999998 5699999987543 45889999999999999999999 889999999999999831
Q ss_pred ---------CCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccccc
Q 012219 311 ---------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS 381 (468)
Q Consensus 311 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~ 381 (468)
+..++|.|||.|..-. ...+..+.|..|.|||++.+..++.++||||+||||.|+.||...|+.-...
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3457899999998743 3446678899999999999999999999999999999999999887643211
Q ss_pred chhhhcccccc-------------------cccC---CCC----------CCc---cchhHHHHHHHHHHHHHhcccCCC
Q 012219 382 SWSLDKNIKLI-------------------DLLD---PRL----------SPP---VDQKIRQDIILVSTVAFSCLRSQP 426 (468)
Q Consensus 382 ~~~~~~~~~~~-------------------~~~~---~~~----------~~~---~~~~~~~~~~~l~~l~~~cl~~dP 426 (468)
. ...-.+.+. .-+| ... ..+ .......+...|.+|+.+|+..||
T Consensus 316 E-HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 E-HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred H-HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 0 000000000 0011 000 000 000112344569999999999999
Q ss_pred CCCCCHHHHH-HHHHh
Q 012219 427 KSRPTMQLVS-NEFIA 441 (468)
Q Consensus 427 ~~RPs~~~v~-~~l~~ 441 (468)
.+|+|+.|++ +.|++
T Consensus 395 ~~RiTl~EAL~HpFF~ 410 (415)
T KOG0671|consen 395 ARRITLREALSHPFFA 410 (415)
T ss_pred cccccHHHHhcCHHhh
Confidence 9999998887 44444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.65 Aligned_cols=239 Identities=30% Similarity=0.429 Sum_probs=190.1
Q ss_pred CCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhhh
Q 012219 182 GYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL 260 (468)
Q Consensus 182 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 260 (468)
+||.||+|... +++.+++|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999875 589999999986554321 578899999999999999999999999999999999999999999998
Q ss_pred hcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceecccccc
Q 012219 261 RTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340 (468)
Q Consensus 261 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 340 (468)
..... +++..++.++.+++.++.+|| ..+++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGR---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred HhccC---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 76443 788999999999999999999 7799999999999999999999999999998765332 2334567889
Q ss_pred ccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHh
Q 012219 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFS 420 (468)
Q Consensus 341 y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 420 (468)
|+|||......++.++||||||++++++++|..||.............. . ........ .. .....+.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~-~~~~~~~~-~~---~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---K-PKPPFPPP-EW---KISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---c-cCCCCccc-cc---cCCHHHHHHHHH
Confidence 9999999888899999999999999999999999875322111111000 0 00000000 00 011237789999
Q ss_pred cccCCCCCCCCHHHHHH
Q 012219 421 CLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 421 cl~~dP~~RPs~~~v~~ 437 (468)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.40 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=187.1
Q ss_pred ccccceeeeeCCce-EEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEE
Q 012219 172 FHIKYCIGTGGYGS-VYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 172 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 249 (468)
|.-.+.+|.|+.|+ ||+|.. +|+.||||++..... ....+|+..++.- +|||||++++.-.++...||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44456789998875 599988 688999999975543 2345899998877 69999999999999999999999
Q ss_pred eccCCChhhhhhcCcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---C--CCeEEeeccccc
Q 012219 250 YMEMGSLFCVLRTDEEAV-GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---E--LEAFVADFGVAR 323 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~--~~~kl~Dfg~~~ 323 (468)
.|. .+|.+++....... .......+.+..|++.||++|| +.+||||||||+|||++. + ..++|+|||+++
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 996 59999998741111 1122456788999999999999 789999999999999976 3 578999999999
Q ss_pred cccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCC
Q 012219 324 LLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 324 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
.+...... .....||-+|+|||++....-+.++||||+||++|..++ |++||.+.-............... +
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~----L 735 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH----L 735 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee----e
Confidence 98754433 234679999999999999888889999999999999999 599998543221111111110100 1
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.+.. ++ +-.++|.+|++.||..||++.+|+++-
T Consensus 736 ~~~~-----d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 736 EPLP-----DC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ccCc-----hH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 1110 01 245789999999999999999998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=285.08 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=167.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-C----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEE-----
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-S----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF----- 237 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~----- 237 (468)
..++|.+.+.||+|+||.||+|++. + +..||+|++......+ .+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999764 4 6899999886433221 11111 1111122222221111
Q ss_pred -EeeCCEEEEEEEeccCCChhhhhhcCccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 012219 238 -CLHRKCMFLIYEYMEMGSLFCVLRTDEEA-----------------VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHR 299 (468)
Q Consensus 238 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 299 (468)
+......++|+||+.+++|.+++...... .......+..++.|++.||.||| +.+|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence 24566789999999999999988653211 00122345679999999999999 7899999
Q ss_pred CCCCCceeeCC-CCCeEEeeccccccccCC-CCCceeccccccccccccccCC----------------------CCCcc
Q 012219 300 DISSNNVLLNS-ELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAYTM----------------------VVTEK 355 (468)
Q Consensus 300 dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~ 355 (468)
||||+|||++. ++.+||+|||+++.+... ........+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 579999999999865432 2223445789999999965321 24456
Q ss_pred chhhHHHHHHHHHHhCCCCCCcccccch-hhhcc----cccccccCCCCCCccchhH---HHHHHHHHHHHHhcccCCCC
Q 012219 356 CDVYSFGVVALEVLMGKHPGELLSSSSW-SLDKN----IKLIDLLDPRLSPPVDQKI---RQDIILVSTVAFSCLRSQPK 427 (468)
Q Consensus 356 ~Dv~s~Gvil~el~tg~~p~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~ 427 (468)
+|||||||++|||+++..|++....... ..... ........+.......... ........+++.+|++.||+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 7999999999999998877543110000 00000 0000111111111100000 00001234799999999999
Q ss_pred CCCCHHHHHHH
Q 012219 428 SRPTMQLVSNE 438 (468)
Q Consensus 428 ~RPs~~~v~~~ 438 (468)
+|||+++++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=260.90 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=195.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 247 (468)
.+|+....||+|+||.|..+.. .+...+|||+++++..-.....+.-+.|-++|... +-|.++++..+++.-+.++.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4799999999999999999954 45678999999876543333344445666777655 578899999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+.||+|--+++.-+. +.+..+.-+|..||-||-+|| ++||+.||||..|||+|.+|.+||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888876544 777888889999999999999 89999999999999999999999999999987655
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
+.......+||+.|+|||++....|+..+|.|||||+||||+.|++||+..+..... ..+.+....- +...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~ehnvsy--PKsl 573 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIMEHNVSY--PKSL 573 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHHccCcC--cccc
Confidence 666777889999999999999999999999999999999999999999875543221 1112222221 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPT 431 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs 431 (468)
+.+ -..+....+.+.|.+|..
T Consensus 574 SkE---Av~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 574 SKE---AVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cHH---HHHHHHHHhhcCCccccC
Confidence 222 345677888999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=273.11 Aligned_cols=264 Identities=17% Similarity=0.190 Sum_probs=177.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-----------------CCCCEEEEEEecCcchhhh-----------hhHHHHHHHH
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-----------------PSGKVVALKKLHRSETEEL-----------ASLESFGNEA 220 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~ 220 (468)
.++|.+.++||+|+||.||+|.+ ..++.||||++........ ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999953 2456899999875432210 0112344577
Q ss_pred HHHhhccCCce-----eeEEEEEee--------CCEEEEEEEeccCCChhhhhhcCcc---------------------c
Q 012219 221 RLLSQIRHRNI-----VKLYGFCLH--------RKCMFLIYEYMEMGSLFCVLRTDEE---------------------A 266 (468)
Q Consensus 221 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 266 (468)
.++.+++|.++ ++++++|.. ....++||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777876654 677787753 3468999999999999999864211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC-ceeccccccccccc
Q 012219 267 VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPE 345 (468)
Q Consensus 267 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE 345 (468)
..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ .....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 13467788899999999999999 779999999999999999999999999999765432211 11223478999999
Q ss_pred cccCCC--------------------C--CccchhhHHHHHHHHHHhCCC-CCCcccccchhhhccccc----ccccCCC
Q 012219 346 LAYTMV--------------------V--TEKCDVYSFGVVALEVLMGKH-PGELLSSSSWSLDKNIKL----IDLLDPR 398 (468)
Q Consensus 346 ~~~~~~--------------------~--~~~~Dv~s~Gvil~el~tg~~-p~~~~~~~~~~~~~~~~~----~~~~~~~ 398 (468)
.+.... + ..+.||||+||+++||++|.. |+................ .......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875332 1 124799999999999999886 664322111110000000 0000000
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHH
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQP---KSRPTMQLVSNE 438 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~~v~~~ 438 (468)
....... ..-....+++.+|+..+| .+|+|++|++++
T Consensus 461 ~~~~~~d---~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDFSLLD---RNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCccccc---ccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000000 011125568888998766 689999999854
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=270.22 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred hCccccceeeeeCCceEEEEEcCCCC-EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++.....||-|+||.|=.+..+..+ .+|+|.+++....+..+.+....|-.+|...+.|.||++|-.+.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999999875544 38999888766655566677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|-|-||.+...++..+. ++.....-++..+.+|++||| +++||.|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999987554 788888889999999999999 889999999999999999999999999999998744
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....++||+.|.|||++.+...+.++|.||+|+++|||+||++||...+..... ..+..-+|..- .+..+.
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY----n~ILkGid~i~---~Pr~I~ 645 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY----NLILKGIDKIE---FPRRIT 645 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH----HHHHhhhhhhh---cccccc
Confidence 3445579999999999999999999999999999999999999999865432111 11111111100 011111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
. .-.+++.+.+..+|.+|.. +.++.++
T Consensus 646 k---~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 646 K---TATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h---hHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 1446788889999999986 5666643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=249.31 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=201.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+...||+|+|.+|..+++ ++.+.+|+|++++.-..+.+.++..+.|-.+..+- +||.+|-+..++..+..++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46799999999999999999976 46788999999887666656666667787777776 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|.||++||+|--+++.+.+ +++..+.-+...|+-||.||| ++||+.||||..|||+|..|.+|++|+|.++.--
T Consensus 329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999777765443 888888888999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc-cCCCCCCccch
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL-LDPRLSPPVDQ 405 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 405 (468)
.+....+.++||+.|.|||.+.+..|...+|.|++||+++||+.|+.||+.............-+.++ +...+..+-+-
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 66677778999999999999999999999999999999999999999998654332211111111111 12222211111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPT 431 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs 431 (468)
. .....+...-+++||.+|..
T Consensus 483 s-----vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 483 S-----VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred e-----hhhHHHHHHhhcCCcHHhcC
Confidence 1 11334667889999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=229.36 Aligned_cols=206 Identities=25% Similarity=0.380 Sum_probs=167.1
Q ss_pred HHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
...++..-...||+|++|.|-+.++ .+|+..|+|.+...-.. ...+...+|+.+..+- .+|.+|.++|...+....
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3345555667799999999988864 68999999999765443 3446677888876554 799999999999999999
Q ss_pred EEEEEeccCCChhhhhhc-CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 245 FLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
++.||.|. .||..+.+. -.....+++.-.-+|+..|.+||.|||+ ...++|||+||+|||++.+|++|++|||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999996 477766543 1233447888888999999999999996 5689999999999999999999999999987
Q ss_pred cccCCCCCceeccccccccccccccC----CCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYT----MVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
.+. ++-..+...|-..|||||.+.. ..|+-+|||||+|+.+.||.+++.||+.-
T Consensus 198 ~L~-dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLV-DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeh-hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 664 3333444567788999998753 37899999999999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=257.74 Aligned_cols=203 Identities=23% Similarity=0.381 Sum_probs=173.8
Q ss_pred CccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
-|...+.||-|+||.|.+++ .++...+|.|.+.+.+.-..........|-+||..-..+-||+||-.|.+.+.+|.|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46677889999999999996 45567799999988776655666778889999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|++||++-.+|-..+- +.+..+.-++..+..|+++.| +.|+|||||||.|||+|.||.+||+|||+|.-+....
T Consensus 710 YIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988875442 777777778889999999999 9999999999999999999999999999986542100
Q ss_pred C------------------------------------------CceeccccccccccccccCCCCCccchhhHHHHHHHH
Q 012219 330 S------------------------------------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALE 367 (468)
Q Consensus 330 ~------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~e 367 (468)
. .....+||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 0012368999999999999999999999999999999
Q ss_pred HHhCCCCCCccc
Q 012219 368 VLMGKHPGELLS 379 (468)
Q Consensus 368 l~tg~~p~~~~~ 379 (468)
|+.|+.||-...
T Consensus 864 m~~g~~pf~~~t 875 (1034)
T KOG0608|consen 864 MLVGQPPFLADT 875 (1034)
T ss_pred HhhCCCCccCCC
Confidence 999999996543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=231.12 Aligned_cols=211 Identities=34% Similarity=0.577 Sum_probs=182.8
Q ss_pred eeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCCh
Q 012219 178 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 256 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 256 (468)
||+|++|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998754 8999999998765432 346788999999999999999999999998999999999999999
Q ss_pred hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeeccccccccCCCCCceec
Q 012219 257 FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNFDSSNRTLL 335 (468)
Q Consensus 257 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 335 (468)
.+++.... ..+++..+..++.++++++.+|| +.+++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99987542 24789999999999999999999 779999999999999999 8999999999998765332223345
Q ss_pred cccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHH
Q 012219 336 AGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILV 414 (468)
Q Consensus 336 ~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 414 (468)
.+...|++||..... ..+.++|+|++|++++++ ..+
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~ 190 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL 190 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence 578899999998877 888999999999999999 226
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHH
Q 012219 415 STVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 415 ~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+++.+|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 778999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=240.91 Aligned_cols=131 Identities=26% Similarity=0.480 Sum_probs=111.5
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-----C---CceeeEEEEEee
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-----H---RNIVKLYGFCLH 240 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~ 240 (468)
.+|.+..+||-|.|++||.+. ..+.+.||+|+.+..... .+....||++|++++ | ..||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 689999999999999999996 457889999999876544 355668999999984 3 469999999875
Q ss_pred ----CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 241 ----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 241 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
..+.|||+|++ |.+|..++....- +.++...+.+|+.||+.||.|||..| ||||-||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46799999999 6688888876543 45899999999999999999999865 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=226.54 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=191.0
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeC--CE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHR--KC 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~ 243 (468)
..++|++.+++|+|.++.||.|. ..+...++||+++..+. +...+|+.++..++ ||||++++++..++ ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35789999999999999999995 56788999999986543 45679999999997 99999999998764 45
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~ 322 (468)
..||+||+.+.+....... ++...+...+.+++.||.|+| +.||+|||+||+|+++|.. ...+|+|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchH
Confidence 7899999999887766543 667788889999999999999 8999999999999999976 56899999999
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc-------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN------------- 388 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~------------- 388 (468)
.++.+. ......+.+..|.-||++.. ..|+..-|+|||||++..|+..+.||-...+........
T Consensus 181 EFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 181 EFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 988643 33444566778999998865 468888999999999999999999985433221110000
Q ss_pred cccccccCCCCCC--------ccchhHH---HH--HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 389 IKLIDLLDPRLSP--------PVDQKIR---QD--IILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 389 ~~~~~~~~~~~~~--------~~~~~~~---~~--~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.+-.-.+||.+.. .....+. +. ..+..+++.+.+..|..+|||++|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000002222211 0000000 00 123667888999999999999988874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=249.30 Aligned_cols=203 Identities=24% Similarity=0.331 Sum_probs=172.2
Q ss_pred HHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHH-----HHHHHHHHHhhcc---CCceeeEEEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLE-----SFGNEARLLSQIR---HRNIVKLYGF 237 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~e~~~l~~l~---h~niv~l~~~ 237 (468)
+...+|...+.+|+|+||.|+.+.++ +...|+||.+.+.+.-...+.+ ..-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 44567899999999999999999764 4667899988766543222222 2446999999997 9999999999
Q ss_pred EeeCCEEEEEEEec-cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 238 CLHRKCMFLIYEYM-EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 238 ~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
+++++.++|+||-. ++-+|++++..... +++.++..|+.||+.|+++|| +.+|||||||-+||.++.+|-+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence 99999999999976 56689999987554 889999999999999999999 889999999999999999999999
Q ss_pred eeccccccccCCCCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCc
Q 012219 317 ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 317 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
+|||.+... .......++||..|.|||++.+..| ...-|||++|++||-++....||..
T Consensus 712 idfgsaa~~--ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYT--KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhh--cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999998764 3345566789999999999998876 4568999999999999999999763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=232.20 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=188.8
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC------
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK------ 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 242 (468)
.+|.-...+|.|.- .|..+. .-.++.||+|++...... ....+...+|..++..++|+|+++++.++.-.+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 34555667888877 555553 346899999998776333 233456679999999999999999999886433
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++|||+|. .+|...+.. .++......|..|++.|+.||| +.||+||||||+||++..+...||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence 4789999996 588888762 2677888899999999999999 889999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccccc-chhh----------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS-SWSL---------------- 385 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~-~~~~---------------- 385 (468)
+.-... -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|...... .|..
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 875443 3455677889999999999988999999999999999999999876532110 0000
Q ss_pred -----------hc--cccccc-ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 -----------DK--NIKLID-LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 -----------~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+ .....+ +.|..+.... ...........+++.+||-.+|++|.++++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~-e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVL-EGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccc-cCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 000000 0111111110 0011122336678999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=224.89 Aligned_cols=199 Identities=36% Similarity=0.546 Sum_probs=171.3
Q ss_pred ccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+.+++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 4567889999999999998764 899999999866543 2356888999999999999999999999998999999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC-
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS- 329 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 329 (468)
+++++|.+++...... +++.....++.+++.++.+|| ..+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999998764322 788999999999999999999 6799999999999999999999999999998765332
Q ss_pred CCceeccccccccccccc-cCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 330 SNRTLLAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=253.05 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=199.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.....+|.|.+|.|||++. ..++..|+|+++.....+ .+...+|+-+++..+|+||+.++|.+......++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 36788899999999999999974 578999999998765543 34556899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||||.+|+|.+..+..+. +++.++..+.+...+|++||| +.+-+|||||-.||++++.+.+|++|||.+-.+..
T Consensus 91 MEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999998876554 888899999999999999999 88999999999999999999999999999877765
Q ss_pred CCCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 328 DSSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.-.....+.||+.|||||+.. .+.|..++|||+.|+...|+---++|.-+....+...- -.....+|.-.....
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L---mTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL---MTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH---hhccCCCCCcccCCc
Confidence 555556678999999999763 56799999999999999999887777433222111111 011111221111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
.+ -..+.++++.|+.++|++||+++.++
T Consensus 242 -kw---s~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 -KW---SEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -cc---hHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11 11277899999999999999986554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=223.71 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=183.6
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEE-EeeCCEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGF-CLHRKCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~ 245 (468)
.+.|.+.+.+|+|.||.+-.+.++ +.+.+++|.+...... +++|.+|...--.| .|.||+.-++. ++..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 357889999999999999999765 5778999999877654 57899998876666 58999988765 45567788
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-CC-CCCeEEeeccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL-NS-ELEAFVADFGVAR 323 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll-~~-~~~~kl~Dfg~~~ 323 (468)
.++||++.|+|.+-+... ++.+....+++.|+++|+.|+| +..+||||||.+|||+ +. ..++|++|||..+
T Consensus 99 F~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 999999999998887653 3778888899999999999999 8899999999999998 33 3589999999987
Q ss_pred cccCCCCCceeccccccccccccccCC-----CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTM-----VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
..+.. ......+..|.|||+.... ...+.+|||.||++++..+||+.||+.........-.......-..+.
T Consensus 172 k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 172 KVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred ccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 65421 1222345679999976532 456789999999999999999999974322211111111111112222
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
++..+...... .+++..+-+..+|++|--..++..
T Consensus 249 ~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 249 LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CchhhcccCHH----HHHHHHHhcCCcccccchhHHHHH
Confidence 33222222222 556777889999999965555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-31 Score=229.10 Aligned_cols=195 Identities=32% Similarity=0.393 Sum_probs=160.9
Q ss_pred ccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----EEEEE
Q 012219 174 IKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-----CMFLI 247 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 247 (468)
-...||-|+||.||.++. ++|+.||.|++.... ......+.+.+|++++..++|.|++..+++..-.. +.|++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 356799999999999975 579999999997543 33455678889999999999999999988765432 35778
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+|.|. .+|...+-.... ++...+.-++.||.+||+||| +.+|.||||||.|.|++.+...||+|||+++.-..
T Consensus 136 TELmQ-SDLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheeccCCC---CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 88885 477776654433 677777788999999999999 88999999999999999999999999999987654
Q ss_pred CC-CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCC
Q 012219 328 DS-SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 328 ~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~ 376 (468)
+. ...+..+-|..|+|||.+.+. .|+.+.||||.|||+.|++..+..|+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 32 334445678899999999875 68999999999999999999887775
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=233.84 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=170.5
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc------CCceeeEEEEEee
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR------HRNIVKLYGFCLH 240 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~ 240 (468)
.-.+|.+....|+|-|++|.+|.. .-|..||||++.....- .+.=..|+++|++|+ --|.++++-.|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 346788889999999999999965 45789999999876543 244558999999995 2478888888999
Q ss_pred CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeec
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADF 319 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df 319 (468)
.+++|||+|-+. -+|.+.|...+....+....+..++.|+.-||..|- ..+|+|.||||.|||+++.. ..|||||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccC
Confidence 999999999885 599999999888888999999999999999999999 77999999999999998874 5799999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
|.|...+. ...+...-+..|.|||++.+..|+...|+||.||.||||.||+..|..
T Consensus 582 GSA~~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 582 GSASFASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccccccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 99976542 222333446679999999999999999999999999999999987754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=207.62 Aligned_cols=170 Identities=21% Similarity=0.129 Sum_probs=125.1
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
|+|.++++..+ ..+++.+++.++.||+.||.|||+ .+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997543 348999999999999999999994 44 999999999999999 99998764322
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHH
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIIL 413 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (468)
..|++.|+|||++.+..++.++|||||||++|||+||+.||....................++.... ..... .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~ 140 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRS-NLESV-SAARS 140 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccc-cHHHH-Hhhhh
Confidence 2588999999999999999999999999999999999999865433211111110000000111000 01111 11124
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 414 VSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 414 l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+.+++.+||..+|++||++.++++++....
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 788999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=260.30 Aligned_cols=195 Identities=19% Similarity=0.224 Sum_probs=138.6
Q ss_pred hccC-CceeeEEEEE-------eeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012219 225 QIRH-RNIVKLYGFC-------LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296 (468)
Q Consensus 225 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 296 (468)
.++| +||+++++++ ......+.++||+ +++|.+++.... ..+++.+++.++.||++||.||| +.+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 3455 5788888877 2334577888987 569999997532 34899999999999999999999 7899
Q ss_pred EecCCCCCceeeCC-------------------CCCeEEeeccccccccCCC----------------CCceeccccccc
Q 012219 297 VHRDISSNNVLLNS-------------------ELEAFVADFGVARLLNFDS----------------SNRTLLAGTYGY 341 (468)
Q Consensus 297 vH~dlk~~NIll~~-------------------~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~y 341 (468)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456667777665421100 001113578889
Q ss_pred cccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhc
Q 012219 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSC 421 (468)
Q Consensus 342 ~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 421 (468)
||||++.+..++.++|||||||++|||++|..|+........... .....+... ........++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR-----HRVLPPQIL--------LNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH-----HhhcChhhh--------hcCHHHHHHHHHh
Confidence 999999999999999999999999999999988653211100000 001111110 1112245678899
Q ss_pred ccCCCCCCCCHHHHHHH
Q 012219 422 LRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 422 l~~dP~~RPs~~~v~~~ 438 (468)
|+++|.+||+|.+++++
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=221.60 Aligned_cols=195 Identities=30% Similarity=0.420 Sum_probs=163.6
Q ss_pred HhhCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRK 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 242 (468)
..+.|...++||+|.|++||++.+. ..+.||+|.+...... ....+|+++|..+. +.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4467888999999999999999643 4678999999876544 35779999999995 999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeeccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGV 321 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~ 321 (468)
..++|+||++.....+++.. ++..++...+..+..||+++| ..||||||+||+|++.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence 99999999999999888865 678889999999999999999 8899999999999999865 6678999999
Q ss_pred cccccCC----------------------------------CCC----------ceeccccccccccccccC-CCCCccc
Q 012219 322 ARLLNFD----------------------------------SSN----------RTLLAGTYGYIAPELAYT-MVVTEKC 356 (468)
Q Consensus 322 ~~~~~~~----------------------------------~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~ 356 (468)
|...... +.. .....||++|.|||++.. ..-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9722100 000 011358999999998875 4678899
Q ss_pred hhhHHHHHHHHHHhCCCCCC
Q 012219 357 DVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 357 Dv~s~Gvil~el~tg~~p~~ 376 (468)
||||.|||++.+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999974
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=205.93 Aligned_cols=252 Identities=20% Similarity=0.330 Sum_probs=189.2
Q ss_pred ccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 172 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
..+.-+|.+...|..|+|++.. ..+++|++.-..... ..-++|..|.-.++.+.||||+.++|.|..+....++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4445678899999999999964 456667776544332 23468999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
+.|||+..++.... ...+..++.+++.+||+|++|||+. .+-|.---|.+..|++|++.+++|+ .+-+++.. .
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf----q 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF----Q 342 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee----e
Confidence 99999999997643 4477889999999999999999965 4445556799999999999999874 12222111 1
Q ss_pred ceeccccccccccccccCCCCC---ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 332 RTLLAGTYGYIAPELAYTMVVT---EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 332 ~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+.||+||.++..+.+ +++|+|||.+++||+.|...||.+.+....... -..+-+...+++. +.
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---ialeglrv~ippg----is 415 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---IALEGLRVHIPPG----IS 415 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---hhhccccccCCCC----cc
Confidence 1112457889999998866533 578999999999999999999987654322211 1122333333333 33
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.. +.+++.-|++.||.+||.++.++-.|+++
T Consensus 416 ~h---m~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 416 RH---MNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HH---HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33 44567779999999999999999888765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.23 Aligned_cols=166 Identities=20% Similarity=0.181 Sum_probs=128.0
Q ss_pred HhhCccccceeeeeCCceEEEEEcC--CCCEEEEEEecCcch--hhhhhHHHHHHHHHHHhhccCCceee-EEEEEeeCC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSET--EELASLESFGNEARLLSQIRHRNIVK-LYGFCLHRK 242 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~ 242 (468)
..++|.+.+.||+|+||+||+|+.. +++.+|||++..... ......+.|.+|++++++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3467999999999999999999754 577889998753311 11123467899999999999999985 4432 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeeCCCCCeEEeeccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI-SSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfg~ 321 (468)
..++||||+++++|... .. .. ...++.++++||.||| +.||+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 57999999999999632 11 11 1467889999999999 789999999 99999999999999999999
Q ss_pred cccccCCCCCc--------eeccccccccccccccCC
Q 012219 322 ARLLNFDSSNR--------TLLAGTYGYIAPELAYTM 350 (468)
Q Consensus 322 ~~~~~~~~~~~--------~~~~g~~~y~aPE~~~~~ 350 (468)
|+.+....... ....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 98765432111 234578889999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=195.91 Aligned_cols=259 Identities=31% Similarity=0.426 Sum_probs=196.4
Q ss_pred ccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC-ceeeEEEEEeeCCEEEEEEEe
Q 012219 172 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR-NIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 250 (468)
|.....||.|+||.||++... ..+++|.+.............|.+|+..+..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 88999999876654433467899999999999988 799999999877778999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeeccccccccCCC
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDS 329 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 329 (468)
+.++++.+++........+.......++.|++.++.|+| ..+++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432124788899999999999999999 77899999999999999998 79999999998654333
Q ss_pred C------CceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCccccc---chhhhccc-ccccccC
Q 012219 330 S------NRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSS---SWSLDKNI-KLIDLLD 396 (468)
Q Consensus 330 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~---~~~~~~~~-~~~~~~~ 396 (468)
. ......|+..|+|||.... ..+....|+||+|++++++++|..|+...... ........ .......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2 2355679999999999987 57888999999999999999999997654421 01000000 0000000
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
........ ......+.+++..|+..+|..|.++.+....
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 01111000 1111236678889999999999999776654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=198.00 Aligned_cols=258 Identities=20% Similarity=0.241 Sum_probs=188.9
Q ss_pred CccccceeeeeCCceEEEEEcCCC--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC----CceeeEEEEE-eeCCE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSG--KVVALKKLHRSETEELASLESFGNEARLLSQIRH----RNIVKLYGFC-LHRKC 243 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~ 243 (468)
+|.+...||+|+||.||.+..... ..+|+|.......... ..+..|..++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999976543 4788888776433211 146678888888863 5888888888 47778
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-----CCeEEee
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-----LEAFVAD 318 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~D 318 (468)
.++||+.+ |.+|.++..... ...++....+.|+.|+..+|.++| +.|++||||||.|+++... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 89999988 779999886655 456999999999999999999999 8899999999999999765 4689999
Q ss_pred ccccc--cccCCC--------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc
Q 012219 319 FGVAR--LLNFDS--------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN 388 (468)
Q Consensus 319 fg~~~--~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~ 388 (468)
||+++ ...... .......||..|+++....+...+.+.|+||++.++.|++.|..||.............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 321111 11223559999999999999999999999999999999999999986544321111000
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
........... ......+ +.++...+-..+...+|....+...+....
T Consensus 251 ~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 251 KDPRKLLTDRF----GDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHhhhhccccc----cCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00000000000 1111122 444555555689999999999988875544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-24 Score=218.23 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=182.9
Q ss_pred cccceeeeeCCceEEEEE-cCCCCEEEEEEec----CcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 173 HIKYCIGTGGYGSVYRAR-LPSGKVVALKKLH----RSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.....+|.|++|.|+... ....+..+.|.+. ...... .....+..|+-+-..+.|+|++..+..+.+.....-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~-~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER-KYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH-HHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 346789999999888774 3344445555443 221111 1122256677778889999998887777766666666
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||||++ +|..++..... +...++..++.|+..|+.|+| ..|+.|||+|++|++++.++.+||+|||.+.....
T Consensus 400 mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999999 99999876522 777888899999999999999 88999999999999999999999999999977654
Q ss_pred CCCC----ceeccccccccccccccCCCCCc-cchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 328 DSSN----RTLLAGTYGYIAPELAYTMVVTE-KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 328 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
+... ....+|+..|+|||++....|++ ..||||.|+++..|.+|+.||................. .......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~---~~~~~~~ 549 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD---QRNIFEG 549 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc---ccccccC
Confidence 3332 34467899999999999998876 58999999999999999999875433211110000000 0011111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..............++.++++.||.+|.|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11222222334677899999999999999999983
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-24 Score=218.87 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=181.4
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcch-hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET-EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++...+.||++.|=+|.+|+.++|. |+||++-+... -.....++-..|++ ...++|||.+++.-+-...+..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777888999999999999998887 89999876552 22222333334444 455689999998877777777888889
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC--
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-- 327 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~-- 327 (468)
|+.. +|.|.+....- +...+..-|+.|+..||..+| ..||+|||||.+|||++.-.-+.|+||..-+....
T Consensus 102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9865 89999876443 667788889999999999999 88999999999999999999999999987654321
Q ss_pred CCCC-ce----eccccccccccccccCC-----------CCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccc
Q 012219 328 DSSN-RT----LLAGTYGYIAPELAYTM-----------VVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIK 390 (468)
Q Consensus 328 ~~~~-~~----~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~ 390 (468)
+... .. ....-.+|.|||.+... ..+++.||||+||+++||++ |++||...+...+.......
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 1111 11 12234579999976531 15678999999999999998 89998754322221110000
Q ss_pred cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
....+ ....+. .+.+++..|++.||++|.++++.++.-....
T Consensus 255 ~e~~L----e~Ied~-------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 255 PEQLL----EKIEDV-------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HHHHH----HhCcCc-------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 00000 000000 2667899999999999999999998755443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=177.93 Aligned_cols=258 Identities=19% Similarity=0.237 Sum_probs=191.5
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 247 (468)
-.|.+.++||+|+||.++.|. +-++..||||.-..... ..++..|.+..+.|. .+.|..++-|-.....-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 368999999999999999995 56899999998765443 246778898888885 68898888888888888999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-----CCeEEeecccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-----LEAFVADFGVA 322 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfg~~ 322 (468)
+|.+ |-||.|+..-.+. .++...++.+|.|++.-++|+| ++.+|.|||||+|.|+... ..+.+.|||+|
T Consensus 103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 7799998876543 4899999999999999999999 8899999999999999643 45789999999
Q ss_pred ccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 323 RLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 323 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+.+..... ......||.+||+-.-..+.+-+.+.|.=|+|-+++..+-|..||+.+...... .+..++ -
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeKI---G 252 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEKI---G 252 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-HHHHHh---c
Confidence 98753322 123357999999998888888999999999999999999999999876543211 111111 1
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
+..-..+..........++...+.-.-..+-.+-|+.+-+...|...
T Consensus 253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 253 ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 22222222222222222344444444556777889876666555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=197.63 Aligned_cols=218 Identities=24% Similarity=0.410 Sum_probs=163.0
Q ss_pred HhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 012219 223 LSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS 302 (468)
Q Consensus 223 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 302 (468)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.....++.+|+.||.|+|. ++--.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence 35688999999999999999999999999999999999863 3458999999999999999999994 3333999999
Q ss_pred CCceeeCCCCCeEEeeccccccccC--CCCCceeccccccccccccccCCC-------CCccchhhHHHHHHHHHHhCCC
Q 012219 303 SNNVLLNSELEAFVADFGVARLLNF--DSSNRTLLAGTYGYIAPELAYTMV-------VTEKCDVYSFGVVALEVLMGKH 373 (468)
Q Consensus 303 ~~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~s~Gvil~el~tg~~ 373 (468)
++|+++|..+.+|++|||+...... .........-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999877632 111112223445799999987641 4677999999999999999999
Q ss_pred CCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 374 PGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 374 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
||+.........+....+.+.-.+.+.+...... +....+..++..||..+|++||++++|-..+....+.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9986443222111111111111222222222111 2222478899999999999999999999998877664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=174.40 Aligned_cols=254 Identities=17% Similarity=0.248 Sum_probs=188.8
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-CceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l 246 (468)
...|.+.+.||+|+||.+|.|. ..+|..||+|+-...... .++..|..+...+++ ..|..+..|..+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3579999999999999999994 678999999998765433 356789999999975 567777778888888899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~ 323 (468)
|||.+ |-||.++..-... .++...++-++-|+..-++|+| .++++||||||+|.|..-+ ..+.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 99988 7799998865443 3888899999999999999999 8899999999999999655 456799999998
Q ss_pred cccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC
Q 012219 324 LLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 324 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
.+..... ......||.+|.+-....+..-+...|+=|+|.++..+--|..||+.+........ ...+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK----yEkI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK----YEKISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----HHHHHH
Confidence 8743221 22335799999988877777788899999999999999999999987654322111 111222
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+..+..........++.-.+.-|-..--++-|+..-+.+
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 22222222222222233445566677777777787644443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=177.31 Aligned_cols=143 Identities=20% Similarity=0.185 Sum_probs=108.0
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhh-----------------------HHHHHHHHHHHhhccCCce
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS-----------------------LESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~ni 231 (468)
...||+|+||.||+|...+|+.||||+++......... ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999988899999999997653211000 1122359999999987776
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
.....+... ..++||||++++++....... ..++..+...++.|++.+|.++|+ +.+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-C
Confidence 433332222 238999999988776543222 247889999999999999999932 67999999999999998 4
Q ss_pred CCeEEeeccccccc
Q 012219 312 LEAFVADFGVARLL 325 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~ 325 (468)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=180.68 Aligned_cols=184 Identities=14% Similarity=0.113 Sum_probs=138.2
Q ss_pred CCcCHHHHHH--HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHH------HHHHHHHHhhccCC
Q 012219 158 GRITFQDMIE--ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES------FGNEARLLSQIRHR 229 (468)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~ 229 (468)
....|.++.. ..++|...+.+|+|+||.||.... ++..+|+|.+............. |.+|++.+.+++|+
T Consensus 17 ~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 17 NDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred CcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 3334444433 357899999999999999999866 57789999997654433222233 67999999999999
Q ss_pred ceeeEEEEEeeC--------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 012219 230 NIVKLYGFCLHR--------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI 301 (468)
Q Consensus 230 niv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 301 (468)
+|..+.+++... ...+++|||++|.+|.++.. ++. ....+++.++..+| ..|++|||+
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Di 161 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDP 161 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCC
Confidence 999999886533 35789999999999987732 222 24568999999999 789999999
Q ss_pred CCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHH
Q 012219 302 SSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369 (468)
Q Consensus 302 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~ 369 (468)
+|+||+++.++ ++++|||.......+... ..+.....+..++|+||||+.+.-+.
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999998 999999988654211111 01333445667899999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=169.96 Aligned_cols=143 Identities=22% Similarity=0.254 Sum_probs=110.7
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhh-----------------------hhhHHHHHHHHHHHhhccCCce
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE-----------------------LASLESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~h~ni 231 (468)
...||+|++|.||+|...+|+.||||+++...... ......+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987789999999998653210 0011234578999999999987
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeeCC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVLLNS 310 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIll~~ 310 (468)
.....+.... .++||||++++++....... ..++..+...++.|++.++.++| . .||+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 5444443332 48999999988654432221 23677888999999999999999 5 7999999999999999
Q ss_pred CCCeEEeecccccccc
Q 012219 311 ELEAFVADFGVARLLN 326 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~ 326 (468)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=178.50 Aligned_cols=236 Identities=19% Similarity=0.233 Sum_probs=150.8
Q ss_pred CccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc----------CCceeeEEEEEe
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR----------HRNIVKLYGFCL 239 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~ 239 (468)
.+.....||.|+++.||.+++. +++.+|||++...........+++.+|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456778999999999999764 58999999987666555556778877776555432 222222222221
Q ss_pred ---------eC---C-----EEEEEEEeccCCChhhhhhc----CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 012219 240 ---------HR---K-----CMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVH 298 (468)
Q Consensus 240 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 298 (468)
.. . ..+++|+-+. ++|.+++.. ......+....++.+..|+.+.+++|| +.|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 11 1 1367788774 588777542 111122445666788899999999999 789999
Q ss_pred cCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccC--------CCCCccchhhHHHHHHHHHHh
Q 012219 299 RDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--------MVVTEKCDVYSFGVVALEVLM 370 (468)
Q Consensus 299 ~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~el~t 370 (468)
+||+|+|++++.+|.++|+||+.....+. .......+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765432 1121345577999997643 257889999999999999999
Q ss_pred CCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCC
Q 012219 371 GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR 429 (468)
Q Consensus 371 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 429 (468)
|+.||+.......... .+. .+. +....+..+|..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-----------~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-----------DFS----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-----------GGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-----------cch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999985533211111 011 111 222236779999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=161.68 Aligned_cols=184 Identities=13% Similarity=0.069 Sum_probs=135.9
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh-hhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEEec
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-ASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
....|++|+||+||.+.. .+.+++.+.+.....-.. .....|.+|+++|+++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999998876 677888777765543111 11235789999999995 5789999886 3468999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeeCCCCCeEEeeccccccccCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI-SSNNVLLNSELEAFVADFGVARLLNFDSS 330 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 330 (468)
.|.+|...... ....++.|++.+|.++| ..||+|||| ||+||+++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99988654321 11357789999999999 789999999 79999999999999999999986543322
Q ss_pred C----c---------eeccccccccccccccCC-CCC-ccchhhHHHHHHHHHHhCCCCC
Q 012219 331 N----R---------TLLAGTYGYIAPELAYTM-VVT-EKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 331 ~----~---------~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
. . .....++.|++|+...-. ..+ ...+.++.|.-+|.++||+.|.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 1 0 011246667777643322 222 3568889999999999999884
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=188.19 Aligned_cols=187 Identities=29% Similarity=0.382 Sum_probs=155.0
Q ss_pred eeeeCCceEEEEE----cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEEecc
Q 012219 178 IGTGGYGSVYRAR----LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 178 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
+|+|.||.|+.++ .+.|..+|.|+++.......... ....|..++...+ ||.+|++.-.++.+...+++.+|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999884 34577889998876543322222 4557888888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCc
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 332 (468)
+|.+...+..... +...........++-+++++| +.+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999888765432 566666677788999999999 889999999999999999999999999999875422221
Q ss_pred eeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 333 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
+||..|||||+.. .....+|.||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999988 567789999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=157.16 Aligned_cols=136 Identities=17% Similarity=0.181 Sum_probs=104.1
Q ss_pred cccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-----cCCceeeEEEEEeeCC---E-
Q 012219 173 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-----RHRNIVKLYGFCLHRK---C- 243 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~- 243 (468)
.-...||+|+||.||. +++....+||++...... ..+.+.+|++++..+ .||||++++|++.++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3457899999999996 433333479988754322 245788999999999 5799999999998864 3
Q ss_pred EEEEEEe--ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeeCC----CCCeEE
Q 012219 244 MFLIYEY--MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL-SYLHHDCTPPIVHRDISSNNVLLNS----ELEAFV 316 (468)
Q Consensus 244 ~~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl 316 (468)
..+|+|| +.+|+|.+++.... +++. ..++.+++.++ +||| +.+|+||||||+||+++. +..++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3478999 56799999996531 4444 35677888777 9999 789999999999999974 347999
Q ss_pred eecccc
Q 012219 317 ADFGVA 322 (468)
Q Consensus 317 ~Dfg~~ 322 (468)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 994433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-19 Score=182.73 Aligned_cols=246 Identities=22% Similarity=0.253 Sum_probs=176.8
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc---CCceeeEEEEEeeCCEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR---HRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~ 244 (468)
..+.|.+...||+|+||+||+|...+|+.||+|+-+....-+.- -=.+++.+|+ -+-|..+...+.-.+.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34678888999999999999998888999999998876543221 1223444555 12223333333456677
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-------CCCeEEe
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-------ELEAFVA 317 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-------~~~~kl~ 317 (468)
++|+||.+.|+|.+++... ..++|..++.++.|++.-+++|| ..+||||||||+|.+|.. ...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999999843 34899999999999999999999 889999999999999942 3457999
Q ss_pred eccccccccC--CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 318 DFGVARLLNF--DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 318 Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|||.+-.+.. +.......++|-.+--+|+..+..++.+.|-|.++-+++-|+.|+.-- .. ......+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~----------~g~~~~~ 912 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VK----------NGSSWMV 912 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hc----------CCcceec
Confidence 9999976642 333445567888999999999999999999999999999999998752 00 0111111
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
+..+ ...+..++ ..+++..+|+.|-..=|...++...|++.
T Consensus 913 ~~~~----~Ry~~~~~--W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 913 KTNF----PRYWKRDM--WNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred cccc----hhhhhHHH--HHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 1111 11222222 33566667775555556667776666553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=157.31 Aligned_cols=146 Identities=21% Similarity=0.181 Sum_probs=112.1
Q ss_pred hCccccceeeeeCCceEEEEE--cCCCCEEEEEEecCcchhh---------------------hhhHHHHHHHHHHHhhc
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEE---------------------LASLESFGNEARLLSQI 226 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 226 (468)
..|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ......+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 5689999999987543110 00113456899999999
Q ss_pred cCCc--eeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 012219 227 RHRN--IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP-IVHRDISS 303 (468)
Q Consensus 227 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~ 303 (468)
.+.. +.+++++. ..++||||++++++........ .+...+...++.|++.++.+|| ..+ ++||||||
T Consensus 108 ~~~~i~~p~~~~~~----~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAWR----RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEec----CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence 7633 44445432 3489999999988876543222 2555667889999999999999 778 99999999
Q ss_pred CceeeCCCCCeEEeecccccccc
Q 012219 304 NNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 304 ~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=155.43 Aligned_cols=137 Identities=20% Similarity=0.342 Sum_probs=113.8
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcch-----hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEe
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSET-----EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEY 250 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 250 (468)
+.||+|++|.||+|.. .|..+++|+...... ........+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 677899998664322 1112234678899999999999988877777777788999999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|++|.+.+.... + .+..++.+++.+|.++| ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 77899999999999999 78999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=153.49 Aligned_cols=148 Identities=20% Similarity=0.211 Sum_probs=113.2
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh-------------------hhHHHHHHHHHHH
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-------------------ASLESFGNEARLL 223 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l 223 (468)
+++......|.+.+.||+|+||.||++...+|+.||||++........ .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445778899999999999999888899999998765331100 0112366788999
Q ss_pred hhccCC--ceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 012219 224 SQIRHR--NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI 301 (468)
Q Consensus 224 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 301 (468)
..+.|+ .+...++. ...++||||+++++|...... .....++.+++.++.++| ..+++||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCC
Confidence 999887 44445443 345899999999998765421 234578899999999999 789999999
Q ss_pred CCCceeeCCCCCeEEeecccccccc
Q 012219 302 SSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 302 k~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||+||+++.++.++|+|||.+....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=158.31 Aligned_cols=200 Identities=23% Similarity=0.314 Sum_probs=138.6
Q ss_pred cCCceeeEEEEEee---------------------------CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHH
Q 012219 227 RHRNIVKLYGFCLH---------------------------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK 279 (468)
Q Consensus 227 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 279 (468)
+|||||++.++|.+ +.+.|+||...+ .+|.+++..+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999887643 346789998775 48999987654 45566677899
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCceee--CCCC--CeEEeeccccccccC-----C-CCCceeccccccccccccccC
Q 012219 280 GMCHALSYLHHDCTPPIVHRDISSNNVLL--NSEL--EAFVADFGVARLLNF-----D-SSNRTLLAGTYGYIAPELAYT 349 (468)
Q Consensus 280 ~ia~~l~~LH~~~~~~ivH~dlk~~NIll--~~~~--~~kl~Dfg~~~~~~~-----~-~~~~~~~~g~~~y~aPE~~~~ 349 (468)
|+.+|+.||| .+||.|||+|++|||+ |+|. ...|+|||++-.-.. + .+......|...-||||+...
T Consensus 349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999 7899999999999998 4444 357899998733211 0 111223467888999999875
Q ss_pred CC------CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhccc
Q 012219 350 MV------VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLR 423 (468)
Q Consensus 350 ~~------~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 423 (468)
.. .-.|+|.|+.|-+.||+++...||..-......... ..+---|.++...+.. +.+++...++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~~vpp~-------~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPSRVPPV-------ARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCcccCChH-------HHHHHHHHhc
Confidence 42 235899999999999999999999753221111110 1111113333333322 5568888999
Q ss_pred CCCCCCCCHHHHHHHHHhcCC
Q 012219 424 SQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 424 ~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.||++||+..-..+.+.-..+
T Consensus 496 r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred CCccccCCccHHHhHHHHHHh
Confidence 999999998666655543333
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=151.04 Aligned_cols=133 Identities=23% Similarity=0.373 Sum_probs=107.3
Q ss_pred eeeeeCCceEEEEEcCCCCEEEEEEecCcch-----hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 177 CIGTGGYGSVYRARLPSGKVVALKKLHRSET-----EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
.||+|+||.||+|.+ ++..+++|+...... ........+.+|++++..++|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 578899998654321 11123456788999999999887665555555666678999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+|++|.+.+..... .++.+++.+|.+|| +.+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754211 78999999999999 88999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-19 Score=170.86 Aligned_cols=173 Identities=23% Similarity=0.360 Sum_probs=131.3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++.|++|..++|.+++.........++...+.++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877666678889999999999999998 48999999999999999999999999998
Q ss_pred ccccCCC------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccccccc
Q 012219 323 RLLNFDS------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 323 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
....... ...+...||..||+||.+.+..|+.|+||||+|+|++|+++ -..+++.. ....++-
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 7664333 13344679999999999999999999999999999999997 33332211 1111222
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v 435 (468)
|..+++.......+ =..++.+++...|.+||++-++
T Consensus 474 ~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHH
Confidence 22233222222222 2246778999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=173.45 Aligned_cols=141 Identities=21% Similarity=0.305 Sum_probs=112.5
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEE-ecCc-c---hhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKK-LHRS-E---TEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~---~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
...|...+.||+|+||.||+|.+.+.. +++|+ .... . .......+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999875544 33333 2211 1 1111234568899999999999999988888877777
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998875 34678999999999999 7899999999999999 57899999999997
Q ss_pred cc
Q 012219 324 LL 325 (468)
Q Consensus 324 ~~ 325 (468)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=141.51 Aligned_cols=139 Identities=21% Similarity=0.212 Sum_probs=99.3
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHH---------------------HHHHHHHHHhhccCCc--e
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLE---------------------SFGNEARLLSQIRHRN--I 231 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~n--i 231 (468)
.+.||+|+||.||+|...+++.||||++............ ....|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754322111111 1135666666665443 4
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhh-hhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeeC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCV-LRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVLLN 309 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIll~ 309 (468)
.+.+++. ..++||||++++.+... +.... .. .+...++.+++.++.++| . .+|+|+||||+||+++
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence 4444432 35899999999654321 11110 11 556789999999999999 5 8999999999999999
Q ss_pred CCCCeEEeecccccccc
Q 012219 310 SELEAFVADFGVARLLN 326 (468)
Q Consensus 310 ~~~~~kl~Dfg~~~~~~ 326 (468)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.2e-17 Score=166.99 Aligned_cols=207 Identities=24% Similarity=0.307 Sum_probs=136.0
Q ss_pred hCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|+..+.|..|++|.||.+++++ .+.+|. ++.+...- .+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee----------------
Confidence 578899999999999999998764 566777 33322211 000 22222333333
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|+=...+...+. ++. +++.+++||| +.||+|||+||+|.+++.-|.+|++|||+.+..-..
T Consensus 136 -----gDc~tllk~~g~---lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP---LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhcccCCC---Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333332211 222 2277899999 899999999999999999999999999998765211
Q ss_pred CC---------------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc
Q 012219 329 SS---------------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 329 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
.. .....+||+.|.|||++....|...+|.|++|+|+||.+-|..||.........-.-......
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 10 112357999999999999999999999999999999999999998754322111000001111
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCC
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 431 (468)
..+. ..... .+...++.+.++.+|..|--
T Consensus 277 wpE~--dea~p-------~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 277 WPEE--DEALP-------PEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cccc--CcCCC-------HHHHHHHHHHHHhChHhhcc
Confidence 1111 11111 12556777889999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.1e-16 Score=131.44 Aligned_cols=135 Identities=17% Similarity=0.141 Sum_probs=113.1
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--CceeeEEEEEeeCCEEEEEEEec
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--RNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++++....+..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 35679999999999999854 7899999866543 2467889999999976 58999999888878899999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+++.+..+ +......++.+++++++++|.....+++|+|++|+||+++.++.+++.|||.++.
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98777544 4456677899999999999954446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-15 Score=138.43 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=106.1
Q ss_pred cceee-eeCCceEEEEEcCCCCEEEEEEecCcch----------hhhhhHHHHHHHHHHHhhccCCce--eeEEEEEeeC
Q 012219 175 KYCIG-TGGYGSVYRARLPSGKVVALKKLHRSET----------EELASLESFGNEARLLSQIRHRNI--VKLYGFCLHR 241 (468)
Q Consensus 175 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 241 (468)
...|| .|+.|+||.+... +..++||.+..... ........+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999884 67889998864321 001223567889999999998875 6677765432
Q ss_pred C----EEEEEEEeccC-CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 242 K----CMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 242 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
. ..++|+|++++ .+|.+++... .++.. .+.+++.++.+|| ..||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6898887542 23433 3568999999999 889999999999999999999999
Q ss_pred eeccccccc
Q 012219 317 ADFGVARLL 325 (468)
Q Consensus 317 ~Dfg~~~~~ 325 (468)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-16 Score=163.24 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=182.5
Q ss_pred hCccccceeeeeCCceEEEEEcC--CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 246 (468)
..|.....||+|+|+.|-..... ....+|+|.+.... ...........|..+-..+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34667777999999999888653 34456666665443 11122334445777777776 9999999999999999999
Q ss_pred EEEeccCCChhhhh-hcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeecccccc
Q 012219 247 IYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARL 324 (468)
Q Consensus 247 v~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~ 324 (468)
+.+|..++++.+.+ +.... ..+....-..+.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999888 43321 24555666789999999999995 45899999999999999999 999999999987
Q ss_pred ccC-CCC--Cceeccc-cccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 325 LNF-DSS--NRTLLAG-TYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 325 ~~~-~~~--~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+.. .+. .....+| ++.|+|||...+. ......|+||.|+++.-+++|..|++....................
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 251 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT--- 251 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc---
Confidence 754 222 2233567 9999999998884 4567899999999999999999998754433222111111110000
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
..+ ...... ...++..+++..+|+.|.+.+++.
T Consensus 252 ~~~-~~~~~~---~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QLP-WNSISD---QAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cCc-cccCCh---hhhhcccccccCCchhcccccccc
Confidence 111 111111 145577788889999999988776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.2e-15 Score=153.40 Aligned_cols=70 Identities=33% Similarity=0.615 Sum_probs=38.4
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV 72 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~ 72 (468)
|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence 4455555555555555555555555555555555555555555555555555555555555555555543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=141.49 Aligned_cols=144 Identities=22% Similarity=0.247 Sum_probs=102.1
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhh-------------------------------------hHHHHH
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA-------------------------------------SLESFG 217 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~ 217 (468)
.+.||.|++|.||+|++.+|+.||||+.+........ ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998754321110 001355
Q ss_pred HHHHHHhhcc----CCceeeEEEEEe-eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 012219 218 NEARLLSQIR----HRNIVKLYGFCL-HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH-ALSYLHHD 291 (468)
Q Consensus 218 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~ 291 (468)
+|.+.+.+++ |.+-+.+-.++. .....++||||++|++|.+........ . .+..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~-- 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVL-- 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHH--
Confidence 6666666653 333333333332 234579999999999998876532111 2 23456666665 467788
Q ss_pred CCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 292 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
..|++|+|++|.||+++.++.+++.|||++..+.
T Consensus 275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7799999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3e-14 Score=129.17 Aligned_cols=203 Identities=23% Similarity=0.331 Sum_probs=137.8
Q ss_pred HHHHhhccCCceeeEEEEEeeC-----CEEEEEEEeccCCChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012219 220 ARLLSQIRHRNIVKLYGFCLHR-----KCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCT 293 (468)
Q Consensus 220 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 293 (468)
...+-++-|.|||++..|+.+. .....+.|||..|++..+|++... ...+......+++-||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3455667899999998887653 346889999999999999986432 23355666678999999999999974 8
Q ss_pred CCeEecCCCCCceeeCCCCCeEEeeccccccccC-----CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHH
Q 012219 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-----DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEV 368 (468)
Q Consensus 294 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el 368 (468)
+.|+|+++.-+-|++..++-+|++-- -...... .........+-++|.|||+-.....+.++|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999999999999998887421 1111100 00111123457899999998888888999999999999999
Q ss_pred HhCCCC-CCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 369 LMGKHP-GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 369 ~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..+..- ...... .... ..+...+ ..+.... =..++.+|++..|..||+|++++.+.
T Consensus 276 ailEiq~tnseS~--~~~e--e~ia~~i-~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESK--VEVE--ENIANVI-IGLENGL----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcce--eehh--hhhhhhe-eeccCcc----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 877643 211110 0010 0000000 0000000 11256689999999999999887543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.8e-14 Score=137.43 Aligned_cols=250 Identities=25% Similarity=0.257 Sum_probs=177.2
Q ss_pred Cccccceeee--eCCceEEEEEc---CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEE
Q 012219 171 DFHIKYCIGT--GGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 171 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 244 (468)
.|.....+|. |.+|.||.++. .++..+|+|+-+........ ...=.+|+.....++ |+|.++....+...+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence 4666788999 99999999975 46788999985433221111 112235666666664 99999988888888899
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeec
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH----ALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADF 319 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Df 319 (468)
++-+|++. .+|..+.+..... ++....+....+..+ |+.++| +..++|-|+||.||+...+ ..++++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 99999985 6888777654332 556677777888888 999999 8899999999999999999 88999999
Q ss_pred cccccccCCCCCcee-----ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 320 GVARLLNFDSSNRTL-----LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 320 g~~~~~~~~~~~~~~-----~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|+...+....-.... ..|...|++||...+ -++..+|||++|.++.+-.+|..+....-...|...+...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---- 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---- 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----
Confidence 999887644322222 257788999997644 4778999999999999999988775433223333222111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
+...+.... ...+...+..+++.+|-.|++.+.+.+.-
T Consensus 343 ip~e~~~~~-------s~~l~~~~~~~~d~~~~~~~~~q~~~~l~ 380 (524)
T KOG0601|consen 343 IPLEFCEGG-------SSSLRSVTSQMLDEDPRLRLTAQILTALN 380 (524)
T ss_pred CchhhhcCc-------chhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence 001111111 11144477789999999999998887543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.5e-12 Score=126.65 Aligned_cols=169 Identities=19% Similarity=0.179 Sum_probs=128.4
Q ss_pred EcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCC
Q 012219 190 RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL 269 (468)
Q Consensus 190 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l 269 (468)
+..++.+|.|...+.... .......+.++.++.++||||+++++.+...+..|+|+|-+. .|..++...
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------
Confidence 445788899988876654 233456678899999999999999999999999999999985 677777652
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccC
Q 012219 270 DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349 (468)
Q Consensus 270 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 349 (468)
........+.||+.||.|||+ ..+++|++|.-..|+++..|..||++|-++..............--..|..|+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 345566778999999999996 558999999999999999999999999988654322211111122234666665433
Q ss_pred CCCCccchhhHHHHHHHHHHhCCC
Q 012219 350 MVVTEKCDVYSFGVVALEVLMGKH 373 (468)
Q Consensus 350 ~~~~~~~Dv~s~Gvil~el~tg~~ 373 (468)
.. -..|.|-|||+++|++.|..
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCccc
Confidence 32 24699999999999999943
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=130.66 Aligned_cols=149 Identities=19% Similarity=0.211 Sum_probs=96.9
Q ss_pred hhCccccceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhh-------------------------------------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL------------------------------------- 210 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~------------------------------------- 210 (468)
..+|+. +.||+|++|.||+|++++ |+.||||+.+.......
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999887 99999999975421110
Q ss_pred hhHHHHHHHHHHHhhcc----CCceeeEEEEEee-CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHH-H
Q 012219 211 ASLESFGNEARLLSQIR----HRNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH-A 284 (468)
Q Consensus 211 ~~~~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~ 284 (468)
...-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-... ..+.. .++...+. -
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~---~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMK---LLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHH---HHHHHHHHHH
Confidence 00013555665555553 4444554444433 4557899999999999774221111 12211 12222111 1
Q ss_pred HHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeecccccccc
Q 012219 285 LSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFGVARLLN 326 (468)
Q Consensus 285 l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~~~~~~ 326 (468)
+..+. ..|++|+|+||.||+++.++ .+++.|||++..++
T Consensus 273 ~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 273 FTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 22233 56999999999999999988 99999999987764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.4e-12 Score=112.06 Aligned_cols=130 Identities=22% Similarity=0.209 Sum_probs=94.1
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCcee-eEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV-KLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+.++.|.++.||+++.. ++.+++|........ ...+..|++.+..+.+.+++ +++.+.. ...++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 56889999999999874 778999998654321 12456889999888665544 4554433 2357999999998
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC--TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++.+.- . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.+++.|||.+..
T Consensus 77 ~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 875430 0 11245678999999999432 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=3e-12 Score=133.39 Aligned_cols=88 Identities=40% Similarity=0.615 Sum_probs=81.3
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~ 81 (468)
.++.|+|++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++ +|+.|+++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 378899999999999999999999999999999999999999999999999999999999999998654 56668899
Q ss_pred cccccccCCCC
Q 012219 82 GKNFDVEIPNT 92 (468)
Q Consensus 82 ~n~l~~~~p~~ 92 (468)
+|++.+.+|..
T Consensus 499 ~N~l~g~iP~~ 509 (623)
T PLN03150 499 GNSLSGRVPAA 509 (623)
T ss_pred CCcccccCChH
Confidence 99999988864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.8e-11 Score=104.14 Aligned_cols=140 Identities=19% Similarity=0.188 Sum_probs=98.1
Q ss_pred cceeeeeCCceEEEEEcCC-------CCEEEEEEecCcchh-------------------hhhhHHHHH----HHHHHHh
Q 012219 175 KYCIGTGGYGSVYRARLPS-------GKVVALKKLHRSETE-------------------ELASLESFG----NEARLLS 224 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~-------------------~~~~~~~~~----~e~~~l~ 224 (468)
...||.|--+.||.|...+ +..+|||+.+..... .....+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999997543 578999988632100 001122333 7999999
Q ss_pred hccC--CceeeEEEEEeeCCEEEEEEEeccCCChhh-hhhcCcccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 012219 225 QIRH--RNIVKLYGFCLHRKCMFLIYEYMEMGSLFC-VLRTDEEAVGLDWAKRVNVVKGMCHALSYL-HHDCTPPIVHRD 300 (468)
Q Consensus 225 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~d 300 (468)
++.. -++..++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.++..| | ..+++|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 8853 455566654 34589999997654422 2221 1244455667889999999999 6 77999999
Q ss_pred CCCCceeeCCCCCeEEeecccccccc
Q 012219 301 ISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 301 lk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-12 Score=126.75 Aligned_cols=248 Identities=20% Similarity=0.196 Sum_probs=171.5
Q ss_pred HhhCccccceeeeeCCceEEEEEc--CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 244 (468)
.+.+|.....||.|.|+.|++... .++..+++|.+...-......+.. ..|+-+...+ .|.+++..+..+...+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccccc
Confidence 456789999999999999999853 478889999887655443322222 2455555555 488888877766666677
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeeccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVAR 323 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~~ 323 (468)
++--||++++++....... ..++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 7999999999987666322 23677788999999999999999 8999999999999999887 788999999986
Q ss_pred cccCCCCCceecccccccc--ccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 324 LLNFDSSNRTLLAGTYGYI--APELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.+... .....+.-++. +|+......+..+.|+||||.-+.|..+|..--..... | ..+..-.-+....
T Consensus 416 ~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--~-----~~i~~~~~p~~~~ 485 (524)
T KOG0601|consen 416 RLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--S-----LTIRSGDTPNLPG 485 (524)
T ss_pred cccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--c-----eeeecccccCCCc
Confidence 43211 11122333344 55555566788999999999999999998754221111 1 1111111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~ 440 (468)
.. ..+..+...+..+++..||.+.++..+..
T Consensus 486 ----~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 486 ----LK----LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----hH----HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 11445666789999999999988775543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.6e-11 Score=99.16 Aligned_cols=133 Identities=22% Similarity=0.338 Sum_probs=98.1
Q ss_pred eeeeeCCceEEEEEcCCCCEEEEEEec-C----cchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 177 CIGTGGYGSVYRARLPSGKVVALKKLH-R----SETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~~~~vavK~~~-~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
.+++|+-+.+|.+.+.+.. +++|.-. + ......-....-.+|++++.+++--.|...+=|..++....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4788999999999774433 5555332 1 11122222345678999999887655555555666777788999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+|..|.+.+... ...++..+-.-+.-|| ..||+|+||.++||++..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888754 2446666777788899 88999999999999999876 88999999965
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=106.14 Aligned_cols=143 Identities=21% Similarity=0.253 Sum_probs=108.7
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--CceeeEEEEEeeCC---EEEEEEEe
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--RNIVKLYGFCLHRK---CMFLIYEY 250 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~ 250 (468)
+.|+.|..+.||++...+|+.+++|........ .....+..|.++++.+++ .++.+++.++.... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 458999999999998877789999998654331 123467789999999976 34567777776543 56899999
Q ss_pred ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 012219 251 MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC-------------------------------------- 292 (468)
Q Consensus 251 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 292 (468)
++|+++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888776532 12566777778888888888888421
Q ss_pred ---------------CCCeEecCCCCCceeeCC--CCCeEEeecccccc
Q 012219 293 ---------------TPPIVHRDISSNNVLLNS--ELEAFVADFGVARL 324 (468)
Q Consensus 293 ---------------~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~ 324 (468)
...++|+|+.|.||+++. ++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.4e-10 Score=93.72 Aligned_cols=146 Identities=19% Similarity=0.246 Sum_probs=104.3
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEe-----cCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKL-----HRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
....+-+|+-+.|+++.+ .|+...||.- ........-..+...+|++.+.+++--.|....-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999998 4666666533 2222222233456778999999887555554445566666678999
Q ss_pred EeccC-CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEeecccccc
Q 012219 249 EYMEM-GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARL 324 (468)
Q Consensus 249 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~ 324 (468)
||+++ .++.+++......... ......++..|-+.+.-|| ..+|+||||..+||++..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4778887665433222 2223678888999999999 78999999999999996654 347999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.1e-11 Score=132.22 Aligned_cols=92 Identities=34% Similarity=0.544 Sum_probs=82.7
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Ccccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~ 79 (468)
+++|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|..+.+|++|+.|+|++|+++|.+|..+. +|..|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 35788999999999999999999999999999999999999999999999999999999999999998654 566688
Q ss_pred cccccccccCCCCCC
Q 012219 80 VYGKNFDVEIPNTSE 94 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~ 94 (468)
+++|++++.+|....
T Consensus 554 Ls~N~l~~~~p~~l~ 568 (968)
T PLN00113 554 LSQNQLSGEIPKNLG 568 (968)
T ss_pred CCCCcccccCChhHh
Confidence 999999998886543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.8e-11 Score=85.67 Aligned_cols=60 Identities=35% Similarity=0.565 Sum_probs=54.8
Q ss_pred CCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCccc
Q 012219 4 SKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 64 (468)
|+|+.|+|++|+|+ .+| ..|.++++|++|+|++|++++.-|..|.+|++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 68999999999999 555 6789999999999999999977777899999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-11 Score=125.67 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=161.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..+.+.+.+.+-+|.++.++.+.-. .|...+.|+......-.....+....+-.+.-..+||-+++..-.+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777778889999999887532 343334443332211111111222222223333445666655444445566899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
+++|..+++|...++.... .+..-.......+.++++||| +..+.|+|++|.|.+...++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999886542 343444455666788999999 6679999999999999999999999998433221
Q ss_pred CC-----C--------------------------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 012219 327 FD-----S--------------------------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 327 ~~-----~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
.- . .......+|+.|.+||...+......+|.|+.|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0112246899999999999999999999999999999999999998
Q ss_pred CcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHH
Q 012219 376 ELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 433 (468)
......... .. ++......+ ....+......+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~f----~n---i~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF----EN---ILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh----hc---cccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 754432111 11 111111111 11111222355677778889999998775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.5e-09 Score=92.59 Aligned_cols=129 Identities=26% Similarity=0.350 Sum_probs=82.4
Q ss_pred eEEEEEcCCCCEEEEEEecCcchh-----------------------hhhhHHHHHHHHHHHhhccCC--ceeeEEEEEe
Q 012219 185 SVYRARLPSGKVVALKKLHRSETE-----------------------ELASLESFGNEARLLSQIRHR--NIVKLYGFCL 239 (468)
Q Consensus 185 ~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 239 (468)
.||.|...+|..+|||..+..... .........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999889999999988632110 001234567899999999765 456666553
Q ss_pred eCCEEEEEEEecc--CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 240 HRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY-LHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 240 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
. .++||||++ |..+..+.... ++......++.++...+.. +| ..||+||||.+.||+++++ .+.+
T Consensus 80 -~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 -R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp -T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred -C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence 2 379999998 55554433322 1123345567777775555 56 7899999999999999988 8999
Q ss_pred eecccccccc
Q 012219 317 ADFGVARLLN 326 (468)
Q Consensus 317 ~Dfg~~~~~~ 326 (468)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.9e-09 Score=95.91 Aligned_cols=144 Identities=19% Similarity=0.126 Sum_probs=100.4
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh--------hhHHHHHHHHHHHhhccCCc--eeeEEEEEee-----
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL--------ASLESFGNEARLLSQIRHRN--IVKLYGFCLH----- 240 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 240 (468)
+.+-+.....|+++.+ +|+.+.||.......... .....+.+|.+.+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3455455556777766 678899997754432110 11124778988888874332 2334555433
Q ss_pred CCEEEEEEEeccCC-ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-------CC
Q 012219 241 RKCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-------EL 312 (468)
Q Consensus 241 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-------~~ 312 (468)
....++|+|++++. +|.+++..... ...+......++.+++..+.-|| ..||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 78888753211 22455677789999999999999 889999999999999975 46
Q ss_pred CeEEeecccccc
Q 012219 313 EAFVADFGVARL 324 (468)
Q Consensus 313 ~~kl~Dfg~~~~ 324 (468)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998853
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6e-11 Score=98.21 Aligned_cols=83 Identities=29% Similarity=0.540 Sum_probs=75.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccc---e
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPH---L 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~---l 78 (468)
++++++.|.||+|.++ .+|+.++.|.+|+.|++++|+++ .+|.+++.|++|+.|+++-|++. .+|.+|+.++. |
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 5677889999999999 99999999999999999999999 89999999999999999999999 89998887765 5
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++..|+++.
T Consensus 108 dltynnl~e 116 (264)
T KOG0617|consen 108 DLTYNNLNE 116 (264)
T ss_pred hcccccccc
Confidence 677777765
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.8e-11 Score=97.87 Aligned_cols=87 Identities=31% Similarity=0.573 Sum_probs=76.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCccccc-ccCCcCCCc---cc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSG-SIPESVRKV---PH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l---~~ 77 (468)
.|.+|+.|+++||++. .+|.++++|++|+.|+++-|++. .+|..|+.++.|+.|||++|+++- .+|..|.-+ ..
T Consensus 54 ~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlra 131 (264)
T KOG0617|consen 54 ELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRA 131 (264)
T ss_pred Hhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHH
Confidence 5788999999999999 99999999999999999999999 999999999999999999999974 688876544 45
Q ss_pred eecccccccccCC
Q 012219 78 LYVYGKNFDVEIP 90 (468)
Q Consensus 78 l~~~~n~l~~~~p 90 (468)
|+++.|.|....|
T Consensus 132 lyl~dndfe~lp~ 144 (264)
T KOG0617|consen 132 LYLGDNDFEILPP 144 (264)
T ss_pred HHhcCCCcccCCh
Confidence 7888888866443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-08 Score=98.10 Aligned_cols=170 Identities=16% Similarity=0.269 Sum_probs=127.0
Q ss_pred CCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe----eCCEEEEEEEeccC-CC
Q 012219 182 GYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL----HRKCMFLIYEYMEM-GS 255 (468)
Q Consensus 182 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gs 255 (468)
...+.|++. ..||..+++|+++..+..... .-..-+++++++.|+|+|++.+++. .+...++||+|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 446779995 458999999999655433211 1124578899999999999988776 35568999999886 56
Q ss_pred hhhhhhcC------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 256 LFCVLRTD------------EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 256 L~~~l~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
|.+.-... ......++...|.++.|+..||.++| +.|+.-+-|.+.+|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEeccccee
Confidence 76654322 12334678899999999999999999 7799999999999999999999999888776
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
.+..+.. |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 442 vl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 6543320 11111 1356888999999999999543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.9e-08 Score=93.95 Aligned_cols=253 Identities=17% Similarity=0.182 Sum_probs=152.6
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEE------eeC-CEEE
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFC------LHR-KCMF 245 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~-~~~~ 245 (468)
....||+|+-+.+|-.-- -...+.|+++.....-.. +.++.|... .||-+-.-+.+= -++ ...-
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 356699999999986532 122356777765433111 223333333 455433211111 112 2245
Q ss_pred EEEEeccCC-Chhhhhhc---CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 246 LIYEYMEMG-SLFCVLRT---DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 246 lv~e~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
+.|..+.+. -...++.. ...-...+|...++++..+|.+.+-|| ..|.+-||+.++|+|+++++.+.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 667766653 22333321 112223789999999999999999999 78999999999999999999999988654
Q ss_pred cccccCCCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhC-CCCCCcccccchhh---h------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMG-KHPGELLSSSSWSL---D------ 386 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg-~~p~~~~~~~~~~~---~------ 386 (468)
-.. ..........+|...|.+||... +...+...|-|-+|+++++++.| ++||..+....... +
T Consensus 164 fqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 164 FQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 332 23344445567899999999754 34567789999999999999985 99998654321100 0
Q ss_pred ----cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCC--CCCCCCHHHHHHHHHhc
Q 012219 387 ----KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQ--PKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 387 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~~v~~~l~~~ 442 (468)
..........+....+.... . ..+..+..+|+... +.-|||++.++..|-..
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~L-p---p~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSML-P---PDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhc-C---HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00000000111111111111 1 12555667788653 56899998888766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-09 Score=109.38 Aligned_cols=155 Identities=21% Similarity=0.289 Sum_probs=103.1
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC---------ceecccccccccccccc
Q 012219 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---------RTLLAGTYGYIAPELAY 348 (468)
Q Consensus 278 ~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~ 348 (468)
+.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+++......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455689999996 789999999999999999999999999988654331110 01122455799999999
Q ss_pred CCCCCccchhhHHHHHHHHHHh-CCCCCCccccc-chhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCC
Q 012219 349 TMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSS-SWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQP 426 (468)
Q Consensus 349 ~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 426 (468)
....+.++|+||+||++|-+.. |+.-+...... ...... ...+.-........+.. +.+=+.+++..++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--~~~~~~~~~~s~~~p~e-------l~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--NLLNAGAFGYSNNLPSE-------LRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--cccccccccccccCcHH-------HHHHHHHHhcCCc
Confidence 9888999999999999999995 55443322111 111111 11111111111222222 4445567899999
Q ss_pred CCCCCHHHHHHHHHhcC
Q 012219 427 KSRPTMQLVSNEFIARN 443 (468)
Q Consensus 427 ~~RPs~~~v~~~l~~~~ 443 (468)
..||++..+........
T Consensus 254 ~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 254 AVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ccCcchhhhhcccccCC
Confidence 99999888876655443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.3e-09 Score=91.25 Aligned_cols=77 Identities=39% Similarity=0.604 Sum_probs=16.2
Q ss_pred CCCcEEEccCCcccccCCcccc-cCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCccce
Q 012219 4 SKLRVLELGNNLLSGSIPSEIN-KLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPHL 78 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l 78 (468)
.+++.|+|++|+|+ .|. .++ .+.+|+.|+||+|+|+ .++ .+..|+.|++|++++|+++ .+++ .+.+|..|
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 34555555555555 443 343 3555555555555555 332 3555555555555555555 3332 23445555
Q ss_pred ecccccc
Q 012219 79 YVYGKNF 85 (468)
Q Consensus 79 ~~~~n~l 85 (468)
++++|.+
T Consensus 94 ~L~~N~I 100 (175)
T PF14580_consen 94 YLSNNKI 100 (175)
T ss_dssp E-TTS--
T ss_pred ECcCCcC
Confidence 5555554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.5e-08 Score=87.58 Aligned_cols=138 Identities=24% Similarity=0.236 Sum_probs=94.4
Q ss_pred ccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh-------------------hhHHHHHHHHHHHhhccCC--c
Q 012219 172 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-------------------ASLESFGNEARLLSQIRHR--N 230 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~h~--n 230 (468)
..+...||-|--+.||.|..+.|.++|||.=+....+-. .......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999995432211100 1233466889999988655 6
Q ss_pred eeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 231 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
+.+.+++ +...+||||++|-.|...- ++....-.++..|..-+..+- ..||||||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 6666554 3458999999986554322 112222334444444444333 458999999999999999
Q ss_pred CCCeEEeecccccc
Q 012219 311 ELEAFVADFGVARL 324 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~ 324 (468)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999966543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.1e-08 Score=96.57 Aligned_cols=143 Identities=21% Similarity=0.231 Sum_probs=94.8
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh-------------------------------------hhHHHHHH
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-------------------------------------ASLESFGN 218 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~~~~ 218 (468)
..|+.++-|.||+|++++|+.||||+.+..-.... ...-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999975432211 01113555
Q ss_pred HHHHHhhcc----CCceeeEEEEEee-CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHH-HHHHhcC
Q 012219 219 EARLLSQIR----HRNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL-SYLHHDC 292 (468)
Q Consensus 219 e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~ 292 (468)
|...+.+++ ...-+.+=.+|++ .+...|+|||++|-.+.+....... ..+... ++..++++. ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~--- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHH---
Confidence 555555552 2222333334433 4567999999999988887432222 144333 333333321 1221
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 293 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
..|+.|.|..|.||+++.+++..+.|||....++
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3489999999999999999999999999987664
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.1e-09 Score=97.06 Aligned_cols=83 Identities=36% Similarity=0.582 Sum_probs=70.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccc----------------------cccccc-ccCCCCCceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSIN----------------------GKILSQ-LGEIPRIDTVD 58 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~----------------------g~~p~~-~~~l~~L~~l~ 58 (468)
.+++|+.|+|+||-+. .+|.+++.+..||.|++|+|+|. |.+|.+ +.++.+|.+||
T Consensus 433 ~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLD 511 (565)
T KOG0472|consen 433 QLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLD 511 (565)
T ss_pred hhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceec
Confidence 4788999999999998 99999999999999999999985 334344 78899999999
Q ss_pred ccCcccccccCCcCCCcc---ceeccccccc
Q 012219 59 LSMNNLSGSIPESVRKVP---HLYVYGKNFD 86 (468)
Q Consensus 59 l~~N~l~g~~p~~~~~l~---~l~~~~n~l~ 86 (468)
|.+|.+. .||..+++++ .|.+.||+|.
T Consensus 512 L~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 512 LQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999 8998776654 5778999987
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.1e-07 Score=82.40 Aligned_cols=105 Identities=22% Similarity=0.307 Sum_probs=81.1
Q ss_pred HHHHHHHHHhhccC--CceeeEEEEEeeC----CEEEEEEEeccCC-ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHH
Q 012219 215 SFGNEARLLSQIRH--RNIVKLYGFCLHR----KCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287 (468)
Q Consensus 215 ~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 287 (468)
...+|...+..+.. -.+.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAK 133 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHH
Confidence 46678887777743 2344556665542 2458999999874 78888875332 4556778899999999999
Q ss_pred HHhcCCCCeEecCCCCCceeeCCCC---CeEEeeccccccc
Q 012219 288 LHHDCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARLL 325 (468)
Q Consensus 288 LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~~ 325 (468)
|| ..||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 88999999999999999887 7889999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.5e-07 Score=78.14 Aligned_cols=141 Identities=15% Similarity=0.089 Sum_probs=101.2
Q ss_pred eeeeCCceEEEEEcCCCCEEEEEEecCcchhh---hhhHHHHHHHHHHHhhccCC--ceeeEEEEEe-e----CCEEEEE
Q 012219 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEE---LASLESFGNEARLLSQIRHR--NIVKLYGFCL-H----RKCMFLI 247 (468)
Q Consensus 178 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~----~~~~~lv 247 (468)
-|+||-+.|++..+. |+.+-+|+-...-... ......|.+|+..+.++... .+.+++ ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888999998874 4468888765211111 11346899999999998532 244444 332 1 2236899
Q ss_pred EEeccC-CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEeecccccc
Q 012219 248 YEYMEM-GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE--AFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~~ 324 (468)
+|-+.+ -+|.+++..... .+.+..++..++.+++..+.-|| ..|+.|+|+.+.||+++.++. +++.||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 578888754322 23577778899999999999999 889999999999999986666 89999976654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.3e-07 Score=80.40 Aligned_cols=139 Identities=15% Similarity=0.150 Sum_probs=84.7
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc--eeeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN--IVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
..||+|..+.||+. .+..+++|....... .....+|.+.+..+..-. +.++++++...+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 46899999999984 245677888865332 234568999998886433 46678888777778899999998
Q ss_pred CC-hhhhh---------------------hcCcccCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEe
Q 012219 254 GS-LFCVL---------------------RTDEEAVGLDWAKRVN-VVK----------GMCH-ALSYLHHD-CTPPIVH 298 (468)
Q Consensus 254 gs-L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~ivH 298 (468)
.+ +...+ +.-.. .......... +.. .+.. ...+|... ....++|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 63 21111 11000 0011111000 000 0111 12222211 1346789
Q ss_pred cCCCCCceeeCCCCCeEEeecccccc
Q 012219 299 RDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 299 ~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+|+.|.||++++++ +.+.||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 89999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.4e-08 Score=64.06 Aligned_cols=36 Identities=42% Similarity=0.705 Sum_probs=19.4
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCcccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSIN 41 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 41 (468)
+|++|+|++|+|+ .+|+++++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45555555555555555555555
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.6e-08 Score=63.97 Aligned_cols=40 Identities=35% Similarity=0.622 Sum_probs=34.7
Q ss_pred CCCCEeeccCccccccccccccCCCCCceecccCcccccccC
Q 012219 28 QELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIP 69 (468)
Q Consensus 28 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p 69 (468)
++|++|+|++|+|+ .+|+.|++|++|+.|++++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57999999999999 78888999999999999999999 554
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-08 Score=100.84 Aligned_cols=82 Identities=24% Similarity=0.375 Sum_probs=61.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccc-ccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
.|..|+.||||.|+|+ ..|..+.+-.++-.|+||+|+|. +||.+ |-+|+.|-.||||+|+|. .+|.. +..|+.
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt 177 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT 177 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence 4667788888888888 78888877778888888888887 77766 667888888888888888 66653 344566
Q ss_pred eeccccccc
Q 012219 78 LYVYGKNFD 86 (468)
Q Consensus 78 l~~~~n~l~ 86 (468)
|.+++|++.
T Consensus 178 L~Ls~NPL~ 186 (1255)
T KOG0444|consen 178 LKLSNNPLN 186 (1255)
T ss_pred hhcCCChhh
Confidence 677777653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.3e-08 Score=86.09 Aligned_cols=82 Identities=32% Similarity=0.445 Sum_probs=39.4
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccc-cCCCCCceecccCcccccccCC-----cCCCc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSMNNLSGSIPE-----SVRKV 75 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~g~~p~-----~~~~l 75 (468)
.|++|+.|+||+|+|+ .++ .+..|+.|+.|+|++|+|+ .+++.+ ..+++|+.|+|++|++. .+-+ .+.+|
T Consensus 40 ~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L 115 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKL 115 (175)
T ss_dssp T-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT-
T ss_pred hhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCc
Confidence 4678999999999999 776 6888999999999999999 666555 47999999999999998 4443 45667
Q ss_pred cceecccccccc
Q 012219 76 PHLYVYGKNFDV 87 (468)
Q Consensus 76 ~~l~~~~n~l~~ 87 (468)
..|.+.+|+++.
T Consensus 116 ~~L~L~~NPv~~ 127 (175)
T PF14580_consen 116 RVLSLEGNPVCE 127 (175)
T ss_dssp -EEE-TT-GGGG
T ss_pred ceeeccCCcccc
Confidence 778899988753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.5e-08 Score=99.24 Aligned_cols=84 Identities=27% Similarity=0.371 Sum_probs=43.8
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC------cCCCccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE------SVRKVPH 77 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~------~~~~l~~ 77 (468)
.+|++|+||+|+|+..-|++|..|.+|+.|+|++|+++..--..|..+++|+.|||++|.+++.|-+ ++..|..
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 3455555555555522233455555555555555555533333455566666666666666655543 3344445
Q ss_pred eecccccccc
Q 012219 78 LYVYGKNFDV 87 (468)
Q Consensus 78 l~~~~n~l~~ 87 (468)
|.+.||++..
T Consensus 397 L~l~gNqlk~ 406 (873)
T KOG4194|consen 397 LRLTGNQLKS 406 (873)
T ss_pred eeecCceeee
Confidence 5566666543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-08 Score=99.49 Aligned_cols=89 Identities=19% Similarity=0.247 Sum_probs=52.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~ 77 (468)
+|++|+.|+||+|.|...-++++.-+++|++|+||+|+|+..-|.+|..|+.|++|+|++|+++ .+-+ .+.+|..
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~ 369 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHK 369 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhh
Confidence 4555666666666666444555555666666666666666444444666666666666666665 3332 3455666
Q ss_pred eecccccccccCCC
Q 012219 78 LYVYGKNFDVEIPN 91 (468)
Q Consensus 78 l~~~~n~l~~~~p~ 91 (468)
|++.+|.++..+-+
T Consensus 370 LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 370 LDLRSNELSWCIED 383 (873)
T ss_pred hcCcCCeEEEEEec
Confidence 77777777665544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-07 Score=67.10 Aligned_cols=58 Identities=28% Similarity=0.449 Sum_probs=46.6
Q ss_pred CCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccceecccccc
Q 012219 28 QELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLYVYGKNF 85 (468)
Q Consensus 28 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~l 85 (468)
++|++|+|++|+|+..-+..|.++++|+.|++++|+++...|..|. +++.|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999955456799999999999999999954444554 455678888864
|
... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-06 Score=75.72 Aligned_cols=140 Identities=18% Similarity=0.194 Sum_probs=90.4
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHH------HHHHHHHHhhccCC---ceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES------FGNEARLLSQIRHR---NIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~---niv~l~~~~~ 239 (468)
..+|...+.+.......|.+-.. +|+.+++|.......-....... ..+.+..+.+++.. ....++....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35677777888877777777776 57889999886543322111221 22334444444322 2222222222
Q ss_pred -----eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 240 -----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 240 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
.....+++|||++|..|.+... ++. .++..+.+++.-+| ..|+.|+|..|+|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence 2344679999999988876543 221 24456778899999 88999999999999999665 8
Q ss_pred EEeecccccc
Q 012219 315 FVADFGVARL 324 (468)
Q Consensus 315 kl~Dfg~~~~ 324 (468)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 8999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=88.10 Aligned_cols=145 Identities=19% Similarity=0.217 Sum_probs=93.3
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh----------------------------------hhHHHHHHHH
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL----------------------------------ASLESFGNEA 220 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------~~~~~~~~e~ 220 (468)
.+.||.-+.|.||+|++++|+.||||+-+..-.... ...-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 367999999999999999999999999875432210 0111355666
Q ss_pred HHHhhc----cCCc---eeeEEEEEee-CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012219 221 RLLSQI----RHRN---IVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292 (468)
Q Consensus 221 ~~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~ 292 (468)
+-..+. .|-+ -|.+=.++++ .....|+||||+|..+.+.-.-... .++...+..-+.+...-.-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf----- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIF----- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHH-----
Confidence 554443 3555 1222233332 3457999999999888665322221 24545443333332222222
Q ss_pred CCCeEecCCCCCceeeCC----CCCeEEeecccccccc
Q 012219 293 TPPIVHRDISSNNVLLNS----ELEAFVADFGVARLLN 326 (468)
Q Consensus 293 ~~~ivH~dlk~~NIll~~----~~~~kl~Dfg~~~~~~ 326 (468)
..|++|+|-.|.||+++. ++.+.+-|||+...+.
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 348999999999999984 6788999999987654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-08 Score=99.25 Aligned_cols=81 Identities=33% Similarity=0.522 Sum_probs=53.4
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCcc---cee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVP---HLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~---~l~ 79 (468)
|.+|..+|||.|+|. .+|+.+-++.+|+.|+||+|+|+ .+....+.-.+|++||||+|+|+ .+|+.+..|+ .|+
T Consensus 221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy 297 (1255)
T KOG0444|consen 221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY 297 (1255)
T ss_pred hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence 456667777777777 77777777777777777777777 55555555566777777777777 6777554443 345
Q ss_pred ccccccc
Q 012219 80 VYGKNFD 86 (468)
Q Consensus 80 ~~~n~l~ 86 (468)
+.+|.++
T Consensus 298 ~n~NkL~ 304 (1255)
T KOG0444|consen 298 ANNNKLT 304 (1255)
T ss_pred hccCccc
Confidence 5555554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.3e-08 Score=90.68 Aligned_cols=88 Identities=19% Similarity=0.272 Sum_probs=76.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
+|++|+.|+|++|.|++.-+.+|..+..|+.|+|..|+|.-.--..|.+|++|++|+|.+|+++...|..|. .+..|
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l 351 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL 351 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence 589999999999999988889999999999999999999855566799999999999999999977777654 45667
Q ss_pred ecccccccccC
Q 012219 79 YVYGKNFDVEI 89 (468)
Q Consensus 79 ~~~~n~l~~~~ 89 (468)
++..|++.+.+
T Consensus 352 ~l~~Np~~CnC 362 (498)
T KOG4237|consen 352 NLLSNPFNCNC 362 (498)
T ss_pred ehccCcccCcc
Confidence 88888887753
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3e-08 Score=92.96 Aligned_cols=85 Identities=20% Similarity=0.282 Sum_probs=64.2
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccccc-CCCCCceecccCcccccccCCcC---CCcc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG-EIPRIDTVDLSMNNLSGSIPESV---RKVP 76 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~---~~l~ 76 (468)
|.+.+|.-|+|..|.|+ .+| +|++|..|..|+++.|++. .+|++.. .|++|.+|||-.|+++ .+|+.+ .++.
T Consensus 203 g~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~ 278 (565)
T KOG0472|consen 203 GGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE 278 (565)
T ss_pred cchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh
Confidence 34667777888888888 777 8888888888888888887 7777754 7888888888888888 788754 4455
Q ss_pred ceecccccccccC
Q 012219 77 HLYVYGKNFDVEI 89 (468)
Q Consensus 77 ~l~~~~n~l~~~~ 89 (468)
.|++++|.+++..
T Consensus 279 rLDlSNN~is~Lp 291 (565)
T KOG0472|consen 279 RLDLSNNDISSLP 291 (565)
T ss_pred hhcccCCccccCC
Confidence 6778887776643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.8e-06 Score=73.98 Aligned_cols=157 Identities=22% Similarity=0.255 Sum_probs=100.6
Q ss_pred CcCHHHHHHHhhCccccceee---eeCCceEEEEEcCCCCEEEEEEecCcchhhhh---------------------hHH
Q 012219 159 RITFQDMIEATEDFHIKYCIG---TGGYGSVYRARLPSGKVVALKKLHRSETEELA---------------------SLE 214 (468)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~ 214 (468)
..+++.+....+...+....| .|.-+.||+|...++..+|||+++........ ...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345566666666666666555 56667899998888999999999744322111 011
Q ss_pred HHHHHHHHHhhcc--CCceeeEEEEEeeCCEEEEEEEeccCCCh-hhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 012219 215 SFGNEARLLSQIR--HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291 (468)
Q Consensus 215 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 291 (468)
.-..|+..|.++. +-.+.+.+++. .-.|||||+..... .-.|. ..++...+...+..++.+.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHH-
Confidence 2345666676663 33333444433 24799999965311 11111 1112333566677778788777763
Q ss_pred CCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 292 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
..++||+||+.-|||+. ++.+.|+|||.|....
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 47999999999999999 8899999999886654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.9e-08 Score=101.21 Aligned_cols=80 Identities=38% Similarity=0.610 Sum_probs=45.6
Q ss_pred CCCCcEEEccCCcccccCCcc-cccCCCCCEeeccCccccccccc----------------------cccCCCCCceecc
Q 012219 3 CSKLRVLELGNNLLSGSIPSE-INKLQELNYLNLSHNSINGKILS----------------------QLGEIPRIDTVDL 59 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~----------------------~~~~l~~L~~l~l 59 (468)
.++|+.|+|++|+|. ++|+. +.+|..|+.|+||+|+|+ .+|. ++.+++.|+.+||
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDL 459 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEec
Confidence 345555555555554 45543 445555555555555555 4443 5566667777777
Q ss_pred cCcccc-cccCCcC--CCccceeccccc
Q 012219 60 SMNNLS-GSIPESV--RKVPHLYVYGKN 84 (468)
Q Consensus 60 ~~N~l~-g~~p~~~--~~l~~l~~~~n~ 84 (468)
|.|+|+ +.+|... .+|+.|+++||.
T Consensus 460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ccchhhhhhhhhhCCCcccceeeccCCc
Confidence 777775 2344432 466777777765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-07 Score=85.89 Aligned_cols=78 Identities=27% Similarity=0.417 Sum_probs=67.0
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC---cCCCccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE---SVRKVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~---~~~~l~~l~~~ 81 (468)
.|+.||||+|.|+ .|..++.-++.++.|++|+|.++ .+- ++..|++|+.||||+|.++ .+-. .+++.+.|.++
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4889999999999 99999999999999999999998 553 4999999999999999998 4443 57788888888
Q ss_pred ccccc
Q 012219 82 GKNFD 86 (468)
Q Consensus 82 ~n~l~ 86 (468)
+|.+.
T Consensus 361 ~N~iE 365 (490)
T KOG1259|consen 361 QNKIE 365 (490)
T ss_pred hhhHh
Confidence 77653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.5e-08 Score=99.18 Aligned_cols=70 Identities=29% Similarity=0.445 Sum_probs=62.9
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccc-ccCCCCCceecccCcccccccCCcCCC
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLSMNNLSGSIPESVRK 74 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~~~~ 74 (468)
++.|+.|+|.+|.|+...=+.+.+...|+.|+|++|+|+ .+|++ +.+|..|+.|+||+|+|+ .+|+.+.+
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~ 428 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVAN 428 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHh
Confidence 456899999999999988889999999999999999999 88877 899999999999999999 88875433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.4e-06 Score=74.59 Aligned_cols=143 Identities=20% Similarity=0.208 Sum_probs=83.2
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC--ceeeEEEEEee---CCEEEEEEEe
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR--NIVKLYGFCLH---RKCMFLIYEY 250 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~ 250 (468)
+.++.|..+.||+....+ ..+++|...... ....+.+|..++..+... .+.+++.++.. ....+++|++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~-----~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPD-----AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHH-----HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCC-----CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 568999999999999877 689999976551 234566788888877533 34566665433 3457899999
Q ss_pred ccCCChhh----------------hh---hcC-cccCCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 012219 251 MEMGSLFC----------------VL---RTD-EEAVGLDWAK---------RVNV------------VKGMCH-ALSYL 288 (468)
Q Consensus 251 ~~~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~~L 288 (468)
+++..+.. .+ +.. .......+.. .... ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988777 11 111 0111111100 0000 111222 23333
Q ss_pred Hh----cCCCCeEecCCCCCceeeC-CCCCeEEeecccccc
Q 012219 289 HH----DCTPPIVHRDISSNNVLLN-SELEAFVADFGVARL 324 (468)
Q Consensus 289 H~----~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~ 324 (468)
+. .....++|+|+.|+||+++ +++.+.|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 32 1256799999999999999 556667999987743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2e-07 Score=92.75 Aligned_cols=181 Identities=20% Similarity=0.187 Sum_probs=129.9
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc-eeeEEEEEeeCCEEEEEEEeccCC
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN-IVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+-+++|++++++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 346789999999997544444445555433 22346889999999999 777777777777889999999877
Q ss_pred -ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCce
Q 012219 255 -SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333 (468)
Q Consensus 255 -sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 333 (468)
+....... ....+...+...+...-+++++++| +..=+|+| ||+.++ ...+..||+....+.... ...
T Consensus 320 rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~ 388 (829)
T KOG0576|consen 320 RSSALEMTV--SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR 388 (829)
T ss_pred ccccccCCh--hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence 22221111 1112334445556666778899999 33357888 777766 678999999987775432 445
Q ss_pred eccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 012219 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 334 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
...+++.|+|||+.....+..+.|+|+.|+-..++--|-+|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567999999999999999999999999998777777777663
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.1e-06 Score=73.05 Aligned_cols=105 Identities=24% Similarity=0.324 Sum_probs=82.7
Q ss_pred HHHHHHHhhccC-CceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012219 217 GNEARLLSQIRH-RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295 (468)
Q Consensus 217 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 295 (468)
..|.-+++.+++ +++.+++|+|- .+++.||...+++...-..-..-...+|..+.+||.++++.+.++++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999994 3779999987766432111111123689999999999999999999765556
Q ss_pred eEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 296 IVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 296 ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+.-.|++++|+-+++++++|+.|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=2e-05 Score=72.81 Aligned_cols=139 Identities=13% Similarity=0.101 Sum_probs=84.4
Q ss_pred eeeeCC-ceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEEeccCCC
Q 012219 178 IGTGGY-GSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEMGS 255 (468)
Q Consensus 178 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 255 (468)
|..|.+ ..||+.... +..+.+|...... .....+|++++..+. +--+.+++++....+..++|||+++|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 455555 788999764 4678888886543 123557888887774 3445577777776667899999999987
Q ss_pred hhhhh-------------------hcCcc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHh---
Q 012219 256 LFCVL-------------------RTDEE-AVGLD--WAKRVNVVK--------------------GMCHALSYLHH--- 290 (468)
Q Consensus 256 L~~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~--- 290 (468)
+.... +.... ..++. ......... .+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 11100 00111 000010000 01111222211
Q ss_pred -cCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 291 -DCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 291 -~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.....++|+|+.|.||+++++..+.|.||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 114569999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.2e-05 Score=84.01 Aligned_cols=149 Identities=19% Similarity=0.291 Sum_probs=91.5
Q ss_pred cceeeeeCCceEEEEEcCCC---CEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCce--eeEEEEEeeC---CEEE
Q 012219 175 KYCIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNI--VKLYGFCLHR---KCMF 245 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~ 245 (468)
...++.|.++.+|+....++ ..+++|+....... .....+.+|+++++.+. |.++ .+++.+|.+. +..+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 45688999999999876554 46777776543221 11246779999999995 6654 7788888764 4578
Q ss_pred EEEEeccCCChhhh-----------------------hhcCc-cc-------CCCCH--HHHHHH---------------
Q 012219 246 LIYEYMEMGSLFCV-----------------------LRTDE-EA-------VGLDW--AKRVNV--------------- 277 (468)
Q Consensus 246 lv~e~~~~gsL~~~-----------------------l~~~~-~~-------~~l~~--~~~~~i--------------- 277 (468)
+||||++|..+.+. ||.-. .. .+..+ .+.-.+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 99999998653211 11100 00 00111 011111
Q ss_pred HHHHHHHHHHHHhcCC--------CCeEecCCCCCceeeCCC-CC-eEEeeccccccc
Q 012219 278 VKGMCHALSYLHHDCT--------PPIVHRDISSNNVLLNSE-LE-AFVADFGVARLL 325 (468)
Q Consensus 278 ~~~ia~~l~~LH~~~~--------~~ivH~dlk~~NIll~~~-~~-~kl~Dfg~~~~~ 325 (468)
...+...+.+|..+.. ..++|+|+++.||+++.+ .. +-|.||.++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 1123344567743221 359999999999999853 33 468999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-06 Score=90.33 Aligned_cols=75 Identities=24% Similarity=0.458 Sum_probs=39.5
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC-Cccceecccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR-KVPHLYVYGK 83 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~~~n 83 (468)
+|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. +|..|++++|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N 272 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFHN 272 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcCC
Confidence 4666666666666 5665544 35666666666666 4554432 24555555555554 4444322 3444444444
Q ss_pred ccc
Q 012219 84 NFD 86 (468)
Q Consensus 84 ~l~ 86 (468)
++.
T Consensus 273 ~L~ 275 (754)
T PRK15370 273 KIS 275 (754)
T ss_pred ccC
Confidence 444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-06 Score=89.28 Aligned_cols=32 Identities=22% Similarity=0.458 Sum_probs=14.2
Q ss_pred CCceecccCcccccccCCcCCCccceecccccc
Q 012219 53 RIDTVDLSMNNLSGSIPESVRKVPHLYVYGKNF 85 (468)
Q Consensus 53 ~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~l 85 (468)
+|+.|+|++|+|+ .+|....++..|++++|.+
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L 374 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRL 374 (788)
T ss_pred ccceEecCCCccC-CCCCCCcccceehhhcccc
Confidence 4455555555555 3443333333344444333
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.7e-07 Score=72.62 Aligned_cols=72 Identities=22% Similarity=0.415 Sum_probs=54.2
Q ss_pred CCCcEEEccCCcccccCCcccccC-CCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccce
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKL-QELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHL 78 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l 78 (468)
..|+..+|++|.|. .+|+.|... +.+++|+|++|.|+ .+|.++..++.|+.||++.|.|. ..|.-+..|..+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l 125 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKL 125 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhH
Confidence 34667788888888 778777664 37888888888888 77888888888888888888888 677655444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.7e-07 Score=87.69 Aligned_cols=78 Identities=33% Similarity=0.523 Sum_probs=58.5
Q ss_pred CcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccc--eecccc
Q 012219 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPH--LYVYGK 83 (468)
Q Consensus 6 l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~--l~~~~n 83 (468)
|+.|.++||+++ .+|..++.+..|..||.|.|.+. .+|+.+++|.+|+.|++..|++. .+|..+..|+- |+++.|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccC
Confidence 778888888888 88888888888888888888888 78888888877777777666666 56665555443 555666
Q ss_pred ccc
Q 012219 84 NFD 86 (468)
Q Consensus 84 ~l~ 86 (468)
+++
T Consensus 222 kis 224 (722)
T KOG0532|consen 222 KIS 224 (722)
T ss_pred cee
Confidence 554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.3e-06 Score=87.46 Aligned_cols=71 Identities=23% Similarity=0.390 Sum_probs=36.8
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceeccccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYGKN 84 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~ 84 (468)
+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+.+|..|++++|.
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~ 293 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQ 293 (788)
T ss_pred CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhchhhcCEEECcCCc
Confidence 4667777777776 56642 456777777777776 45532 234444444444444 333333333333333333
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.6e-05 Score=64.07 Aligned_cols=130 Identities=20% Similarity=0.259 Sum_probs=88.8
Q ss_pred cccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceee-EEEEEeeCCEEEEEEEec
Q 012219 173 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK-LYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~ 251 (468)
...+.||+|.+|.||+|.+. |..+|+|+-..+.. ...+..|++++..+.-.++.+ ++.|-.+ .+.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 34567999999999999995 45788888776654 357889999999988666543 4444332 4459999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCceeeCCCCCeEEeeccccccc
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS-SNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk-~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
.|-.|.+.-... +-... ..++..---|- ..||-|+.|. |..+++..+..+.|+||..|...
T Consensus 95 ~G~~L~~~~~~~------~rk~l----~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG------DRKHL----LRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc------cHHHH----HHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 988887665421 11222 23344433333 6689999987 55556666669999999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00014 Score=69.13 Aligned_cols=77 Identities=19% Similarity=0.161 Sum_probs=56.3
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC---CceeeEEEEEee---CCEEEEE
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH---RNIVKLYGFCLH---RKCMFLI 247 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv 247 (468)
-.+.||.|..+.||+....+++ +++|..+.... ...|..|.+.++.+.- -.+.+++++|.. .+..++|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFST-----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEeccccc-----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3467999999999999876664 66676543111 1467789999988853 367788888754 3568999
Q ss_pred EEeccCCCh
Q 012219 248 YEYMEMGSL 256 (468)
Q Consensus 248 ~e~~~~gsL 256 (468)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00019 Score=63.40 Aligned_cols=136 Identities=21% Similarity=0.304 Sum_probs=90.5
Q ss_pred ccceeeeeCCceEEEEEcCCCCEEEEEEecCcchh-------------hhhhHHHHHHHHHHHhhcc------CCceeeE
Q 012219 174 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-------------ELASLESFGNEARLLSQIR------HRNIVKL 234 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------h~niv~l 234 (468)
....||+|+.-.||. +++....+||+....... .....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999988885 445666789988766500 0012356667777666665 8899999
Q ss_pred EEEEeeCCEEEEEEEeccC--C----ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 235 YGFCLHRKCMFLIYEYMEM--G----SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 235 ~~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
+|+..++...-+|+|.+.+ | +|.+++.... ++. +..+.+.+. ..||- ...|+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEE
Confidence 9999999999999998754 2 4666664322 444 333333333 34554 5579999999999999
Q ss_pred CCCC----CeEEee-cccc
Q 012219 309 NSEL----EAFVAD-FGVA 322 (468)
Q Consensus 309 ~~~~----~~kl~D-fg~~ 322 (468)
.... .+.|.| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 5432 455665 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.7e-06 Score=86.58 Aligned_cols=77 Identities=26% Similarity=0.470 Sum_probs=51.1
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC-Cccceeccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR-KVPHLYVYG 82 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~~~ 82 (468)
++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. +|..|++++
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~ 292 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYD 292 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCC
Confidence 46777777777777 6666554 35777777777776 6666654 46777777777777 5666443 566677777
Q ss_pred ccccc
Q 012219 83 KNFDV 87 (468)
Q Consensus 83 n~l~~ 87 (468)
|++..
T Consensus 293 N~Lt~ 297 (754)
T PRK15370 293 NSIRT 297 (754)
T ss_pred Ccccc
Confidence 76654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.8e-05 Score=65.31 Aligned_cols=128 Identities=23% Similarity=0.400 Sum_probs=90.9
Q ss_pred hCccccceeeeeCC-ceEEEEEcCCCCEEEEEEecC---cch---------hhh------hhHHHHHHHHHHHhhcc---
Q 012219 170 EDFHIKYCIGTGGY-GSVYRARLPSGKVVALKKLHR---SET---------EEL------ASLESFGNEARLLSQIR--- 227 (468)
Q Consensus 170 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~---------~~~------~~~~~~~~e~~~l~~l~--- 227 (468)
.+++..+.||.|.- |.||+++. +|+.+|+|.+.. ... .+. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 577999999331 100 000 12346888999888885
Q ss_pred CCce--eeEEEEEeeC------------------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHH
Q 012219 228 HRNI--VKLYGFCLHR------------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287 (468)
Q Consensus 228 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 287 (468)
+.++ |+.+||..-. ....||.||++... .+.. +-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 8999987422 12467888776533 1222 234456667888
Q ss_pred HHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 288 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 89 889999999999986 4578999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.9e-05 Score=68.81 Aligned_cols=73 Identities=14% Similarity=0.214 Sum_probs=44.3
Q ss_pred ceeeeeCCc-eEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC---ceeeEEEEEeeC---CEEEEEE
Q 012219 176 YCIGTGGYG-SVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR---NIVKLYGFCLHR---KCMFLIY 248 (468)
Q Consensus 176 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~ 248 (468)
+.|+.|+.. .||+. +..+++|..+.... ...+.+|.+.+..+... .+.++++..... ...+++|
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~-----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGY-----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccch-----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 346766665 58876 23467776554221 23677899988877532 334444444332 2347899
Q ss_pred EeccCCChh
Q 012219 249 EYMEMGSLF 257 (468)
Q Consensus 249 e~~~~gsL~ 257 (468)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.6e-06 Score=81.45 Aligned_cols=70 Identities=23% Similarity=0.357 Sum_probs=58.2
Q ss_pred CCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecc-cCcccccccCC-cCCCcc
Q 012219 5 KLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL-SMNNLSGSIPE-SVRKVP 76 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l-~~N~l~g~~p~-~~~~l~ 76 (468)
.-+.|+|..|+|+ .|| ..|+.+.+|+.||||+|+|+-+-|++|.+|.+|..|-+ ++|+|+ .+|. .|..|.
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~ 140 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLS 140 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHH
Confidence 4578999999999 666 57999999999999999999888999999999976655 559999 8886 344443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.3e-05 Score=90.32 Aligned_cols=83 Identities=17% Similarity=0.243 Sum_probs=67.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceeccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYG 82 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~ 82 (468)
+++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|....+++.|++.+
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~ 855 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSR 855 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCC
Confidence 3578999999998888999999999999999999987555888776 788888888888765557777666777777777
Q ss_pred cccc
Q 012219 83 KNFD 86 (468)
Q Consensus 83 n~l~ 86 (468)
|.+.
T Consensus 856 n~i~ 859 (1153)
T PLN03210 856 TGIE 859 (1153)
T ss_pred CCCc
Confidence 7665
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.9e-06 Score=76.13 Aligned_cols=60 Identities=27% Similarity=0.406 Sum_probs=44.6
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
++.++.|+||.|+|+ .+-. ++.|.+|+.||||+|.|+ .+-..=..|-++++|+|+.|.+.
T Consensus 306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE 365 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE 365 (490)
T ss_pred ccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh
Confidence 578899999999998 6654 888999999999999998 44443344555666666666554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.83 E-value=2.4e-05 Score=88.11 Aligned_cols=88 Identities=19% Similarity=0.256 Sum_probs=62.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc--CCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES--VRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~ 79 (468)
++++|+.|+|++|...+.+| .++.+++|+.|+|++|...+.+|.++.+|++|+.|++++|+..+.+|.. +.+|..|.
T Consensus 632 ~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~ 710 (1153)
T PLN03210 632 SLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLN 710 (1153)
T ss_pred cCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEe
Confidence 46788888888776555777 4777888888888887766688888888888888888876544477763 45566666
Q ss_pred cccccccccCC
Q 012219 80 VYGKNFDVEIP 90 (468)
Q Consensus 80 ~~~n~l~~~~p 90 (468)
++++......|
T Consensus 711 Lsgc~~L~~~p 721 (1153)
T PLN03210 711 LSGCSRLKSFP 721 (1153)
T ss_pred CCCCCCccccc
Confidence 66665433333
|
syringae 6; Provisional |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 3e-90
Identities = 99/289 (34%), Positives = 153/289 (52%), Gaps = 17/289 (5%)
Query: 159 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN 218
R + +++ A+++F K +G GG+G VY+ RL G +VA+K+L E F
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQT 76
Query: 219 EARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNV 277
E ++S HRN+++L GFC+ L+Y YM GS+ C+ E LDW KR +
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLA 336
G L+YLH C P I+HRD+ + N+LL+ E EA V DFG+A+L+++ ++ T +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS----------WSLD 386
GT G+IAPE T +EK DV+ +GV+ LE++ G+ +L ++ L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
K KL L+D L + ++ + VA C +S P RP M V
Sbjct: 257 KEKKLEALVDVDLQGNYKDE---EVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-80
Identities = 98/287 (34%), Positives = 145/287 (50%), Gaps = 24/287 (8%)
Query: 159 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN 218
R+ D+ EAT +F K+ IG G +G VY+ L G VALK+ ++ +E F
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFET 84
Query: 219 EARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNV 277
E LS RH ++V L GFC R M LIY+YME G+L L +D + + W +R+ +
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR----T 333
G L YLH T I+HRD+ S N+LL+ + DFG+++ ++ T
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK--GTELDQTHLST 199
Query: 334 LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKH------PGELLSSSSW--SL 385
++ GT GYI PE +TEK DVYSFGVV EVL + P E+++ + W
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM 432
N +L ++DP L+ + + + A CL + RP+M
Sbjct: 260 HNNGQLEQIVDPNLADKIRPE---SLRKFGDTAVKCLALSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-72
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 25/293 (8%)
Query: 159 RITFQDMIEATEDFHIKYC------IGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS 212
+F ++ T +F + +G GG+G VY+ + VA+KKL
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 213 LES-FGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW 271
L+ F E +++++ +H N+V+L GF + L+Y YM GSL L + L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDS 329
R + +G + +++LH + +HRDI S N+LL+ A ++DFG+AR +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK------HPGELLSSSSW 383
+ + GT Y+APE A +T K D+YSFGVV LE++ G +LL
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 384 SLDKN-IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
++ + D +D +++ + + +VA CL + RP ++ V
Sbjct: 249 EIEDEEKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-63
Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNE 219
+ +++ + + G +G V++A+L + VA+K + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ----NEYE 68
Query: 220 ARLLSQIRHRNIVKLYGFCLH----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 275
L ++H NI++ G ++LI + E GSL L+ + + W +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELC 124
Query: 276 NVVKGMCHALSYLHHD-------CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
++ + M L+YLH D P I HRDI S NVLL + L A +ADFG+A
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 329 SS--NRTLLAGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSS- 380
S + GT Y+APE+ + + D+Y+ G+V E+ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 381 ----------SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP 430
SL+ +++ R + + ++ C ++R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 431 TMQLV 435
+ V
Sbjct: 305 SAGCV 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-62
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 13/264 (4%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
D +IK IG G +G+V+RA G VA+K L + + F E ++ ++RH
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHP 94
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NIV G + ++ EY+ GSL+ +L LD +R+++ + ++YLH
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT 349
+ PPIVHR++ S N+L++ + V DFG++RL + AGT ++APE+
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 350 MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409
EK DVYSFGV+ E+ + P L+ + K + ++ ++
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---CKRLEIPRNLNPQVA- 269
Query: 410 DIILVSTVAFSCLRSQPKSRPTMQ 433
II C ++P RP+
Sbjct: 270 AIIE------GCWTNEPWKRPSFA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-62
Identities = 75/297 (25%), Positives = 133/297 (44%), Gaps = 23/297 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ ++ +G G +G V +A+ K VA+K++ + +F E R LS++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK-----AFIVELRQLSRVNHP 61
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NIVKLYG CL+ C+ + EY E GSL+ VL E A ++ ++YLH
Sbjct: 62 NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
++HRD+ N+LL + + DFG A + +N G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFE 176
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+EKCDV+S+G++ EV+ + P + + ++ + + + P L + + I
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH--NGTRPPLIKNLPKPIE 234
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF--IARNKAPMQKPFHEISILELRNQE 463
++ C P RP+M+ + + R +P L E
Sbjct: 235 -SLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-60
Identities = 79/278 (28%), Positives = 124/278 (44%), Gaps = 32/278 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHR----SETEELASLESFGNEARLLS 224
+ + IG GG+G V++ RL VVA+K L ETE + + F E ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+ H NIVKLYG + M + E++ G L+ L + W+ ++ ++ +
Sbjct: 79 NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAF-----VADFGVARLLNFDSSNRTLLAGTY 339
+ Y+ + PPIVHRD+ S N+ L S E VADFG+++ S G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190
Query: 340 GYIAPEL--AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397
++APE A TEK D YSF ++ +L G+ P + S I+ L
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--- 247
Query: 398 RLSPP--VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
R + P ++R ++I C PK RP
Sbjct: 248 RPTIPEDCPPRLR-NVIE------LCWSGDPKKRPHFS 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-59
Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA-SLESFGNEARLLSQIRH 228
+ ++ IG GG+G VYRA G VA+K E+++ ++E+ EA+L + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NI+ L G CL + L+ E+ G L VL + VN + ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYL 121
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAF--------VADFGVARLLNFDSSNRTLLAGTYG 340
H + PI+HRD+ S+N+L+ ++E + DFG+AR + + AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYA 179
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400
++APE+ + ++ DV+S+GV+ E+L G+ P + + + + L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-----KLALP 234
Query: 401 PP--VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
P + + ++ C P SRP+
Sbjct: 235 IPSTCPEPFAK-LME------DCWNPDPHSRPSFT 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-55
Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
D +G G +G + +G+V+ +K+L R + E + +F E +++ + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEH 66
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N++K G K + I EY++ G+L ++++ + W++RV+ K + ++YL
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL 124
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--------------RTL 334
H + I+HRD++S+N L+ VADFG+ARL+ + + R
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394
+ G ++APE+ EK DV+SFG+V E++ + + N++
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--GF 239
Query: 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
LD P + C P+ RP+
Sbjct: 240 LDRYCPPNCPPSFFP-------ITVRCCDLDPEKRPSFV 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-55
Identities = 52/272 (19%), Positives = 100/272 (36%), Gaps = 30/272 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ + + G +++ R G + +K L + F E L H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHP 67
Query: 230 NIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
N++ + G C LI +M GSL+ VL V +D ++ V M +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAF 126
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL- 346
LH P I ++S +V+++ ++ A ++ V S ++APE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180
Query: 347 --AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS---LDKNIKLIDLLDPRLSP 401
D++SF V+ E++ + P LS+ + ++ + P +SP
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGISP 238
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
V + ++ C+ P RP
Sbjct: 239 HVSKLMKI-----------CMNEDPAKRPKFD 259
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 65/301 (21%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E I IG G +G VY R G+V A++ + E L++F E Q RH
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKREVMAYRQTRHE 89
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
N+V G C+ + +I + +L+ V+R + LD K + + + + YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH 147
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-----TLLAGTYGYIAP 344
I+H+D+ S NV + + + DFG+ + + R + G ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 345 EL---------AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS--WSLDKNIKLID 393
E+ + ++ DV++ G + E+ + P + + + W + +K +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-N 262
Query: 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN--EFIARNKAPMQKPF 451
L + + DI+L C + + RPT + + E + + + P
Sbjct: 263 LSQIGMGKEI-----SDILL------FCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311
Query: 452 H 452
H
Sbjct: 312 H 312
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 63/272 (23%), Positives = 127/272 (46%), Gaps = 26/272 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ IG+G +G+VY+ + G V A+K L+ + L++F NE +L + RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 80
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NI+ G+ + ++ ++ E SL+ L E + K +++ + + YLH
Sbjct: 81 NILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH 137
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTYGYIAPEL- 346
I+HRD+ SNN+ L+ + + DFG+A + S L+G+ ++APE+
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 347 --AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS---WSLDKNIKLIDLLDPRLSP 401
+ + + DVY+FG+V E++ G+ P +++ + + DL ++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL--SKVRS 252
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
++++ ++ CL+ + RP+
Sbjct: 253 NCPKRMK-RLMA------ECLKKKRDERPSFP 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 62/318 (19%), Positives = 112/318 (35%), Gaps = 53/318 (16%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNE 219
+ ++ + IG G YG+VY+ L + VA+K + ++F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINE 55
Query: 220 AR--LLSQIRHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWA 272
+ + H NI + L+ EY GSL L DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 273 KRVNVVKGMCHALSYLHHD------CTPPIVHRDISSNNVLLNSELEAFVADFGVARLL- 325
+ + L+YLH + P I HRD++S NVL+ ++ ++DFG++ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 326 -------NFDSSNRTLLAGTYGYIAPELAYTMV-------VTEKCDVYSFGVVALEVLMG 371
+ + GT Y+APE+ V ++ D+Y+ G++ E+ M
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 372 KH-------------PGELLSSSSWSLDKNIKLIDLLDPRLS-PPVDQKIRQDIILVSTV 417
+ + + + L+ R P ++ + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 418 AFSCLRSQPKSRPTMQLV 435
C ++R T Q
Sbjct: 292 IEDCWDQDAEARLTAQXA 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-49
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 42/296 (14%)
Query: 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARL--LSQI 226
D + C+G G YG V+R G+ VA+K + +S+ E L +
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59
Query: 227 RHRNIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC 282
RH NI+ + + ++LI Y EMGSL+ L+ LD + +V +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIA 115
Query: 283 HALSYLHHD-----CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS----NRT 333
L++LH + P I HRD+ S N+L+ + +AD G+A + + ++
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 334 LLAGTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGKHPG----------EL 377
GT Y+APE+ ++ D+++FG+V EV
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ + S + K++ + R + P + ++ + C P +R T
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-49
Identities = 68/295 (23%), Positives = 111/295 (37%), Gaps = 42/295 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEAR--LLSQIR 227
+ + IG G YG V+ + G+ VA+K +E S+ E +R
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE------EASWFRETEIYQTVLMR 89
Query: 228 HRNIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
H NI+ + ++LI +Y E GSL+ L++ LD + +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVS 145
Query: 284 ALSYLH-----HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL--- 335
L +LH P I HRD+ S N+L+ +AD G+A D++ +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 336 -AGTYGYIAPE-LAYTMVV-----TEKCDVYSFGVVALEVLMGKHPG----------ELL 378
GT Y+ PE L ++ D+YSFG++ EV G L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
S S + +++ + R S P + + + + C P SR T
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 62/295 (21%), Positives = 114/295 (38%), Gaps = 42/295 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEAR--LLSQIR 227
++ IG G +G V+R + G+ VA+K E S+ EA +R
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94
Query: 228 HRNIVKLYGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
H NI+ ++L+ +Y E GSLF L + + +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTAS 150
Query: 284 ALSYLHHD-----CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL--- 335
L++LH + P I HRD+ S N+L+ +AD G+A + + +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 336 -AGTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMG----------KHPGELL 378
GT Y+APE+ ++ D+Y+ G+V E+ + P L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
S S+++ K++ R + P + + + +++ + C + +R T
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 32/290 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKK--LHRSETEELASLESFGNEARLLSQI 226
E + IG G +G + G+ +K+ + R ++E E +L+ +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR---REVAVLANM 80
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNVVKGM 281
+H NIV+ ++++ +Y E G LF + +E LDW + +
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------I 134
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
C AL ++H I+HRDI S N+ L + + DFG+AR+LN GT Y
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
++PE+ K D+++ G V E+ KH E + S +L I P +S
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIISGSF--PPVSL 247
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
+R LVS + P+ RP++ ++ FIA+ P
Sbjct: 248 HYSYDLRS---LVS----QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 65/299 (21%), Positives = 115/299 (38%), Gaps = 34/299 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+F I+ IG G + VYRA L G VALKK+ + + + E LL Q+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--------DEEAVGLDWAKRVNVVKG 280
N++K Y + + ++ E + G L +++ E V + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQ------ 144
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+C AL ++H ++HRDI NV + + + D G+ R + ++ L GT
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI---KLIDLLDP 397
Y++PE + K D++S G + E+ + P + +SL K I L
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHEIS 455
S + + ++ C+ P+ RP + + H
Sbjct: 262 HYSEEL-----RQLVN------MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 69/282 (24%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 177 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235
IG G + +VY+ + VA +L + + + + F EA +L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 236 GFCL----HRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHALSY 287
+KC+ L+ E M G+L L+ + + W +++ L +
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS-WCRQI------LKGLQF 144
Query: 288 LHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
LH TPPI+HRD+ +N+ + + D G+A L +S + GT ++APE+
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM 201
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL-----DPRLSP 401
Y E DVY+FG+ LE+ ++P +S +N I P
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTSGVKPASFD 252
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIAR 442
V ++II C+R R + L+++ F
Sbjct: 253 KVAIPEVKEIIE------GCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 75/294 (25%), Positives = 121/294 (41%), Gaps = 35/294 (11%)
Query: 165 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSE--TEELASLESFGNEAR 221
M ED+ + Y IGTG YG + R GK++ K+L E L +E
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 222 LLSQIRHRNIVKLYG-FCLHRKCMFLIY-EYMEMGSLFCVLRTD-------EEAVGLDWA 272
LL +++H NIV+ Y I EY E G L V+ +E L
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 273 KRVNVVKGMCHALSYLH--HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
+ + AL H D ++HRD+ NV L+ + + DFG+AR+LN D+S
Sbjct: 118 TQ------LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK 390
GT Y++PE M EK D++S G + E+ P + S L I+
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIR 229
Query: 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARN 443
R+ ++ + +++ L + RP++ +++ N I +
Sbjct: 230 EGKF--RRIPYRYSDELNE---IIT----RMLNLKDYHRPSVEEILENPLILEH 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 59/299 (19%), Positives = 118/299 (39%), Gaps = 58/299 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
DF IG+GG+G V++A+ GK +K++ + + E + L+++ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-------REVKALAKLDH 63
Query: 229 RNIVKLYGF----------------CLHRKCMFLIYEYMEMGSLFCVLRT------DEEA 266
NIV G KC+F+ E+ + G+L + D+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 267 VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
L+ ++ + + Y+H +++RD+ +N+ L + + DFG+ L
Sbjct: 124 A-LELFEQ------ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD 386
D GT Y++PE + ++ D+Y+ G++ E+L +
Sbjct: 174 NDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF---------E 223
Query: 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNK 444
+ DL D +S D+K + L+ L +P+ RP +++ + +
Sbjct: 224 TSKFFTDLRDGIISDIFDKKEKT---LLQ----KLLSKKPEDRPNTSEILRTLTVWKKS 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 56/310 (18%), Positives = 114/310 (36%), Gaps = 44/310 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
DF C+G GG+G V+ A+ A+K++ E + E E + L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 229 RNIVKLYGFCLHRKCM------------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 276
IV+ + L + ++ + +L + + + ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------- 329
+ + A+ +LH + ++HRD+ +N+ + V DFG+ ++ D
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 330 -----SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS 384
+ T GT Y++PE + + K D++S G++ E+L +P S+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP---FSTQMER 233
Query: 385 LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARN 443
+ + +L P L +V L P RP ++ N
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYV---MVQ----DMLSPSPMERPEAINIIENAVFEDL 286
Query: 444 KAPMQKPFHE 453
P + +
Sbjct: 287 DFPGKTVLRQ 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 83/300 (27%), Positives = 128/300 (42%), Gaps = 58/300 (19%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
E F IG G +G V++ + KVVA+K + E E+ +E E +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCD 78
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNVVKGMCHA 284
+ K YG L +++I EY+ GS +L DE + +++ +
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKG 131
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L YLH + +HRDI + NVLL+ E +ADFGVA L R GT ++AP
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKLIDLLDPR 398
E+ K D++S G+ A+E+ G+ HP ++L L P+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------------FLIPK 233
Query: 399 LSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPT-MQLVSNEFIARNKAPMQ 448
+PP + +S CL +P RPT +L+ ++FI RN
Sbjct: 234 NNPPTLEG-----------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 65/304 (21%), Positives = 134/304 (44%), Gaps = 38/304 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ I IG+GG V++ ++ A+K ++ E + +L+S+ NE L++++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 230 N--IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ I++LY + + + ++++ E L L+ ++++ K K M A+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 142
Query: 288 LH-HDCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIA 343
+H H IVH D+ N L+ + L+ + DFG+A + D+++ + GT Y+
Sbjct: 143 IHQHG----IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 344 PEL-----------AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392
PE ++ K DV+S G + + GK P + K +I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAII 253
Query: 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPF 451
D P + +K QD++ CL+ PK R ++ +L+++ ++ P+ +
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 307
Query: 452 HEIS 455
+
Sbjct: 308 KGTT 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 36/299 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + +G GG+ V L G ALK++ E ++ + EA + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---READMHRLFNH 85
Query: 229 RNIVKLYGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNVVKGMCH 283
NI++L +CL + +L+ + + G+L+ + ++ L + + ++ G+C
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA------- 336
L +H HRD+ N+LL E + + D G
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 337 --GTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK 390
T Y APEL ++ V+ E+ DV+S G V ++ G+ P +++ S+ +
Sbjct: 203 QRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--ALA 259
Query: 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQ 448
+ + L SP + Q L++ S + P RP + L+S + AP Q
Sbjct: 260 VQNQLSIPQSPRHSSALWQ---LLN----SMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-39
Identities = 66/304 (21%), Positives = 134/304 (44%), Gaps = 38/304 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH- 228
+ I IG+GG V++ ++ A+K ++ E + +L+S+ NE L++++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 229 -RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
I++LY + + + ++++ E L L+ + +D +R + K M A+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHT 123
Query: 288 LH-HDCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIA 343
+H H IVH D+ N L+ + L+ + DFG+A + D+++ + GT Y+
Sbjct: 124 IHQHG----IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 344 PEL-----------AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392
PE ++ K DV+S G + + GK P + K +I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAII 234
Query: 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPF 451
D P + +K QD++ CL+ PK R ++ +L+++ ++ P+ +
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 288
Query: 452 HEIS 455
+
Sbjct: 289 KGTT 292
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED + IG G +G V+ RL + VA+K + + F EAR+L Q H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NIV+L G C ++ ++++ E ++ G LRT+ + + + +V + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYL 229
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----A 343
+HRD+++ N L+ + ++DFG++R +G + A
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTA 283
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RLS 400
PE + + DV+SFG++ E G P LS N + + ++ RL
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQTREFVEKGGRLP 335
Query: 401 PPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
P + ++ C +P RP+ + E
Sbjct: 336 CPELCPDAV-FRLME------QCWAYEPGQRPSFSTIYQEL 369
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 56/291 (19%)
Query: 177 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY 235
+G G YG VY R L + +A+K++ ++ L E L ++H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH---EEIALHKHLKHKNIVQYL 85
Query: 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP 295
G + + E + GSL +LR+ + + K + L YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 296 IVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVV- 352
IVHRDI +NVL+N+ + +DFG ++ L + GT Y+APE ++
Sbjct: 143 IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE-----IID 196
Query: 353 ------TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP--------- 397
+ D++S G +E+ GK P + +L +P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPP--------FY--------ELGEPQAAMFKVGM 240
Query: 398 -RLSPPVDQKIRQDIILVSTVAF--SCLRSQPKSRPT-MQLVSNEFIARNK 444
++ P + + + + AF C P R L+ +EF+ +
Sbjct: 241 FKVHPEIPESMSAEAK-----AFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 66/311 (21%), Positives = 123/311 (39%), Gaps = 59/311 (18%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
DF +G G +G V +AR + A+KK+ +E + + +E LL+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60
Query: 228 HRNIVKLYGFCLHR-------------KCMFLIYEYMEMGSLFCVLRT----DEEAVGLD 270
H+ +V+ Y L R +F+ EY E G+L+ ++ + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-- 328
+++ ALSY+H I+HRD+ N+ ++ + DFG+A+ ++
Sbjct: 121 LFRQI------LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 329 ------------SSNRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375
S N T GT Y+A E L T EK D+YS G++ E++ G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 376 ELLSSSSWSLDKNIKLIDL-LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-Q 433
++ K ++ + + P + + II + P RP
Sbjct: 232 MERV----NILKKLRSVSIEFPPDFDDNKMKVEK-KIIR------LLIDHDPNKRPGART 280
Query: 434 LVSNEFIARNK 444
L+++ ++
Sbjct: 281 LLNSGWLPVKH 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 64/307 (20%), Positives = 132/307 (42%), Gaps = 44/307 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH- 228
+ I IG+GG V++ ++ A+K ++ E + +L+S+ NE L++++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 114
Query: 229 -RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
I++LY + + + ++++ E L L+ + +D +R + K M A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHT 170
Query: 288 LH-HDCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIA 343
+H H IVH D+ N L+ + L+ + DFG+A + D+++ G Y+
Sbjct: 171 IHQHG----IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 344 PEL-----------AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI--K 390
PE ++ K DV+S G + + GK P + N K
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------FQQIINQISK 276
Query: 391 LIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQ 448
L ++DP +D+ ++ CL+ PK R ++ +L+++ ++ P+
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLK----CCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
Query: 449 KPFHEIS 455
+ +
Sbjct: 333 QMAKGTT 339
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 73/312 (23%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKK--LHRSETEELASLESFGNEARLL 223
E + +G G +G V+R + +G A+KK L EEL
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----------AC 104
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
+ + IV LYG + + E +E GSL +++ E+ +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLG 157
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTL---- 334
L YLH I+H D+ ++NVLL+S+ A + DFG A L D ++L
Sbjct: 158 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 335 -LAGTYGYIAPELAYTMVVTE-----KCDVYSFGVVALEVLMGKHPGELLSSSSWS---- 384
+ GT ++APE VV K D++S + L +L G HP W+
Sbjct: 215 YIPGTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP--------WTQYFR 261
Query: 385 ------LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN 437
+ I + P +P Q I++ LR +P R + M+L
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQE-----------GLRKEPVHRASAMELRRK 310
Query: 438 EFIARNKAPMQK 449
A + K
Sbjct: 311 VGKALQEVGGLK 322
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 71/308 (23%), Positives = 139/308 (45%), Gaps = 60/308 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+D+ ++ IG+G V A P + VA+K+++ + + S++ E + +SQ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHH 72
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMCH 283
NIV Y + + ++L+ + + GS+ +++ + ++ LD + +++ +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN-----FDSSNRTLLAGT 338
L YLH + +HRD+ + N+LL + +ADFGV+ L + R GT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 339 YGYIAPELAYTMVVTE------KCDVYSFGVVALEVLMGK------HPGELLSSSSWSLD 386
++APE V+ + K D++SFG+ A+E+ G P ++L
Sbjct: 190 PCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-------- 236
Query: 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPT-MQLVS 436
+L + PP + QD ++ + CL+ P+ RPT +L+
Sbjct: 237 -------MLTLQNDPPSLETGVQDKEMLK--KYGKSFRKMISLCLQKDPEKRPTAAELLR 287
Query: 437 NEFIARNK 444
++F + K
Sbjct: 288 HKFFQKAK 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 59/286 (20%), Positives = 98/286 (34%), Gaps = 45/286 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLSQ 225
+ F +G G YG V++ R G++ A+K+ R + L E +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL----AEVGSHEK 112
Query: 226 I-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNVVKG 280
+ +H V+L ++L E SL EA + +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD------ 165
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
AL++LH +VH D+ N+ L + DFG+ L + G
Sbjct: 166 TLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPR 221
Query: 341 YIAPEL---AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397
Y+APEL +Y DV+S G+ LEV W + L
Sbjct: 222 YMAPELLQGSY----GTAADVFSLGLTILEVACNMELPH--GGEGWQQLRQGYLPPEFTA 275
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIAR 442
LS + + +++ L PK R T L++ + +
Sbjct: 276 GLSSEL-----RSVLV------MMLEPDPKLRATAEALLALPVLRQ 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 76/314 (24%), Positives = 123/314 (39%), Gaps = 53/314 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF +G G G V++ PSG V+A K +H + E ++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNS 90
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
IV YG + + E+M+ GSL VL+ E+ +G V +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKG 143
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+YL I+HRD+ +N+L+NS E + DFGV+ L DS + GT Y++P
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSP 199
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHP------------------------------ 374
E + + D++S G+ +E+ +G++P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 375 -GELLSSSSWSLDKNIKLIDLLD--PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
G L+ + + +LLD PP + V CL P R
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERAD 318
Query: 432 -MQLVSNEFIARNK 444
QL+ + FI R+
Sbjct: 319 LKQLMVHAFIKRSD 332
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 70/303 (23%), Positives = 127/303 (41%), Gaps = 64/303 (21%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
E + I +G G +G VY+A+ +G + A K + EEL E + E +L+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCD 74
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMC 282
H IVKL G H ++++ E+ G++ ++ E + + V + M
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQML 127
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
AL++LH I+HRD+ + NVL+ E + +ADFGV+ R GT ++
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 343 APELAYTMVVTE-----KCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKL 391
APE+ + + K D++S G+ +E+ + +P + +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------RVLLK 233
Query: 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPT-MQLVSNEFIA 441
I + PP L++ +S L P++RP+ QL+ + F++
Sbjct: 234 I----AKSDPPT---------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
Query: 442 RNK 444
Sbjct: 281 SIT 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 85/284 (29%), Positives = 139/284 (48%), Gaps = 32/284 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF I +G G +G+VY AR S ++ALK L +++ E+ E + S +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
NI++LYG+ ++LI EY +G+++ L+ DE+ + + +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR-----TAT--YITELANA 121
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
LSY H ++HRDI N+LL S E +ADFG + SS RT L GT Y+ P
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPP 176
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPPV 403
E+ + EK D++S GV+ E L+GK P E +++ K I ++ P ++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAP 446
+D+I L+ P RP + +++ + +I N +
Sbjct: 235 -----RDLIS------RLLKHNPSQRPMLREVLEHPWITANSSK 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 53/296 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFGNEARLLS 224
+F +G+G +G+VY+ KV VA+K+L + + + + + +EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKG 280
+ + ++ +L G CL + LI + M G L +R ++ +G L+W V + KG
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKG 129
Query: 281 MCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG- 337
M +YL +VHRD+++ NVL+ + + DFG+A+LL + G
Sbjct: 130 M----NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 338 -----TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391
A E + T + DV+S+GV E++ G P + ++
Sbjct: 181 VPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIPASEI 228
Query: 392 IDLLDP--RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF--IARN 443
+L+ RL P I V + C SRP + + EF +AR+
Sbjct: 229 SSILEKGERLPQPPICTID-----VYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 69/295 (23%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ + IG G G+VY A + +G+ VA+++++ + + E NE ++ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNVVKGMCHA 284
+ NIV L ++++ EY+ GSL V+ DE + V + A
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQA 128
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L +LH + ++HRDI S+N+LL + + DFG + + S R+ + GT ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 345 ELAYTMVVTE-----KCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKLID 393
E VVT K D++S G++A+E++ G+ +P + + LI
Sbjct: 186 E-----VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLI- 228
Query: 394 LLDPRLSPPV-DQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNKAP 446
P + I + CL + R + +L+ ++F+ K
Sbjct: 229 ---ATNGTPELQNPEKLSAIFRDFLN-RCLEMDVEKRGSAKELLQHQFLKIAKPL 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 70/291 (24%), Positives = 128/291 (43%), Gaps = 32/291 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ +G GG+ + + +V A K + +S + E E + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNVVKGMCH 283
+++V +GF +F++ E SL + + T+ EA R ++ +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
YLH + ++HRD+ N+ LN +LE + DFG+A + +D + +L GT YIA
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPP 402
PE+ + + DV+S G + +L+GK P E +S IK + P+ ++P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINPV 241
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFH 452
+I L++ P +RPT+ +L+++EF P + P
Sbjct: 242 A-----ASLIQ------KMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 35/277 (12%), Positives = 76/277 (27%), Gaps = 40/277 (14%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFGNEARL 222
++ ++ + +G G + VY A + + LK + E
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT---QLMER 120
Query: 223 LSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNVVKG 280
L +K Y L + L+ E G+L + + + ++
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-----------VADFGVARLLNFDS 329
M + + +H I+H DI +N +L + + D G + +
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 330 SNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387
T G+ E+ + D + +L G + +
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
Query: 388 NIK----------LIDLL---DPRLSPPVDQKIRQDI 411
+ ++ P +RQ +
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 32/289 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ +G GG+ + + +V A K + +S + E E + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNVVKGMCH 283
+++V +GF +F++ E SL + + T+ EA R ++ +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
YLH + ++HRD+ N+ LN +LE + DFG+A + +D + +L GT YIA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPP 402
PE+ + + DV+S G + +L+GK P E +S IK + P+ ++P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINPV 267
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
I++ L++ P +RPT+ +L+++EF P + P
Sbjct: 268 AASLIQK-----------MLQTDPTARPTINELLNDEFFTSGYIPARLP 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 66/289 (22%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
IG G G V AR SG+ VA+K + + + E NE ++ +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ 100
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNVVKGMCHA 284
H N+V++Y L + ++++ E+++ G+L ++ +EE + V + + A
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQA 153
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L+YLH ++HRDI S+++LL + ++DFG ++ D R L GT ++AP
Sbjct: 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKLIDLLDPR 398
E+ + + D++S G++ +E++ G+ P + +K + P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-----------QAMKRLRDSPP- 258
Query: 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNKAP 446
P + + +L + L P+ R T +L+ + F+ + P
Sbjct: 259 --PKLKNSHKVSPVLRDFLE-RMLVRDPQERATAQELLDHPFLLQTGLP 304
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIR 227
D +G+G G V++ R +G V+A+K++ RS +E + + +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHD 82
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCH 283
IV+ +G + +F+ E M + R E +G + +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVK 135
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
AL YL ++HRD+ +N+LL+ + + DFG++ L D + AG Y+A
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMA 192
Query: 344 PELAYTMVVTE-----KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD-- 396
PE T+ + DV+S G+ +E+ G+ P ++L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP----------YKNCKTDFEVLTKV 242
Query: 397 PRLSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPT-MQLVSNEFIARNKAP 446
+ PP+ L + FS CL + RP +L+ + FI R +
Sbjct: 243 LQEEPPL---------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 59/344 (17%), Positives = 122/344 (35%), Gaps = 71/344 (20%)
Query: 159 RITFQDMIEA---TEDFHIKYCIGTG--GYGSVYRAR-LPSGKVVALKK--LHRSETEEL 210
+ FQ M + + IG G +V AR P+G+ V +++ L E +
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 211 ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT------DE 264
L+ E + H NIV + ++++ +M GS ++ T +E
Sbjct: 71 TFLQ---GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 265 EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
A+ +++G+ AL Y+HH VHR + ++++L++ + + +++
Sbjct: 128 LAIAY-------ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 325 LNFDSSNRTLL-------AGTYGYIAPELAYTMVV--TEKCDVYSFGVVALEVLMGK--- 372
+ + ++ +++PE+ + K D+YS G+ A E+ G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 373 ---HP-------------------GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410
+ S +++ L D +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 411 IILVSTVAFS---------CLRSQPKSRPT-MQLVSNEFIARNK 444
FS CL+ P +RP+ L+++ F + K
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 35/318 (11%), Positives = 77/318 (24%), Gaps = 48/318 (15%)
Query: 152 AIWNYDGRITFQDMI-EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE 209
+W + T ++ + + + G V+ R + + ALK
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 210 LASLESFGNEARLLSQIRHRNIVKLYGFC--------------------------LHRKC 243
+ LE +++ + +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 244 MFLIYEYM--EMGSLFCVLRTDEEAVG-LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300
L+ ++ LF L G + + + L +VH
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH 219
Query: 301 ISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL--AYTMVVTEKCDV 358
+ +N+ + + + D + + + Y E A T T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 359 YSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR---QDIILVS 415
+ G+ V P L++ K L L+ + + +I
Sbjct: 277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-- 334
Query: 416 TVAFSCLRSQPKSRPTMQ 433
L + R
Sbjct: 335 ----RFLNFDRRRRLLPL 348
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 10/232 (4%)
Query: 178 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G GG G VY A ++VALK + + + + EAR +++ ++V ++
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
F +++ + L +LR L + V +V+ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVTEK 355
HRD+ N+L++++ A++ DFG+A + + GT Y+APE T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 356 CDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
D+Y+ V E L G P G+ LS +++ I + P + D
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 73/279 (26%), Positives = 116/279 (41%), Gaps = 42/279 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQ 225
+D + +G G +G V R PSGK VA+K L + +++ F E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGM 281
+ HRN+++LYG L M ++ E +GSL LR + +A V V +GM
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGM 134
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT--- 338
YL +HRD+++ N+LL + + DFG+ R L + + +
Sbjct: 135 ----GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 339 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397
+ + APE T + D + FGV E+ G+ P W +++ +D
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDK 239
Query: 398 ---RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
RL P D Q I V C +P+ RPT
Sbjct: 240 EGERLPRPEDCPQDIYN-------VMVQCWAHKPEDRPT 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 61/298 (20%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
E F + +G G YGSVY+A +G++VA+K++ E L+ E ++ Q
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVES--DLQEIIKEISIMQQCD 82
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMC 282
++VK YG ++++ EY GS+ ++R E+ + +++
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTL 135
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
L YLH +HRDI + N+LLN+E A +ADFGVA L + R + GT ++
Sbjct: 136 KGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM 192
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKLIDLLD 396
APE+ + D++S G+ A+E+ GK HP + I +I
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----------RAIFMI---- 237
Query: 397 PRLSPPVDQKIRQDIILVSTVAFS---------CLRSQPKSRPT-MQLVSNEFIARNK 444
P PP +S CL P+ R T QL+ + F+ K
Sbjct: 238 PTNPPPT---------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 77/306 (25%), Positives = 125/306 (40%), Gaps = 56/306 (18%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI- 226
F + +G G YG VY+ R + +G++ A+K + + EE E E +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYS 78
Query: 227 RHRNIVKLYGFCLHRKC------MFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKR 274
HRNI YG + + ++L+ E+ GS+ +++ EE +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY----- 133
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
+ + + LS+LH ++HRDI NVLL E + DFGV+ L+ R
Sbjct: 134 --ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 335 LAGTYGYIAPELAYTMVVTE-----KCDVYSFGVVALEVLMGK------HPGELLSSSSW 383
GT ++APE+ + K D++S G+ A+E+ G HP
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------- 239
Query: 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIAR 442
+ + LI PR P + + S + SCL RP QL+ + FI
Sbjct: 240 --MRALFLI----PRNPAPRLKSKKWSKKFQSFIE-SCLVKNHSQRPATEQLMKHPFIRD 292
Query: 443 NKAPMQ 448
Q
Sbjct: 293 QPNERQ 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 71/298 (23%), Positives = 112/298 (37%), Gaps = 49/298 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLS 224
+G G +G V R +G+ VA+K L + E +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILR 78
Query: 225 QIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVV 278
+ H NIVK G C + LI E++ GSL L ++ + L +A V +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA--VQIC 136
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 337
KGM YL VHRD+++ NVL+ SE + + DFG+ + + D T
Sbjct: 137 KGM----DYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VK 186
Query: 338 TYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD----- 386
APE DV+SFGV E+L ++ +
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 387 -KNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+L++ L RL P + ++ Q ++ C QP +R + Q + F
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQ-LMR------KCWEFQPSNRTSFQNLIEGF 297
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 51/304 (16%), Positives = 102/304 (33%), Gaps = 54/304 (17%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFGNEARLLS 224
T +FH IG+G +GSV++ G + A+K+ +E +L E +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL----REVYAHA 65
Query: 225 QI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNVVKGMC 282
+ +H ++V+ + M + EY GSL + + + A+ +++ +
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV-------------------ADFGVAR 323
L Y+H +VH DI +N+ ++ D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 324 LLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS 382
++ G ++A E L K D+++ + + +
Sbjct: 183 RISSPQV----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-------- 230
Query: 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
I P + Q + Q+ L+ + P+ RP+ M LV + +
Sbjct: 231 PRNGDQWHEIRQGRL---PRIPQVLSQEFTELLK----VMIHPDPERRPSAMALVKHSVL 283
Query: 441 ARNK 444
Sbjct: 284 LSAS 287
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 71/284 (25%), Positives = 132/284 (46%), Gaps = 21/284 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF + +G G + VYRA + +G VA+K + + + ++ NE ++ Q++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+I++LY + ++L+ E G + L+ + + A+ + + + YL
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL 128
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H I+HRD++ +N+LL + +ADFG+A L L GT YI+PE+A
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPPVDQKI 407
+ DV+S G + +L+G+ P + + + + + L D P LS
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVLADYEMPSFLSIEA---- 239
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
+D+I LR P R ++ ++ + F++RN + K
Sbjct: 240 -KDLIH------QLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 68/299 (22%), Positives = 116/299 (38%), Gaps = 51/299 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIR 227
ED IG G YGSV + PSG+++A+K++ + E+ + + ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSD 79
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------VVKGM 281
IV+ YG ++ E M S + + + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD----DVIPEEILGKITLAT 134
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
AL++L + I+HRDI +N+LL+ + DFG++ L DS +T AG Y
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPY 191
Query: 342 IAPE--------LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393
+APE Y + DV+S G+ E+ G+ P K + D
Sbjct: 192 MAPERIDPSASRQGY----DVRSDVWSLGITLYELATGRFP----------YPKWNSVFD 237
Query: 394 LLD-------PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNK 444
L P+LS +++ ++ V CL RP +L+ + FI +
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPS--FINFVN-LCLTKDESKRPKYKELLKHPFILMYE 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 71/298 (23%), Positives = 117/298 (39%), Gaps = 59/298 (19%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ F IG G +G+VY AR + + +VVA+KK+ S + + E R L ++R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNVVKGMC 282
H N ++ G L +L+ EY GS +L E + V G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-------VTHGAL 164
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
L+YLH ++HRD+ + N+LL+ + DFG A ++ + GT ++
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWM 217
Query: 343 APELAYTMVVTE---KCDVYSFGVVALEVLMGK------HPGELLSSSSWSLDKNIKLI- 392
APE+ M + K DV+S G+ +E+ K + + I
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIA 266
Query: 393 -----DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNK 444
L S + CL+ P+ RPT L+ + F+ R +
Sbjct: 267 QNESPALQSGHWSEYFRNFVDS-----------CLQKIPQDRPTSEVLLKHRFVLRER 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 63/279 (22%), Positives = 118/279 (42%), Gaps = 40/279 (14%)
Query: 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHR 229
F K +G G G++ + + VA+K++ E +LL + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD------REVQLLRESDEHP 78
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+++ + R+ ++ E +L V + D +GL+ + +++ L++L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 289 HHDCTPPIVHRDISSNNVLL-----NSELEAFVADFGVARLLNFDSSNRTLL---AGTYG 340
H IVHRD+ +N+L+ + +++A ++DFG+ + L + + GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 341 YIAPEL---AYTMVVTEKCDVYSFGVVALEVL-MGKHP-GELLSSSSWSLDKNIKLIDLL 395
+IAPE+ T D++S G V V+ G HP G+ L NI L
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----QANILLGACS 246
Query: 396 DPRLSPPVDQ-KIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
L P + I +++I + P+ RP+ +
Sbjct: 247 LDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAK 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ IG+G +G V+ + VA+K + E E F EA ++ ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 63
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL- 288
+V+LYG CL + + L+ E+ME G L LRT + + + +C ++YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLE 121
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI-- 342
++HRD+++ N L+ V+DFG+ R + D SS T +
Sbjct: 122 EAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKW 171
Query: 343 -APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--R 398
+PE+ + K DV+SFGV+ EV GK P E S N ++++ + R
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR 223
Query: 399 LSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447
L P + Q I+ C R +P+ RP + + ++ +
Sbjct: 224 LYKPRLASTHVYQ-IMN------HCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 45/279 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFGNEARLLS 224
+F +G+G +G+VY+ KV VA+K+L + + + + + +EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKG 280
+ + ++ +L G CL + LI + M G L +R ++ +G L+W V + KG
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKG 129
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
M +YL +VHRD+++ NVL+ + + DFG+A+LL + G
Sbjct: 130 M----NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGG 179
Query: 341 YI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394
+ A E + T + DV+S+GV E++ G P + ++ +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIPASEISSI 231
Query: 395 LDP--RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
L+ RL P I V + C SRP
Sbjct: 232 LEKGERLPQPPICTID-----VYMIMVKCWMIDADSRPK 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 60/271 (22%), Positives = 114/271 (42%), Gaps = 38/271 (14%)
Query: 174 IKYCIGTGGYGSVYRARL--PSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+G G +GSV + ++ VA+K L + + E EA+++ Q+ +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPY 71
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL-- 288
IV+L G C + + L+ E G L L E + + ++ + + YL
Sbjct: 72 IVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE 128
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APE 345
+ VHRD+++ NVLL + A ++DFG+++ L D S T + + APE
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPP 402
+ + DV+S+GV E L G+ P + K +++ ++ R+ P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVMAFIEQGKRMECP 235
Query: 403 VD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
+ ++ ++ C + + RP
Sbjct: 236 PECPPELYA-LMS------DCWIYKWEDRPD 259
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 58/286 (20%), Positives = 120/286 (41%), Gaps = 29/286 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIR 227
+D +G G YG V + R +PSG+++A+K++ + + + + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVD 64
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
V YG +++ E M+ + ++ + + + AL +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-- 345
LH + ++HRD+ +NVL+N+ + + DFG++ L D + + AG Y+APE
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 346 ------LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399
Y++ K D++S G+ +E+ + + P S + ++++ P+L
Sbjct: 182 NPELNQKGYSV----KSDIWSLGITMIELAILRFP---YDSWGTPFQQLKQVVEEPSPQL 234
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIARNK 444
D CL+ K RPT +L+ + F ++
Sbjct: 235 PADKFSAEFVDFTS------QCLKKNSKERPTYPELMQHPFFTLHE 274
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRH 228
D +K+ +G G YG VY + VA+K L E E F EA ++ +I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 275
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G C ++I E+M G+L LR + + + + A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL 334
Query: 289 H-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAP 344
+ +HR++++ N L+ VADFG++RL+ D + + AP
Sbjct: 335 EKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAP 388
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
E + K DV++FGV+ E+ G P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 178 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G GG +VY A L VA+K + E+ +L+ F E SQ+ H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
C +L+ EY+E +L + + L +N + + + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM--- 130
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTYGYIAPELAYTMVVT 353
IVHRDI N+L++S + DFG+A+ L+ S +T + GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 354 EKCDVYSFGVVALEVLMGKHP 374
E D+YS G+V E+L+G+ P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 44/275 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+D +GTG +G V + VA+K + E + F EA+++ + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 79
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL- 288
+V+LYG C ++ +F+I EYM G L LR + + + K +C A+ YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE 137
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI-- 342
+HRD+++ N L+N + V+DFG++R + D SS + +
Sbjct: 138 SKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRW 187
Query: 343 -APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--R 398
PE+ + K D+++FGV+ E+ GK P E + N + + + R
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLR 239
Query: 399 LSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
L P +K+ I+ SC + RPT
Sbjct: 240 LYRPHLASEKVYT-IMY------SCWHEKADERPT 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 50/298 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLS 224
+G G +GSV R +G +VA+K+L S + F E ++L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILK 79
Query: 225 QIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVV 278
+ IVK G R+ + L+ EY+ G L L+ + L ++ +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQIC 137
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 337
KGM YL C VHRD+++ N+L+ SE +ADFG+A+LL D
Sbjct: 138 KGM----EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VR 187
Query: 338 TYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHP------GELLSSSSWSL 385
G APE + + + DV+SFGVV E+ + +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 386 DKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+L++LL+ RL P ++ + ++ C P+ RP+ + +
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHE-LMK------LCWAPSPQDRPSFSALGPQL 298
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 85/297 (28%), Positives = 132/297 (44%), Gaps = 40/297 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFGNEARLLSQ 225
+ I +G G +G V RL VA+K L TE+ F EA ++ Q
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
H NI++L G K + ++ EYME GSL LR + + V +++G+ +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGM 160
Query: 286 SYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI- 342
YL VHRD+++ N+L+NS L V+DFG+ R+L D G I
Sbjct: 161 KYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 343 --APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP-- 397
+PE T DV+S+G+V EV+ G+ P +S N +I +D
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGY 267
Query: 398 RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN-EFIARNKAPMQKP 450
RL PP+D + Q ++L C + +RP Q+VS + + RN ++
Sbjct: 268 RLPPPMDCPAALYQ-LML------DCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL---PSGKV-VALKKLHRSETEELASLESFGNEARLLSQ 225
HI+ IG+G G V RL V VA+K L TE F +EA ++ Q
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
H NI++L G + ++ EYME GSL LRT + + V +++G+ +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGM 164
Query: 286 SYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI- 342
YL VHRD+++ NVL++S L V+DFG++R+L D T G I
Sbjct: 165 RYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIP 217
Query: 343 ----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP 397
APE + DV+SFGVV EVL G+ P ++ N +I ++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEE 269
Query: 398 --RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN-EFIARNKAPMQK 449
RL P+ + Q ++L C RP Q+VS + + R+ ++
Sbjct: 270 GYRLPAPMGCPHALHQ-LML------DCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I +G G +G+VY AR + ++ALK L +S+ E+ E + S +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHA 284
NI+++Y + RK ++L+ E+ G L+ L R DE+ + ++ + A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-----SAT--FMEELADA 126
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L Y H ++HRDI N+L+ + E +ADFG + S R + GT Y+ P
Sbjct: 127 LHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLPP 181
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR-LSPPV 403
E+ EK D++ GV+ E L+G P + S S + I +DL P LS
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHE 453
+D+I LR P R + ++ + ++ N + P ++
Sbjct: 240 -----KDLIS------KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 51/299 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLS 224
+G G +GSV R +G+VVA+KKL + TEE L F E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEE--HLRDFEREIEILK 66
Query: 225 QIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVV 278
++H NIVK G C R+ + LI EY+ GSL L+ +E + L + +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 124
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 337
KGM YL +HRD+++ N+L+ +E + DFG+ ++L D
Sbjct: 125 KGM----EYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VK 174
Query: 338 TYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD------ 386
G APE + DV+SFGVV E+ + + +
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 387 --KNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
LI+LL RL P +I I+ C + RP+ + ++
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYM-IMT------ECWNNNVNQRPSFRDLALRV 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 172 FHIKYCIGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ +K CI GG G +Y A + +G+ V LK L S E E + L+++ H
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEA--QAMAMAERQFLAEVVH 138
Query: 229 RNIVKLYGFCLH-----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
+IV+++ F H +++ EY+ SL + L A+ + + +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILP 193
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
ALSYLH +V+ D+ N++L E + + D G +N L GT G+ A
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQA 245
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
PE+ T T D+Y+ G + +
Sbjct: 246 PEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 42/269 (15%)
Query: 178 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G +G+V + KV VA+K L ++E + A + EA ++ Q+ + IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL--HHDC 292
G C + L+ E E+G L L+ + + + +V + + YL +
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-----APELA 347
VHRD+++ NVLL ++ A ++DFG+++ L D + A T+G APE
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECI 192
Query: 348 YTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVD 404
+ K DV+SFGV+ E G+ P + K ++ +L+ R+ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP--------YRGMKGSEVTAMLEKGERMGCPAG 244
Query: 405 --QKIRQDIILVSTVAFSCLRSQPKSRPT 431
+++ ++ C ++RP
Sbjct: 245 CPREMYD-LMN------LCWTYDVENRPG 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 78/291 (26%), Positives = 117/291 (40%), Gaps = 51/291 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFGNEARLLS 224
+G G +GSV R +G+VVA+KKL + TEE L F E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEE--HLRDFEREIEILK 97
Query: 225 QIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVV 278
++H NIVK G C R+ + LI EY+ GSL L+ +E + L + +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 155
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 337
KGM YL +HRD+++ N+L+ +E + DFG+ ++L D
Sbjct: 156 KGM----EYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VK 205
Query: 338 TYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD------ 386
G APE + DV+SFGVV E+ + + +
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265
Query: 387 --KNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
LI+LL RL P +I I+ C + RP+
Sbjct: 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYM-IMT------ECWNNNVNQRPS 309
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E+ + +G+G +G V + VA+K + E + F EA+ + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHP 63
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL- 288
+VK YG C ++++ EY+ G L LR+ + L+ ++ + + +C +++L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLE 121
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---AP 344
H +HRD+++ N L++ +L V+DFG+ R + D + GT + AP
Sbjct: 122 SHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAP 174
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RLSP 401
E+ + + K DV++FG++ EV GK P +L + N +++ + RL
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHRLYR 226
Query: 402 PVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
P I I+ SC P+ RPT
Sbjct: 227 PHLASDTI-YQIMY------SCWHELPEKRPT 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 49/281 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL----PSGKV-VALKKLHRSETEELASLESFGNEARLLS 224
+ +G+G +G+V++ S K+ V +K + + S ++ + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKG 280
+ H +IV+L G C + L+ +Y+ +GSL +R A+G L+W V + KG
Sbjct: 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKG 127
Query: 281 MCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 338
M YL H +VHR++++ NVLL S + VADFGVA LL D +
Sbjct: 128 M----YYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYS 175
Query: 339 YGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392
A E + T + DV+S+GV E++ G P L ++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--------LAEVP 227
Query: 393 DLLDP--RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
DLL+ RL+ P I V V C RPT
Sbjct: 228 DLLEKGERLAQPQICTID-----VYMVMVKCWMIDENIRPT 263
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 239
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LY + ++++ EYM GSL L+ + L + V++ + ++Y+
Sbjct: 240 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPEL 346
VHRD+ + N+L+ L VADFG+ARL+ + + + APE
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEA 352
Query: 347 AYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
A T K DV+SFG++ E+ G+ P
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 40/274 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFGNEARLLSQIRH 228
D +K+ +G G YG VY + VA+K L E E F EA ++ +I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 68
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G C ++I E+M G+L LR + + + + A+ YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL 127
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI----- 342
+ +HRD+++ N L+ VADFG++RL+ D T A
Sbjct: 128 EKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWT 179
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RL 399
APE + K DV++FGV+ E+ G P + ++ +LL+ R+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKDYRM 231
Query: 400 SPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
P +K+ +++ +C + P RP+
Sbjct: 232 ERPEGCPEKV-YELMR------ACWQWNPSDRPS 258
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 322
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LY ++++ EYM GSL L+ + L + V++ + ++Y+
Sbjct: 323 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 380
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYIAPEL 346
VHRD+ + N+L+ L VADFG+ARL+ + + + APE
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEA 435
Query: 347 AYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
A T K DV+SFG++ E+ G+ P
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 63/288 (21%), Positives = 110/288 (38%), Gaps = 47/288 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLS 224
+G G +G V +G++VA+K L + + E +L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 225 QIRHRNIVKLYGFCLHRKC--MFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNVVKG 280
+ H +I+K G C + L+ EY+ +GSL L + L +A + +G
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEG 146
Query: 281 MCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
M +YLH +HRD+++ NVLL+++ + DFG+A+ +
Sbjct: 147 M----AYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VRED 196
Query: 340 GYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLD------K 387
G APE DV+SFGV E+L + +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 388 NIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
++L +LL+ RL P ++ ++ +C ++ RPT
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYH-LMK------NCWETEASFRPT 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 84/277 (30%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFGNEARLLS 224
+ IG G +G VY+ L SGK VA+K L TE+ F EA ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
Q H NI++L G K M +I EYME G+L LR + + V +++G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAG 159
Query: 285 LSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
+ YL + VHRD+++ N+L+NS L V+DFG++R+L D +G I
Sbjct: 160 MKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 343 ---APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP- 397
APE T DV+SFG+V EV+ G+ P LS N +++ ++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDG 266
Query: 398 -RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
RL P+D I Q +++ C + + RP
Sbjct: 267 FRLPTPMDCPSAIYQ-LMM------QCWQQERARRPK 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 58/306 (18%), Positives = 117/306 (38%), Gaps = 53/306 (17%)
Query: 163 QDMIEATEDFHIKYC----IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN 218
++ + +G G G+V G+ VA+K++ +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL------M 57
Query: 219 EARLLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAK 273
E +LL++ H N+++ Y + +++ E +L ++ +DE
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116
Query: 274 RVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-------------VADFG 320
+++++ + +++LH I+HRD+ N+L+++ ++DFG
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 321 VARLLNFDSSNRTL----LAGTYGYIAPEL-------AYTMVVTEKCDVYSFGVVALEVL 369
+ + L+ S+ +GT G+ APEL +T D++S G V +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 370 -MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPK 427
GKHP +S + NI + D+ + + L+S + P
Sbjct: 234 SKGKHPF----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS----QMIDHDPL 285
Query: 428 SRPTMQ 433
RPT
Sbjct: 286 KRPTAM 291
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ + IG G +G V G VA+K + T + +F EA +++Q+RH
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 246
Query: 230 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G + K ++++ EYM GSL LR+ +V L + +C A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 305
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
++ VHRD+++ NVL++ + A V+DFG+ + + L + APE
Sbjct: 306 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEAL 358
Query: 348 YTMVVTEKCDVYSFGVVALEVLM-GKHP 374
+ K DV+SFG++ E+ G+ P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 178 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G G +GSV + K VA+K L + + E EA+++ Q+ + IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL--HHDC 292
G C + + L+ E G L L E + + ++ + + YL +
Sbjct: 402 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APELAYT 349
VHR++++ NVLL + A ++DFG+++ L D S T + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 350 MVVTEKCDVYSFGVVALEVLM-GKHP 374
+ + DV+S+GV E L G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 53/289 (18%), Positives = 111/289 (38%), Gaps = 61/289 (21%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEAR 221
ED +G G + +++ V LK L ++ ESF A
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 222 LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM 281
++S++ H+++V YG C+ L+ E+++ GSL L+ ++ + + W ++ V K +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 282 CHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAF--------VADFGVARLLNFDSSN 331
A+ +L + ++H ++ + N+LL E + ++D G++ +
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 332 RTLLAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWS 384
PE + + D +SFG E+ G P L
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----- 223
Query: 385 LDKNIKLIDLLDP--RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPT 431
+ + + + +L P ++ +I +C+ +P RP+
Sbjct: 224 ---SQRKLQFYEDRHQLPAPKAAELAN-LIN------NCMDYEPDHRPS 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 68/274 (24%), Positives = 127/274 (46%), Gaps = 42/274 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E + +G G +G V+ VA+K L + ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL- 288
+V+LY +++I EYME GSL L+T L K +++ + ++++
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLAGTYGYI--- 342
+ +HRD+ + N+L++ L +ADFG+ARL+ + + I
Sbjct: 127 ERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT 177
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RL 399
APE T K DV+SFG++ E++ G+ P ++ N ++I L+ R+
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYRM 229
Query: 400 SPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
P + +++ Q ++ C + +P+ RPT
Sbjct: 230 VRPDNCPEELYQ-LMR------LCWKERPEDRPT 256
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ A VA+K + E+F EA ++ ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQHD 243
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL- 288
+VKL+ ++ +++I E+M GSL L++DE + K ++ + ++++
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE 301
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI---APE 345
+ +HRD+ + N+L+++ L +ADFG+AR++ + T G I APE
Sbjct: 302 QRNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPE 355
Query: 346 LAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
T K DV+SFG++ +E++ G+ P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 73/329 (22%), Positives = 123/329 (37%), Gaps = 44/329 (13%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ +K +GTGG+G V R +G+ VA+K+ + + + + E + E +++ ++ H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72
Query: 230 NIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
N+V L EY E G L L E GL ++ +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTYG 340
AL YLH + I+HRD+ N++L + + D G A+ L+ + GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQ 188
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP-----------------GELLSSSSW 383
Y+APEL T D +SFG +A E + G P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 384 SLDKNIKLI-DLLDP-RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE--F 439
L +K L P LS + K+ + + + L + R T N F
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM-------LMWHQRQRGTDPQNPNVGCF 301
Query: 440 IARNKAPMQKPFHEISILELRNQEMYLVD 468
A + K ++++ R + +
Sbjct: 302 QALDSILSLKLLSVMNMVSGRVHTYPVTE 330
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + +G G +V+R R +G + A+K + ++ E +L ++ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 229 RNIVKLYGF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS 286
+NIVKL+ + LI E+ GSL+ VL A GL ++ + V++ + ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTYGYI 342
+L + IVHR+I N++ + + DFG AR L D +L GT Y+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182
Query: 343 APELAYTMVV--------TEKCDVYSFGVVALEVLMGKHP 374
P++ V+ D++S GV G P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 178 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G GG V+ A R + VA+K L + + F EA+ + + H IV +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 235 Y--GF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
Y G +++ EY++ +L ++ T+ + + + V+ C AL++ H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT---LLAGTYGYIAPELA 347
+ I+HRD+ N+++++ V DFG+AR + ++ T + GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP 374
V + DVYS G V EVL G+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 64/274 (23%), Positives = 120/274 (43%), Gaps = 46/274 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ + IG G +G V G VA+K + T + +F EA +++Q+RH
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 74
Query: 230 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G + K ++++ EYM GSL LR+ +V L + +C A+ YL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 133
Query: 289 -HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI----- 342
++ VHRD+++ NVL++ + A V+DFG+ + + G +
Sbjct: 134 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWT 181
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP--RL 399
APE + K DV+SFG++ E+ G+ P + ++ ++ ++
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKM 233
Query: 400 SPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
P + + ++ +C RP+
Sbjct: 234 DAPDGCPPAVYE-VMK------NCWHLDAAMRPS 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQ 225
ED + +G G +G VY G+ VA+K + T + + E F +EA ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGM 281
+ H +IVKL G + ++I E G L L ++ ++ + ++ + + K M
Sbjct: 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAM 126
Query: 282 CHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---SSNRTLLA 336
+YL + VHRDI+ N+L+ S + DFG++R + + ++ T L
Sbjct: 127 ----AYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 337 GTYGYI---APELAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
I +PE T DV+ F V E+L GK P
Sbjct: 178 -----IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + +G G +V+R R +G + A+K + ++ E +L ++ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 229 RNIVKLYGF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS 286
+NIVKL+ + LI E+ GSL+ VL A GL ++ + V++ + ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTYGYI 342
+L + IVHR+I N++ + + DFG AR L D +L GT Y+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182
Query: 343 APELAYTMVV--------TEKCDVYSFGVVALEVLMGKHP 374
P++ V+ D++S GV G P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 78/371 (21%), Positives = 129/371 (34%), Gaps = 57/371 (15%)
Query: 96 SPPPHHKKIATR-----LVAIILPMVALLALIFGILFVRRRRDKRVEPAETGEITKCADE 150
P HH R I++P + + + +E
Sbjct: 5 DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64
Query: 151 FAIWNYDGRITFQDMIEATEDF-----HIKYCIGTGGYGSVYRARLPSGK----VVALKK 201
+ Q + H IG G +G VY L A+K
Sbjct: 65 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 202 LHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVL 260
L+R + F E ++ H N++ L G CL + ++ YM+ G L +
Sbjct: 125 LNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 261 RTDEEAVG----LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316
R + + + + V KGM L+ VHRD+++ N +L+ + V
Sbjct: 183 RNETHNPTVKDLIGFG--LQVAKGMKF-LASKK------FVHRDLAARNCMLDEKFTVKV 233
Query: 317 ADFGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM- 370
ADFG+AR + +D ++ T + A E T T K DV+SFGV+ E++
Sbjct: 234 ADFGLARDM-YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 371 GKHPGELLSSSSWSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQP 426
G P ++ + L RL P + + V C +
Sbjct: 293 GAPP-------YPDVN-TFDITVYLLQGRRLLQPEYCPDPLYE-------VMLKCWHPKA 337
Query: 427 KSRPT-MQLVS 436
+ RP+ +LVS
Sbjct: 338 EMRPSFSELVS 348
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 67/296 (22%), Positives = 112/296 (37%), Gaps = 55/296 (18%)
Query: 164 DMIEATEDFHIKY---------CIGTGGYGSVYRARLPSGK----VVALKKLHRSETEEL 210
++++A + I IG G +G VY L A+K L+R
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG- 68
Query: 211 ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVG- 268
+ F E ++ H N++ L G CL + ++ YM+ G L +R +
Sbjct: 69 -EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 269 ---LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325
+ + + V KGM + L+ VHRD+++ N +L+ + VADFG+AR +
Sbjct: 128 KDLIGFG--LQVAKGMKY-LASKK------FVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 326 NFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLS 379
T + A E T T K DV+SFGV+ E++ G P
Sbjct: 179 YDKEYYSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----- 232
Query: 380 SSSWSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
++ + L RL P + + V C + + RP+
Sbjct: 233 --YPDVN-TFDITVYLLQGRRLLQPEYCPDPLYE-------VMLKCWHPKAEMRPS 278
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 52/287 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQ 225
E + CIG G +G V++ P VA+K ++ E F EA + Q
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 72
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKGM 281
H +IVKL G +++I E +G L L+ + ++ + +A + +
Sbjct: 73 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA--YQLSTAL 129
Query: 282 CHALSYL-HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+YL VHRDI++ NVL++S + DFG++R + + + + G
Sbjct: 130 ----AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKG 177
Query: 341 YI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394
+ APE T DV+ FGV E+LM G P + + N +I
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGR 229
Query: 395 LDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVS 436
++ RL P + + ++ C P RP +L +
Sbjct: 230 IENGERLPMPPNCPPTLYS-LMT------KCWAYDPSRRPRFTELKA 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 47/287 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFGNEARLLSQ 225
H IG G +G VY A+K L R + +E+F E L+
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRG 78
Query: 226 IRHRNIVKLYGFCLHRKCM-FLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNVVKG 280
+ H N++ L G L + + ++ YM G L +R+ + + + + V +G
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARG 136
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
M + L+ VHRD+++ N +L+ VADFG+AR + D ++ +
Sbjct: 137 MEY-LAEQK------FVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHA 188
Query: 341 YI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDL 394
+ A E T T K DV+SFGV+ E+L G P +D L
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-------YRHID-PFDLTHF 240
Query: 395 LDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVS 436
L RL P + ++ C + P RPT LV
Sbjct: 241 LAQGRRLPQPEYCPDSL-YQVMQ------QCWEADPAVRPTFRVLVG 280
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/319 (19%), Positives = 112/319 (35%), Gaps = 45/319 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFG------------ 217
D+ I + G + + K ALKK +S E+
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 218 --NEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLD 270
NE ++++ I++ + G + +++IYEYME S+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
++K + ++ SY+H++ I HRD+ +N+L++ ++DFG +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDK 205
Query: 331 NRTLLAGTYGYIAPELAYTMVVTE------KCDVYSFGVVALEVLMGKHPGELLSSSSWS 384
GTY ++ PE E K D++S G+ + P L S
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-LKISLVE 260
Query: 385 LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSC---------LRSQPKSRPTM-QL 434
L NI+ ++ P + S S LR P R T
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 435 VSNEFIARNKAPMQKPFHE 453
+ +E++A + F +
Sbjct: 321 LKHEWLADTNIEDLREFSK 339
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
T F +Y G G +G V + +G+ A+K + + + ++ ES E +LL
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
Q+ H NI+KLY F + +L+ E G LF + + E +++
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIR 133
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLA 336
+ ++Y+H + IVHRD+ N+LL S+ + + DFG++ +
Sbjct: 134 QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KI 189
Query: 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 190 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 67/318 (21%), Positives = 122/318 (38%), Gaps = 46/318 (14%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HR 229
++ + GG+ VY A+ + SG+ ALK+L +E E+ ++ E + ++ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII---QEVCFMKKLSGHP 86
Query: 230 NIVKLYGFCLHRK-------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC 282
NIV+ K FL+ + G L L+ E L + + C
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA------ 336
A+ ++H PPI+HRD+ N+LL+++ + DFG A ++
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 337 ------GTYGYIAPELAYTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387
T Y PE+ + EK D+++ G + + +HP E D
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---------DG 256
Query: 388 NIKLIDLLDPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446
I ++ + S P L+ + L+ P+ R ++ V ++ + A
Sbjct: 257 AKLRI--VNGKYSIPPHDTQYTVFHSLIR----AMLQVNPEERLSIAEVVHQ--LQEIAA 308
Query: 447 MQKPFHEISILELRNQEM 464
+ + I EL Q
Sbjct: 309 ARNVNPKSPITELLEQNG 326
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 70/324 (21%), Positives = 123/324 (37%), Gaps = 62/324 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
E + +G G +G VY VA+K ++ + + F NEA ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 82
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-------------LD 270
+ ++V+L G + +I E M G L LR+ A+ +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
A + GM + L+ VHRD+++ N ++ + + DFG+ R +
Sbjct: 143 MA--GEIADGMAY-LNANK------FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 331 NRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWS 384
R G G + +PE V T DV+SFGVV E+ + P + LS
Sbjct: 194 YR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----- 245
Query: 385 LDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440
N +++ + L P + + +++ C + PK RP+ E I
Sbjct: 246 ---NEQVLRFVMEGGLLDKPDNCPDMLF-ELMR------MCWQYNPKMRPSFL----EII 291
Query: 441 ARNKAPMQKPFHEISILELRNQEM 464
+ K M+ F E+S ++
Sbjct: 292 SSIKEEMEPGFREVSFYYSEENKL 315
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 70/277 (25%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFGNEARLLSQ 225
E + CIG G +G V++ P VA+K ++ E F EA + Q
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
H +IVKL G +++I E +G L L+ + ++ L A + + AL
Sbjct: 448 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504
Query: 286 SYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI-- 342
+YL VHRDI++ NVL++S + DFG++R + + + + G +
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPI 556
Query: 343 ---APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDP- 397
APE T DV+ FGV E+LM G P + + N +I ++
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG 608
Query: 398 -RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
RL P + + ++ C P RP
Sbjct: 609 ERLPMPPNCPPTL-YSLMT------KCWAYDPSRRPR 638
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 54/340 (15%), Positives = 109/340 (32%), Gaps = 85/340 (25%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL-----------HRSETEELASLE--- 214
DF C+G GG+G V+ A+ A+K++ E + LA LE
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 215 -----------------------------------------SFGNEARLLSQIRHRNIVK 233
+ + R + +N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
+ +++ + +L + + +++ + A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS------------NRTLLAGTYGY 341
++HRD+ +N+ + V DFG+ ++ D T GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
++PE + + K D++S G++ E+L ++ + D+ + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFPL 293
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFI 440
QK Q+ ++V L P RP ++ N
Sbjct: 294 LFTQKYPQEHMMVQ----DMLSPSPTERPEATDIIENAIF 329
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 64/254 (25%), Positives = 100/254 (39%), Gaps = 35/254 (13%)
Query: 132 RDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCI----GTGGYGSVY 187
+ KR EI ++ + +T D + +Y + G+G G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFF-DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVK 152
Query: 188 RAR-LPSGKVVALK-----KLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241
A + K VA++ K E + E +L ++ H I+K+ F
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA 211
Query: 242 KCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+ +++ E ME G LF V + M A+ YLH + I
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLYFYQMLLAVQYLHENG---I 260
Query: 297 VHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVV 352
+HRD+ NVLL+S+ E + DFG +++L S RT L GT Y+APE L
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTA 319
Query: 353 --TEKCDVYSFGVV 364
D +S GV+
Sbjct: 320 GYNRAVDCWSLGVI 333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
Y G+G YG V R + A+K + ++ +S E +L
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVL 90
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
+ H NI+KLY F ++ +L+ E + G LF + +E ++K
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIK 143
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLA 336
+ ++YLH IVHRD+ N+LL S+ + + DFG++ + +
Sbjct: 144 QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-RL 199
Query: 337 GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 200 GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 38/297 (12%), Positives = 90/297 (30%), Gaps = 64/297 (21%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA---RLLSQIRHRNIVK 233
+G + A +G+ + + +E +++ E RLL I+++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 234 LYGFCLHRKCM------------------------FLIYEYME--MGSLFCVLRTDEEAV 267
++ + + F +Y M+ + + VL +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 268 G-LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
L R+ + + L+ LHH +VH + +++L+ F+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 327 FDSSNRTLLAGTYG---YIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHP--GE 376
+S + + + A + ++T D ++ G+ + P +
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 377 LLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ + I + PV + ++ LR + R
Sbjct: 321 -------AALGGSEWIFRSCKNIPQPV-----RALLE------GFLRYPKEDRLLPL 359
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFGNEARLLSQ 225
+ F + +G G +GSV A+L VA+K L + +E F EA + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKE 81
Query: 226 IRHRNIVKLYGFCL------HRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVN 276
H ++ KL G L +I +M+ G L L E L V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 277 VVKGMCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
+ + + YL + +HRD+++ N +L ++ VADFG++R + R
Sbjct: 142 FMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-- 194
Query: 335 LAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
G + A E + T DV++FGV E++ G+ P
Sbjct: 195 -QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 73/304 (24%), Positives = 121/304 (39%), Gaps = 58/304 (19%)
Query: 178 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY ++ PS VA+K L +E+ F EA ++S+ H+NI
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNI 95
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVN----VVKGMCH 283
V+ G L F++ E M G L LR + L ++ + G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV---ADFGVARLLNFDSSNRTLLAGTYG 340
L H +HRDI++ N LL V DFG+AR + S R G
Sbjct: 156 -LEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCA 205
Query: 341 YI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLID 393
+ PE + T K D +SFGV+ E+ +G P S N ++++
Sbjct: 206 MLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLE 256
Query: 394 LLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN-EFIARNKAPM 447
+ R+ PP + + + I+ C + QP+ RP ++ E+ ++ +
Sbjct: 257 FVTSGGRMDPPKNCPGPVYR-IMT------QCWQHQPEDRPNFAIILERIEYCTQDPDVI 309
Query: 448 QKPF 451
Sbjct: 310 NTAL 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 41/304 (13%), Positives = 91/304 (29%), Gaps = 77/304 (25%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA---RLLSQIR------ 227
+G + A +G+ + + +E +++ E RLL I+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 228 ----------------HRNIVKLYGFCLHRKCM--FLIYEYMEM------GSLFCVLRTD 263
+ ++++ + F +Y M+ L T
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 264 EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
+ L R+ + + L+ LHH +VH + +++L+ F+ F
Sbjct: 201 KS---LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 324 LLNFDSSNRTLLAGTYGYIAPEL-----------AYTMVVTEKCDVYSFGVVALEVLMGK 372
R + + + G+ PEL ++T D ++ G+V +
Sbjct: 255 RDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 373 HPGELLSSSSWSLDKNIKLIDLL---DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR 429
P + D + + + + PV + ++ LR + R
Sbjct: 311 LP--------ITKDAALGGSEWIFRSCKNIPQPV-----RALLE------GFLRYPKEDR 351
Query: 430 PTMQ 433
Sbjct: 352 LLPL 355
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 166 IEATEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA 220
+ F +Y I G G +G V + + + + A+K ++++ + + E
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREV 72
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRV 275
LL ++ H NI+KL+ +++ E G LF + ++ +A
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------A 124
Query: 276 NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNR 332
++K + ++Y+H IVHRD+ N+LL S+ + + DFG++ ++ +
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 333 TLLAGTYGYIAPEL---AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT YIAPE+ Y EKCDV+S GV+ +L G P
Sbjct: 182 D-RIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 50/225 (22%), Positives = 89/225 (39%), Gaps = 29/225 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFGNEARLLSQ 225
+ +G G +GSV L VA+K + + + +E F +EA +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 226 IRHRNIVKLYGFCL-----HRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNV 277
H N+++L G C+ +I +M+ G L L + + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 278 VKGMCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 335
+ + + YL + +HRD+++ N +L ++ VADFG+++ + R
Sbjct: 153 MVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--- 204
Query: 336 AGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
G + A E V T K DV++FGV E+ G P
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 60/220 (27%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 178 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G VY ++ PS VA+K L +E+ F EA ++S+ H+NI
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNI 136
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVN----VVKGMCH 283
V+ G L F++ E M G L LR + L ++ + G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV---ADFGVARLLNFDSSNRTLLAGTYG 340
L H +HRDI++ N LL V DFG+AR + R G
Sbjct: 197 -LEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCA 246
Query: 341 YI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ PE + T K D +SFGV+ E+ +G P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 64/229 (27%), Positives = 93/229 (40%), Gaps = 36/229 (15%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRS----------ETEELASL 213
Y G+G YG V + A+K + +S
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 214 ESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVG 268
E NE LL + H NI+KL+ +K +L+ E+ E G LF + + +A
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-- 148
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLL 325
N++K + + YLH IVHRDI N+LL ++ + DFG++
Sbjct: 149 ------ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ D R GT YIAPE EKCDV+S GV+ +L G P
Sbjct: 200 SKDYKLRD-RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 44/233 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFGNEARLLSQI 226
D + IG G +G V +AR+ + A+K++ +++ F E +L ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82
Query: 227 -RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------- 276
H NI+ L G C HR ++L EY G+L LR N
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 277 --------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
V +GM + LS +HRD+++ N+L+ A +ADFG++R
Sbjct: 143 QLLHFAADVARGMDY-LSQKQ------FIHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 329 SSNRTLLAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+ T G + A E L Y+ V T DV+S+GV+ E++ +G P
Sbjct: 191 -GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 66/289 (22%)
Query: 178 IGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G V+ A + +VA+K L + + EA LL+ ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQHQHI 105
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------------- 276
V+ +G C + + +++EYM G L LR+ L
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 277 -VVKGMCHALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333
V GM YL H VHRD+++ N L+ L + DFG++R + R
Sbjct: 166 QVAAGM----VYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR- 215
Query: 334 LLAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLD 386
G + PE + Y T + DV+SFGVV E+ GK P LS
Sbjct: 216 --VGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS------- 265
Query: 387 KNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
N + ID + L P ++ I+ C + +P+ R +
Sbjct: 266 -NTEAIDCITQGRELERPRACPPEV-YAIMR------GCWQREPQQRHS 306
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 56/293 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFGNEARLL 223
+G +G VY+ L VA+K L L E F +EA L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLR 66
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG--- 280
++++H N+V L G + + +I+ Y G L L + VK
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 281 ------MCH----ALSYL--HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
+ + YL HH +VH+D+++ NVL+ +L ++D G+ R +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 329 SSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSS 382
+ + APE + D++S+GVV EV G P S
Sbjct: 182 DYYK---LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--- 235
Query: 383 WSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
N +++++ L P D + +++ C P RP
Sbjct: 236 -----NQDVVEMIRNRQVLPCPDDCPAWV-YALMI------ECWNEFPSRRPR 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 16/216 (7%)
Query: 161 TFQDMIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRS--ETEELASL 213
DM + F Y IG G + V R +G+ A+K + + + S
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 214 ESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWA 272
E EA + ++H +IV+L +++++E+M+ L +++ + A
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 273 KRVNVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 328
+ ++ + AL Y H ++ I+HRD+ + VLL S+ + + FGVA L
Sbjct: 131 VASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVV 364
GT ++APE+ + DV+ GV+
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 46/205 (22%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+G G +G V++ +G +A K + ++ ++ NE +++Q+ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHA 146
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNVVKGMCH 283
N+++LY + + L+ EY++ G LF + T+ + + +K +C
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT--------ILFMKQICE 198
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGY 341
+ ++H I+H D+ N+L + + DFG+AR + GT +
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEF 254
Query: 342 IAPE-LAYTMVVTEKCDVYSFGVVA 365
+APE + Y V+ D++S GV+A
Sbjct: 255 LAPEVVNYD-FVSFPTDMWSVGVIA 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 58/258 (22%), Positives = 106/258 (41%), Gaps = 33/258 (12%)
Query: 132 RDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCI----GTGGYGSVY 187
+V G D+F + + Q + + Y I G+G +G V+
Sbjct: 10 HGSKVRGKYDGPKINDYDKF-YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 188 RAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246
R +G+V K ++ + +++ NE +++Q+ H ++ L+ + M L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 247 IYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNVVKGMCHALSYLH-HDCTPPIVHR 299
I E++ G LF ++ E +N ++ C L ++H H IVH
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEV--------INYMRQACEGLKHMHEHS----IVHL 173
Query: 300 DISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAYTMVVTEKC 356
DI N++ ++ + V DFG+A LN D + T + APE + V
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIVDREP-VGFYT 231
Query: 357 DVYSFGVVALEVLMGKHP 374
D+++ GV+ +L G P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ Y I GTG +G V+R +G A K + + ++ E + +
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTM 208
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
S +RH +V L+ M +IYE+M G LF + +E + + V ++ +C
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCK 266
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGY 341
L ++H + VH D+ N++ ++ + DFG+ L+ S + GT +
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEF 322
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
APE+A V D++S GV++ +L G P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 67/306 (21%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
+G G +G V A + VA+K L S E+ +E ++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 224 SQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------ 276
S + H NIV L G C +I EY G L LR ++
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 277 -------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
V KGM L+ + +HRD+++ N+LL + DFG+AR
Sbjct: 141 ALDLEDLLSFSYQVAKGMAF-LASKN------CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 324 LLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP--G 375
+ DS+ + APE + V T + DV+S+G+ E+ +G P G
Sbjct: 194 DIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 376 ELLSSSSWSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
+ + K ++ R+ P ++ DI+ +C + P RPT
Sbjct: 251 ---------MPVDSKFYKMIKEGFRMLSPEHAPAEM-YDIMK------TCWDADPLKRPT 294
Query: 432 -MQLVS 436
Q+V
Sbjct: 295 FKQIVQ 300
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFGNEA 220
+ Y I G+G + V + R +G A K K + E E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 275
+L Q+ H NI+ L+ +R + LI E + G LF + ++EEA
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------T 118
Query: 276 NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSN 331
+ +K + ++YLH I H D+ N++L + + DFG+A +
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 332 RTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 365
+ + GT ++APE + Y + + D++S GV+
Sbjct: 176 KN-IFGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
T + + G+G + V+ + +GK+ ALK + +S +SLE NE +L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVL 60
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVV 278
+I+H NIV L +L+ + + G LF + R T+++A V+
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA--------SLVI 112
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL 334
+ + A+ YLH + IVHRD+ N+L + E + DFG++++ + +
Sbjct: 113 QQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMST 166
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVV 364
GT GY+APE+ ++ D +S GV+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 65/297 (21%), Positives = 110/297 (37%), Gaps = 61/297 (20%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ + +G G +G V A + + VA+K L T + +E ++L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 224 SQI-RHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN----- 276
I H N+V L G C + +I E+ + G+L LR+ +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 277 ------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
V KGM L+ +HRD+++ N+LL+ + + DFG+AR
Sbjct: 145 LTLEHLICYSFQVAKGMEF-LASRK------CIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 325 LNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELL 378
+ D + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 198 IYKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---- 250
Query: 379 SSSSWSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
+ + + L R+ P ++ +L C +P RPT
Sbjct: 251 ---YPGVKIDEEFCRRLKEGTRMRAPDYTTPEM-YQTML------DCWHGEPSQRPT 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG V + R +G++VA+KK S+ +++ + E +LL Q+RH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-REIKLLKQLRHENLVNLLE 91
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
C +K +L++E+++ ++ L + GLD+ + + + + + H I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMV 351
+HRDI N+L++ + DFG AR L T Y APEL Y
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 352 VTEKCDVYSFGVVALEVLMGK 372
V DV++ G + E+ MG+
Sbjct: 206 V----DVWAIGCLVTEMFMGE 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 61/287 (21%)
Query: 178 IGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G G +G V+ A + +VA+K L + T + F EA LL+ ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA--RKDFQREAELLTNLQHEHI 79
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------------- 276
VK YG C + +++EYM+ G L LR + +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 277 --VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
+ GM + L+ H VHRD+++ N L+ + L + DFG++R + R
Sbjct: 140 SQIASGMVY-LASQH------FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190
Query: 335 LAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKN 388
G + + PE T + DV+SFGV+ E+ GK P LS N
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------N 241
Query: 389 IKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT 431
++I+ + L P +++ D++L C + +P+ R
Sbjct: 242 TEVIECITQGRVLERPRVCPKEV-YDVML------GCWQREPQQRLN 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
F +Y I G G +G V + + + + A+K ++++ + + E LL
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVV 278
++ H NI+KL+ +++ E G LF + R ++ +A ++
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARII 127
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 335
K + ++Y+H IVHRD+ N+LL S+ + + DFG++ ++ +
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-R 183
Query: 336 AGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 364
GT YIAPE+ Y EKCDV+S GV+
Sbjct: 184 IGTAYYIAPEVLRGTY----DEKCDVWSAGVI 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 59/292 (20%)
Query: 178 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRN 230
+G G +G V A + VA+K L + + E+ +E +++S + +H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHEN 111
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------- 276
IV L G C H + +I EY G L LR + D A +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 277 -VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 335
V +GM L+ + +HRD+++ NVLL + A + DFG+AR + DS+
Sbjct: 172 QVAQGMAF-LASKN------CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--- 221
Query: 336 AGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNI 389
+ APE + V T + DV+S+G++ E+ +G +P + N
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-------YPGILVNS 274
Query: 390 KLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVS 436
K L+ +++ P + I I+ +C +P RPT Q+ S
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNI-YSIMQ------ACWALEPTHRPTFQQICS 319
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 170 EDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLS 224
++ + KY I G G +G V+R S K K + T++ E +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILN 56
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNVV 278
RHRNI+ L+ + + +I+E++ +F + E V+ V
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI--------VSYV 108
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLL 335
+C AL +LH H+ I H DI N++ + + + +FG AR L + R L
Sbjct: 109 HQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-L 163
Query: 336 AGTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y APE + + V+ D++S G + +L G +P
Sbjct: 164 FTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFGNEA 220
+ Y I G+G + V + R +G A K K + S E E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 275
+L Q+ H N++ L+ +R + LI E + G LF + ++EEA
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120
Query: 276 NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSN 331
+K + ++YLH I H D+ N++L + + DFG+A +
Sbjct: 121 --IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 332 RTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 365
+ + GT ++APE + Y + + D++S GV+
Sbjct: 176 KN-IFGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
+G+G + V + R +GK A K K S + S E E +L +IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVVKGMCHALSYL 288
L+ ++ + LI E + G LF + T++EA +K + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--------TQFLKQILDGVHYL 124
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTYGYIAP 344
H I H D+ N++L + + DFG+A + + + + GT ++AP
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAP 180
Query: 345 E-LAYTMVVTEKCDVYSFGVVA 365
E + Y + + D++S GV+
Sbjct: 181 EIVNYEP-LGLEADMWSIGVIT 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 169 TEDFHIKYC----IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
F +Y +G G + V R + +G+ A ++ + + EAR+
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARIC 64
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVV 278
++H NIV+L+ +LI++ + G LF V R ++ +A + +
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA--------SHCI 116
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL 334
+ + A+ + H +VHR++ N+LL S+L+ +ADFG+A + +
Sbjct: 117 QQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 335 LAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 364
AGT GY++PE+ Y + D+++ GV+
Sbjct: 173 FAGTPGYLSPEVLRKDPY----GKPVDLWACGVI 202
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
D + Y + G G +G V A + A KK+ + + ++ F E ++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIM 60
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVV 278
+ H NI++LY ++L+ E G LF V + + +A ++
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIM 112
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL 334
K + A++Y H + + HRD+ N L ++ + DFG+A RT
Sbjct: 113 KDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT- 167
Query: 335 LAGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 364
GT Y++P++ Y +CD +S GV+
Sbjct: 168 KVGTPYYVSPQVLEGLY----GPECDEWSAGVM 196
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 33/253 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ F I IG G +G V + + K+ A+K +++ + E + + E +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 229 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCH 283
+V L Y F MF++ + + G L L+ EE V L + +
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVM 126
Query: 284 ALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
AL YL I+HRD+ +N+LL+ + DF +A +L ++ T +AGT Y+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181
Query: 343 APEL-------AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395
APE+ Y+ V D +S GV A E+L G+ P + SS+ S + + +
Sbjct: 182 APEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETT 235
Query: 396 DPRLSPPVDQKIR 408
Q++
Sbjct: 236 VVTYPSAWSQEMV 248
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFGNEA 220
E+ Y G+G + V + R +G A K K + S E E
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 221 RLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 275
+L +I+H N++ L+ ++ + LI E + G LF + T+EEA
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF------ 119
Query: 276 NVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSS 330
+K + + + YLH I H D+ N++L + DFG+A ++F +
Sbjct: 120 --LKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 331 NRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 365
+ + GT ++APE + Y + + D++S GV+
Sbjct: 174 FKN-IFGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 158 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESF 216
GR + F K +G+G +G V+ SG +K +++ ++ +E
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQI 67
Query: 217 GNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRV 275
E +L + H NI+K++ M+++ E E G L + + + L
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 276 NVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSN 331
++K M +AL+Y H +VH+D+ N+L + DFG+A L D +
Sbjct: 128 ELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 332 RTLLAGTYGYIAPEL---AYTMVVTEKCDVYSFGVV 364
AGT Y+APE+ T KCD++S GVV
Sbjct: 184 TN-AAGTALYMAPEVFKRDV----TFKCDIWSAGVV 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 71/301 (23%), Positives = 116/301 (38%), Gaps = 68/301 (22%)
Query: 178 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRN 230
+G+G +G V A VA+K L E+ +E ++++Q+ H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHEN 110
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------- 276
IV L G C ++LI+EY G L LR+ E D + N
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 277 ----------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
V KGM L + VHRD+++ NVL+ + DFG+AR +
Sbjct: 171 FEDLLCFAYQVAKGMEF-LEFKS------CVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 327 FDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSS 380
DS+ + APE + + T K DV+S+G++ E+ +G +P
Sbjct: 224 SDSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------ 274
Query: 381 SSWSLDKNIKLIDLLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLV 435
+ + L+ ++ P ++I I+ SC + RP+ L
Sbjct: 275 -YPGIPVDANFYKLIQNGFKMDQPFYATEEI-YIIMQ------SCWAFDSRKRPSFPNLT 326
Query: 436 S 436
S
Sbjct: 327 S 327
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN----EARLLSQIRHRNIVK 233
IG G YG VY+A+ G+ ALKK+ R E E+ E + E +L +++H NIVK
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI-RLEKED----EGIPSTTIREISILKELKHSNIVK 64
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
LY +K + L++E+++ L +L D GL+ + + + + ++Y H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AY 348
++HRD+ N+L+N E E +ADFG+AR T T Y AP++ Y
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 349 TMVVTEKCDVYSFGVVALEVLMGK 372
+ + D++S G + E++ G
Sbjct: 179 STTI----DIWSVGCIFAEMVNGT 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF I IG G +G V +L + KV A+K L++ E + A F E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 229 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ I L Y F ++L+ +Y G L +L E+ + + A+ + M A+
Sbjct: 134 KWITTLHYAFQDDNN-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--YLAEMVIAIDS 190
Query: 288 LH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPE 345
+H VHRDI +N+L++ +ADFG L D + ++ +A GT YI+PE
Sbjct: 191 VHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 346 LAYTMVVTEK-----CDVYSFGVVALEVLMGKHP 374
+ M + CD +S GV E+L G+ P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFGNEARL 222
+++ + +G+G G V A + K VA+K K E + E +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 223 LSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNV 277
L ++ H I+K+ F + +++ E ME G LF V +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 119
Query: 278 VKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL 334
M A+ YLH + I+HRD+ NVLL+S+ E + DFG +++L S RT
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT- 175
Query: 335 LAGTYGYIAPE-LAYTMVV--TEKCDVYSFGVV 364
L GT Y+APE L D +S GV+
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 51/263 (19%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS--LESF 216
++E + +H+K IG G YG V A + + A+K +++++ ++ +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 217 GNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF------------------- 257
E RL+ ++ H NI +LY + + L+ E G L
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 258 ------CVLRTDEEAVGLDWAKRV------------NVVKGMCHALSYLHHDCTPPIVHR 299
C +E G R N+++ + AL YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 300 DISSNNVLLNSELEAFV--ADFGVARLLNFDSSNR----TLLAGTYGYIAPELAYTMV-- 351
DI N L ++ + DFG+++ ++ T AGT ++APE+ T
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 352 VTEKCDVYSFGVVALEVLMGKHP 374
KCD +S GV+ +LMG P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ + + G G VYR + + K ALK L ++ ++ E +L
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVL 102
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVV 278
++ H NI+KL + L+ E + G LF V + ++ +A + V
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA--------ADAV 154
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 335
K + A++YLH + IVHRD+ N+L + +ADFG+++++ +T +
Sbjct: 155 KQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-V 210
Query: 336 AGTYGYIAPELAYTMVVTEKCDVYSFGVV 364
GT GY APE+ + D++S G++
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 51/243 (20%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFGNEARLL 223
+ IG G +G V++AR P +VA+K L + + F EA L+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 104
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------- 276
++ + NIVKL G C K M L++EYM G L LR+ +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 277 ------------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318
V GM + LS VHRD+++ N L+ + +AD
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAY-LSERK------FVHRDLATRNCLVGENMVVKIAD 217
Query: 319 FGVARLLNFDSSNRTLLAGTYGYI-----APE-LAYTMVVTEKCDVYSFGVVALEVL-MG 371
FG++R + + A I PE + Y T + DV+++GVV E+ G
Sbjct: 218 FGLSRNIYSADYYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYG 273
Query: 372 KHP 374
P
Sbjct: 274 LQP 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 169 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRS--ETEELASLESFGNEAR 221
+ F Y + G G + V R +G A K ++ + LE EAR
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57
Query: 222 LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVN 276
+ +++H NIV+L+ +L+++ + G LF V R ++ +A +
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SH 109
Query: 277 VVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNR 332
++ + +++Y H + IVHR++ N+LL S+ + +ADFG+A +N +
Sbjct: 110 CIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165
Query: 333 TLLAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 364
AGT GY++PE+ Y ++ D+++ GV+
Sbjct: 166 G-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVI 196
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 44/237 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEAR 221
+ + +G G +G V A VA+K L TE+ L +E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 222 LLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 276
++ I +H+NI+ L G C +++I EY G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 277 -------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
+ +GM + L+ +HRD+++ NVL+ +ADFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEY-LASQK------CIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 324 LLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+N + T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 206 DINNIDYYK---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G YG V++ R +G++VA+KK SE + + + E R+L Q++H N+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-REIRMLKQLKHPNLVNLLE 69
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
++ + L++EY + ++ L D G+ ++ A+++ H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMV 351
+HRD+ N+L+ + DFG ARLL S T Y +PEL Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 352 VTEKCDVYSFGVVALEVLMGK 372
V DV++ G V E+L G
Sbjct: 184 V----DVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN----EARLLSQIRHRNIVK 233
+G G YG VY+A+ G++VALK++ R + E+ E + E LL ++ H NIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI-RLDAED----EGIPSTAIREISLLKELHHPNIVS 83
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
L +C+ L++E+ME L VL DE GL ++ + + +++ H
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR- 139
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AY 348
I+HRD+ N+L+NS+ +ADFG+AR + T T Y AP++ Y
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 349 TMVVTEKCDVYSFGVVALEVLMGK 372
+ V D++S G + E++ GK
Sbjct: 198 STSV----DIWSIGCIFAEMITGK 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I IG G + V ++ +G+V A+K +++ + + + F E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 229 RNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
R I +L+ F ++L+ EY G L +L E + + A+ + + A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF--YLAEIVMAIDS 177
Query: 288 LH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTYGYIAPE 345
+H VHRDI +N+LL+ +ADFG L D + R+L+A GT Y++PE
Sbjct: 178 VHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 346 LAYTMVVTEK-------CDVYSFGVVALEVLMGKHP 374
+ + CD ++ GV A E+ G+ P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 40/220 (18%)
Query: 165 MIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRS--ETEELASLESFG 217
M+ A+ F Y +G G + V R +G A K ++ + LE
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE--- 76
Query: 218 NEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWA 272
EAR+ +++H NIV+L+ +L+++ + G LF V R ++ +A
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------ 130
Query: 273 KRVNVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 328
+ ++ + +++Y H + IVHR++ N+LL S+ + +ADFG+A +N
Sbjct: 131 --SHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 329 SSNRTLLAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 364
+ AGT GY++PE+ Y ++ D+++ GV+
Sbjct: 185 EAWHG-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVI 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 56/242 (23%), Positives = 103/242 (42%), Gaps = 49/242 (20%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
++ + +G G +G V +A VA+K L + + L +E +L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------- 276
Q+ H +++KLYG C + LI EY + GSL LR + +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 277 ------------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318
+ +GM + L+ + +VHRD+++ N+L+ + ++D
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQY-LAEMK------LVHRDLAARNILVAEGRKMKISD 193
Query: 319 FGVARLLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGK 372
FG++R + + S + G I A E + + T + DV+SFGV+ E++ +G
Sbjct: 194 FGLSRDVYEEDSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250
Query: 373 HP 374
+P
Sbjct: 251 NP 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 44/237 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEAR 221
+ + +G G +G V A VA+K L TE+ L +E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 222 LLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 276
++ I +H+NI+ L G C +++I EY G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 277 -------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
+ +GM + L+ +HRD+++ NVL+ +ADFG+AR
Sbjct: 199 QMTFKDLVSCTYQLARGMEY-LASQK------CIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 324 LLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
+N + T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 252 DINNIDYYK---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 36/263 (13%), Positives = 72/263 (27%), Gaps = 47/263 (17%)
Query: 177 CIGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK 233
G ++A L + VAL + L+ + LS+I + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 234 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT 293
+ R ++ E++ GSL V T + ++ + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 294 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT 353
+ + V ++ + + +A +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYP--------------------ATMPD-------AN 180
Query: 354 EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI-I 412
+ D+ G +L+ + P S D P I +DI
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRS------GLAPAERDTAGQPIEPADIDRDIPF 234
Query: 413 LVSTVAFSCLRSQPKSRPTMQLV 435
+S VA ++ R L+
Sbjct: 235 QISAVAARSVQGDGGIRSASTLL 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 44/237 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEAR 221
+ + +G G +G V A VA+K L TE+ L +E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 222 LLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 276
++ I +H+NI+ L G C +++I EY G+L L+ +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 277 -------------VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
V +GM + L+ +HRD+++ NVL+ + +ADFG+AR
Sbjct: 187 QLSSKDLVSCAYQVARGMEY-LASKK------CIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 324 LLNFDSSNRTLLAGTYGYI-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP 374
++ + T G + APE + + T + DV+SFGV+ E+ +G P
Sbjct: 240 DIHHIDYYK---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN----EARLLSQIRHRNIV 232
IG G YG+V++A+ + ++VALK++ R + ++ E + E LL +++H+NIV
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDD----EGVPSSALREICLLKELKHKNIV 64
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+L+ K + L++E+ + L D LD + + + L + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----A 347
++HRD+ N+L+N E +A+FG+AR + T Y P++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y+ + D++S G + E+ P
Sbjct: 179 YSTSI----DMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 166 IEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE---LASLESFGNEAR 221
+ ++ F +G G Y +VY+ +G VALK++ + ++EE ++ E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR----EIS 55
Query: 222 LLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNVVK 279
L+ +++H NIV+LY + L++E+M+ GL+
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ L++ H + I+HRD+ N+L+N + + DFG+AR + + T
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 340 GYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y AP++ Y+ + D++S G + E++ GK
Sbjct: 173 WYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 169 TEDFHIKYCI-----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFGNE 219
E+F+ Y + G G + V + +G+ A K K R + +E
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR----AEILHE 78
Query: 220 ARLLSQIRHR-NIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLRTDE-----EAVGLDW 271
+L + ++ L+ + + LI EY G +F C+ E +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV----- 133
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 328
+ ++K + + YLH + IVH D+ N+LL+S + DFG++R +
Sbjct: 134 ---IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 329 SSNRTLLAGTYGYIAPE-LAYTMVVTEKCDVYSFGVVA 365
R ++ GT Y+APE L Y +T D+++ G++A
Sbjct: 188 CELREIM-GTPEYLAPEILNYDP-ITTATDMWNIGIIA 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 4e-23
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 174 IKYCIGTGGYGSVYRAR---LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+G G YG VY+A+ K ALK++ +++ E LL +++H N
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR----EIALLRELKHPN 79
Query: 231 IVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--VVKG----MC 282
++ L L + ++L+++Y E L+ +++ + ++ +VK +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAG- 337
+ YLH + ++HRD+ N+L+ E +AD G ARL F+S + L
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLD 193
Query: 338 ----TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
T+ Y APEL YT + D+++ G + E+L +
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 164 DMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN---- 218
D+ + + +G G + +VY+AR + ++VA+KK+ E +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK--DGINRTALR 61
Query: 219 EARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
E +LL ++ H NI+ L H+ + L++++ME L ++ + ++ L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHI 114
Query: 279 KG----MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
K L YLH I+HRD+ NN+LL+ +ADFG+A+ F S NR
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAY 169
Query: 335 --LAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
T Y APEL Y + V D+++ G + E+L+
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 15/236 (6%)
Query: 146 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHR 204
K D F D +D+ ED+ + IG G +G V R + KV A+K L +
Sbjct: 45 KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 104
Query: 205 SETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 264
E + + F E +++ +V+L+ + ++++ EYM G L ++
Sbjct: 105 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--N 162
Query: 265 EAVGLDWAKRVNVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323
V WA+ + AL +H +HRD+ +N+LL+ +ADFG
Sbjct: 163 YDVPEKWARF--YTAEVVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 324 LLNFDSSNRT-LLAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+N + R GT YI+PE+ +CD +S GV E+L+G P
Sbjct: 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN----EARLLS 224
+ IG G +G V++AR +G+ VALKK+ E E+ E F E ++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEK----EGFPITALREIKILQ 71
Query: 225 QIRHRNIVKLYG--------FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 276
++H N+V L + + ++L++++ E L +L V ++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKR 128
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 336
V++ + + L Y+H + I+HRD+ + NVL+ + +ADFG+AR F + +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA--FSLAKNSQPN 183
Query: 337 G------TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
T Y PEL Y + D++ G + E+
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEE---LASLESFGNEARLLSQ 225
E + +G G Y +VY+ + + +VALK++ R E EE ++ E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR----EVSLLKD 56
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
++H NIV L+ K + L++EY++ L L D+ ++ + + L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIA 343
+Y H ++HRD+ N+L+N E +ADFG+AR +T T Y
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRP 168
Query: 344 PEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
P++ Y+ + D++ G + E+ G+
Sbjct: 169 PDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 167 EATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEAR 221
+T F+ Y +G G V R P+ K A+K + + ++ E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 222 LLSQIR-------HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGL 269
L ++ H NI++L FL+++ M+ G LF + +++E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127
Query: 270 DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329
+++ + + LH IVHRD+ N+LL+ ++ + DFG + L+
Sbjct: 128 ------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 330 SNRTLLAGTYGYIAPE-LAYTMVV-----TEKCDVYSFGVV 364
R + GT Y+APE + +M ++ D++S GV+
Sbjct: 179 KLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 72/322 (22%), Positives = 113/322 (35%), Gaps = 56/322 (17%)
Query: 169 TEDFHIKY-------CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA 220
F+ Y +G G + + S + A+K + + + E
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEI 56
Query: 221 RLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKR 274
L H NIVKL+ + FL+ E + G LF + ++ EA
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------- 108
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSN 331
+++ + A+S++H +VHRD+ N+L E + + DFG ARL D+
Sbjct: 109 SYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 332 RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK-----HPGELLSSSSWSLD 386
T Y APEL E CD++S GV+ +L G+ H L +S+ +
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 387 KNIKL--IDLLDP---RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
K IK +S I+ L P R M L NE++
Sbjct: 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQG-----------LLTVDPNKRLKMSGLRYNEWL 274
Query: 441 ARNKAPMQKPFHEISILELRNQ 462
P IL
Sbjct: 275 QDGSQLSSNPLMTPDILGSSGA 296
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 168 ATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFG 217
A ++F+ KY IG G V R +G A+K S + E+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 218 NEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDW 271
E +L Q+ H +I+ L MFL+++ M G LF + +++E
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET----- 202
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331
++++ + A+S+LH + IVHRD+ N+LL+ ++ ++DFG + L
Sbjct: 203 ---RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 332 RTLLAGTYGYIAPE-LAYTMVVTEK-----CDVYSFGVV 364
R L GT GY+APE L +M T D+++ GV+
Sbjct: 257 RE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 71/325 (21%), Positives = 119/325 (36%), Gaps = 61/325 (18%)
Query: 169 TEDFHIKY-----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARL 222
Y +G G G V +G+ ALK L+ S E
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDH 74
Query: 223 LSQI-RHRNIVKLYGFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLD 270
Q +IV + ++C+ +I E ME G LF T+ EA
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--- 131
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNF 327
+++ + A+ +LH I HRD+ N+L S+ + + DFG A+
Sbjct: 132 -----EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--T 181
Query: 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSL 385
+ T Y+APE+ + CD++S GV+ +L G P + S +
Sbjct: 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 386 DKNIKL--IDLLDP---RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEF 439
+ I+L +P +S Q IR L++ P R T+ Q +++ +
Sbjct: 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRL-----------LLKTDPTERLTITQFMNHPW 290
Query: 440 IARNKAPMQKPFHEISILELRNQEM 464
I ++ Q P H +L+
Sbjct: 291 INQSMVVPQTPLHTARVLQEDKDHW 315
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 19/80 (23%), Positives = 44/80 (55%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++L L + + +SG+IP +++++ L L+ S+N+++G + + +P + +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 62 NNLSGSIPESVRKVPHLYVY 81
N +SG+IP+S L+
Sbjct: 159 NRISGAIPDSYGSFSKLFTS 178
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 1/72 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTV-DLS 60
L L+ N LSG++P I+ L L + N I+G I G ++ T +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 61 MNNLSGSIPESV 72
N L+G IP +
Sbjct: 183 RNRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 6e-20
Identities = 20/91 (21%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
L ++L N+L G + ++L+ NS+ + ++G ++ +DL N +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRI 256
Query: 65 SGSIPESVRKVP---HLYVYGKNFDVEIPNT 92
G++P+ + ++ L V N EIP
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 31/78 (39%), Positives = 47/78 (60%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGN-NLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N L L +G N L G IP I KL +L+YL ++H +++G I L +I + T+D S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 61 MNNLSGSIPESVRKVPHL 78
N LSG++P S+ +P+L
Sbjct: 134 YNALSGTLPPSISSLPNL 151
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 18/70 (25%), Positives = 36/70 (51%), Gaps = 1/70 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ + + L N L+ + + + LN L+L +N I G + L ++ + ++++S
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 62 NNLSGSIPES 71
NNL G IP+
Sbjct: 278 NNLCGEIPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 18/70 (25%), Positives = 32/70 (45%), Gaps = 2/70 (2%)
Query: 2 NCSKL-RVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ SKL + + N L+G IP L L +++LS N + G G + L+
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 61 MNNLSGSIPE 70
N+L+ + +
Sbjct: 230 KNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 20/97 (20%), Positives = 44/97 (45%), Gaps = 6/97 (6%)
Query: 2 NCSKLRVLELGNNLLSGS--IPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVD 58
++ L+L L IPS + L LN+L + N++ G I + ++ ++ +
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 59 LSMNNLSGSIPESV---RKVPHLYVYGKNFDVEIPNT 92
++ N+SG+IP+ + + + L +P +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 4e-12
Identities = 21/68 (30%), Positives = 35/68 (51%), Gaps = 1/68 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L L+L NN + G++P + +L+ L+ LN+S N++ G+I Q G + R D +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYAN 300
Query: 62 NNLSGSIP 69
N P
Sbjct: 301 NKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 6/86 (6%)
Query: 13 NNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDLS-MNNLSGSIP 69
N G + + +N L+LS ++ I S L +P ++ + + +NNL G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 70 ESVRKVPHL---YVYGKNFDVEIPNT 92
++ K+ L Y+ N IP+
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDF 120
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN----EARLLSQIRHRNIV 232
+G G YG VY+A + + VA+K++ R E EE E E LL +++HRNI+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEE----EGVPGTAIREVSLLKELQHRNII 96
Query: 233 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+L H + LI+EY E L + ++ + + + + + +++ H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 293 TPPIVHRDISSNNVLLNSELEAF-----VADFGVARLLNFDSSNRTLLAGTYGYIAPEL- 346
+HRD+ N+LL+ + + DFG+AR T T Y PE+
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 347 ----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y+ V D++S + E+LM
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 43/214 (20%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSE---TEELASLESFGNEARLLS 224
T+ + +K IG G Y R + A+K + +S+ TEE LL
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---------IEILLR 71
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNVVK 279
+H NI+ L K ++++ E M+ G L + + ++ EA V+
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA--------SAVLF 123
Query: 280 GMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTL 334
+ + YLH +VHRD+ +N+L E + DFG A+ L ++
Sbjct: 124 TITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 335 LAGTYGYIAPEL----AYTMVVTEKCDVYSFGVV 364
T ++APE+ Y CD++S GV+
Sbjct: 180 PCYTANFVAPEVLERQGY----DAACDIWSLGVL 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF +G G + +V AR + + A+K L + + + E ++S++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHA 284
VKLY + ++ Y + G L +R DE A+ + A
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSA 142
Query: 285 LSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTL-LAGTYGY 341
L YLH I+HRD+ N+LLN ++ + DFG A++L+ +S R GT Y
Sbjct: 143 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
++PEL + D+++ G + +++ G P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 55/309 (17%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235
+G G G V + + + ALK L E L + + +IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 121
Query: 236 GFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNVVKGMCHA 284
RKC+ ++ E ++ G LF T+ EA ++K + A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 173
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTYGY 341
+ YLH I HRD+ N+L S+ + DFG A+ +S T T Y
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYY 229
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKL--IDLLDP 397
+APE+ + CD++S GV+ +L G P + S + I++ + +P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 398 ---RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHE 453
+S V IR L+++P R T+ + +++ +I ++ Q P H
Sbjct: 290 EWSEVSEEVKMLIRN-----------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 338
Query: 454 ISILELRNQ 462
+L+ +
Sbjct: 339 SRVLKEDKE 347
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-20
Identities = 29/79 (36%), Positives = 44/79 (55%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
NCS+L L L N LSG+IPS + L +L L L N + G+I +L + ++T+ L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 62 NNLSGSIPESVRKVPHLYV 80
N+L+G IP + +L
Sbjct: 476 NDLTGEIPSGLSNCTNLNW 494
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 28/70 (40%), Positives = 43/70 (61%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L++ N+LSG IP EI + L LNL HN I+G I ++G++ ++ +DLS
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689
Query: 62 NNLSGSIPES 71
N L G IP++
Sbjct: 690 NKLDGRIPQA 699
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-20
Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDLS 60
C L L+L N G++P L L LS N+ +G++ + L ++ + +DLS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 61 MNNLSGSIPESVRKVP----HLYVYGKNFDVEIPNTSENSPPPH 100
N SG +PES+ + L + NF I +P
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-19
Identities = 28/70 (40%), Positives = 44/70 (62%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
NC+ L + L NN L+G IP I +L+ L L LS+NS +G I ++LG+ + +DL+
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 62 NNLSGSIPES 71
N +G+IP +
Sbjct: 548 NLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-19
Identities = 26/78 (33%), Positives = 42/78 (53%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
M L L L N L+G IPS ++ LN+++LS+N + G+I +G + + + LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 61 MNNLSGSIPESVRKVPHL 78
N+ SG+IP + L
Sbjct: 523 NNSFSGNIPAELGDCRSL 540
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 9e-19
Identities = 31/70 (44%), Positives = 45/70 (64%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L +L LG+N +SGSIP E+ L+ LN L+LS N ++G+I + + + +DLS
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 62 NNLSGSIPES 71
NNLSG IPE
Sbjct: 714 NNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-18
Identities = 28/80 (35%), Positives = 46/80 (57%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ SKLR L+L N+L G IP E+ ++ L L L N + G+I S L ++ + LS
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 61 MNNLSGSIPESVRKVPHLYV 80
N L+G IP+ + ++ +L +
Sbjct: 499 NNRLTGEIPKWIGRLENLAI 518
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-18
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
L+ L L N +G IP + L L+LS N G + G ++++ LS
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 61 MNNLSGSIPESV----RKVPHLYVYGKNFDVEIPNT 92
NN SG +P R + L + F E+P +
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-18
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+CS L+ L++ N LSG I+ EL LN+S N G I + + + L+
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAE 278
Query: 62 NNLSGSIPESV----RKVPHLYVYGKNFDVEIPN 91
N +G IP+ + + L + G +F +P
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 27/77 (35%), Positives = 42/77 (54%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ L+ L L NN +G IP ++ EL L+LS N ++G I S LG + ++ + L +N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 64 LSGSIPESVRKVPHLYV 80
L G IP+ + V L
Sbjct: 454 LEGEIPQELMYVKTLET 470
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-18
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 2/96 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
C L L++ +N S IP + L +L++S N ++G + + +++S
Sbjct: 198 RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 62 NNLSGSIPES-VRKVPHLYVYGKNFDVEIPNTSENS 96
N G IP ++ + +L + F EIP+ +
Sbjct: 257 NQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGA 292
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 18/77 (23%), Positives = 39/77 (50%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S + + + G + + +L++S+N ++G I ++G +P + ++L
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 62 NNLSGSIPESVRKVPHL 78
N++SGSIP+ V + L
Sbjct: 666 NDISGSIPDEVGDLRGL 682
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 26/80 (32%), Positives = 37/80 (46%), Gaps = 2/80 (2%)
Query: 3 CSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ L L+L +N SG I + N L L L +N GKI L + ++ LS
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 61 MNNLSGSIPESVRKVPHLYV 80
N LSG+IP S+ + L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRD 446
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 19/80 (23%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L +L+L NN SG+IP+E+ + L +L+L+ N NG I + + + + ++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAA 567
Query: 62 NNLSGSIPESVRKVPHLYVY 81
N ++G ++
Sbjct: 568 NFIAGKRYVYIKNDGMKKEC 587
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 5/73 (6%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI---NKLQELNYLNLSHNSINGKILSQLGEIPRIDTV 57
+ + L VL+L N +SG+ + EL +L +S N I+G + + ++ +
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFL 205
Query: 58 DLSMNNLSGSIPE 70
D+S NN S IP
Sbjct: 206 DVSSNNFSTGIPF 218
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 28/94 (29%), Positives = 40/94 (42%), Gaps = 5/94 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKI---LSQLGEIPRIDTV 57
+CS L+ L + +N L S KL L L+LS NSI+G + +
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 58 DLSMNNLSGSIPES-VRKVPHLYVYGKNFDVEIP 90
+S N +SG + S + L V NF IP
Sbjct: 184 AISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 22/98 (22%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPS--EINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVD 58
+ L L+L N LSG + + + L +LN+S N+++ +S ++ ++ +D
Sbjct: 98 CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157
Query: 59 LSMNNLSGSIPESVRKVP------HLYVYGKNFDVEIP 90
LS N++SG+ HL + G ++
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 17/72 (23%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 2 NCSKLRVLELGNNL--LSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
N + NL G ++N+L N N++ G + +D+
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 60 SMNNLSGSIPES 71
S N LSG IP+
Sbjct: 640 SYNMLSGYIPKE 651
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 7/95 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI--LSQLGEIPRIDTVDL 59
+ + L L L N+ ++GS+ L L+LS NS++G + L+ LG + +++
Sbjct: 75 SLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNV 133
Query: 60 SMNNLSGSIPESV----RKVPHLYVYGKNFDVEIP 90
S N L S + L + +
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 13/101 (12%), Positives = 27/101 (26%), Gaps = 22/101 (21%)
Query: 2 NCSKLRVLELGNNLLSGS--------------------IPSEINKLQELNYLNLSHNSIN 41
+C L L+L NL +G+ I + + N +
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 42 --GKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYV 80
G QL + + +++ G + +
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 11/98 (11%)
Query: 3 CSKLRV--LELGNNLLS---GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTV 57
C +V ++L + L+ ++ S + L L L LS++ ING + S + ++
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSL 105
Query: 58 DLSMNNLSGSIPESV-----RKVPHLYVYGKNFDVEIP 90
DLS N+LSG + + L V D
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEA-------RLLSQIRHR 229
IG G YG+VY+AR SG VALK + R R L H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGG-GGLPISTVREVALLRRLEAFEHP 74
Query: 230 NIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
N+V+L C + + L++E+++ L L GL ++++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRG 132
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIA 343
L +LH +C IVHRD+ N+L+ S +ADFG+AR+ + T + T Y A
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI--YSYQMALTPVVVTLWYRA 187
Query: 344 PEL----AYTMVVTEKCDVYSFGVVALEVLMGK 372
PE+ Y V D++S G + E+ K
Sbjct: 188 PEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 41/223 (18%)
Query: 169 TEDFHIKY-----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARL 222
+ F Y +G G + V L + + A+K + + E +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEM 63
Query: 223 LSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVN 276
L Q + HRN+++L F +L++E M GS+ R + EA
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA--------SV 115
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRT 333
VV+ + AL +LH I HRD+ N+L + + DF + + +
Sbjct: 116 VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 334 L-------LAGTYGYIAPELAYTMVVT-----EKCDVYSFGVV 364
+ G+ Y+APE+ ++CD++S GV+
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 178 IGTGGYGSVYRAR--LPSGKVVALKKLH-RSETE--------ELASLESFGNEARLLSQI 226
IG G YG V++AR G+ VALK++ ++ E E+A L R L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-------RHLETF 71
Query: 227 RHRNIVKLY-----GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM 281
H N+V+L+ + L++E+++ L L G+ +++ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQL 129
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYG 340
L +LH +VHRD+ N+L+ S + +ADFG+AR+ + T + T
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 341 YIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGK 372
Y APE+ +Y V D++S G + E+ K
Sbjct: 185 YRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ F +GTG +G V + SG A+K L + + +L +E NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHAL 285
+VKL ++++ EY+ G +F LR E +A ++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI------VLTF 154
Query: 286 SYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIA 343
YLH D +++RD+ N+L++ + V DFG A+ + RT L GT +A
Sbjct: 155 EYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALA 206
Query: 344 PEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
PE+ Y V D ++ GV+ E+ G P
Sbjct: 207 PEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 178 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G +G VY+A+L SG++VA+KK+ + + + E +++ ++ H NIV+L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 237 FCLHR------KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKG----MCHAL 285
F + L+ +Y+ +++ V R L V VK + +L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSL 169
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAP 344
+Y+H + I HRDI N+LL+ + + DFG A+ L N + + Y Y AP
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAP 225
Query: 345 EL-----AYTMVVTEKCDVYSFGVVALEVLMGKH--PGE 376
EL YT + DV+S G V E+L+G+ PG+
Sbjct: 226 ELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD 260
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 63/274 (22%), Positives = 103/274 (37%), Gaps = 53/274 (19%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN---EARLLSQIRHR--NI 231
+G+GG+GSVY + VA+K + + + L + E LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 232 VKLYGFCLHRKCMFLIYEYME-MGSLF--CVLRT--DEEAVGLDWAKRVNVVKGMCHALS 286
++L + LI E E + LF R EE A+ + A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSF--FWQVLEAVR 163
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
+ H+ ++HRDI N+L++ E + DFG LL D+ GT Y PE
Sbjct: 164 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD-FDGTRVYSPPE 218
Query: 346 L----AYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPR-L 399
Y V+S G++ L ++ G P + D+ I + + +
Sbjct: 219 WIRYHRYH---GRSAAVWSLGIL-LYDMVCGDIP--------FEHDEEIIRGQVFFRQRV 266
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
S IR CL +P RPT +
Sbjct: 267 SSECQHLIRW-----------CLALRPSDRPTFE 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 63/276 (22%), Positives = 106/276 (38%), Gaps = 55/276 (19%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN---EARLLSQIR----HR 229
+G GG+G+V+ L VA+K + R+ + L E LL ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGS-LF--CVLRT--DEEAVGLDWAKRVNVVKGMCHA 284
+++L + ++ L+ E LF + E ++ + A
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-----SRC--FFGQVVAA 151
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
+ + H +VHRDI N+L++ A + DFG LL+ D GT Y
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYSP 206
Query: 344 PEL----AYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPR 398
PE Y V+S G++ L ++ G P + D+ I +L P
Sbjct: 207 PEWISRHQYH---ALPATVWSLGIL-LYDMVCGDIP--------FERDQEILEAELHFPA 254
Query: 399 -LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+SP IR+ CL +P SRP+++
Sbjct: 255 HVSPDCCALIRR-----------CLAPKPSSRPSLE 279
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G + V AR + +G+ VA+K + +++ SL+ E R++ + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNVVKGMCHALSYLHHD 291
K ++LI EY G +F L ++EA + A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------IVSAVQYCHQK 133
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 347
IVHRD+ + N+LL++++ +ADFG + G Y APEL
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKK 189
Query: 348 YTMVVTEKCDVYSFGVVALEVLM-GKHP 374
Y + DV+S GV+ L L+ G P
Sbjct: 190 YD---GPEVDVWSLGVI-LYTLVSGSLP 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
F +G GG+G V ++ +GK+ A KKL + ++ NE ++L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 229 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
R +V L + K + L+ M G L + +A G A+ V +C L
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLED 301
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL- 346
LH + IV+RD+ N+LL+ ++D G+A + + + GT GY+APE+
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV 357
Query: 347 ---AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
YT D ++ G + E++ G+ P
Sbjct: 358 KNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 18/242 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ F +G GG+G V+ ++ +GK+ A KKL++ ++ + E ++L+++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 229 RNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG-MCHALS 286
R IV L + K + L+ M G + + +E R + L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
+LH I++RD+ NVLL+ + ++D G+A L + AGT G++APEL
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 347 ----AYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKLIDLLDPR-L 399
Y V D ++ GV E++ + P + L + + + P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416
Query: 400 SP 401
SP
Sbjct: 417 SP 418
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 44/223 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I +GTG +G V+ R +G+ A+K L + L +E +E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEA------VGLDWAKRVNV 277
I++++G + +F+I +Y+E G LF +LR + A V L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117
Query: 278 VKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-L 335
AL YLH D I++RD+ N+LL+ + DFG A+ + + T L
Sbjct: 118 ------ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTL 163
Query: 336 AGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT YIAPE+ Y + D +SFG++ E+L G P
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGN-------- 218
+ ++ I +G YG+V G VA+K++ + ++ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV-NILSDSFLCKRVL 77
Query: 219 -EARLLSQIRHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWA 272
E RLL+ H NI+ L +H + ++L+ E M L V+ +
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV--ISPQ 134
Query: 273 KRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332
+ + L LH +VHRD+ N+LL + + DF +AR +N+
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANK 190
Query: 333 TLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
T Y APEL +T +V D++S G V E+ K
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V +G VA+K L+R + L + E + L RH +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNVVKGMCHALSYLHHD 291
F++ EY+ G LF + R +E EA L + A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ--------ILSAVDYCHRH 130
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 347
+VHRD+ NVLL++ + A +ADFG++ +++ RT G+ Y APE+
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRL 186
Query: 348 YTMVVTEKCDVYSFGVVALEVLM 370
Y + D++S GV+ L L+
Sbjct: 187 YA---GPEVDIWSCGVI-LYALL 205
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237
IG G +G V++A+L VA+KK+ + + + E +++ ++H N+V L F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAF 100
Query: 238 CLHR------KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKG----MCHALS 286
+ L+ EY+ +++ R + + + ++K + +L+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLA 155
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
Y+H + I HRDI N+LL+ + DFG A++L N + + Y Y APE
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YRAPE 211
Query: 346 L-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
L YT + D++S G V E++ G+
Sbjct: 212 LIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 50/238 (21%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKK--LHRS----ETEELASLESFGNE 219
+ + F ++ G G +G+V + +G VA+KK E + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIM--------- 70
Query: 220 ARLLSQIRHRNIVKLYGFCLHRK-------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 272
+ L+ + H NIV+L + + ++ EY+ +L R A
Sbjct: 71 -QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVA 125
Query: 273 KRVNVVKG----MCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLL 325
++K + ++ LH + + HRDI +NVL+N L+ + DFG A+ L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKL 182
Query: 326 NFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKH--PGE 376
+ N + Y Y APEL YT V D++S G + E+++G+ G+
Sbjct: 183 SPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGD 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 30/208 (14%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFGNEARLLSQIRHRNI 231
+G+G +G V+ A K V +K K+ E L E +LS++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 232 VKLYGFCLHRKCMFLIYEYMEMGS-LFCVL----RTDEEAVGLDWAKRVNVVKGMCHALS 286
+K+ ++ L+ E G LF + R DE A + + + A+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-----ASY--IFRQLVSAVG 144
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
YL I+HRDI N+++ + + DFG A L T GT Y APE+
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEV 200
Query: 347 ----AYTMVVTEKCDVYSFGVVALEVLM 370
Y + +++S GV L L+
Sbjct: 201 LMGNPYR---GPELEMWSLGVT-LYTLV 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 78/310 (25%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLY 235
+G G G V + + + ALK L E L + + +IV++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77
Query: 236 GFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNVVKGMCHA 284
RKC+ ++ E ++ G LF T+ EA ++K + A
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 129
Query: 285 LSYLH-HDCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTYG 340
+ YLH + I HRD+ N+L S+ + DFG A + Y
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTGEKYD 176
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKL--IDLLD 396
+ CD++S GV+ +L G P + S + I++ + +
Sbjct: 177 -------------KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 397 P---RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFH 452
P +S V IR L+++P R T+ + +++ +I ++ Q P H
Sbjct: 224 PEWSEVSEEVKMLIRN-----------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272
Query: 453 EISILELRNQ 462
+L+ +
Sbjct: 273 TSRVLKEDKE 282
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 52/282 (18%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
+ + IG+G G V A + VA+KKL R F N
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP----------FQNQTHAKRA 71
Query: 219 --EARLLSQIRHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLD 270
E L+ + H+NI+ L +K + +++ E M+ +L V++ + LD
Sbjct: 72 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LD 125
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
+ ++ M + +LH + I+HRD+ +N+++ S+ + DFG+AR S
Sbjct: 126 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSF 181
Query: 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKH--PGELLSSSSWSLDKN 388
T T Y APE+ M E D++S G + E++ G PG + +D+
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG------TDHIDQW 235
Query: 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRP 430
K+I+ L +P + + + + + ++PK
Sbjct: 236 NKVIEQLG---TPC-----PEFMKKLQPTVRTYVENRPKYAG 269
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 57/239 (23%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
+ + +G GG G V+ A K VA+KK+ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHA 55
Query: 219 --EARLLSQIRHRNIVKLY--------------GFCLHRKCMFLIYEYMEMGSLFCVLRT 262
E +++ ++ H NIVK++ G ++++ EYME L VL
Sbjct: 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ 114
Query: 263 DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGV 321
L + + L Y+H + ++HRD+ N+ +N+E L + DFG+
Sbjct: 115 GP----LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 322 ARLLNFDSSNRTLLAG---TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
AR+++ S++ L+ T Y +P L YT + D+++ G + E+L GK
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 24/215 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+F +G G +G V + +G+ A+K L + + E R+L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 229 RNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCH 283
+ L + + + EY G LF L E+ A+ +
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVS 259
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
AL YLH + +V+RD+ N++L+ + + DFG+ + D + GT Y+A
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 344 PEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
PE+ Y V D + GVV E++ G+ P
Sbjct: 318 PEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-- 226
DF + IG GG+G VY R +GK+ A+K L + + NE +LS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 227 -RHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKG 280
IV + Y F K + I + M G L L E + A+
Sbjct: 249 GDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+ L ++H+ +V+RD+ N+LL+ ++D G+A + + GT+G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHG 355
Query: 341 YIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y+APE+ AY D +S G + ++L G P
Sbjct: 356 YMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA--SLESFGNEARLL 223
+ + IG G YG V A + VA+KK+ E + +L E ++L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKIL 79
Query: 224 SQIRHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
+ RH NI+ + ++++ + ME L+ +L+T L +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----LSNDHICYFL 134
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG- 337
+ L Y+H + ++HRD+ +N+LLN+ + + DFG+AR+ + D + L
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 338 --TYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGK 372
T Y APE+ YT + D++S G + E+L +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 36/222 (16%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
+ + IG+G G V A + VA+KKL R F N
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP----------FQNQTHAKRA 108
Query: 219 --EARLLSQIRHRNIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD 270
E L+ + H+NI+ L + ++L+ E M+ +L V++ + LD
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LD 162
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
+ ++ M + +LH + I+HRD+ +N+++ S+ + DFG+AR S
Sbjct: 163 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSF 218
Query: 331 NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK 372
T T Y APE+ M E D++S G + E++ K
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 52/233 (22%), Positives = 91/233 (39%), Gaps = 50/233 (21%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------------------ 218
IG G YG V A A+K L + + A
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 219 -----EARLLSQIRHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAV 267
E +L ++ H N+VKL + +++++E + G + V ++++A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 268 GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
+ + + YLH+ I+HRDI +N+L+ + +ADFGV+ F
Sbjct: 141 --------FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE--F 187
Query: 328 DSSNRTL--LAGTYGYIAPEL---AYTMVVTEKCDVYSFGVVALEVLM-GKHP 374
S+ L GT ++APE + + DV++ GV L + G+ P
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT-LYCFVFGQCP 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V + +G VA+K L+R + L + E + L RH +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNVVKGMCHALSYLHHD 291
+F++ EY+ G LF + R DE E+ L + + Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ--------ILSGVDYCHRH 135
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 347
+VHRD+ NVLL++ + A +ADFG++ +++ RT G+ Y APE+
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRL 191
Query: 348 YTMVVTEKCDVYSFGVVALEVLM 370
Y + D++S GV+ L L+
Sbjct: 192 YA---GPEVDIWSSGVI-LYALL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG V A + + VA+K + + E+ E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+L EY G LF + E +G+ + + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL----AYTM 350
HRDI N+LL+ ++DFG+A + +++ R L + GT Y+APEL +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH- 185
Query: 351 VVTEKCDVYSFGVVALEVLM 370
E DV+S G+V L ++
Sbjct: 186 --AEPVDVWSCGIV-LTAML 202
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 64/348 (18%), Positives = 113/348 (32%), Gaps = 102/348 (29%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ + +G G +G V A + + VA+K L T + +E ++L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 224 SQI-RHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRT------------------- 262
I H N+V L G C + +I E+ + G+L LR+
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139
Query: 263 -DEEAVGLDWAKRVNVVKGMCHALS----------------YLHHDCTPPIVHRDISS-- 303
A+ +D +R++ + + S + +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 304 ----------------------NNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
N+LL+ + + DFG+AR + D
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDAR 256
Query: 342 I-----APELAYTMVVTEKCDVYSFGVVALEVL-MGKHP--GELLSSSSWSLDKNIKLID 393
+ APE + V T + DV+SFGV+ E+ +G P G + + +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---------VKIDEEFCR 307
Query: 394 LLDP--RLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVS 436
L R+ P ++ +L C +P RPT +LV
Sbjct: 308 RLKEGTRMRAPDYTTPEMY-QTML------DCWHGEPSQRPTFSELVE 348
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
E + +G+G YG+V A +G VA+KKL+R F +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP----------FQSELFAKRA 71
Query: 219 --EARLLSQIRHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLD 270
E RLL +RH N++ L + + +L+ +M L +++ ++ L
Sbjct: 72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LG 126
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
+ +V M L Y+H I+HRD+ N+ +N + E + DFG+AR S
Sbjct: 127 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DS 180
Query: 331 NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK 372
T T Y APE+ M T+ D++S G + E++ GK
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLES-FGNEARLLSQIRHRNIVKLY 235
+G G YG V + A+K L + + + + E+ E +LL ++RH+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 236 GFCLH--RKCMFLIYEYMEMGS--LFCVL---RTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+ ++ M+++ EY G + + R A + L YL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ-----AHGY--FCQLIDGLEYL 125
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL 346
H IVH+DI N+LL + ++ GVA L+ +++ T G+ + PE+
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 347 AYTMVVTE--KCDVYSFGVVALEVLM-GKHP 374
A + K D++S GV L + G +P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVT-LYNITTGLYP 212
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
E + + +G+G YGSV A SG+ VA+KKL R F +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP----------FQSEIFAKRA 70
Query: 219 --EARLLSQIRHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLD 270
E LL ++H N++ L + +L+ +M+ L ++
Sbjct: 71 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FS 124
Query: 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 330
K +V M L Y+H + +VHRD+ N+ +N + E + DFG+AR + +
Sbjct: 125 EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD---A 178
Query: 331 NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK 372
T T Y APE+ + M + D++S G + E+L GK
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G +G V A + + VALK + R ++ E L +RH +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNVVKGMCHALSYLHHD 291
+ ++ EY G LF + R E E + A+ Y H
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQ--------IICAIEYCHRH 127
Query: 292 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL----A 347
IVHRD+ N+LL+ L +ADFG++ ++ + +T G+ Y APE+
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 348 YTMVVTEKCDVYSFGVVALEVLM 370
Y + DV+S G+V L V++
Sbjct: 184 YA---GPEVDVWSCGIV-LYVML 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 51/241 (21%)
Query: 159 RITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA--SLES 215
RI + + DF +K +G G YG V A P+G++VA+KK+ + A +L
Sbjct: 4 RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR- 58
Query: 216 FGNEARLLSQIRHRNIVKLY---------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA 266
E ++L +H NI+ ++ F +++I E M+ L V+ T
Sbjct: 59 ---EIKILKHFKHENIITIFNIQRPDSFENF----NEVYIIQELMQT-DLHRVISTQM-- 108
Query: 267 VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326
L + A+ LH ++HRD+ +N+L+NS + V DFG+AR+++
Sbjct: 109 --LSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 327 FDSSNRTLLAGTYG----------YIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMG 371
+++ + G Y APE+ Y+ + DV+S G + E+ +
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLR 219
Query: 372 K 372
+
Sbjct: 220 R 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
+G G YG V A + + VA+K + + E+ E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+L EY G LF + E +G+ + + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL----AYTM 350
HRDI N+LL+ ++DFG+A + +++ R L + GT Y+APEL +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH- 185
Query: 351 VVTEKCDVYSFGVVALEVLM 370
E DV+S G+V L ++
Sbjct: 186 --AEPVDVWSCGIV-LTAML 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLH------RSETEELASLESFGNE 219
F + +G G +G V+ + + ++ A+K L R E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-------E 76
Query: 220 ARLLSQIRHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKR 274
+L ++ H IVKL Y F K ++LI +++ G LF L EE V A+
Sbjct: 77 RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 134
Query: 275 VNVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 333
+ AL +LH I++RD+ N+LL+ E + DFG+++ + D +
Sbjct: 135 ------LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKA 183
Query: 334 L-LAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT Y+APE+ +T D +SFGV+ E+L G P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
E E + +G+G YGSV A +G VA+KKL R + + ++ E RLL
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKH 84
Query: 226 IRHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVK 279
++H N++ L + + +L+ M L +++ + L ++
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK----LTDDHVQFLIY 139
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTY 339
+ L Y+H + I+HRD+ +N+ +N + E + DFG+AR + T T
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATR 193
Query: 340 GYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK 372
Y APE+ M + D++S G + E+L G+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 45/218 (20%), Positives = 90/218 (41%), Gaps = 19/218 (8%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
+ + + I++ IGTG YG V A +VVA+KK+ R + + E +L++
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNR 108
Query: 226 IRHRNIVKLY-----GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
+ H ++VK+ ++++ E + + RT L ++
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY---LTELHIKTLLYN 164
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+ + Y+H + I+HRD+ N L+N + V DFG+AR +++ + + L +
Sbjct: 165 LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 341 YIAPELAYTMVVTEKCDVYSFGVV-----ALEVLMGKH 373
L + VV A E+++ +
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 33/219 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
DF +G G +G V R +G+ A L+K +E+A + E+R+L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQN 61
Query: 226 IRHRNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGM 281
RH + L + + + EY G LF L + E + +
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI------ 114
Query: 282 CHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTY 339
AL YLH D +V+RDI N++L+ + + DFG+ + GT
Sbjct: 115 VSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 340 GYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y+APE+ Y V D + GVV E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 39/224 (17%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHR----SETEELASLESFGNEAR 221
E F + +G GGYG V++ R +GK+ A+K L + ++ A ++ E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERN 73
Query: 222 LLSQIRHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVN 276
+L +++H IV L Y F K ++LI EY+ G LF L E+ A+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE--- 129
Query: 277 VVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL- 334
+ AL +LH I++RD+ N++LN + + DFG+ + + T
Sbjct: 130 ----ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT 180
Query: 335 LAGTYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT Y+APE+ + V D +S G + ++L G P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 65/254 (25%)
Query: 158 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESF 216
GR+ + + +G G YG V+++ +G+VVA+KK+ +F
Sbjct: 1 GRVDR----HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD----------AF 46
Query: 217 GN---------EARLLSQIR-HRNIVKLYGFCL--HRKCMFLIYEYMEMGSLFCVLRTDE 264
N E +L+++ H NIV L + + ++L+++YME L V+R +
Sbjct: 47 QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI 105
Query: 265 EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324
L+ + VV + + YLH + ++HRD+ +N+LLN+E VADFG++R
Sbjct: 106 ----LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 325 LNFDSSNRTLLAGTYG---------------------YIAPEL-----AYTMVVTEKCDV 358
+ + Y APE+ YT + D+
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DM 214
Query: 359 YSFGVVALEVLMGK 372
+S G + E+L GK
Sbjct: 215 WSLGCILGEILCGK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSE-TEELASLESFGNEARLLS 224
E+F + +GTG YG V+ R +GK+ A+K L ++ ++ + E E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 225 QIRHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVV 278
IR +V L Y F K + LI +Y+ G LF L E V + +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----- 167
Query: 279 KGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LA 336
+ AL +LH I++RDI N+LL+S + DFG+++ D + R
Sbjct: 168 --IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 337 GTYGYIAPEL------AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
GT Y+AP++ + V D +S GV+ E+L G P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 18/75 (24%), Positives = 31/75 (41%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L L+L L P+ N L L LN+SHN+ + + +D S+
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 62 NNLSGSIPESVRKVP 76
N++ S + ++ P
Sbjct: 528 NHIMTSKKQELQHFP 542
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 14/77 (18%), Positives = 27/77 (35%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +L+VL+L + L L+ L L+ N I L + + +
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 62 NNLSGSIPESVRKVPHL 78
NL+ + + L
Sbjct: 110 TNLASLENFPIGHLKTL 126
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ S L L L N + + L L L ++ +G + + ++++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 62 NNL-SGSIPESVRKVPHL 78
N + S +PE + +L
Sbjct: 134 NLIQSFKLPEYFSNLTNL 151
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 1/69 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPR-IDTVDLS 60
+ S L+VL + +N L L L+ S N I +L P + ++L+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 61 MNNLSGSIP 69
N+ + +
Sbjct: 552 QNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 10/73 (13%), Positives = 28/73 (38%), Gaps = 1/73 (1%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
+ +L L+ ++ L + L+ L YL++SH + ++ + +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 60 SMNNLSGSIPESV 72
+ N+ + +
Sbjct: 453 AGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 16/80 (20%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
S L VL++ N + +I +L+ L +L+LS + + + + +++S
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 61 MNNLSGSIPESVRKVPHLYV 80
NN + + L V
Sbjct: 503 HNNFFSLDTFPYKCLNSLQV 522
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 14/75 (18%), Positives = 24/75 (32%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ L+L N L EL L+LS I + + T+ L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 64 LSGSIPESVRKVPHL 78
+ + + L
Sbjct: 88 IQSLALGAFSGLSSL 102
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 13/78 (16%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDLS 60
+ L+ L+L N + + S L++L +L+ H+++ S + + +D+S
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 61 MNNLSGSIPESVRKVPHL 78
+ + + L
Sbjct: 430 HTHTRVAFNGIFNGLSSL 447
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 19/74 (25%), Positives = 31/74 (41%), Gaps = 3/74 (4%)
Query: 1 MNCSKLRVLELGNNLLS--GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVD 58
++ L L+L N LS G L YL+LS N + + S + +++ +D
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 59 LSMNNLSGSIPESV 72
+NL SV
Sbjct: 403 FQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 22/102 (21%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINKLQELNYLNLSHNSINGKI---LSQLGEIPRID-T 56
+ L+ L + N + S +P + L L +L+LS N I L L ++P ++ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 57 VDLSMNNLSGSIPESVRKVP--HLYVYGKNFDVEIPNTSENS 96
+DLS+N ++ P + +++ L + + + T
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 7/81 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ LEL N ++ L+ L + + + ++P ++ +DLS
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSR 356
Query: 62 NNLS--GSIPESVRKVPHLYV 80
N LS G +S L
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKY 377
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 9/81 (11%), Positives = 21/81 (25%), Gaps = 5/81 (6%)
Query: 2 NCSKLRVLEL---GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVD 58
L + E + I N L ++ +L +I + ++
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLE 310
Query: 59 LSMNNLSGSIPESVRKVPHLY 79
L ++ + L
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLT 331
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 13/79 (16%), Positives = 24/79 (30%), Gaps = 7/79 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSE-INKLQELNYLNLSHNSINGK------ILSQLGEIPRI 54
+L L L NN S ++ I L L L + S L + +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 55 DTVDLSMNNLSGSIPESVR 73
+ + L + + +
Sbjct: 258 TIEEFRLAYLDYYLDDIID 276
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 54/250 (21%), Positives = 95/250 (38%), Gaps = 63/250 (25%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN------- 218
+++ IK+ IG G YG VY A + K VA+KK++R F +
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM----------FEDLIDCKRI 72
Query: 219 --EARLLSQIRHRNIVKLYGFCL--HRKCM---FLIYEYMEMGSLFCVLRTDEEAVGLDW 271
E +L++++ I++LY + +++ E + L + +T L
Sbjct: 73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF---LTE 128
Query: 272 AKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331
++ + +++H I+HRD+ N LLN + V DFG+AR +N +
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 332 RTLLAGTYG----------------------YIAPEL-----AYTMVVTEKCDVYSFGVV 364
+ Y APEL YT + D++S G +
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCI 241
Query: 365 ALEVLMGKHP 374
E+L
Sbjct: 242 FAELLNMLQS 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 34/206 (16%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG+G +G R + ++VA+K + R + E+ E +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83
Query: 237 FCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
L + +I EY G L+ + R E+ A+ + + +SY H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDE-----ARF--FFQQLLSGVSYCHSMQ 136
Query: 293 TPPIVHRDISSNNVLL--NSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM 350
I HRD+ N LL + + DFG ++ S ++ + GT YIAPE
Sbjct: 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE----- 187
Query: 351 VVTEK------CDVYSFGVVALEVLM 370
V+ + DV+S GV L V++
Sbjct: 188 VLLRQEYDGKIADVWSCGVT-LYVML 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 64/247 (25%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGN-EARLLSQIRHRNIVKLY 235
+GTG +G V + SGK ALKK+ + + N E ++ + H NI+KL
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDP--------RYKNRELDIMKVLDHVNIIKLV 66
Query: 236 GF---CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR----VNVV---------- 278
+ + + + +NV+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 279 ------KG---------------MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-V 316
+ + A+ ++H + I HRDI N+L+NS+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 317 ADFGVARLLNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMG 371
DFG A+ L + + + Y APEL YT + D++S G V E+++G
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCVFGELILG 238
Query: 372 KH--PGE 376
K GE
Sbjct: 239 KPLFSGE 245
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 9/86 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSI--------NGKILSQLGEIPR 53
N L +E+ N +P+ + L E+ +N++ N + + L+ +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 54 IDTVDLSMNNL-SGSIPESVRKVPHL 78
I + + NNL + + S++K+ L
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKL 332
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 14/104 (13%), Positives = 28/104 (26%), Gaps = 9/104 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING----KILSQLGEIPRIDTV 57
+ ++ L L SG +P I +L EL L L + + +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 58 DLSMNNLSGSIP-----ESVRKVPHLYVYGKNFDVEIPNTSENS 96
+ + E + + I +S +
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 13/78 (16%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
K++++ + NNL + + + + K+++L L +N + GK+ + G ++ +++L+
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLA 361
Query: 61 MNNLSGSIPESVRKVPHL 78
N ++ +
Sbjct: 362 YNQITEIPANFCGFTEQV 379
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 12/77 (15%), Positives = 25/77 (32%), Gaps = 8/77 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-------KILSQLGEIPRI 54
+ + L NN +S + L+ +NL N + +
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 55 DTVDLSMNNLSGSIPES 71
++DL N L+ + +
Sbjct: 491 TSIDLRFNKLT-KLSDD 506
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 10/85 (11%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSINGKI------LSQLGEIPR 53
N L ++L N L+ + + L L ++LS+NS + S L
Sbjct: 486 NTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543
Query: 54 IDTVDLSMNNLSGSIPESVRKVPHL 78
+ D N PE + P L
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPSL 568
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 15/80 (18%), Positives = 21/80 (26%), Gaps = 15/80 (18%)
Query: 2 NCSKLRVLELGNNL------LSGSIPSEINKLQELNYLNLSHNSING---KILSQLGEIP 52
N S L+ + N P I L L + N I KI + +
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVL- 592
Query: 53 RIDTVDLSMNNLSGSIPESV 72
D+ N V
Sbjct: 593 -----DIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 7/78 (8%), Positives = 32/78 (41%), Gaps = 9/78 (11%)
Query: 2 NCSKLRVLELGNNLL--------SGSIPSEINKLQELNYLNLSHNSI-NGKILSQLGEIP 52
+++++ + N ++ +++ + + +N++ + + L ++
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330
Query: 53 RIDTVDLSMNNLSGSIPE 70
++ ++ N L G +P
Sbjct: 331 KLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 14/91 (15%)
Query: 2 NCSKLRVLELGNNLLSG-------SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRI 54
+ S + ++ N + + K ++ +NLS+N I+ +
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 55 DTVDLSMNNLSG-------SIPESVRKVPHL 78
+++L N L+ E+ + L
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 2/70 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
KL +LE N L G +P +L LNL++N I + G +++ + +
Sbjct: 328 KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386
Query: 62 NNLSGSIPES 71
N L IP
Sbjct: 387 NKLK-YIPNI 395
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 10/77 (12%), Positives = 25/77 (32%), Gaps = 5/77 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KLR +GN+ E + + Y + + + V++
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYN 258
Query: 62 NNLSGSIPESVRKVPHL 78
+P ++ +P +
Sbjct: 259 CPNLTKLPTFLKALPEM 275
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 11/76 (14%), Positives = 29/76 (38%), Gaps = 1/76 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLS 60
+ KL L L N ++ + +++ L+ +HN + + + + +D S
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 61 MNNLSGSIPESVRKVP 76
N + ++ +
Sbjct: 411 YNEIGSVDGKNFDPLD 426
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 11/64 (17%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
C L L++G+N + + +I ++ L++ N LS + L
Sbjct: 564 LCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 62 NNLS 65
+
Sbjct: 621 DKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 6/77 (7%), Positives = 22/77 (28%), Gaps = 1/77 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ S L + ++ SI + + N+I + + + ++ +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215
Query: 62 NNLSGSIPESVRKVPHL 78
+ + +
Sbjct: 216 SPFVAENICEAWENENS 232
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 8/100 (8%), Positives = 27/100 (27%), Gaps = 6/100 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQ--ELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
+ + + +L ++ + I + +
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 60 SMNNLSGSIPESVRKVP---HLYVYGKNFDVEIPNTSENS 96
NN++ + ++V ++ Y+ F E + +
Sbjct: 191 LSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/235 (18%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 154 WNYD-GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA 211
W+Y+ + + +D+ + +G G Y V+ A + + + V +K L + +++
Sbjct: 23 WDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 78
Query: 212 SLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMF---LIYEYMEMGSLFCVLR--TDEE 265
E ++L +R NI+ L + L++E++ + + TD +
Sbjct: 79 ------REIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD 131
Query: 266 AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARL 324
+ + AL Y H + I+HRD+ +NV+++ E + + D+G+A
Sbjct: 132 IRFY--------MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 325 LNFDSSNRTLLAGTYGYIAPEL-----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+ + + + PEL Y + D++S G + ++ K P
Sbjct: 181 YH-PGQEYNVRVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-R 227
DF+ +G G +G V + + ++ A+K L + + +E E R+L+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 228 HRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVKGMC 282
+ +L+ C ++ + EY+ G L + R E A+ +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IA 452
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTYGY 341
L +L I++RD+ +NV+L+SE +ADFG+ + + + +T GT Y
Sbjct: 453 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDY 508
Query: 342 IAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
IAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 509 IAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 49/249 (19%), Positives = 100/249 (40%), Gaps = 45/249 (18%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR--------- 227
+G G + +V+ A+ + + VA+K + + A+ + E +LL ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKEDS 82
Query: 228 --HRNIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNVVKG 280
+I+KL H+ + +++E + +L ++ + + + L + K++ K
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI--SKQ 139
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF------VADFGVARLLNFDSSNRTL 334
+ L Y+H C I+H DI NVL+ +AD G A + + T
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTN 194
Query: 335 LAGTYGYIAPE----LAYTMVVTEKCDVYSFGVVALEVLMGKH--PGELLSSSSWSLDKN 388
T Y +PE + D++S + E++ G + S + D
Sbjct: 195 SIQTREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 389 IKLIDLLDP 397
++I+LL
Sbjct: 251 AQIIELLGE 259
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
EDF + +G G +G V+ A + + A LKK +++ E R+LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSL 73
Query: 226 -IRHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVK 279
H + + F +F + EY+ G L + + D A+
Sbjct: 74 AWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE------ 126
Query: 280 GMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAG 337
+ L +LH IV+RD+ +N+LL+ + +ADFG+ + + D+ T G
Sbjct: 127 -IILGLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCG 180
Query: 338 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
T YIAPE+ Y V D +SFGV+ E+L+G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
+DF + IG G Y V RL + ++ A +KK ++ E++ +++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 65
Query: 226 I-RHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
H +V L F + +F + EY+ G L ++ EE A+
Sbjct: 66 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 118
Query: 280 GMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAG 337
+ AL+YLH I++RD+ +NVLL+SE + D+G+ + L + T G
Sbjct: 119 -ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCG 172
Query: 338 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK 390
T YIAPE+ Y V D ++ GV+ E++ G+ P +++ SS
Sbjct: 173 TPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQ-IR 227
DFH IG G +G V AR A+K L + + + +E +L + ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 228 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMC 282
H +V L + F K ++ + +Y+ G LF L+ E A+ +
Sbjct: 98 HPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------IA 149
Query: 283 HALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYG 340
AL YLH + IV+RD+ N+LL+S+ + DFG+ + N + ++ T GT
Sbjct: 150 SALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 341 YIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
Y+APE+ Y V D + G V E+L G P
Sbjct: 205 YLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 4/94 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L +L L +N L EL ++L N++N S + +++L
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 62 NNLSGSIPESVRKV----PHLYVYGKNFDVEIPN 91
N ++ + L + FD +
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 21/77 (27%), Positives = 33/77 (42%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L+VL L +N LS L L+L NSI + + + T+DLS
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 62 NNLSGSIPESVRKVPHL 78
N LS + + ++ +L
Sbjct: 131 NGLSSTKLGTQVQLENL 147
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 12/79 (15%), Positives = 26/79 (32%), Gaps = 2/79 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDL 59
+ + L N + + L L L ++ S + + +DL
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 60 SMNNLSGSIPESVRKVPHL 78
S NN++ + + + L
Sbjct: 488 SNNNIANINDDMLEGLEKL 506
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 19/77 (24%), Positives = 30/77 (38%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S+L L++G N +S P KL L LNL HN ++ + + L
Sbjct: 47 RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMS 106
Query: 62 NNLSGSIPESVRKVPHL 78
N++ K +L
Sbjct: 107 NSIQKIKNNPFVKQKNL 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
C+ L L L +N + + K + L L+LSHN ++ L ++ + + LS
Sbjct: 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 62 NNLSGSIPESVRKVP-----HLYVYGKNFDVEIPNT 92
N + E + L + P
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG----EIPRIDTV 57
L L + +N + G + L L YL+LS++ + + L+ + +
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 58 DLSMNNLSGSIPESVRKVPHLYV 80
+L+ N +S ++ + HL V
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEV 409
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSIN--------GKILSQLGEIPR 53
L +L+L NN ++ + L++L L+L HN++ G + L +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 54 IDTVDLSMNNLSGSIPESVRKVPHL 78
+ ++L N E + + L
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFEL 562
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 18/79 (22%), Positives = 30/79 (37%), Gaps = 2/79 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDL 59
L L+L +N LS + +L+ L L LS+N I + + ++L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 60 SMNNLSGSIPESVRKVPHL 78
S N + P + L
Sbjct: 179 SSNQIKEFSPGCFHAIGRL 197
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEI---PRIDTV 57
S L+ LEL +N + P + + L L L++ + + +L I +
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 58 DLSMNNLSGSIPES 71
LS + LS + +
Sbjct: 228 SLSNSQLSTTSNTT 241
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 1/79 (1%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDL 59
+ S L +L L N +S + L L L+L N I ++ + + I + L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 60 SMNNLSGSIPESVRKVPHL 78
S N S VP L
Sbjct: 438 SYNKYLQLTRNSFALVPSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 17/80 (21%), Positives = 31/80 (38%), Gaps = 3/80 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
L VL+LG N + + E L+ + + LS+N + +P + + L
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 61 MNNLSG--SIPESVRKVPHL 78
L S P + + +L
Sbjct: 463 RVALKNVDSSPSPFQPLRNL 482
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 18/79 (22%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQ--ELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
+ +R L L N+ LS + + L+ L L+LS+N++N +P+++ L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 60 SMNNLSGSIPESVRKVPHL 78
NN+ S+ + ++
Sbjct: 280 EYNNIQHLFSHSLHGLFNV 298
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 15/75 (20%), Positives = 33/75 (44%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ + VL L +N L + + +L L++ N+I+ ++P + ++L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 64 LSGSIPESVRKVPHL 78
LS ++ +L
Sbjct: 85 LSQLSDKTFAFCTNL 99
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 2 NCSKLRVLELGNNLLS--------GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPR 53
KL +L+L +N L+ G + L L+ LNL N + + ++
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 54 IDTVDLSMNNLSGSIPESVRKVPHL 78
+ +DL +NNL+ L
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSL 586
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 12/86 (13%), Positives = 29/86 (33%), Gaps = 9/86 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHN---------SINGKILSQLGEIP 52
+L L N + ++ L + YLNL + S+ +
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 53 RIDTVDLSMNNLSGSIPESVRKVPHL 78
++ +++ N++ G + +L
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINL 355
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 10/89 (11%)
Query: 2 NCSKLRVLELGNNLLSG--SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
L+ L L L S PS L+ L L+LS+N+I L + +++ +DL
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 60 SMNNLS--------GSIPESVRKVPHLYV 80
NNL+ G ++ + HL++
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 15/69 (21%), Positives = 28/69 (40%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ + L +L+L N L+ L +L Y L +N+I L + + ++L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 61 MNNLSGSIP 69
+ SI
Sbjct: 305 RSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 15/79 (18%), Positives = 26/79 (32%), Gaps = 9/79 (11%)
Query: 2 NCSKLRVLELGNNLLSGSI---------PSEINKLQELNYLNLSHNSINGKILSQLGEIP 52
+R L L + SI L+ L +LN+ N I G + +
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 53 RIDTVDLSMNNLSGSIPES 71
+ + LS + S +
Sbjct: 354 NLKYLSLSNSFTSLRTLTN 372
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
+DF + IG G Y V RL + ++ A +KK ++ E++ +++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQ 108
Query: 226 I-RHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVK 279
H +V L+ C + +F + EY+ G L ++ EE A+
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 161
Query: 280 GMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAG 337
+ AL+YLH I++RD+ +NVLL+SE + D+G+ + L + T G
Sbjct: 162 -ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCG 215
Query: 338 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK 390
T YIAPE+ Y V D ++ GV+ E++ G+ P +++ SS
Sbjct: 216 TPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
DF+ +G G +G V + + ++ A LKK + +++ E R+L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLAL 76
Query: 226 I-RHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVK 279
+ + +L F + ++ + EY+ G L + R E A+
Sbjct: 77 PGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------ 129
Query: 280 GMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGT 338
+ L +L I++RD+ +NV+L+SE +ADFG+ + N T GT
Sbjct: 130 -IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGT 184
Query: 339 YGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
YIAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRSETEELASLESFGNEARLLSQ 225
++F +G G +G V AR+ +G + A LKK + +++ + E R+LS
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT---EKRILSL 79
Query: 226 I-RHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNVVK 279
H + +L F + +F + E++ G L + R DE A+
Sbjct: 80 ARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------ 132
Query: 280 GMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAG 337
+ AL +LH I++RD+ +NVLL+ E +ADFG+ + + + T G
Sbjct: 133 -IISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCG 186
Query: 338 TYGYIAPEL----AYTMVVTEKCDVYSFGVVALEVLMGKHP 374
T YIAPE+ Y V D ++ GV+ E+L G P
Sbjct: 187 TPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-11
Identities = 32/238 (13%), Positives = 64/238 (26%), Gaps = 50/238 (21%)
Query: 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLES 215
+ F + TE IG G +G V++ K++A++ + E
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 216 FGNEARLLSQI---------RHRNIVKLYGFCLHRKC----------------------- 243
E + ++ R + L +
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 244 -------MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296
+F++ E+ G +RT A +++ + +L+
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEASL--RF 183
Query: 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTE 354
HRD+ NVLL + + S + Y E +V +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 19/80 (23%), Positives = 28/80 (35%), Gaps = 10/80 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING---------KILSQLGEIP 52
N L +EL N +P + L EL LN++ N ++ P
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 53 RIDTVDLSMNNLSGSIPESV 72
+I + NNL P S
Sbjct: 549 KIQIFYMGYNNLE-EFPASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 18/86 (20%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSING-----KILSQLGEIPRI 54
N L ++L N L+ S+ + L L+ +++S+N + SQL
Sbjct: 726 NTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIR 784
Query: 55 DTVDLSMNNLSGSIPESVRKVPHLYV 80
D N + P + P L
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQ 810
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 13/69 (18%), Positives = 23/69 (33%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N ++ L L G +P I +L EL L+ +S E D +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 62 NNLSGSIPE 70
+ + +
Sbjct: 381 HRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 11/78 (14%), Positives = 23/78 (29%), Gaps = 8/78 (10%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSI-------NGKILSQLGEIPR 53
+ L N + ++ + LS+N +
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729
Query: 54 IDTVDLSMNNLSGSIPES 71
+ T+DL N L+ S+ +
Sbjct: 730 LTTIDLRFNKLT-SLSDD 746
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 8/84 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPS--EINKLQELNYLNLSHNSINGKILSQLGEIP-----RI 54
++ L +N L IP+ + + ++ S+N I + + +
Sbjct: 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 55 DTVDLSMNNLSGSIPESVRKVPHL 78
TV LS N + E +
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPI 699
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 17/73 (23%), Positives = 32/73 (43%), Gaps = 6/73 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSE--INKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
K+++ +G N L P+ + K+ +L L+ HN + + L G ++ + L
Sbjct: 546 TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKL 602
Query: 60 SMNNLSGSIPESV 72
N + IPE
Sbjct: 603 DYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 10/94 (10%), Positives = 30/94 (31%), Gaps = 10/94 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ ++ L N + I I +L +L + +++ ++ E +
Sbjct: 424 SLKDTQIGNLTNRI--TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE-----DANSDY 476
Query: 62 NNLSGSIPESVRKVP---HLYVYGKNFDVEIPNT 92
+ S + + +Y ++P+
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 9/77 (11%), Positives = 25/77 (32%), Gaps = 5/77 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL+++ N+ + + + N + + + V+L
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 62 NNLSGSIPESVRKVPHL 78
+P+ + +P L
Sbjct: 501 CPNMTQLPDFLYDLPEL 517
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 7/86 (8%), Positives = 26/86 (30%), Gaps = 9/86 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ + L++L + L + ++ L ++P + +++++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 62 NNLSG---------SIPESVRKVPHL 78
N + + P +
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 3/71 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDL 59
KL L+L N + IP + ++ L SHN + + + + +VD
Sbjct: 593 TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDF 651
Query: 60 SMNNLSGSIPE 70
S N +
Sbjct: 652 SYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 17/79 (21%), Positives = 28/79 (35%), Gaps = 16/79 (20%)
Query: 2 NCSKLRVLEL------GNNLLSGSIPSEINKLQELNYLNLSHNSING---KILSQLGEIP 52
N S+L+ + N + P+ I L L + N I K+ QL +
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYIL- 832
Query: 53 RIDTVDLSMNNLSGSIPES 71
D++ N SI +
Sbjct: 833 -----DIADNPNI-SIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 16/76 (21%), Positives = 32/76 (42%), Gaps = 6/76 (7%)
Query: 2 NCSKLRVLELGNNLLSG---SIPSEINKLQELN--YLNLSHNSINGKILSQLGEIPRIDT 56
+ + ++ N + +I ++ + +N + LS+N I I T
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 57 VDLSMNNLSGSIPESV 72
+ LS N ++ SIPE+
Sbjct: 702 IILSNNLMT-SIPENS 716
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 7/79 (8%), Positives = 28/79 (35%), Gaps = 11/79 (13%)
Query: 2 NCSKLRVLELGNNLLSG---------SIPSEINKLQELNYLNLSHNSING-KILSQLGEI 51
+ +L+ L + N + + + ++ + +N++ + L ++
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKM 572
Query: 52 PRIDTVDLSMNNLSGSIPE 70
++ +D N + +
Sbjct: 573 VKLGLLDCVHNKVR-HLEA 590
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 9/64 (14%), Positives = 24/64 (37%), Gaps = 3/64 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
C L L++G+N + + ++ +L L+++ N ++ + L
Sbjct: 804 TCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 62 NNLS 65
+
Sbjct: 861 DKTQ 864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 45/217 (20%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR- 229
+ + IG G +G V +A + VALK + + + E E R+L +R +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQD 154
Query: 230 -----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
N++ + R + + +E + M +L+ +++ ++ G +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKF-QGFSLPLVRKFAHSILQC 212
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS---NRTLLAGTYGY 341
L LH I+H D+ N+LL + + + ++++F SS ++ + Y Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGI------KVIDFGSSCYEHQRV----YTY 259
Query: 342 I------APELAYTMVVTEKCDVYSFGVVALEVLMGK 372
I APE+ D++S G + E+L G
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 19/77 (24%), Positives = 30/77 (38%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L+L L + L L LN+SHN++ S ++ + T+D S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 62 NNLSGSIPESVRKVPHL 78
N + S L
Sbjct: 531 NRIETSKGILQHFPKSL 547
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 13/77 (16%), Positives = 28/77 (36%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N S+L+ L+L + + L L+ L L+ N I + ++ +
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 62 NNLSGSIPESVRKVPHL 78
L+ + ++ L
Sbjct: 114 TKLASLESFPIGQLITL 130
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 16/78 (20%), Positives = 24/78 (30%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLS 60
+ KL L++ L LN L ++ NS LS + +DLS
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 61 MNNLSGSIPESVRKVPHL 78
L + L
Sbjct: 482 KCQLEQISWGVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 12/78 (15%), Positives = 27/78 (34%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L L L N + P + L L L + +G++ + ++++
Sbjct: 78 GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137
Query: 62 NNLSG-SIPESVRKVPHL 78
N + +P + +L
Sbjct: 138 NFIHSCKLPAYFSNLTNL 155
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 2/79 (2%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDL 59
+ + LR L+L N + + L+EL +L+ H+++ S + ++ +D+
Sbjct: 373 LGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 60 SMNNLSGSIPESVRKVPHL 78
S N + L
Sbjct: 432 SYTNTKIDFDGIFLGLTSL 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 14/78 (17%), Positives = 29/78 (37%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ L L++ N + S + L +L+LS + + R+ +++S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 61 MNNLSGSIPESVRKVPHL 78
NNL ++ L
Sbjct: 506 HNNLLFLDSSHYNQLYSL 523
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 13/73 (17%), Positives = 33/73 (45%), Gaps = 1/73 (1%)
Query: 1 MNCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
M +L+ L+ ++ L S L++L YL++S+ + + ++T+ +
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 60 SMNNLSGSIPESV 72
+ N+ + +V
Sbjct: 456 AGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 14/64 (21%), Positives = 28/64 (43%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L++L + +N L S N+L L+ L+ S N I + +L+
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 62 NNLS 65
N+++
Sbjct: 555 NSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 15/75 (20%), Positives = 27/75 (36%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S + ++L N L + EL +L+LS I + + + L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 64 LSGSIPESVRKVPHL 78
+ P S + L
Sbjct: 92 IQSFSPGSFSGLTSL 106
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 19/82 (23%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHNSING---KILSQLGEIPR-IDT 56
L+ L + +N + +P+ + L L +++LS+N I L L E P+ +
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185
Query: 57 VDLSMNNLSGSIPESVRKVPHL 78
+D+S+N + I + + L
Sbjct: 186 LDMSLNPID-FIQDQAFQGIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 19/79 (24%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSIN--GKILSQLGEIPRIDTVDL 59
+ L+ L L N S I + L L+YL+LS N+++ G + +DL
Sbjct: 326 DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 60 SMNNLSGSIPESVRKVPHL 78
S N + + + L
Sbjct: 384 SFNGAI-IMSANFMGLEEL 401
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 5/70 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
K + L + L P+ L L L L+ N + I + +P + +DLS
Sbjct: 305 KHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSR 359
Query: 62 NNLSGSIPES 71
N LS S S
Sbjct: 360 NALSFSGCCS 369
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 58/306 (18%), Positives = 110/306 (35%), Gaps = 88/306 (28%)
Query: 170 EDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLS 224
+ F+ +Y + G G + +V+ + + K VA+K + +E +L +E RLL
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLK 88
Query: 225 QIR--------HRNIVKLYG-FCLHRK-----CMFLIYEYMEMGSLFCVL-RTDEEAVGL 269
+R +V+L F + CM ++E + L + +++ + + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVLGH-HLLKWIIKSNYQGLPL 145
Query: 270 DWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE------------------ 311
K++ ++ + L YLH C I+H DI N+LL+
Sbjct: 146 PCVKKI--IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 312 -------------------------------LEAFVADFGVARLLNFDSSNRTLLAGTYG 340
L+ +AD G A + + T T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQ 258
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI--KLIDLLDPR 398
Y + E+ D++S +A E+ G + E S ++ D++ +I+LL
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK- 317
Query: 399 LSPPVD 404
P
Sbjct: 318 --VPRK 321
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR- 229
+ I IG G +G V +A + VA+K + + + E RLL +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHD 111
Query: 230 -----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
IV L + R + L++E + +L+ +LR G+ + MC A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTA 169
Query: 285 LSYLH-HDCTPPIVHRDISSNNVLLNSELEAF--VADFGVARLLNFDSSNRTLLAGTYGY 341
L +L + + I+H D+ N+LL + + + DFG + + Y
Sbjct: 170 LLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQSRFY 224
Query: 342 IAPE----LAYTMVVTEKCDVYSFGVVALEVLMGK 372
+PE + Y + D++S G + +E+ G+
Sbjct: 225 RSPEVLLGMPYDL----AIDMWSLGCILVEMHTGE 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 12/77 (15%), Positives = 25/77 (32%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L+ L +S ++ + L L L N I+ L + ++ +D
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162
Query: 62 NNLSGSIPESVRKVPHL 78
N + E + +
Sbjct: 163 NAIHYLSKEDMSSLQQA 179
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 13/77 (16%), Positives = 27/77 (35%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +L L L N L + ++ + L +L I+ L ++++ L
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 62 NNLSGSIPESVRKVPHL 78
N++S L
Sbjct: 139 NHISSIKLPKGFPTEKL 155
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 17/77 (22%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L +L L LS L+ +N+++LSHN + + L + I ++L+
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLAS 532
Query: 62 NNLSGSIPESVRKVPHL 78
N++S +P + +
Sbjct: 533 NHISIILPSLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 1/80 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDLS 60
N S L+ L L N + +L L+L+ + K S + + ++LS
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 61 MNNLSGSIPESVRKVPHLYV 80
+ L S + +P L
Sbjct: 434 HSLLDISSEQLFDGLPALQH 453
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 10/77 (12%), Positives = 20/77 (25%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L L+L + L+ L L+ N + + L + +
Sbjct: 55 RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114
Query: 62 NNLSGSIPESVRKVPHL 78
+S + L
Sbjct: 115 TGISSIDFIPLHNQKTL 131
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 1/70 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L+ L+L LS +PS + L L L LS N P + + +
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 62 NNLSGSIPES 71
N +
Sbjct: 335 NTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 3/80 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEI---PRIDTVD 58
N L+VL L ++LL S + L L +LNL N + + + R++ +
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 59 LSMNNLSGSIPESVRKVPHL 78
LS +LS + + +
Sbjct: 483 LSFCDLSSIDQHAFTSLKMM 502
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 2/73 (2%)
Query: 2 NCSKLRVLELGNNLL--SGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
N LR L+L ++ + S ++ L L LNLS+N E P+++ +DL
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407
Query: 60 SMNNLSGSIPESV 72
+ L +S
Sbjct: 408 AFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQE---LNYLNLSHNSINGKILSQLGEIPRIDTVD 58
L+ L L N + N LQ L L LS ++ + ++ VD
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 59 LSMNNLSGSIPESVRKVPHLYVY 81
LS N L+ S E++ + +Y+
Sbjct: 507 LSHNRLTSSSIEALSHLKGIYLN 529
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 3/82 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLS 60
S L+ L L N + L +L++ N+ ++ + L + + +DLS
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 61 MNNL--SGSIPESVRKVPHLYV 80
+++ S +R + HL
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQS 380
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 16/80 (20%), Positives = 35/80 (43%), Gaps = 5/80 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING---KILSQLGEIPRIDTVD 58
N L L LG+N +S + ++L L+ +N+I+ + +S L + +++
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA-TNLSLN 185
Query: 59 LSMNNLSGSIPESVRKVPHL 78
L+ N+++ I
Sbjct: 186 LNGNDIA-GIEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 1/71 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
C +L +L+L L S L L LNLSH+ ++ +P + ++L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 61 MNNLSGSIPES 71
N+ +
Sbjct: 458 GNHFPKGNIQK 468
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 12/78 (15%), Positives = 27/78 (34%), Gaps = 1/78 (1%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ + + L + + + L L+L+ ++ ++ S L + + + LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 61 MNNLSGSIPESVRKVPHL 78
N S P L
Sbjct: 310 ANKFENLCQISASNFPSL 327
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 17/66 (25%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ + ++L +N L+ S ++ L+ + YLNL+ N I+ + S L + + T++L
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556
Query: 62 NNLSGS 67
N L +
Sbjct: 557 NPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 16/75 (21%), Positives = 29/75 (38%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ LE N+L + ++L L +L+L+ I R+DT+ L+ N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 64 LSGSIPESVRKVPHL 78
L ++ L
Sbjct: 93 LIFMAETALSGPKAL 107
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 7/81 (8%), Positives = 22/81 (27%), Gaps = 4/81 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSINGKILSQLGEIPR--IDTV 57
+ + + L G I + + +Q L + + ++++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 58 DLSMNNLSGSIPESVRKVPHL 78
+L + + L
Sbjct: 260 NLQKHYFFNISSNTFHCFSGL 280
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 11/83 (13%), Positives = 19/83 (22%), Gaps = 5/83 (6%)
Query: 2 NCSKLRVLEL--GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG--EIPRIDTV 57
+ + L L N ++ I LN I L I +
Sbjct: 175 SLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 58 DLSMNNLSGSIPESVRKVPHLYV 80
+ P + + V
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSV 256
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 16/67 (23%), Positives = 35/67 (52%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L L + ++ ++ L L L++SH++ + IL+++ +P+++++DLS
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 62 NNLSGSI 68
N I
Sbjct: 146 NGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 12/77 (15%), Positives = 29/77 (37%), Gaps = 2/77 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ L + N + + I+ L L L + + + L + + +D+S
Sbjct: 64 YAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 62 NNLSGSIPESVRKVPHL 78
+ SI + +P +
Sbjct: 122 SAHDDSILTKINTLPKV 138
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 11/65 (16%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
K+ ++L N I + L EL LN+ + ++ + + P+++ +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190
Query: 62 NNLSG 66
+ G
Sbjct: 191 QTIGG 195
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 20/68 (29%), Positives = 41/68 (60%), Gaps = 2/68 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +KL++L +G+N +S S +N L +LN L L++N + + + +G + + T+ LS
Sbjct: 263 DLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 62 NNLSGSIP 69
N+++ P
Sbjct: 321 NHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N S+L L L NN L I L L L LS N I + L + ++D+ D +
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFAN 342
Query: 62 NNLS 65
+
Sbjct: 343 QVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 21/77 (27%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N S+L LE+G N +S + + L +L LN+ N I+ +S L + +++++ L+
Sbjct: 241 NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNN 296
Query: 62 NNLSGSIPESVRKVPHL 78
N L E + + +L
Sbjct: 297 NQLGNEDMEVIGGLTNL 313
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 16/69 (23%), Positives = 33/69 (47%), Gaps = 4/69 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N KL L +G N ++ S + L L L L+ ++I+ +S L + ++ +++L
Sbjct: 86 NLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGA 141
Query: 62 NNLSGSIPE 70
N+ +
Sbjct: 142 NHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 7e-07
Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L L L N + P + L L+Y N I ++ + + R++++ +
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGN 230
Query: 62 NNLSGSIP 69
N ++ P
Sbjct: 231 NKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 15/68 (22%), Positives = 33/68 (48%), Gaps = 3/68 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N +K+ L LG N S S ++ + LNYL ++ + + ++ + + + ++ L+
Sbjct: 130 NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNY 186
Query: 62 NNLSGSIP 69
N + P
Sbjct: 187 NQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ + L N ++ P + + LN L + +N I LS L + ++ +++
Sbjct: 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGT 252
Query: 62 NNLSG 66
N +S
Sbjct: 253 NQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 6/68 (8%), Positives = 28/68 (41%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ ++ L ++ + +L+ + L ++ + + + + ++ ++L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNG 75
Query: 62 NNLSGSIP 69
N ++ P
Sbjct: 76 NQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L + ++ SI I L L YLNL+ N I +S L + ++ + +
Sbjct: 42 ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGT 97
Query: 62 NNLSGSIPESVRKVPHL 78
N + + +++ + +L
Sbjct: 98 NKI--TDISALQNLTNL 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 5/92 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +KL+ L NN +S S + L +N+L+ HN I+ L+ L + RI + L+
Sbjct: 329 SLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLND 384
Query: 62 NNLSGSIPESVRKVPHLY-VYGKNFDVEIPNT 92
+ + V V + P T
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAPAT 416
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 20/95 (21%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N L L L N +S P ++ L +L L +N ++ +S L + I+ +
Sbjct: 307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGH 362
Query: 62 NNLSGSIP-ESVRKVPHLYVYGKNFDVEIPNTSEN 95
N +S P ++ ++ L + + + N N
Sbjct: 363 NQISDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL L+LG N +S P + L L L L+ N + +S + + + + L
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 318
Query: 62 NNLSGSIP 69
NN+S P
Sbjct: 319 NNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L NN +S P + L L+ L+L+ N + + L + + +DL+
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252
Query: 62 NNLSGSIP 69
N +S P
Sbjct: 253 NQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L L N L + L L L+L++N I+ L+ L + ++ + L
Sbjct: 219 ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGA 274
Query: 62 NNLSGSIP 69
N +S P
Sbjct: 275 NQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 14/68 (20%), Positives = 31/68 (45%), Gaps = 5/68 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L+ L GN + + L L L++S N ++ +S L ++ ++++ +
Sbjct: 154 GLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATN 208
Query: 62 NNLSGSIP 69
N +S P
Sbjct: 209 NQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 13/68 (19%), Positives = 29/68 (42%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L + NN L+ P + L +L + +++N I ++ L + + + L
Sbjct: 66 YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFN 121
Query: 62 NNLSGSIP 69
N ++ P
Sbjct: 122 NQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N +KL + + NN ++ P + L L L L +N I + L + ++ ++LS
Sbjct: 88 NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSS 143
Query: 62 NNLSG 66
N +S
Sbjct: 144 NTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 10/68 (14%), Positives = 25/68 (36%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ LG ++ ++ L ++ L I K + + + + ++ S
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 62 NNLSGSIP 69
N L+ P
Sbjct: 78 NQLTDITP 85
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 9/68 (13%), Positives = 28/68 (41%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ ++ L+ + + L L +N S+N + ++ L + ++ + ++
Sbjct: 44 DLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNN 99
Query: 62 NNLSGSIP 69
N ++ P
Sbjct: 100 NQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 18/65 (27%), Positives = 32/65 (49%), Gaps = 5/65 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + L LEL +N +S S ++ L L L+ + + K L+ L ++ +D+S
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANL---TTLERLDISS 186
Query: 62 NNLSG 66
N +S
Sbjct: 187 NKVSD 191
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N L + NN L +P L+ + +N + + L +L +P + T+
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLSLES---IVAGNNIL--EELPELQNLPFLTTIYADN 246
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSEN 95
N L ++P+ + L V N+ ++P ++
Sbjct: 247 NLLK-TLPDLPPSLEALNVRD-NYLTDLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 18/105 (17%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILS---------QLGEIP 52
L L N L+ +P L+ L N + +++ QL ++P
Sbjct: 89 LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP 147
Query: 53 RID------TVDLSMNNLSGSIPESVRKVPHLYVYGKNFDVEIPN 91
+ +D+ N+L +P+ + + N E+P
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGN-NQLEELPE 190
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 18/103 (17%), Positives = 31/103 (30%), Gaps = 17/103 (16%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGE----------- 50
N L +NL +P E ++ + + GE
Sbjct: 10 NTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 51 --IPRIDTVDLSMNNLSGSIPESVRKVPHLYVYGKNFDVEIPN 91
+ ++L+ LS S+PE + L N E+P
Sbjct: 68 CLDRQAHELELNNLGLS-SLPELPPHLESLVASC-NSLTELPE 108
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 20/129 (15%), Positives = 40/129 (31%), Gaps = 35/129 (27%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELN-----------------YLNLSHNSING-- 42
L L + NN L +P+ +L+ L L++ +N +
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLREFP 373
Query: 43 ---------KILSQLGEIPRI----DTVDLSMNNLSGSIPESVRKVPHLYVYGKNFDVEI 89
++ S L E+P + + + N L P+ V L + V+
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLRMNS-ERVVDP 431
Query: 90 PNTSENSPP 98
+ +
Sbjct: 432 YEFAHETTD 440
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLS 60
L + GNN+L E+ L L + +N L L P ++ +++
Sbjct: 213 LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNL-----LKTLPDLPPSLEALNVR 265
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSEN 95
N L+ +PE + + L V +N + N
Sbjct: 266 DNYLT-DLPELPQSLTFLDV-SENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 9/80 (11%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
L L++ N+ S + L YLN S N I S P ++ +++S N
Sbjct: 276 PQSLTFLDVSENIFS-GLSELPPNLY---YLNASSNEIR----SLCDLPPSLEELNVSNN 327
Query: 63 NLSGSIPESVRKVPHLYVYG 82
L +P ++ L
Sbjct: 328 KLI-ELPALPPRLERLIASF 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 17/107 (15%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNL 64
LEL + L P + +L L ++ + + ++ + + ++T+ L+ N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139
Query: 65 SGSIPESV---RKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRL 108
++P S+ ++ L + E+P ++ + L
Sbjct: 140 R-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 11/71 (15%), Positives = 28/71 (39%), Gaps = 2/71 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L+ + + L +P + + L L L+ N + + + + + R+ + +
Sbjct: 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159
Query: 62 NNLSGSIPESV 72
+PE +
Sbjct: 160 CPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 16/94 (17%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L+ L L + S+P+ I LQ L L + ++ ++ + + +P+++ +DL
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238
Query: 62 NNLSGSIPESVRKVP---HLYVYGKNFDVEIPNT 92
+ P L + + + +P
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N L+ L++ N+ LS ++ I+ L +L L+L + G + + L
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 62 NNLSGSIPESVRKVPHL 78
+ ++P + ++ L
Sbjct: 263 CSNLLTLPLDIHRLTQL 279
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 13/77 (16%), Positives = 27/77 (35%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ KL L+L + P L L L S + + + +++ +DL
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286
Query: 62 NNLSGSIPESVRKVPHL 78
+P + ++P
Sbjct: 287 CVNLSRLPSLIAQLPAN 303
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 15/79 (18%), Positives = 34/79 (43%), Gaps = 5/79 (6%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ L+ L L + L ++P +I++L +L L+L ++ S + ++P + +
Sbjct: 251 GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 61 MN---NLSGSIPESVRKVP 76
+ L P + P
Sbjct: 310 PHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 8/79 (10%), Positives = 26/79 (32%), Gaps = 5/79 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELN--YLNLSHNSINGKILSQLGEIPRIDTVDL 59
N + ++ L + + + L L + + Q + + + +
Sbjct: 54 NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI 111
Query: 60 SMNNLSGSIPESVRKVPHL 78
L +P+++++ L
Sbjct: 112 DAAGLM-ELPDTMQQFAGL 129
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 16/104 (15%), Positives = 38/104 (36%), Gaps = 16/104 (15%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINK---------LQELNYLNLSHNSINGKILSQLGEI 51
+ ++LR L + L+ +P + L L L L I + + + +
Sbjct: 148 SLNRLRELSIRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL 205
Query: 52 PRIDTVDLSMNNLSGSIPESVRKVP---HLYVYGKNFDVEIPNT 92
+ ++ + + LS ++ ++ +P L + G P
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 16/82 (19%), Positives = 35/82 (42%), Gaps = 4/82 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L L + NN L ++ + L L+LSHN + + + R++ + L
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327
Query: 62 NNLSGSIPESV-RKVPHLYVYG 82
N++ ++ S + +L +
Sbjct: 328 NSIV-TLKLSTHHTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 4/78 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N L ++L N L I K+Q L L +S+N + + IP + +DLS
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303
Query: 61 MNNLSGSIPESVRKVPHL 78
N+L + + + L
Sbjct: 304 HNHLL-HVERNQPQFDRL 320
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 17/75 (22%), Positives = 30/75 (40%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
++ L +G N + +P + + L L L N S+ I P++ T+
Sbjct: 91 YAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTL 146
Query: 58 DLSMNNLSGSIPESV 72
+S NNL I +
Sbjct: 147 SMSNNNLE-RIEDDT 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 10/76 (13%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDT 56
+ + +++ N+ + +P+ + + +++ LNL+ I+ + I
Sbjct: 42 ITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQK 97
Query: 57 VDLSMNNLSGSIPESV 72
+ + N + +P V
Sbjct: 98 LYMGFNAIR-YLPPHV 112
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/79 (21%), Positives = 36/79 (45%), Gaps = 9/79 (11%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
+L +L+L +N L+ +N L ++LS+N I ++ R++ + +
Sbjct: 225 NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKM---QRLERLYI 279
Query: 60 SMNNLSGSIPESVRKVPHL 78
S N L ++ + +P L
Sbjct: 280 SNNRLV-ALNLYGQPIPTL 297
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 15/71 (21%), Positives = 35/71 (49%), Gaps = 9/71 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L+ L+L +N L+ + ++ + L + N+S+N + S L ++ +D S
Sbjct: 163 ATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 214
Query: 62 NNLSGSIPESV 72
N+++ + V
Sbjct: 215 NSIN-VVRGPV 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 6e-07
Identities = 64/482 (13%), Positives = 141/482 (29%), Gaps = 127/482 (26%)
Query: 61 MNNLSGSIPESVRKVPHLYV--YGKNFDV-EIPNTSENSPPPHHKKIATRLVAIIL---P 114
M+ +G + + ++ + NFD ++ + ++ ++ + I+
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-------LSKEEIDHIIMSKD 59
Query: 115 MVALLALIFGILFVRRRRDKRVEPAETGEITKCADEFAIWNYDGRITFQDMIEATEDFHI 174
V+ +F L ++++ V+ + NY F ++ +
Sbjct: 60 AVSGTLRLFWTL--LSKQEEMVQKFVEEVLRI--------NYK----F--LMSPIKTEQR 103
Query: 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+ + T Y R RL + V K + S + L + L ++R V +
Sbjct: 104 QPSMMTRMYIE-QRDRLYNDNQV-FAKYNVSRLQPYLKLR------QALLELRPAKNVLI 155
Query: 235 YGF------CL----------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
G + K F I+ ++ + + C + E + + +
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKN--C--NSPETVLEMLQKLLYQID 210
Query: 279 KGMCHALSYLHHDCTPPIVHRDISS-----------NNVLL------NSE-LEAFVADFG 320
S H + I + N LL N++ AF +
Sbjct: 211 PNWT---SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF--NLS 265
Query: 321 VARLL--NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVAL-----------E 367
++L L+ ++M +T ++ E
Sbjct: 266 -CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD---EVKSLLLKYLDCRPQDLPRE 321
Query: 368 VLMGKHP------GELLSS--SSW------SLDKNIKLIDL-LDPRLSPPVDQK------ 406
VL +P E + ++W + DK +I+ L+ L P +K
Sbjct: 322 VLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMFDRLS 379
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF-----IARNKAPMQKPFHEISILELRN 461
+ + T+ S + M +V N+ + + I +
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVV-NKLHKYSLVEKQPKESTISIPSIYLELKVK 438
Query: 462 QE 463
E
Sbjct: 439 LE 440
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 5e-06
Identities = 65/455 (14%), Positives = 118/455 (25%), Gaps = 148/455 (32%)
Query: 2 NCSKLR-VLELGNNLL-------------SGSIPSEINKLQ-ELNYLNLSHNSING---- 42
NC+ VLE+ LL S +I I+ +Q EL L S N
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 43 ----------------KILSQLGEIPRIDTVDLS-MNNLSGSIPESVRKVPHLYVYGKNF 85
KIL + T + LS + + H +
Sbjct: 251 LNVQNAKAWNAFNLSCKIL--------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 86 DVEI----PNTSENSPPPHHKKIATRLVAIILPMVALLALIFGILF----------VRRR 131
+ + P R ++II + + +
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSII---AESIR-DGLATWDNWKHVNCDKLTTI 358
Query: 132 RDKRVEPAETGEITKCADEFAIWNYDGRIT------------FQDMIEATEDFHIKYCIG 179
+ + E E K D +++ I D++ H +
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 180 TGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLY---- 235
S +PS ++ +L NE L HR+IV Y
Sbjct: 419 KQPKESTI--SIPS--------IYLELKVKLE------NEYAL-----HRSIVDHYNIPK 457
Query: 236 GFCLHRK---------CMFLIY-----EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM 281
F + + E+ E +LF ++ D + ++ K
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFLEQ----K-- 506
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDSSNRTLLAGTYG 340
+ HD T I N L + + ++ D + L
Sbjct: 507 ------IRHDSTAWNASGSI--LNTLQQLKFYKPYICD---------NDPKYERLVNAIL 549
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375
P++ ++ ++ D+ LM +
Sbjct: 550 DFLPKIEENLICSKYTDLLRIA------LMAEDEA 578
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 16/78 (20%), Positives = 32/78 (41%), Gaps = 4/78 (5%)
Query: 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
S+++ L+L N + + L +LNL +N I + ++ T+DLS
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLS 199
Query: 61 MNNLSGSIPESVRKVPHL 78
N L+ + + +
Sbjct: 200 SNKLA-FMGPEFQSAAGV 216
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 14/71 (19%), Positives = 29/71 (40%), Gaps = 2/71 (2%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ +KL+ L+L +N L+ + E + +++L +N + I L ++ DL
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245
Query: 61 MNNLSGSIPES 71
N
Sbjct: 246 GNGFHCGTLRD 256
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 12/69 (17%), Positives = 33/69 (47%), Gaps = 1/69 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N ++ ++ ++ ++ L ++ S + L+LS N ++ + L +++ ++LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 62 NNLSGSIPE 70
N L +
Sbjct: 68 NVLY-ETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 22/104 (21%), Positives = 35/104 (33%), Gaps = 9/104 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLS 60
+ + + + L NN L I + Q L + +L N + L + R+ TV
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKI 104
E VP L YG E+ P P ++
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGA-------YCCEDLPAPFADRL 307
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 8/71 (11%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL +L L +N+L ++ L L L+L++N + +L P I+T+ +
Sbjct: 56 PFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAAN 108
Query: 62 NNLSGSIPESV 72
NN+S + S
Sbjct: 109 NNIS-RVSCSR 118
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 15/77 (19%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L L N + + ++ +L L+LS N + + + + + L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 62 NNLSGSIPESVRKVPHL 78
N L I +++R +L
Sbjct: 224 NKLV-LIEKALRFSQNL 239
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 14/71 (19%), Positives = 29/71 (40%), Gaps = 2/71 (2%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ +KL+ L+L +N L+ + E + +++L +N + I L ++ DL
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245
Query: 61 MNNLSGSIPES 71
N
Sbjct: 246 GNGFHCGTLRD 256
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 12/69 (17%), Positives = 33/69 (47%), Gaps = 1/69 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N ++ ++ ++ ++ L ++ S + L+LS N ++ + L +++ ++LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 62 NNLSGSIPE 70
N L +
Sbjct: 68 NVLY-ETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 16/78 (20%), Positives = 32/78 (41%), Gaps = 4/78 (5%)
Query: 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
S+++ L+L N + + L +LNL +N I + ++ T+DLS
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLS 199
Query: 61 MNNLSGSIPESVRKVPHL 78
N L+ + + +
Sbjct: 200 SNKLA-FMGPEFQSAAGV 216
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLS 60
+ + + + L NN L I + Q L + +L N + L + R+ TV
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDVEIPN 91
E VP L YG ++P
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 19/70 (27%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL +L L +N+L ++ L L L+L++N + +L P I+T+ +
Sbjct: 56 PFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAAN 108
Query: 62 NNLSGSIPES 71
NN+S + S
Sbjct: 109 NNIS-RVSCS 117
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 11/70 (15%), Positives = 25/70 (35%), Gaps = 2/70 (2%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLSMN 62
+ + L NN ++ + + YL+L N I+ ++ ++L N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 63 NLSGSIPESV 72
+ + V
Sbjct: 180 FIY-DVKGQV 188
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 3/62 (4%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ L NN +S + Q + L++N I G R+ +DL +N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 64 LS 65
+
Sbjct: 156 ID 157
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 21/92 (22%), Positives = 37/92 (40%), Gaps = 15/92 (16%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILS---------QLGEIPR- 53
+LR LE+ N L+ S+P L EL+ + + QL +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139
Query: 54 ---IDTVDLSMNNLSGSIPESVRKVPHLYVYG 82
+ + +S N L+ S+P ++ L+ Y
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELCKLWAYN 170
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 19/77 (24%), Positives = 36/77 (46%), Gaps = 11/77 (14%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSM 61
S L+ L + N L+ S+P ++L+E L +S N L+ L + ++ +
Sbjct: 220 PSGLKELIVSGNRLT-SLPVLPSELKE---LMVSGNR-----LTSLPMLPSGLLSLSVYR 270
Query: 62 NNLSGSIPESVRKVPHL 78
N L+ +PES+ +
Sbjct: 271 NQLT-RLPESLIHLSSE 286
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 19/79 (24%), Positives = 37/79 (46%), Gaps = 5/79 (6%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S+L+ L + N L+ S+P + L L+ + N + ++ L + TV+L N
Sbjct: 241 SELKELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 64 LSGSIPESVRKVPHLYVYG 82
LS +++R++ Y
Sbjct: 296 LSERTLQALREITSAPGYS 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 17/79 (21%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSM 61
+ VL +G + L+ ++P + + L + N+ L+ L P + T+++S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNN-----LTSLPALPPELRTLEVSG 90
Query: 62 NNLSGSIPESVRKVPHLYV 80
N L+ S+P + L +
Sbjct: 91 NQLT-SLPVLPPGLLELSI 108
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 10/92 (10%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
S L+ L + +N L+ S+P+ ++L +L N S+ + S L E+ +S N
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLP-ALPSGLKEL------IVSGNR 232
Query: 64 LSGSIPESVRKVPHLYVYGKNFDVEIPNTSEN 95
L+ S+P ++ L V G N +P
Sbjct: 233 LT-SLPVLPSELKELMVSG-NRLTSLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 16/92 (17%), Positives = 39/92 (42%), Gaps = 10/92 (10%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ + L + +N L+ S+P+ +L+ L +S N + + + + + +
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 64 LSGSIPESVRKVPHLYVYGKNFDVEIPNTSEN 95
L ++P + K L+++G N +P
Sbjct: 116 LP-ALPSGLCK---LWIFG-NQLTSLPVLPPG 142
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 18/79 (22%), Positives = 37/79 (46%), Gaps = 11/79 (13%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSMN 62
L+ L + +N L+ S+P+ ++L + L +N L+ L + + +S N
Sbjct: 141 PGLQELSVSDNQLA-SLPALPSELCK---LWAYNNQ-----LTSLPMLPSGLQELSVSDN 191
Query: 63 NLSGSIPESVRKVPHLYVY 81
L+ S+P ++ L+ Y
Sbjct: 192 QLA-SLPTLPSELYKLWAY 209
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 14/77 (18%), Positives = 27/77 (35%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +L+VL+L + L L+ L L+ N I L + + +
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 62 NNLSGSIPESVRKVPHL 78
NL+ + + L
Sbjct: 110 TNLASLENFPIGHLKTL 126
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ S L L L N + + L L L ++ +G + + ++++
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 62 NNL-SGSIPESVRKVPHL 78
N + S +PE + +L
Sbjct: 134 NLIQSFKLPEYFSNLTNL 151
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 19/74 (25%), Positives = 31/74 (41%), Gaps = 3/74 (4%)
Query: 1 MNCSKLRVLELGNNLLS--GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVD 58
++ L L+L N LS G L YL+LS N + + S + +++ +D
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 402
Query: 59 LSMNNLSGSIPESV 72
+NL SV
Sbjct: 403 FQHSNLKQMSEFSV 416
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 13/78 (16%), Positives = 33/78 (42%), Gaps = 2/78 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI-LSQLGEIPRIDTVDLS 60
+ L+ L+L N + ++ S L++L +L+ H+++ S + + +D+S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 61 MNNLSGSIPESVRKVPHL 78
+ + + L
Sbjct: 430 HTHTRVAFNGIFNGLSSL 447
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 2/72 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLS 60
+ L L++ + + N L L L ++ NS L E+ + +DLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 61 MNNLSGSIPESV 72
L + +
Sbjct: 479 QCQLE-QLSPTA 489
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 14/69 (20%), Positives = 22/69 (31%), Gaps = 2/69 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
L L+L L + N L L LN++ N + + + + L
Sbjct: 468 ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 61 MNNLSGSIP 69
N S P
Sbjct: 527 TNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 2 NCSKLRVLELGNNLL-SGSIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRID-T 56
+ L+ L + +NL+ S +P + L L +L+LS N SI L L ++P ++ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 57 VDLSMNNLSGSIPESVRKVPHL 78
+DLS+N ++ I K L
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRL 202
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 14/75 (18%), Positives = 24/75 (32%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
+ L+L N L EL L+LS I + + T+ L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 64 LSGSIPESVRKVPHL 78
+ + + L
Sbjct: 88 IQSLALGAFSGLSSL 102
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 45/234 (19%), Positives = 84/234 (35%), Gaps = 47/234 (20%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR- 229
F + +G G +G V + + + K A+K + + ++ EA +L +I++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDD 92
Query: 230 ----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNVVKGMCHA 284
NIVK +G ++ M LI+E + SL+ ++ + ++ K + A
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLY--CIEILKA 149
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT------ 338
L+YL + + H D+ N+LL+ +
Sbjct: 150 LNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 339 ----------YGYI------APE----LAYTMVVTEKCDVYSFGVVALEVLMGK 372
I APE L + + D++SFG V E+ G
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDV----SSDMWSFGCVLAELYTGS 256
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 8/82 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLS 60
L VL+ +N L ++ + L L L L +N + + L PR+ ++L
Sbjct: 484 ALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541
Query: 61 MNNLSGSIPESVRKV----PHL 78
N+L ++ P +
Sbjct: 542 GNSLC-QEEGIQERLAEMLPSV 562
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 3/64 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L+L +N L ++P + L+ L L S N++ + + + +PR+ + L
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCN 517
Query: 62 NNLS 65
N L
Sbjct: 518 NRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 16/70 (22%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
M + +RVL L + L+ + + +L + +L+LSHN + + L + ++ + S
Sbjct: 438 MEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494
Query: 61 MNNLSGSIPE 70
N L ++
Sbjct: 495 DNALE-NVDG 503
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 7/77 (9%)
Query: 2 NCSKLRVLELGNNLLSGSI-------PSEINKLQELNYLNLSHNSINGKILSQLGEIPRI 54
L L+L +N G P + LQ L N + +G + ++
Sbjct: 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230
Query: 55 DTVDLSMNNLSGSIPES 71
+DLS N+L +
Sbjct: 231 QGLDLSHNSLRDAAGAP 247
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 5/69 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+L+ L+L +N L + + + +LN LNLS + ++ L ++ +DLS
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLS 282
Query: 61 MNNLSGSIP 69
N L P
Sbjct: 283 YNRLD-RNP 290
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI----LSQLGEIPRIDTVDLSM 61
L+VL + ++ L+ L+LS N G+ + P + + L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 62 NNLS 65
+
Sbjct: 211 AGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 3/69 (4%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVD 58
+ S L+ L L N ++G+ P + +LN LNL + S + L E+ +
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPG 150
Query: 59 LSMNNLSGS 67
L + +++ +
Sbjct: 151 LKVLSIAQA 159
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 6/70 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
KL L L N L+ + ++ +L L+ + I S +G+IP ++ +
Sbjct: 316 QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAE 370
Query: 62 NNLSGSIPES 71
++P+
Sbjct: 371 GQTI-TMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 6/64 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L +N L+ ++ + L +L YLN N + +SQ P + ++ +
Sbjct: 83 QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQN---PLLTYLNCAR 136
Query: 62 NNLS 65
N L+
Sbjct: 137 NTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 16/70 (22%), Positives = 33/70 (47%), Gaps = 7/70 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++L L+ N ++ + +++ + LN LN N+I L+Q ++ +D S
Sbjct: 168 PQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLNQN---IQLTFLDCSS 221
Query: 62 NNLSGSIPES 71
N L+ I +
Sbjct: 222 NKLT-EIDVT 230
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 6/64 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L L+ +N L+ I + L +L Y + S N + +S L ++ T+
Sbjct: 210 QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTL---SKLTTLHCIQ 263
Query: 62 NNLS 65
+L
Sbjct: 264 TDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 11/70 (15%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L +N ++ ++ +++ L YL N + ++ L ++ ++
Sbjct: 62 KLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTPL---TKLTYLNCDT 115
Query: 62 NNLSGSIPES 71
N L+ + S
Sbjct: 116 NKLT-KLDVS 124
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 5/64 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ ++L L+ N + + +L L+ S N I +SQ ++ ++
Sbjct: 146 HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQN---KLLNRLNCDT 200
Query: 62 NNLS 65
NN++
Sbjct: 201 NNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L+ N+ ++ + I KL L L + N+I LSQ + +
Sbjct: 40 QLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTLDLSQN---TNLTYLACDS 94
Query: 62 NNLSGSIP 69
N L+ ++
Sbjct: 95 NKLT-NLD 101
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 4/78 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N L ++L N L I K+Q L L +S+N + + IP + +DLS
Sbjct: 252 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 61 MNNLSGSIPESVRKVPHL 78
N+L + + + L
Sbjct: 310 HNHLL-HVERNQPQFDRL 326
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 5/96 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L+VL+L +N L + + L L L HNSI + +L + + LS
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL--KLSTHHTLKNLTLSH 354
Query: 62 NNLSG-SIPESVRKVPHLYVYGKNFDVEIPNTSENS 96
N+ S+ R V V + +I E+
Sbjct: 355 NDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHG 390
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 17/75 (22%), Positives = 30/75 (40%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
++ L +G N + +P + + L L L N S+ I P++ T+
Sbjct: 97 YAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTL 152
Query: 58 DLSMNNLSGSIPESV 72
+S NNL I +
Sbjct: 153 SMSNNNLE-RIEDDT 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 17/71 (23%), Positives = 28/71 (39%), Gaps = 6/71 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L+ +N ++ + + EL L L HN++ + L P + VDLS
Sbjct: 209 IPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSY 263
Query: 62 NNLSGSIPESV 72
N L I
Sbjct: 264 NELE-KIMYHP 273
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 10/75 (13%), Positives = 30/75 (40%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ +++ N+ + +P+ + + +++ LNL+ I+ + I +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQKL 104
Query: 58 DLSMNNLSGSIPESV 72
+ N + +P V
Sbjct: 105 YMGFNAIR-YLPPHV 118
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 16/71 (22%), Positives = 35/71 (49%), Gaps = 9/71 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L+ L+L +N L+ + ++ + L + N+S+N LS L ++ +D S
Sbjct: 169 ATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL-----LSTLAIPIAVEELDASH 220
Query: 62 NNLSGSIPESV 72
N+++ + V
Sbjct: 221 NSIN-VVRGPV 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 43/240 (17%), Positives = 80/240 (33%), Gaps = 63/240 (26%)
Query: 172 FHIKYCIGTGGYGSVYRA--RLPSGKVVALK------KLHRSETEELASLESFGNEARLL 223
+ I +G G +G V VALK K A+ E +L
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE------AARL----EINVL 70
Query: 224 SQIRHR------NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVN 276
+I+ + V + + M + +E + + F L+ + + L + +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHM- 128
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-----------RLL 325
+CHAL +LH + + H D+ N+L + + + + R+
Sbjct: 129 -AYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 326 NFDSS---NRTLLAGTYGYI------APE----LAYTMVVTEKCDVYSFGVVALEVLMGK 372
+F S+ + + PE L + CDV+S G + E G
Sbjct: 185 DFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQ----PCDVWSIGCILFEYYRGF 236
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 19/98 (19%), Positives = 40/98 (40%), Gaps = 8/98 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
C+ L+VL L ++ ++ +I + L L +L+LS N ++ S G + + ++L
Sbjct: 48 ACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106
Query: 61 MNNLSGSIPESV-----RKVPHLYVYGKNFDVEIPNTS 93
N ++ + + L + EI
Sbjct: 107 GNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 11/87 (12%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN 63
L VL++ NN L S + +LQEL +S N + K L P + + +S N
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLPRLQELY---ISRNKL--KTLPDASLFPVLLVMKISRNQ 484
Query: 64 LSGSIPESV----RKVPHLYVYGKNFD 86
L S+P+ + + ++++ +D
Sbjct: 485 LK-SVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 11/84 (13%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVD 58
L L++ N +P +++ +LNLS + I L + D
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL------D 437
Query: 59 LSMNNLSGSIPESVRKVPHLYVYG 82
+S NNL S + ++ LY+
Sbjct: 438 VSNNNLD-SFSLFLPRLQELYISR 460
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 15/78 (19%), Positives = 27/78 (34%), Gaps = 1/78 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSE-INKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N + L+ L +GN I L LN L + S+ L I I + L
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 61 MNNLSGSIPESVRKVPHL 78
++ + + + +
Sbjct: 181 LSESAFLLEIFADILSSV 198
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 17/68 (25%), Positives = 32/68 (47%), Gaps = 5/68 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQ---LGEIPRIDTV 57
K++ + + N+ + +P L+ L +L+LS N + + L G P + T+
Sbjct: 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 58 DLSMNNLS 65
LS N+L
Sbjct: 367 VLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 12/73 (16%), Positives = 27/73 (36%), Gaps = 4/73 (5%)
Query: 2 NCSKLRVLELGNNLLS--GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
L+ L L N L + L+ L L++S N+ + + ++ ++L
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 60 SMNNLSGSIPESV 72
S + + +
Sbjct: 418 SSTGIR-VVKTCI 429
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 9/65 (13%), Positives = 25/65 (38%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L LE+ L + ++++++L L + + + + ++L
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 62 NNLSG 66
NL+
Sbjct: 206 TNLAR 210
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-06
Identities = 16/78 (20%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
S ++ L L + G + ++ +EL +L+ + + ++ L ++ ++ ++LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 61 MNNLSGSIPESVRKVPHL 78
N +SG + K P+L
Sbjct: 73 DNRVSGGLEVLAEKCPNL 90
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLS 60
+KL+ LEL +N +SG + K L +LNLS N I + L ++ + ++DL
Sbjct: 62 KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
Query: 61 MN 62
Sbjct: 122 NC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 22/78 (28%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L L N L+ SI + + KL +L L LS N ++G + + P + ++LS
Sbjct: 40 EFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 62 NNLSG-SIPESVRKVPHL 78
N + S E ++K+ +L
Sbjct: 98 NKIKDLSTIEPLKKLENL 115
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
S L+VL L +N L+ S+P + + L L L+L+ N + +LS ++ +D+S
Sbjct: 478 GLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDIS 534
Query: 61 MNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTS 93
N L P+ + L + F E ++
Sbjct: 535 RNQLLAPNPDVFVSLSVLDITHNKFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 18/81 (22%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQ--LGEIPRIDTVD 58
N LR+L+LG++ + + + L L L L ++ +L + + +D
Sbjct: 71 NLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129
Query: 59 LSMNNLSG-SIPESVRKVPHL 78
LS N + + S K+ L
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSL 150
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 15/71 (21%), Positives = 28/71 (39%), Gaps = 1/71 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+L++LELG+ +I E L L L+L + I + + + L
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 61 MNNLSGSIPES 71
LS ++ +
Sbjct: 106 FCGLSDAVLKD 116
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 18/77 (23%), Positives = 34/77 (44%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
L+VL L N ++ L L LNLS+N + S +P++ +DL
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 62 NNLSGSIPESVRKVPHL 78
N+++ ++ + + L
Sbjct: 348 NHIAIIQDQTFKFLEKL 364
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
N L L+L N + + KL L ++ S N + L L + +
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL-QGKTLSFF 179
Query: 58 DLSMNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENS 96
L+ N+L + K + + +N +EI + S N
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPF---RNMVLEILDVSGNG 215
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 17/78 (21%), Positives = 33/78 (42%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ S +R L+L + + L++L LNL++N IN + + ++LS
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322
Query: 61 MNNLSGSIPESVRKVPHL 78
N L + +P +
Sbjct: 323 YNLLGELYSSNFYGLPKV 340
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ KL+ L L +N +S I + L +L L L +N I ++ L + ++DT+ L
Sbjct: 107 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 162
Query: 62 NNLS 65
N +S
Sbjct: 163 NQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 23/102 (22%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL L L +N +S I + L +L L LS N I L L + +D ++L
Sbjct: 151 RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFS 206
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKK 103
+ KN D + S ++K
Sbjct: 207 QECLNKPINHQSNLVVPNTV-KNTDGSLVTPEIISDDGDYEK 247
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L N L+ I + L+ L +L L N I K LS L ++ ++ ++ L
Sbjct: 63 YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEH 118
Query: 62 NNLS 65
N +S
Sbjct: 119 NGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 17/64 (26%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N L L L N + + S + L++L L+L HN I ++ L +P+++++ L
Sbjct: 85 NLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGN 140
Query: 62 NNLS 65
N ++
Sbjct: 141 NKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 9/64 (14%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ L ++ ++ N+L ++ + +++ I K + + +P + + L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 74
Query: 62 NNLS 65
N L+
Sbjct: 75 NKLT 78
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 4/76 (5%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMN 62
L+ L++ N +S + + L LN+S N + I L PRI +DL N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431
Query: 63 NLSGSIPESVRKVPHL 78
+ SIP+ V K+ L
Sbjct: 432 KIK-SIPKQVVKLEAL 446
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 22/74 (29%), Positives = 34/74 (45%), Gaps = 12/74 (16%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ SKLR+L + +N + + + QEL YL+LSHN I+ L +
Sbjct: 43 SLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL------ 95
Query: 58 DLSMNNLSGSIPES 71
DLS N ++P
Sbjct: 96 DLSFNAFD-ALPIC 108
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 20/75 (26%), Positives = 34/75 (45%), Gaps = 6/75 (8%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEI----PRIDTV 57
S L+ NNLL+ ++ L EL L L N + K LS++ E+ + +
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL--KELSKIAEMTTQMKSLQQL 379
Query: 58 DLSMNNLSGSIPESV 72
D+S N++S +
Sbjct: 380 DISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDLS 60
+++VL+L +N + SIP ++ KL+ L LN++ N S+ I +L + + L
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL---TSLQKIWLH 476
Query: 61 MNNL 64
N
Sbjct: 477 TNPW 480
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 38/240 (15%), Positives = 87/240 (36%), Gaps = 63/240 (26%)
Query: 172 FHIKYCIGTGGYGSVYRA--RLPSGKVVALK------KLHRSETEELASLESFGNEARLL 223
+ I +G G +G V G+ VA+K + A+ E ++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE------AARS----EIQVL 65
Query: 224 SQIRHR------NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVN 276
+ V++ + H + +++E + + S + ++ LD +++
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKM- 123
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-----------RLL 325
+C ++++LH + + H D+ N+L + + +++
Sbjct: 124 -AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 326 NFDSS---NRTLLAGTYGYI------APE----LAYTMVVTEKCDVYSFGVVALEVLMGK 372
+F S+ + + APE L ++ CDV+S G + +E +G
Sbjct: 180 DFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQ----PCDVWSIGCILIEYYLGF 231
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 19/81 (23%), Positives = 35/81 (43%), Gaps = 5/81 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ L VL L NN + + + +L L LS N +++ ++P++ +
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLL 168
Query: 58 DLSMNNLSGSIPESVRKVPHL 78
DLS N L ++K+P
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAW 189
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 17/75 (22%), Positives = 32/75 (42%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
LR L+L +N L ++ + + LQ L L L +N ++ + ++ +
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM---AQLQKL 141
Query: 58 DLSMNNLSGSIPESV 72
LS N +S P +
Sbjct: 142 YLSQNQIS-RFPVEL 155
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 19/80 (23%), Positives = 36/80 (45%), Gaps = 10/80 (12%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
+ L L L +N L+ I SE + L YL+LS N +++ + S L ++ + L
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL---QALEVLLL 119
Query: 60 SMNNLSGSIPESV-RKVPHL 78
N++ + + + L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQL 138
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/64 (26%), Positives = 32/64 (50%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S L+VL L N ++ +I S + L L YL++ + + L+ L + ++ T+
Sbjct: 127 GLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADD 182
Query: 62 NNLS 65
N +S
Sbjct: 183 NKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 12/64 (18%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ L+L + ++ P + L L L L N I +S L + + + +
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGN 160
Query: 62 NNLS 65
+S
Sbjct: 161 AQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N SKL L+ +N +S I S + L L ++L +N I+ +S L + V L+
Sbjct: 171 NLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
Query: 62 NNLSGSIPESVRKVPHLYVYGKNFDVEIPNTS 93
++ + V I +
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/64 (25%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L LEL +N ++ + + + L ++ L LS N + K +S + + I T+DL+
Sbjct: 61 YLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTS 116
Query: 62 NNLS 65
++
Sbjct: 117 TQIT 120
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 15/77 (19%), Positives = 32/77 (41%), Gaps = 3/77 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + R L+L + I + L + + ++ S N I + L + R+ T+ ++
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 73
Query: 62 NNLSGSIPESVRKVPHL 78
N + + +P L
Sbjct: 74 NRICRIGEGLDQALPDL 90
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 1/62 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLS 60
+L+ L + NN + L +L L L++NS+ L L + + + +
Sbjct: 62 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 121
Query: 61 MN 62
N
Sbjct: 122 RN 123
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 22/93 (23%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ L L L N L SI S + L +L L+LS+N ++ + L P + +
Sbjct: 321 GLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL---PNLKEL 376
Query: 58 DLSMNNLSGSIPESV----RKVPHLYVYGKNFD 86
L N L S+P+ + + ++++ +D
Sbjct: 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQ--LGEIPRIDTVDLS 60
S L +L+L N + + N L L L L+ +++G +LS + ++ + L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 61 MNNLSGSIPESV 72
NN+ P S
Sbjct: 138 DNNIKKIQPASF 149
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 17/80 (21%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKI-------LSQLGEIP 52
+ S ++ +L + + ++ + + +L L L+ N IN KI L+ L ++
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL- 328
Query: 53 RIDTVDLSMNNLSGSIPESV 72
+LS N L SI +
Sbjct: 329 -----NLSQNFLG-SIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 8/74 (10%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
L+ L++ I + L L L L +N + + L ++ + L
Sbjct: 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGL---ANLEVLTL 110
Query: 60 SMNNL-SGSIPESV 72
+ NL + +
Sbjct: 111 TQCNLDGAVLSGNF 124
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ KL+ L L +N +S I + L +L L L +N I ++ L + ++DT+ L
Sbjct: 110 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 165
Query: 62 NNLS 65
N +S
Sbjct: 166 NQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 18/77 (23%), Positives = 29/77 (37%), Gaps = 4/77 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+KL L L +N +S I + L +L L LS N I+ L L + +D ++L
Sbjct: 154 RLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
Query: 62 NNLSGSIPESVRKVPHL 78
+
Sbjct: 210 QECLNKPINHQSNLVVP 226
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 17/64 (26%), Positives = 30/64 (46%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L L N L+ I + L+ L +L L N + K LS L ++ ++ ++ L
Sbjct: 66 YLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEH 121
Query: 62 NNLS 65
N +S
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 9/64 (14%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ L ++ ++ N+L ++ + +++ I K + + +P + + L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 62 NNLS 65
N L+
Sbjct: 78 NKLT 81
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 12/74 (16%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
S+LRVL L +N + S+ + Q+L YL++SHN +I+ ++ L +
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHL------ 126
Query: 58 DLSMNNLSGSIPES 71
DLS N+ +P
Sbjct: 127 DLSFNDFD-VLPVC 139
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 9/50 (18%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPR 53
K++VL+L NN + SIP ++ LQ L LN++ N QL +P
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN--------QLKSVPD 490
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 18/78 (23%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 2 NCSKLRVLEL-GNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ +R L L G I + L +L+L + + +S L ++P++ ++LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 61 MNNLSGSIPESVRKVPHL 78
N + G + K+P+L
Sbjct: 80 ENRIFGGLDMLAEKLPNL 97
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 1/62 (1%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLS 60
KL+ LEL N + G + KL L +LNLS N + L L ++ + ++DL
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128
Query: 61 MN 62
Sbjct: 129 NC 130
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 18/72 (25%), Positives = 36/72 (50%), Gaps = 4/72 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
SKL L LG+N + I + + L L L+L +N ++ ++ + L ++ + V L
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 61 MNNLSGSIPESV 72
NN++ + +
Sbjct: 273 TNNIT-KVGVND 283
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 18/85 (21%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING------KILSQLGEIPRID 55
LR L L NN LS +P+ + L+ L + L N+I + + +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 56 TVDLSMNNLS-GSIPESV-RKVPHL 78
+ L N + + + R V
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 22/79 (27%), Positives = 32/79 (40%), Gaps = 9/79 (11%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
L L L +N + +I E + +L L L HN I LS L P + + L
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL---PTLRELHL 248
Query: 60 SMNNLSGSIPESVRKVPHL 78
N LS +P + + L
Sbjct: 249 DNNKLS-RVPAGLPDLKLL 266
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 31/164 (18%), Positives = 64/164 (39%), Gaps = 30/164 (18%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-R 229
+ + IG+G +G +Y + +G+ VA+K + L E+++ ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLH---IESKIYKMMQGGV 65
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEM--GSL-----FCVLRTDEEAVGLDWAKRVNVVKGMC 282
I + ++ ME+ SL FC + + V + + M
Sbjct: 66 GIPTIRWCGAEGDYNVMV---MELLGPSLEDLFNFCSRKFSLKTV-------LLLADQMI 115
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR 323
+ Y+H +HRD+ +N L+ ++ DFG+A+
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ L +L + NN L SI + L +L L+L N I L + +++ +DL+
Sbjct: 126 HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTG 181
Query: 62 NNLS 65
Sbjct: 182 QKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 9/66 (13%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELN--YLNLSHNSINGKILSQLGEIPRIDTVDL 59
+ +KL L + N L +N + L L +N + + L + ++ + +
Sbjct: 83 DLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSI 135
Query: 60 SMNNLS 65
N L
Sbjct: 136 RNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 15/64 (23%), Positives = 31/64 (48%), Gaps = 4/64 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
S ++ N+ + S+ + + L L+LSHN I LS L ++ +++ + ++
Sbjct: 39 ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNR 94
Query: 62 NNLS 65
N L
Sbjct: 95 NRLK 98
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 17/75 (22%), Positives = 26/75 (34%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+L L L L + + L L YL L N ++ L + +
Sbjct: 103 GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL---GNLTHL 158
Query: 58 DLSMNNLSGSIPESV 72
L N +S S+PE
Sbjct: 159 FLHGNRIS-SVPERA 172
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 16/80 (20%), Positives = 32/80 (40%), Gaps = 9/80 (11%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
+ L L+L +N S+ + L L+ L+L + + L + + L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL---AALQYLYL 136
Query: 60 SMNNLSGSIPESV-RKVPHL 78
N L ++P+ R + +L
Sbjct: 137 QDNALQ-ALPDDTFRDLGNL 155
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN----SINGKILSQLGEIPRIDT 56
C L +L L +N+L+ I + L L L+LS N S++ L R+ T
Sbjct: 54 ACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL---GRLHT 109
Query: 57 VDLSMNNLSGSIPESV 72
+ L L + +
Sbjct: 110 LHLDRCGLQ-ELGPGL 124
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 19/81 (23%), Positives = 33/81 (40%), Gaps = 11/81 (13%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSM 61
++ VLE+ N L S+P L+ YL+ N LS L + +D+
Sbjct: 79 PPQITVLEITQNALI-SLPELPASLE---YLDACDNR-----LSTLPELPASLKHLDVDN 129
Query: 62 NNLSGSIPESVRKVPHLYVYG 82
N L+ +PE + ++
Sbjct: 130 NQLT-MLPELPALLEYINADN 149
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 19/80 (23%), Positives = 35/80 (43%), Gaps = 10/80 (12%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDLSMN 62
++ L+L LS S+P + ++ L ++ N+ L L ++ +D N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNA-----LISLPELPASLEYLDACDN 110
Query: 63 NLSGSIPESVRKVPHLYVYG 82
LS ++PE + HL V
Sbjct: 111 RLS-TLPELPASLKHLDVDN 129
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 15/79 (18%), Positives = 31/79 (39%), Gaps = 8/79 (10%)
Query: 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTV-DL 59
+ L VL + NN L+ +P L+ L++S N + + + +
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESLEA---LDVSTNLLESLPAVPVRNHHSEETEIFFRC 214
Query: 60 SMNNLSGSIPESVRKVPHL 78
N ++ IPE++ +
Sbjct: 215 RENRIT-HIPENILSLDPT 232
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 13/77 (16%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDLSM 61
+ L + NN L+ +P L+ L+ + +N + ++ L + D+S
Sbjct: 140 ALLEYINADNNQLT-MLPELPTSLEVLS---VRNNQLTFLPELPESLEAL------DVST 189
Query: 62 NNLSGSIPESVRKVPHL 78
N L S+P + H
Sbjct: 190 NLLE-SLPAVPVRNHHS 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 52/179 (29%)
Query: 178 IGTGGYGSVYRARLPSGKVVALK-----KLHRSETEEL---------ASLESFGNEARLL 223
IG GG+G +Y A + S + V K+ S+ L A+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEM---G--------------SLFCVLRTDEEA 266
++++ + K +G LH K Y +M M G S VL+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL---- 157
Query: 267 VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE--AFVADFGVAR 323
+ R + L Y+H VH DI ++N+LLN + ++ D+G+A
Sbjct: 158 -----SLR------ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 31/174 (17%), Positives = 60/174 (34%), Gaps = 48/174 (27%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-R 229
F + IG G +G + + L + + VA+K + E R Q+
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGD 65
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEM-G--------------SLFCVLRTDEEAVGLDWAKR 274
I ++Y F K ++ +E+ G SL VL +
Sbjct: 66 GIPQVYYFGPCGKYNAMV---LELLGPSLEDLFDLCDRTFSLKTVLMIAIQ--------- 113
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 323
+ + Y+H +++RD+ N L+ ++ + DF +A+
Sbjct: 114 ------LISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 16/79 (20%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
L L L N ++ + + L L L LS N +++ L+ P + + L
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT---PHLRELHL 247
Query: 60 SMNNLSGSIPESVRKVPHL 78
+ N L +P + ++
Sbjct: 248 NNNKLV-KVPGGLADHKYI 265
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ L L L N +S ++ + L L+L++N + K+ L + I V L
Sbjct: 214 GLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271
Query: 61 MNNLSGSIPESV 72
NN+S +I +
Sbjct: 272 NNNIS-AIGSND 282
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/75 (21%), Positives = 32/75 (42%), Gaps = 8/75 (10%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
S L VL++ N + +I +L+ L +L+LS ++ + L + +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL---SSLQVL 204
Query: 58 DLSMNNLSGSIPESV 72
++S NN S+
Sbjct: 205 NMSHNNFF-SLDTFP 218
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 13/84 (15%), Positives = 34/84 (40%), Gaps = 10/84 (11%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSE--INKLQELNYLNLSHN---SINGKILSQLGEIPRID 55
+ +L L+ ++ L + L+ L YL++SH I + L ++
Sbjct: 98 LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL---SSLE 153
Query: 56 TVDLSMNNLSGSIPESV-RKVPHL 78
+ ++ N+ + + ++ +L
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNL 177
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 13/74 (17%), Positives = 34/74 (45%), Gaps = 7/74 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG---EIPRIDTVD 58
+ L+ L+L N + ++ S L++L +L+ H+++ K +S+ + + +D
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLD 132
Query: 59 LSMNNLSGSIPESV 72
+S + +
Sbjct: 133 ISHTHTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 18/75 (24%), Positives = 31/75 (41%), Gaps = 3/75 (4%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILS--QLGEIPRIDTVDLSMNN 63
LEL +N L +KL +L L+LS N ++ K + +DLS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 64 LSGSIPESVRKVPHL 78
+ ++ + + L
Sbjct: 90 VI-TMSSNFLGLEQL 103
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 32/164 (19%), Positives = 68/164 (41%), Gaps = 30/164 (18%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HR 229
F + IG+G +G +Y + + + VA+K + + L E+++ ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLL---YESKIYRILQGGT 63
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEM--GSL-----FCVLRTDEEAVGLDWAKRVNVVKGMC 282
I + F + L+ M++ SL FC + + V + + M
Sbjct: 64 GIPNVRWFGVEGDYNVLV---MDLLGPSLEDLFNFCSRKLSLKTV-------LMLADQMI 113
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR 323
+ + ++H +HRDI +N L+ + ++ DFG+A+
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 22/91 (24%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIP--------RI 54
+L+ L L N L ++P + +L L+L++N L E+P +
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANN--------NLTELPAGLLNGLENL 174
Query: 55 DTVDLSMNNLSGSIPESV---RKVPHLYVYG 82
DT+ L N+L +IP+ +P +++G
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 21/72 (29%), Positives = 32/72 (44%), Gaps = 8/72 (11%)
Query: 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDLS 60
L L+L +N L S+P L L L++S N S+ L LGE + + L
Sbjct: 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE---LQELYLK 132
Query: 61 MNNLSGSIPESV 72
N L ++P +
Sbjct: 133 GNELK-TLPPGL 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 20/76 (26%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSI----NGKILSQLGEIPRIDT 56
S L+ L L+ S+ + L+ L LN++HN I + S L ++
Sbjct: 98 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL---TNLEH 153
Query: 57 VDLSMNNLSGSIPESV 72
+DLS N + SI +
Sbjct: 154 LDLSSNKIQ-SIYCTD 168
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 2 NCSKLRVLELGNNLLSGSIPSE--INKLQELNYLNLSHN---SINGKILSQLGEIPRID- 55
+ L+ L + +NL+ S + L L +L+LS N SI L L ++P ++
Sbjct: 122 HLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 56 TVDLSMNNLSGSIPESVRKVPHL 78
++DLS+N ++ I K L
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRL 202
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ +L+VL+L + +I L L+ L L+ N S+ S L + +
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL---SSLQKL 105
Query: 58 DLSMNNLSGSIPESV 72
NL+ S+
Sbjct: 106 VAVETNLA-SLENFP 119
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSE-INKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
L LE+ N I + L L L + ++ I L + +
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL---ASLVEL 271
Query: 58 DLSMNNLSGSIPESV 72
+L+ NNLS S+P +
Sbjct: 272 NLAHNNLS-SLPHDL 285
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 18/80 (22%), Positives = 29/80 (36%), Gaps = 7/80 (8%)
Query: 2 NCSKLRVLELGN-NLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
L L+LG L I L L YLNL +I + L + ++ +++
Sbjct: 169 RVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEM 225
Query: 60 SMNNLSGSIPESV-RKVPHL 78
S N+ I + L
Sbjct: 226 SGNHFP-EIRPGSFHGLSSL 244
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 17/75 (22%), Positives = 32/75 (42%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
+ LR L L N +S +I + ++L L + L + L + +
Sbjct: 246 HLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL---NYLRVL 301
Query: 58 DLSMNNLSGSIPESV 72
++S N L+ ++ ESV
Sbjct: 302 NVSGNQLT-TLEESV 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQL-GEIPRIDTVDL 59
N LR L L +N L IP + L L L++S N I +L + ++ + ++++
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135
Query: 60 SMNNLSGSIPESV 72
N+L I
Sbjct: 136 GDNDLV-YISHRA 147
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
+ L L L L+ SIP+E + L L L L H +IN + R+ +++S
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 61 MNNLSGSIPESVRKVPHL 78
++ + +L
Sbjct: 209 HWPYLDTMTPNCLYGLNL 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 25/80 (31%), Positives = 38/80 (47%), Gaps = 7/80 (8%)
Query: 2 NCSKLRVLELG-NNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDL 59
LR L+LG LS I L L YLNL+ ++ + L + ++D +DL
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDL 214
Query: 60 SMNNLSGSIPESV-RKVPHL 78
S N+LS +I + + HL
Sbjct: 215 SGNHLS-AIRPGSFQGLMHL 233
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 9/75 (12%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTV 57
KL L+L N LS +I L L L + + I L + +
Sbjct: 205 PLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL---QSLVEI 260
Query: 58 DLSMNNLSGSIPESV 72
+L+ NNL+ +P +
Sbjct: 261 NLAHNNLT-LLPHDL 274
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGE-IPRIDTVDLS 60
+ L L N + I S ++ ++ L L+L N I K + L ++ + +S
Sbjct: 46 TLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI--KKIENLDAVADTLEELWIS 101
Query: 61 MNNLS 65
N ++
Sbjct: 102 YNQIA 106
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 40.7 bits (94), Expect = 7e-04
Identities = 11/82 (13%), Positives = 33/82 (40%), Gaps = 7/82 (8%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI---NKLQELNYLNLSHNSINGK----ILSQLGEIPR 53
L+ L + + + + L +L +++S + + +L + +I
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 54 IDTVDLSMNNLSGSIPESVRKV 75
+ +++ N LS + + ++K
Sbjct: 309 LKFINMKYNYLSDEMKKELQKS 330
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 9/73 (12%)
Query: 4 SKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHN---SINGKILSQLGEIPRIDTVDL 59
KLR ++L NN +S + + L+ LN L L N + + L + + L
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGL---FSLQLLLL 111
Query: 60 SMNNLSGSIPESV 72
+ N ++ +
Sbjct: 112 NANKIN-CLRVDA 123
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.47 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.43 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.35 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.35 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.33 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.33 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.32 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.31 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.3 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.29 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.28 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.26 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.25 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.22 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.21 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.21 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.2 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.2 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.18 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.17 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.17 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.16 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.13 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.1 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.1 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.1 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.1 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.08 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.08 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.07 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.06 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.05 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.04 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.04 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.03 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.03 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.02 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.02 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.02 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.02 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.01 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.01 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.01 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.01 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.01 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.0 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.99 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.99 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.99 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.99 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.98 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.98 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.97 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.97 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.93 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.93 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.93 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.93 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.92 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.92 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.92 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.91 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.91 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.9 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.9 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.9 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.89 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.88 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.87 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.86 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.86 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.84 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.8 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.79 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.79 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.78 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.76 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.75 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.74 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.72 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.69 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.68 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.68 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.67 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.67 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.67 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.6 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.59 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.59 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.59 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.58 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.54 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.53 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.45 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.35 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.17 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.95 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.72 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.66 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.66 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.55 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.53 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.97 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.66 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.27 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.52 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.15 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 94.84 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.73 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.35 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.66 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.06 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.47 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.9 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.76 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.55 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.19 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=435.71 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=205.9
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||+||+|++. +++.||||+++..... ..++|.+|++++++++|||||+++|+|.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 56788899999999999999864 4788999999865433 45789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
.+||||||++|+|.++++.... ..+++|.+++.|+.|||.||+||| +.+|+||||||+|||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCC
Confidence 9999999999999999976432 235899999999999999999999 7799999999999999999
Q ss_pred CCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcc
Q 012219 312 LEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKN 388 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 388 (468)
+.+||+|||+++....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||......... .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-~-- 271 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-D-- 271 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH-H--
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH-H--
Confidence 9999999999987643322 2234579999999999999999999999999999999999 99999865432211 1
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
.+.+...+..+...+ + .+.+++.+||+.||++||||+||++.|+.+.+.|
T Consensus 272 -~i~~g~~~~~p~~~~----~---~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 272 -CITQGRELERPRACP----P---EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -HHHHTCCCCCCTTCC----H---HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -HHHcCCCCCCccccc----H---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 011111111222222 2 2677999999999999999999999999886654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-58 Score=432.47 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=208.8
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||+||+|++. ++..||||+++..... ..++|.+|++++++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH---HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56888999999999999999753 4788999999865433 35789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE 313 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~ 313 (468)
.++|||||++|+|.++++... ....++|.+++.++.|||.||+||| +++|+||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCc
Confidence 999999999999999997642 2346999999999999999999999 779999999999999999999
Q ss_pred eEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccc
Q 012219 314 AFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIK 390 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~ 390 (468)
+||+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||...........
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~---- 242 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---- 242 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 9999999998764332221 22468999999999999999999999999999999999 9999986543211110
Q ss_pred cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
+.....+..+...+ + .+.+++.+||+.||++||||++|...|++..+
T Consensus 243 i~~~~~~~~p~~~~----~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVLQRPRTCP----Q---EVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccch----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00100111111121 2 26789999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-57 Score=425.91 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=203.0
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+++.+.+.||+|+||+||+|++++ .||||+++...... ...+.|.+|++++++++|||||+++|+|.+ +..+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578889999999999999999754 59999997554332 346789999999999999999999999865 4579999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|.++++.... .++|.+++.|+.|||.||+||| +.+||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999976433 4899999999999999999999 779999999999999999999999999999876432
Q ss_pred C--CCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 S--SNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
. .......||+.|||||++.. ..|+.++|||||||++|||+||+.||.............. .....|.+....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~ 263 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG--RGYASPDLSKLY 263 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--TTCCCCCSTTSC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh--cCCCCCCccccc
Confidence 2 22344689999999999864 4689999999999999999999999976543221111100 111122211111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .. ...+.+++.+||+.||++||||.+|++.|+....
T Consensus 264 ~-~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 264 K-NC---PKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp T-TS---CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c-cc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 11 1226779999999999999999999999887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=431.51 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=207.4
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.++.+.+.||+|+||+||+|.+. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 45677889999999999999863 4678999999755432 345789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
.++|||||++|+|.++|..... ...++|.+++.|+.|||.||+||| +.+||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence 9999999999999999965321 235899999999999999999999 779999999999999999
Q ss_pred CCCeEEeeccccccccCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.+||+|||+++...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...........
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~- 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM- 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH-
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 9999999999998764322 22334579999999999999999999999999999999999 8999986543211110
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
+.....+..+...+ ..+.+++.+||+.||++||||.+|++.|+..
T Consensus 260 ---i~~~~~~~~p~~~~-------~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ---IRNRQVLPCPDDCP-------AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHcCCCCCCcccch-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00000011111111 2267899999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=427.82 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=202.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||+||+|+. .+|+.||||++....... ...+.|.+|++++++++|||||++++++.+++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 6899999999999999999975 579999999998654432 34578999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||+||+|.+++...+ ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999997543 234789999999999999999999 789999999999999999999999999999876433
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||........... +...--+......+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~~~~~~~s---- 250 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSFPPVSLHYS---- 250 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCCCTTSC----
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCCCCCccCC----
Confidence 2233456799999999999999999999999999999999999999975432211110 00000111122122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .+.+++.+||+.||++|||++|++++
T Consensus 251 ~---~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 251 Y---DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 26679999999999999999999853
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=418.78 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=209.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4688899999999999999975 57999999999754433 2346789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999753 3899999999999999999999 779999999999999999999999999999987665
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ..+.+...+.+.. ...+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~----~~i~~~~~~~~~~--~~~~s 297 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM----KMIRDNLPPRLKN--LHKVS 297 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSSCCCCSC--GGGSC
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCCCCCCc--cccCC
Confidence 55566778999999999999999999999999999999999999999754322111 1111111122211 11111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
. .+.+++.+||+.||++|||++|++++ |..
T Consensus 298 ~---~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 298 P---SLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp H---HHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 2 26679999999999999999999864 444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=414.07 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=207.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999974 579999999998765544455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++||+|.+++...+ .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997643 3899999999999999999999 789999999999999999999999999999987533
Q ss_pred C--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 S--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||........ ...... .+..++...+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~----~~~~~p~~~s-- 258 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-FAKIIK----LEYDFPEKFF-- 258 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----TCCCCCTTCC--
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHc----CCCCCCcccC--
Confidence 2 234456899999999999999999999999999999999999999975432111 111000 1112222222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
. .+.+++.+||+.||++|||++|+.
T Consensus 259 --~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 259 --P---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --H---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --H---HHHHHHHHHccCCHhHCcChHHHc
Confidence 2 256799999999999999998864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=411.66 Aligned_cols=264 Identities=21% Similarity=0.314 Sum_probs=199.5
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 245 (468)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+++ ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4678889999999999999998 5899999999754322 122335666677899999999999998653 589
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD-----CTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
||||||++|+|.++++.. .++|..+++++.|+|.||+|||++ +.++|+||||||+|||++.++++||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999999754 389999999999999999999953 13499999999999999999999999999
Q ss_pred ccccccCCCCC----ceeccccccccccccccCC------CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh----
Q 012219 321 VARLLNFDSSN----RTLLAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD---- 386 (468)
Q Consensus 321 ~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~---- 386 (468)
+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||+.|+...........
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876543221 2235799999999998754 478899999999999999999887653322111100
Q ss_pred ------c--ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 387 ------K--NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 387 ------~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. ........+|.++.... ..+....+.+++.+||+.||++||||.+|++.|+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCcccc--chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0 00011122222222111 11334457889999999999999999999999987643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=404.37 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=196.1
Q ss_pred cccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCEEEEE
Q 012219 173 HIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKCMFLI 247 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 247 (468)
.+.+.||+|+||+||+|.. .++..||+|++....... ...+.|.+|++++++++|||||++++++.. +...++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 5667899999999999975 568999999997654332 345789999999999999999999999865 3558999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCC-CCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLNS-ELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~ 324 (468)
||||++|+|.+++.... .+++..+..++.||+.||+||| +.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999997643 4899999999999999999999 555 999999999999985 79999999999986
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.. .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||............ +.... .+....
T Consensus 182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~---i~~~~---~~~~~~ 252 (290)
T 3fpq_A 182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGV---KPASFD 252 (290)
T ss_dssp CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTC---CCGGGG
T ss_pred CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH---HHcCC---CCCCCC
Confidence 43 334456789999999998865 6999999999999999999999999754332111111 00000 011111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~~---~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 26679999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=411.47 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=201.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|.+.+.||+|+||+||+|+. .+|+.||||+++.... +.+|++++++++|||||++++++.+++..+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5688889999999999999975 5699999999976432 237999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~ 327 (468)
|||+||+|.++++..+ .+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 130 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999997643 3899999999999999999999 88999999999999999997 699999999988754
Q ss_pred CCCC-----ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 328 DSSN-----RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 328 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||...........-... ......+.+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 281 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPIREIPPS 281 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGGGGSCTT
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCchhcCcc
Confidence 3221 22357999999999999999999999999999999999999999754332111100000 0000011222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+. .+.+++.+||+.||++|||+.|+++++...
T Consensus 282 ~s~-------~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 282 CAP-------LTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp SCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 221 266789999999999999999999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=422.36 Aligned_cols=267 Identities=22% Similarity=0.331 Sum_probs=214.0
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-CceeeE
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNIVKL 234 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 234 (468)
..+|+...++|++.+.||+|+||+||+|.+. .++.||||++...... ...+.|.+|++++.+++| ||||++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456666789999999999999999999753 2468999999865543 235789999999999965 899999
Q ss_pred EEEEeeC-CEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 012219 235 YGFCLHR-KCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300 (468)
Q Consensus 235 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 300 (468)
+|+|.+. +..++|||||++|+|.++|+.... ...+++.+++.++.|||.||+||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9999764 568999999999999999976432 234899999999999999999999 77999999
Q ss_pred CCCCceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCc
Q 012219 301 ISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGEL 377 (468)
Q Consensus 301 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~ 377 (468)
|||+|||+++++.+||+|||+|+.+...... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877543332 223568999999999999999999999999999999998 9999986
Q ss_pred ccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.......... +.+...+..+...+ . .+.+++.+||+.||++|||+.+|+++|.++.
T Consensus 291 ~~~~~~~~~~---i~~g~~~~~p~~~~----~---~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKIDEEFCRR---LKEGTRMRAPDYTT----P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCSHHHHHH---HHHTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHH---HHcCCCCCCCccCC----H---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 5432221111 11111112222121 1 2677899999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=401.95 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=191.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999975 579999999998765554455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+ +|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 679999997654 3999999999999999999999 77999999999999999999999999999987643
Q ss_pred CCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.......+||+.|||||++.+..+ +.++||||+||++|||+||+.||......... .. +.. -...++...+
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-~~---i~~-~~~~~p~~~s--- 236 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-KN---ISN-GVYTLPKFLS--- 236 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---HHH-TCCCCCTTSC---
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HH---HHc-CCCCCCCCCC---
Confidence 233345689999999999998876 57999999999999999999999754322111 10 000 0111222222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
+ .+.+++.+||+.||++|||++|+++ .|.+
T Consensus 237 -~---~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 237 -P---GAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp -H---HHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred -H---HHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 2 2567899999999999999999985 3443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=420.31 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=209.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|++.+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|+++|+.++|||||++++++.+.+..||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999975 579999999997654332 346789999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||+||+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999753 3899999999999999999999 779999999999999999999999999999987666
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ..+.....+.+... ..+.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~----~~i~~~~~~~~~~~--~~~s 374 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM----KMIRDNLPPRLKNL--HKVS 374 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSCCCCCSCT--TSSC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCCCCCccc--ccCC
Confidence 55666778999999999999999999999999999999999999999754322111 11111111222111 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
. .+.+++.+||+.||++|||++|++++ |..
T Consensus 375 ~---~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 375 P---SLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp H---HHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred H---HHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 1 26679999999999999999999864 444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=408.28 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=196.3
Q ss_pred hCccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||+||+|+. ..++.||||+++...... .....+.+|++++++++|||||++++++.+++..+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5799999999999999999974 257899999997654322 12246788999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|||||+||+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999997643 3899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
..........+||+.|||||++.+..|+.++||||+||++|||+||+.||......... .. +.. ....++...+
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-~~---i~~-~~~~~p~~~s- 250 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM-TM---ILK-AKLGMPQFLS- 250 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---HHH-CCCCCCTTSC-
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH-HH---HHc-CCCCCCCcCC-
Confidence 54444555678999999999999999999999999999999999999999754322111 10 000 0111222222
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTM-----QLVSN 437 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~v~~ 437 (468)
. .+.+++.+||+.||++|||+ +|+++
T Consensus 251 ---~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 251 ---P---EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---H---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---H---HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2 26679999999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=397.25 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=191.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC------
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK------ 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 242 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 5699999999999999999975 57999999999765433 23467899999999999999999999987543
Q ss_pred ------EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 012219 243 ------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFV 316 (468)
Q Consensus 243 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 316 (468)
..++|||||++|+|.+++.........++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999987655445677888999999999999999 779999999999999999999999
Q ss_pred eeccccccccCCCCC------------ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh
Q 012219 317 ADFGVARLLNFDSSN------------RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS 384 (468)
Q Consensus 317 ~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~ 384 (468)
+|||+|+.+...... .+..+||+.|||||++.+..|+.++|||||||++|||++ ||........
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~- 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR- 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH-
Confidence 999999887533221 223579999999999999999999999999999999996 7653211100
Q ss_pred hhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 385 LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..........+ ...........+++.+||+.||++|||+.|++++
T Consensus 236 -----~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 -----TLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -----HHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----HHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111111111 1122222335679999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=389.60 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=200.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee------CC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------RK 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 242 (468)
++|.+.+.||+|+||+||+|+. .+|+.||||+++...... ...+.+.+|+++|++++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 5799999999999999999975 579999999997654322 335678899999999999999999999764 35
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..|+|||||+ |+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67999997643 4999999999999999999999 789999999999999999999999999999
Q ss_pred ccccCC----CCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---cc------
Q 012219 323 RLLNFD----SSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD---KN------ 388 (468)
Q Consensus 323 ~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~---~~------ 388 (468)
+.+... .......+||+.|||||++.+. .++.++||||+||++|||++|++||........... ..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 2233456899999999998775 568999999999999999999999975432110000 00
Q ss_pred -------cc---cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 389 -------IK---LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 389 -------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
.. ....+.+....+...........+.+++.+||+.||++|||++|+++ .|.+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 00 00000011111100000000123668999999999999999999985 45443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=376.65 Aligned_cols=196 Identities=27% Similarity=0.345 Sum_probs=168.6
Q ss_pred hhCccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 243 (468)
.++|++.+.||+|+||+||+|+. ..++.||+|++..... ...+.+|++++..+ +||||+++++++.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 47899999999999999999964 2578899999876543 24577899999998 69999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~ 322 (468)
.++||||+++|+|.+++.. +++.++..++.||+.||+||| +.||+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999842 889999999999999999999 7899999999999999877 79999999999
Q ss_pred ccccCCC----------------------------CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCC
Q 012219 323 RLLNFDS----------------------------SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKH 373 (468)
Q Consensus 323 ~~~~~~~----------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~ 373 (468)
+...... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 7653211 112235799999999998775 58999999999999999999999
Q ss_pred CCCcc
Q 012219 374 PGELL 378 (468)
Q Consensus 374 p~~~~ 378 (468)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 99543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=394.21 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=199.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHH---HHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGN---EARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||+||+|+. .+|+.||+|++.+.............+ ++++++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999975 579999999997654333222333334 45667778999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
|+||||++||+|.+++.... .+++..+..++.||+.||+||| +.+||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997643 3899999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccch-hhhcccccccccCCCCCCc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW-SLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 402 (468)
+... .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........ ..... .......++..
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~~~~~p~~ 416 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPDS 416 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHCCCCCCTT
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCCCCCCCcc
Confidence 6533 2345689999999999974 5799999999999999999999999975332111 11100 00011122222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
.+. .+.+++.+||+.||++|++ ++|+++
T Consensus 417 ~S~-------~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 417 FSP-------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp SCH-------HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCH-------HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 222 1567999999999999998 688874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=369.91 Aligned_cols=284 Identities=36% Similarity=0.641 Sum_probs=228.4
Q ss_pred CCCcCHHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEE
Q 012219 157 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236 (468)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 236 (468)
...+++.++....++|.+.+.||+|+||.||+|+..+++.||||++....... ....+.+|+++++.++||||+++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEE
Confidence 34678899999999999999999999999999998889999999998654332 2236889999999999999999999
Q ss_pred EEeeCCEEEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 237 FCLHRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 237 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
++...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+..+|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998654 234589999999999999999999954444999999999999999999999
Q ss_pred EeeccccccccCCCCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc--------h--h
Q 012219 316 VADFGVARLLNFDSSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS--------W--S 384 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~--------~--~ 384 (468)
|+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||+...... + .
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999876533322 233459999999999988889999999999999999999999996321100 0 0
Q ss_pred hhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 385 LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
...........+......... +....+.+++.+||+.||++|||+.+|+++|+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKD---EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCH---HHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HhhchhhhhhcChhhccccCH---HHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 011122233334444333332 3445588999999999999999999999999876544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=393.99 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=206.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+++|+.++|||||++++++.+.+..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999975 57999999999765543 245788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC--CCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE--LEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~~~~~ 325 (468)
||||+||+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999986533 24899999999999999999999 7899999999999999865 89999999999987
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......... .... ..+..+......
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-~~i~----~~~~~~~~~~~~ 381 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-RNVK----SCDWNMDDSAFS 381 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHH----TTCCCCCSGGGT
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHH----hCCCCCCccccc
Confidence 533 3345568999999999999999999999999999999999999999754332111 0000 011111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+.+ .+.+|+.+||+.||++|||++|++++
T Consensus 382 ~~s~---~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 382 GISE---DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 25678999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=363.23 Aligned_cols=266 Identities=27% Similarity=0.418 Sum_probs=205.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..++|.+.+.||+|+||+||+|+. .++.||||++....... ...+.|.+|++++++++||||+++++++......++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 356899999999999999999987 68899999997654332 3456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++........+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999987654445899999999999999999999 677 999999999999999999999999999865
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
...........||+.|+|||++.+..++.++|||||||++|||+||+.||............. ............+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---FKCKRLEIPRNLNP 266 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---HSCCCCCCCTTSCH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCCCccCCH
Confidence 544334445679999999999999999999999999999999999999997654322111100 00011111222221
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQ 448 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~ 448 (468)
.+.+++.+||+.||++|||+.++++.|+...+...+
T Consensus 267 -------~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 267 -------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp -------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred -------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 266799999999999999999999999887665433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.24 Aligned_cols=275 Identities=34% Similarity=0.545 Sum_probs=222.5
Q ss_pred cCHHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe
Q 012219 160 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL 239 (468)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 239 (468)
+++.++...+++|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3344455567899999999999999999999888999999998765433 3567889999999999999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
..+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999976432 235899999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccch------h--hhcc
Q 012219 319 FGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW------S--LDKN 388 (468)
Q Consensus 319 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~------~--~~~~ 388 (468)
||+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ . ....
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 99998654221 222334689999999999888999999999999999999999999864332110 0 1112
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
......+++........ +....+.+++.+||+.||++|||+.++++.|+...
T Consensus 263 ~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRP---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TCCCSSSSSSCTTCSCH---HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCH---HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22334444444433332 33445888999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=352.10 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=209.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||+||+|.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 36799999999999999999974 67899999999754432 245788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999754 3899999999999999999999 77999999999999999999999999999988765
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||............ .....+.... ....
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~~~~~--~~~~ 242 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTPELQN--PEKL 242 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSCCCSC--GGGS
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCCCC--cccc
Confidence 555556678999999999999999999999999999999999999999754322111110 0000111111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhcC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIARN 443 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~~ 443 (468)
. ..+.+++.+||+.||++|||++++++ .|.+..
T Consensus 243 ~---~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 243 S---AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp C---HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred C---HHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 1 12667999999999999999999985 444443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.18 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=207.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.|.+|+.++.+++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5799999999999999999974 578999999987655444455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999997643 4899999999999999999999 779999999999999999999999999999876432
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||............................+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP--- 241 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC---
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC---
Confidence 22 22335689999999999999999999999999999999999999976543221111100000000001111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhcCCC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFIARNKA 445 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-s~~~v~~~l~~~~~~ 445 (468)
..+.+++.+|++.||++|| +++++.+.|......
T Consensus 242 ----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 242 ----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 2267799999999999998 889999999886543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=351.02 Aligned_cols=258 Identities=25% Similarity=0.458 Sum_probs=207.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 35789999999999999999975 46899999998664432 457899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++..... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999999986432 4899999999999999999999 77999999999999999999999999999987643
Q ss_pred CCCCc--------------eeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc
Q 012219 328 DSSNR--------------TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 328 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
..... ....||+.|+|||++.+..++.++||||||+++|||++|..|+........... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--~~~~~ 238 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--LNVRG 238 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--BCHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--hhhhc
Confidence 22211 145689999999999999999999999999999999999999865332211110 01111
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+.......+. .+.+++.+||+.||++|||+.++++.|+...
T Consensus 239 ~~~~~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 239 FLDRYCPPNCPP-------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHTCCTTCCT-------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111222221 1667899999999999999999999988765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=347.78 Aligned_cols=277 Identities=29% Similarity=0.501 Sum_probs=223.7
Q ss_pred CCcCHHHHHHHhhCcccc------ceeeeeCCceEEEEEcCCCCEEEEEEecCcch-hhhhhHHHHHHHHHHHhhccCCc
Q 012219 158 GRITFQDMIEATEDFHIK------YCIGTGGYGSVYRARLPSGKVVALKKLHRSET-EELASLESFGNEARLLSQIRHRN 230 (468)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~n 230 (468)
..+++.++..++++|... +.||+|+||.||+|.. +++.||||++..... ......+.|.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457899999999999887 8999999999999987 688999999875432 11234567899999999999999
Q ss_pred eeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 231 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
|+++++++...+..++||||+++|+|.+++........+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999986555556999999999999999999999 779999999999999999
Q ss_pred CCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh---
Q 012219 311 ELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL--- 385 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~--- 385 (468)
++.+||+|||+++........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876432221 223468999999998765 58899999999999999999999997544321110
Q ss_pred ----hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 386 ----DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 386 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.......+.+++.+.... ......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDAD----STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCCC----HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHhhhhhhhhhhhccccccccc----hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 011112233343333221 123345788999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=352.17 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=213.4
Q ss_pred CCcCHHHHHHHhhC----------ccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc
Q 012219 158 GRITFQDMIEATED----------FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI 226 (468)
Q Consensus 158 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l 226 (468)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence 45788888887764 677789999999999999865 7999999999754432 346788999999999
Q ss_pred cCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 227 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
+||||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence 9999999999999999999999999999999998643 3899999999999999999999 67999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD 386 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~ 386 (468)
+++.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-- 250 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-- 250 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 999999999999999987765444445567999999999999999999999999999999999999999754321111
Q ss_pred cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
........+..... .... ..+.+++.+||+.||++|||+.+++++-
T Consensus 251 --~~~~~~~~~~~~~~--~~~~---~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 --KRLRDSPPPKLKNS--HKVS---PVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp --HHHHHSSCCCCTTG--GGSC---HHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred --HHHhcCCCCCcCcc--ccCC---HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11111111111111 1111 1266799999999999999999999653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=354.70 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=207.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+. .+|+.||+|+++..........+.+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36799999999999999999975 46999999999865443344567788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999987543 3899999999999999999999 77999999999999999999999999999986544
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... -...++...+.
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--i~~---~~~~~p~~~s~-- 230 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--ILM---EEIRFPRTLSP-- 230 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH---CCCCCCTTSCH--
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH--HHc---CCCCCCCCCCH--
Confidence 44445567899999999999999999999999999999999999999975432211100 000 01112222221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+.+++.+||+.||++|| ++++++++
T Consensus 231 -----~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 231 -----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 266789999999999999 89999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.50 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=204.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 46799999999999999999975 689999999997654322 3456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997643 3899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCCceeccccccccccccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .......||+.|+|||++.+..++ .++||||+||++|||+||+.||+........... .. -....+...+.
T Consensus 167 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i----~~-~~~~~p~~~s~- 239 (328)
T 3fe3_A 167 G-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV----LR-GKYRIPFYMST- 239 (328)
T ss_dssp S-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HH-CCCCCCTTSCH-
T ss_pred C-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-CCCCCCCCCCH-
Confidence 3 334456799999999999887765 7999999999999999999999754322111100 00 00111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+.+++.+||+.||++|||+++++++
T Consensus 240 ------~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 240 ------DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 25678999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.87 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=208.7
Q ss_pred hhCccccceeeeeCCceEEEEEc--------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||+|.. .++..||||+++..... ...+.+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 36799999999999999999974 24567999999865433 3457899999999999 8999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
..+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence 99999999999999999999976432 234789999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
|++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987643322 1223456789999999999999999999999999999999 9999976543221
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
... ......+....... ..+.+++.+||+.||++|||+.++++.|.++.
T Consensus 315 ~~~----~~~~~~~~~~~~~~-------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FKL----LKEGHRMDKPANCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHH----HHTTCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HhcCCCCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 00111111111111 12677999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=353.82 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=203.3
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 244 (468)
.++|.+.+.||+|+||.||+|+.. ++.||||++...... ...+.+|+.++.+++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 467999999999999999999875 789999999755432 244567899999999999999999998743 47
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCceeeCCCCCe
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP----------PIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~----------~ivH~dlk~~NIll~~~~~~ 314 (468)
++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999999753 3899999999999999999999 66 99999999999999999999
Q ss_pred EEeeccccccccCCCCC--ceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-
Q 012219 315 FVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD- 386 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~- 386 (468)
||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999876543222 223578999999999876 3567789999999999999999999875322110000
Q ss_pred -------ccccccc-ccCCCCCCccchh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 387 -------KNIKLID-LLDPRLSPPVDQK--IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 387 -------~~~~~~~-~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
......+ .......+..... .......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000000 0111111111111 0123344888999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=347.39 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=199.8
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh--ccCCceeeEEEEEee----CC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ--IRHRNIVKLYGFCLH----RK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~ 242 (468)
.++|.+.+.||+|+||.||+|+. +++.||||++.... .+.+..|.+++.. ++||||+++++++.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 36799999999999999999988 68999999997543 2445567777766 799999999998764 34
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD-----CTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||.. ++.+|+||||||+||+++.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 589999999999999999643 489999999999999999999932 15689999999999999999999999
Q ss_pred eccccccccCCCCC----ceeccccccccccccccCC------CCCccchhhHHHHHHHHHHhC----------CCCCCc
Q 012219 318 DFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMG----------KHPGEL 377 (468)
Q Consensus 318 Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~el~tg----------~~p~~~ 377 (468)
|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876433222 1234789999999998876 556799999999999999999 777754
Q ss_pred ccccchhhhcccc--cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 378 LSSSSWSLDKNIK--LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 378 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
............. ......+..... .........+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3222111111000 111111222111 11112334588899999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.74 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=206.6
Q ss_pred hCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|... .+..||||+++..... ...+.|.+|++++++++||||+++++++.+.+..+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 57889999999999999999863 3456999999865433 23567999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999997543 24899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCc---eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNR---TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... ...........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~ 277 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEEGYRLPAPM 277 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHTTCCCCCCT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HHcCCCCCCCC
Confidence 5432222 12345778999999998899999999999999999999 9999975443221111 01111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
..+ . .+.+++.+||+.||++|||+.++++.|......+
T Consensus 278 ~~~----~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 278 GCP----H---ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CcC----H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111 1 2677999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=342.50 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=209.1
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|+..++..||+|++...... .+.+.+|++++.+++||||+++++++......++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3678999999999999999999988889999999865433 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999997643 24899999999999999999999 779999999999999999999999999999876432
Q ss_pred CCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||............ ............+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~-- 231 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----SQGHRLYRPHLAS-- 231 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCCCCTTSC--
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----HcCCCCCCCCcCh--
Confidence 211 122345678999999998899999999999999999999 99999755432221111 0000111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+ .+.+++.+||+.||++|||+.++++.|+...+.
T Consensus 232 --~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 232 --D---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --H---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 267799999999999999999999999887543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=351.68 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=203.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999975 678999999997654443334467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+ +|+|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 689998886543 3899999999999999999999 679999999999999999999999999999876432
Q ss_pred CCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+......... .... .....+...+
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~-~~~~~p~~~s--- 232 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNS-CVYVMPDFLS--- 232 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----CCCS-SCCCCCTTSC---
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----HHHc-CCCCCcccCC---
Confidence 33344579999999999988776 689999999999999999999997543211100 0000 0011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
. .+.+++.+||+.||.+|||++|+++ .|.+.
T Consensus 233 -~---~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 233 -P---GAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -H---HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -H---HHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 1 2667999999999999999999984 45543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.89 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=205.7
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|.. .+|+.+|+|++....... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 356799999999999999999964 578999999998665432 335678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN---SELEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~ 323 (468)
||||+++|+|.+.+.... .+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999997654 3899999999999999999999 77999999999999998 46789999999998
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.....................+.. ...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~ 240 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW-DTV 240 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT-TTS
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc-ccC
Confidence 7765544445568999999999999999999999999999999999999999754322111110000011111111 111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+ . .+.+++.+||+.||++|||+.+++++
T Consensus 241 s----~---~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 241 T----P---EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C----H---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----H---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 1 26679999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.09 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=209.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC--EEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 246 (468)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 57899999999999999999764 5899999999754432 23567889999999999999999999998755 7899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEeecccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL----NSELEAFVADFGVA 322 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~~ 322 (468)
||||+++|+|.+++........+++.+++.++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999987665556999999999999999999999 7799999999999999 78888999999999
Q ss_pred ccccCCCCCceecccccccccccccc--------CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc--
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAY--------TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI-- 392 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-- 392 (468)
+...... ......||+.|+|||++. +..++.++|||||||++|||+||+.||.................
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8765432 333456999999999876 56789999999999999999999999964332111100000000
Q ss_pred ----------cc------cCCCCC--CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 393 ----------DL------LDPRLS--PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 393 ----------~~------~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.. ....+. ..... .....+.+++.+||+.||++|||++|++++.....-.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSR---GLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCH---HHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCcccchhhhcccCCccccCccCCcccccch---hHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 00 000111 11112 2333477899999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.06 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=208.7
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3578999999999999999999888999999999865533 357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999976433 4899999999999999999999 779999999999999999999999999999865321
Q ss_pred C-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 S-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .......+++.|+|||++.+..++.++||||||+++|||++ |+.||........... .............+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~-- 233 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGFRLYKPRLAS-- 233 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTCCCCCCTTSC--
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----HhcCccCCCCCcCC--
Confidence 1 11223356778999999998899999999999999999999 9999976443221111 11111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .+.+++.+||+.||++|||+.++++.|.++.+
T Consensus 234 --~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 234 --T---HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp --H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H---HHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1 26679999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=347.92 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=200.8
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||+||+|+..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3679999999999999999999888999999999765432 233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 8888876543 34899999999999999999999 779999999999999999999999999999887654
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc--------------cccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI--------------KLID 393 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------------~~~~ 393 (468)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ....
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 445555678999999999876 5689999999999999999999999975443211100000 0000
Q ss_pred ccCCCC---CC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 LLDPRL---SP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 ~~~~~~---~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+... .. ............+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 00 0000000011236789999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.87 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=201.1
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999975 46899999999876544445567788999999988 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997643 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. ... ...+.....
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-~i-~~~---~~~~p~~~~-- 248 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-AI-LND---EVVYPTWLH-- 248 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HH-HHC---CCCCCTTSC--
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH-HH-HcC---CCCCCCCCC--
Confidence 44444556689999999999999899999999999999999999999997543221110 00 000 111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTM------QLVSN 437 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~------~~v~~ 437 (468)
. .+.+++.+||+.||++||++ +++++
T Consensus 249 --~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 249 --E---DATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --H---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --H---HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 15678999999999999998 67764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=359.65 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999754 6889999999876544333445678899999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999997643 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-cccc-ccc--cCCCCCCc
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-NIKL-IDL--LDPRLSPP 402 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-~~~~-~~~--~~~~~~~~ 402 (468)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||............ .... ..+ ....++..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 4445556678999999999999999999999999999999999999999643221110000 0000 000 11112222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTM------QLVSN 437 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~v~~ 437 (468)
.+. .+.+++.+||+.||++||++ +++++
T Consensus 285 ~s~-------~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 285 LSV-------KAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp SCH-------HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCH-------HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 221 26678999999999999985 56664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.79 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=206.7
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||||+++..... ...+.|.+|++++++++||||+++++++...+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 467999999999999999999875 7899999999755322 2345788999999999999999999999998899999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999997543 23889999999999999999999 77999999999999999999999999999976432
Q ss_pred CCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 328 DSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 328 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .....++..|+|||++....++.++|||||||++|||+| |+.||........... .............+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 341 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF----VEKGGRLPCPELCP 341 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH----HHTTCCCCCCTTCC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC
Confidence 1111 111235678999999998899999999999999999998 9999976543211110 00000111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 342 ----~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 342 ----D---AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----H---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1 26779999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.40 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=204.1
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++........ ...+.+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 36799999999999999999975 4689999999976543211 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeecc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFG 320 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 320 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997543 4899999999999999999999 77999999999999998877 79999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +.. ....+.
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~----i~~-~~~~~~ 238 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITA-VSYDFD 238 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHT-TCCCCC
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-cCCCCC
Confidence 99876532 233445799999999999998999999999999999999999999975432211100 000 000111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....... ...+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~---s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEFFSQT---SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhccCC---CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100111 1226679999999999999999998853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=358.15 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=211.6
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceee
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVK 233 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 233 (468)
...++....++|.+.+.||+|+||.||+|++ .+++.||||+++..... ...+.+.+|++++.++ +||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceee
Confidence 4455556678999999999999999999963 35689999999865433 2356789999999999 7999999
Q ss_pred EEEEEeeCCE-EEEEEEeccCCChhhhhhcCcc-----------------------------------------------
Q 012219 234 LYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEE----------------------------------------------- 265 (468)
Q Consensus 234 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 265 (468)
+++++...+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987544 8999999999999999976432
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 266 ----------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 266 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999 7799999999999999999999999999998764332
Q ss_pred C--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 330 S--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 330 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||............. .............
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~-- 322 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---KEGTRMRAPDYTT-- 322 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH---HHTCCCCCCTTCC--
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH---HcCCCCCCCCCCC--
Confidence 2 2233567889999999999999999999999999999998 999997544322111110 0111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
. .+.+++.+||+.||++|||+.+++++|+...
T Consensus 323 --~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 --P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp --H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --H---HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 2677899999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.36 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=196.2
Q ss_pred hCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|+.. ++..||||+++..... ...+.|.+|++++++++||||+++++++...+..+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 57899999999999999999764 5778999999765432 24568999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.++++... ..+++.+++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999997643 34899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCc---eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNR---TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||........... ...........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----i~~~~~~~~~~ 273 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----VDEGYRLPPPM 273 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH----HHTTEECCCCT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCc
Confidence 5332211 12235678999999999999999999999999999998 9999975433211110 00000011111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
... ..+.+++.+||+.||++||++.+|++.|.+...
T Consensus 274 ~~~-------~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 274 DCP-------AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp TCB-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccc-------HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111 226789999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.42 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=203.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.+|+|.+..... ....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 36799999999999999999975 4688999999975543 235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++.... ..+++.+++.++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999997543 34899999999999999999999 779999999999999987 789999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+........ ..
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~~~-~~ 225 (321)
T 1tki_A 155 KP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-------NIMNAEYTFD-EE 225 (321)
T ss_dssp CT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCCCCC-HH
T ss_pred CC-CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH-------HHHcCCCCCC-hh
Confidence 53 233445679999999999998889999999999999999999999997543221110 0000111100 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
........+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000111236789999999999999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=352.31 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=204.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999764 6889999999866544334566788999999988 899999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997543 3899999999999999999999 77999999999999999999999999999986544
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-hcccccc-cc--cCCCCCCcc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-DKNIKLI-DL--LDPRLSPPV 403 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-~~~~~~~-~~--~~~~~~~~~ 403 (468)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .+ ....++...
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 4444556689999999999999999999999999999999999999997532211000 0000000 00 011122212
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTM------QLVSN 437 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~~v~~ 437 (468)
+. .+.+++.+||+.||++||++ +++++
T Consensus 243 s~-------~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 243 SV-------KAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CH-------HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CH-------HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 21 26678999999999999995 67764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.75 Aligned_cols=252 Identities=20% Similarity=0.335 Sum_probs=200.7
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999865 7999999999755432 23567899999999999999999999986543
Q ss_pred ----------------------------------------------------EEEEEEEeccCCChhhhhhcCcccCCCC
Q 012219 243 ----------------------------------------------------CMFLIYEYMEMGSLFCVLRTDEEAVGLD 270 (468)
Q Consensus 243 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~ 270 (468)
..++||||+++|+|.+++.........+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 3799999999999999998876656678
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC------------CCceecccc
Q 012219 271 WAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------------SNRTLLAGT 338 (468)
Q Consensus 271 ~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~g~ 338 (468)
+..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 8889999999999999999 7799999999999999999999999999998775432 122334699
Q ss_pred ccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHH
Q 012219 339 YGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVA 418 (468)
Q Consensus 339 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 418 (468)
+.|+|||++.+..++.++|||||||++|||++|..|+...... .......... .........+.+++
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~~~~~li 306 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI---------ITDVRNLKFP----LLFTQKYPQEHMMV 306 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---------HHHHHTTCCC----HHHHHHCHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---------HHHhhccCCC----cccccCChhHHHHH
Confidence 9999999999999999999999999999999998875321110 0001111111 11122223467899
Q ss_pred HhcccCCCCCCCCHHHHHHH
Q 012219 419 FSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 419 ~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+||+.||++|||+.+++++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.76 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=200.4
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 368999999999999999999754 78999999997554332 235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999997543 3899999999999999999999 77999999999999999999999999999986542
Q ss_pred CC--CCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 328 DS--SNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 328 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.................... ...
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~- 231 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----NPW- 231 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-----TTG-
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-----Ccc-
Confidence 22 22334579999999999987765 7789999999999999999999975443222111111100000 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~---~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDS---APLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCH---HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111 25679999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.37 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=198.5
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+.+.||+|+||.||+|+..+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4788999999999999999988889999999997654332 234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9985 8998887543 24889999999999999999999 7799999999999999999999999999998765443
Q ss_pred CCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc-----------ccc--cccc
Q 012219 330 SNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN-----------IKL--IDLL 395 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~-----------~~~--~~~~ 395 (468)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............. ... ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 44445578999999999876 458999999999999999999999997543221100000 000 0001
Q ss_pred CCCCCC----ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRLSP----PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
++.... +...........+.+++.+||+.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111110 0000000011226689999999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.99 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=195.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhh-----------------------hhhHHHHHHHHHHHh
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE-----------------------LASLESFGNEARLLS 224 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~ 224 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999975 568899999997654221 112356889999999
Q ss_pred hccCCceeeEEEEEee--CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 012219 225 QIRHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDIS 302 (468)
Q Consensus 225 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 302 (468)
+++||||+++++++.. ....++||||+++++|.+++.. ..+++.+++.++.||+.||+||| +.+|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 9999999999999986 5689999999999999886543 34899999999999999999999 7799999999
Q ss_pred CCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCC---CCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 303 SNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 303 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987754444344567999999999987654 4788999999999999999999997543
Q ss_pred ccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.......... ............ + .+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~---~~~~~~~~~~~~----~---~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLHSKIKS---QALEFPDQPDIA----E---DLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHH---CCCCCCSSSCCC----H---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhc---ccCCCCCccccC----H---HHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2211110000 000000011111 1 2667999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=344.27 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=205.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36799999999999999999975 47999999999865544444567788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999997644 3899999999999999999999 88999999999999999999999999999987542
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.. ....+......
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~---i~~-~~~~~p~~~~~-- 228 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EK---ILN-AELRFPPFFNE-- 228 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH---HHH-CCCCCCTTSCH--
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HH---HHh-CCCCCCCCCCH--
Confidence 233457999999999999999999999999999999999999999754321111 00 000 01112222221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+.+++.+|++.||++|| ++++++++
T Consensus 229 -----~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 229 -----DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 266789999999999999 88998843
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=351.95 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=205.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5799999999999999999975 468899999998765544456678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.+|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 9999999999997643 3899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||........... ...............+.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI--VHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH--HHHHHHCCCCCCTTSCH
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhhcccCCCCcCCH
Confidence 333455679999999999864 4589999999999999999999999974332211100 00000011112222221
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSN 437 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~v~~ 437 (468)
.+.+++.+||+.||++||+ ++++.+
T Consensus 246 -------~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 246 -------EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2667999999999999999 788875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.76 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=203.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh--hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL--ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++........ ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999975 5789999999965432211 134678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEeecccc
Q 012219 247 IYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADFGVA 322 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg~~ 322 (468)
||||+++|+|.+.+.... ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988876432 2334899999999999999999999 779999999999999987654 999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +........
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------i~~~~~~~~ 252 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG--------IIKGKYKMN 252 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH--------HHHTCCCCC
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH--------HHcCCCCCC
Confidence 887654444455679999999999999999999999999999999999999997532211100 000001000
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..........+.+++.+||+.||++|||+.++++
T Consensus 253 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 -PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011123678999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=346.84 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=202.4
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--C
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--K 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 242 (468)
++|++.+.||+|+||.||+|++ .+++.||||++...... ..+.|.+|++++++++||||+++++++... .
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 6799999999999999999973 36889999999865433 356788999999999999999999998653 4
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 58999999999999999976543 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--------cccc
Q 012219 323 RLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--------NIKL 391 (468)
Q Consensus 323 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~--------~~~~ 391 (468)
+....... ......++..|+|||.+.+..++.++||||||+++|||+||..|+............ ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87643322 122345677899999999999999999999999999999999998643221000000 0000
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.+.+......+...... ..+.+++.+||+.||++|||+.++++.|.++..
T Consensus 242 ~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCCCCCCTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccCcCCCCcCcC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111111111111111 227789999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=352.07 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=205.2
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
..++|.+.+.||+|+||.||+|+. .+++.||+|+++..........+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999976 46899999999865443334456788899999887 8999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999997643 3899999999999999999999 779999999999999999999999999999865
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. .. .-.+.+.....
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~-i~---~~~~~~p~~~s- 242 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HS-IR---MDNPFYPRWLE- 242 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-HH---HCCCCCCTTSC-
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-HH-HH---hCCCCCCcccC-
Confidence 44444455678999999999999999999999999999999999999999754322111 00 00 01112222122
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQ-LVS 436 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~v~ 436 (468)
. .+.+++.+||+.||++||++. +++
T Consensus 243 ---~---~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 243 ---K---EAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---H---HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---H---HHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 266789999999999999997 775
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=350.97 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=203.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999975 468999999997654322 3456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~ 324 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999987543 3899999999999999999999 77999999999999998654 599999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .........
T Consensus 181 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~ 254 (362)
T 2bdw_A 181 VND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-----AYDYPSPEW 254 (362)
T ss_dssp CTT-CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----CCCCCTTGG
T ss_pred ecC-CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----CCCCCcccc
Confidence 653 23334467999999999999989999999999999999999999999754322111000000 001111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.... ..+.+++.+||+.||++|||+.+++++
T Consensus 255 ~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 DTVT---PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 226679999999999999999998854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=341.28 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=205.6
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|...++..||+|++...... .+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4679999999999999999999988889999999865443 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999976332 3899999999999999999999 779999999999999999999999999999865321
Q ss_pred C-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 S-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .......+++.|+|||++.+..++.++||||||+++|||+| |+.||........... ..............
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~-- 247 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLAS-- 247 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTCCCCCCTTCC--
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----HhcccCCCCCCcCC--
Confidence 1 11122346778999999998899999999999999999998 9999976543211111 11111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+ .+.+++.+||+.||++|||++++++.|.+..
T Consensus 248 --~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 248 --E---KVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --H---HHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1 2667999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=346.77 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=204.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++........ ...+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999975 4689999999976543211 1356788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeecc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFG 320 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 320 (468)
++||||+++|+|.+++.... .+++.+++.++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 4899999999999999999999 77999999999999999887 79999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... . . .......
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~---~-~~~~~~~ 237 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-V---S-AVNYEFE 237 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-H---H-HTCCCCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-H---H-hcCCCcC
Confidence 998765332 23345799999999999989999999999999999999999999965432111100 0 0 0011111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .....+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccc---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 111236689999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=350.51 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=209.8
Q ss_pred HhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
..++|.+.+.||+|+||.||+|+.. +++.||||+++..... ...+.|.+|++++++++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3578999999999999999999763 3588999999865433 2456799999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 300 (468)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 999999999999999999976421 145899999999999999999999 77999999
Q ss_pred CCCCceeeCCCCCeEEeeccccccccCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCc
Q 012219 301 ISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGEL 377 (468)
Q Consensus 301 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~ 377 (468)
|||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999998764322 12233567889999999998899999999999999999999 9999975
Q ss_pred ccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
......... ..+...+......+ ..+.+++.+||+.||++|||+.++++.|.++...
T Consensus 280 ~~~~~~~~~----~~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHEEVIYY----VRDGNILACPENCP-------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHHHHHHH----HHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChHHHHHH----HhCCCcCCCCCCCC-------HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 443211110 00000011111111 1267799999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=339.18 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=199.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||+||+|.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 5789999999999999999975 468999999997654332 33467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++ ++.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99986 5655554432 24899999999999999999999 779999999999999999999999999999887655
Q ss_pred CCCceeccccccccccccccCCC-CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc------------cccccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------------KLIDLL 395 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------------~~~~~~ 395 (468)
........||+.|+|||++.+.. ++.++|||||||++|||++|..|+.............. ......
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 55555567899999999987765 89999999999999999998888532221111100000 000000
Q ss_pred CC----CC--CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DP----RL--SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~----~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+. .. ..............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00 000000000011226689999999999999999999854
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.81 Aligned_cols=265 Identities=25% Similarity=0.271 Sum_probs=207.6
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 240 (468)
+.++....++|.+.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455689999999999999999999865 578999999976544333334458899999999999999999999999
Q ss_pred CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999997632 23899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCC-ceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 321 VARLLNFDSSN-RTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 321 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
+++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...................
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99876533322 23357999999999987 5678999999999999999999999997543221110000000011
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
.-+......+. .+.+++.+|+..+|++ ||+++|++++
T Consensus 301 ~~p~~~~~~s~-------~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 301 QFPTQVTDVSE-------NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSSCCCSCH-------HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCcccccCCH-------HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111111221 1567889999888888 9999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=337.87 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=185.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999975 57999999999765544434457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997543 34899999999999999999999 77999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||........... .. ..+........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~---~~~~~~~~~~~--- 236 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--VV---LADYEMPSFLS--- 236 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CC---SSCCCCCTTSC---
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--Hh---hcccCCccccC---
Confidence 43334456789999999999988899999999999999999999999875432211100 00 00111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .+.+++.+||+.||++|||+++++++
T Consensus 237 -~---~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 237 -I---EAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -H---HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -H---HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1 26679999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=341.59 Aligned_cols=260 Identities=17% Similarity=0.183 Sum_probs=206.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++...... +.+.+|++++..+ +|+|++++++++......++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 5799999999999999999974 67999999998754432 3577899999999 799999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-----eEEeecccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-----AFVADFGVA 322 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfg~~ 322 (468)
|||+ +++|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 85 ~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 9999999986432 4899999999999999999999 889999999999999987776 999999999
Q ss_pred ccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh--hccccc-c
Q 012219 323 RLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL--DKNIKL-I 392 (468)
Q Consensus 323 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~~~~~-~ 392 (468)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ...... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 2234579999999999999999999999999999999999999997643221100 000000 0
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
....+......+ ..+.+++.+||+.||++|||+++|++.|.+......
T Consensus 239 ~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 239 STPLRELCAGFP-------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HSCHHHHTTTSC-------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CccHHHHHhhCc-------HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000000001111 237789999999999999999999999988764433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=352.98 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=209.1
Q ss_pred hhCccccceeeeeCCceEEEEEc--------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||+|.. ..+..||||++...... ...+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--HHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 36799999999999999999974 23467999999865433 3457789999999999 9999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
..+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 99999999999999999999976432 235899999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987643322 2223457889999999999999999999999999999999 9999875443211
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
... .............. . .+.+++.+||+.||++|||+.++++.|+++.
T Consensus 303 ~~~----~~~~~~~~~~~~~~----~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 FKL----LKEGHRMDKPSNCT----N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHH----HHTTCCCCCCSSCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HHcCCCCCCCccCC----H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 01111111111111 1 2677999999999999999999999998775
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=336.90 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=192.6
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhh-hhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE-LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... ++.||||++....... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57899999999999999999874 8899999997654332 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--------CCCeEEeecc
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS--------ELEAFVADFG 320 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~--------~~~~kl~Dfg 320 (468)
||+++++|.+++... .+++..++.++.|++.||.|||+....+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999998632 4899999999999999999999432123999999999999986 6789999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+++..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||............. .........
T Consensus 162 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA---MNKLALPIP 236 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---TSCCCCCCC
T ss_pred cccccccc--cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---cCCCCCCCC
Confidence 99865432 2234568999999999998899999999999999999999999997654322111110 011111111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
...+ ..+.+++.+||+.||++|||+.++++.|++
T Consensus 237 ~~~~-------~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 237 STCP-------EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cccC-------HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 126779999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.22 Aligned_cols=264 Identities=26% Similarity=0.388 Sum_probs=199.8
Q ss_pred HHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc--cCCceeeEEEEEeeC--
Q 012219 166 IEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI--RHRNIVKLYGFCLHR-- 241 (468)
Q Consensus 166 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~-- 241 (468)
....++|.+.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344578999999999999999999885 89999999965432 3344566665554 899999999999887
Q ss_pred --CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeEecCCCCCceeeCCC
Q 012219 242 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP--------PIVHRDISSNNVLLNSE 311 (468)
Q Consensus 242 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~--------~ivH~dlk~~NIll~~~ 311 (468)
...++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+||+++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence 7899999999999999999653 3899999999999999999999 56 99999999999999999
Q ss_pred CCeEEeeccccccccCCCCC----ceeccccccccccccccCCCCCcc------chhhHHHHHHHHHHhC----------
Q 012219 312 LEAFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTMVVTEK------CDVYSFGVVALEVLMG---------- 371 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~s~Gvil~el~tg---------- 371 (468)
+.+||+|||+++........ .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 99999999999776433222 123479999999999987766655 9999999999999999
Q ss_pred CCCCCcccccchhhhcc--cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 372 KHPGELLSSSSWSLDKN--IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 372 ~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+.||............. ........+....... .......+.+++.+||+.||++|||+.++++.|+.....
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS--SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG--GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccCccccccch--hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 55554322211111100 0011111222221111 113344588899999999999999999999999887543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.91 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=206.1
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+.+..|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999765 5789999999876544444567788999999988 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999997543 3899999999999999999999 7799999999999999999999999999998654
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.. ....++...+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~---i~~-~~~~~p~~~s-- 245 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-QS---IME-HNVAYPKSMS-- 245 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---HHH-CCCCCCTTSC--
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-HH---HHh-CCCCCCCCCC--
Confidence 4444455678999999999999999999999999999999999999999754322111 00 000 0111222122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
. .+.+++.+||+.||++||+ +++++++
T Consensus 246 --~---~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 246 --K---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --H---HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --H---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 2667999999999999995 5777753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=360.06 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=203.6
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-EEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-CMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... ++.||||+++... ..+.|.+|++++++++||||+++++++.... ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 467899999999999999999885 7899999998654 2367899999999999999999999987765 78999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999986432 23789999999999999999999 77999999999999999999999999999986432
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .....++..|+|||++.+..++.++|||||||++|||+| |+.||........... .............+
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~~~~~~~p~~~~-- 412 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEKGYKMDAPDGCP-- 412 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH----HHTTCCCCCCTTCC--
T ss_pred c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCcCC--
Confidence 2 222357889999999999999999999999999999998 9999976543221111 00111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 413 -----~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 413 -----PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12677999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.64 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=187.4
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... .+.+.+|++++++++||||+++++++...+..++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999765 588999999986532 35678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~ 324 (468)
|||+++|+|.+++.... .+++.+++.++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999997543 3899999999999999999999 779999999999999975 88999999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............................
T Consensus 201 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 201 VEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred cCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 6432 223345789999999999999999999999999999999999999975443221111110000000001111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+.+++.+||+.||++|||+.+++++
T Consensus 280 -------~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 280 -------LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 126679999999999999999999865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.47 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=206.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 46899999999999999999975 468999999997654322 3456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg~~~~ 324 (468)
|||+++++|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998887543 3899999999999999999999 779999999999999987655 99999999977
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....................+.. ....
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (284)
T 3kk8_A 158 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW-DTVT 235 (284)
T ss_dssp CCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT-TTSC
T ss_pred cccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh-cccC
Confidence 6532 2333457899999999999999999999999999999999999999754332211111001111111110 1111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhcCCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIARNKA 445 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~~~~ 445 (468)
. .+.+++.+||+.||++|||+.+++++ +......
T Consensus 236 ----~---~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 236 ----P---EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ----H---HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ----H---HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 1 26679999999999999999999853 4444333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.33 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=208.7
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++++++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 46799999999999999999974 34588999999765432 34577899999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI 301 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 301 (468)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 99999999999999999976432 234889999999999999999999 779999999
Q ss_pred CCCceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcc
Q 012219 302 SSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELL 378 (468)
Q Consensus 302 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~ 378 (468)
||+||+++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876433221 223456788999999998889999999999999999999 99999765
Q ss_pred cccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
........ ......+......+ + .+.+++.+||+.||++|||+.++++.|+++.
T Consensus 257 ~~~~~~~~----~~~~~~~~~~~~~~----~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 PPERLFNL----LKTGHRMERPDNCS----E---EMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CGGGHHHH----HHTTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHH----hhcCCcCCCCccCC----H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43221111 00001111111111 1 2677999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.65 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=198.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCE----EEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKV----VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|.+. +++. ||+|.+...... ...+.|.+|+.++++++||||++++++|.... .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 57899999999999999999753 4443 588888644322 34578999999999999999999999998765 7
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+++|+|.+++..... .+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 789999999999999976543 4899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||............ ..........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 242 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLPQPP 242 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCCCCT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----HcCCCCCCCc
Confidence 7543322 223456789999999999999999999999999999999 99999765432211100 0000111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
... ..+.+++.+||+.||++|||+.++++.|.....
T Consensus 243 ~~~-------~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 243 ICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TBC-------HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 126779999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.17 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=208.7
Q ss_pred HHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
...++|.+.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++. .+..++
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34578999999999999999999998889999999986542 3578999999999999999999999987 556899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.++++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999997543 224788999999999999999999 7799999999999999999999999999998764
Q ss_pred CCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 327 FDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 327 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... ......++..|+|||++....++.++|||||||++|||+| |+.||........... +............+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LERGYRMPRPENCP 411 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHHTCCCCCCTTSC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC
Confidence 2111 1122346778999999998899999999999999999999 9999976543211110 00101111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
..+.+++.+||+.||++|||+++|++.|+.....
T Consensus 412 -------~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 412 -------EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1267899999999999999999999999987554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=348.17 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=207.3
Q ss_pred HhhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH 240 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|.. .++..||+|++...... ...+.+.+|++++.++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 357899999999999999999975 24668999999754322 2346788999999999 89999999999999
Q ss_pred CCEEEEEEEeccCCChhhhhhcCccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEA--------------------VGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRD 300 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 300 (468)
.+..++||||+++|+|.+++...... ..+++..++.++.||+.||.||| +.+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 99999999999999999999764321 23789999999999999999999 77999999
Q ss_pred CCCCceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCc
Q 012219 301 ISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGEL 377 (468)
Q Consensus 301 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~ 377 (468)
|||+||+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543322 123456789999999998899999999999999999998 9999976
Q ss_pred ccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012219 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQ 448 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~ 448 (468)
.......... ......+......+ + .+.+++.+||+.||.+|||+.++++.|.........
T Consensus 278 ~~~~~~~~~~---~~~~~~~~~~~~~~----~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 278 IPVDANFYKL---IQNGFKMDQPFYAT----E---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CCCSHHHHHH---HHTTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CCcHHHHHHH---HhcCCCCCCCCCCC----H---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 5432211110 00111111111111 1 267799999999999999999999999988665433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=358.63 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=206.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999764 79999999998655444345677899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999997543 3899999999999999999999 789999999999999999999999999999876532
Q ss_pred CCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.......... +.... ........
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~----i~~~~-~~~p~~~s--- 240 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGI-FYTPQYLN--- 240 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH----HHTTC-CCCCTTCC---
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH----HhcCC-cCCCccCC---
Confidence 33445679999999999988765 6899999999999999999999975432211110 00000 01111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~ 441 (468)
. .+.+++.+||+.||++|||++++++ .+..
T Consensus 241 -~---~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 241 -P---SVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp -H---HHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred -H---HHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 1 2667999999999999999999995 3444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=347.34 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=205.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999975 478999999997665544455678889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999997643 3899999999999999999999 779999999999999999999999999999876432
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.. -...+....+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~---i~~-~~~~~p~~~~~--- 263 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EK---IVS-GKVRFPSHFSS--- 263 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---HHH-CCCCCCTTCCH---
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-HH---HHc-CCCCCCCCCCH---
Confidence 23457999999999999999999999999999999999999999754321111 00 000 01112222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
.+.+++.+||+.||++||+ +++++++
T Consensus 264 ----~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 264 ----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2667999999999999998 8888753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=340.67 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=198.7
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|.+.+.||+|+||.||+|+.. ++.||+|++.... ..+.|.+|++++++++||||+++++++.+. .++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEE
Confidence 57889999999999999999874 7889999997543 246788999999999999999999998743 689999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-eEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-AFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfg~~~~~~~~ 328 (468)
|+++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999987655445789999999999999999999543379999999999999998887 799999999765422
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||............ .......+......+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---- 230 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTRPPLIKNLP---- 230 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--HHHTTCCCCCBTTCC----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--HHhcCCCCCcccccC----
Confidence 23346899999999999999999999999999999999999999754332211110 000011111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .+.+++.+||+.||++|||++++++.|.....
T Consensus 231 ~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 231 K---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred H---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 26679999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=345.90 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=193.7
Q ss_pred hhCccccceeeeeCCceEEEEEcCCC----CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|..... ..||||++....... ...+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 46799999999999999999986543 279999997654322 3457899999999999999999999999877655
Q ss_pred ------EEEEEeccCCChhhhhhcCc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 245 ------FLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 245 ------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
++||||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 2225899999999999999999999 77999999999999999999999
Q ss_pred EeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~ 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----I 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----h
Confidence 999999987643222 1223456788999999999999999999999999999999 99999765432221110 0
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQ 448 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~ 448 (468)
............ ..+.+++.+||+.||++|||+.++++.|++....++.
T Consensus 254 ~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 GGNRLKQPPECM-------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TTCCCCCCTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cCCCCCCCCccC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 000111111111 1267899999999999999999999999887755543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=352.46 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=206.1
Q ss_pred hCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 57899999999999999999843 4678999999754433 234578899999999999999999999999989
Q ss_pred EEEEEEeccCCChhhhhhcCc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEE
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAFV 316 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl 316 (468)
.++||||+++|+|.+++.... ....+++.+++.++.||+.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997643 2235899999999999999999999 77999999999999999554 5999
Q ss_pred eeccccccccCC--CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccccc
Q 012219 317 ADFGVARLLNFD--SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 317 ~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
+|||+++..... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||........... ...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~----i~~ 301 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----VTS 301 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHT
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc
Confidence 999999865322 122334567899999999999999999999999999999998 9999975443211110 000
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
........... . .+.+++.+||+.||++|||+.++++.|.....
T Consensus 302 ~~~~~~~~~~~----~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 302 GGRMDPPKNCP----G---PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCC----H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 00111111111 1 26679999999999999999999999977653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.48 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=204.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+++++.++||||+++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999975 478999999997654332 35688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999987543 24899999999999999999999 779999999999999974 478999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ..........++......+
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s- 278 (387)
T 1kob_A 202 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKRCDWEFDEDAFSSVS- 278 (387)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHHCCCCCCSSTTTTSC-
T ss_pred CCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCCccccccCC-
Confidence 533 3334557999999999999999999999999999999999999999754322111 1000000001111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .+.+++.+||+.||++|||+.+++++
T Consensus 279 ---~---~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 279 ---P---EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---H---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---H---HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 26679999999999999999999965
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=357.26 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=204.6
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
+....++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999764 689999999976443333334568899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999998753 3889999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC-CceeccccccccccccccCCC----CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC
Q 012219 324 LLNFDSS-NRTLLAGTYGYIAPELAYTMV----VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 324 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
....... .....+||+.|+|||++.+.. ++.++|||||||++|||+||+.||.......... ........+...
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-~i~~~~~~~~~p 295 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-KIMNHKNSLTFP 295 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHTHHHHCCCC
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH-HHHhccccccCC
Confidence 7653322 223467999999999987655 8899999999999999999999997543221111 000000000000
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKS--RPTMQLVSNE 438 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~~v~~~ 438 (468)
.....+ . .+.+++.+||..+|.+ ||+++|++++
T Consensus 296 ~~~~~s----~---~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 DDNDIS----K---EAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TTCCCC----H---HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Cccccc----H---HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011111 1 2567899999999988 9999999965
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=341.27 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=197.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +|+.||+|++....... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57899999999999999999764 58999999987654332 33567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998887543 3899999999999999999999 779999999999999999999999999999877644
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc-------------------
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN------------------- 388 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~------------------- 388 (468)
........||+.|+|||++.+ ..++.++||||||+++|||+||+.||.............
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 444455678999999999876 678999999999999999999999997543321110000
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.......++................+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000111111000000000111236789999999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=355.60 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=206.3
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 240 (468)
+.+.....++|.+.+.||+|+||.||+++. .+|+.||+|++...........+.+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344444568899999999999999999976 4799999999976544333344568899999999999999999999999
Q ss_pred CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999997543 24899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCC-ceecccccccccccccc-------CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc
Q 012219 321 VARLLNFDSSN-RTLLAGTYGYIAPELAY-------TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 321 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 392 (468)
+++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||......... .......
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~~~ 286 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-GKIVHYK 286 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc
Confidence 99876543322 22357999999999987 457899999999999999999999999754322111 0000000
Q ss_pred -cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 012219 393 -DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR---PTMQLVSNE 438 (468)
Q Consensus 393 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~~v~~~ 438 (468)
....+......+. .+.+++.+||. +|++| |++++++++
T Consensus 287 ~~~~~p~~~~~~s~-------~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 EHLSLPLVDEGVPE-------EARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHCCCC----CCCH-------HHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCcCCCccccCCCH-------HHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0101111111111 26678999999 99998 689999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=362.72 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=195.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.............+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999974 57899999999765433333456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997543 4899999999999999999999 5 799999999999999999999999999998654
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||............ . .-...+......
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--~---~~~~~~p~~~~~- 374 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--L---MEEIRFPRTLGP- 374 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H---HCCCCCCTTSCH-
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--H---hCCCCCCccCCH-
Confidence 4444455678999999999999999999999999999999999999999754332111100 0 001112222221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRP-----TMQLVSN 437 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~ 437 (468)
.+.+++.+||+.||++|| +++++++
T Consensus 375 ------~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 375 ------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 266799999999999999 9999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=344.74 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=193.3
Q ss_pred hhCccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
.++|.+.+.||+|+||.||+++. .+++.||+|+++..... .......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999976 57899999999865422 12234567899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997543 3889999999999999999999 7799999999999999999999999999997
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.. ....+....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~---i~~-~~~~~p~~~ 244 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI-DK---ILK-CKLNLPPYL 244 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HH---HHH-TCCCCCTTS
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-HH---HHh-CCCCCCCCC
Confidence 6544434444567999999999999999999999999999999999999999754322111 00 000 011122212
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.. .+.+++.+||+.||++|| ++.+++++
T Consensus 245 ~~-------~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 245 TQ-------EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CH-------HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CH-------HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 21 266789999999999999 77888753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=345.83 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=203.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|...+.||+|+||.||+|+. .+++.||||++...........+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5588899999999999999974 678999999997654444445678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+. |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 68888875432 34899999999999999999999 67999999999999999999999999999976542
Q ss_pred CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC-Cccc
Q 012219 329 SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS-PPVD 404 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 404 (468)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||........... ......+... ...+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWS 279 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCC
Confidence 23357899999999884 56789999999999999999999999875432211111 0111111111 1111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
+ .+.+++.+||+.||++|||+++++++..-...
T Consensus 280 ----~---~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 280 ----E---YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp ----H---HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ----H---HHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 1 26678999999999999999999966544433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=341.88 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=209.5
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+++++++ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46799999999999999999974 35788999999865433 2346789999999999 999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE---------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||.||| +.+|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 999999999999999999976532 224899999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||+| |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9999999999999999876543322 123456788999999998899999999999999999999 9999976543221
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..... .....+......+ ..+.+++.+||+.||++|||+.++++.|++..
T Consensus 257 ~~~~~---~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FYKMI---KEGFRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHH---HHTCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh---ccCCCCCCcccCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11110 0111111111111 12677999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.35 Aligned_cols=247 Identities=23% Similarity=0.248 Sum_probs=191.1
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||+||+|... +++.||||++......... ...+..|+..+.++ +||||++++++|.+.+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999765 7999999998765433322 33445566555555 899999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+ +++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 679988887543 34899999999999999999999 67999999999999999999999999999987643
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... +.. +............
T Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~--------~~~~~~~~~~~~~- 276 (311)
T 3p1a_A 210 A-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--WQQ--------LRQGYLPPEFTAG- 276 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--HHH--------HTTTCCCHHHHTT-
T ss_pred C-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHH--------HhccCCCcccccC-
Confidence 2 23334569999999998876 789999999999999999999766543211 100 0001111101111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+||+.||++|||+++++++
T Consensus 277 --~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 277 --LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11237789999999999999999999853
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.05 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=198.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999975 57999999999864433334567889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 248 YEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|||+++|+|.+++.... ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986522 2344889999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC-Cccch
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS-PPVDQ 405 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 405 (468)
..........|++.|+|||++.+..++.++||||||+++|||++|+.||............. ......+... ....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~- 264 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK--IEQCDYPPLPSDHYS- 264 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH--HHTTCSCCCCTTTSC-
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH--hhcccCCCCcccccC-
Confidence 44433445578999999999999999999999999999999999999986543221111110 0000001111 1111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .+.+++.+||+.||++|||+.++++.|.++..
T Consensus 265 ---~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 265 ---E---ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---H---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1 26679999999999999999999999987753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.89 Aligned_cols=251 Identities=31% Similarity=0.475 Sum_probs=202.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46799999999999999999965 46789999999765554444567789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999987543 3899999999999999999999 78999999999999999999999999999865432
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ..............
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~-- 232 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTE-- 232 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHHTCCCCCTTSCH--
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-----HHhCCCCCCCcCCH--
Confidence 223445789999999999999999999999999999999999999975432211110 00111112221221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.+.+++.+||+.||++|||+++++++-
T Consensus 233 -----~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 233 -----GARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -----HHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -----HHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 256789999999999999999999543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=345.58 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 244 (468)
++|.+.+.||+|+||.||+|+. .+++.||||++...........+.|.+|++++.+++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6799999999999999999974 678999999998765544455678899999999999999999999987643 34
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997543 3899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||............. ......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-------~~~~~~ 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-------REDPIP 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HCCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-------cCCCCC
Confidence 643222 2223468999999999999999999999999999999999999997544322111100 000000
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCH-HHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-~~v~~~l~~~~~~ 445 (468)
. ..........+.+++.+||+.||++||++ +++.+.|.+....
T Consensus 239 ~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 P-SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp H-HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred c-ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 00000011226679999999999999975 6666778776544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=365.35 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=208.8
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|.+. ++..||||+++.... ..+.|.+|++++++++||||++++++|......++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3467899999999999999999865 488999999986543 24679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999976432 34899999999999999999999 7799999999999999999999999999998764
Q ss_pred CCCCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 327 FDSSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 327 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
..... .....++..|+|||++....++.++|||||||++|||+| |+.||......... +.+.........
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~--------~~~~~~~~~~~~ 441 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------ELLEKDYRMERP 441 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------HHHHTTCCCCCC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH--------HHHHcCCCCCCC
Confidence 32211 112345678999999998899999999999999999999 99999765432111 111111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
....+ .+.+++.+||+.||++|||+.++++.|+....
T Consensus 442 ~~~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11111 26779999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.67 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=204.6
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--CEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--KCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 247 (468)
++|.+.+.||+|+||.||+|+.. ++.||||++....... ...+.|.+|++++++++||||+++++++... ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 57899999999999999999984 8899999998654332 3356799999999999999999999999887 778999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+ ++||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999986432 34899999999999999999999 667 999999999999999999999999987543
Q ss_pred cCCCCCceeccccccccccccccCCCCCc---cchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTE---KCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.. ....||+.|+|||.+.+..++. ++||||||+++|||+||+.||............ ......+.....
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV---ALEGLRPTIPPG 235 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH---HHSCCCCCCCTT
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH---HhcCCCCCCCCC
Confidence 22 2246899999999998765544 799999999999999999999765432211110 011111222222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.+. .+.+++.+||+.||++|||++++++.|.+...
T Consensus 236 ~~~-------~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 ISP-------HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 221 26679999999999999999999999988643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.15 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=201.1
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999975 47889999999876554444557889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997543 3899999999999999999999 77999999999999999999999999999977643
Q ss_pred CC-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DS-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||.................. ........+.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~- 263 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPR--PSTVRPGIPV- 263 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCC--GGGTSTTCCT-
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCC--ccccCCCCCH-
Confidence 22 2223456899999999999999999999999999999999999999754332111100000000 0011111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhcCCCC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFIARNKAP 446 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RP-s~~~v~~~l~~~~~~~ 446 (468)
.+.+++.+||+.||++|| +++++++.|++.....
T Consensus 264 ------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 264 ------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 266789999999999999 9999999999876553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=332.48 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=201.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh----hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL----ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|+. .+++.||+|++........ ...+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6799999999999999999975 5789999999975443221 12267889999999999999999999997766
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCC-----eEEe
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLNSELE-----AFVA 317 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~ 317 (468)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999887543 34899999999999999999999 667 999999999999988776 9999
Q ss_pred eccccccccCCCCCceecccccccccccccc--CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAY--TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|||+++... .......|++.|+|||++. ...++.++|||||||++|||++|+.||.............. .....
T Consensus 172 Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 247 (287)
T 4f0f_A 172 DFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-REEGL 247 (287)
T ss_dssp CCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-HHSCC
T ss_pred CCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-hccCC
Confidence 999997543 2344467899999999984 45678999999999999999999999976543322111100 01111
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
.+......+ ..+.+++.+||+.||++|||++++++.|++
T Consensus 248 ~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 RPTIPEDCP-------PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCcccC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 122222222 126779999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.28 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=208.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++... +++.+|+|++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57899999999999999999764 68899999997654333345577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999887543 3899999999999999999999 779999999999999999999999999999877544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||++.+..++.++||||||+++|||++|+.||.............. ..........
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~---- 239 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYSIPKHIN---- 239 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-----TCCCCCTTSC----
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-----ccCCCccccC----
Confidence 4445556799999999999998899999999999999999999999975432211110000 0111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIAR 442 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~ 442 (468)
. .+.+++.+||+.||++|||+++++++ +...
T Consensus 240 ~---~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 240 P---VAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred H---HHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 1 26678999999999999999999964 4443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=345.50 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=207.8
Q ss_pred hhCccccceeeeeCCceEEEEEc--------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||+|.. .++..||+|++...... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 46899999999999999999975 35678999999865432 3456788999999999 8999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
..+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 99999999999999999999976432 224889999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||........
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999999987653322 1223356788999999988889999999999999999999 9999875433211
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
... .............. ..+.+++.+||+.||++|||+.++++.|.++...
T Consensus 269 ~~~----~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 269 FKL----LKEGHRMDKPANCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHH----HHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HhcCCCCCCCccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 110 00111111111111 1267799999999999999999999999887543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=361.03 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=203.5
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..++|.+.+.||+|+||.||+|.+.++..||||+++..... .+.|.+|++++++++||||+++++++.+ +..++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 35678999999999999999999988888999999865432 3678999999999999999999999976 568999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999997532 234889999999999999999999 77999999999999999999999999999987643
Q ss_pred CCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 328 DSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 328 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... ......++..|+|||++....++.++|||||||++|||+| |+.||........... .............+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~~~~~~~~~~~~- 407 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VERGYRMPCPPECP- 407 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCCTTSC-
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC-
Confidence 221 1223456788999999998899999999999999999999 9999976543211110 00101111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+ .+.+++.+||+.||++|||++++++.|+.....
T Consensus 408 ---~---~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 408 ---E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1 267799999999999999999999999887544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.64 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=191.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 367999999999999999999764 7899999999765432 25678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE--AFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999987543 3899999999999999999999 779999999999999987765 999999999754
Q ss_pred cCCCCCceeccccccccccccccCCCCCcc-chhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEK-CDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.. ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||............. ..........+..
T Consensus 169 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 169 VL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---QRILSVKYSIPDD 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH---HHHHTTCCCCCTT
T ss_pred cc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH---HHHhcCCCCCCCc
Confidence 32 222334579999999999988877655 899999999999999999997543321111100 0111111111110
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~s~---~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 IRISP---ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCCCH---HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCH---HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00111 26679999999999999999999954
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.14 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=207.6
Q ss_pred HHhhCccccceeeeeCCceEEEEEcCC------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
...++|.+.+.||+|+||.||+|.... ...||+|.+...... ...+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345789999999999999999997532 347999999865433 2356789999999999 8999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
..+..++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 99999999999999999999875321 234789999999999999999999 7799999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhh
Q 012219 309 NSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSL 385 (468)
Q Consensus 309 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~ 385 (468)
+.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||+| |..||..........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 99999999999999866433222 223456788999999998899999999999999999999 999987644322111
Q ss_pred hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
... ............+ ..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 278 ~~~---~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 278 KLV---KDGYQMAQPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHH---HHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---hcCCCCCCCCCCC-------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 100 0001111111111 12667999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.87 Aligned_cols=258 Identities=17% Similarity=0.214 Sum_probs=204.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++...... +.+.+|+++++++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 5799999999999999999974 67899999998755332 3577999999999 999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-----eEEeecccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-----AFVADFGVA 322 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfg~~ 322 (468)
|||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 9999 999999998642 34899999999999999999999 779999999999999999887 999999999
Q ss_pred ccccCCCCC-------ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 323 RLLNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 323 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~-~~~i~~~- 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER-YQKIGDT- 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH-HHHHHHH-
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH-HHHHHhh-
Confidence 876433221 2346799999999999999999999999999999999999999986432211000 0000000
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
....+..... .....+.+++..||+.||.+||+++++.+.|....
T Consensus 236 --~~~~~~~~~~-~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 236 --KRATPIEVLC-ENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp --HHHSCHHHHT-TTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred --hccCCHHHHh-ccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000000000 00014778999999999999999999999887553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=344.72 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=177.2
Q ss_pred cceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEEecc
Q 012219 175 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+|++++..+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 37899999999999976 468999999996532 246678999999997 9999999999999999999999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEeeccccccccCCC
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARLLNFDS 329 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~~~~~~~~~ 329 (468)
+|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 90 GGELFERIKKKK---HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp SCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999998653 4899999999999999999999 77999999999999998765 89999999998765554
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..................+........ ......
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~ 242 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-GEAWKN 242 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-SHHHHT
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-cccccC
Confidence 4555667899999999999999999999999999999999999999754321100000000011111111111 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+.+++.+||+.||++|||+++++++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12237789999999999999999998843
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.35 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=193.9
Q ss_pred hhCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|.... +..||+|++...... ...+.|.+|+.++++++||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 4679999999999999999997642 457999998764332 34567899999999999999999999985 4567
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 89999999999999997643 24899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 325 LNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 325 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... ......+++.|+|||++....++.++||||||+++|||++ |+.||........... +...........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~ 241 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGERLPMPPN 241 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTCCCCCCTT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----HHcCCCCCCCCC
Confidence 643222 1223456788999999998899999999999999999997 9999976543221110 000001111121
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.+ ..+.+++.+||+.||++|||+.++++.|..+.
T Consensus 242 ~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 242 CP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22 12667999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.36 Aligned_cols=264 Identities=21% Similarity=0.298 Sum_probs=189.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 46789999999999999999976 46899999999765432 2335688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDE---EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
|||++ |+|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 59998886532 2234889999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-----------ccccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK-----------NIKLI 392 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~-----------~~~~~ 392 (468)
............||+.|+|||++.+ ..++.++|||||||++|||+||+.||............ .....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 7544444455678999999999876 46899999999999999999999999754321110000 00000
Q ss_pred c--ccCCCCCCccchhHHH---------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 D--LLDPRLSPPVDQKIRQ---------DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ~--~~~~~~~~~~~~~~~~---------~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ...+...........+ ....+.+++.+||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000000000000 01237789999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=349.86 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=192.5
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHH-HhhccCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARL-LSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999764 688999999986654333344566677776 577899999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997643 3889999999999999999999 7799999999999999999999999999998754
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .+... ...+......
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~---~i~~~-~~~~~~~~~~- 264 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-D---NILNK-PLQLKPNITN- 264 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-H---HHHHS-CCCCCSSSCH-
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-H---HHHhc-ccCCCCCCCH-
Confidence 4444455678999999999999999999999999999999999999999754322111 0 00000 1111222221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQ 433 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ 433 (468)
.+.+++.+||+.||++||++.
T Consensus 265 ------~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 265 ------SARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ------HHHHHHHHHTCSSGGGSTTTT
T ss_pred ------HHHHHHHHHcccCHHhCCCCC
Confidence 256789999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=344.45 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=199.8
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCE----EEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKV----VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|... +++. ||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 57889999999999999999753 4443 788887544322 223457789999999999999999999874 458
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+++|+|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 899999999999999976532 4888999999999999999999 77999999999999999999999999999988
Q ss_pred ccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||............ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 240 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKGERLAQPQ 240 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTTCBCCCCT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCCCCCC
Confidence 754322 2334567889999999998999999999999999999999 99999765432211110 0000111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.... .+.+++.+||+.||++|||+.++++.|......
T Consensus 241 ~~~~-------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 241 ICTI-------DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TBCT-------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCcH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 155688899999999999999999999887543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=333.63 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=207.9
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 3578899999999999999999888899999999865433 357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999997643 24889999999999999999999 779999999999999999999999999999865321
Q ss_pred C-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 S-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .......++..|+|||++.+..++.++||||||+++|||++ |+.||........... .............+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~~~~~~~~~~~~-- 231 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGFRLYKPRLAS-- 231 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTCCCCCCTTSC--
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----HhcCCcCCCCccCc--
Confidence 1 11122356778999999998889999999999999999999 8999875432211110 00101111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
. .+.+++.+||+.||++|||+.++++.|.++.+
T Consensus 232 --~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 232 --T---HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 26679999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=350.71 Aligned_cols=265 Identities=17% Similarity=0.229 Sum_probs=201.5
Q ss_pred hhCccccceeeeeCCceEEEEEcCC------CCEEEEEEecCcchhhhhhH--------HHHHHHHHHHhhccCCceeeE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASL--------ESFGNEARLLSQIRHRNIVKL 234 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~h~niv~l 234 (468)
.++|.+.+.||+|+||.||+|.+.+ ++.||||++........... ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998654 47899999876653211111 234456667788899999999
Q ss_pred EEEEeeC----CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-
Q 012219 235 YGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN- 309 (468)
Q Consensus 235 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~- 309 (468)
++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence 9998764 4589999999 999999997643 34899999999999999999999 77999999999999999
Q ss_pred -CCCCeEEeeccccccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccccc
Q 012219 310 -SELEAFVADFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSS 381 (468)
Q Consensus 310 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~ 381 (468)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987643221 113345999999999999999999999999999999999999999853322
Q ss_pred chhhh-----cccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 382 SWSLD-----KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 382 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
..... ......+.+++.+... .....+.+++..||+.||++||+++++++.|......
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAA------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTT------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccc------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11110 0011112222111100 0012367899999999999999999999998776543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=347.41 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=203.3
Q ss_pred hhCccccceeeee--CCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 169 TEDFHIKYCIGTG--GYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
.++|.+.+.||+| +||.||+|+.. +++.||||++....... ...+.+.+|+++++.++||||+++++++...+..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4679999999999 99999999764 79999999997654332 34567889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999976532 33899999999999999999999 779999999999999999999999999988654
Q ss_pred cCCC-------CCceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc-cccccc
Q 012219 326 NFDS-------SNRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI-KLIDLL 395 (468)
Q Consensus 326 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~ 395 (468)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 11222468899999999987 6799999999999999999999999976443222111100 000000
Q ss_pred CCCCCC---------------------------------ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRLSP---------------------------------PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~~~---------------------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+..... ............+.+++.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 0000000011237789999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.86 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=209.1
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||++... +++.||+|++...........+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999754 5889999999765433334557788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.... .+++.+++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999887543 3899999999999999999999 77999999999999999999999999999987754
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||.............. ....+......
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~-- 266 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYSIPKHINP-- 266 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----TCCCCCTTSCH--
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc-----CCCCCCccCCH--
Confidence 44445556799999999999998999999999999999999999999975432211110000 01111111211
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
.+.+++.+||+.||++|||++++++ .|...
T Consensus 267 -----~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 267 -----VAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp -----HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -----HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 2667899999999999999999995 34443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.45 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=196.1
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--CceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--RNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||++...+++.||||++....... ...+.+.+|++++.+++| +||+++++++......++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 5689999999999999999998889999999997654332 345788999999999986 9999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|| +.+|+|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 56789999998643 3899999999999999999999 77999999999999997 57899999999987643
Q ss_pred CCC--CceeccccccccccccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 328 DSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 328 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~ 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------HAI 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH------HHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH------HHH
Confidence 322 2234579999999999864 678899999999999999999999997543221111 111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
+++............ .+.+++.+||+.||++|||+.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 IDPNHEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HCTTSCCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcCCcccCCcccCCH---HHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111111111111 266799999999999999999998543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.89 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=197.0
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc--CCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR--HRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 459999999999999999999888999999999765432 234578899999999996 59999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|| +.+++|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999998654 4889999999999999999999 78999999999999996 58999999999987643
Q ss_pred CCC--CceeccccccccccccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 328 DSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 328 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------~~~~ 280 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAI 280 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH------HHHH
Confidence 222 2234579999999999865 36889999999999999999999999754321111 1111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
+++............ .+.+++.+||+.||++|||+.+++++-
T Consensus 281 ~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HCTTSCCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hCccccCCCCccchH---HHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 222111111111111 266799999999999999999999543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=334.19 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=194.9
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|+..+ .||+|+++...... ...+.|.+|++++++++||||+++++++. ....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3679999999999999999998743 59999997654332 34578999999999999999999999764 45578999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999996543 34899999999999999999999 779999999999999999999999999999765421
Q ss_pred --CCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 --SSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 --~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
........||+.|+|||++. ...++.++||||||+++|||++|+.||.............. .....+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 251 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--RGSLSPDLSKVR 251 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH--HTSCCCCTTSSC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc--ccccCcchhhcc
Confidence 12223456899999999986 56788899999999999999999999976543222111100 001111111100
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.. ....+.+++.+||+.||++|||+.++++.|++..+
T Consensus 252 ~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 252 SN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 01 11227789999999999999999999999988654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=349.11 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=199.0
Q ss_pred CccccceeeeeCCceEEEEEcC--CC--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP--SG--KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCMF 245 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 245 (468)
.|.+.+.||+|+||.||+|... ++ ..||||.+...... ...+.|.+|+.++++++||||++++++|.. .+..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4677789999999999999753 22 46899998754322 345789999999999999999999999765 45789
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999975432 3788999999999999999999 779999999999999999999999999999866
Q ss_pred cCCCC----CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCC
Q 012219 326 NFDSS----NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 326 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... ......+++.|+|||++.+..++.++|||||||++|||+| |.+||............ .........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~~~~~p 318 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRRLLQP 318 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTCCCCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCCCCCCC
Confidence 43221 1223456788999999999999999999999999999999 77787654332211110 000011111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCCCcccc
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEI 454 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~~~~~~ 454 (468)
...+ . .+.+++.+||+.||++|||+.++++.|.++........+.++
T Consensus 319 ~~~~----~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~ 365 (373)
T 3c1x_A 319 EYCP----D---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 365 (373)
T ss_dssp TTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCC
T ss_pred CCCC----H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeec
Confidence 1111 1 267799999999999999999999999988766665555544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=345.42 Aligned_cols=248 Identities=22% Similarity=0.278 Sum_probs=193.6
Q ss_pred cccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 173 HIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
...+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3356899999999999975 57899999999876543 3467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--CCCCCeEEeeccccccccCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL--NSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 9999999887543 23899999999999999999999 7799999999999999 66789999999999876533
Q ss_pred CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHH
Q 012219 330 SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQ 409 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (468)
.......||+.|+|||++....++.++|||||||++|||++|+.||........... .... .............
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-i~~~----~~~~~~~~~~~~~- 316 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN-ILAC----RWDLEDEEFQDIS- 316 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHHT----CCCSCSGGGTTSC-
T ss_pred cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc----cCCCChhhhccCC-
Confidence 223345699999999999989999999999999999999999999975432211100 0000 0001111001111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 410 DIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 410 ~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+.+++.+||+.||++|||+.++++
T Consensus 317 --~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 --EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22678999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=343.11 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh--hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
+....++|.+.+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445567899999999999999999975 57889999999754321 123457889999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------AVGLDWAKRVNVVKGMCHA 284 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~ 284 (468)
+..++||||+++|+|.+++..... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852100 1123567788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceeeCCCC--CeEEeeccccccccCCCC----CceeccccccccccccccC--CCCCccc
Q 012219 285 LSYLHHDCTPPIVHRDISSNNVLLNSEL--EAFVADFGVARLLNFDSS----NRTLLAGTYGYIAPELAYT--MVVTEKC 356 (468)
Q Consensus 285 l~~LH~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 356 (468)
|+||| +.+|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 77999999999999998776 899999999986543211 2344579999999999865 6789999
Q ss_pred hhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 012219 357 DVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVS 436 (468)
Q Consensus 357 Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~ 436 (468)
|||||||++|||++|+.||................ .....+...... ..+.+++.+||+.||++|||+.+++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK-----LCFENPNYNVLS---PLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----CCTTSGGGGGSC---HHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc-----cccCCcccccCC---HHHHHHHHHHcCCChhHCCCHHHHh
Confidence 99999999999999999997544321111100000 001111111111 1267899999999999999999998
Q ss_pred HH
Q 012219 437 NE 438 (468)
Q Consensus 437 ~~ 438 (468)
++
T Consensus 330 ~h 331 (345)
T 3hko_A 330 QH 331 (345)
T ss_dssp HS
T ss_pred cC
Confidence 54
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.72 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=210.1
Q ss_pred HHHHHhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 164 DMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
++....++|.+.+.||+|+||.||+|... +++.||+|.+...... .....|.+|+++++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34445678999999999999999999653 4788999999765433 234678899999999999999999999
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCcc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS 310 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~ 310 (468)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcC
Confidence 9999999999999999999999875321 234789999999999999999999 779999999999999999
Q ss_pred CCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhc
Q 012219 311 ELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDK 387 (468)
Q Consensus 311 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~ 387 (468)
++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||+| |+.||............
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999999865432211 122356788999999998899999999999999999999 89998754332111100
Q ss_pred ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 388 NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
.. ... +......+ ..+.+++.+||+.||++|||+.++++.|++...
T Consensus 254 ~~--~~~--~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 ME--GGL--LDKPDNCP-------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HT--TCC--CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Hc--CCc--CCCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00 000 11111111 126679999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.72 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=202.0
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC--C
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR--K 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 242 (468)
++|++.+.||+|+||.||+|++ .+++.||+|++...... ...+.+.+|++++++++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4688899999999999999983 46899999999865432 3457788999999999999999999999876 6
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence 6899999999999999996543 23899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh-------hhcccccc
Q 012219 323 RLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS-------LDKNIKLI 392 (468)
Q Consensus 323 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~~~~~~ 392 (468)
+....... ......+|..|+|||++.+..++.++||||||+++|||+||+.|+......... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87654332 223346788899999999999999999999999999999999986432110000 00000001
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+............. ..+.+++.+||+.||++|||+.++++.|++.
T Consensus 254 ~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHTTCCCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111111111111111 1267899999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=334.83 Aligned_cols=253 Identities=21% Similarity=0.391 Sum_probs=200.2
Q ss_pred hCccccceeeeeCCceEEEEEcCC-C-------CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-G-------KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
++|.+.+.||+|+||.||+|.... + ..||+|++..... ...+.|.+|++++++++||||+++++++...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 578999999999999999997542 3 5799999975443 2356789999999999999999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-------- 313 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-------- 313 (468)
+..++||||+++|+|.+++..... .+++..++.++.||+.||.||| +.+|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999986543 3889999999999999999999 779999999999999998887
Q ss_pred eEEeeccccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCC-CCCCcccccchhhhccccc
Q 012219 314 AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGK-HPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~ 391 (468)
+||+|||++.... ......+++.|+|||++.+ ..++.++||||||+++|||++|. .|+........... ...
T Consensus 160 ~kl~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~- 233 (289)
T 4fvq_A 160 IKLSDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YED- 233 (289)
T ss_dssp EEECCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT-
T ss_pred eeeccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhc-
Confidence 9999999986542 2233468899999999987 67899999999999999999955 45543322111110 000
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
........... +.+++.+||+.||++|||++++++.|.+...+..
T Consensus 234 ----~~~~~~~~~~~-------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 234 ----RHQLPAPKAAE-------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ----TCCCCCCSSCT-------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ----cCCCCCCCCHH-------HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11111111111 5678999999999999999999999998865433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=346.22 Aligned_cols=273 Identities=18% Similarity=0.216 Sum_probs=203.0
Q ss_pred hCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhh--------hHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELA--------SLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
++|.+.+.||+|+||.||+|... ++..+|+|++......... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999864 5788999999765432111 12346788899999999999999999
Q ss_pred Eee----CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-
Q 012219 238 CLH----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL- 312 (468)
Q Consensus 238 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~- 312 (468)
+.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence 988 77899999999 999999997654 4899999999999999999999 77999999999999999887
Q ss_pred -CeEEeeccccccccCCC-------CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh
Q 012219 313 -EAFVADFGVARLLNFDS-------SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS 384 (468)
Q Consensus 313 -~~kl~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~ 384 (468)
.+||+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999998764221 1123457899999999999999999999999999999999999999643221111
Q ss_pred hh-cccccccccCCCCCCccchhHH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCCCccc
Q 012219 385 LD-KNIKLIDLLDPRLSPPVDQKIR--QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHE 453 (468)
Q Consensus 385 ~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~~~~~ 453 (468)
.. ....... ........... .....+.+++.+||+.||++|||+++|++.|+.......+..+..
T Consensus 270 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~~ 337 (345)
T 2v62_A 270 VQTAKTNLLD----ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFST 337 (345)
T ss_dssp HHHHHHHHHH----TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCCC
T ss_pred HHHHHHhhcc----cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCccc
Confidence 10 0000000 00000000000 011137789999999999999999999999998776555554443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=357.23 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=207.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|++++++++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6788889999999999999976 469999999998665544445678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++|+|.+++..... ...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876432 345899999999999999999999 77999999999999999999999999999987754
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||...............+.. ....+....+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~-- 418 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSP-- 418 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCH--
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCH--
Confidence 444444568999999999999999999999999999999999999999754321110000000000 01111222221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTM-----QLVSN 437 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~-----~~v~~ 437 (468)
.+.+++.+||+.||++||++ +++++
T Consensus 419 -----~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 419 -----ASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 26678999999999999975 66764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=349.95 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=208.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC--EEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK--CMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 246 (468)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++.... ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 57899999999999999999764 5899999999764432 23567889999999999999999999998755 6899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEeecccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL----NSELEAFVADFGVA 322 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfg~~ 322 (468)
||||+++|+|.+++........+++..++.++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999987655555999999999999999999999 7799999999999999 77888999999999
Q ss_pred ccccCCCCCceeccccccccccccccC--------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc--
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT--------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI-- 392 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-- 392 (468)
+...... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||.................
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 8764322 2234569999999998865 5678899999999999999999999864332111000000000
Q ss_pred ----------cc------cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 393 ----------DL------LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 393 ----------~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.. ....+.... .........+.+++.+||+.||++||+++++++.+..+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTC-SSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCccc-ccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00 000111100 11122333477899999999999999999999998876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=358.67 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=207.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999976 47999999999765544444556788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999997643 234899999999999999999999 77999999999999999999999999999987653
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...........+....+.
T Consensus 339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~-i~~~i~~~~~~~p~~~s~-- 414 (576)
T 2acx_A 339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEVPEEYSERFSP-- 414 (576)
T ss_dssp T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH-HHHHHHHCCCCCCTTSCH--
T ss_pred C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH-HHHHhhcccccCCccCCH--
Confidence 2 233445899999999999999999999999999999999999999975432111000 000000111122222221
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+.+++.+||+.||++|| +++|++++
T Consensus 415 -----~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 -----QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 266799999999999999 78888853
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=337.63 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=208.4
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|... ++..||+|++...... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3578999999999999999999764 5889999999765432 4678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999976432 34899999999999999999999 6799999999999999999999999999998765
Q ss_pred CCCCC-ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 327 FDSSN-RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 327 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||........... .............+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 238 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRMERPEGCP 238 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHTTCCCCCCTTCC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhccCCCCCCCCCC
Confidence 33221 122356788999999998899999999999999999999 9999875443221111 01111111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 -------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 239 -------EKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1267799999999999999999999998765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.25 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=204.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++........ ...+.+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35799999999999999999975 4689999999976543211 1356788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeecc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFG 320 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 320 (468)
++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997543 3889999999999999999999 77999999999999999988 79999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ... ......
T Consensus 165 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~-~~~~~~ 238 (321)
T 2a2a_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITS-VSYDFD 238 (321)
T ss_dssp TCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHT-TCCCCC
T ss_pred cceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHh-cccccC
Confidence 99876532 223445689999999999999999999999999999999999999975432211110 000 000111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .....+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFS---HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhc---ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 111236789999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.25 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=187.9
Q ss_pred hCcccc-ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh-ccCCceeeEEEEEee----CC
Q 012219 170 EDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQ-IRHRNIVKLYGFCLH----RK 242 (468)
Q Consensus 170 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~ 242 (468)
++|.+. +.||+|+||+||++.. .+++.||||++... ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 466665 6899999999999975 46899999999643 245578887744 589999999998875 56
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeec
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADF 319 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Df 319 (468)
..++||||+++|+|.+++.... ...+++.++..++.||+.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence 7899999999999999997643 234899999999999999999999 779999999999999998 789999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh--hhcccccccccCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS--LDKNIKLIDLLDP 397 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 397 (468)
|+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... .
T Consensus 209 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~---~ 284 (400)
T 1nxk_A 209 GFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---Y 284 (400)
T ss_dssp TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC---C
T ss_pred ccccccCC-CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc---c
Confidence 99987542 22334567899999999999999999999999999999999999999754322110 000000000 0
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
............ .+.+++.+||+.||++|||+.+++++-
T Consensus 285 ~~~~~~~~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 EFPNPEWSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCCTTTTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCCcccccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 111110011111 266799999999999999999999653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.30 Aligned_cols=263 Identities=16% Similarity=0.254 Sum_probs=199.2
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEE-eeCCEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFC-LHRKCMF 245 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~ 245 (468)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... +.+.+|++++..++|++++..++++ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 357899999999999999999974 67899999987654432 3577899999999988877766655 5677889
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVA 322 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~ 322 (468)
+||||+ +++|.+++..... .+++..++.++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 9999999975432 3899999999999999999999 7799999999999999 78899999999999
Q ss_pred ccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 323 RLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 323 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~ 231 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ERIS 231 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH----HHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh----hhhh
Confidence 87654322 223457899999999999999999999999999999999999999764332110000 0000
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
......+...........+.+++.+||+.||++|||++++++.|......
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00000000000000012377899999999999999999999998876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=329.20 Aligned_cols=253 Identities=27% Similarity=0.450 Sum_probs=206.2
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999764 67889999997654443344567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999997643 3899999999999999999999 78999999999999999999999999999876542
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||........... .. ..+..+....+.
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~--- 237 (284)
T 2vgo_A 167 -LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IV-NVDLKFPPFLSD--- 237 (284)
T ss_dssp -SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTCCCCCTTSCH---
T ss_pred -cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH----Hh-ccccCCCCcCCH---
Confidence 223345789999999999999999999999999999999999999975432211110 00 011122222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
.+.+++.+||+.||++|||++++++ .+.+.
T Consensus 238 ----~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 238 ----GSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ----HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 2667999999999999999999995 34433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.45 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=203.3
Q ss_pred ccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEE
Q 012219 172 FHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCM 244 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 244 (468)
|.+.+.||+|+||.||++.+ .+++.||||++...... ...+.+.+|++++++++||||+++++++.+ ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48899999999999998854 26889999999865432 345678999999999999999999999987 4678
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999997543 899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-------hcccccccc
Q 012219 325 LNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL-------DKNIKLIDL 394 (468)
Q Consensus 325 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~-------~~~~~~~~~ 394 (468)
...... ......++..|+|||++.+..++.++||||||+++|||+||+.||.......... .......+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 654322 1223457888999999998899999999999999999999999986432210000 000011111
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+............. ..+.+++.+||+.||++|||++++++.|+...
T Consensus 264 ~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCcccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111111111111 22778999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=333.45 Aligned_cols=250 Identities=30% Similarity=0.431 Sum_probs=206.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|.+.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5688999999999999999974 57899999999765433 24578899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999998642 4899999999999999999999 779999999999999999999999999999877544
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........|++.|+|||++.+..++.++||||||+++|||++|+.||........... ......+.+....+.
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~--- 245 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNNPPTLEGNYSK--- 245 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCSSCCH---
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCCCCCCccccCH---
Confidence 4444556789999999999999999999999999999999999999875433211111 011111122222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
.+.+++.+||+.||++|||+.+++++.
T Consensus 246 ----~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 246 ----PLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ----HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ----HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 266799999999999999999999654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.19 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=190.9
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57889999999999999999764 78999999997554321 1124557999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++ |+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9997 589888876433 4889999999999999999999 779999999999999999999999999999876544
Q ss_pred CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC-----------
Q 012219 329 SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD----------- 396 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 396 (468)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 444455678999999999876 56899999999999999999999999754322110000000000000
Q ss_pred ------CCCCCc-cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 397 ------PRLSPP-VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 397 ------~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
+..... ...........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00000001123678999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=334.43 Aligned_cols=259 Identities=17% Similarity=0.235 Sum_probs=202.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEE-eeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFC-LHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|+. .+++.||||++...... +.+.+|+++++.++|++++..++++ ......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46799999999999999999975 67999999998765432 3578999999999988866666655 56778899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~ 323 (468)
||||+ +++|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 899999997543 24899999999999999999999 7799999999999999 488999999999998
Q ss_pred cccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh--hhcc-ccccc
Q 012219 324 LLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS--LDKN-IKLID 393 (468)
Q Consensus 324 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~--~~~~-~~~~~ 393 (468)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654322 123457999999999999999999999999999999999999999764321110 0000 00000
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 394 LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
...+......+ ..+.+++.+||+.||++|||++++++.|.+....
T Consensus 237 ~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 237 TPIEVLCKGYP-------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SCHHHHTTTSC-------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CchHHHHhhCC-------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00000001111 2277899999999999999999999999876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=331.53 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=204.6
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.. +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 4679999999999999999999888889999999765432 4678899999999999999999999875 4578999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... ...+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999997532 224899999999999999999999 779999999999999999999999999999876432
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... .............+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~-- 236 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERGYRMVRPDNCP-- 236 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCCTTCC--
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----HhcccCCCCccccc--
Confidence 21 1122346778999999988889999999999999999999 9999875433211110 00111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+.+++.+|++.||++|||++++++.|....
T Consensus 237 -----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 237 -----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 12677999999999999999999999887653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=336.42 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=203.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMF 245 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 245 (468)
.++|.+.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 36799999999999999999975 478999999997654322 345678999999999999999999998854 57899
Q ss_pred EEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceeeCCCCCeEEeec
Q 012219 246 LIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPP-----IVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
+||||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999997543 2334899999999999999999999 445 999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
|+++.............|++.|+|||.+.+..++.++||||||+++|||+||+.||.......... .+.....+.+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~i~~~~~~~~ 236 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKFRRI 236 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH----HHhhcccccC
Confidence 999876543333334578999999999999899999999999999999999999997653221110 0001001111
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
....+ . .+.+++.+||+.||++|||++++++++...
T Consensus 237 ~~~~~----~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 237 PYRYS----D---ELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CTTSC----H---HHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred CcccC----H---HHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11111 1 267799999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=340.85 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=201.5
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhh-----hhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEEL-----ASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
..++|.+.+.||+|+||.||+|. ..+++.||||++........ ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35689999999999999999997 45789999999986542211 1234567899999999999999999999999
Q ss_pred CEEEEEEEeccCC-ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 242 KCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 242 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
+..++||||+.+| +|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999987654 3899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+++..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+
T Consensus 176 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~~~-- 243 (335)
T 3dls_A 176 SAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------EAAIHP-- 243 (335)
T ss_dssp TCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------TTCCCC--
T ss_pred cceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------hhccCC--
Confidence 99876533 33344679999999999988776 789999999999999999999997532110 000000
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+ . .+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~----~---~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PYLVS----K---ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CcccC----H---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1 26679999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.18 Aligned_cols=268 Identities=22% Similarity=0.334 Sum_probs=211.1
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceee
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVK 233 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 233 (468)
...++....++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++.++ +||||++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeee
Confidence 3444555568899999999999999999963 35789999999865433 2346788999999999 7999999
Q ss_pred EEEEEeeCC-EEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 012219 234 LYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHR 299 (468)
Q Consensus 234 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 299 (468)
+++++...+ ..++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999988754 48999999999999999976543 122789999999999999999999 7799999
Q ss_pred CCCCCceeeCCCCCeEEeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCC
Q 012219 300 DISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGE 376 (468)
Q Consensus 300 dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~ 376 (468)
||||+||+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999876433222 123457889999999999999999999999999999998 999997
Q ss_pred cccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 377 LLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
........... .............. ..+.+++.+||+.||++|||+.+++++|....
T Consensus 253 ~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 253 GVKIDEEFCRR---LKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TCCCSHHHHHH---HHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHHH---hccCccCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 54432211111 00101111111111 12677999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=331.04 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=203.2
Q ss_pred hCccccc-eeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+ .||+|+||.||+|... ++..||+|+++..... ...+.+.+|++++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 4566666 8999999999999753 6788999999875432 3457789999999999999999999999 455689
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999997533 34899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||........... +.....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~~~~~~~~~ 236 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGKRMECPP 236 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHTTCCCCCCT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HhcCCcCCCCC
Confidence 433221 122346789999999988889999999999999999999 9999976543221110 00111111222
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+ ..+.+++.+||+.||++||++.++++.|....
T Consensus 237 ~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 237 ECP-------PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222 12677999999999999999999999987653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=333.31 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=201.0
Q ss_pred hCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 244 (468)
.+|.+.+.||+|+||.||+|...+ ...+|+|.+...... ...+.+.+|++++++++||||+++++++.. ++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH--HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 468888999999999999997532 235899998764433 345778999999999999999999998654 5578
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999997543 34789999999999999999999 77999999999999999999999999999986
Q ss_pred ccCCC----CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCC
Q 012219 325 LNFDS----SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 325 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||............. .......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 253 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRRLLQ 253 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----TTCCCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----cCCCCCC
Confidence 54321 12233457789999999999999999999999999999999 566665443322111110 0001111
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCC
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAP 446 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~ 446 (468)
....+ . .+.+++.+||+.||++|||++++++.|.++....
T Consensus 254 ~~~~~----~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 PEYCP----D---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CccCC----H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 1 2677999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=331.35 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=196.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||++.. .++..+|+|++...... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 5799999999999999999975 56899999999765432 23567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccccc
Q 012219 249 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVARL 324 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~ 324 (468)
||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999886532 2345899999999999999999999 7799999999999999 5568899999999977
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......|++.|+|||++. ..++.++||||||+++|||++|+.||............ ....+.......
T Consensus 177 ~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~~ 249 (285)
T 3is5_A 177 FKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-----TYKEPNYAVECR 249 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCCCCC--C
T ss_pred cCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-----ccCCcccccccC
Confidence 6432 2334457899999999875 56889999999999999999999999754432211110 000111111100
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
... ..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 PLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 12667999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.13 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=206.0
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe--eCC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL--HRK 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~ 242 (468)
++|.+.+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++++++||||+++++++. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH---HHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 6799999999999999999983 46889999999876443 3467889999999999999999999887 456
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++++|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred eEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 78999999999999999976432 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-------cccccc
Q 012219 323 RLLNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-------KNIKLI 392 (468)
Q Consensus 323 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-------~~~~~~ 392 (468)
+....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||........... ......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87653322 12234578889999999988899999999999999999999999864322110000 000011
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
+.+............. ..+.+++.+||+.||++|||+.++++.|+....
T Consensus 255 ~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACP---AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhcccCCCCCCccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111111111 126789999999999999999999999988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=331.86 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=203.3
Q ss_pred CccccceeeeeCCceEEEEEcC-C---CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE-E
Q 012219 171 DFHIKYCIGTGGYGSVYRARLP-S---GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM-F 245 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~ 245 (468)
.|...+.||+|+||.||+|... + +..+|+|.+...... ...+.|.+|++++++++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4556689999999999999742 2 237999999764433 3457889999999999999999999999876554 9
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|+||+.+|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999997643 34789999999999999999999 779999999999999999999999999999765
Q ss_pred cCC----CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC-CCcccccchhhhcccccccccCCCCC
Q 012219 326 NFD----SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP-GELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 326 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
... ........+++.|+|||.+.+..++.++||||||+++|||+||..| |......... .. ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~-~~---~~~~~~~~~~ 250 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-HF---LAQGRRLPQP 250 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH-HH---HHTTCCCCCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH-HH---hhcCCCCCCC
Confidence 321 1222335678899999999999999999999999999999995555 4432221111 10 0000011111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCCCc
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPF 451 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~~~ 451 (468)
...+ + .+.+++.+||+.||++|||++++++.|.+.........+
T Consensus 251 ~~~~----~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 251 EYCP----D---SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp TTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred ccch----H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 1111 1 267799999999999999999999999887665444444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.33 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 467999999999999999999764 7899999999754432 2346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999986543 3899999999999999999999 77999999999999999999999999999976542
Q ss_pred CC--CCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 328 DS--SNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 328 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.................. .. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~-~~~- 231 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----YL-NPW- 231 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----TS-TTG-
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----cc-Cch-
Confidence 22 22334568999999999987665 77899999999999999999999764432211111100000 00 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 232 KKIDS---APLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhcCH---HHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11111 26679999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=333.92 Aligned_cols=264 Identities=25% Similarity=0.315 Sum_probs=197.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh--hhhhHHHHHHHHHHHhhcc---CCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFGNEARLLSQIR---HRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||+||+|+. .+++.||+|++...... .......+.+|++++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999985 57899999998743311 1111235567777777665 999999999998754
Q ss_pred -----EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 243 -----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 243 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
..++||||+. |+|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5899999997 599999976543 33899999999999999999999 7799999999999999999999999
Q ss_pred eccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccc------
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL------ 391 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~------ 391 (468)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876432 33345678999999999999999999999999999999999999997543321110000000
Q ss_pred -----c----cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 392 -----I----DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 392 -----~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ....+...........+....+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 0000000000000000111236789999999999999999998854
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=334.70 Aligned_cols=262 Identities=22% Similarity=0.362 Sum_probs=196.8
Q ss_pred HhhCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
..++|.+.+.||+|+||.||+|... .+..||+|++....... ...+.+.+|++++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 4578999999999999999999653 34589999997654332 345678999999999999999999999987543
Q ss_pred -----EEEEEEeccCCChhhhhhcC---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 244 -----MFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 244 -----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
.++||||+++|+|.+++... .....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 59999999999999998542 22345899999999999999999999 78999999999999999999999
Q ss_pred EeeccccccccCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........... ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~ 263 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY----LL 263 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----HH
Confidence 99999998764322 12233457889999999999999999999999999999999 8999875443221111 00
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
....+....... ..+.+++.+||+.||++|||+.++++.|.+...
T Consensus 264 ~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 HGHRLKQPEDCL-------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TTCCCCCBTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCcccc-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 001111111111 126779999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=337.58 Aligned_cols=258 Identities=29% Similarity=0.391 Sum_probs=199.7
Q ss_pred hCccccceeeeeCCceEEEEEcCC-----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|.... +..||||++...... .....|.+|++++++++||||+++++++...+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 467788999999999999997532 246999999765433 2346789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... ..+++.+++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999997643 34899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCC
Q 012219 325 LNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 325 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.......... ...+.......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~~~~~~~~~ 272 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AINDGFRLPTP 272 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTTCCCCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHHCCCcCCCc
Confidence 6432211 122345778999999998999999999999999999999 999997543221110 00111111111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.... ..+.+++.+||+.||++||++.++++.|.+....
T Consensus 273 ~~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 273 MDCP-------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TTCB-------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 1267799999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=328.69 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=200.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .++..+|+|++...... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 46799999999999999999975 45779999999765432 346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~ 324 (468)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999887543 3899999999999999999999 7799999999999999 7889999999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......||+.|+|||++.+. ++.++||||||+++|||++|+.||............ .......+.
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~- 228 (277)
T 3f3z_A 159 FKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------REGTFTFPE- 228 (277)
T ss_dssp CCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCCCCH-
T ss_pred ccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCCCCCCc-
Confidence 6533 333445799999999988654 899999999999999999999999754332111110 000011100
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.........+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001123678999999999999999999884
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=329.08 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=197.4
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999764 79999999997655444445678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++.... .+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999997543 3899999999999999999999 679999999999999999999999999999876432
Q ss_pred CCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........... .... .........
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~--- 235 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGG-VFYIPEYLN--- 235 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHC-CCCCCTTSC---
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcC-cccCchhcC---
Confidence 22334568999999999987765 6899999999999999999999975432111100 0000 011111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
. .+.+++.+||+.||++|||+.+++++ +.+
T Consensus 236 -~---~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 236 -R---SVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp -H---HHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred -H---HHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 1 26679999999999999999999974 443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.41 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcch-----hhhhhHHHHHHHHHHHhhc-cCCceeeE
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSET-----EELASLESFGNEARLLSQI-RHRNIVKL 234 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~l 234 (468)
+.......++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344455678999999999999999999864 799999999875431 1122346788999999999 79999999
Q ss_pred EEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 235 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
++++......++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999997532 4899999999999999999999 6799999999999999999999
Q ss_pred EEeeccccccccCCCCCceeccccccccccccccC------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc
Q 012219 315 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN 388 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~ 388 (468)
||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........
T Consensus 240 kl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-- 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-- 316 (365)
T ss_dssp EECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred EEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH--
Confidence 99999999876533 23344679999999998863 3588899999999999999999999975332111000
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 389 IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+......... .........+.+++.+||+.||++|||+.+++++
T Consensus 317 -----i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 -----IMEGQYQFSS-PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----HHHTCCCCCH-HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHhCCCCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000000000 0000111236789999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=339.81 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=198.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+|++++.++ +||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 46799999999999999999975 4688999999976542 234688888888 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC----CCeEEeecccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVA 322 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~ 322 (468)
||||+++|+|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+||++.++ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999997643 3899999999999999999999 7799999999999998543 35999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccch-hhhcccccccccCCCCCC
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSW-SLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 401 (468)
+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ......
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---~~~~~~ 244 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG---KFSLSG 244 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---CCCCCS
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---CcccCc
Confidence 8776554445566899999999999888899999999999999999999999975322111 000000000 001111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.......+ .+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 GYWNSVSD---TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTTTSCH---HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccccCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111112 26679999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=344.07 Aligned_cols=206 Identities=24% Similarity=0.320 Sum_probs=177.6
Q ss_pred CHHHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-----CCceeeE
Q 012219 161 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-----HRNIVKL 234 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l 234 (468)
++++.....++|.+.+.||+|+||.||+|+. .+++.||||++..... ..+.+..|+++++.++ ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH----HHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh----hhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3344344467899999999999999999975 5789999999975432 2356778999999986 9999999
Q ss_pred EEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC----
Q 012219 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---- 310 (468)
Q Consensus 235 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---- 310 (468)
++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence 99999999999999999 8999999976543 24899999999999999999999 779999999999999975
Q ss_pred ---------------------CCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHH
Q 012219 311 ---------------------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL 369 (468)
Q Consensus 311 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~ 369 (468)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78999999999986542 223457899999999999999999999999999999999
Q ss_pred hCCCCCCcc
Q 012219 370 MGKHPGELL 378 (468)
Q Consensus 370 tg~~p~~~~ 378 (468)
||+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=330.11 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|... +++.||+|++........ ...+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999765 689999999976543211 13567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeeccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFGV 321 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~ 321 (468)
+||||+++++|.+++.... .+++.+++.++.|++.||.||| +.+++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997533 4899999999999999999999 77999999999999998887 899999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
++..... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........... . . ........
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~---~-~~~~~~~~ 232 (283)
T 3bhy_A 159 AHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN-I---S-AVNYDFDE 232 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-H---H-TTCCCCCH
T ss_pred ceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-h---H-hcccCCcc
Confidence 9876432 223345689999999999989999999999999999999999999975432211100 0 0 00011110
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.. .......+.+++.+||+.||++|||+.++++
T Consensus 233 ~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 0011123678999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.93 Aligned_cols=268 Identities=23% Similarity=0.347 Sum_probs=206.5
Q ss_pred HHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhh--ccCCceeeEEEEEeeCC
Q 012219 165 MIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQ--IRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 165 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~ 242 (468)
-....++|.+.+.||+|+||.||+|+. +++.||||++.... .+.+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 344567899999999999999999988 58999999996432 2467788888887 78999999999998775
Q ss_pred ----EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeeCCCCC
Q 012219 243 ----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC-----TPPIVHRDISSNNVLLNSELE 313 (468)
Q Consensus 243 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~NIll~~~~~ 313 (468)
..++||||+++|+|.+++... .+++.+++.++.|++.||.|||... +.+|+||||||+||+++.++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 789999999999999999753 3899999999999999999999321 458999999999999999999
Q ss_pred eEEeeccccccccCCCCC----ceeccccccccccccccCC------CCCccchhhHHHHHHHHHHhC----------CC
Q 012219 314 AFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMG----------KH 373 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~el~tg----------~~ 373 (468)
+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876543321 2334689999999998765 344789999999999999999 67
Q ss_pred CCCcccccchhhhc--ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 374 PGELLSSSSWSLDK--NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 374 p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
||............ .........+.+.... ...+....+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 77543221111110 0001111122222111 1113344588899999999999999999999999887543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.65 Aligned_cols=256 Identities=12% Similarity=0.050 Sum_probs=183.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc--cCCceeeEE-------EEEe
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI--RHRNIVKLY-------GFCL 239 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 239 (468)
.+|.+.+.||+|+||.||+|.. .+++.||||++...........+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588899999999999999975 47899999999987654445567788886555555 699988855 4443
Q ss_pred eC-----------------CEEEEEEEeccCCChhhhhhcCcccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 012219 240 HR-----------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR------VNVVKGMCHALSYLHHDCTPPI 296 (468)
Q Consensus 240 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~i 296 (468)
.+ ...++||||++ |+|.+++...... +.+..+ +.++.||+.||+||| +.+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQ---SKGL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence 32 34899999999 8999999864322 444555 778899999999999 7799
Q ss_pred EecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCC
Q 012219 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 297 vH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986532 2224567799999999987 6799999999999999999999999
Q ss_pred CCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 375 GELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
|..........................+....... .+.+++.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD---FVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCH---HHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCH---HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97653221111110000011111111111011111 2677999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.67 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=199.5
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
+|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 345556899999999999974 57889999999765432 34678899999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEeeccccccccCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNFD 328 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~ 328 (468)
|+++++|.+++........+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999999999987655556788999999999999999999 779999999999999987 899999999999876543
Q ss_pred CCCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SSNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
........|++.|+|||++.+. .++.++||||||+++|||++|+.||............. ......+.+......
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~- 253 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMFKVHPEIPESMSA- 253 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHHCCCCCCCTTSCH-
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--ccccccccccccCCH-
Confidence 3334455789999999998764 38899999999999999999999997543321111110 000111222222221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+.+++.+||+.||++|||+.+++++
T Consensus 254 ------~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 254 ------EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ------HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 26678999999999999999999853
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=328.90 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=200.3
Q ss_pred hhCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...... ...+.|.+|++++++++||||+++++++.+. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 4679999999999999999997432 346999999865432 2357789999999999999999999998754 46
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 89999999999999997543 34889999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 325 LNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 325 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||........... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~ 238 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV----LEKGDRLPKPDL 238 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH----HHHTCCCCCCTT
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH----HhcCCCCCCCCC
Confidence 643222 2233456789999999988899999999999999999998 9999975433221110 000000111111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+ + .+.+++.+||+.||++|||+.++++.|...
T Consensus 239 ~~----~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 239 CP----P---VLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----H---HHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11 1 266799999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=338.46 Aligned_cols=257 Identities=24% Similarity=0.395 Sum_probs=198.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCE----EEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKV----VALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
++|.+.+.||+|+||.||+|.. .+++. ||+|.+...... ...+.+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 5799999999999999999975 34443 577777644322 24567889999999999999999999998765 7
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++|+||+.+|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 889999999999999976543 3899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||............ ..........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~ 242 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLPQPP 242 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCCCCT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCCCc
Confidence 643222 2223456778999999999999999999999999999999 99999765432221110 0000111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
... . .+.+++.+||+.||++|||+.++++.|.+....
T Consensus 243 ~~~----~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 243 ICT----I---DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TBC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred cCC----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111 1 266799999999999999999999999887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=338.22 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=192.3
Q ss_pred HhhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|. ..+++.||||++....... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 35789999999999999999996 4578999999997654332 334567899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-----CCCCeEEeeccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-----SELEAFVADFGV 321 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~Dfg~ 321 (468)
||||++ |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 499999976543 899999999999999999999 77999999999999994 455699999999
Q ss_pred cccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc----------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK---------- 390 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~---------- 390 (468)
++.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 98876544445556789999999998874 5899999999999999999999999754322111000000
Q ss_pred -cccc--cCCCCCCccchhHHH-----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 391 -LIDL--LDPRLSPPVDQKIRQ-----DIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 391 -~~~~--~~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.... ............... ....+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 000000000000000 11236789999999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=348.26 Aligned_cols=257 Identities=24% Similarity=0.300 Sum_probs=191.0
Q ss_pred HHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh-----hhhhHHHHHHHHHHHhhccCCceeeEEEEEee
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-----ELASLESFGNEARLLSQIRHRNIVKLYGFCLH 240 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 240 (468)
...++|.+.+.||+|+||.||+|.. .+++.||||++...... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3457899999999999999999965 56899999999764321 11122357899999999999999999999754
Q ss_pred CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEe
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVA 317 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~ 317 (468)
+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.+ ..+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence 55799999999999999887543 3899999999999999999999 7799999999999999754 459999
Q ss_pred eccccccccCCCCCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.............
T Consensus 285 DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i------ 357 (419)
T 3i6u_A 285 DFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------ 357 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH------
T ss_pred ecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH------
Confidence 9999987653 223344679999999999853 578889999999999999999999997543221111100
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...... ............+.+++.+||+.||++|||+++++++
T Consensus 358 ~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCC-CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0001000111237789999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=331.06 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=200.5
Q ss_pred hhCccccc-eeeeeCCceEEEEEc---CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKY-CIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|.+.+ .||+|+||.||+|.. .+++.||||++...... ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 45788887 999999999999953 34788999999765432 23357799999999999999999999999 55678
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999998643 3899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCC
Q 012219 325 LNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 325 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........... ......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~ 242 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKGERMGCP 242 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCCC
Confidence 6533321 122345688999999988889999999999999999999 9999976443211110 0010111111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
...+ . .+.+++.+||+.||++|||+.++++.|+..
T Consensus 243 ~~~~----~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 243 AGCP----R---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTCC----H---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC----H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 1 267799999999999999999999999765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=339.68 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=198.2
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 467999999999999999999764 58999999987654332 3346688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988876443 3899999999999999999999 77999999999999999999999999999987655
Q ss_pred CCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-----------------ccc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-----------------KNI 389 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-----------------~~~ 389 (468)
.........|++.|+|||++.+. .++.++|||||||++|||++|+.||........... ...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 44444556789999999998775 789999999999999999999999975432211000 000
Q ss_pred ccccccCCCCCCc--cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 KLIDLLDPRLSPP--VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.......+..... ...........+.+++.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001111100 000000111237789999999999999999998853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.56 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=207.3
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..++|.+.+.||+|+||.||+|.+.++..||||+++..... .+.|.+|++++++++|+||+++++++.+ +..++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 35678999999999999999999988889999999865432 3678999999999999999999999976 568999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999997532 234889999999999999999999 77999999999999999999999999999987542
Q ss_pred CC-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 328 DS-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 328 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
.. .......++..|+|||++....++.++|||||||++|||+| |+.||........... +.............
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i~~~~~~~~~~~~~- 490 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VERGYRMPCPPECP- 490 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----HHTTCCCCCCTTCC-
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC-
Confidence 11 11122346788999999998899999999999999999999 9999976543211110 00101111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
+ .+.+++.+||+.||++|||+++|++.|+.....
T Consensus 491 ---~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 491 ---E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1 267799999999999999999999999987554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.78 Aligned_cols=259 Identities=23% Similarity=0.254 Sum_probs=193.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------ 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 241 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 46799999999999999999964 56899999999765322 23456788999999999999999999999654
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
...++||||++++ +.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 4679999999864 6666542 2889999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------c
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------K 387 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------~ 387 (468)
++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||........... .
T Consensus 211 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 211 ARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp C------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987653 2334456799999999999999999999999999999999999999975432110000 0
Q ss_pred -ccccccccC---------------CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 -NIKLIDLLD---------------PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 -~~~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.......+. ....+............+.+++.+||+.||++|||++|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000000011111113347889999999999999999999854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.38 Aligned_cols=266 Identities=22% Similarity=0.353 Sum_probs=203.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKC 243 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 243 (468)
.++|.+.+.||+|+||.||++.. .+++.||||++...... ..+.+.+|+++++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH---HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 36799999999999999999975 67999999998654432 35678899999999999999999999873 347
Q ss_pred EEEEEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
.++|+||+++|+|.+++.... ....+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999987521 2345899999999999999999999 779999999999999999999999999998
Q ss_pred ccccCCCCC---------ceeccccccccccccccCCC---CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc
Q 012219 323 RLLNFDSSN---------RTLLAGTYGYIAPELAYTMV---VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK 390 (468)
Q Consensus 323 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~ 390 (468)
+........ .....|++.|+|||++.... ++.++||||||+++|||++|+.||.............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-- 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH--
Confidence 764321111 11234689999999987543 7889999999999999999999986432111111000
Q ss_pred cccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012219 391 LIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQK 449 (468)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~ 449 (468)
.............+ ..+.+++.+||+.||++|||+.++++.|.....+.+..
T Consensus 260 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 VQNQLSIPQSPRHS-------SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp HHCC--CCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred hhccCCCCccccCC-------HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00000011111111 12678999999999999999999999999987654443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.79 Aligned_cols=251 Identities=14% Similarity=0.184 Sum_probs=200.6
Q ss_pred hhCccccceeeeeCCceEEEEE------cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc---CCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR---HRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||+|. ..+++.||||++..... ..+..|++++..++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4679999999999999999993 45789999999976543 35677888887776 999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-------
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS------- 310 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~------- 310 (468)
..+..++||||+++|+|.+++.... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999997522 2345999999999999999999999 789999999999999998
Q ss_pred ----CCCeEEeeccccccccC--CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchh
Q 012219 311 ----ELEAFVADFGVARLLNF--DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWS 384 (468)
Q Consensus 311 ----~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~ 384 (468)
++.+||+|||+++.+.. .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......+.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 89999999999976542 222334467999999999999999999999999999999999999998643321111
Q ss_pred hhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHHhcCC
Q 012219 385 LDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSR-PTMQLVSNEFIARNK 444 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~~v~~~l~~~~~ 444 (468)
+...+...... + .+.+++..|++.+|.+| |+++++.+.|+....
T Consensus 295 ----------~~~~~~~~~~~---~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ----------PEGLFRRLPHL---D---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------ECSCCTTCSSH---H---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------echhccccCcH---H---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 11111111111 1 25568889999999998 677888877776543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=332.01 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=195.1
Q ss_pred hCccccceeeeeCCceEEEEEc--CCCC--EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL--PSGK--VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|.+ .+++ .||+|+++..........+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 5799999999999999999974 2333 68999997654443345678999999999999999999999998765 78
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999997643 23889999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.............. .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 248 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK---EGERLPRPE 248 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---SCCCCCCCT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc---cCCCCCCCc
Confidence 533221 123457788999999988889999999999999999999 9999975543211110000 000011111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
..+ ..+.+++.+||+.||++|||+.++++.|.+..+.
T Consensus 249 ~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 249 DCP-------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcC-------HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111 1267799999999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.75 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=205.7
Q ss_pred CcCHHHHHHHhhCcccc-ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEE
Q 012219 159 RITFQDMIEATEDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLY 235 (468)
Q Consensus 159 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 235 (468)
.+.++......++|.+. +.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.++..++ ||||++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 34455556666778877 8899999999999975 468999999998654432 23567889999999995 69999999
Q ss_pred EEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CC
Q 012219 236 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---EL 312 (468)
Q Consensus 236 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~ 312 (468)
+++...+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+|+||||||+||+++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999986532 234899999999999999999999 779999999999999998 78
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 392 (468)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus 172 ~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 250 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250 (327)
T ss_dssp CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence 9999999999876532 223345799999999999999999999999999999999999999975433211111000000
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. ......... ..+.+++.+||+.||++|||+++++++
T Consensus 251 ~~-~~~~~~~~~-------~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DY-SEETFSSVS-------QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC-CTTTTTTSC-------HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc-CchhhcccC-------HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 011111111 126679999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.21 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=203.4
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 240 (468)
..+|.+.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 467999999999999999999765 79999999997654 245689999999999999999998854
Q ss_pred ---------CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 241 ---------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 241 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 445899999999999999997543 234899999999999999999999 7799999999999999999
Q ss_pred CCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccc
Q 012219 312 LEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 312 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 391 (468)
+.+||+|||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|..|+........
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------- 229 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT-------- 229 (284)
T ss_dssp TEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH--------
T ss_pred CCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH--------
Confidence 999999999998765332 23345689999999999999999999999999999999999998643211000
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
...+.......+. .+.+++.+||+.||++|||+.++++.|....+.+.
T Consensus 230 -~~~~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 -DLRDGIISDIFDK-------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -HHHTTCCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -HhhcccccccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111112222221 25678999999999999999999999998876544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=355.85 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999764 7899999999765433333457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~ 324 (468)
|||+.+|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999987644 3899999999999999999999 7799999999999999 5678999999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||............ .. -......+..
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~-~~~~~~~~~~ 251 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----EK-GKYTFELPQW 251 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HH-CCCCCCSGGG
T ss_pred cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----Hc-CCCCCCCccc
Confidence 6533 33444679999999999866 6899999999999999999999999754332111100 00 0001111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
....+ .+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 252 KKVSE---SAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCH---HHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11112 2667999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=325.57 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=197.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 244 (468)
..|.+.+.||+|+||.||+|.. .++..||+|++....... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3477888999999999999975 568899999997654332 345778999999999999999999998875 4568
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeC-CCCCeEEeeccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLN-SELEAFVADFGV 321 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~ 321 (468)
++||||+++|+|.+++.... .+++..++.++.|++.||.||| +.+ |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999997643 3899999999999999999999 666 99999999999998 789999999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
+.... ........|++.|+|||++. ..++.++||||||+++|+|++|+.||.............. . .....
T Consensus 179 ~~~~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~---~~~~~ 249 (290)
T 1t4h_A 179 ATLKR--ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---S---GVKPA 249 (290)
T ss_dssp GGGCC--TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---T---TCCCG
T ss_pred ccccc--ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh---c---cCCcc
Confidence 97643 23344567999999999876 4589999999999999999999999975443222111100 0 00000
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...... ...+.+++.+||+.||++|||+++++++
T Consensus 250 ~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 SFDKVA---IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCCC---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011111 1127789999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=338.07 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=193.4
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHH--HhhccCCceeeEEEEEee-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARL--LSQIRHRNIVKLYGFCLH-----R 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~ 241 (468)
.++|.+.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46899999999999999999987 689999999975433 233444444 456899999999986542 3
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCceeeCCCC
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP---------PIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~---------~ivH~dlk~~NIll~~~~ 312 (468)
...++||||+++|+|.+++.... .++..++.++.||+.||.||| +. +|+||||||+|||++.++
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 46789999999999999997543 588999999999999999999 66 999999999999999999
Q ss_pred CeEEeeccccccccCCC--------CCceeccccccccccccccC-------CCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 313 EAFVADFGVARLLNFDS--------SNRTLLAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
.+||+|||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||+||..|+..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998764321 11223469999999999876 4567899999999999999999777532
Q ss_pred ccccc-hhhh------c--------ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 378 LSSSS-WSLD------K--------NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 378 ~~~~~-~~~~------~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..... .... . .........+.+...... .......+.+++.+||+.||++|||++++++.|.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 22110 0000 0 000001111122111111 012233488899999999999999999999999876
Q ss_pred CC
Q 012219 443 NK 444 (468)
Q Consensus 443 ~~ 444 (468)
..
T Consensus 317 l~ 318 (336)
T 3g2f_A 317 MM 318 (336)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=363.06 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=197.1
Q ss_pred Cccccc-eeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 171 DFHIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 171 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
++.+.+ .||+|+||.||+|.+. ++..||||+++..... ...+.|.+|++++++++||||++++++|.. +..++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 344444 7999999999999653 5667999999865322 245789999999999999999999999976 45899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999997543 34899999999999999999999 7799999999999999999999999999998764
Q ss_pred CCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 327 FDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 327 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .....+++.|+|||++....++.++|||||||++|||+| |+.||........... +...........
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~~~~~~~p~~ 563 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGKRMECPPE 563 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHTTCCCCCCTT
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCCCCCCCCc
Confidence 32221 122345688999999998999999999999999999998 9999986543221110 000001111111
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+ ..+.+++.+||+.||++||++.+|++.|...
T Consensus 564 ~~-------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 564 CP-------PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CC-------HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 2277899999999999999999999888764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=329.10 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=196.8
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-CEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-KCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .|+.||||++.... ..+.|.+|++++++++||||+++++++... +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 46799999999999999999987 48899999997654 236788999999999999999999997654 468999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999975432 23788999999999999999999 77999999999999999999999999999976542
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........... ......+......+
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~-- 240 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEKGYKMDAPDGCP-- 240 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HTTTCCCCCCTTCC--
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCCCCCCcccCC--
Confidence 2 223457889999999998899999999999999999998 9999976543221111 00111111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 241 -----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 241 -----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 12667999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.25 Aligned_cols=266 Identities=22% Similarity=0.251 Sum_probs=196.3
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhh--hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL--ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
..++|.+.+.||+|+||.||+|... +|+.||||++........ ...+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999864 689999999975433211 1124678999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 8888886543 34788899999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc-----------c--
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI-----------K-- 390 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~-----------~-- 390 (468)
............||+.|+|||++.+. .++.++|||||||++|||++|.+||.............. .
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 75544445556789999999998754 588999999999999999999999875432111000000 0
Q ss_pred -cccccCCCCCCccc--hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 391 -LIDLLDPRLSPPVD--QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 391 -~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..+.......+... .........+.+++.+||+.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000000000 00001112377899999999999999999999653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.10 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=199.7
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|... +|+.||+|.+..... .+.+.+|++++.+++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467999999999999999999764 689999999976432 3568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999986422 34899999999999999999999 7799999999999999999999999999998765
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
..........|++.|+|||++.+..++.++||||||+++|+|++|+.||........... ......+.... ...
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~--~~~ 250 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM----IPTNPPPTFRK--PEL 250 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSS--GGG
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HhcCCCcccCC--ccc
Confidence 443444456789999999999999999999999999999999999999975433211110 00011111111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. ..+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~---~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 251 WS---DNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SC---HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 126789999999999999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.79 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=202.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCE--EEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKV--VALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+.||+|+||.||+|+.. ++.. +|+|.+...... ...+.+.+|++++.++ +||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 57999999999999999999754 4554 499988754332 2346788999999999 8999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 246 LIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
+||||+++|+|.+++.... ....+++.+++.++.||+.||.||| +.+|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCC
Confidence 9999999999999997643 2345899999999999999999999 77999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhccccc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 391 (468)
.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||.......... ..
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~ 254 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL 254 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HG
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH----Hh
Confidence 9999999999754321 12233456889999999988889999999999999999998 999997544321111 11
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
............+ ..+.+++.+||+.||++|||+.++++.|.+....
T Consensus 255 ~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 PQGYRLEKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GGTCCCCCCTTBC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111111 1267799999999999999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=326.23 Aligned_cols=248 Identities=17% Similarity=0.261 Sum_probs=198.2
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++....... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 467999999999999999999764 79999999998654332 2346788999999999 99999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---------------
Q 012219 247 IYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS--------------- 310 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~--------------- 310 (468)
||||+++|+|.+++..... ...+++..++.++.||+.||+||| +.+|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976432 234899999999999999999999 779999999999999984
Q ss_pred ----CCCeEEeeccccccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhh
Q 012219 311 ----ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385 (468)
Q Consensus 311 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~ 385 (468)
...+||+|||.+....... ...|++.|+|||++.+. .++.++|||||||++|||++|.+|+........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-- 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE-- 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH--
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH--
Confidence 4479999999998764322 23589999999998766 667899999999999999999987653321110
Q ss_pred hcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+.+....+. .+.+++.+||+.||++|||+.+++++
T Consensus 240 -----~~~~~~~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 -----IRQGRLPRIPQVLSQ-------EFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHTTCCCCCSSCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHcCCCCCCCcccCH-------HHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111122222221 26679999999999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.32 Aligned_cols=245 Identities=16% Similarity=0.140 Sum_probs=189.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHH---HHHhhccCCceeeEE-------EE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEA---RLLSQIRHRNIVKLY-------GF 237 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 237 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...........+.|.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999985 56999999999755433334567889999 555666899999998 66
Q ss_pred EeeCC-----------------EEEEEEEeccCCChhhhhhcCcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012219 238 CLHRK-----------------CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296 (468)
Q Consensus 238 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 296 (468)
+..++ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 66543 278999999 6899999975422 112446888899999999999999 7799
Q ss_pred EecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCC-----------CCCccchhhHHHHHH
Q 012219 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-----------VVTEKCDVYSFGVVA 365 (468)
Q Consensus 297 vH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvil 365 (468)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999998643 23344567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 366 LEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 366 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
|||+||+.||........ ..... ... ...+. .+.+++.+||+.||++|||+.++++
T Consensus 304 ~elltg~~Pf~~~~~~~~-------~~~~~-~~~-~~~~~-------~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG-------SEWIF-RSC-KNIPQ-------PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CC-------SGGGG-SSC-CCCCH-------HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccc-------hhhhh-hhc-cCCCH-------HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999865332111 00011 101 11111 2667999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.97 Aligned_cols=259 Identities=19% Similarity=0.200 Sum_probs=202.3
Q ss_pred hCccccceeeeeCCceEEEEEcCC---------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceee-------
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS---------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVK------- 233 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 233 (468)
++|.+.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 579999999999999999998653 789999999754 24678999999999999987
Q ss_pred --------EEEEEee-CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 012219 234 --------LYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSN 304 (468)
Q Consensus 234 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 304 (468)
+++++.. ....++||||+ +++|.+++.... ...+++.+++.++.||+.||.||| +.+|+||||||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 6777776 77899999999 999999998652 234899999999999999999999 779999999999
Q ss_pred ceeeCCCC--CeEEeeccccccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 012219 305 NVLLNSEL--EAFVADFGVARLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 305 NIll~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999987643221 123347899999999999999999999999999999999999999
Q ss_pred Ccccccchhhhc-cc----ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 376 ELLSSSSWSLDK-NI----KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 376 ~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
............ .. ......+.... ..... ..+.+++.+||+.||++|||++++++.|.+......
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGH---WIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSC---EECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccc---cCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 865422111111 00 01111111100 00001 126779999999999999999999999988765443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=327.62 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=201.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+++. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 46799999999999999999975 47899999999865432 235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~ 324 (468)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999987543 3899999999999999999999 7799999999999999 7889999999999975
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.................. .........+
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~ 235 (304)
T 2jam_A 159 EQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFWDDIS 235 (304)
T ss_dssp CCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-CCTTTTTTSC
T ss_pred cCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccccCC
Confidence 432 2233456899999999999999999999999999999999999999754322111000000000 0111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
..+.+++.+||+.||++|||+.++++ .+...
T Consensus 236 -------~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 236 -------ESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -------HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -------HHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 12677999999999999999999985 44443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.28 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=187.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEe--------
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCL-------- 239 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 239 (468)
.+|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 5789999999999999999975 57899999998655433 3467889999999996 999999999984
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEe
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~ 317 (468)
.....++|+||+. |+|.+++........+++..++.++.||+.||.||| +.+ |+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3456899999996 799998876444445999999999999999999999 667 9999999999999999999999
Q ss_pred eccccccccCCCCC------------ceeccccccccccccc---cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc
Q 012219 318 DFGVARLLNFDSSN------------RTLLAGTYGYIAPELA---YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS 382 (468)
Q Consensus 318 Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~ 382 (468)
|||+++........ .....||+.|+|||++ .+..++.++|||||||++|||+||+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876432211 1134589999999998 56678999999999999999999999997533211
Q ss_pred hhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCC
Q 012219 383 WSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPM 447 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~ 447 (468)
... ............. .+.+++.+||+.||++|||+.++++.|........
T Consensus 261 ~~~-------~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 IVN-------GKYSIPPHDTQYT-------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------CCCCTTCCSSG-------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hhc-------CcccCCcccccch-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 110 0000011111111 15578999999999999999999999988765433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.64 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=202.6
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 36799999999999999999974 35778999999754433 23467889999999999999999999999998
Q ss_pred EEEEEEEeccCCChhhhhhcCcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAF 315 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~k 315 (468)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||.||| +.+|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999986532 234889999999999999999999 779999999999999984 45699
Q ss_pred EeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||........... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~ 259 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----VT 259 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH----Hh
Confidence 999999986543221 2233467889999999988899999999999999999998 9999875432211100 00
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
....+....... . .+.+++.+||+.||++|||+.++++.|.....
T Consensus 260 ~~~~~~~~~~~~----~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 SGGRMDPPKNCP----G---PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCC----H---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 000111111111 1 26679999999999999999999999987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.15 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=195.8
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|+. .++..||+|++....... .....+.+|+++++.++||||+++++++......++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999975 478999999998654332 2246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~~ 324 (468)
|||+++|+|.+.+.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.+ +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999886543 3899999999999999999999 7799999999999999764 5599999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||................ .....+..
T Consensus 189 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~ 261 (494)
T 3lij_A 189 FENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK-----YTFDSPEW 261 (494)
T ss_dssp CBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----CCCCSGGG
T ss_pred CCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCchhc
Confidence 6533 2334457999999999876 468999999999999999999999997544321111100000 01111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||+.+++++
T Consensus 262 ~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 262 KNVSE---GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TTSCH---HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccCCH---HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111 26679999999999999999998843
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.04 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=195.4
Q ss_pred ceeeeeCCceEEEEEc---CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEecc
Q 012219 176 YCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
+.||+|+||.||+|.+ ..++.||||+++..... ....+.|.+|++++++++|||||+++++|..+ ..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccC
Confidence 4799999999999954 35678999999765432 23457899999999999999999999999754 5789999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCC--
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-- 330 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 330 (468)
+|+|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999997543 3899999999999999999999 77999999999999999999999999999987653322
Q ss_pred -CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 331 -NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 331 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
......+|+.|+|||++....++.++|||||||++|||+| |+.||........... +............+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~~~~~~~p~~~~---- 598 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKGERMGCPAGCP---- 598 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCCTTCC----
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCCCCCC----
Confidence 1223346788999999999999999999999999999998 9999976543211110 00111111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+.+++.+||+.||++||++.+|++.|+..
T Consensus 599 ---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 599 ---REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2267799999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.75 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=206.7
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
..++|.+.+.||+|+||.||+|+. .+++.||||+++..........+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999975 46889999999865443334556788999999987 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998643 3899999999999999999999 779999999999999999999999999999875
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.. -...++....
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~-~~~~~p~~~s- 566 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IME-HNVAYPKSMS- 566 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHS-SCCCCCTTSC-
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHh-CCCCCCccCC-
Confidence 4444555667899999999999999999999999999999999999999975432211110 000 0111222222
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTM-----QLVSN 437 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~~v~~ 437 (468)
. .+.+++.+||+.||++||++ ++|++
T Consensus 567 ---~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 567 ---K---EAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---H---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---H---HHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 26679999999999999997 77774
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.35 Aligned_cols=194 Identities=28% Similarity=0.424 Sum_probs=154.2
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----CE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----KC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 243 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 6799999999999999999975 47899999999754322 23457788999999999999999999999543 56
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||+. |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 68999887543 3899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC---------------------------Cceeccccccccccccc-cCCCCCccchhhHHHHHHHHHHhC
Q 012219 324 LLNFDSS---------------------------NRTLLAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMG 371 (468)
Q Consensus 324 ~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~el~tg 371 (468)
....... .....+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 22345789999999976 566799999999999999999994
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.54 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=199.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||+||+|.. .+++.||||++....... .....+.+|++++++++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999975 478999999996543221 2356788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN---SELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~ 324 (468)
|||+++|+|.+.+.... .+++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887543 3899999999999999999999 77999999999999995 456799999999987
Q ss_pred ccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||............ . . .......+..
T Consensus 174 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--~--~-~~~~~~~~~~ 246 (486)
T 3mwu_A 174 FQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--E--T-GKYAFDLPQW 246 (486)
T ss_dssp BCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H--H-TCCCSCSGGG
T ss_pred CCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H--h-CCCCCCCccc
Confidence 6432 23344579999999999875 5899999999999999999999999754322111100 0 0 0001111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... .+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~s~---~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 247 RTISD---DAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGSCH---HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCH---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112 26689999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.29 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=195.4
Q ss_pred HHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee---
Q 012219 166 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH--- 240 (468)
Q Consensus 166 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 240 (468)
....++|.+.+.||+|+||.||+|+. .+++.||+|++...... .+.+.+|++++.++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33467899999999999999999975 57899999999765432 35788999999999 79999999999987
Q ss_pred ---CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 241 ---RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 241 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
....++||||+++|+|.+++.... ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999997653 234889999999999999999999 7799999999999999999999999
Q ss_pred eccccccccCCCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccc
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 392 (468)
|||++..............|++.|+|||++. ...++.++|||||||++|+|++|+.||........... ..
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~ 247 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IP 247 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HH
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hh
Confidence 9999987654333344557899999999986 56788999999999999999999999975433211110 00
Q ss_pred cccCCCCC-CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 DLLDPRLS-PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
....+... ...+ . .+.+++.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~----~---~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPAPRLKSKKWS----K---KFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCCCCCSCSCSC----H---HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCccccCCccccC----H---HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00111111 1111 1 26679999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.86 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=203.6
Q ss_pred hCccccceeeeeCCceEEEEEc-----CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC--
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK-- 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 242 (468)
++|.+.+.||+|+||.||+++. .+++.||||++...... ..+.+.+|++++++++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH---HHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 5688999999999999999973 46889999999765432 3567899999999999999999999987654
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++++|.+++..... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 67999999999999999976532 4899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc--------cccc
Q 012219 323 RLLNFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK--------NIKL 391 (468)
Q Consensus 323 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~--------~~~~ 391 (468)
+........ .....++..|+|||.+.+..++.++||||||+++|||+||+.|+............ ....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 876543321 12235677899999999888999999999999999999999997643211000000 0001
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
.+.+......+...... ..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 273 ~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTTCCCCCCTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111111111 22778999999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=344.75 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=167.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 36899999999999999999975 56889999999764332 23456788999999999999999999999765 5
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||++ |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999996 59999997643 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC----------------------Cceeccccccccccccc-cCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 012219 323 RLLNFDSS----------------------NRTLLAGTYGYIAPELA-YTMVVTEKCDVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 323 ~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~el~tg~~p~~ 376 (468)
+....... .....+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643221 12456789999999985 56679999999999999999999766654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.24 Aligned_cols=199 Identities=28% Similarity=0.356 Sum_probs=174.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 57999999999999999999764 7899999999865432 24567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
||+++|+|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++....
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999997643 3899999999999999999999 53 899999999999999999999999999976532
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 223357899999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.35 Aligned_cols=203 Identities=30% Similarity=0.428 Sum_probs=162.9
Q ss_pred HhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCC--E
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRK--C 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 243 (468)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.++..+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 457899999999999999999974 57899999998654322 233467789999999997 999999999997544 6
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||++ |+|..++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 5899888753 3889999999999999999999 7799999999999999999999999999998
Q ss_pred cccCC---------------------CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 324 LLNFD---------------------SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 324 ~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321 112233579999999999876 678999999999999999999999997543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=332.41 Aligned_cols=259 Identities=20% Similarity=0.326 Sum_probs=193.5
Q ss_pred hCcccc-ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEE
Q 012219 170 EDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 170 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 246 (468)
+.|.+. +.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 567774 7899999999999975 57899999999765422 346788999999985 79999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg~~~ 323 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999997643 3899999999999999999999 779999999999999998876 9999999997
Q ss_pred cccCCCC-------CceeccccccccccccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCcccccc--hhhhc--
Q 012219 324 LLNFDSS-------NRTLLAGTYGYIAPELAYT-----MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS--WSLDK-- 387 (468)
Q Consensus 324 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~--~~~~~-- 387 (468)
....... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... |....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6532211 1223458999999999875 568899999999999999999999997543211 00000
Q ss_pred ---cccc-ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 ---NIKL-IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.... ..+.......+. .........+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 000011111110 0000011237789999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.33 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=198.1
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh----------hhHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL----------ASLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
.++|.+.+.||+|+||+||+|.. .+++.||+|++........ ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999975 4688999999976543211 234678899999999999999999999
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---Ce
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL---EA 314 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~ 314 (468)
+.+....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999987543 3899999999999999999999 77999999999999998876 69
Q ss_pred EEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 315 FVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 315 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+|||+++..... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||............
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV------- 259 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------
Confidence 99999999876533 3334457999999999887 46899999999999999999999999754332111100
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......... .........+.+++.+||+.||.+|||+++++++
T Consensus 260 ~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000010000 0000011236789999999999999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=335.12 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=198.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 240 (468)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++....... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 36799999999999999999976 578999999997654332 223567799999999999999999999987
Q ss_pred -CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
.+..++||||+++ +|.+.+..... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999985 77777765432 3899999999999999999999 779999999999999999999999999
Q ss_pred cccccccCC----CCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 320 GVARLLNFD----SSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 320 g~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|+++..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........... .......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL-ISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCC
Confidence 999876422 122234568999999998876 4689999999999999999999999975432111000 0000000
Q ss_pred cCCCC---------------CCccchhHHHHH------HHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 012219 395 LDPRL---------------SPPVDQKIRQDI------ILVSTVAFSCLRSQPKSRPTMQLVSNEF 439 (468)
Q Consensus 395 ~~~~~---------------~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPs~~~v~~~l 439 (468)
..+.. .........+.. ..+.+++.+||+.||++|||++|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00000 000000011111 2377899999999999999999998543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.37 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=201.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcch------hhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEee
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET------EELASLESFGNEARLLSQIR-HRNIVKLYGFCLH 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999976 4689999999975431 11233467889999999996 9999999999999
Q ss_pred CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 241 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 241 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
.+..++||||+++++|.+++.... .+++..++.++.||+.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999997543 4899999999999999999999 7799999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccccccccc------CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAY------TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
++...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||...............
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 244 (298)
T 1phk_A 170 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG---- 244 (298)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred chhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC----
Confidence 99876532 2334457899999999875 456889999999999999999999998754322111000000
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
......+..... ...+.+++.+||+.||++|||+.++++
T Consensus 245 -~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 -NYQFGSPEWDDY---SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -CCCCCTTTGGGS---CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CcccCccccccc---CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 001111111111 122678999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=330.32 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=196.0
Q ss_pred hhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 467999999999999999999764 689999999875533 2456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999886532 23899999999999999999999 77999999999999999999999999999764322
Q ss_pred CCCCceeccccccccccccc-----cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 328 DSSNRTLLAGTYGYIAPELA-----YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.........|++.|+|||++ ....++.++||||||+++|||++|+.||............ .....+....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~- 244 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----AKSDPPTLLT- 244 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCSS-
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----hccCCcccCC-
Confidence 21222335689999999988 3667889999999999999999999998764432111110 0000011110
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ..+.+++.+||+.||++|||+.+++++
T Consensus 245 -~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 -PSKWS---VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -GGGSC---HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -ccccC---HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111 126779999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.76 Aligned_cols=259 Identities=22% Similarity=0.238 Sum_probs=190.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 36799999999999999999974 57899999999764322 234567889999999999999999999997654
Q ss_pred -EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 243 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 243 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 78887752 2889999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccc----ccc----
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIK----LID---- 393 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~----~~~---- 393 (468)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ..+
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9876432 2233457899999999999999999999999999999999999999754321110000000 000
Q ss_pred -------c--cCCCC-------------CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 -------L--LDPRL-------------SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 -------~--~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. ..+.. .+............+.+++.+||+.||++|||+++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 00000 000111111223457899999999999999999999854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.79 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=199.8
Q ss_pred hhCccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|+. .+++.||||+++..... .....+.+.+|++++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999976 47899999998754321 111234566899999999 6999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997543 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCC-CCceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 323 RLLNFDS-SNRTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 323 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.................. ..+..
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 285 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPY 285 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCC
Confidence 8653222 22234579999999999885 35789999999999999999999999743321111100000000 11222
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRP-----TMQLVSNEFI 440 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~l~ 440 (468)
...... .+.+++.+||+.||++|| ++++++++..
T Consensus 286 ~~~~~~-------~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 286 PQEMSA-------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CTTSCH-------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CcccCH-------HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 222221 266799999999999999 9999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=331.41 Aligned_cols=254 Identities=26% Similarity=0.316 Sum_probs=193.2
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh-----hhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-----ELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... .......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999975 46889999999764321 1122345889999999999999999999987665
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEeec
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADF 319 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Df 319 (468)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999987543 4899999999999999999999 779999999999999987654 999999
Q ss_pred cccccccCCCCCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|+++..... .......|++.|+|||++. ...++.++|||||||++|||++|+.||.............. .. .
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~-~ 236 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SG-K 236 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HT-C
T ss_pred ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hC-c
Confidence 999876422 2223456899999999874 56788999999999999999999999975432211111000 00 0
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
....+ .........+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YNFIP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCc---hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 000011123678999999999999999999885
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=345.55 Aligned_cols=260 Identities=18% Similarity=0.267 Sum_probs=202.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-CceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++...... +.+.+|++++..++| +++..+..++...+..++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 6799999999999999999974 67999999988755432 357789999999987 5666677777788889999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL---NSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfg~~~~ 324 (468)
|||+ +++|.+++..... .+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 me~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999 9999999975432 4899999999999999999999 7799999999999999 6889999999999987
Q ss_pred ccCCCCC-------ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCC
Q 012219 325 LNFDSSN-------RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397 (468)
Q Consensus 325 ~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..+.+ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~---~ 231 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISE---K 231 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH-HHHHH---H
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH-HHHhh---c
Confidence 6543221 22457999999999999999999999999999999999999999865432111000 00000 0
Q ss_pred CCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 398 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
................+.+++..||+.||++||++.+|++.|+....
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00000000000011237789999999999999999999998877643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.77 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=202.5
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhh--------------HHHHHHHHHHHhhccCCceeeE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS--------------LESFGNEARLLSQIRHRNIVKL 234 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l 234 (468)
.++|.+.+.||+|+||.||+|.. +++.||+|++.......... .+.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999988 89999999997544322111 1678999999999999999999
Q ss_pred EEEEeeCCEEEEEEEeccCCChhhh------hhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCcee
Q 012219 235 YGFCLHRKCMFLIYEYMEMGSLFCV------LRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCT-PPIVHRDISSNNVL 307 (468)
Q Consensus 235 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~dlk~~NIl 307 (468)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.||| + .+|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 9999999999999999999999998 5432 1345899999999999999999999 5 79999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCceeccccccccccccccCC-CCCc-cchhhHHHHHHHHHHhCCCCCCcccccchhh
Q 012219 308 LNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTE-KCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385 (468)
Q Consensus 308 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~ 385 (468)
++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|||++|+.||..........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876432 33445789999999999877 6666 9999999999999999999997654311111
Q ss_pred hccc-cccccc-------CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 DKNI-KLIDLL-------DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 ~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.... ...... .+................+.+++.+||+.||++|||+.+++++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 000000 0000000000000011237789999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.77 Aligned_cols=270 Identities=22% Similarity=0.259 Sum_probs=197.7
Q ss_pred HHHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchh--------hhhhHHHHHHHHHHHhhccCCceee
Q 012219 162 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE--------ELASLESFGNEARLLSQIRHRNIVK 233 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~ 233 (468)
..++....++|.+.+.||+|+||.||+|...+|+.||||++...... .....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998653321 1123467899999999999999999
Q ss_pred EEEEEee-----CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 012219 234 LYGFCLH-----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL 308 (468)
Q Consensus 234 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll 308 (468)
+++++.. ....++||||++ |+|.+.+.... ..+++..+..++.||+.||.||| +.+|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 9999854 346899999998 68888887543 34899999999999999999999 7799999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc
Q 012219 309 NSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK 387 (468)
Q Consensus 309 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~ 387 (468)
+.++.+||+|||+++..... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999765422 23344578999999998876 67899999999999999999999999754321110000
Q ss_pred ----------------ccccccccCCCCC----CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 ----------------NIKLIDLLDPRLS----PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 ----------------~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+.+..... .............+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000000 00000000111237789999999999999999999954
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.93 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=184.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++.+++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 46899999999999999999975 46899999998755432 2346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcC-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 248 YEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
|||+++++|.+++... .....+++..++.++.||+.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998641 12334899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC-----CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc---
Q 012219 323 RLLNFDSS-----NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID--- 393 (468)
Q Consensus 323 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 393 (468)
........ ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||..................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 77643211 1233568999999999876 56899999999999999999999999765432221110000000
Q ss_pred --ccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 394 --LLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 394 --~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..++....... ..+.+++.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYG-------KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCC-------HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhh-------HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00111111111 126679999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=321.88 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=197.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhh-hhhHHHHHHHHHHHhhccCCceeeEEEEEe--eCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE-LASLESFGNEARLLSQIRHRNIVKLYGFCL--HRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 244 (468)
.++|.+.+.||+|+||.||++.. .+++.||+|++....... ....+.+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999986 468899999997654322 234567899999999999999999999984 45578
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||++++ |.+++.... ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 777776543 234899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCC--CCceeccccccccccccccCCC--CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 325 LNFDS--SNRTLLAGTYGYIAPELAYTMV--VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 325 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... .......|++.|+|||++.+.. ++.++||||||+++|||++|+.||........... +.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----i~~-~~~~~~ 233 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGK-GSYAIP 233 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHH-CCCCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH----Hhc-CCCCCC
Confidence 64322 2223456899999999987643 47899999999999999999999975432111100 000 011112
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhc
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIAR 442 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~ 442 (468)
..... .+.+++.+||+.||++|||+++++++ +.+.
T Consensus 234 ~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 234 GDCGP-------PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp SSSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CccCH-------HHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 21221 26679999999999999999999964 4443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=335.78 Aligned_cols=258 Identities=24% Similarity=0.270 Sum_probs=192.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 36799999999999999999975 57999999999654332 234567889999999999999999999997653
Q ss_pred -EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 243 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 243 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
..++||||+ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 78999998752 3889999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc----cc-------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK----NI------- 389 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~----~~------- 389 (468)
++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||............ ..
T Consensus 175 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987542 2334578999999999877 67999999999999999999999999754321110000 00
Q ss_pred --------ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 --------KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+..................+.+++.+||+.||++|||+++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000000000000111236789999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.05 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=185.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.++...++.++||||+++++++...+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46799999999999999999975 578999999997654332 2334455566668889999999999999999999999
Q ss_pred EEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
|||++ |+|.+++... .....+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5887777542 12345899999999999999999999 65 9999999999999999999999999999876
Q ss_pred cCCCCCceeccccccccccccc----cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSNRTLLAGTYGYIAPELA----YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
... .......||+.|+|||++ ....++.++||||||+++|||+||+.||............. .....+....
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 236 (290)
T 3fme_A 161 VDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV---VEEPSPQLPA 236 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH---HHSCCCCCCT
T ss_pred ccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH---hccCCCCccc
Confidence 432 223334689999999996 56678999999999999999999999997533221111110 0111111111
Q ss_pred -ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 402 -PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 402 -~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
..+ . .+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~----~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFS----A---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSC----H---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCC----H---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1 2677999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=325.30 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=196.0
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEee--CCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLH--RKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~ 245 (468)
++|.+.+.||+|+||.||+|. ..+++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 679999999999999999996 4678999999997543 256889999999997 9999999999987 66789
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeecccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARL 324 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~ 324 (468)
+||||+++++|.+++.. +++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 99999999999998853 788999999999999999999 77999999999999999776 899999999987
Q ss_pred ccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc------cccc-----
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN------IKLI----- 392 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~------~~~~----- 392 (468)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||............. ....
T Consensus 181 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 181 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 6533 23344578999999999877 678999999999999999999999985432211100000 0000
Q ss_pred ----------cccC--------CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 ----------DLLD--------PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ----------~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+... ........... ...+.+++.+||+.||++|||+++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLV---SPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGC---CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccC---CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00000000001 1237789999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.82 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=197.7
Q ss_pred HHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc--CCceeeEEEEEeeCCEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR--HRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~ 244 (468)
...++|.+.+.||+|+||.||++...+++.||||++...... ....+.+.+|++++.+++ |+||+++++++...+..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345679999999999999999999888999999999765432 234578899999999997 59999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||| +.+++|.+++.... .+++.+++.++.|++.||.||| +.+|+||||||+||++++ +.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 56789999998654 4899999999999999999999 779999999999999965 8999999999987
Q ss_pred ccCCCC--CceeccccccccccccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccc
Q 012219 325 LNFDSS--NRTLLAGTYGYIAPELAYT-----------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 325 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 391 (468)
...... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||..........
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~------ 249 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------ 249 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH------
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH------
Confidence 643222 1234568999999999865 468889999999999999999999997543221111
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
....++............ .+.+++.+||+.||++|||+.++++ .+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHCTTSCCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHhcccccCCcccchH---HHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 111111111111111111 2667899999999999999999995 44443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=321.75 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=189.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 240 (468)
.++|.+.+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46799999999999999999975 579999999996532 234678899999999999999999998865
Q ss_pred ------CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 012219 241 ------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEA 314 (468)
Q Consensus 241 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 314 (468)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence 356899999999999999997643 33788999999999999999999 7799999999999999999999
Q ss_pred EEeeccccccccCC--------------CCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 315 FVADFGVARLLNFD--------------SSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 315 kl~Dfg~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
||+|||+++..... ........|++.|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999765421 1122345689999999998764 78999999999999999998 543221
Q ss_pred ccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
........... ............. ...+.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ERVNILKKLRS----VSIEFPPDFDDNK---MKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHS----TTCCCCTTCCTTT---SHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhccc----cccccCccccccc---hHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111000 1111111111111 1226679999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=318.59 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=200.1
Q ss_pred HhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 246 (468)
..++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3468999999999999999999764 7899999999754432 1235678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE---LEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~~~ 323 (468)
|+||+++++|.+++.... .+++.+++.++.|++.||.||| +.+++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999886543 3899999999999999999999 7799999999999999764 479999999998
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
..... .......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.............. .. .....+.
T Consensus 173 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~---~~~~~~~ 245 (287)
T 2wei_A 173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GK---YAFDLPQ 245 (287)
T ss_dssp TBCCC-SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CC---CCCCSGG
T ss_pred eecCC-CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CC---CCCCchh
Confidence 76432 22334468999999998865 488999999999999999999999875432211110000 00 0001000
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ..+.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRTIS---DDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhcC---HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 01111 126789999999999999999999963
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=330.51 Aligned_cols=259 Identities=23% Similarity=0.270 Sum_probs=197.4
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++++.+++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 35799999999999999999975 47889999999754332 2346788999999999999999999999764 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++|+||+. |+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999997 5899988653 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc----------
Q 012219 323 RLLNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN---------- 388 (468)
Q Consensus 323 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~---------- 388 (468)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87643221 1234579999999998654 458999999999999999999999997543221110000
Q ss_pred ----------cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 389 ----------IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 389 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
........+ ...+...........+.+++.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCc-cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000000000111237789999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.23 Aligned_cols=199 Identities=21% Similarity=0.291 Sum_probs=171.5
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc------cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI------RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~ 241 (468)
..+|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 35799999999999999999965 5689999999976532 235677888888877 577999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEeec
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE--AFVADF 319 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Df 319 (468)
...++||||+. ++|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999996 699998876542 34899999999999999999999 679999999999999999987 999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
|+++.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 247 G~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99976532 2334578999999999999999999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=329.37 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=198.5
Q ss_pred HhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
..++|.+.+.||+|+||.||+|...+ .+|+|+++...... ...+.|.+|+.++++++||||+++++++......++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999998754 49999987543221 2234577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
+||+++++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+||+++ ++.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999997643 34889999999999999999999 77999999999999998 67999999999876532
Q ss_pred C-----CCCceeccccccccccccccC---------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccc
Q 012219 328 D-----SSNRTLLAGTYGYIAPELAYT---------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLID 393 (468)
Q Consensus 328 ~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 393 (468)
. ........|++.|+|||++.. ..++.++||||||+++|||++|+.||........... ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~ 257 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ----MGT 257 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH----HHT
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcc
Confidence 1 122233468999999998864 3578899999999999999999999976443221111 011
Q ss_pred ccCCCCCC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 394 LLDPRLSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 394 ~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
...+.... ..+. .+.+++.+||+.||++|||+.++++.|+...+.
T Consensus 258 ~~~~~~~~~~~~~-------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMKPNLSQIGMGK-------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCCCCCCCSSCCT-------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCCcCCCCH-------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 1111 166789999999999999999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.18 Aligned_cols=258 Identities=23% Similarity=0.265 Sum_probs=180.6
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------ 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 241 (468)
.++|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3679999999999999999997 457899999999764322 23456788999999999999999999998754
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
...++|+|++ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 6899888865 23899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc----c--------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK----N-------- 388 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~----~-------- 388 (468)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .
T Consensus 179 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 179 ARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 987542 2334578999999999876 67899999999999999999999999754321110000 0
Q ss_pred ----c---ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 389 ----I---KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 389 ----~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .....+..................+.+++.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000000000000011236789999999999999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.75 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=191.1
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC------E
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK------C 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 243 (468)
.+|.+.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++.... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 468999999999999999999877777999988654322 236999999999999999999986433 3
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-SELEAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~ 322 (468)
.++||||++++.+............+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 7899999987554443332222345899999999999999999999 77999999999999999 7899999999999
Q ss_pred ccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccc------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNI------------ 389 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~------------ 389 (468)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 190 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876433 233345789999999988764 589999999999999999999999975432111000000
Q ss_pred ccccccCCCCCC----ccchhHH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 KLIDLLDPRLSP----PVDQKIR-QDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 ~~~~~~~~~~~~----~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.........+.. +...... .....+.+++.+||+.||++|||+.+++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000011100 0000000 011237789999999999999999999854
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=324.27 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=170.4
Q ss_pred hhCccccc-eeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CC
Q 012219 169 TEDFHIKY-CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RK 242 (468)
Q Consensus 169 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~ 242 (468)
.++|.+.+ .||+|+||.||+|... +++.||||++...... ..+....+..++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46788854 6999999999999764 7999999999754321 1123334566799999999999876 45
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeec
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADF 319 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Df 319 (468)
..++||||+++|+|.+++..... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 58999999999999999986532 35899999999999999999999 779999999999999986 455999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
|+++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ........
T Consensus 176 g~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 252 (336)
T 3fhr_A 176 GFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-IRLGQYGF 252 (336)
T ss_dssp TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CC
T ss_pred ccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-hhcccccc
Confidence 99986542 2233456899999999998889999999999999999999999999654332111100000 00000111
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+....... .+.+++.+||+.||++|||+++++++
T Consensus 253 ~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 253 PNPEWSEVSE---DAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CchhhccCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111111 26679999999999999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=334.07 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc--------CCceeeEEEEEe-
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR--------HRNIVKLYGFCL- 239 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~- 239 (468)
++|.+.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+++++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 6799999999999999999964 5788999999975432 3467889999999986 788999999987
Q ss_pred ---eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCC---
Q 012219 240 ---HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSEL--- 312 (468)
Q Consensus 240 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~--- 312 (468)
.....++||||+ ++++.+.+.... ...+++..++.++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 456789999999 566666665432 234899999999999999999999 66 999999999999999775
Q ss_pred ----------------------------------------------CeEEeeccccccccCCCCCceecccccccccccc
Q 012219 313 ----------------------------------------------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346 (468)
Q Consensus 313 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~ 346 (468)
.+||+|||+++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 8999999999876432 334578999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh--hccccc------------------ccccCC--------C
Q 012219 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL--DKNIKL------------------IDLLDP--------R 398 (468)
Q Consensus 347 ~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~~~~~------------------~~~~~~--------~ 398 (468)
+.+..++.++|||||||++|||+||+.||.......... ...... .+.... .
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997543211100 000000 000000 0
Q ss_pred CCC-ccc-------hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 399 LSP-PVD-------QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 399 ~~~-~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+ ... .........+.+++.+||+.||++|||+.+++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 000 0011233458899999999999999999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=324.93 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=197.1
Q ss_pred HhhCccccceeeeeCCceEEEEEc--CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEe---
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCL--- 239 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 239 (468)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 347899999999999999999986 468899999997544321 1123455777777666 8999999999987
Q ss_pred --eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 240 --HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 240 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 699999876543 24899999999999999999999 7799999999999999999999999
Q ss_pred eccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc--------c
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN--------I 389 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~--------~ 389 (468)
|||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||............. .
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99999765422 22334568999999999999999999999999999999999999997543211100000 0
Q ss_pred cc-------ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 KL-------IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 ~~-------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. ......................+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000000000000000011226679999999999999999999953
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.73 Aligned_cols=273 Identities=20% Similarity=0.233 Sum_probs=188.7
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 241 (468)
.......++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.++++.+..++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34556778999999999999999999976 56899999998654332 23456788888999999999999998653
Q ss_pred CE-------EEEEEEeccCCChhhhhhc-CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CC
Q 012219 242 KC-------MFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-EL 312 (468)
Q Consensus 242 ~~-------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~ 312 (468)
.. .++||||+++ +|...+.. ......+++..+..++.|++.||.|||.+ +.+|+||||||+||+++. ++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 32 7899999986 44443332 22334588999999999999999999943 679999999999999997 89
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc---
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN--- 388 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~--- 388 (468)
.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.............
T Consensus 170 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999999876533 233345789999999998655 48999999999999999999999997543221100000
Q ss_pred ----cccccccCCCC---------CCccchhH----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhc
Q 012219 389 ----IKLIDLLDPRL---------SPPVDQKI----RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIAR 442 (468)
Q Consensus 389 ----~~~~~~~~~~~---------~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~~ 442 (468)
.......++.. ........ ......+.+++.+||+.||++|||+.|++++ |++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 00000000000 00000000 0012347789999999999999999999954 4433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.94 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=197.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|++++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 36799999999999999999975 46899999999754332 2346788999999999999999999998764 6
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+. |+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7899999997 5899988753 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCC----------ceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc---
Q 012219 323 RLLNFDSSN----------RTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN--- 388 (468)
Q Consensus 323 ~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~--- 388 (468)
+........ .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876432111 122468999999998754 678999999999999999999999997543211100000
Q ss_pred --------------cccccccC--CCCC-CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 389 --------------IKLIDLLD--PRLS-PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 389 --------------~~~~~~~~--~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
....+... +... .............+.+++.+||+.||++|||+.+++++ +.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00000000 0000 00000000111236789999999999999999999953 443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.09 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=154.7
Q ss_pred hCccc-cceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCE
Q 012219 170 EDFHI-KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKC 243 (468)
Q Consensus 170 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 243 (468)
+.|.+ .++||+|+||.||+|+.. +++.||+|++...... ..+.+|++++++++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34665 457999999999999854 5789999999765432 467799999999999999999999954 678
Q ss_pred EEEEEEeccCCChhhhhhcCc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCC
Q 012219 244 MFLIYEYMEMGSLFCVLRTDE------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL----NSELE 313 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~ 313 (468)
.++||||+. |+|.+++.... ....+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence 999999997 47877775321 2234899999999999999999999 7799999999999999 67789
Q ss_pred eEEeeccccccccCCC---CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 314 AFVADFGVARLLNFDS---SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999998764322 223345789999999998874 5899999999999999999999999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.31 Aligned_cols=259 Identities=24% Similarity=0.275 Sum_probs=191.5
Q ss_pred HHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC----
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR---- 241 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 241 (468)
...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3467899999999999999999964 67999999999755322 23799999999999999999998543
Q ss_pred ----------------------------------CEEEEEEEeccCCChhhhhhcC-cccCCCCHHHHHHHHHHHHHHHH
Q 012219 242 ----------------------------------KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNVVKGMCHALS 286 (468)
Q Consensus 242 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~ 286 (468)
...++||||++ |+|.+.+... .....+++..+..++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999998 5877776531 12345899999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCceeeC-CCCCeEEeeccccccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHH
Q 012219 287 YLHHDCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVV 364 (468)
Q Consensus 287 ~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvi 364 (468)
||| +.+|+||||||+||+++ .++.+||+|||+++..... .......+|+.|+|||++.+. .++.++||||+||+
T Consensus 156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999 88999999999999998 6889999999999876433 233445789999999988764 58999999999999
Q ss_pred HHHHHhCCCCCCcccccchhhhcc---------------cccccccCCCCCCc-cchhH-HHHHHHHHHHHHhcccCCCC
Q 012219 365 ALEVLMGKHPGELLSSSSWSLDKN---------------IKLIDLLDPRLSPP-VDQKI-RQDIILVSTVAFSCLRSQPK 427 (468)
Q Consensus 365 l~el~tg~~p~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~-~~~~~-~~~~~~l~~l~~~cl~~dP~ 427 (468)
+|||++|+.||............. ....+..-+..... ..... ......+.+++.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999997543221100000 00000000000000 00000 00112267899999999999
Q ss_pred CCCCHHHHHH
Q 012219 428 SRPTMQLVSN 437 (468)
Q Consensus 428 ~RPs~~~v~~ 437 (468)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.14 Aligned_cols=257 Identities=18% Similarity=0.273 Sum_probs=198.2
Q ss_pred hCccccceeeeeCCceEEEEEc--CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc------eeeEEEEEeeC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN------IVKLYGFCLHR 241 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~ 241 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+++++.++|++ ++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 5799999999999999999975 4688999999975432 3467889999999887654 99999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS----------- 310 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~----------- 310 (468)
+..++||||+ +++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 8899999976542 34889999999999999999999 779999999999999987
Q ss_pred --------CCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc
Q 012219 311 --------ELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS 382 (468)
Q Consensus 311 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~ 382 (468)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 67899999999986542 2234578999999999999999999999999999999999999997543211
Q ss_pred hhhhcc---cc----------ccccc---CCCCCCcc----------------chhHHHHHHHHHHHHHhcccCCCCCCC
Q 012219 383 WSLDKN---IK----------LIDLL---DPRLSPPV----------------DQKIRQDIILVSTVAFSCLRSQPKSRP 430 (468)
Q Consensus 383 ~~~~~~---~~----------~~~~~---~~~~~~~~----------------~~~~~~~~~~l~~l~~~cl~~dP~~RP 430 (468)
...... .. ..... ........ ..........+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 100000 00 00000 00000000 000001223478899999999999999
Q ss_pred CHHHHHHH
Q 012219 431 TMQLVSNE 438 (468)
Q Consensus 431 s~~~v~~~ 438 (468)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=330.73 Aligned_cols=257 Identities=25% Similarity=0.295 Sum_probs=193.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE---
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM--- 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 244 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 36789999999999999999974 578999999997654332 3456788999999999999999999999876654
Q ss_pred ---EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 245 ---FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 245 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
++||||+. ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588887742 2899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc----c-------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN----I------- 389 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~----~------- 389 (468)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 191 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 986542 2334578999999999887 688999999999999999999999997543211100000 0
Q ss_pred --------ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 390 --------KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 390 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+..................+.+++.+||+.||++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000110000000111237789999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.81 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=201.2
Q ss_pred HhhCccccceeeeeCCceEEEEEcC----CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC 243 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 243 (468)
..++|.+.+.||+|+||.||+|.+. .+..||+|++...... ...+.|.+|+.++++++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 3467888999999999999999763 2567999998764432 234678999999999999999999999854 55
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 899999999999999997543 34899999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 324 LLNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 324 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......... .+..........
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~ 615 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGERLPMPP 615 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHHTCCCCCCT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHcCCCCCCCc
Confidence 7643222 1223456789999999998899999999999999999997 999997544321111 000101111122
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+ ..+.+++.+||+.||++|||+.++++.|..+
T Consensus 616 ~~~-------~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 616 NCP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp TCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 121 1266799999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=335.60 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=189.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------C
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------K 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 242 (468)
.+|.+.+.||+|+||.||+|+. .+|+.||||++..... .+.+|+++++.++||||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4688899999999999999986 4689999999975432 233799999999999999999988542 2
Q ss_pred EEEEEEEeccCCChhhhhhc-CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeecc
Q 012219 243 CMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFG 320 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg 320 (468)
..++||||+++ ++.+.+.. ......+++..+..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999986 56555542 122345899999999999999999999 7899999999999999965 568999999
Q ss_pred ccccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc------------
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK------------ 387 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~------------ 387 (468)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998764322 23345789999999998764 7999999999999999999999999754321110000
Q ss_pred ---ccccccccCCCCCCc-cchhH-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 ---NIKLIDLLDPRLSPP-VDQKI-RQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 ---~~~~~~~~~~~~~~~-~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+..-+.+... ..... ......+.+++.+||+.||++|||+.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000111100 00000 0001237789999999999999999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=321.57 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=190.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe---------
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL--------- 239 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------- 239 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH---HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 57899999999999999999765 5899999999765432 4567889999999999999999999874
Q ss_pred -----eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCC
Q 012219 240 -----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-SELE 313 (468)
Q Consensus 240 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~ 313 (468)
.....++||||++ |+|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+||+++ .++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999998 699999864 23889999999999999999999 77999999999999997 5679
Q ss_pred eEEeeccccccccCCC---CCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc-
Q 012219 314 AFVADFGVARLLNFDS---SNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN- 388 (468)
Q Consensus 314 ~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~- 388 (468)
+||+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|||+||+.||.............
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998764321 12233457899999998765 678999999999999999999999997543211100000
Q ss_pred ----------cccccc----cCCC---CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 389 ----------IKLIDL----LDPR---LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 389 ----------~~~~~~----~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
...... +... ...............+.+++.+||+.||++|||+++++++ +..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 000000 0000 0000000000011237789999999999999999999853 444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=322.03 Aligned_cols=255 Identities=24% Similarity=0.302 Sum_probs=175.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHH-HHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEAR-LLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||.||+|.. .+|+.||||++....... ....+..|+. +++.++||||+++++++...+..++|
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 6789999999999999999976 478999999997654332 2345555665 77788999999999999999999999
Q ss_pred EEeccCCChhhhhhcC--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTD--EEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
|||+++ +|.+++... .....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 887777531 11234899999999999999999999 66 999999999999999999999999999987
Q ss_pred ccCCCCCceeccccccccccccc----cCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELA----YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.... .......|++.|+|||++ .+..++.++||||||+++|||++|+.||........... .......+.+.
T Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~ 251 (327)
T 3aln_A 176 LVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT---QVVKGDPPQLS 251 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C---CCCCSCCCCCC
T ss_pred cccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH---HHhcCCCCCCC
Confidence 6432 222334689999999998 456789999999999999999999999975432111111 11111111111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
......... .+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEEREFSP---SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcccccCCH---HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111011111 2677999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=324.24 Aligned_cols=200 Identities=25% Similarity=0.356 Sum_probs=170.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CC-----ceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HR-----NIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 241 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ....+..|+++++.++ |+ +++++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 47899999999999999999975 4688999999975432 2456778888888885 44 499999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEeec
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN--SELEAFVADF 319 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Df 319 (468)
+..++||||+. |+|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 599999976532 3489999999999999999999953 46999999999999995 4788999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 23457899999999999999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=334.57 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=183.9
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 249 (468)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 455568899999999987766689999999987543 24567899999886 89999999999999999999999
Q ss_pred eccCCChhhhhhcCcccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-------------C
Q 012219 250 YMEMGSLFCVLRTDEEAV----GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-------------L 312 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-------------~ 312 (468)
|+. |+|.+++....... ...+..++.++.||+.||+||| +.+|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 996 69999997643211 1133345789999999999999 7799999999999999754 4
Q ss_pred CeEEeeccccccccCCCCC----ceeccccccccccccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCcccc
Q 012219 313 EAFVADFGVARLLNFDSSN----RTLLAGTYGYIAPELAYT-------MVVTEKCDVYSFGVVALEVLM-GKHPGELLSS 380 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~ 380 (468)
.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999877543221 223579999999999865 578999999999999999999 9999975432
Q ss_pred cchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
......... ... +........ .....+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~i~~~~--~~~--~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESNIIRGI--FSL--DEMKCLHDR---SLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHTC--CCC--CCCTTCCCH---HHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHhcCC--CCc--ccccccccc---cchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 211111000 000 111111111 22234778999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=322.52 Aligned_cols=259 Identities=24% Similarity=0.292 Sum_probs=193.7
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE-----
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC----- 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 243 (468)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 5788999999999999999975 57899999999764332 2345678899999999999999999999987653
Q ss_pred -EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 244 -MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 244 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
.++||||+. |+|.+++.. .+++.++..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588877742 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc----c--------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN----I-------- 389 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~----~-------- 389 (468)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||............. .
T Consensus 174 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 76542 2334578999999999876 678999999999999999999999997543211100000 0
Q ss_pred -------ccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 390 -------KLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 390 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
.....+..................+.+++.+||+.||++|||+.+++++ +.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0000000000000000000111237789999999999999999999854 443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.00 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=178.7
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.++..+++.++||||+++++++...+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 46789999999999999999976 478999999998654432 2234455556678888999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeCCCCCeEEeecccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLNSELEAFVADFGVARLLN 326 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 326 (468)
|||+ ++.+..+.... ...+++..++.++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 45555554432 234899999999999999999999 53 89999999999999999999999999997664
Q ss_pred CCCCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 327 FDSSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.. .......|++.|+|||++. ...++.++||||||+++|||++|+.||............ ......+....
T Consensus 177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 252 (318)
T 2dyl_A 177 DD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK---VLQEEPPLLPG 252 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---HHHSCCCCCCS
T ss_pred CC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH---HhccCCCCCCc
Confidence 32 2233456899999999984 456889999999999999999999999754322111111 00111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.. .... .+.+++.+||+.||.+|||+++++++
T Consensus 253 ~~--~~~~---~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HM--GFSG---DFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SS--CCCH---HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cC--CCCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0111 26679999999999999999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=330.46 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=184.5
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 468888999999999976555568999999999754332 245799999999 7999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----CCCeEEeeccccc
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-----ELEAFVADFGVAR 323 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfg~~~ 323 (468)
||+. |+|.+++...... ..+..++.++.||+.||.||| +.+|+||||||+||+++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 5999999765432 444556789999999999999 779999999999999953 3467899999998
Q ss_pred cccCCC---CCceecccccccccccccc---CCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccC
Q 012219 324 LLNFDS---SNRTLLAGTYGYIAPELAY---TMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLD 396 (468)
Q Consensus 324 ~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||............... ..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~----~~ 247 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC----SL 247 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC----CC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC----Cc
Confidence 765332 2233457999999999987 4567889999999999999999 99998643322111110000 00
Q ss_pred CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 397 PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 397 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
...... . .....+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLHPE-K----HEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCTT-C----HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcc-c----cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 011111 1 11223668999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=318.71 Aligned_cols=198 Identities=24% Similarity=0.364 Sum_probs=169.4
Q ss_pred hCccccceeeeeCCceEEEEEcC-CC-CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc------eeeEEEEEeeC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SG-KVVALKKLHRSETEELASLESFGNEARLLSQIRHRN------IVKLYGFCLHR 241 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~ 241 (468)
++|.+.+.||+|+||.||+|... ++ +.||+|++..... ..+.+.+|+++++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 67999999999999999999753 34 6899999975432 2457788999999998766 99999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-------------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLL------------- 308 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll------------- 308 (468)
+..++||||+ ++++.+++..... ..+++.+++.++.||+.||+||| +.+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 6677777765432 34899999999999999999999 7899999999999999
Q ss_pred ------CCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCccc
Q 012219 309 ------NSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLS 379 (468)
Q Consensus 309 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~ 379 (468)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678999999999986532 2234578999999999999999999999999999999999999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=321.70 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=196.7
Q ss_pred hhCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhcc--CCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIR--HRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||.||+|. ..+++.||||++........ ...+.+.+|+.++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 4679999999999999999996 46789999999976533210 11234668999999996 599999999999999
Q ss_pred EEEEEEEeccC-CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEeecc
Q 012219 243 CMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-SELEAFVADFG 320 (468)
Q Consensus 243 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg 320 (468)
..++|+|++.+ ++|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999986 89999987643 3899999999999999999999 77999999999999999 77999999999
Q ss_pred ccccccCCCCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 321 VARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+++.... .......||+.|+|||++.+..+ +.++||||||+++|||+||+.||...... ... . ...
T Consensus 196 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~----~----~~~ 262 (320)
T 3a99_A 196 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IRG----Q----VFF 262 (320)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHC----C----CCC
T ss_pred ccccccc--ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---hcc----c----ccc
Confidence 9987643 22334568999999999877665 67899999999999999999998743210 000 0 011
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...... .+.+++.+||+.||++|||+++++++
T Consensus 263 ~~~~~~-------~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSS-------ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCH-------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 26679999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.20 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=190.0
Q ss_pred HHHhhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhc----cCCceeeEEEE
Q 012219 166 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQI----RHRNIVKLYGF 237 (468)
Q Consensus 166 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~niv~l~~~ 237 (468)
....++|.+.+.||+|+||.||+|.. .+++.||||++........ .....+.+|++++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999975 5789999999976543211 1223456799999998 89999999999
Q ss_pred EeeCCEEEEEEEe-ccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeE
Q 012219 238 CLHRKCMFLIYEY-MEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN-SELEAF 315 (468)
Q Consensus 238 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~~k 315 (468)
+...+..++|+|| +.+++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 9998999999999 78999999997643 3899999999999999999999 67999999999999999 889999
Q ss_pred EeeccccccccCCCCCceeccccccccccccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccc
Q 012219 316 VADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVT-EKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 394 (468)
|+|||+++..... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||...... ...
T Consensus 181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~------- 248 (312)
T 2iwi_A 181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---LEA------- 248 (312)
T ss_dssp ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHT-------
T ss_pred EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---hhh-------
Confidence 9999999876532 23345689999999998776664 5899999999999999999998743210 000
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+...... .+.+++.+||+.||++|||+.+++++
T Consensus 249 -~~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 -ELHFPAHVSP-------DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -CCCCCTTSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -ccCCcccCCH-------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111 26679999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.49 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=193.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-----------CCceeeEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-----------HRNIVKLYGF 237 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 237 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++++++ |+||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 5799999999999999999975 5789999999976443 2356778999998886 8999999999
Q ss_pred EeeCC----EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceeeC---
Q 012219 238 CLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP-PIVHRDISSNNVLLN--- 309 (468)
Q Consensus 238 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~NIll~--- 309 (468)
+...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+||| +. +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence 88654 789999999 8899999976432 34899999999999999999999 66 999999999999994
Q ss_pred ---CCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-
Q 012219 310 ---SELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL- 385 (468)
Q Consensus 310 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~- 385 (468)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 233478999999999999999999999999999999999999997543211100
Q ss_pred -hcccccccc------------------------cCCCCCC---ccch-------hHHHHHHHHHHHHHhcccCCCCCCC
Q 012219 386 -DKNIKLIDL------------------------LDPRLSP---PVDQ-------KIRQDIILVSTVAFSCLRSQPKSRP 430 (468)
Q Consensus 386 -~~~~~~~~~------------------------~~~~~~~---~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RP 430 (468)
.....+.+. ....... +... ........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 000000000 0000000 0000 0012334578899999999999999
Q ss_pred CHHHHHHH
Q 012219 431 TMQLVSNE 438 (468)
Q Consensus 431 s~~~v~~~ 438 (468)
|+.+++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=304.59 Aligned_cols=235 Identities=13% Similarity=0.051 Sum_probs=184.0
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|.+.+.||+|+||.||+|... +++.||||++...........+.|.+|+..+.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999764 58999999998765543345678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++++|.+++... ....++..++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999998542 355678899999999999999 7799999999999999999999997543
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
|++| ++.++|||||||++|||+||+.||........... ........... ......
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~ 230 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----AERDTAGQPIE-PADIDR 230 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----CCBCTTSCBCC-HHHHCT
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----HHHHhccCCCC-hhhccc
Confidence 3333 67899999999999999999999975433211000 00000000000 000000
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.....+.+++.+||+.||++| |+.++++.|.+....
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 011226789999999999999 999999999987654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=340.03 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=195.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee------C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------R 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~ 241 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ...+.|.+|++++++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 36899999999999999999975 56899999998765332 345678999999999999999999999765 6
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEee
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVAD 318 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 318 (468)
+..++||||+++|+|.+++........+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 678999999999999999987665556889999999999999999999 779999999999999997765 89999
Q ss_pred ccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccc-hhh------hccccc
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSS-WSL------DKNIKL 391 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~-~~~------~~~~~~ 391 (468)
||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... +.. ......
T Consensus 168 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9999876533 23344679999999999999999999999999999999999999986431110 000 000000
Q ss_pred cccc------CCCC--CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 012219 392 IDLL------DPRL--SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQL 434 (468)
Q Consensus 392 ~~~~------~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~ 434 (468)
.+.. .... ......... ..+.+++.+||..||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls---~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILA---GKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGH---HHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhh---HHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 0000 111112222 23778999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=338.85 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=190.7
Q ss_pred hCccccceeeeeCCceEEEEEcC--CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCE----
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKC---- 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 243 (468)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.|.+|++++.+++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 68999999999999999999764 6899999999754332 235678899999999999999999999987554
Q ss_pred -EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 244 -MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 244 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
.++||||+++++|.+++.. .+++.+++.++.||+.||.||| +.+|+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887754 4899999999999999999999 7799999999999999986 8999999999
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+...... . +...
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~-----~~~~ 287 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------G-----LPED 287 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------S-----CCTT
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------c-----cccc
Confidence 876432 3456999999999887654 88999999999999999999887532110 0 0000
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHh
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPT-MQLVSNEFIA 441 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~~v~~~l~~ 441 (468)
. ........+.+++.+||+.||++||+ ++++.+.|..
T Consensus 288 ~--~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 288 D--PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C--HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c--cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 01111234778999999999999995 5777776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=300.98 Aligned_cols=231 Identities=23% Similarity=0.343 Sum_probs=175.5
Q ss_pred hCcccc-ceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHH-hhccCCceeeEEEEEee----CC
Q 012219 170 EDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLL-SQIRHRNIVKLYGFCLH----RK 242 (468)
Q Consensus 170 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~ 242 (468)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 567776 7799999999999975 57899999999643 2455788887 55689999999999876 67
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeec
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADF 319 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Df 319 (468)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 78999999999999999986432 34899999999999999999999 779999999999999998 789999999
Q ss_pred cccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCC
Q 012219 320 GVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 320 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
|++.... +..++.++|||||||++|||+||+.||............. . .......
T Consensus 165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-~--~~~~~~~ 219 (299)
T 3m2w_A 165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-T--RIRMGQY 219 (299)
T ss_dssp TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-C--SSCTTCC
T ss_pred ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-H--HHhhccc
Confidence 9986532 2346789999999999999999999996543221110000 0 0000001
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..+ ..........+.+++.+||+.||++|||+.+++++
T Consensus 220 ~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC-chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 00000111237789999999999999999999953
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.84 Aligned_cols=244 Identities=15% Similarity=0.143 Sum_probs=178.6
Q ss_pred hCccccceeeeeCCceEEEEE-cCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-Cce---------e------
Q 012219 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNI---------V------ 232 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni---------v------ 232 (468)
..|...+.||+|+||.||+|. ..+|+.||||++...........+.|.+|+.++..++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457788999999999999997 56799999999985554444456789999999999987 221 1
Q ss_pred e------EEEEEee-----CCEEEEEEEeccCCChhhhhhc----CcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012219 233 K------LYGFCLH-----RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIV 297 (468)
Q Consensus 233 ~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 297 (468)
. ++.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||+.||+||| +.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1 1111111 12356777765 5799988852 112334788899999999999999999 77999
Q ss_pred ecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccccccccccccc----------cCCCCCccchhhHHHHHHHH
Q 012219 298 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA----------YTMVVTEKCDVYSFGVVALE 367 (468)
Q Consensus 298 H~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~s~Gvil~e 367 (468)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999765422 334567 999999998 55678899999999999999
Q ss_pred HHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 368 VLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 368 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
|+||+.||......... ...+... ...+ ..+.+++.+||+.||++||++.++++
T Consensus 310 lltg~~Pf~~~~~~~~~-------~~~~~~~--~~~~-------~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGS-------EWIFRSC--KNIP-------QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGSCS-------GGGGSSC--CCCC-------HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhhhH-------HHHHhhc--ccCC-------HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999754321110 0111100 1111 12677999999999999999877653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.44 Aligned_cols=246 Identities=16% Similarity=0.156 Sum_probs=184.0
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchh-----hhhhHHHHHHHHHHHhhcc---------CCceeeE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-----ELASLESFGNEARLLSQIR---------HRNIVKL 234 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~niv~l 234 (468)
.++|.+.+.||+|+||.||+|+. +|+.||||++...... .....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36789999999999999999988 6899999999865321 1223467889999998886 8888888
Q ss_pred EEEEe------------------------------eCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHH
Q 012219 235 YGFCL------------------------------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284 (468)
Q Consensus 235 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 284 (468)
.+.+. ..+..++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77643 26789999999999987776643 237999999999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCceeeCCCC--------------------CeEEeeccccccccCCCCCceecccccccccc
Q 012219 285 LSYLHHDCTPPIVHRDISSNNVLLNSEL--------------------EAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344 (468)
Q Consensus 285 l~~LH~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aP 344 (468)
|+|||+ +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 999993 24899999999999999887 8999999999876522 34799999999
Q ss_pred ccccCCCCCccchhhHHHHH-HHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhccc
Q 012219 345 ELAYTMVVTEKCDVYSFGVV-ALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLR 423 (468)
Q Consensus 345 E~~~~~~~~~~~Dv~s~Gvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 423 (468)
|++.+.. +.++||||+|++ .+++++|..||....+............ ........ .........+.+++.+||+
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-TFKTKCNT---PAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-CCSSCCCS---HHHHHHHHHHHHHHHHGGG
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-ccCcccch---hhhhhcCHHHHHHHHHHhc
Confidence 9998766 889999998776 7888899999864221111111000000 01111111 1122233458889999999
Q ss_pred CCCCCCCCHHHHH
Q 012219 424 SQPKSRPTMQLVS 436 (468)
Q Consensus 424 ~dP~~RPs~~~v~ 436 (468)
.| |++|++
T Consensus 322 ~d-----sa~e~l 329 (336)
T 2vuw_A 322 FS-----SATDLL 329 (336)
T ss_dssp SS-----SHHHHH
T ss_pred cC-----CHHHHH
Confidence 76 998887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=277.09 Aligned_cols=187 Identities=19% Similarity=0.099 Sum_probs=132.7
Q ss_pred eeeeCCceEEEEE-cCCCCEEEEEEecCcc-------hhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEEEEE
Q 012219 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSE-------TEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 178 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.+.|++|.+..++ .--|+.+++|++.... .......++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555555442 3357889999997542 12223457899999999999 6999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++|++|.+.+...+. ++.. +|+.||+.||+|+| +.|||||||||+|||++.++.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999986543 5543 58899999999999 789999999999999999999999999999987665
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
.......+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 555666789999999999875 466789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=250.45 Aligned_cols=187 Identities=16% Similarity=0.203 Sum_probs=146.4
Q ss_pred cccceeeeeCCceEEEEEcCCCCEEEEEEecCcch-----hhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 173 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET-----EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
...+.||+|+||.||+|.. .++.+++|+...... ......+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 577889988654321 1222345689999999999999999666666676777999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++++|.+++.. +..++.|++.||.||| +.+|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 4589999999999999 779999999999999999 999999999988653
Q ss_pred CCCC-------ceeccccccccccccccC--CCCCccchhhHHHHHHHHHHhCCCCCC
Q 012219 328 DSSN-------RTLLAGTYGYIAPELAYT--MVVTEKCDVYSFGVVALEVLMGKHPGE 376 (468)
Q Consensus 328 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~el~tg~~p~~ 376 (468)
.... .....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 134679999999999987 568889999999999999888877753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=204.53 Aligned_cols=167 Identities=17% Similarity=0.155 Sum_probs=126.4
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhh---------------hhHHHHHHHHHHHhhcc
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL---------------ASLESFGNEARLLSQIR 227 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~ 227 (468)
..+......|.+.+.||+|+||.||+|...+|+.||+|+++....... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334444556777899999999999999887899999999975432111 13467889999999999
Q ss_pred CCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 012219 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVL 307 (468)
Q Consensus 228 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIl 307 (468)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence 4 555554433 44699999999999988 432 123469999999999999 789999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCceeccccccccccccccC----------CCCCccchhhH
Q 012219 308 LNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYT----------MVVTEKCDVYS 360 (468)
Q Consensus 308 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Dv~s 360 (468)
++ ++.+||+|||+++.. ..++|||++.. ..+...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 999999999999643 34688998743 33445566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.2e-20 Score=169.30 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=106.3
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCE--EEEEEecCcchhh---------------------hhhHHHHHHHHHHHhhc
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKV--VALKKLHRSETEE---------------------LASLESFGNEARLLSQI 226 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 226 (468)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ......+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366788999999999999987 68888 9999976432110 01123678999999999
Q ss_pred cCCce--eeEEEEEeeCCEEEEEEEeccC-C----ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 012219 227 RHRNI--VKLYGFCLHRKCMFLIYEYMEM-G----SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHR 299 (468)
Q Consensus 227 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 299 (468)
+|+++ ..++++ ...++||||+.+ | +|.+.... .++.....++.|++.||.|||. +.+|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence 88754 344443 245899999942 4 56655432 2234567899999999999994 3589999
Q ss_pred CCCCCceeeCCCCCeEEeeccccccc
Q 012219 300 DISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 300 dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=158.44 Aligned_cols=141 Identities=13% Similarity=0.121 Sum_probs=101.1
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchh---------------hhh----hHHHHHHHHHHHhhccCCce
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE---------------ELA----SLESFGNEARLLSQIRHRNI 231 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~----~~~~~~~e~~~l~~l~h~ni 231 (468)
-|.+...||+|++|.||+|...+|+.||||+++..... ... .......|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48899999999999999999989999999987643210 000 00112356777777765543
Q ss_pred eeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 012219 232 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE 311 (468)
Q Consensus 232 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~ 311 (468)
....-+.... .+|||||++|++|..+... .....++.|++.+|.+|| ..|||||||||.|||++++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence 2221121222 3799999999888665432 123467899999999999 6799999999999999887
Q ss_pred CC----------eEEeeccccccc
Q 012219 312 LE----------AFVADFGVARLL 325 (468)
Q Consensus 312 ~~----------~kl~Dfg~~~~~ 325 (468)
+. +.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 63 789999987543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.5e-14 Score=151.04 Aligned_cols=91 Identities=34% Similarity=0.601 Sum_probs=85.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCC---ccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRK---VPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l 78 (468)
++++|+.|||++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|.+|++|++|+.||||+|+++|.+|..+.+ |+.|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 4688999999999999999999999999999999999999999999999999999999999999999987654 5668
Q ss_pred ecccccccccCCCC
Q 012219 79 YVYGKNFDVEIPNT 92 (468)
Q Consensus 79 ~~~~n~l~~~~p~~ 92 (468)
++++|++++.+|..
T Consensus 710 ~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 710 DLSNNNLSGPIPEM 723 (768)
T ss_dssp ECCSSEEEEECCSS
T ss_pred ECcCCcccccCCCc
Confidence 99999999999865
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=120.67 Aligned_cols=93 Identities=18% Similarity=0.249 Sum_probs=70.4
Q ss_pred CCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccceec
Q 012219 5 KLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYV 80 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~ 80 (468)
+|+.|+|++|+|++..|. .|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+ .+|+.|++
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 688888888888854443 37888888888888888887778888888888888888888886666544 45566778
Q ss_pred ccccccccCCCCCCCCC
Q 012219 81 YGKNFDVEIPNTSENSP 97 (468)
Q Consensus 81 ~~n~l~~~~p~~~~~~~ 97 (468)
++|.+.+..|..+...+
T Consensus 110 ~~N~l~~~~~~~~~~l~ 126 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLN 126 (192)
T ss_dssp CSSCCCEECTTSSTTCT
T ss_pred CCCcCCeeCHHHhhcCC
Confidence 88888877776655443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=116.29 Aligned_cols=95 Identities=16% Similarity=0.216 Sum_probs=71.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+ .+|..|
T Consensus 55 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp GCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred cCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 46778888888888886666678888888888888888887767778888888888888888886666654 345567
Q ss_pred ecccccccccCCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~~ 96 (468)
++++|.+.+..|..+...
T Consensus 135 ~L~~N~l~~~~~~~~~~l 152 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTL 152 (220)
T ss_dssp ECTTSCCCCBCTTTTTTC
T ss_pred ECCCCcCCEECHHHhcCC
Confidence 788888877666655443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-12 Score=111.94 Aligned_cols=86 Identities=17% Similarity=0.328 Sum_probs=63.7
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~ 80 (468)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+ .+|+.|++
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 567888888888886667778888888888888888886555567888888888888888885433333 45566778
Q ss_pred ccccccccC
Q 012219 81 YGKNFDVEI 89 (468)
Q Consensus 81 ~~n~l~~~~ 89 (468)
++|.+.+.+
T Consensus 110 ~~N~~~c~c 118 (170)
T 3g39_A 110 LNNPWDCAC 118 (170)
T ss_dssp CSSCBCTTB
T ss_pred CCCCCCCCc
Confidence 888776643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.6e-12 Score=117.04 Aligned_cols=90 Identities=17% Similarity=0.171 Sum_probs=79.3
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
+++++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..+. ++..
T Consensus 78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 157 (220)
T 2v70_A 78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157 (220)
T ss_dssp TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE
Confidence 3688999999999999977777799999999999999999988899999999999999999999977787665 5566
Q ss_pred eecccccccccCC
Q 012219 78 LYVYGKNFDVEIP 90 (468)
Q Consensus 78 l~~~~n~l~~~~p 90 (468)
|++++|++.+.++
T Consensus 158 L~L~~N~l~c~c~ 170 (220)
T 2v70_A 158 LNLLANPFNCNCY 170 (220)
T ss_dssp EECCSCCEECSGG
T ss_pred EEecCcCCcCCCc
Confidence 8899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.7e-12 Score=117.93 Aligned_cols=145 Identities=11% Similarity=0.045 Sum_probs=112.2
Q ss_pred HHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 245 (468)
.....|.+...++.|+.+.||++... ++.+++|+........ ...+.+|+++++.+. +..+.++++++...+..+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34567888888888899999999864 6889999987532111 135778999999885 677888999999888999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC--------------------------------- 292 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------- 292 (468)
+||||++|.+|.+.+.. ......++.+++++|..||...
T Consensus 87 lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999998876421 1123467889999999999610
Q ss_pred -----------------------CCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 293 -----------------------TPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 293 -----------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
...++|+|++|.||+++++..+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876666799998774
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.1e-12 Score=111.74 Aligned_cols=84 Identities=24% Similarity=0.454 Sum_probs=58.9
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc-C---CCcccee
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES-V---RKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~---~~l~~l~ 79 (468)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++ +|.. + .+|..|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce-eCHHHhccccCCCEEE
Confidence 467778888888876667777778888888888888875444446777888888888888874 4442 3 4455667
Q ss_pred ccccccccc
Q 012219 80 VYGKNFDVE 88 (468)
Q Consensus 80 ~~~n~l~~~ 88 (468)
+++|.+...
T Consensus 112 L~~N~~~c~ 120 (174)
T 2r9u_A 112 LYNNPWDCE 120 (174)
T ss_dssp CCSSCBCTT
T ss_pred eCCCCcccc
Confidence 777776653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-12 Score=139.34 Aligned_cols=87 Identities=37% Similarity=0.560 Sum_probs=78.5
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc--CCCccce
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES--VRKVPHL 78 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l 78 (468)
++|++|+.|+|++|+|+|.||++|++|++|+.||||+|+|+|.+|..+++|++|+.||||+|+|+|.||.. +.+++..
T Consensus 653 ~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~ 732 (768)
T 3rgz_A 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGG
T ss_pred hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHH
Confidence 36889999999999999999999999999999999999999999999999999999999999999999974 5566666
Q ss_pred eccccc-ccc
Q 012219 79 YVYGKN-FDV 87 (468)
Q Consensus 79 ~~~~n~-l~~ 87 (468)
.+.+|. +++
T Consensus 733 ~~~gN~~Lcg 742 (768)
T 3rgz_A 733 KFLNNPGLCG 742 (768)
T ss_dssp GGCSCTEEES
T ss_pred HhcCCchhcC
Confidence 677775 444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.3e-12 Score=113.50 Aligned_cols=92 Identities=21% Similarity=0.306 Sum_probs=76.6
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~ 80 (468)
++|+.|+|++|+|+ .+|+.|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+ .+|..|++
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 57899999999998 899999999999999999999997777889999999999999999996555545 45667889
Q ss_pred ccccccccCCCCCCCC
Q 012219 81 YGKNFDVEIPNTSENS 96 (468)
Q Consensus 81 ~~n~l~~~~p~~~~~~ 96 (468)
++|.+....+..+...
T Consensus 110 ~~N~l~~~~~~~~~~l 125 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDL 125 (193)
T ss_dssp CSSCCCBCCTTTTTTC
T ss_pred CCCCCCeeChhhhhcC
Confidence 9999887655545443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-13 Score=136.17 Aligned_cols=85 Identities=15% Similarity=0.177 Sum_probs=54.1
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccccc-CCCCCceecccCcccccccCC-cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG-EIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
+++|+.|+|++|+|++..|..|+++++|++|+|++|+|++.+|..+. +|++|+.|+|++|+|++..+. .+.+|..|++
T Consensus 119 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L 198 (487)
T 3oja_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDL 198 (487)
T ss_dssp CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEEC
T ss_pred cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEEC
Confidence 56677777777777766666777777777777777777776666665 566666666666666643221 2344555555
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
++|.+++
T Consensus 199 s~N~l~~ 205 (487)
T 3oja_A 199 SSNKLAF 205 (487)
T ss_dssp CSSCCCE
T ss_pred CCCCCCC
Confidence 5555544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-12 Score=125.06 Aligned_cols=96 Identities=33% Similarity=0.548 Sum_probs=81.0
Q ss_pred CCCCCcEEEccC-CcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccc
Q 012219 2 NCSKLRVLELGN-NLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~ 77 (468)
++++|+.|+|++ |+++|.+|..|+++++|++|+|++|+++|.+|..|.++++|++|+|++|+++|.+|..+ .+|+.
T Consensus 74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence 578899999994 99999999999999999999999999999999999999999999999999998888755 45566
Q ss_pred eecccccccccCCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENSP 97 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~~ 97 (468)
|++++|.+.+.+|......+
T Consensus 154 L~L~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGSFS 173 (313)
T ss_dssp EECCSSCCEEECCGGGGCCC
T ss_pred EECcCCcccCcCCHHHhhhh
Confidence 78889988877776655443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.30 E-value=6.4e-12 Score=113.08 Aligned_cols=88 Identities=23% Similarity=0.271 Sum_probs=42.7
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCcccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~ 79 (468)
+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..+ .+|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 4455555555555554445555555555555555555552222234555555555555555554334333 2333445
Q ss_pred cccccccccCC
Q 012219 80 VYGKNFDVEIP 90 (468)
Q Consensus 80 ~~~n~l~~~~p 90 (468)
+++|.+....+
T Consensus 135 L~~N~l~~~~~ 145 (220)
T 2v9t_B 135 LYDNKLQTIAK 145 (220)
T ss_dssp CCSSCCSCCCT
T ss_pred CCCCcCCEECH
Confidence 55555544433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.4e-12 Score=124.06 Aligned_cols=94 Identities=22% Similarity=0.394 Sum_probs=82.4
Q ss_pred CCCcEEEccCCcccc--cCCcccccCCCCCEeeccC-ccccccccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 4 SKLRVLELGNNLLSG--SIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
.+++.|+|++|+++| .+|+.|+++++|++|+|++ |+++|.+|..|+++++|++|+|++|+++|.+|..+. +|+.
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999999 8999999999999999995 999999999999999999999999999999998654 5667
Q ss_pred eecccccccccCCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENSP 97 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~~ 97 (468)
|++++|.+.+..|......+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~ 149 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp EECCSSEEESCCCGGGGGCT
T ss_pred EeCCCCccCCcCChHHhcCC
Confidence 88999999887776655443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=122.90 Aligned_cols=86 Identities=20% Similarity=0.275 Sum_probs=67.2
Q ss_pred CCCCCcEEEccC-CcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCC--ccc
Q 012219 2 NCSKLRVLELGN-NLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRK--VPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~--l~~ 77 (468)
++++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|++|+|++ +|. .+.. |..
T Consensus 29 ~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~ 107 (347)
T 2ifg_A 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQE 107 (347)
T ss_dssp SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCE
T ss_pred CCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCceE
Confidence 467788888886 88886666778888888888888888888878888888888888888888884 554 3332 667
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++.+|.+.+.
T Consensus 108 l~l~~N~~~c~ 118 (347)
T 2ifg_A 108 LVLSGNPLHCS 118 (347)
T ss_dssp EECCSSCCCCC
T ss_pred EEeeCCCccCC
Confidence 78888887664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=9.2e-12 Score=109.60 Aligned_cols=86 Identities=21% Similarity=0.299 Sum_probs=73.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cC---CCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SV---RKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~---~~l~~ 77 (468)
++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|. .+ .++..
T Consensus 52 ~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~ 130 (193)
T 2wfh_A 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH 130 (193)
T ss_dssp GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCE
T ss_pred cccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccE
Confidence 5788999999999999766778999999999999999999877888999999999999999999 4554 34 45667
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++.+|++.+.
T Consensus 131 L~L~~N~~~C~ 141 (193)
T 2wfh_A 131 LAIGANPLYCD 141 (193)
T ss_dssp EECCSSCEECS
T ss_pred EEeCCCCeecC
Confidence 88999988764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=8.5e-12 Score=109.76 Aligned_cols=89 Identities=22% Similarity=0.299 Sum_probs=79.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
++++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++.+|..+. ++..|
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 578999999999999988899999999999999999999988888899999999999999999988887665 56668
Q ss_pred ecccccccccCC
Q 012219 79 YVYGKNFDVEIP 90 (468)
Q Consensus 79 ~~~~n~l~~~~p 90 (468)
++++|.+.+.++
T Consensus 132 ~L~~N~l~c~c~ 143 (192)
T 1w8a_A 132 NLASNPFNCNCH 143 (192)
T ss_dssp ECTTCCBCCSGG
T ss_pred EeCCCCccCcCc
Confidence 899999987543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.7e-12 Score=119.79 Aligned_cols=88 Identities=18% Similarity=0.292 Sum_probs=48.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Ccccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~ 79 (468)
+++|+.|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..++++++|+.|+|++|++.+.+|..+. +|+.|+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 555666666666665 55555555556666666666555 3444555555555555555555555555432 333445
Q ss_pred cccccccccCCCC
Q 012219 80 VYGKNFDVEIPNT 92 (468)
Q Consensus 80 ~~~n~l~~~~p~~ 92 (468)
+++|++.+.+|..
T Consensus 260 L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 260 LKDCSNLLTLPLD 272 (328)
T ss_dssp CTTCTTCCBCCTT
T ss_pred CCCCCchhhcchh
Confidence 5555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=9.6e-12 Score=107.84 Aligned_cols=92 Identities=20% Similarity=0.177 Sum_probs=72.9
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCcccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~ 79 (468)
.++|+.|+|++|++++..+..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.. +.+|+.|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 367999999999999655566899999999999999999666666899999999999999999554443 35677788
Q ss_pred cccccccccCCCCCC
Q 012219 80 VYGKNFDVEIPNTSE 94 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~ 94 (468)
+++|.+....+..+.
T Consensus 107 l~~N~l~~~~~~~~~ 121 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFD 121 (177)
T ss_dssp CCSSCCSCCCTTTTT
T ss_pred CcCCcceEeCHHHhc
Confidence 999988765444333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=110.23 Aligned_cols=83 Identities=17% Similarity=0.292 Sum_probs=41.4
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~ 80 (468)
++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|.. +.+|+.|++
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 34555555555555444555555555555555555554333333455555555555555555322221 233444455
Q ss_pred cccccc
Q 012219 81 YGKNFD 86 (468)
Q Consensus 81 ~~n~l~ 86 (468)
++|.+.
T Consensus 120 s~N~l~ 125 (229)
T 3e6j_A 120 CCNKLT 125 (229)
T ss_dssp CSSCCC
T ss_pred cCCccc
Confidence 555544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.9e-11 Score=112.86 Aligned_cols=137 Identities=16% Similarity=0.114 Sum_probs=99.4
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc--eeeEEEEEeeCCEEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN--IVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ 248 (468)
.+.+....+.|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.+ +.+++++....+..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 344433334556699999988778889999976542 134668999999886544 456888888777889999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC------------------------------------ 292 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 292 (468)
||++|.++. ... .+ ...++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 211 11 1256777888888888531
Q ss_pred -------------------CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 293 -------------------TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 293 -------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
...++|+|++|.||+++++..+.|.|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=128.29 Aligned_cols=85 Identities=22% Similarity=0.317 Sum_probs=41.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC----Cccce
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR----KVPHL 78 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~----~l~~l 78 (468)
+++|+.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+. +|+.|
T Consensus 493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence 44455555555555544444455555555555555555544444455555555555555555544444332 23334
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++++|++.+
T Consensus 573 ~L~~Np~~C 581 (635)
T 4g8a_A 573 NLTQNDFAC 581 (635)
T ss_dssp ECTTCCBCC
T ss_pred EeeCCCCcc
Confidence 455555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-11 Score=110.40 Aligned_cols=94 Identities=17% Similarity=0.248 Sum_probs=77.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+ .+|..|
T Consensus 62 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred CccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 6789999999999998444456799999999999999999766667899999999999999999 888855 456678
Q ss_pred ecccccccccCCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~~ 96 (468)
++++|.+....+..+...
T Consensus 141 ~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp ECCSSCCCCCCTTTTTTC
T ss_pred ECCCCcCCccCHHHHhCC
Confidence 899999987655444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-11 Score=108.79 Aligned_cols=92 Identities=13% Similarity=0.240 Sum_probs=79.7
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCcccee
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~ 79 (468)
++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|. .+.+|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEE
Confidence 47999999999999666678999999999999999999888999999999999999999999 5665 345677889
Q ss_pred cccccccccCCCCCCCC
Q 012219 80 VYGKNFDVEIPNTSENS 96 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~~~ 96 (468)
+++|.+....|..+...
T Consensus 111 L~~N~l~~~~~~~~~~l 127 (220)
T 2v9t_B 111 LNANKINCLRVDAFQDL 127 (220)
T ss_dssp CCSSCCCCCCTTTTTTC
T ss_pred CCCCCCCEeCHHHcCCC
Confidence 99999988777655443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4.2e-11 Score=110.03 Aligned_cols=83 Identities=19% Similarity=0.294 Sum_probs=41.1
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~ 81 (468)
+|+.|+|++|++++..|..|+++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.. +.+|..|+++
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 3555555555555444444555555555555555555444444555555555555555555322222 2333444455
Q ss_pred cccccc
Q 012219 82 GKNFDV 87 (468)
Q Consensus 82 ~n~l~~ 87 (468)
+|.+..
T Consensus 116 ~N~l~~ 121 (251)
T 3m19_A 116 GNQLKS 121 (251)
T ss_dssp SSCCCC
T ss_pred CCcCCC
Confidence 555443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2e-11 Score=125.36 Aligned_cols=85 Identities=22% Similarity=0.336 Sum_probs=51.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCccccccc-CCcCC---Cccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI-PESVR---KVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~-p~~~~---~l~~ 77 (468)
+|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.. |..+. +|..
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~ 537 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCE
Confidence 3556666666666666 666666666666666666666664 55 5666666666666666666443 55433 3444
Q ss_pred eecccccccccC
Q 012219 78 LYVYGKNFDVEI 89 (468)
Q Consensus 78 l~~~~n~l~~~~ 89 (468)
|++++|++++..
T Consensus 538 L~L~~N~l~~~~ 549 (567)
T 1dce_A 538 LNLQGNSLCQEE 549 (567)
T ss_dssp EECTTSGGGGSS
T ss_pred EEecCCcCCCCc
Confidence 556666665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.8e-11 Score=106.26 Aligned_cols=93 Identities=23% Similarity=0.304 Sum_probs=74.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|+|++..+..|+++++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|.. +.+|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 5789999999999999554556789999999999999999666666899999999999999999544433 4567778
Q ss_pred ecccccccccCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSE 94 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~ 94 (468)
++++|.+....+..+.
T Consensus 130 ~l~~N~l~~~~~~~~~ 145 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFD 145 (208)
T ss_dssp ECCSSCCSCCCTTTTT
T ss_pred ECCCCccceeCHHHhc
Confidence 8999988865554343
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.8e-11 Score=105.27 Aligned_cols=92 Identities=15% Similarity=0.163 Sum_probs=74.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCcccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~ 79 (468)
.++|+.|+|++|++++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|.. +.+|+.|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 457999999999999655566899999999999999999666666899999999999999999544433 45677788
Q ss_pred cccccccccCCCCCC
Q 012219 80 VYGKNFDVEIPNTSE 94 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~ 94 (468)
+++|.+....+..+.
T Consensus 107 L~~N~l~~~~~~~~~ 121 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFD 121 (208)
T ss_dssp CCSSCCCCCCTTTTT
T ss_pred cCCCcCcccCHhHhc
Confidence 999998876554443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.18 E-value=6.1e-11 Score=108.96 Aligned_cols=92 Identities=21% Similarity=0.234 Sum_probs=64.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.. +.+|+.|
T Consensus 57 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 4677888888888888666666788888888888888887666666777788888888888877433332 3455667
Q ss_pred ecccccccccCCCCC
Q 012219 79 YVYGKNFDVEIPNTS 93 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~ 93 (468)
++++|.+....+..+
T Consensus 137 ~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 137 RLNTNQLQSIPAGAF 151 (251)
T ss_dssp ECCSSCCCCCCTTTT
T ss_pred ECcCCcCCccCHHHc
Confidence 777777765554333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.2e-11 Score=101.90 Aligned_cols=87 Identities=17% Similarity=0.335 Sum_probs=69.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-c---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-S---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~---~~~l~~ 77 (468)
++++|+.|+|++|+|++..+..|+++++|++|+|++|+|++..|..+.++++|+.|+|++|++++ +|. . +.++..
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~ 128 (177)
T 2o6r_A 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQK 128 (177)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCE
T ss_pred CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE-eCHHHhcCCcccCE
Confidence 57889999999999985555567899999999999999997666668899999999999999984 554 2 345667
Q ss_pred eecccccccccC
Q 012219 78 LYVYGKNFDVEI 89 (468)
Q Consensus 78 l~~~~n~l~~~~ 89 (468)
|++++|++.+.+
T Consensus 129 L~l~~N~~~~~~ 140 (177)
T 2o6r_A 129 IWLHTNPWDCSC 140 (177)
T ss_dssp EECCSSCBCCCH
T ss_pred EEecCCCeeccC
Confidence 888888887643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.17 E-value=5.6e-11 Score=110.57 Aligned_cols=94 Identities=22% Similarity=0.321 Sum_probs=77.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|+.|+|++|++++..|.. +.+|+.|
T Consensus 107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 5789999999999999666667899999999999999999777777899999999999999999655543 4567778
Q ss_pred ecccccccccCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSEN 95 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~ 95 (468)
++++|.+.+..|..+..
T Consensus 187 ~L~~N~l~~~~~~~~~~ 203 (272)
T 3rfs_A 187 RLYQNQLKSVPDGVFDR 203 (272)
T ss_dssp ECCSSCCSCCCTTTTTT
T ss_pred ECCCCcCCccCHHHHhC
Confidence 89999998766654443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.4e-11 Score=101.11 Aligned_cols=83 Identities=20% Similarity=0.366 Sum_probs=68.6
Q ss_pred CCCCcEEEccCCccc-ccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 3 CSKLRVLELGNNLLS-GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 3 l~~l~~l~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
.++|+.|+|++|+++ |.+|..++.+++|++|+|++|++++. ..++++++|+.|+|++|++++.+|.. +.++..|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888999999988 78888888889999999999988865 67888889999999999988667763 5677778
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++++|.+..
T Consensus 94 ~ls~N~i~~ 102 (149)
T 2je0_A 94 NLSGNKIKD 102 (149)
T ss_dssp ECTTSCCCS
T ss_pred ECCCCcCCC
Confidence 888888766
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.16 E-value=8.5e-11 Score=109.36 Aligned_cols=94 Identities=16% Similarity=0.147 Sum_probs=78.9
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|+.|+|++|++++..|.. +.+|+.
T Consensus 82 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 36889999999999999766677899999999999999999777777999999999999999999655543 456777
Q ss_pred eecccccccccCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSE 94 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~ 94 (468)
|++++|.+....+..+.
T Consensus 162 L~l~~n~l~~~~~~~~~ 178 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFD 178 (272)
T ss_dssp EECCSSCCCCCCTTTTT
T ss_pred EECCCCCcCccCHHHhc
Confidence 89999999876654443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.7e-11 Score=128.25 Aligned_cols=90 Identities=20% Similarity=0.395 Sum_probs=80.4
Q ss_pred CCCCCCcEEEccCCccccc-----------------CCcccc--cCCCCCEeeccCccccccccccccCCCCCceecccC
Q 012219 1 MNCSKLRVLELGNNLLSGS-----------------IPSEIN--KLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 61 (468)
+++++|+.|+|++|+|+|. +|+.++ ++++|++|+|++|+++|.+|..|++|++|+.|+|++
T Consensus 203 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 282 (636)
T 4eco_A 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282 (636)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTT
T ss_pred hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcC
Confidence 3688999999999999986 999999 999999999999999999999999999999999999
Q ss_pred cc-ccc-ccCCcC---------CCccceecccccccccCCC
Q 012219 62 NN-LSG-SIPESV---------RKVPHLYVYGKNFDVEIPN 91 (468)
Q Consensus 62 N~-l~g-~~p~~~---------~~l~~l~~~~n~l~~~~p~ 91 (468)
|+ ++| .+|..+ .+|+.|++++|.+. .+|.
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 98 998 888754 56777889999988 6776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.1e-11 Score=114.68 Aligned_cols=93 Identities=16% Similarity=0.253 Sum_probs=64.1
Q ss_pred CCCCCcEEEccCCcccccCCccccc---------CCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINK---------LQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV 72 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~---------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~ 72 (468)
++++|+.|+|++|++.|.+|..++. +++|++|+|++|+|+ .+|..++++++|+.|+|++|+++ .+|..+
T Consensus 148 ~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l 225 (328)
T 4fcg_A 148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225 (328)
T ss_dssp GCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGG
T ss_pred cCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhh
Confidence 4667777777777777777776654 777777777777777 77777777777777777777777 355543
Q ss_pred ---CCccceecccccccccCCCCCCCC
Q 012219 73 ---RKVPHLYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 73 ---~~l~~l~~~~n~l~~~~p~~~~~~ 96 (468)
.+|..|++++|++.+.+|......
T Consensus 226 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l 252 (328)
T 4fcg_A 226 HHLPKLEELDLRGCTALRNYPPIFGGR 252 (328)
T ss_dssp GGCTTCCEEECTTCTTCCBCCCCTTCC
T ss_pred ccCCCCCEEECcCCcchhhhHHHhcCC
Confidence 345556677777777666655443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.13 E-value=6.7e-11 Score=104.42 Aligned_cols=84 Identities=20% Similarity=0.361 Sum_probs=42.4
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~ 80 (468)
+++|+.|+|++|++++..|..|+.+++|++|+|++|++++..|..++++++|+.|+|++|++.+.+|. .+.+|+.|++
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l 166 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNI 166 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEEC
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEEC
Confidence 45555555555555544555555555555555555555554555555555555555555552223442 2233444455
Q ss_pred cccccc
Q 012219 81 YGKNFD 86 (468)
Q Consensus 81 ~~n~l~ 86 (468)
++|.+.
T Consensus 167 ~~n~i~ 172 (197)
T 4ezg_A 167 QFDGVH 172 (197)
T ss_dssp TTBCCC
T ss_pred CCCCCc
Confidence 555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.13 E-value=4.8e-11 Score=100.23 Aligned_cols=85 Identities=21% Similarity=0.278 Sum_probs=73.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccc-cCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGS-IPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~---~~~l~~ 77 (468)
++++|+.|+|++|++++. +.++++++|++|+|++|++++.+|..+.++++|+.|++++|++++. .|.. +.++..
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 578999999999999955 7899999999999999999988999899999999999999999962 3344 456677
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++++|.+...
T Consensus 118 L~l~~N~l~~~ 128 (149)
T 2je0_A 118 LDLFNCEVTNL 128 (149)
T ss_dssp EECTTCGGGGS
T ss_pred EeCcCCcccch
Confidence 88999988764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=108.99 Aligned_cols=87 Identities=24% Similarity=0.261 Sum_probs=52.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.. +.+|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3556666666666666 66666666666666666666666555555666666666666666666332222 2345556
Q ss_pred ecccccccccC
Q 012219 79 YVYGKNFDVEI 89 (468)
Q Consensus 79 ~~~~n~l~~~~ 89 (468)
++++|++....
T Consensus 154 ~L~~N~l~~l~ 164 (290)
T 1p9a_G 154 SLANNNLTELP 164 (290)
T ss_dssp ECTTSCCSCCC
T ss_pred ECCCCcCCccC
Confidence 66666665433
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-10 Score=111.61 Aligned_cols=142 Identities=18% Similarity=0.290 Sum_probs=105.4
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEec--CcchhhhhhHHHHHHHHHHHhhcc--CCceeeEEEEEeeC---CEEEEE
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLH--RSETEELASLESFGNEARLLSQIR--HRNIVKLYGFCLHR---KCMFLI 247 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 247 (468)
.+.++.|.++.||+....+ ..+++|+.. ..... .....+.+|+++++.+. +..+.++++++.+. +..++|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4568999999999998754 678888776 32211 12246778999999987 45678899998776 447899
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC----------------------------------- 292 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------- 292 (468)
|||++|..+.+... ..++..++..++.+++..|+.||...
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999987754211 12677888899999999999999621
Q ss_pred --------------------CCCeEecCCCCCceeeCCCCC--eEEeecccccc
Q 012219 293 --------------------TPPIVHRDISSNNVLLNSELE--AFVADFGVARL 324 (468)
Q Consensus 293 --------------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~~~~ 324 (468)
...++|||+++.||+++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999998753 58999998864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.8e-11 Score=128.05 Aligned_cols=90 Identities=23% Similarity=0.382 Sum_probs=58.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
++++|+.|+|++|+|+ .+|..+++|++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .+|..++ +|..|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 3566777777777776 66666667777777777777776 66766777777777777777777 6666543 34445
Q ss_pred ecccccccccCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSEN 95 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~ 95 (468)
++++|.+. .+|..+..
T Consensus 299 ~L~~N~l~-~lp~~~~~ 314 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGN 314 (727)
T ss_dssp ECCSSCCC-CCCSSTTS
T ss_pred ECCCCCCC-ccChhhhc
Confidence 66666664 44544433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=99.34 Aligned_cols=84 Identities=27% Similarity=0.313 Sum_probs=57.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccC--Cc---CCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIP--ES---VRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p--~~---~~~l~ 76 (468)
++++|+.|+|++|.|++. ..++.+++|++|+|++|++++.+|..+.++++|+.|+|++|++++ +| .. +.+|.
T Consensus 47 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~ 123 (168)
T 2ell_A 47 EFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLK 123 (168)
T ss_dssp GGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCC
T ss_pred hCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCC
Confidence 356777777777777743 667777777777777777776677667777777777777777774 33 33 34455
Q ss_pred ceeccccccccc
Q 012219 77 HLYVYGKNFDVE 88 (468)
Q Consensus 77 ~l~~~~n~l~~~ 88 (468)
.|++++|.+...
T Consensus 124 ~L~l~~N~l~~~ 135 (168)
T 2ell_A 124 SLDLFNCEVTNL 135 (168)
T ss_dssp EEECCSSGGGTS
T ss_pred EEEeeCCcCcch
Confidence 667777776654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-10 Score=116.66 Aligned_cols=94 Identities=18% Similarity=0.185 Sum_probs=78.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+|+.|
T Consensus 297 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 376 (455)
T 3v47_A 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376 (455)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence 57899999999999998888899999999999999999998888889999999999999999997777755 456668
Q ss_pred ecccccccccCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSEN 95 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~ 95 (468)
++++|.+....+..+..
T Consensus 377 ~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 377 ALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp ECCSSCCSCCCTTTTTT
T ss_pred ECCCCccccCCHhHhcc
Confidence 89999988755544433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.10 E-value=1.9e-10 Score=98.92 Aligned_cols=90 Identities=16% Similarity=0.182 Sum_probs=75.2
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~ 81 (468)
+.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. +.+|+.|+++
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3688999999999 7998875 89999999999999888999999999999999999999544433 4567778999
Q ss_pred cccccccCCCCCCCCC
Q 012219 82 GKNFDVEIPNTSENSP 97 (468)
Q Consensus 82 ~n~l~~~~p~~~~~~~ 97 (468)
+|.+....+..+...+
T Consensus 87 ~N~l~~~~~~~~~~l~ 102 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLK 102 (170)
T ss_dssp SSCCCCCCTTTTTTCT
T ss_pred CCccCEeCHHHhcCCC
Confidence 9999886665554433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.8e-11 Score=129.60 Aligned_cols=90 Identities=18% Similarity=0.337 Sum_probs=78.8
Q ss_pred CCCCCCcEEEccCCcccc-----------------cCCcccc--cCCCCCEeeccCccccccccccccCCCCCceecccC
Q 012219 1 MNCSKLRVLELGNNLLSG-----------------SIPSEIN--KLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 61 (468)
++|++|+.|+|++|+|+| .+|+.++ +|++|++|+|++|++.|.+|..|++|++|+.|+|++
T Consensus 445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~ 524 (876)
T 4ecn_A 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524 (876)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence 368899999999999998 4999988 999999999999999999999999999999999999
Q ss_pred cc-ccc-ccCCcCC----------CccceecccccccccCCC
Q 012219 62 NN-LSG-SIPESVR----------KVPHLYVYGKNFDVEIPN 91 (468)
Q Consensus 62 N~-l~g-~~p~~~~----------~l~~l~~~~n~l~~~~p~ 91 (468)
|+ ++| .+|..+. +|+.|++++|.+. .+|.
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 98 998 7887443 6777889999988 6776
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.3e-10 Score=98.78 Aligned_cols=87 Identities=17% Similarity=0.245 Sum_probs=73.9
Q ss_pred CcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCccceecc
Q 012219 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPHLYVY 81 (468)
Q Consensus 6 l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~~ 81 (468)
-+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++ +|. .+.+|+.|+++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECC
Confidence 478999999998 9999886 899999999999998889999999999999999999995 554 34567788999
Q ss_pred cccccccCCCCCCCC
Q 012219 82 GKNFDVEIPNTSENS 96 (468)
Q Consensus 82 ~n~l~~~~p~~~~~~ 96 (468)
+|.+....+..+...
T Consensus 90 ~N~l~~l~~~~~~~l 104 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNL 104 (174)
T ss_dssp SSCCCCCCTTTTTTC
T ss_pred CCccceeCHHHhccc
Confidence 999987655444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.8e-11 Score=100.75 Aligned_cols=85 Identities=22% Similarity=0.355 Sum_probs=76.2
Q ss_pred CCCCCcEEEccCCccc-ccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNLLS-GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
..++|+.|+|++|+++ |.+|..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.+|.. +.+|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3578999999999998 89999999999999999999999965 78999999999999999999767763 667888
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++++|.+...
T Consensus 100 L~Ls~N~l~~~ 110 (168)
T 2ell_A 100 LNLSGNKLKDI 110 (168)
T ss_dssp EECBSSSCCSS
T ss_pred EeccCCccCcc
Confidence 99999998764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2.3e-10 Score=107.51 Aligned_cols=86 Identities=22% Similarity=0.309 Sum_probs=74.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~ 77 (468)
++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|. .+.+|+.
T Consensus 98 ~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~ 176 (290)
T 1p9a_G 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176 (290)
T ss_dssp TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCE
T ss_pred cCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCE
Confidence 5789999999999999666678999999999999999999776677899999999999999999 5665 3456778
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++++|.+...
T Consensus 177 L~L~~N~l~~i 187 (290)
T 1p9a_G 177 LLLQENSLYTI 187 (290)
T ss_dssp EECCSSCCCCC
T ss_pred EECCCCcCCcc
Confidence 89999998743
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.8e-10 Score=108.97 Aligned_cols=95 Identities=16% Similarity=0.218 Sum_probs=81.3
Q ss_pred CCCCCcEEEccCCcccc-cCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
++++|+.|+|++|++++ .+|..++.+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+.. +.+|+.
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 57899999999999997 58899999999999999999999888889999999999999999999544434 456777
Q ss_pred eecccccccccCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~ 96 (468)
|++++|.+.+..|......
T Consensus 228 L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp EECTTSCCCBCSSSSCCCC
T ss_pred eECCCCCCcccCHHHHHhh
Confidence 8999999988877665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.5e-10 Score=114.36 Aligned_cols=94 Identities=16% Similarity=0.122 Sum_probs=77.8
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCcccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~ 79 (468)
+++|+.|+|++|++++.+|..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|.. +.+|+.|+
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 368999999999999888888999999999999999999888888999999999999999998665655 45566788
Q ss_pred cccccccccCCCCCCCC
Q 012219 80 VYGKNFDVEIPNTSENS 96 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~~~ 96 (468)
+++|.+....|..+...
T Consensus 354 Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGL 370 (455)
T ss_dssp CCSSCCCEECTTTTTTC
T ss_pred CCCCcccccChhhcccc
Confidence 99998887767655443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=120.25 Aligned_cols=89 Identities=17% Similarity=0.097 Sum_probs=58.6
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~ 81 (468)
+++.|||++|+|++..|.+|.+|++|++|+|++|+|++..|.+|.+|++|++|+|++|+|++..|.. +.+|+.|+++
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 5777777777777444556777777777777777777555666777777777777777777322232 3445566677
Q ss_pred cccccccCCCCC
Q 012219 82 GKNFDVEIPNTS 93 (468)
Q Consensus 82 ~n~l~~~~p~~~ 93 (468)
+|++....+..+
T Consensus 133 ~N~l~~l~~~~~ 144 (635)
T 4g8a_A 133 ETNLASLENFPI 144 (635)
T ss_dssp TSCCCCSTTCCC
T ss_pred CCcCCCCChhhh
Confidence 777665544333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.9e-10 Score=111.58 Aligned_cols=85 Identities=26% Similarity=0.241 Sum_probs=38.9
Q ss_pred CcEEEccCCcccccCCcccc-cCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceecc
Q 012219 6 LRVLELGNNLLSGSIPSEIN-KLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYVY 81 (468)
Q Consensus 6 l~~l~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~ 81 (468)
|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..|.. +.+|..|+++
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44555555555533333343 4555555555555555444444555555555555555554222222 2233344455
Q ss_pred cccccccCC
Q 012219 82 GKNFDVEIP 90 (468)
Q Consensus 82 ~n~l~~~~p 90 (468)
+|.+....|
T Consensus 121 ~N~i~~~~~ 129 (361)
T 2xot_A 121 NNHIVVVDR 129 (361)
T ss_dssp SSCCCEECT
T ss_pred CCcccEECH
Confidence 554444333
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.4e-10 Score=108.13 Aligned_cols=91 Identities=19% Similarity=0.184 Sum_probs=79.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccc-cccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING-KILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
++++|+.|+|++|.+++..|..|+++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++..|..+. +|+.
T Consensus 124 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 203 (306)
T 2z66_A 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203 (306)
T ss_dssp TCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred hccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCE
Confidence 57899999999999998888899999999999999999997 6889999999999999999999976677554 5667
Q ss_pred eecccccccccCCCC
Q 012219 78 LYVYGKNFDVEIPNT 92 (468)
Q Consensus 78 l~~~~n~l~~~~p~~ 92 (468)
|++++|.+....+..
T Consensus 204 L~L~~N~l~~~~~~~ 218 (306)
T 2z66_A 204 LNMSHNNFFSLDTFP 218 (306)
T ss_dssp EECTTSCCSBCCSGG
T ss_pred EECCCCccCccChhh
Confidence 889999987755433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.9e-10 Score=111.67 Aligned_cols=90 Identities=17% Similarity=0.173 Sum_probs=76.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.+|++|+.|+|++|++++..|..+ .+|..|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 68999999999999997667789999999999999999997777789999999999999999996656655 456678
Q ss_pred ecccccccccCCC
Q 012219 79 YVYGKNFDVEIPN 91 (468)
Q Consensus 79 ~~~~n~l~~~~p~ 91 (468)
++++|.+....+.
T Consensus 142 ~L~~N~l~~l~~~ 154 (361)
T 2xot_A 142 YLSQNQISRFPVE 154 (361)
T ss_dssp ECCSSCCCSCCGG
T ss_pred ECCCCcCCeeCHH
Confidence 8999998774433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=4.2e-10 Score=105.35 Aligned_cols=92 Identities=17% Similarity=0.238 Sum_probs=65.9
Q ss_pred CCCCCcEEEccCCc-ccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNL-LSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
++++|+.|+|++|. +++..|..|.++++|++|+|++|++++..|..+.++++|+.|+|++|++++..+.. +.+|+.
T Consensus 78 ~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 157 (285)
T 1ozn_A 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157 (285)
T ss_dssp TCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccE
Confidence 46778888888886 66444677888888888888888888776777888888888888888888433333 345666
Q ss_pred eecccccccccCCCCC
Q 012219 78 LYVYGKNFDVEIPNTS 93 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~ 93 (468)
|++++|.+....+..+
T Consensus 158 L~l~~n~l~~~~~~~~ 173 (285)
T 1ozn_A 158 LFLHGNRISSVPERAF 173 (285)
T ss_dssp EECCSSCCCEECTTTT
T ss_pred EECCCCcccccCHHHh
Confidence 7777777765544333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.5e-10 Score=103.70 Aligned_cols=91 Identities=16% Similarity=0.253 Sum_probs=61.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-c---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-S---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~---~~~l~~ 77 (468)
++++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++ +|. . +.+|+.
T Consensus 83 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~ 161 (270)
T 2o6q_A 83 ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKE 161 (270)
T ss_dssp SCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc-cCHhHccCCcccce
Confidence 46778888888888875444556777788888888888776666667777777777777777774 443 2 345556
Q ss_pred eecccccccccCCCCC
Q 012219 78 LYVYGKNFDVEIPNTS 93 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~ 93 (468)
|++++|.+....+..+
T Consensus 162 L~L~~n~l~~~~~~~~ 177 (270)
T 2o6q_A 162 LRLYNNQLKRVPEGAF 177 (270)
T ss_dssp EECCSSCCSCCCTTTT
T ss_pred eEecCCcCcEeChhHh
Confidence 6777777665544333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.7e-10 Score=103.61 Aligned_cols=92 Identities=20% Similarity=0.295 Sum_probs=75.4
Q ss_pred CCCCCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~ 77 (468)
++++|+.|+|++|+|+ .+|. .|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..|.. +.+|+.
T Consensus 59 ~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 137 (270)
T 2o6q_A 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137 (270)
T ss_dssp SCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE
Confidence 6789999999999999 5554 5788999999999999999766667899999999999999999655544 456777
Q ss_pred eecccccccccCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSE 94 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~ 94 (468)
|++++|.+....+..+.
T Consensus 138 L~Ls~n~l~~~~~~~~~ 154 (270)
T 2o6q_A 138 LSLGYNELQSLPKGVFD 154 (270)
T ss_dssp EECCSSCCCCCCTTTTT
T ss_pred EECCCCcCCccCHhHcc
Confidence 88999998876554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.03 E-value=3.2e-10 Score=120.00 Aligned_cols=88 Identities=25% Similarity=0.371 Sum_probs=80.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCC---ccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRK---VPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l 78 (468)
+|++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .+|..+++ |..|
T Consensus 245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L 321 (727)
T 4b8c_D 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL 321 (727)
T ss_dssp GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence 5889999999999999 99999999999999999999999 88999999999999999999998 89987654 5568
Q ss_pred ecccccccccCCCC
Q 012219 79 YVYGKNFDVEIPNT 92 (468)
Q Consensus 79 ~~~~n~l~~~~p~~ 92 (468)
++++|.+.+.+|..
T Consensus 322 ~L~~N~l~~~~p~~ 335 (727)
T 4b8c_D 322 GVEGNPLEKQFLKI 335 (727)
T ss_dssp ECTTSCCCSHHHHH
T ss_pred eCCCCccCCCChHH
Confidence 89999998876644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.03 E-value=2.5e-10 Score=98.76 Aligned_cols=81 Identities=17% Similarity=0.266 Sum_probs=60.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCC-CCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQ-ELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~ 76 (468)
++++|+.|+|++|+++ .+|. +..+. +|++|+|++|+|++. ..|..+++|+.|+|++|+++ .+|. .+.+|.
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 91 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred CcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCCC
Confidence 4677888888888888 5654 55554 888888888888854 57888888888888888888 4554 345677
Q ss_pred ceecccccccc
Q 012219 77 HLYVYGKNFDV 87 (468)
Q Consensus 77 ~l~~~~n~l~~ 87 (468)
.|++++|.+..
T Consensus 92 ~L~L~~N~i~~ 102 (176)
T 1a9n_A 92 ELILTNNSLVE 102 (176)
T ss_dssp EEECCSCCCCC
T ss_pred EEECCCCcCCc
Confidence 77888887743
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=2.9e-10 Score=118.21 Aligned_cols=91 Identities=14% Similarity=0.196 Sum_probs=73.9
Q ss_pred CCCCCcEEEccCCcccc-cCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 2 NCSKLRVLELGNNLLSG-SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
++++|+.|+|++|++++ .+|..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+. +|+.
T Consensus 446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 525 (606)
T 3vq2_A 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525 (606)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence 57889999999999987 4788888999999999999999988888889999999999999999877787654 4556
Q ss_pred eecccccccccCCCCC
Q 012219 78 LYVYGKNFDVEIPNTS 93 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~ 93 (468)
|++++|++.. +|...
T Consensus 526 L~l~~N~l~~-~p~~~ 540 (606)
T 3vq2_A 526 LDCSFNRIET-SKGIL 540 (606)
T ss_dssp EECTTSCCCC-EESCG
T ss_pred EECCCCcCcc-cCHhH
Confidence 7888888873 44433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=6.8e-10 Score=103.91 Aligned_cols=91 Identities=16% Similarity=0.137 Sum_probs=60.6
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcc-cccccCCcC---CCcccee
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNN-LSGSIPESV---RKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~g~~p~~~---~~l~~l~ 79 (468)
++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|+ +++..|..+ .+|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 467777777777775555667777777777777777776667777777777777777776 553334433 3455566
Q ss_pred cccccccccCCCCCC
Q 012219 80 VYGKNFDVEIPNTSE 94 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~ 94 (468)
+++|.+....|....
T Consensus 112 l~~n~l~~~~~~~~~ 126 (285)
T 1ozn_A 112 LDRCGLQELGPGLFR 126 (285)
T ss_dssp CTTSCCCCCCTTTTT
T ss_pred CCCCcCCEECHhHhh
Confidence 777776665554433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-10 Score=108.38 Aligned_cols=84 Identities=18% Similarity=0.272 Sum_probs=69.6
Q ss_pred CCCCCcEEEccCCcccccCCc----ccccCCCCCEeeccCccccccccccccCC---CCCceecccCcccccccCCcC-C
Q 012219 2 NCSKLRVLELGNNLLSGSIPS----EINKLQELNYLNLSHNSINGKILSQLGEI---PRIDTVDLSMNNLSGSIPESV-R 73 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~g~~p~~~-~ 73 (468)
++++|+.|+|++|+|+ .+|. .++++++|++|+|++|+|++.+|..+..+ ++|+.|+|++|+|+ .+|..+ .
T Consensus 195 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~ 272 (310)
T 4glp_A 195 KFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPA 272 (310)
T ss_dssp SSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCS
T ss_pred cCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcC
Confidence 5788999999999997 5554 25788999999999999998888888777 69999999999999 788754 4
Q ss_pred Cccceecccccccc
Q 012219 74 KVPHLYVYGKNFDV 87 (468)
Q Consensus 74 ~l~~l~~~~n~l~~ 87 (468)
+|+.|++++|.+.+
T Consensus 273 ~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 273 KLRVLDLSSNRLNR 286 (310)
T ss_dssp CCSCEECCSCCCCS
T ss_pred CCCEEECCCCcCCC
Confidence 68888999998876
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.4e-10 Score=99.84 Aligned_cols=85 Identities=20% Similarity=0.409 Sum_probs=71.0
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccce
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHL 78 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l 78 (468)
++|++|+.|+|++|++++..|..++.+++|++|+|++|++.+.+| .+..+++|+.|++++|++++ +|. .+.+|+.|
T Consensus 109 ~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L 186 (197)
T 4ezg_A 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQL 186 (197)
T ss_dssp TTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEE
T ss_pred cCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEE
Confidence 368899999999999998899999999999999999999444777 79999999999999999995 553 45677788
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++++|++..
T Consensus 187 ~l~~N~i~~ 195 (197)
T 4ezg_A 187 YAFSQTIGG 195 (197)
T ss_dssp EECBC----
T ss_pred EeeCcccCC
Confidence 999998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.2e-10 Score=121.71 Aligned_cols=88 Identities=23% Similarity=0.384 Sum_probs=79.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcc-ccc-cccccccCC------CCCceecccCcccccccCC--c
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNS-ING-KILSQLGEI------PRIDTVDLSMNNLSGSIPE--S 71 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~l~l~~N~l~g~~p~--~ 71 (468)
++++|+.|+|++|+++|.+|+.|+++++|++|+|++|+ ++| .+|..+++| ++|+.|+|++|+++ .+|. .
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~ 325 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS 325 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence 68999999999999999999999999999999999998 999 899998887 99999999999999 8998 5
Q ss_pred C---CCccceecccccccccCC
Q 012219 72 V---RKVPHLYVYGKNFDVEIP 90 (468)
Q Consensus 72 ~---~~l~~l~~~~n~l~~~~p 90 (468)
+ .+|+.|++++|.+.+.+|
T Consensus 326 l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 326 LQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp HTTCTTCCEEECCSCCCEEECC
T ss_pred hccCCCCCEEeCcCCcCccchh
Confidence 4 456668899999987777
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.5e-10 Score=116.13 Aligned_cols=88 Identities=18% Similarity=0.308 Sum_probs=76.2
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceeccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYVYG 82 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~ 82 (468)
.|+.|+|++|+|+ .+|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +|. .+.+|..|++++
T Consensus 442 ~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCC
Confidence 5899999999999 5887 999999999999999999 999999999999999999999995 882 334566788999
Q ss_pred ccccccC-CCCCCCC
Q 012219 83 KNFDVEI-PNTSENS 96 (468)
Q Consensus 83 n~l~~~~-p~~~~~~ 96 (468)
|.+.+.. |......
T Consensus 518 N~l~~~~~p~~l~~l 532 (567)
T 1dce_A 518 NRLQQSAAIQPLVSC 532 (567)
T ss_dssp SCCCSSSTTGGGGGC
T ss_pred CCCCCCCCcHHHhcC
Confidence 9998875 6655443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-10 Score=112.70 Aligned_cols=91 Identities=14% Similarity=0.128 Sum_probs=69.0
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+ .+|..|
T Consensus 194 ~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 271 (452)
T 3zyi_A 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271 (452)
T ss_dssp TCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence 5678888888888888 555 57788888888888888887778888888888888888888886666544 455667
Q ss_pred ecccccccccCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSE 94 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~ 94 (468)
++++|.+....+..+.
T Consensus 272 ~L~~N~l~~~~~~~~~ 287 (452)
T 3zyi_A 272 NLAHNNLSSLPHDLFT 287 (452)
T ss_dssp ECCSSCCSCCCTTSST
T ss_pred ECCCCcCCccChHHhc
Confidence 7888887765554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.9e-10 Score=109.34 Aligned_cols=86 Identities=23% Similarity=0.228 Sum_probs=74.1
Q ss_pred CCCCCcEEEccCCcccccCCccc--ccCCCCCEeeccCccccccccccccCC-----CCCceecccCcccccccCCcC--
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEI--NKLQELNYLNLSHNSINGKILSQLGEI-----PRIDTVDLSMNNLSGSIPESV-- 72 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~l~l~~N~l~g~~p~~~-- 72 (468)
++++|+.|+|++|+++|.+|..+ +.+++|++|+|++|++++. |..++.+ ++|+.|+|++|++++..|..+
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 58899999999999999999987 8999999999999999977 8888877 999999999999997666655
Q ss_pred -CCccceeccccccccc
Q 012219 73 -RKVPHLYVYGKNFDVE 88 (468)
Q Consensus 73 -~~l~~l~~~~n~l~~~ 88 (468)
.+|+.|++++|.+.+.
T Consensus 172 l~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGE 188 (312)
T ss_dssp CSSCCEEECCSCTTCHH
T ss_pred CCCCCEEECCCCCcCcc
Confidence 4566688999987654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.1e-10 Score=112.33 Aligned_cols=91 Identities=16% Similarity=0.191 Sum_probs=67.0
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..+ .+|+.|
T Consensus 183 ~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 260 (440)
T 3zyj_A 183 GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260 (440)
T ss_dssp TCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred cccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence 4677888888888887 666 47778888888888888887777778888888888888888886555544 445567
Q ss_pred ecccccccccCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSE 94 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~ 94 (468)
++++|++....+..+.
T Consensus 261 ~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 261 NLAHNNLTLLPHDLFT 276 (440)
T ss_dssp ECTTSCCCCCCTTTTS
T ss_pred ECCCCCCCccChhHhc
Confidence 7888877765554433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.7e-10 Score=124.68 Aligned_cols=87 Identities=25% Similarity=0.314 Sum_probs=67.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceecc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVY 81 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~ 81 (468)
++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|+|..|..+.++..|++.
T Consensus 478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~ 555 (844)
T 3j0a_A 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDIT 555 (844)
T ss_dssp CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEE
T ss_pred CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEec
Confidence 457777888888888866667778888888888888888865555554 788888888888888888888888888888
Q ss_pred cccccccCC
Q 012219 82 GKNFDVEIP 90 (468)
Q Consensus 82 ~n~l~~~~p 90 (468)
+|++.+.++
T Consensus 556 ~Np~~C~c~ 564 (844)
T 3j0a_A 556 HNKFICECE 564 (844)
T ss_dssp EECCCCSSS
T ss_pred CCCcccccc
Confidence 888877554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.99 E-value=6.8e-10 Score=107.05 Aligned_cols=86 Identities=13% Similarity=0.158 Sum_probs=74.0
Q ss_pred cEEEccCC-cccccCCcccccCCCCCEeeccC-ccccccccccccCCCCCceecccCcccccccCCcC---CCccceecc
Q 012219 7 RVLELGNN-LLSGSIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYVY 81 (468)
Q Consensus 7 ~~l~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~~ 81 (468)
..+++++| +|+ .||. |+.+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..| .+|..|+++
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 999 7999 99999999999996 99998878899999999999999999998777654 566678999
Q ss_pred cccccccCCCCCC
Q 012219 82 GKNFDVEIPNTSE 94 (468)
Q Consensus 82 ~n~l~~~~p~~~~ 94 (468)
+|.+.+..+..+.
T Consensus 89 ~N~l~~~~~~~~~ 101 (347)
T 2ifg_A 89 FNALESLSWKTVQ 101 (347)
T ss_dssp SSCCSCCCSTTTC
T ss_pred CCccceeCHHHcc
Confidence 9999876555443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.9e-10 Score=115.49 Aligned_cols=95 Identities=16% Similarity=0.182 Sum_probs=79.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccc-ccccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSIN-GKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
++++|+.|+|++|++++.+|..|.++++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..+. +|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 5788999999999999888888999999999999999998 67898899999999999999999977787654 4566
Q ss_pred eecccccccccCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~ 96 (468)
|++++|.+.+..|..+...
T Consensus 499 L~l~~n~l~~~~~~~~~~l 517 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRL 517 (570)
T ss_dssp EECCSSCCSCCCTTTTTTC
T ss_pred EeCCCCcCCCCCHHHhhcc
Confidence 7888998887766554433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=7e-10 Score=103.30 Aligned_cols=89 Identities=17% Similarity=0.091 Sum_probs=66.6
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccceecc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYVY 81 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~~ 81 (468)
+|+.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+ .+|+.|++.
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 58888888888886555678888888888888888886666678888888888888888886555544 455567778
Q ss_pred cccccccCCCCC
Q 012219 82 GKNFDVEIPNTS 93 (468)
Q Consensus 82 ~n~l~~~~p~~~ 93 (468)
+|.+....+...
T Consensus 109 ~n~l~~~~~~~~ 120 (276)
T 2z62_A 109 ETNLASLENFPI 120 (276)
T ss_dssp TSCCCCSTTCCC
T ss_pred CCCccccCchhc
Confidence 887766544333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.99 E-value=7e-10 Score=115.12 Aligned_cols=94 Identities=17% Similarity=0.220 Sum_probs=75.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc----CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES----VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l~~ 77 (468)
++++|+.|+|++|+|++..|..|+++++|++|+|++|.|++..|..|++|++|+.|+|++|+++ .+|.. +.+|..
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~ 151 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 151 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCE
Confidence 4678899999999998777778999999999999999999877777889999999999999998 45542 355667
Q ss_pred eecccccccccCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~ 96 (468)
|++++|.+.+..|..+...
T Consensus 152 L~Ls~N~l~~~~~~~~~~l 170 (597)
T 3oja_B 152 LSMSNNNLERIEDDTFQAT 170 (597)
T ss_dssp EECCSSCCCBCCTTTTTTC
T ss_pred EEeeCCcCCCCChhhhhcC
Confidence 8888888887766555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=6.8e-10 Score=115.42 Aligned_cols=86 Identities=16% Similarity=0.138 Sum_probs=49.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|++|++|++|+|++|++++..|..+ .+|+.|
T Consensus 54 ~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 133 (606)
T 3vq2_A 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133 (606)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEE
T ss_pred CCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEE
Confidence 45566666666666665555566666666666666666665556666666666666666666663333333 334445
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++++|.+..
T Consensus 134 ~L~~n~l~~ 142 (606)
T 3vq2_A 134 NVAHNFIHS 142 (606)
T ss_dssp ECCSSCCCC
T ss_pred eCCCCcccc
Confidence 566665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=8.9e-10 Score=111.08 Aligned_cols=87 Identities=20% Similarity=0.288 Sum_probs=50.9
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-c---CCCccceec
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-S---VRKVPHLYV 80 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~---~~~l~~l~~ 80 (468)
+|+.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.+|++|+.|+|++|+++ .+|. . +.+|+.|++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEEC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEEC
Confidence 4666666666666555556666666666666666666555666666666666666666666 3432 2 234445556
Q ss_pred ccccccccCCCC
Q 012219 81 YGKNFDVEIPNT 92 (468)
Q Consensus 81 ~~n~l~~~~p~~ 92 (468)
++|.+....|..
T Consensus 112 s~n~i~~~~~~~ 123 (477)
T 2id5_A 112 SENKIVILLDYM 123 (477)
T ss_dssp TTSCCCEECTTT
T ss_pred CCCccccCChhH
Confidence 666555544433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.4e-10 Score=108.54 Aligned_cols=89 Identities=16% Similarity=0.139 Sum_probs=58.4
Q ss_pred CcEEEccCCcc-cccCCcccc-------cCCCCCEeeccCccccccccccc--cCCCCCceecccCcccccccCCcC---
Q 012219 6 LRVLELGNNLL-SGSIPSEIN-------KLQELNYLNLSHNSINGKILSQL--GEIPRIDTVDLSMNNLSGSIPESV--- 72 (468)
Q Consensus 6 l~~l~l~~N~l-~g~~p~~~~-------~l~~L~~L~l~~N~l~g~~p~~~--~~l~~L~~l~l~~N~l~g~~p~~~--- 72 (468)
|+.|+|++|++ .+.+|..+. ++++|++|+|++|+++|.+|..+ ..+++|+.|+|++|++++. |..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 56667777777 455666655 67777777777777777777765 6777777777777777754 5422
Q ss_pred -----CCccceecccccccccCCCCCCC
Q 012219 73 -----RKVPHLYVYGKNFDVEIPNTSEN 95 (468)
Q Consensus 73 -----~~l~~l~~~~n~l~~~~p~~~~~ 95 (468)
.+++.|++++|.+....|.....
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 45666677777776655554443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.97 E-value=3e-10 Score=121.66 Aligned_cols=87 Identities=24% Similarity=0.316 Sum_probs=77.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcc-ccc-cccccccCCC-------CCceecccCcccccccCC--
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNS-ING-KILSQLGEIP-------RIDTVDLSMNNLSGSIPE-- 70 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l~-------~L~~l~l~~N~l~g~~p~-- 70 (468)
+|++|+.|+|++|++.|.+|..|++|++|+.|+|++|+ |+| .+|..+++|+ +|+.|+|++|+++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 567 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA 567 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence 68999999999999999999999999999999999998 999 8998777665 9999999999999 8998
Q ss_pred cC---CCccceecccccccccCC
Q 012219 71 SV---RKVPHLYVYGKNFDVEIP 90 (468)
Q Consensus 71 ~~---~~l~~l~~~~n~l~~~~p 90 (468)
.+ .+|..|++++|.+. .+|
T Consensus 568 ~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 568 SLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp HHTTCTTCCEEECTTSCCC-BCC
T ss_pred hhhcCCCCCEEECCCCCcc-cch
Confidence 55 45666889999988 666
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=6.9e-10 Score=103.33 Aligned_cols=94 Identities=18% Similarity=0.204 Sum_probs=77.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|+.|++++|++++..+..+ .+|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 129 (276)
T 2z62_A 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129 (276)
T ss_dssp TCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred cccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEE
Confidence 57899999999999996666789999999999999999998878889999999999999999996444344 556678
Q ss_pred eccccccccc-CCCCCCC
Q 012219 79 YVYGKNFDVE-IPNTSEN 95 (468)
Q Consensus 79 ~~~~n~l~~~-~p~~~~~ 95 (468)
++++|.+... +|.....
T Consensus 130 ~l~~n~l~~~~l~~~~~~ 147 (276)
T 2z62_A 130 NVAHNLIQSFKLPEYFSN 147 (276)
T ss_dssp ECCSSCCCCCCCCGGGGG
T ss_pred ECcCCccceecCchhhcc
Confidence 8999988763 4554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.97 E-value=6.4e-10 Score=96.16 Aligned_cols=81 Identities=14% Similarity=0.203 Sum_probs=68.1
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cC---CCccce
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SV---RKVPHL 78 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~---~~l~~l 78 (468)
++|+.|+|++|+|++. +.|+++++|++|+|++|+|++..|..+.++++|+.|+|++|+++ .+|. .+ .++..|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999954 68999999999999999999544444599999999999999997 6776 44 456678
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++++|.+..
T Consensus 119 ~l~~N~i~~ 127 (176)
T 1a9n_A 119 CILRNPVTN 127 (176)
T ss_dssp ECCSSGGGG
T ss_pred EecCCCCCC
Confidence 899999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=9.2e-10 Score=104.09 Aligned_cols=183 Identities=19% Similarity=0.168 Sum_probs=119.5
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCc--eeeEEEEEeeCC---EEEEEE
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRN--IVKLYGFCLHRK---CMFLIY 248 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~ 248 (468)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++.+..... ..++||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3568999999999864 45888886543 12356789999998883 322 345555544333 347899
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD------------------------------------- 291 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------- 291 (468)
|+++|.++.+.... .++..++..++.+++..++.||..
T Consensus 96 ~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 99999888653321 256677778888888888888851
Q ss_pred ------------------CCCCeEecCCCCCceeeCC--CCCeEEeeccccccccCCCCCceeccccccc---ccccccc
Q 012219 292 ------------------CTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLLNFDSSNRTLLAGTYGY---IAPELAY 348 (468)
Q Consensus 292 ------------------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y---~aPE~~~ 348 (468)
....++|+|++|.||++++ +..+.|.||+.+........ ......+ ..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D----l~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND----FISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH----HHTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH----HHHHHhhccccCHHHHH
Confidence 1245899999999999998 45678999998865421100 0000001 1222111
Q ss_pred C-----C---------CCCccchhhHHHHHHHHHHhCCCCC
Q 012219 349 T-----M---------VVTEKCDVYSFGVVALEVLMGKHPG 375 (468)
Q Consensus 349 ~-----~---------~~~~~~Dv~s~Gvil~el~tg~~p~ 375 (468)
. + ......+.|++|.++|.+.+|+.+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 0112358999999999999999875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=105.83 Aligned_cols=84 Identities=23% Similarity=0.358 Sum_probs=62.4
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCcccee
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~ 79 (468)
++|+.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+++ .+|. .+.+|+.|+
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~ 130 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLN 130 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEE
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEE
Confidence 46788888888888544457888888888888888888766777888888888888888888 4553 345666777
Q ss_pred ccccccccc
Q 012219 80 VYGKNFDVE 88 (468)
Q Consensus 80 ~~~n~l~~~ 88 (468)
+++|.+...
T Consensus 131 L~~n~l~~l 139 (353)
T 2z80_A 131 LLGNPYKTL 139 (353)
T ss_dssp CTTCCCSSS
T ss_pred CCCCCCccc
Confidence 888777643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=6.9e-10 Score=113.13 Aligned_cols=91 Identities=22% Similarity=0.274 Sum_probs=78.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccc--cccccccCCCCCceecccCcccccccCCc----CCCc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDLSMNNLSGSIPES----VRKV 75 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l 75 (468)
++++|+.|+|++|++++.+|..++++++|++|+|++|++++ .+|..++++++|+.|+|++|++++.+|.. +.++
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 57889999999999998899999999999999999999997 67788999999999999999999767753 4567
Q ss_pred cceecccccccccCCCC
Q 012219 76 PHLYVYGKNFDVEIPNT 92 (468)
Q Consensus 76 ~~l~~~~n~l~~~~p~~ 92 (468)
+.|++++|.+.+..|..
T Consensus 402 ~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRC 418 (520)
T ss_dssp CEEECCSSCCCGGGGGS
T ss_pred CEEECcCCCCCcchhhh
Confidence 77889999987766544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1.2e-09 Score=109.44 Aligned_cols=91 Identities=20% Similarity=0.219 Sum_probs=75.1
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~ 80 (468)
++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|.. +.+|+.|++
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 47899999999999888889999999999999999999888888999999999999999999443333 456677889
Q ss_pred ccccccccCCCCCC
Q 012219 81 YGKNFDVEIPNTSE 94 (468)
Q Consensus 81 ~~n~l~~~~p~~~~ 94 (468)
++|.+....+..+.
T Consensus 155 ~~N~l~~~~~~~~~ 168 (452)
T 3zyi_A 155 RNNPIESIPSYAFN 168 (452)
T ss_dssp CSCCCCEECTTTTT
T ss_pred CCCCcceeCHhHHh
Confidence 99988765544443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.95 E-value=5.4e-10 Score=112.87 Aligned_cols=88 Identities=22% Similarity=0.191 Sum_probs=65.3
Q ss_pred CCCCCcEEEccCCcccccCCcccc-cCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEIN-KLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~ 77 (468)
++++|+.|+|++|+|++.+|..+. ++++|+.|+|++|.|++. | .+..+++|+.|+|++|+|++ +|..+ .+|..
T Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~ 218 (487)
T 3oja_A 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218 (487)
T ss_dssp GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred CCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccE
Confidence 467888888888888887887776 788888888888888855 3 34468888888888888885 44433 45666
Q ss_pred eecccccccccCCCCC
Q 012219 78 LYVYGKNFDVEIPNTS 93 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~ 93 (468)
|++++|.+.+ +|...
T Consensus 219 L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 219 ISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EECTTSCCCE-ECTTC
T ss_pred EEecCCcCcc-cchhh
Confidence 7888888875 44433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-09 Score=106.71 Aligned_cols=92 Identities=17% Similarity=0.220 Sum_probs=66.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc----CCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES----VRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l~~ 77 (468)
++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+++ .+|.. +.+|+.
T Consensus 67 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~ 145 (390)
T 3o6n_A 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145 (390)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred ccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcE
Confidence 3677888888888887655667888888888888888888766777788888888888888887 56543 345666
Q ss_pred eecccccccccCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSE 94 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~ 94 (468)
|++++|.+....|....
T Consensus 146 L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 146 LSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECCSSCCCBCCTTTTS
T ss_pred EECCCCccCccChhhcc
Confidence 77777777665554443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.3e-09 Score=112.34 Aligned_cols=95 Identities=15% Similarity=0.234 Sum_probs=74.9
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc-cccCCcCC---Ccc
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS-GSIPESVR---KVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~~~---~l~ 76 (468)
++++|+.|+|++|.+++..| ..+.++++|++|+|++|++++.+|..+.++++|+.|+|++|+++ +.+|..+. +|+
T Consensus 394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~ 473 (570)
T 2z63_A 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473 (570)
T ss_dssp TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence 57788888888888887666 46888888888888888888888888888888888888888887 57887554 455
Q ss_pred ceecccccccccCCCCCCCC
Q 012219 77 HLYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 77 ~l~~~~n~l~~~~p~~~~~~ 96 (468)
.|++++|.+.+..|..+...
T Consensus 474 ~L~l~~n~l~~~~~~~~~~l 493 (570)
T 2z63_A 474 FLDLSQCQLEQLSPTAFNSL 493 (570)
T ss_dssp EEECTTSCCCEECTTTTTTC
T ss_pred EEECCCCccccCChhhhhcc
Confidence 67788888887766655443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-09 Score=103.37 Aligned_cols=88 Identities=24% Similarity=0.334 Sum_probs=56.7
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~ 80 (468)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|+++ .+|..+. +++.|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 45666666666666655666777777777777777777655556777777777777777777 6666443 3445666
Q ss_pred ccccccccCCCC
Q 012219 81 YGKNFDVEIPNT 92 (468)
Q Consensus 81 ~~n~l~~~~p~~ 92 (468)
++|+++...+..
T Consensus 271 ~~N~i~~~~~~~ 282 (330)
T 1xku_A 271 HNNNISAIGSND 282 (330)
T ss_dssp CSSCCCCCCTTS
T ss_pred CCCcCCccChhh
Confidence 666666544433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=8.6e-10 Score=112.43 Aligned_cols=91 Identities=29% Similarity=0.300 Sum_probs=75.9
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceeccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYVYG 82 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~~~ 82 (468)
++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|++|++|++|+|++|+++ .+|. .+.+|+.|++++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~L~~ 99 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSF 99 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECCCCCCCSEEECCS
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCccccCCccEEeccC
Confidence 57899999999999766678999999999999999999888889999999999999999999 6776 566778888999
Q ss_pred ccccc-cCCCCCCC
Q 012219 83 KNFDV-EIPNTSEN 95 (468)
Q Consensus 83 n~l~~-~~p~~~~~ 95 (468)
|.+.+ ..|.....
T Consensus 100 N~l~~~~~p~~~~~ 113 (520)
T 2z7x_B 100 NAFDALPICKEFGN 113 (520)
T ss_dssp SCCSSCCCCGGGGG
T ss_pred Cccccccchhhhcc
Confidence 98876 45555443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-09 Score=112.42 Aligned_cols=88 Identities=17% Similarity=0.227 Sum_probs=74.7
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPH 77 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~ 77 (468)
+++++|+.|+|++|.|++..|..|+++++|++|+|++|+|++..|..|+++++|+.|+|++|++++..|..+. +|..
T Consensus 96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 175 (597)
T 3oja_B 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175 (597)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence 3688999999999999987777899999999999999999955445579999999999999999987776554 5666
Q ss_pred eeccccccccc
Q 012219 78 LYVYGKNFDVE 88 (468)
Q Consensus 78 l~~~~n~l~~~ 88 (468)
|++++|.+.+.
T Consensus 176 L~L~~N~l~~~ 186 (597)
T 3oja_B 176 LQLSSNRLTHV 186 (597)
T ss_dssp EECTTSCCSBC
T ss_pred EECcCCCCCCc
Confidence 88999988764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=7.1e-10 Score=115.28 Aligned_cols=91 Identities=21% Similarity=0.282 Sum_probs=72.7
Q ss_pred CCCCCcEEEccCCccccc---CCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCcc--
Q 012219 2 NCSKLRVLELGNNLLSGS---IPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVP-- 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~-- 76 (468)
++++|+.|+|++|.+++. .+..++.+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+.+++
T Consensus 447 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp TCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred CCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 578899999999998862 235688889999999999999988888889999999999999999888887665555
Q ss_pred ceecccccccccCCCC
Q 012219 77 HLYVYGKNFDVEIPNT 92 (468)
Q Consensus 77 ~l~~~~n~l~~~~p~~ 92 (468)
.|++++|.+.+..|..
T Consensus 527 ~L~L~~N~l~~~~~~~ 542 (606)
T 3t6q_A 527 YLNLASNHISIILPSL 542 (606)
T ss_dssp EEECCSSCCCCCCGGG
T ss_pred EEECcCCcccccCHhh
Confidence 5667888887665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-09 Score=112.23 Aligned_cols=61 Identities=23% Similarity=0.243 Sum_probs=29.1
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 87 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC
Confidence 3444444444444444444444444444444444444444444444444444444444444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=112.05 Aligned_cols=91 Identities=18% Similarity=0.270 Sum_probs=76.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccc--cccccccCCCCCceecccCcccccccCCc----CCCc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDLSMNNLSGSIPES----VRKV 75 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l 75 (468)
++++|+.|+|++|++++.+|..++++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++.+|.. +.++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 56889999999999998899999999999999999999996 45677899999999999999999767763 4567
Q ss_pred cceecccccccccCCCC
Q 012219 76 PHLYVYGKNFDVEIPNT 92 (468)
Q Consensus 76 ~~l~~~~n~l~~~~p~~ 92 (468)
+.|++++|.+.+..|..
T Consensus 431 ~~L~l~~n~l~~~~~~~ 447 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRC 447 (562)
T ss_dssp CEEECCSSCCCGGGGSS
T ss_pred CEEECCCCCCCcchhhh
Confidence 77889998887766544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.3e-09 Score=106.89 Aligned_cols=86 Identities=29% Similarity=0.404 Sum_probs=39.7
Q ss_pred CCCCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 3 CSKLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
+++|+.|+|++|+..+.+|. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..|..+. +|+.|
T Consensus 159 l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 236 (440)
T 3zyj_A 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236 (440)
T ss_dssp CTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEE
Confidence 44555555555332223333 3455555555555555555 333 345555555555555555543343332 23334
Q ss_pred ecccccccccCC
Q 012219 79 YVYGKNFDVEIP 90 (468)
Q Consensus 79 ~~~~n~l~~~~p 90 (468)
++++|.+....+
T Consensus 237 ~L~~n~l~~~~~ 248 (440)
T 3zyj_A 237 WMIQSQIQVIER 248 (440)
T ss_dssp ECTTCCCCEECT
T ss_pred ECCCCceeEECh
Confidence 455555444433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.1e-09 Score=99.65 Aligned_cols=83 Identities=11% Similarity=0.205 Sum_probs=56.4
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCcc-ccccccccccCCCCCceecccC-cccccccCCc---CCCcccee
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNS-INGKILSQLGEIPRIDTVDLSM-NNLSGSIPES---VRKVPHLY 79 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~---~~~l~~l~ 79 (468)
+|+.|+|++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|+.|+|++ |++++..|.. +.+|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 57777777777775445567777777777777776 7644445677777777777777 7777333333 34556667
Q ss_pred cccccccc
Q 012219 80 VYGKNFDV 87 (468)
Q Consensus 80 ~~~n~l~~ 87 (468)
+++|.+..
T Consensus 112 l~~n~l~~ 119 (239)
T 2xwt_C 112 IFNTGLKM 119 (239)
T ss_dssp EEEECCCS
T ss_pred CCCCCCcc
Confidence 77777665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-09 Score=117.99 Aligned_cols=66 Identities=21% Similarity=0.266 Sum_probs=31.3
Q ss_pred CCCCcEEEccCCcccccC-CcccccCCCCCEeeccCccccccccccccCCCCCceecccCccccccc
Q 012219 3 CSKLRVLELGNNLLSGSI-PSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSI 68 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 68 (468)
+++|+.|+|++|.+.+.+ |..|++|++|++|+|++|++++..|..|++|++|+.|+|++|++++.+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 113 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccc
Confidence 444445555544444344 334444444555555544444444444444444444444444444433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=2.3e-09 Score=111.44 Aligned_cols=63 Identities=14% Similarity=0.075 Sum_probs=30.3
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 118 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118 (606)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS
T ss_pred CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcc
Confidence 444444444444444444444444444444444444444444444444444444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=1e-09 Score=104.05 Aligned_cols=90 Identities=14% Similarity=0.202 Sum_probs=58.2
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccc--cccc--ccCCCCCceecccCcccccccCC-------c
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGK--ILSQ--LGEIPRIDTVDLSMNNLSGSIPE-------S 71 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~--~~~l~~L~~l~l~~N~l~g~~p~-------~ 71 (468)
+++|+.|+|++|++++..|..|+++++|++|+|++|+++|. +|.. ++++++|++|+|++|+++ .+|. .
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 56777777777777766666777777777777777776653 3222 356777777777777776 2332 2
Q ss_pred CCCccceecccccccccCCCCC
Q 012219 72 VRKVPHLYVYGKNFDVEIPNTS 93 (468)
Q Consensus 72 ~~~l~~l~~~~n~l~~~~p~~~ 93 (468)
+.+|+.|++++|.+....|...
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~ 244 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSA 244 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCC
T ss_pred CCCCCEEECCCCCCCccchhhH
Confidence 3566677777777776655443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.2e-09 Score=108.17 Aligned_cols=96 Identities=20% Similarity=0.200 Sum_probs=82.0
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPH 77 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~ 77 (468)
.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..+ .+|+.
T Consensus 53 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCE
Confidence 368899999999999998889999999999999999999996555668999999999999999997777655 45667
Q ss_pred eecccccccccCCCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSENS 96 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~~~ 96 (468)
|++++|.+....|..+...
T Consensus 133 L~l~~n~l~~~~~~~~~~l 151 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGL 151 (477)
T ss_dssp EEECCTTCCEECTTSSTTC
T ss_pred EECCCCccceeChhhccCC
Confidence 8899999887766655543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.7e-09 Score=102.21 Aligned_cols=87 Identities=21% Similarity=0.252 Sum_probs=73.9
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC-CCccceeccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV-RKVPHLYVYG 82 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~ 82 (468)
++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+++ .+|..+ .+++.|++++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~L~~L~l~~ 132 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHD 132 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCCTTCCEEECCS
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccccccCCEEECCC
Confidence 57899999999999766778999999999999999999888889999999999999999999 677654 5788889999
Q ss_pred ccccccCCC
Q 012219 83 KNFDVEIPN 91 (468)
Q Consensus 83 n~l~~~~p~ 91 (468)
|.+....+.
T Consensus 133 n~i~~~~~~ 141 (332)
T 2ft3_A 133 NRIRKVPKG 141 (332)
T ss_dssp SCCCCCCSG
T ss_pred CccCccCHh
Confidence 888765443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.8e-09 Score=110.87 Aligned_cols=90 Identities=20% Similarity=0.231 Sum_probs=77.8
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCccccc-ccCCcC---CCcc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSG-SIPESV---RKVP 76 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~---~~l~ 76 (468)
+++++|++|+|++|++++..|+.|+++++|++|+|++|++++..|..|++|++|++|+|++|++++ .+|..+ .+|+
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred hcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 368899999999999998888899999999999999999998888789999999999999999996 355544 5566
Q ss_pred ceecccccccccCC
Q 012219 77 HLYVYGKNFDVEIP 90 (468)
Q Consensus 77 ~l~~~~n~l~~~~p 90 (468)
.|++++|.+.+.+|
T Consensus 127 ~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 127 TLRIGNVETFSEIR 140 (549)
T ss_dssp EEEEEESSSCCEEC
T ss_pred EEECCCCccccccC
Confidence 78899998655555
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.8e-09 Score=111.14 Aligned_cols=83 Identities=29% Similarity=0.339 Sum_probs=70.8
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceeccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYVYG 82 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~~~ 82 (468)
++|+.|+|++|+|++..|..|+++++|++|+|++|++++..|..|++|++|++|+|++|+++ .+|. .+.+|+.|++++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~Ls~ 130 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLSF 130 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSCCCTTCSEEECCS
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCccccccCCEEECCC
Confidence 57899999999999666678999999999999999999887888999999999999999998 6776 566777888998
Q ss_pred ccccc
Q 012219 83 KNFDV 87 (468)
Q Consensus 83 n~l~~ 87 (468)
|.+..
T Consensus 131 N~l~~ 135 (562)
T 3a79_B 131 NDFDV 135 (562)
T ss_dssp SCCSB
T ss_pred CCccc
Confidence 88876
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.88 E-value=2e-09 Score=103.01 Aligned_cols=90 Identities=22% Similarity=0.262 Sum_probs=71.5
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~ 80 (468)
++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+. +|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 47888888888888766678888889999999999998777778888889999999999888 7887554 4556788
Q ss_pred ccccccccCCCCCC
Q 012219 81 YGKNFDVEIPNTSE 94 (468)
Q Consensus 81 ~~n~l~~~~p~~~~ 94 (468)
++|.+....+..+.
T Consensus 272 ~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 272 HTNNITKVGVNDFC 285 (332)
T ss_dssp CSSCCCBCCTTSSS
T ss_pred CCCCCCccChhHcc
Confidence 88888765554443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=3e-09 Score=112.18 Aligned_cols=91 Identities=21% Similarity=0.223 Sum_probs=54.0
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|++|++|++|+|++|++++..|..+ .+|+.|
T Consensus 47 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 126 (680)
T 1ziw_A 47 RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126 (680)
T ss_dssp GGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEE
T ss_pred CCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEE
Confidence 35566666666666666556666666666666666666663333346666666666666666664333433 334455
Q ss_pred ecccccccccCCCC
Q 012219 79 YVYGKNFDVEIPNT 92 (468)
Q Consensus 79 ~~~~n~l~~~~p~~ 92 (468)
++++|.+.+..|..
T Consensus 127 ~Ls~n~l~~~~~~~ 140 (680)
T 1ziw_A 127 DLSHNGLSSTKLGT 140 (680)
T ss_dssp ECCSSCCSCCCCCS
T ss_pred ECCCCcccccCchh
Confidence 66666665554443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.6e-09 Score=102.16 Aligned_cols=86 Identities=21% Similarity=0.309 Sum_probs=70.4
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC-CCccceeccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV-RKVPHLYVYG 82 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~ 82 (468)
++|+.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+++ .+|..+ .+++.|++++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~ 130 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHE 130 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCS
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCC
Confidence 46888999999998665668889999999999999999777888999999999999999988 677644 5678888888
Q ss_pred ccccccCC
Q 012219 83 KNFDVEIP 90 (468)
Q Consensus 83 n~l~~~~p 90 (468)
|.+....+
T Consensus 131 n~l~~~~~ 138 (330)
T 1xku_A 131 NEITKVRK 138 (330)
T ss_dssp SCCCBBCH
T ss_pred CcccccCH
Confidence 88765443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=4e-09 Score=101.89 Aligned_cols=82 Identities=22% Similarity=0.241 Sum_probs=65.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--c---CCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--S---VRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~---~~~l~ 76 (468)
++++|+.|+|++|++++..|..|+++++|++|+|++|++++..+..|+++++|+.|+|++|+++ .+|. . +.+|+
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 5788999999999999777778999999999999999998544445888999999999999988 5665 3 44566
Q ss_pred ceeccccc
Q 012219 77 HLYVYGKN 84 (468)
Q Consensus 77 ~l~~~~n~ 84 (468)
.|++++|+
T Consensus 153 ~L~l~~n~ 160 (353)
T 2z80_A 153 ILRVGNMD 160 (353)
T ss_dssp EEEEEESS
T ss_pred EEECCCCc
Confidence 67888875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.9e-09 Score=102.70 Aligned_cols=87 Identities=17% Similarity=0.251 Sum_probs=74.0
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccc-ccCCCCCceecccCcccccccCCcC---CCcc
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLSMNNLSGSIPESV---RKVP 76 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~ 76 (468)
+++++|+.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. |+++++|+.|+|++|++++..|..+ .+|+
T Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (390)
T 3o6n_A 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168 (390)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCC
T ss_pred cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCC
Confidence 36889999999999999777788999999999999999999 56655 6999999999999999997666555 4566
Q ss_pred ceeccccccccc
Q 012219 77 HLYVYGKNFDVE 88 (468)
Q Consensus 77 ~l~~~~n~l~~~ 88 (468)
.|++++|.+...
T Consensus 169 ~L~l~~n~l~~~ 180 (390)
T 3o6n_A 169 NLQLSSNRLTHV 180 (390)
T ss_dssp EEECCSSCCSBC
T ss_pred EEECCCCcCCcc
Confidence 788999988654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.6e-09 Score=103.17 Aligned_cols=86 Identities=21% Similarity=0.270 Sum_probs=73.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceecc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVY 81 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~ 81 (468)
.+++|+.|+|++|++++..|..|+++++|++|+|++|++++..| +..+++|+.|+|++|++++ +|.. .+++.|+++
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~~~-~~L~~L~l~ 107 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLVG-PSIETLHAA 107 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EEEC-TTCCEEECC
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-ccCC-CCcCEEECC
Confidence 35689999999999997777899999999999999999997665 9999999999999999994 5532 678888999
Q ss_pred cccccccCCC
Q 012219 82 GKNFDVEIPN 91 (468)
Q Consensus 82 ~n~l~~~~p~ 91 (468)
+|.+....+.
T Consensus 108 ~n~l~~~~~~ 117 (317)
T 3o53_A 108 NNNISRVSCS 117 (317)
T ss_dssp SSCCSEEEEC
T ss_pred CCccCCcCcc
Confidence 8888765443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.6e-09 Score=97.92 Aligned_cols=67 Identities=30% Similarity=0.426 Sum_probs=55.3
Q ss_pred CCCCCcEEEccCCcccc--cCCcccccCCCCCEeeccCccccccccccccCCC--CCceecccCcccccccCC
Q 012219 2 NCSKLRVLELGNNLLSG--SIPSEINKLQELNYLNLSHNSINGKILSQLGEIP--RIDTVDLSMNNLSGSIPE 70 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~g~~p~ 70 (468)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 47889999999999997 6677888999999999999999965 3344444 899999999999987774
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.80 E-value=4e-09 Score=95.92 Aligned_cols=92 Identities=12% Similarity=0.141 Sum_probs=72.4
Q ss_pred CCCCCcEEEccCCc-ccccCCcccccCCCCCEeeccC-ccccccccccccCCCCCceecccCcccccccCC--cCCCcc-
Q 012219 2 NCSKLRVLELGNNL-LSGSIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVP- 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~- 76 (468)
++++|+.|+|++|+ +++..+..|.++++|++|+|++ |+|++..|..|.++++|+.|++++|++++ +|. .+.+++
T Consensus 53 ~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~ 131 (239)
T 2xwt_C 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDI 131 (239)
T ss_dssp TCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCS
T ss_pred CCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-cccccccccccc
Confidence 57899999999997 8844455799999999999998 99996666789999999999999999994 786 344555
Q ss_pred --ceecccc-cccccCCCCCC
Q 012219 77 --HLYVYGK-NFDVEIPNTSE 94 (468)
Q Consensus 77 --~l~~~~n-~l~~~~p~~~~ 94 (468)
.|++++| .+....+..+.
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~ 152 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQ 152 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTT
T ss_pred ccEEECCCCcchhhcCccccc
Confidence 7778888 77655444443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.80 E-value=5.1e-09 Score=100.80 Aligned_cols=85 Identities=27% Similarity=0.415 Sum_probs=63.0
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|.+++ + +.+..+++|++|+|++|++++. +.+..+++|+.|++++|++++..|.. +.+++.|
T Consensus 241 ~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp TCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred cCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 56788888888888874 4 4677888888888888888853 35778888888888888888666553 4556667
Q ss_pred ecccccccccCC
Q 012219 79 YVYGKNFDVEIP 90 (468)
Q Consensus 79 ~~~~n~l~~~~p 90 (468)
++++|.+....|
T Consensus 317 ~L~~n~l~~~~~ 328 (347)
T 4fmz_A 317 FLSQNHITDIRP 328 (347)
T ss_dssp ECCSSSCCCCGG
T ss_pred EccCCccccccC
Confidence 788888776554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.80 E-value=5.8e-09 Score=97.90 Aligned_cols=82 Identities=28% Similarity=0.459 Sum_probs=61.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccC-CcCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIP-ESVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~ 80 (468)
++++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. ..++.+++|+.|+|++|++++..| ..+.+|+.|++
T Consensus 110 ~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L 185 (291)
T 1h6t_A 110 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185 (291)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEEC
T ss_pred cCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEEC
Confidence 57788888888888884 4 4688888888888888888854 578888888888888888885433 13445666778
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
++|.+..
T Consensus 186 ~~N~i~~ 192 (291)
T 1h6t_A 186 SKNHISD 192 (291)
T ss_dssp CSSCCCB
T ss_pred CCCcCCC
Confidence 8887765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.79 E-value=8.5e-09 Score=95.22 Aligned_cols=82 Identities=17% Similarity=0.303 Sum_probs=68.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
++++|+.|+|++|+++ .+| .++.+++|++|+|++|+|++. |. +.++++|+.|+|++|++++ +|. ...+|..|++
T Consensus 39 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L 113 (263)
T 1xeu_A 39 ELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFL 113 (263)
T ss_dssp HHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEEC
T ss_pred hcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccccCcccEEEc
Confidence 3678999999999998 787 799999999999999999955 44 9999999999999999995 554 2267888899
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
++|.+...
T Consensus 114 ~~N~l~~~ 121 (263)
T 1xeu_A 114 DNNELRDT 121 (263)
T ss_dssp CSSCCSBS
T ss_pred cCCccCCC
Confidence 99888763
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.79 E-value=8.5e-09 Score=105.45 Aligned_cols=76 Identities=20% Similarity=0.287 Sum_probs=44.8
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceeccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYG 82 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~ 82 (468)
+++|+.|+|++|+|++ +|. +++ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+.+|..|++++
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRN 169 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCS
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCC
Confidence 4556666666666663 555 444 56666666666664 554 45666666666666663 555555566666666
Q ss_pred ccccc
Q 012219 83 KNFDV 87 (468)
Q Consensus 83 n~l~~ 87 (468)
|.+.+
T Consensus 170 N~L~~ 174 (571)
T 3cvr_A 170 NQLTF 174 (571)
T ss_dssp SCCSC
T ss_pred CCCCC
Confidence 66554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=5.1e-09 Score=110.34 Aligned_cols=87 Identities=24% Similarity=0.355 Sum_probs=53.5
Q ss_pred CCCCCcEEEccCCcccccC----C----cccccCCCCCEeeccCccccccccc-cccCCCCCceecccCcccccccCC-c
Q 012219 2 NCSKLRVLELGNNLLSGSI----P----SEINKLQELNYLNLSHNSINGKILS-QLGEIPRIDTVDLSMNNLSGSIPE-S 71 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~----p----~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~-~ 71 (468)
++++|+.|+|++|++++.. | ..|+++++|+.|+|++|+|+ .+|. .|.+|++|+.|+|++|+++ .+|. .
T Consensus 502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~ 579 (680)
T 1ziw_A 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLN-TLPASV 579 (680)
T ss_dssp TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCC-cCCHhH
Confidence 4667777777777776431 1 12666777777777777777 4443 4677777777777777777 3443 2
Q ss_pred C---CCccceecccccccccCC
Q 012219 72 V---RKVPHLYVYGKNFDVEIP 90 (468)
Q Consensus 72 ~---~~l~~l~~~~n~l~~~~p 90 (468)
+ .+|+.|++++|.+++..|
T Consensus 580 ~~~l~~L~~L~L~~N~l~~~~~ 601 (680)
T 1ziw_A 580 FNNQVSLKSLNLQKNLITSVEK 601 (680)
T ss_dssp TTTCTTCCEEECTTSCCCBCCH
T ss_pred hCCCCCCCEEECCCCcCCccCh
Confidence 2 445556666666665443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.77 E-value=5.2e-09 Score=99.48 Aligned_cols=83 Identities=16% Similarity=0.199 Sum_probs=41.3
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccccccccc-CCCCCceecccCcccccccCC--cCCCcccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLG-EIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
+++|+.|+|++|++++..|..++.+++|++|+|++|++++..|..+. .+++|+.|+|++|++++ +|. .+.++..|+
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~l~~L~~L~ 197 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLD 197 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECCCCCTTCCEEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cccccccccCCEEE
Confidence 34455555555555544444555555555555555555554444442 45555555555555552 232 133444444
Q ss_pred ccccccc
Q 012219 80 VYGKNFD 86 (468)
Q Consensus 80 ~~~n~l~ 86 (468)
+++|.+.
T Consensus 198 Ls~N~l~ 204 (317)
T 3o53_A 198 LSSNKLA 204 (317)
T ss_dssp CCSSCCC
T ss_pred CCCCcCC
Confidence 4444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-08 Score=105.43 Aligned_cols=83 Identities=28% Similarity=0.432 Sum_probs=59.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
+|++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. ..|..|++|+.|+|++|+|++..|- .+.+|..|++
T Consensus 107 ~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~L 182 (605)
T 1m9s_A 107 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 182 (605)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEEC
T ss_pred cCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEEC
Confidence 56778888888888874 4 4577888888888888888754 5677888888888888888765441 3345566777
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
++|.+...
T Consensus 183 s~N~i~~l 190 (605)
T 1m9s_A 183 SKNHISDL 190 (605)
T ss_dssp CSSCCCBC
T ss_pred cCCCCCCC
Confidence 77777653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-08 Score=96.32 Aligned_cols=82 Identities=15% Similarity=0.258 Sum_probs=52.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
++++|+.|+|++|++++ +|+ ++.+++|++|+|++|++++..| ++++++|+.|+|++|++++ +|. .+.+|+.|+
T Consensus 105 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~ 179 (308)
T 1h6u_A 105 GLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLK 179 (308)
T ss_dssp TCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEE
T ss_pred CCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-ChhhcCCCCCCEEE
Confidence 46677777777777773 443 7777777777777777774433 6677777777777777763 332 334455566
Q ss_pred ccccccccc
Q 012219 80 VYGKNFDVE 88 (468)
Q Consensus 80 ~~~n~l~~~ 88 (468)
+++|.+...
T Consensus 180 l~~n~l~~~ 188 (308)
T 1h6u_A 180 ADDNKISDI 188 (308)
T ss_dssp CCSSCCCCC
T ss_pred CCCCccCcC
Confidence 666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.75 E-value=1.1e-08 Score=95.84 Aligned_cols=79 Identities=15% Similarity=0.204 Sum_probs=39.4
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceecc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYVY 81 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~ 81 (468)
++|+.|++++|.++ .+| .++.+++|++|+|++|++++..| +.++++|+.|+|++|++++ +|. .+.+|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECT
T ss_pred CcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECC
Confidence 44555555555555 333 25555555555555555553322 5555555555555555552 332 23334445555
Q ss_pred cccccc
Q 012219 82 GKNFDV 87 (468)
Q Consensus 82 ~n~l~~ 87 (468)
+|.+..
T Consensus 121 ~n~i~~ 126 (291)
T 1h6t_A 121 HNGISD 126 (291)
T ss_dssp TSCCCC
T ss_pred CCcCCC
Confidence 555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.74 E-value=3.3e-10 Score=99.97 Aligned_cols=60 Identities=22% Similarity=0.298 Sum_probs=28.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+++|+.|+|++|+|++ +| .++++++|++|+|++|+++ .+|..+..+++|+.|+|++|+++
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~ 106 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCC
Confidence 3444444454444442 44 4444444444555444444 34444444444444444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.74 E-value=1.4e-08 Score=96.02 Aligned_cols=84 Identities=21% Similarity=0.347 Sum_probs=69.7
Q ss_pred CCCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccce
Q 012219 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHL 78 (468)
Q Consensus 1 ~~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l 78 (468)
+++++|+.|+|++|++++ +| .++++++|++|+|++|++++ +|. +..+++|+.|+|++|++++ +|. .+.+|+.|
T Consensus 82 ~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L 156 (308)
T 1h6u_A 82 KNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYL 156 (308)
T ss_dssp TTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEE
T ss_pred ccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-CccccCCCCccEE
Confidence 368899999999999984 54 79999999999999999995 453 9999999999999999995 443 45667788
Q ss_pred ecccccccccC
Q 012219 79 YVYGKNFDVEI 89 (468)
Q Consensus 79 ~~~~n~l~~~~ 89 (468)
++++|.+....
T Consensus 157 ~l~~n~l~~~~ 167 (308)
T 1h6u_A 157 SIGNAQVSDLT 167 (308)
T ss_dssp ECCSSCCCCCG
T ss_pred EccCCcCCCCh
Confidence 99999887643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.5e-08 Score=93.51 Aligned_cols=80 Identities=16% Similarity=0.285 Sum_probs=47.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
++++|+.|+|++|+|+ .+|+ ++++++|++|+|++|++++ +|.. .. ++|+.|+|++|++++ +|. .+.+|+.|+
T Consensus 61 ~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~~l~~l~~L~~L~ 134 (263)
T 1xeu_A 61 FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TDSLIHLKNLEILS 134 (263)
T ss_dssp GCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SGGGTTCTTCCEEE
T ss_pred hCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-ChhhcCcccccEEE
Confidence 4677788888888887 4444 7777777777777777774 3322 22 555555555555553 332 233344455
Q ss_pred cccccccc
Q 012219 80 VYGKNFDV 87 (468)
Q Consensus 80 ~~~n~l~~ 87 (468)
+++|.+..
T Consensus 135 Ls~N~i~~ 142 (263)
T 1xeu_A 135 IRNNKLKS 142 (263)
T ss_dssp CTTSCCCB
T ss_pred CCCCcCCC
Confidence 55555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.69 E-value=3e-09 Score=104.06 Aligned_cols=86 Identities=17% Similarity=0.238 Sum_probs=59.2
Q ss_pred CCCCCcEEEccCCccc--c---cCCcccccCCCCCEeeccCcccc----ccccccccCCCCCceecccCcccccc----c
Q 012219 2 NCSKLRVLELGNNLLS--G---SIPSEINKLQELNYLNLSHNSIN----GKILSQLGEIPRIDTVDLSMNNLSGS----I 68 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~g~----~ 68 (468)
++++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|++++. +
T Consensus 185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 264 (386)
T 2ca6_A 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264 (386)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHH
Confidence 3567777777777776 3 34446777777777777777775 56777777777777777777777654 3
Q ss_pred CCc-----CCCccceecccccccc
Q 012219 69 PES-----VRKVPHLYVYGKNFDV 87 (468)
Q Consensus 69 p~~-----~~~l~~l~~~~n~l~~ 87 (468)
|.. ..+|..|++++|.+..
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHHHhhccCCCeEEEECcCCcCCH
Confidence 443 4556667777777665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.6e-09 Score=108.39 Aligned_cols=84 Identities=15% Similarity=0.127 Sum_probs=46.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCC-------------ceecccCccccccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRI-------------DTVDLSMNNLSGSI 68 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L-------------~~l~l~~N~l~g~~ 68 (468)
+.++|+.|++++|+| |.+|++|++|++|++|+|++|+++|.+|.+++++++| +.|++++|+++ .+
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CC
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cC
Confidence 357899999999999 7999999999999999999999999999999888764 77777777777 46
Q ss_pred CCcCCCccceecccccccc
Q 012219 69 PESVRKVPHLYVYGKNFDV 87 (468)
Q Consensus 69 p~~~~~l~~l~~~~n~l~~ 87 (468)
|....+++.|++++|.+.+
T Consensus 87 p~~~~~L~~L~l~~n~l~~ 105 (454)
T 1jl5_A 87 PELPPHLESLVASCNSLTE 105 (454)
T ss_dssp CSCCTTCSEEECCSSCCSS
T ss_pred CCCcCCCCEEEccCCcCCc
Confidence 6655666777777777665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.7e-08 Score=101.73 Aligned_cols=74 Identities=22% Similarity=0.381 Sum_probs=38.2
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC-Cccceecccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR-KVPHLYVYGK 83 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~l~~~~n 83 (468)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +. +|..|++++|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N 130 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPASLKHLDVDNN 130 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSS
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhcCCCEEECCCC
Confidence 55556666666653 555443 45555555555555 445 334555555555555553 444 33 4444555555
Q ss_pred cccc
Q 012219 84 NFDV 87 (468)
Q Consensus 84 ~l~~ 87 (468)
.+.+
T Consensus 131 ~l~~ 134 (571)
T 3cvr_A 131 QLTM 134 (571)
T ss_dssp CCSC
T ss_pred cCCC
Confidence 5444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.67 E-value=2.8e-08 Score=99.44 Aligned_cols=74 Identities=20% Similarity=0.281 Sum_probs=57.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceecc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVY 81 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~ 81 (468)
++++|+.|+|++|+|++ + .++.+++|+.|+|++|+|++ +| ++.+++|+.|++++|++++..+..+.+++.|+++
T Consensus 189 ~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~ 262 (457)
T 3bz5_A 189 QNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCI 262 (457)
T ss_dssp TCTTCCEEECCSSCCSC-C--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECT
T ss_pred cCCCCCEEECcCCcCCe-e--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEecc
Confidence 57788899999999885 3 38888889999999999986 66 8888889999999998887555556655544333
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.67 E-value=1.7e-09 Score=95.44 Aligned_cols=82 Identities=21% Similarity=0.268 Sum_probs=73.2
Q ss_pred CCCCcEEEccCCcccccCCc------ccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---C
Q 012219 3 CSKLRVLELGNNLLSGSIPS------EINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---R 73 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~------~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~ 73 (468)
..+++.++|+.|.|+|.+|. .|+++++|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+ .
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 46788899999999999998 99999999999999999996 78 9999999999999999999 788744 5
Q ss_pred Cccceecccccccc
Q 012219 74 KVPHLYVYGKNFDV 87 (468)
Q Consensus 74 ~l~~l~~~~n~l~~ 87 (468)
+++.|++++|.+.+
T Consensus 94 ~L~~L~L~~N~l~~ 107 (198)
T 1ds9_A 94 TLEELWISYNQIAS 107 (198)
T ss_dssp HCSEEEEEEEECCC
T ss_pred cCCEEECcCCcCCc
Confidence 67788999988765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.67 E-value=3.2e-08 Score=102.16 Aligned_cols=84 Identities=25% Similarity=0.423 Sum_probs=66.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
+|++|+.|+|++|+|+ .+| .+++|++|+.|+|++|+|++ + +.+.+|++|+.|+|++|++++ ++. .+.+|..|+
T Consensus 85 ~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLS 159 (605)
T ss_dssp GCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGGGGSCTTCSEEE
T ss_pred cCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-chhhcccCCCCEEE
Confidence 5788999999999988 455 78888999999999999885 3 368888999999999999885 442 456677788
Q ss_pred cccccccccCC
Q 012219 80 VYGKNFDVEIP 90 (468)
Q Consensus 80 ~~~n~l~~~~p 90 (468)
+++|.+....|
T Consensus 160 Ls~N~l~~~~~ 170 (605)
T 1m9s_A 160 LEDNQISDIVP 170 (605)
T ss_dssp CCSSCCCCCGG
T ss_pred CcCCcCCCchh
Confidence 88888877655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.60 E-value=5.5e-08 Score=93.51 Aligned_cols=86 Identities=20% Similarity=0.470 Sum_probs=68.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
++++|+.|+|++|+++ .+|. +..+++|++|+|++|++++ + +.+..+++|+.|++++|++++ +|. .+.+++.|+
T Consensus 219 ~~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~ 293 (347)
T 4fmz_A 219 NMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLF 293 (347)
T ss_dssp GCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEEE
T ss_pred cCCcCCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-ChhhcCCCCCCEEE
Confidence 4788999999999998 5555 8889999999999999985 4 468899999999999999984 553 456777888
Q ss_pred cccccccccCCCC
Q 012219 80 VYGKNFDVEIPNT 92 (468)
Q Consensus 80 ~~~n~l~~~~p~~ 92 (468)
+++|.+....|..
T Consensus 294 L~~n~l~~~~~~~ 306 (347)
T 4fmz_A 294 LNNNQLGNEDMEV 306 (347)
T ss_dssp CCSSCCCGGGHHH
T ss_pred CcCCcCCCcChhH
Confidence 9988887655443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.60 E-value=1.1e-08 Score=97.96 Aligned_cols=79 Identities=13% Similarity=0.172 Sum_probs=51.3
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCcccccc-ccccccCCCCCceecccCcccccccCCc---CCCcccee
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGK-ILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~ 79 (468)
++|+.|+|++|.+++.+|. +.++++|++|+|++|.+++. +|..+.++++|+.|+|++|++++..|.. +.+|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5667777777777754443 55677777777777777655 6666777777777777777776555543 34455566
Q ss_pred cccc
Q 012219 80 VYGK 83 (468)
Q Consensus 80 ~~~n 83 (468)
+++|
T Consensus 149 L~~~ 152 (336)
T 2ast_B 149 LSGC 152 (336)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 6666
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.4e-07 Score=84.69 Aligned_cols=135 Identities=19% Similarity=0.171 Sum_probs=96.0
Q ss_pred eeeeeCCc-eEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYG-SVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.+..|..| .||+.... ++..+++|+-.... ...+.+|.+.++.+. +-.+.++++++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45666666 58988754 56778899875432 245778999888874 33466788999999999999999999
Q ss_pred CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 012219 254 GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC----------------------------------------- 292 (468)
Q Consensus 254 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------- 292 (468)
.++.+...... .....++.+++..|..||...
T Consensus 105 ~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 105 KTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 88776543221 122345556666666666321
Q ss_pred --------------CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 293 --------------TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 293 --------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
...++|+|+.+.||++++++.+-|.||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887777999988753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.59 E-value=5.6e-08 Score=97.54 Aligned_cols=83 Identities=27% Similarity=0.425 Sum_probs=55.6
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
++++|+.|+|++|++++ +|+ ++.+++|+.|+|++|++++..| +..+++|+.|+|++|++++..|- .+.+|+.|++
T Consensus 263 ~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l 338 (466)
T 1o6v_A 263 GLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFF 338 (466)
T ss_dssp TCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEEC
T ss_pred cCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeEC
Confidence 46777777777777774 443 7777777777777777775443 67777777777777777755442 3445556666
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
++|.+.+.
T Consensus 339 ~~n~l~~~ 346 (466)
T 1o6v_A 339 YNNKVSDV 346 (466)
T ss_dssp CSSCCCCC
T ss_pred CCCccCCc
Confidence 66666553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.59 E-value=4.7e-08 Score=98.08 Aligned_cols=84 Identities=23% Similarity=0.339 Sum_probs=57.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
++++|+.|+|++|++++ +|+ ++.+++|+.|+|++|++++..| +..+++|+.|++++|++++ +|. .+.+|..|+
T Consensus 285 ~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 285 GLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLS 359 (466)
T ss_dssp TCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEE
T ss_pred CCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC-chhhccCCCCCEEe
Confidence 46778888888888874 333 7777788888888888776655 6677777777777777774 332 344555666
Q ss_pred cccccccccCC
Q 012219 80 VYGKNFDVEIP 90 (468)
Q Consensus 80 ~~~n~l~~~~p 90 (468)
+++|.+.+..|
T Consensus 360 l~~n~l~~~~~ 370 (466)
T 1o6v_A 360 AGHNQISDLTP 370 (466)
T ss_dssp CCSSCCCBCGG
T ss_pred CCCCccCccch
Confidence 77777766554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.59 E-value=1.1e-07 Score=94.98 Aligned_cols=80 Identities=19% Similarity=0.200 Sum_probs=49.8
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
++++|+.|+|++|+|++ +| ++.+++|+.|+|++|++++. .++.+++|+.|++++|++++ +|- .+.++..|++
T Consensus 168 ~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l 240 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDC 240 (457)
T ss_dssp TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEEC
T ss_pred cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEe
Confidence 35566666666666663 44 66666666666666666643 36666777777777777775 452 3344555667
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
++|.+.+.
T Consensus 241 ~~N~l~~~ 248 (457)
T 3bz5_A 241 SVNPLTEL 248 (457)
T ss_dssp CSSCCSCC
T ss_pred eCCcCCCc
Confidence 77766654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.58 E-value=8.8e-08 Score=95.67 Aligned_cols=77 Identities=21% Similarity=0.389 Sum_probs=48.3
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceecc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYVY 81 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~ 81 (468)
++|+.|+|++|++++ +| +|+++++|++|++++|++++ +|..+ ++|+.|++++|++++ +|. .+.+++.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECC
Confidence 467888888888874 77 57778888888888777774 55433 356666666666663 552 22333445555
Q ss_pred cccccc
Q 012219 82 GKNFDV 87 (468)
Q Consensus 82 ~n~l~~ 87 (468)
+|.+.+
T Consensus 204 ~N~l~~ 209 (454)
T 1jl5_A 204 NNSLKK 209 (454)
T ss_dssp SSCCSS
T ss_pred CCcCCc
Confidence 555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.56 E-value=7.1e-08 Score=92.98 Aligned_cols=86 Identities=16% Similarity=0.167 Sum_probs=64.8
Q ss_pred CCCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccc-cccCCCCCce-ecccCcccccccCCcC---CCccc
Q 012219 4 SKLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILS-QLGEIPRIDT-VDLSMNNLSGSIPESV---RKVPH 77 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~-l~l~~N~l~g~~p~~~---~~l~~ 77 (468)
++|+.|+|++|+|+ .||+ .|.+|++|++|+|++|++.+.+|. .|.+|++|.. +.+++|++++..|..+ .+|+.
T Consensus 30 ~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~ 108 (350)
T 4ay9_X 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 108 (350)
T ss_dssp TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCE
T ss_pred CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccc
Confidence 46889999999998 5664 688999999999999998877775 4788888764 6667788885445544 45566
Q ss_pred eecccccccccCC
Q 012219 78 LYVYGKNFDVEIP 90 (468)
Q Consensus 78 l~~~~n~l~~~~p 90 (468)
|++++|.+....+
T Consensus 109 L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 109 LLISNTGIKHLPD 121 (350)
T ss_dssp EEEEEECCSSCCC
T ss_pred ccccccccccCCc
Confidence 7888888766543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.9e-08 Score=98.35 Aligned_cols=85 Identities=20% Similarity=0.313 Sum_probs=68.8
Q ss_pred CCCcEEEccCCccc-ccCC---cccccCCCCCEeeccCcccc--c---cccccccCCCCCceecccCcccc----cccCC
Q 012219 4 SKLRVLELGNNLLS-GSIP---SEINKLQELNYLNLSHNSIN--G---KILSQLGEIPRIDTVDLSMNNLS----GSIPE 70 (468)
Q Consensus 4 ~~l~~l~l~~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~ 70 (468)
++|+.|+|++|+|+ +.+| ..+..+++|++|+|++|+++ | .+|..+..+++|+.|+|++|+++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 78999999999997 5666 46788999999999999998 4 45558889999999999999996 56775
Q ss_pred cC---CCccceeccccccccc
Q 012219 71 SV---RKVPHLYVYGKNFDVE 88 (468)
Q Consensus 71 ~~---~~l~~l~~~~n~l~~~ 88 (468)
.+ .+|+.|++++|.+...
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHH
T ss_pred HHccCCCcCEEECCCCCCchh
Confidence 44 5667788998887654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.53 E-value=1.3e-07 Score=97.84 Aligned_cols=34 Identities=24% Similarity=0.329 Sum_probs=15.8
Q ss_pred CCCceecccCcccccccCCcCCCccceeccccccc
Q 012219 52 PRIDTVDLSMNNLSGSIPESVRKVPHLYVYGKNFD 86 (468)
Q Consensus 52 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~l~ 86 (468)
++|+.|+|++|+|+ .+|..+.+|..|++++|.+.
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPMLPSGLLSLSVYRNQLT 274 (622)
T ss_dssp TTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCC
T ss_pred CcCcEEECCCCCCC-cCCcccccCcEEeCCCCCCC
Confidence 44444444444444 34444444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.51 E-value=1.4e-07 Score=97.66 Aligned_cols=72 Identities=22% Similarity=0.392 Sum_probs=35.7
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceeccccc
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYGKN 84 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~ 84 (468)
+|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|++|+++ .+|..+.++..|++++|+
T Consensus 62 ~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~~l~~L~~L~L~~N~ 132 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQ 132 (622)
T ss_dssp TCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCCCCTTCCEEECCSSC
T ss_pred CCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCCCCCCcCEEECCCCC
Confidence 4555555555555 4554 3455555555555555 3443 3444555555555554 344444444444444444
Q ss_pred c
Q 012219 85 F 85 (468)
Q Consensus 85 l 85 (468)
+
T Consensus 133 l 133 (622)
T 3g06_A 133 L 133 (622)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1e-06 Score=83.08 Aligned_cols=135 Identities=17% Similarity=0.117 Sum_probs=89.8
Q ss_pred ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC---ceeeEEEEEe-eCCEEEEEEEec
Q 012219 176 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR---NIVKLYGFCL-HRKCMFLIYEYM 251 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 251 (468)
..++.|....||+. |..+++|+-... .....+.+|.+++..+.+. .+.+++.++. ..+..++||||+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 45788888899988 466788875322 1235688999999999752 3556666664 345578999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD---------------------------------------- 291 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 291 (468)
+|.++.+.... .++..+...++.+++..|+.||..
T Consensus 96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99887653111 123333344444444444444421
Q ss_pred -----------------CCCCeEecCCCCCceeeCC---CCC-eEEeecccccc
Q 012219 292 -----------------CTPPIVHRDISSNNVLLNS---ELE-AFVADFGVARL 324 (468)
Q Consensus 292 -----------------~~~~ivH~dlk~~NIll~~---~~~-~kl~Dfg~~~~ 324 (468)
....++|+|++|.||+++. ++. +.|.||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999998 455 47999998754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.45 E-value=4.5e-08 Score=94.83 Aligned_cols=87 Identities=23% Similarity=0.196 Sum_probs=68.5
Q ss_pred CCCCcEEEccCCcccccCC----cccccCC-CCCEeeccCccccccccccccCC-----CCCceecccCcccccccCC--
Q 012219 3 CSKLRVLELGNNLLSGSIP----SEINKLQ-ELNYLNLSHNSINGKILSQLGEI-----PRIDTVDLSMNNLSGSIPE-- 70 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~l~l~~N~l~g~~p~-- 70 (468)
.++|+.|+|++|+|++..+ ..+.+++ +|++|+|++|+|++..+..+..+ ++|+.|+|++|++++..+.
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3459999999999985555 6778888 89999999999998777777765 8999999999999865443
Q ss_pred -----cC-CCccceecccccccccC
Q 012219 71 -----SV-RKVPHLYVYGKNFDVEI 89 (468)
Q Consensus 71 -----~~-~~l~~l~~~~n~l~~~~ 89 (468)
.. .+++.|++++|.+....
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKS 125 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred HHHHHhCCCCccEEECcCCcCCcHH
Confidence 12 56788889988886643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.43 E-value=8.8e-08 Score=92.77 Aligned_cols=81 Identities=17% Similarity=0.185 Sum_probs=53.3
Q ss_pred EEEccCCcccccCCcccccCCCCCEeeccCcccccccc----ccccCCC-CCceecccCcccccccCCcC--------CC
Q 012219 8 VLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKIL----SQLGEIP-RIDTVDLSMNNLSGSIPESV--------RK 74 (468)
Q Consensus 8 ~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p----~~~~~l~-~L~~l~l~~N~l~g~~p~~~--------~~ 74 (468)
.+.|+.|+++|.+|..+....+|++|+|++|+|++..+ ..|.+++ +|+.|+|++|++++..+..+ .+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777777666666667777777777775555 5666776 67777777777775444321 45
Q ss_pred ccceeccccccccc
Q 012219 75 VPHLYVYGKNFDVE 88 (468)
Q Consensus 75 l~~l~~~~n~l~~~ 88 (468)
++.|++++|.+...
T Consensus 82 L~~L~Ls~n~l~~~ 95 (362)
T 3goz_A 82 VTSLNLSGNFLSYK 95 (362)
T ss_dssp CCEEECCSSCGGGS
T ss_pred ccEEECcCCcCChH
Confidence 66677777776554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.35 E-value=3.1e-07 Score=87.70 Aligned_cols=61 Identities=16% Similarity=0.254 Sum_probs=41.1
Q ss_pred CC-CCcEEEccCC--ccc-ccCCcccccCCCCCEeeccCcc-ccccccccccCCCCCceecccCcc
Q 012219 3 CS-KLRVLELGNN--LLS-GSIPSEINKLQELNYLNLSHNS-INGKILSQLGEIPRIDTVDLSMNN 63 (468)
Q Consensus 3 l~-~l~~l~l~~N--~l~-g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l~~N~ 63 (468)
++ +|+.|+|++| .++ +.+|..+.++++|+.|+|++|. +++..+..+.++++|+.|+|++|.
T Consensus 193 l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 193 VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred cccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 45 6777777777 444 4566666677777777777777 666666667777777777777774
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1e-07 Score=87.36 Aligned_cols=80 Identities=23% Similarity=0.336 Sum_probs=62.6
Q ss_pred EEccCCcccccCCc----ccccCCCCCEeeccCccccc--cccccccCCCCCceecccCcccccccC--CcCC--Cccce
Q 012219 9 LELGNNLLSGSIPS----EINKLQELNYLNLSHNSING--KILSQLGEIPRIDTVDLSMNNLSGSIP--ESVR--KVPHL 78 (468)
Q Consensus 9 l~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p--~~~~--~l~~l 78 (468)
++++.|+.. .++. ...++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. . ..+. +|..|
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceE
Confidence 567788544 4443 23578999999999999998 5678889999999999999999963 2 2333 77889
Q ss_pred ecccccccccCC
Q 012219 79 YVYGKNFDVEIP 90 (468)
Q Consensus 79 ~~~~n~l~~~~p 90 (468)
++.+|++++..|
T Consensus 226 ~L~~Npl~~~~~ 237 (267)
T 3rw6_A 226 WLDGNSLCDTFR 237 (267)
T ss_dssp ECTTSTTGGGCS
T ss_pred EccCCcCccccC
Confidence 999999987554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.5e-07 Score=86.69 Aligned_cols=84 Identities=19% Similarity=0.226 Sum_probs=66.4
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccC-ccccccccc-cccCCCCCceecccCcccccccCC-cCCCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSH-NSINGKILS-QLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~ 80 (468)
..|+.|+|++|+|+ .||+.....++|+.|++++ |.++ .+|. .|.++++|+.|||++|+|+ .+|. .+.+++.|..
T Consensus 154 ~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 230 (350)
T ss_dssp SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEEC
T ss_pred hhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhh
Confidence 35888999999999 7888777788999999985 5565 7765 5899999999999999999 6765 5788888876
Q ss_pred ccccccccCC
Q 012219 81 YGKNFDVEIP 90 (468)
Q Consensus 81 ~~n~l~~~~p 90 (468)
.+++-...+|
T Consensus 231 l~~~~l~~lP 240 (350)
T 4ay9_X 231 RSTYNLKKLP 240 (350)
T ss_dssp TTCTTCCCCC
T ss_pred ccCCCcCcCC
Confidence 6554444444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.3e-06 Score=84.34 Aligned_cols=83 Identities=7% Similarity=-0.014 Sum_probs=54.5
Q ss_pred cee-eeeCCceEEEEEcC-------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-C--CceeeEEEEEeeC---
Q 012219 176 YCI-GTGGYGSVYRARLP-------SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-H--RNIVKLYGFCLHR--- 241 (468)
Q Consensus 176 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 241 (468)
+.| +.|....+|+.... ++..+++|...............+.+|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998764 26678888765432000000124567888888774 2 3566788887665
Q ss_pred CEEEEEEEeccCCChhh
Q 012219 242 KCMFLIYEYMEMGSLFC 258 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~ 258 (468)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.19 E-value=3.8e-07 Score=91.15 Aligned_cols=86 Identities=14% Similarity=0.120 Sum_probs=71.1
Q ss_pred CCCCcEEEccCCccccc----CCcccccCCCCCEeeccCccccccccccccC-----CCCCceecccCccccc----ccC
Q 012219 3 CSKLRVLELGNNLLSGS----IPSEINKLQELNYLNLSHNSINGKILSQLGE-----IPRIDTVDLSMNNLSG----SIP 69 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~g----~~p 69 (468)
.++|+.|+|++|.+++. +|..+..+++|++|+|++|++++..+..+.. +++|+.|+|++|++++ .+|
T Consensus 312 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~ 391 (461)
T 1z7x_W 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHH
Confidence 46899999999999966 6777888999999999999999776665543 7899999999999996 677
Q ss_pred Cc---CCCccceeccccccccc
Q 012219 70 ES---VRKVPHLYVYGKNFDVE 88 (468)
Q Consensus 70 ~~---~~~l~~l~~~~n~l~~~ 88 (468)
.. ..+|..|++++|++...
T Consensus 392 ~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 392 ATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHhCCCccEEECCCCCCCHH
Confidence 64 46777889999988653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.17 E-value=4.1e-07 Score=90.92 Aligned_cols=86 Identities=16% Similarity=0.089 Sum_probs=71.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccC-----CCCCEeeccCcccccc----ccccccCCCCCceecccCcccccccCCc-
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKL-----QELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSGSIPES- 71 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~- 71 (468)
++++|+.|+|++|.+++..+..+... ++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++..+..
T Consensus 282 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l 361 (461)
T 1z7x_W 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361 (461)
T ss_dssp HCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred hCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHH
Confidence 47899999999999987666555543 7999999999999976 6788889999999999999998643332
Q ss_pred -------CCCccceecccccccc
Q 012219 72 -------VRKVPHLYVYGKNFDV 87 (468)
Q Consensus 72 -------~~~l~~l~~~~n~l~~ 87 (468)
..++..|++++|.+..
T Consensus 362 ~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 362 CQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHHHcCCCCceEEEECCCCCCCh
Confidence 3478889999998874
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.10 E-value=6.9e-07 Score=86.59 Aligned_cols=61 Identities=20% Similarity=0.267 Sum_probs=26.6
Q ss_pred CCcEEEccCCcccccCCcccc-----cCCCCCEeeccCccccc----cccccccCCCCCceecccCcccc
Q 012219 5 KLRVLELGNNLLSGSIPSEIN-----KLQELNYLNLSHNSING----KILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~-----~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+|+.|+|++|+|+..-...++ ..++|+.|+|++|.|+. .++..+..+++|++|+|++|+++
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 444555555555432222221 23445555555555442 13333344445555555555444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.7e-05 Score=73.34 Aligned_cols=139 Identities=19% Similarity=0.306 Sum_probs=78.0
Q ss_pred eeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-----CCceeeEE-E--EEeeCCEEEEEE
Q 012219 177 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-----HRNIVKLY-G--FCLHRKCMFLIY 248 (468)
Q Consensus 177 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~ 248 (468)
.|+.|..+.||+....+| .+++|+..... ..+..|.+++..+. .|.++... | +....+..++++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 455677889999987655 48899887532 12223444444442 34444310 1 112456789999
Q ss_pred EeccCCChh--------------hhhhcCcc----c-------CCCCHHHHH----------------------------
Q 012219 249 EYMEMGSLF--------------CVLRTDEE----A-------VGLDWAKRV---------------------------- 275 (468)
Q Consensus 249 e~~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~---------------------------- 275 (468)
||++|..+. ..++.... . ..-.|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11111100 0 011232110
Q ss_pred ---HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 276 ---NVVKGMCHALSYLHH----------DCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 276 ---~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.+...+..++.+|+. .....++|+|+++.||+++.++.+.|.||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666652 125789999999999999888889999999774
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.98 E-value=1.2e-05 Score=76.49 Aligned_cols=89 Identities=16% Similarity=0.199 Sum_probs=70.7
Q ss_pred CCCCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccccccCCCCCc-eecccCcccccccCC-cCCC---cc
Q 012219 3 CSKLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILSQLGEIPRID-TVDLSMNNLSGSIPE-SVRK---VP 76 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~l~l~~N~l~g~~p~-~~~~---l~ 76 (468)
|++|+.|+|++|+++ .||+ .|.+|++|+.|+|++| ++..-+.+|.+|++|+ .|++++ +++ .|++ .|.+ |+
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence 789999999999999 6665 6999999999999999 8844456699999999 999999 787 5664 5554 45
Q ss_pred ceecccccccccCCCCCCC
Q 012219 77 HLYVYGKNFDVEIPNTSEN 95 (468)
Q Consensus 77 ~l~~~~n~l~~~~p~~~~~ 95 (468)
.+.+.+|++....+..+..
T Consensus 301 ~l~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 301 YVLATGDKITTLGDELFGN 319 (329)
T ss_dssp EEEECSSCCCEECTTTTCT
T ss_pred EEEeCCCccCccchhhhcC
Confidence 5677788877665555543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2e-05 Score=77.03 Aligned_cols=78 Identities=12% Similarity=0.074 Sum_probs=48.7
Q ss_pred cceeeeeCCceEEEEEcC-CCCEEEEEEecCcch--hh--hhhHHHHHHHHHHHhhccC--C-ceeeEEEEEeeCCEEEE
Q 012219 175 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRSET--EE--LASLESFGNEARLLSQIRH--R-NIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 246 (468)
.+.||.|..+.||++... +++.++||....... .. ......+..|.+++..+.. + .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 356899999999999754 468899998653221 00 0112345678888887742 3 344566543 334589
Q ss_pred EEEeccCC
Q 012219 247 IYEYMEMG 254 (468)
Q Consensus 247 v~e~~~~g 254 (468)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.95 E-value=7.4e-05 Score=70.21 Aligned_cols=138 Identities=20% Similarity=0.214 Sum_probs=91.5
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc---CCceeeEEEEEeeCCEEEEEEEec
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR---HRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
.+.|+.|....+|+... ++..+++|+..... ...|..|.+.|+.+. ...+.++++++...+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 45689999999999987 46788889876431 356788999888884 356788888888888899999999
Q ss_pred cCCChhh-----------hhhcCcc--cC-----------------CCCHHHHH---HHHH----------------HHH
Q 012219 252 EMGSLFC-----------VLRTDEE--AV-----------------GLDWAKRV---NVVK----------------GMC 282 (468)
Q Consensus 252 ~~gsL~~-----------~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------~ia 282 (468)
++..+.. .++.... .. .-+|.... ++.. .+.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9886521 1222111 00 12454322 1111 111
Q ss_pred HH-HHHHH-hcCCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 283 HA-LSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 283 ~~-l~~LH-~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
.. ...|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 12332 12256899999999999999887 7888873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.84 E-value=3.2e-06 Score=81.89 Aligned_cols=85 Identities=21% Similarity=0.191 Sum_probs=61.6
Q ss_pred CCCCcEEEccCCcccccCCccc-ccCCCCCEeeccCccccccccccc-----cCCCCCceecccCccccc----ccCC--
Q 012219 3 CSKLRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQL-----GEIPRIDTVDLSMNNLSG----SIPE-- 70 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~~~-----~~l~~L~~l~l~~N~l~g----~~p~-- 70 (468)
.++|+.|+|++|.|+..-...+ ..+.+|+.|+|++|+|+..-...+ ...++|+.|+|++|+|+. .++.
T Consensus 100 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 100 RHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 4689999999999875444443 346789999999999985544444 357889999999999873 1322
Q ss_pred -cCCCccceecccccccc
Q 012219 71 -SVRKVPHLYVYGKNFDV 87 (468)
Q Consensus 71 -~~~~l~~l~~~~n~l~~ 87 (468)
...+|+.|++++|.+..
T Consensus 180 ~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp HTCSSCCEEECTTSSCHH
T ss_pred hcCCCcCEEeCCCCCCCc
Confidence 34567888899888753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.7e-05 Score=70.29 Aligned_cols=79 Identities=18% Similarity=0.160 Sum_probs=56.0
Q ss_pred CccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC---CceeeEEEEEeeCCEEEEE
Q 012219 171 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH---RNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv 247 (468)
...-...+|.|..+.||+.+..||+.+++|+-...... ....|..|.+.|+.+.- -.+.+++++. . .++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 34456779999999999999999999999987644322 12356789998888742 2344555543 2 3789
Q ss_pred EEeccCCCh
Q 012219 248 YEYMEMGSL 256 (468)
Q Consensus 248 ~e~~~~gsL 256 (468)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.79 E-value=3.8e-06 Score=86.73 Aligned_cols=84 Identities=17% Similarity=0.196 Sum_probs=43.8
Q ss_pred CCCCcEEEccC--CcccccCCccccc-CCCCCEeeccCccccc-cccccccCCCCCceecccCcccccc-cCC---cCCC
Q 012219 3 CSKLRVLELGN--NLLSGSIPSEINK-LQELNYLNLSHNSING-KILSQLGEIPRIDTVDLSMNNLSGS-IPE---SVRK 74 (468)
Q Consensus 3 l~~l~~l~l~~--N~l~g~~p~~~~~-l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~-~p~---~~~~ 74 (468)
+++|+.|+|+. |.+++..+..++. +++|++|+|++|++++ .++..+.++++|+.|+|++|.+++. ++. .+.+
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~ 514 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence 34455555542 1244443434333 5566666666666665 2344455666666666666666533 222 2445
Q ss_pred ccceeccccccc
Q 012219 75 VPHLYVYGKNFD 86 (468)
Q Consensus 75 l~~l~~~~n~l~ 86 (468)
|+.|++++|+++
T Consensus 515 L~~L~ls~n~it 526 (592)
T 3ogk_B 515 LRYLWVQGYRAS 526 (592)
T ss_dssp CCEEEEESCBCC
T ss_pred cCeeECcCCcCC
Confidence 566666666644
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.72 E-value=8.6e-06 Score=70.53 Aligned_cols=86 Identities=14% Similarity=0.179 Sum_probs=61.3
Q ss_pred CCCCCcEEEccCC-ccccc----CCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcccccc----c
Q 012219 2 NCSKLRVLELGNN-LLSGS----IPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSGS----I 68 (468)
Q Consensus 2 ~l~~l~~l~l~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~----~ 68 (468)
+.++|+.|+|++| .|... +...+...++|++|+|++|+|+.. +...+...++|+.|+|++|+++.. +
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 4678999999998 87632 344566678899999999998743 445566778899999999988742 2
Q ss_pred CCcC---CCccceec--ccccccc
Q 012219 69 PESV---RKVPHLYV--YGKNFDV 87 (468)
Q Consensus 69 p~~~---~~l~~l~~--~~n~l~~ 87 (468)
...+ .+|+.|++ .+|.+..
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHhCCCceEEEecCCCCCCCH
Confidence 3333 35777888 6677643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.66 E-value=1.3e-05 Score=69.50 Aligned_cols=84 Identities=11% Similarity=0.114 Sum_probs=57.1
Q ss_pred CCCCCcEEEccCCccccc----CCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecc--cCcccccc----
Q 012219 2 NCSKLRVLELGNNLLSGS----IPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDL--SMNNLSGS---- 67 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l--~~N~l~g~---- 67 (468)
+.++|++|+|++|+|... +...+...++|++|+|++|.|+.. +...+...++|+.|+| ++|.++..
T Consensus 63 ~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~ 142 (185)
T 1io0_A 63 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 142 (185)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH
Confidence 356788888888888642 334455567888888888888753 5566777788888888 77888642
Q ss_pred cCCc---CCCccceecccccc
Q 012219 68 IPES---VRKVPHLYVYGKNF 85 (468)
Q Consensus 68 ~p~~---~~~l~~l~~~~n~l 85 (468)
+... -.+++.|++++|.+
T Consensus 143 l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 143 IANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeccCCCC
Confidence 1122 24566677766654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=5.5e-05 Score=61.15 Aligned_cols=57 Identities=21% Similarity=0.332 Sum_probs=46.1
Q ss_pred cEEEccCCccc-ccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 7 RVLELGNNLLS-GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 7 ~~l~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
..++.++++|+ ..+|..+. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47889999996 57786655 46999999999999444455889999999999999775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.63 E-value=2.2e-05 Score=80.91 Aligned_cols=80 Identities=10% Similarity=0.118 Sum_probs=60.1
Q ss_pred CCCCCcEEEccCCccccc----CCcccccCCCCCEeeccCcccc----ccccccccCCCCCceecccCcccccccCCc--
Q 012219 2 NCSKLRVLELGNNLLSGS----IPSEINKLQELNYLNLSHNSIN----GKILSQLGEIPRIDTVDLSMNNLSGSIPES-- 71 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-- 71 (468)
+|++|++|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+++ +|..
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 478899999999988766 4445677888999999999887 4566667788999999999998884 6653
Q ss_pred -CCCccceeccc
Q 012219 72 -VRKVPHLYVYG 82 (468)
Q Consensus 72 -~~~l~~l~~~~ 82 (468)
+.+|+.|.+..
T Consensus 241 ~~~~L~~L~l~~ 252 (592)
T 3ogk_B 241 AAANLEEFCGGS 252 (592)
T ss_dssp HCTTCCEEEECB
T ss_pred hhhHHHhhcccc
Confidence 34555566654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00029 Score=69.36 Aligned_cols=78 Identities=12% Similarity=0.075 Sum_probs=47.9
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCceeccc--cccccccccccCC---CCCccchhhHHHHHHHH
Q 012219 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG--TYGYIAPELAYTM---VVTEKCDVYSFGVVALE 367 (468)
Q Consensus 293 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~e 367 (468)
...++|||++|.||+++.++ +++.||+.+..-... ........ ...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999999876 999999988653210 00000000 1346666654311 11223455677777787
Q ss_pred HHhCC
Q 012219 368 VLMGK 372 (468)
Q Consensus 368 l~tg~ 372 (468)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.55 E-value=1e-05 Score=83.53 Aligned_cols=83 Identities=14% Similarity=0.232 Sum_probs=50.0
Q ss_pred CCCCCcEEEcc--C----Ccccc-----cCCcccccCCCCCEeeccCccccccccccccC-CCCCceecccCcccccccC
Q 012219 2 NCSKLRVLELG--N----NLLSG-----SIPSEINKLQELNYLNLSHNSINGKILSQLGE-IPRIDTVDLSMNNLSGSIP 69 (468)
Q Consensus 2 ~l~~l~~l~l~--~----N~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~l~l~~N~l~g~~p 69 (468)
++++|+.|+|+ + |++++ .++.-+.++++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+
T Consensus 395 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~ 473 (594)
T 2p1m_B 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473 (594)
T ss_dssp HCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHH
T ss_pred hCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHH
Confidence 36777777777 4 55551 1122255667777777766 566555555554 6777777777777654333
Q ss_pred C----cCCCccceecccccc
Q 012219 70 E----SVRKVPHLYVYGKNF 85 (468)
Q Consensus 70 ~----~~~~l~~l~~~~n~l 85 (468)
. .+.+|+.|++++|.+
T Consensus 474 ~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 474 HHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHCTTCCEEEEESCSC
T ss_pred HHHHhcCCCcCEEECcCCCC
Confidence 2 345666667776665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.53 E-value=9.1e-05 Score=70.33 Aligned_cols=73 Identities=14% Similarity=0.108 Sum_probs=61.4
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCC-EeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELN-YLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l 78 (468)
+|++|+.|+|++| ++ .|+ ..|.+|++|+ .|+|++ +++..-+.+|.+|++|+.|++++|+++ .|+. .|.+++.|
T Consensus 248 ~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF~~~~~L 323 (329)
T 3sb4_A 248 QKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELFGNGVPS 323 (329)
T ss_dssp TCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTTCTTCCC
T ss_pred CCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhhcCCcch
Confidence 6889999999999 87 555 5799999999 999999 788455678999999999999999999 6665 66666554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.48 E-value=2.1e-05 Score=81.02 Aligned_cols=82 Identities=12% Similarity=0.180 Sum_probs=55.2
Q ss_pred CCCCcEEEccCCcccccCCcccc-cCCCCCEeeccCc-ccccc-ccccccCCCCCceecccCccccccc-------CCcC
Q 012219 3 CSKLRVLELGNNLLSGSIPSEIN-KLQELNYLNLSHN-SINGK-ILSQLGEIPRIDTVDLSMNNLSGSI-------PESV 72 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~~-------p~~~ 72 (468)
+++|+.|+|++|.+++..+..+. ++++|+.|+|++| .+++. ++..+.++++|+.|+|++|.+++.. +..+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 56788888888887777666665 6778888888877 45533 4444557788888888888766432 2234
Q ss_pred CCccceeccccc
Q 012219 73 RKVPHLYVYGKN 84 (468)
Q Consensus 73 ~~l~~l~~~~n~ 84 (468)
.+|+.|+++++.
T Consensus 184 ~~L~~L~l~~~~ 195 (594)
T 2p1m_B 184 TSLVSLNISCLA 195 (594)
T ss_dssp CCCCEEECTTCC
T ss_pred CcCcEEEecccC
Confidence 466667776654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00048 Score=64.96 Aligned_cols=158 Identities=13% Similarity=0.101 Sum_probs=86.8
Q ss_pred cCHHHHHHHhhCcccc-----ceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc--ee
Q 012219 160 ITFQDMIEATEDFHIK-----YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN--IV 232 (468)
Q Consensus 160 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv 232 (468)
++.+++......|.+. +.|+.|....+|+....+| .+++|........ ..+..|.+++..+.... +.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCC
Confidence 4556666666667652 3466688889999987666 5788888753111 23445677766664212 22
Q ss_pred eEEEE------EeeCCEEEEEEEeccCCChhh--------------hhhcC----ccc----CC-CCHHHHHH-------
Q 012219 233 KLYGF------CLHRKCMFLIYEYMEMGSLFC--------------VLRTD----EEA----VG-LDWAKRVN------- 276 (468)
Q Consensus 233 ~l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~----~~-l~~~~~~~------- 276 (468)
+++.. ....+..+++++|++|..+.. .++.. ... .. ..|...+.
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 22211 122456789999999865421 01110 000 00 11322111
Q ss_pred -----HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 277 -----VVKGMCHALSYLHHD----CTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 277 -----i~~~ia~~l~~LH~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
+...+...+.+++.. ...+++|+|+.+.||+++++..+.|.||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001234455555532 14579999999999999987666799998774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.42 E-value=2.7e-05 Score=74.85 Aligned_cols=86 Identities=12% Similarity=0.217 Sum_probs=61.7
Q ss_pred CCCCCcEEEccC--Cccccc-----CCccc--ccCCCCCEeeccCcccccccccccc---CCCCCceecccCcccccc--
Q 012219 2 NCSKLRVLELGN--NLLSGS-----IPSEI--NKLQELNYLNLSHNSINGKILSQLG---EIPRIDTVDLSMNNLSGS-- 67 (468)
Q Consensus 2 ~l~~l~~l~l~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~l~l~~N~l~g~-- 67 (468)
++++|+.|+|+. |...|. +...+ ..+++|++|+|++|.+++..+..+. .+++|+.|+|+.|.+++.
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 689999999963 222111 11222 3578999999999999866555543 588999999999999863
Q ss_pred --cCCc---CCCccceecccccccc
Q 012219 68 --IPES---VRKVPHLYVYGKNFDV 87 (468)
Q Consensus 68 --~p~~---~~~l~~l~~~~n~l~~ 87 (468)
++.. +.+|+.|++++|.++.
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHhhcccCCcceEEECCCCcCCH
Confidence 4443 5678888998887654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00073 Score=64.09 Aligned_cols=141 Identities=21% Similarity=0.183 Sum_probs=72.5
Q ss_pred eeeeeCCce-EEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--CceeeEEEEEeeCCEEEEEEEeccC
Q 012219 177 CIGTGGYGS-VYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--RNIVKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 177 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 253 (468)
.|+.|.... +|+....++..+++|....... ..+..|++++..+.. -.+.+++.+....+ +++||++.+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 455554444 6787765467777776543321 122345666665532 23455666654444 689999977
Q ss_pred CChhhhhhcCc---------------------c--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH-
Q 012219 254 GSLFCVLRTDE---------------------E--AVGLDWAKRV-------N-------------VVKGMCHALSYLH- 289 (468)
Q Consensus 254 gsL~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~l~~LH- 289 (468)
..+.+.+.... . ...++..... . ....+...+..+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654332110 0 0011111100 0 0001112222221
Q ss_pred --hcCCCCeEecCCCCCceeeCCC----CCeEEeeccccccc
Q 012219 290 --HDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLL 325 (468)
Q Consensus 290 --~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~~~~ 325 (468)
......++|||+.+.||+++.+ ..+.|.||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1125689999999999999875 67899999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0027 Score=59.95 Aligned_cols=158 Identities=12% Similarity=0.123 Sum_probs=87.2
Q ss_pred cCHHHHHHHhhCccc-----cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCC--cee
Q 012219 160 ITFQDMIEATEDFHI-----KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR--NIV 232 (468)
Q Consensus 160 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv 232 (468)
++.+++....+.|.+ ...++ |....||+....+|+.+++|........ ...+..|..++..+... .+.
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeec
Confidence 344555555444433 23466 8888999998777878999998643211 23455677777766421 233
Q ss_pred eEEEE-----EeeCCEEEEEEEeccCCChhh----h----------hhcC----c--ccCCCCHHHH----HHH------
Q 012219 233 KLYGF-----CLHRKCMFLIYEYMEMGSLFC----V----------LRTD----E--EAVGLDWAKR----VNV------ 277 (468)
Q Consensus 233 ~l~~~-----~~~~~~~~lv~e~~~~gsL~~----~----------l~~~----~--~~~~l~~~~~----~~i------ 277 (468)
+++.. ....+..+++++|++|..+.. . ++.. . .....++... ..+
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 33332 122456788999998754321 0 1110 0 0011222111 001
Q ss_pred ---------HHHHHHHHHHHHhc----CCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 278 ---------VKGMCHALSYLHHD----CTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 278 ---------~~~ia~~l~~LH~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
...+...+..+... ....++|||+++.||+++ + .+.+.||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111223333211 245689999999999999 4 889999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00059 Score=67.22 Aligned_cols=72 Identities=24% Similarity=0.294 Sum_probs=48.5
Q ss_pred ceeeeeCCceEEEEEcCC--------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce-eeEEEEEeeCCEEEE
Q 012219 176 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI-VKLYGFCLHRKCMFL 246 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~l 246 (468)
+.|+.|....+|++...+ ++.+++|+...... ...+.+|..++..+...++ .++++.+.. .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 457888889999998753 57899998854221 1234478888888753333 566766542 28
Q ss_pred EEEeccCCCh
Q 012219 247 IYEYMEMGSL 256 (468)
Q Consensus 247 v~e~~~~gsL 256 (468)
|+||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.001 Score=64.16 Aligned_cols=141 Identities=19% Similarity=0.232 Sum_probs=80.9
Q ss_pred ceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEE
Q 012219 176 YCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 246 (468)
+.|..|-...+|++... +++.+++|+.... . .....+.+|.++++.+. +.-..++++++.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 45777888899999875 3578999986321 1 12345568999888874 3223556666643 28
Q ss_pred EEEeccCCChhhh-----------------hhcCcc--cCCCC--HHHHHHHHHHHHH-------------------HHH
Q 012219 247 IYEYMEMGSLFCV-----------------LRTDEE--AVGLD--WAKRVNVVKGMCH-------------------ALS 286 (468)
Q Consensus 247 v~e~~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------~l~ 286 (468)
|+||++|.++..- ++.... ..... |.+..++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 111110 11122 3344444433321 222
Q ss_pred H----HHh-cCCCCeEecCCCCCceeeCCC----CCeEEeecccccc
Q 012219 287 Y----LHH-DCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARL 324 (468)
Q Consensus 287 ~----LH~-~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~~~~ 324 (468)
+ |.. .....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3 321 123479999999999999876 7889999987753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00017 Score=69.33 Aligned_cols=85 Identities=14% Similarity=0.146 Sum_probs=60.4
Q ss_pred CCCCcEEEccCCcccccCCcccc--cCCCCCEeeccC--cccccc-----ccccc--cCCCCCceecccCcccccccCC-
Q 012219 3 CSKLRVLELGNNLLSGSIPSEIN--KLQELNYLNLSH--NSINGK-----ILSQL--GEIPRIDTVDLSMNNLSGSIPE- 70 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~l~l~~N~l~g~~p~- 70 (468)
+++|+.|+|..|.++...-..++ .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+++..+.
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 67999999999988754444555 789999999864 332222 11123 3579999999999998753321
Q ss_pred -----cCCCccceecccccccc
Q 012219 71 -----SVRKVPHLYVYGKNFDV 87 (468)
Q Consensus 71 -----~~~~l~~l~~~~n~l~~ 87 (468)
.+.+|+.|+++.|.+..
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBH
T ss_pred HHhCccCCCCCEEECCCCCCCh
Confidence 35678889999888765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0012 Score=61.52 Aligned_cols=71 Identities=14% Similarity=0.092 Sum_probs=43.1
Q ss_pred cceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce-eeEEEEEeeCCEEEEEEEec-c
Q 012219 175 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI-VKLYGFCLHRKCMFLIYEYM-E 252 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~ 252 (468)
.+.|+.|....+|+. ..+++|+....... . ....+|...++.+....+ .++++++.+ .-++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~---~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-Y---INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-e---eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCC
Confidence 567999999999999 45888887643211 0 112357777776642222 355555433 346899999 6
Q ss_pred CCCh
Q 012219 253 MGSL 256 (468)
Q Consensus 253 ~gsL 256 (468)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0062 Score=53.03 Aligned_cols=102 Identities=20% Similarity=0.144 Sum_probs=64.8
Q ss_pred ChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCCcee
Q 012219 255 SLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334 (468)
Q Consensus 255 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 334 (468)
||.+.|...+. ++++.++|.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 68888876543 49999999999999999876621 11101222346889999999987653 1110
Q ss_pred ccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 012219 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374 (468)
Q Consensus 335 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p 374 (468)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223467888763 4556788999999999998863333
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0023 Score=62.41 Aligned_cols=83 Identities=14% Similarity=0.158 Sum_probs=46.6
Q ss_pred CCCCCcEEEccCCccc-----ccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCC--
Q 012219 2 NCSKLRVLELGNNLLS-----GSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVR-- 73 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~-- 73 (468)
+|++|+.++|++|.+. ..-+..|.+|++|+.++|. |+++-.-...|.+|++|+.|+|.+| ++ .|+. .|.
T Consensus 269 ~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~ 345 (401)
T 4fdw_A 269 YCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT 345 (401)
T ss_dssp TCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS
T ss_pred CCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC
Confidence 4566777776666554 2223456667777777776 3365233345667777777777444 54 4443 232
Q ss_pred Cccceecccccccc
Q 012219 74 KVPHLYVYGKNFDV 87 (468)
Q Consensus 74 ~l~~l~~~~n~l~~ 87 (468)
+|+.+.+.+|.+..
T Consensus 346 ~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 346 GIKEVKVEGTTPPQ 359 (401)
T ss_dssp CCCEEEECCSSCCB
T ss_pred CCCEEEEcCCCCcc
Confidence 44555666665443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0016 Score=62.77 Aligned_cols=73 Identities=15% Similarity=0.077 Sum_probs=43.0
Q ss_pred ceeeeeCCceEEEEEcCC---------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCc-eeeEEEEEeeCCEEE
Q 012219 176 YCIGTGGYGSVYRARLPS---------GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN-IVKLYGFCLHRKCMF 245 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~ 245 (468)
..++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++.. .+ +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 457778888999998654 268888887543211 112346777777775333 33566544 22 6
Q ss_pred EEEEeccCCCh
Q 012219 246 LIYEYMEMGSL 256 (468)
Q Consensus 246 lv~e~~~~gsL 256 (468)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0048 Score=61.05 Aligned_cols=73 Identities=19% Similarity=0.173 Sum_probs=46.3
Q ss_pred ceeeeeCCceEEEEEcCC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce-eeEEEEEeeCCEEEEEEEeccC
Q 012219 176 YCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI-VKLYGFCLHRKCMFLIYEYMEM 253 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 253 (468)
+.|+.|-...+|++...+ +..+++|+....... .-.-.+|..++..+...++ .++++++. + .+|+||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 468888889999998765 477888887432211 0011378888888864444 46677663 2 249999987
Q ss_pred CCh
Q 012219 254 GSL 256 (468)
Q Consensus 254 gsL 256 (468)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0005 Score=58.26 Aligned_cols=78 Identities=12% Similarity=0.234 Sum_probs=56.7
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEeeccCcc-ccccccccccCC----CCCceecccCcc-ccc----ccCCcCCC
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNS-INGKILSQLGEI----PRIDTVDLSMNN-LSG----SIPESVRK 74 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~g----~~p~~~~~ 74 (468)
+|+.||||++.++..--..+.+|++|+.|+|+++. +|..-=..++.+ ++|+.|+|+++. +|. .+ ..+.+
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L-~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIAL-HHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHG-GGCTT
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHH-hcCCC
Confidence 48999999999875544567889999999999985 775544456664 479999999974 652 12 14566
Q ss_pred ccceecccc
Q 012219 75 VPHLYVYGK 83 (468)
Q Consensus 75 l~~l~~~~n 83 (468)
|+.|++++.
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 777777653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0072 Score=57.36 Aligned_cols=32 Identities=28% Similarity=0.468 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 293 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
...++|+|+.+.||+++.++.+.+.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0019 Score=51.91 Aligned_cols=36 Identities=25% Similarity=0.326 Sum_probs=32.3
Q ss_pred CCcEEEccCCcccccCCc-ccccCCCCCEeeccCcccc
Q 012219 5 KLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSIN 41 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~ 41 (468)
+|+.|+|++|+|+ .+|. .|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 7999999999999 6665 5889999999999999885
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.88 E-value=0.0018 Score=54.79 Aligned_cols=62 Identities=10% Similarity=0.089 Sum_probs=48.6
Q ss_pred CCCCCcEEEccCCc-ccccCCcccccC----CCCCEeeccCcc-ccccccccccCCCCCceecccCcc
Q 012219 2 NCSKLRVLELGNNL-LSGSIPSEINKL----QELNYLNLSHNS-INGKILSQLGEIPRIDTVDLSMNN 63 (468)
Q Consensus 2 ~l~~l~~l~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l~~N~ 63 (468)
+|++|+.|+|+++. ++..-=..++.+ ++|++|+|++|. +|..--..+.++++|+.|+|++..
T Consensus 83 ~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 83 GLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp TCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 68999999999995 764333345554 379999999985 886544568899999999999875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0045 Score=53.41 Aligned_cols=81 Identities=12% Similarity=0.245 Sum_probs=55.8
Q ss_pred CCCCcEEEccCC-cccc----cCCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcccccc----cC
Q 012219 3 CSKLRVLELGNN-LLSG----SIPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSGS----IP 69 (468)
Q Consensus 3 l~~l~~l~l~~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~----~p 69 (468)
-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|+|... |-..+..-+.|+.|+|++|+|+.. +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 467999999986 7752 2334566678999999999999743 344555668899999999999732 11
Q ss_pred CcC---CCccceecccc
Q 012219 70 ESV---RKVPHLYVYGK 83 (468)
Q Consensus 70 ~~~---~~l~~l~~~~n 83 (468)
+.+ ..|+.|++++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 122 23666777643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.50 E-value=0.017 Score=56.10 Aligned_cols=64 Identities=16% Similarity=0.250 Sum_probs=52.6
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE 70 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 70 (468)
+|++|+.++|. |+++ .|+ ..|.+|++|+.|+|.+| ++..-+.+|.++ +|+.|++++|.+. .++.
T Consensus 298 ~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~-~l~~ 362 (401)
T 4fdw_A 298 GCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP-QVFE 362 (401)
T ss_dssp TCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC-BCCC
T ss_pred CCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc-cccc
Confidence 58899999999 5588 555 57999999999999665 774456679999 9999999999888 4443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.15 E-value=0.032 Score=54.43 Aligned_cols=73 Identities=8% Similarity=0.024 Sum_probs=46.1
Q ss_pred ceeeeeCCceEEEEEcCC--------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-CceeeEEEEEeeCCEEEE
Q 012219 176 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~l 246 (468)
+.+..|-...+|+....+ ++.+++|+..... .. .-+-.+|.++++.+.- .-..++++.+. + ++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK---FYDSKVELDVFRYLSNINIAPNIIADFP--E--GR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C---CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CE
Confidence 457778888999998753 5789998865432 11 1122367787777742 22345555432 2 68
Q ss_pred EEEeccCCCh
Q 012219 247 IYEYMEMGSL 256 (468)
Q Consensus 247 v~e~~~~gsL 256 (468)
|+||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.038 Score=53.49 Aligned_cols=78 Identities=15% Similarity=0.379 Sum_probs=53.8
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCC---cc
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRK---VP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~---l~ 76 (468)
++++|+.+.+. +.++ .|+ ..|.++.+|+.+.|..| ++..-..+|.+|++|+.+.|..| ++ .|+. .|.+ |+
T Consensus 286 ~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~ 360 (394)
T 4gt6_A 286 NCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALN 360 (394)
T ss_dssp TCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCC
T ss_pred cccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCC
Confidence 57788888886 5566 455 46888999999999765 66333556889999999988654 66 5654 4444 44
Q ss_pred ceeccccc
Q 012219 77 HLYVYGKN 84 (468)
Q Consensus 77 ~l~~~~n~ 84 (468)
.+.+.++.
T Consensus 361 ~i~~~~~~ 368 (394)
T 4gt6_A 361 NIEYSGSR 368 (394)
T ss_dssp EEEESSCH
T ss_pred EEEECCce
Confidence 45555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.73 E-value=0.035 Score=53.72 Aligned_cols=75 Identities=12% Similarity=0.200 Sum_probs=55.7
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCC---cc
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRK---VP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~---l~ 76 (468)
++++|+.+.+.+| ++ .|+ ..|.++++|+.++|.++ ++..-..+|.+|++|+.+++..| ++ .|++ .|.+ |+
T Consensus 295 ~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 295 GCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLK 369 (394)
T ss_dssp TCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCC
T ss_pred ccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCC
Confidence 5788999999866 66 554 56899999999999755 77333567999999999999877 76 6665 4544 44
Q ss_pred ceecc
Q 012219 77 HLYVY 81 (468)
Q Consensus 77 ~l~~~ 81 (468)
.+.+.
T Consensus 370 ~i~lp 374 (394)
T 4fs7_A 370 KVELP 374 (394)
T ss_dssp EEEEE
T ss_pred EEEEC
Confidence 45554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.054 Score=51.99 Aligned_cols=72 Identities=15% Similarity=0.284 Sum_probs=51.0
Q ss_pred CCCCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~ 77 (468)
++.+|+.+.+.++ ++ .++ ..|.++++|+.+.+.+|.++..-+.+|.+|++|+.++|..| ++ .|+. .|.+++.
T Consensus 261 ~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 334 (379)
T 4h09_A 261 NCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKA 334 (379)
T ss_dssp TCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred eeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCC
Confidence 4677888888654 55 444 46888899999999888888333556888899999888754 66 5655 4544433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.52 E-value=0.019 Score=49.45 Aligned_cols=60 Identities=18% Similarity=0.176 Sum_probs=46.1
Q ss_pred CCCcEEEccCCcccccCCc----ccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcc
Q 012219 4 SKLRVLELGNNLLSGSIPS----EINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNN 63 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~ 63 (468)
+.|+.|+|++|+|...--. .+..-+.|+.|+|++|+|+.. +-..+..=+.|+.|+|++|.
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCc
Confidence 5799999999999843333 344568999999999999854 34456666789999999763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.064 Score=51.85 Aligned_cols=70 Identities=17% Similarity=0.225 Sum_probs=47.1
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~ 77 (468)
+++.|+.+.+..+.+. ...|.++.+|+.+.+.+| ++..-..+|.+|++|+.++|.++ ++ .|+. .|.+++.
T Consensus 274 ~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~ 344 (394)
T 4fs7_A 274 NCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTS 344 (394)
T ss_dssp TCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTT
T ss_pred cccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCC
Confidence 4566777777665432 246788889999988765 66333456888999999998754 66 5654 4544433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.66 E-value=0.1 Score=50.03 Aligned_cols=72 Identities=8% Similarity=0.074 Sum_probs=53.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~ 76 (468)
++++|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.+|++|+.+++.+|.++ .|++ .|.++.
T Consensus 238 ~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~ 310 (379)
T 4h09_A 238 GMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCV 310 (379)
T ss_dssp TCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCT
T ss_pred CCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCC
Confidence 5678999999876 66333457888999999999765 66333456899999999999999888 6765 454443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.30 E-value=0.15 Score=49.12 Aligned_cols=72 Identities=13% Similarity=0.222 Sum_probs=52.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~ 77 (468)
+|++|+.+.+.++-.+ .-...|.++.+|+.+.+. +.++..-...|.+|++|+.++|..| ++ .|++ .|.++..
T Consensus 263 ~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~ 335 (394)
T 4gt6_A 263 SCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQ 335 (394)
T ss_dssp TCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred ecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCC
Confidence 5788999999877654 555678999999999996 5577333456999999999999865 66 5655 4544433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.06 E-value=0.3 Score=42.32 Aligned_cols=117 Identities=7% Similarity=0.088 Sum_probs=81.1
Q ss_pred cCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 227 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
.||+.+.. .+-...+.+.+.|+.-+.+.=...++ .++...+++++.+|+....+++ .-+|--|.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceE
Confidence 68888866 56666777777666554322222232 2778899999999998886666 347889999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCc
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~ 377 (468)
+++.++.+++.-.|+...+ +|.- .++..=.-.+=+++..+++++..|+.
T Consensus 111 ~f~~~~~p~i~~RGik~~l-----------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-----------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTTB-----------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccCC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999887765332 2221 11111233577899999999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.47 E-value=0.3 Score=47.26 Aligned_cols=30 Identities=23% Similarity=0.432 Sum_probs=24.8
Q ss_pred CeEecCCCCCceee------CCCCCeEEeecccccc
Q 012219 295 PIVHRDISSNNVLL------NSELEAFVADFGVARL 324 (468)
Q Consensus 295 ~ivH~dlk~~NIll------~~~~~~kl~Dfg~~~~ 324 (468)
.++|+|+.+.||++ +++..+.+.||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567789999987753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.90 E-value=0.77 Score=39.94 Aligned_cols=115 Identities=13% Similarity=0.104 Sum_probs=80.2
Q ss_pred cCCceeeEEEEEeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCc
Q 012219 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS-YLHHDCTPPIVHRDISSNN 305 (468)
Q Consensus 227 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~N 305 (468)
.||++ -..+-.+++.+.+.++.-+++.=...++. ++...+++++.+|+.... +++ .-+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 57777 44555677888887877644433334432 778899999999887766 554 56888999999
Q ss_pred eeeCCCCCeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchh-hHHHHHHHHHHhCCCCCCc
Q 012219 306 VLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDV-YSFGVVALEVLMGKHPGEL 377 (468)
Q Consensus 306 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv-~s~Gvil~el~tg~~p~~~ 377 (468)
|++|.++.+++.-.|+-..+ +|.-.. ..|- -.+=+++..++.++..|+.
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e~~------ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-----------------PPDEWD------DERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-----------------SSCSCC------HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEEeCCCcEEEEEcCCcccC-----------------CCCCCC------HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999877765332 332211 1233 2577888899999988764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.76 E-value=0.11 Score=51.30 Aligned_cols=62 Identities=19% Similarity=0.154 Sum_probs=17.3
Q ss_pred ccceeeeeCCceEEEEEcCC-CCEEEE------EEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEe
Q 012219 174 IKYCIGTGGYGSVYRARLPS-GKVVAL------KKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCL 239 (468)
Q Consensus 174 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 239 (468)
+.+.|| ||.||+|.+.. ..+||| |..+...... .....|.+|..++..++|+|+++..++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEE
Confidence 345666 99999998754 357888 7665433322 33457889999999999999999887754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.55 E-value=1.3 Score=27.46 Aligned_cols=21 Identities=29% Similarity=0.509 Sum_probs=8.0
Q ss_pred hhhHHHHHHHHHHHHhhheec
Q 012219 111 IILPMVALLALIFGILFVRRR 131 (468)
Q Consensus 111 i~~~~~~l~~l~~~~~~~~~~ 131 (468)
++.+++++++++++++++.||
T Consensus 17 VVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 17 MVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHHHHhhh
Confidence 333344433443333333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.19 E-value=1.6 Score=26.99 Aligned_cols=7 Identities=43% Similarity=1.056 Sum_probs=2.6
Q ss_pred hhheecc
Q 012219 126 LFVRRRR 132 (468)
Q Consensus 126 ~~~~~~~ 132 (468)
+++++|+
T Consensus 32 ~~~RRRr 38 (44)
T 2l2t_A 32 VYVRRKS 38 (44)
T ss_dssp HHHHTTC
T ss_pred HHhhhhh
Confidence 3333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 19/278 (6%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED+ + Y IGTG YG + R GK++ K+L E A + +E LL +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 62
Query: 229 RNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNVVKGMCHAL 285
NIV+ Y + R ++++ EY E G L V+ + LD + V+ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 286 SYLH--HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
H D ++HRD+ NV L+ + + DFG+AR+LN D+S GT Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
PE M EK D++S G + E+ P + S L I+ R+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREGKF--RRIPYRY 238
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
++ +II L + RP++ +++ N I
Sbjct: 239 SDELN-EIIT------RMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-62
Identities = 69/282 (24%), Positives = 136/282 (48%), Gaps = 24/282 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ IG+G +G+VY+ + VA+K L+ + L++F NE +L + RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NI+ G+ + ++ ++ E SL+ L E + K +++ + + YLH
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH 121
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPELA 347
I+HRD+ SNN+ L+ +L + DFG+A + + S + L+G+ ++APE+
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 348 YTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
+ + DVY+FG+V E++ G+ P +++ +I ++ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIFMVGRGYLSPDL 231
Query: 405 QKIRQDII-LVSTVAFSCLRSQPKSRPTM-QLVSN-EFIARN 443
K+R + + + CL+ + RP Q++++ E +AR+
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-62
Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 22/278 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF I +G G +G+VY AR S ++ALK L +++ E+ E + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NI++LYG+ ++LI EY +G+++ L+ D + + + +ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H ++HRDI N+LL S E +ADFG + SS RT L GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+ EK D++S GV+ E L+GK P + + + K I ++ V + R
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 409 QDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKA 445
D+I L+ P RP + +++ + +I N +
Sbjct: 233 -DLIS------RLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-60
Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 22/289 (7%)
Query: 168 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI 226
+DF +G G G V++ PSG V+A K +H + E ++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHEC 61
Query: 227 RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALS 286
IV YG + + E+M+ GSL VL+ +A + V + L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLT 118
Query: 287 YLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
YL I+HRD+ +N+L+NS E + DFGV+ L S GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPER 174
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
+ + D++S G+ +E+ +G++P + + L+ D +PP +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPPRPR- 231
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEIS 455
T SRP M + N+ P + P S
Sbjct: 232 ---------TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-59
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 20/267 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E + +G G +G V+ VA+K L + ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LY +++I EYME GSL L+ + L K +++ + ++++
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAGTYGYIAPELAY 348
+HRD+ + N+L++ L +ADFG+ARL+ + R + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
T K DV+SFG++ E++ + N ++I L+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLV 435
+++ + C + +P+ RPT +
Sbjct: 237 EELY---QLMRLCWKERPEDRPTFDYL 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-58
Identities = 67/271 (24%), Positives = 120/271 (44%), Gaps = 23/271 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+D +GTG +G V + VA+K + E + F EA+++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LYG C ++ +F+I EYM G L LR + + + K +C A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAY 348
+HRD+++ N L+N + V+DFG++R + D ++ + PE+
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 349 TMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
+ K D+++FGV+ E+ +GK P + N + + + L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP--------YERFTNSETAEHIAQGLRLYRPHLA 226
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTM-QLVSN 437
+ + T+ +SC + RPT L+SN
Sbjct: 227 SEKVY---TIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-57
Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 20/267 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ IG+G +G V+ + VA+K + E E F EA ++ ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LYG CL + + L++E+ME G L LRT + + +C +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MA 115
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTYGYIAPELAY 348
+ ++HRD+++ N L+ V+DFG+ R + D + + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+ K DV+SFGV+ EV S+S ++ L PRL+
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------ 229
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLV 435
V + C + +P+ RP +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRL 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 7e-57
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 25/283 (8%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ F IG G +G+VY AR + + +VVA+KK+ S + + E R L ++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
H N ++ G L +L+ EY + + + L + V G L+Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH ++HRD+ + N+LL+ + DFG A ++ +S GT ++APE+
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183
Query: 348 YTM---VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
M K DV+S G+ +E+ K P L + ++ S +I + P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNE--SPALQSGHW 239
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAP 446
+ ++ + SCL+ P+ RPT L+ + F+ R + P
Sbjct: 240 SEYFRNFVD------SCLQKIPQDRPTSEVLLKHRFVLRERPP 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-56
Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 20/267 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+V+LY + ++++ EYM GSL L+ E L + V++ + ++Y+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSNRTLLAGTYGYIAPELAY 348
VHRD+ + N+L+ L VADFG+ARL+ + + R + APE A
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
T K DV+SFG++ E+ + N +++D ++ P +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLV 435
+ + + C R +P+ RPT + +
Sbjct: 241 ESLH---DLMCQCWRKEPEERPTFEYL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-56
Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 22/279 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
ED+ + +G G YG V A + + VA+K + + E+ E + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+VK YG +L EY G LF + D G+ + + YL
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYL 119
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL 346
H I HRDI N+LL+ ++DFG+A + +++ R L + GT Y+APEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 347 AYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405
E DV+S G+V +L G+ P + S S + L+P +D
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW--KKIDS 234
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARN 443
++ L P +R T+ + + + +
Sbjct: 235 APL-ALLH------KILVENPSARITIPDIKKDRWYNKP 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 65/278 (23%), Positives = 128/278 (46%), Gaps = 21/278 (7%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ + IG G G+VY A + +G+ VA+++++ + + E NE ++ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
+ NIV L ++++ EY+ GSL V+ +D + V + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEF 131
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH + ++HRDI S+N+LL + + DFG + + S R+ + GT ++APE+
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
K D++S G++A+E++ G+ P L+ + I + + +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNK 444
R D + CL + R + +L+ ++F+ K
Sbjct: 247 R-DFLN------RCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-55
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 24/271 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ + IG G +G V G VA+K + T + +F EA +++Q+RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60
Query: 230 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G + K ++++ EYM GSL LR+ +V L + +C A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
VHRD+++ NVL++ + A V+DFG+ + SS + + APE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+ K DV+SFG++ E+ + ++ ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+ V +C RP+ + +
Sbjct: 227 PAVY---EVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 7e-55
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 37/298 (12%)
Query: 161 TFQDMIEATEDFH---------IKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSET 207
TF+D EA +F I+ IG G +G V L VA+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 208 EELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 267
E+ F +EA ++ Q H N++ L G + +I E+ME GSL LR ++
Sbjct: 68 EK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 268 GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
+ V +++G+ + YL VHRD+++ N+L+NS L V+DFG++R L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 328 DSSNRTLLA-----GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSS 381
D+S+ T + + APE T DV+S+G+V EV+ G+ P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------- 233
Query: 382 SWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+ N +I+ ++ P + + C + RP + N
Sbjct: 234 -YWDMTNQDVINAIEQDYRLPPPMDCPSALH---QLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-54
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 27/293 (9%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ + I +G G +G VY+A+ + + A K + EEL E + E +L+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCD 67
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
H NIVKL + ++++ E+ G++ V+ E L ++ V K AL+Y
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNY 125
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH I+HRD+ + N+L + + +ADFGV+ R GT ++APE+
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 348 YTMV-----VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402
K DV+S G+ +E+ + P + + I +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH--ELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHEI 454
+ D + CL +R T QL+ + F+ + KP E+
Sbjct: 241 WSSNFK-DFLK------KCLEKNVDARWTTSQLLQHPFVTVDS---NKPIREL 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 2e-54
Identities = 69/297 (23%), Positives = 122/297 (41%), Gaps = 28/297 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
D +K+ +G G YG VY VA+K L E +E F EA ++ +I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKH 72
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
N+V+L G C ++I E+M G+L LR + + + + + A+ YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAPELA 347
+HRD+++ N L+ VADFG++RL+ D+ + APE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
+ K DV++FGV+ E+ + ++ +LL+ +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
+ + + +C + P RP+ + F + F E SI + +E+
Sbjct: 242 PEKVY---ELMRACWQWNPSDRPSFAEIHQAF--------ETMFQESSISDEVEKEL 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-54
Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 31/300 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
EDF +G G + +V AR L + + A+K L + + + E ++S++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
VKLY + ++ Y + G L +R D + AL YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYIAPEL 346
H I+HRD+ N+LLN ++ + DFG A++L+ +S GT Y++PEL
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL-LDPRLSPPVDQ 405
+ D+++ G + +++ G P + + + + + I ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIKLEYDFPEKFFPKA-- 237
Query: 406 KIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP-FHEISILELRNQE 463
+D++ L R ++ + P F ++ L Q
Sbjct: 238 ---RDLVE------KLLVLDATKRLGCEEMEGYGPL------KAHPFFESVTWENLHQQT 282
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-54
Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 178 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYG 236
IG G + +VY+ + VA +L + + + + F EA +L ++H NIV+ Y
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 237 FCL----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC 292
+KC+ L+ E M G+L L+ + + + + + L +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 293 TPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMV 351
PPI+HRD+ +N+ + + D G+A L +S + GT ++APE+ Y
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM-YEEK 188
Query: 352 VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDI 411
E DVY+FG+ LE+ ++P +++ + + +++ +I
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK-EI 245
Query: 412 ILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
I C+R R ++ L+++ F
Sbjct: 246 IE------GCIRQNKDERYSIKDLLNHAFF 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 6e-53
Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 23/286 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + I +GTG +G V+R +G A K + + E+ E + +S +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 82
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+V L+ M +IYE+M G LF + +E + + V ++ +C L ++
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
H + VH D+ N++ ++ + DFG+ L+ S + GT + APE+
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEV 196
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
A V D++S GV++ +L G P + D+ ++ + D +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSCDWNMDDSAFSG 251
Query: 407 IRQDII-LVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
I +D + L + P +R T+ Q + + ++ AP +
Sbjct: 252 ISEDGKDFIR----KLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-52
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 27/281 (9%)
Query: 163 QDMIEATEDFHI-KYCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFGN 218
+ + ++ I +G G +GSV + VA+K L + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 58
Query: 219 EARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVV 278
EA+++ Q+ + IV+L G C + + L+ E G L L E + + ++
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115
Query: 279 KGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLL 335
+ + YL VHRD+++ NVLL + A ++DFG+++ L D S R+
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 336 AGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLSSSSWSLDKNIKLIDL 394
+ APE + + DV+S+GV E L G+ P + K +++
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEVMAF 224
Query: 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
++ + ++ + C + + RP V
Sbjct: 225 IEQGKRMECPPECPPELY---ALMSDCWIYKWEDRPDFLTV 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-52
Identities = 60/288 (20%), Positives = 109/288 (37%), Gaps = 38/288 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
+G G +G V A + VA+K L S E+ +E ++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 224 SQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---------------TDEEAV 267
S + H NIV L G C +I EY G L LR +++ +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 268 GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
LD ++ + +++L +HRD+++ N+LL + DFG+AR +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 328 DSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385
DS+ + ++APE + V T + DV+S+G+ E+ +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGM 251
Query: 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ K ++ + ++ + +C + P RPT +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMY---DIMKTCWDADPLKRPTFK 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-52
Identities = 60/284 (21%), Positives = 118/284 (41%), Gaps = 34/284 (11%)
Query: 178 IGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKL 234
+G+G +G+V + K VA+K L + A + EA ++ Q+ + IV++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 73
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
G C + L+ E E+G L L+ + + + +V + + YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLLAGTYGYIAPELAYTMV 351
VHRD+++ NVLL ++ A ++DFG+++ L D + +T + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 352 VTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQD 410
+ K DV+SFGV+ E G+ P + K ++ +L+ ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP--------YRGMKGSEVTAMLEKGERMGCPAGCPRE 238
Query: 411 IILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEI 454
+ + C ++RP V ++ ++++
Sbjct: 239 MY---DLMNLCWTYDVENRPGFAAVELR--------LRNYYYDV 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 8e-52
Identities = 61/297 (20%), Positives = 126/297 (42%), Gaps = 21/297 (7%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + I +G+G +G V+R +G+V K ++ + +++ NE +++Q+ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 85
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
++ L+ + M LI E++ G LF + E + A+ +N ++ C L ++
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHM 143
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIAPEL 346
H IVH DI N++ ++ + V DFG+A LN + T + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEI 199
Query: 347 AYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406
V D+++ GV+ +L G P +N+K D +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 407 IRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHEISILELRNQ 462
+D I + L+ +P+ R T+ + + ++ + + + ++R +
Sbjct: 258 EAKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-51
Identities = 60/295 (20%), Positives = 112/295 (37%), Gaps = 38/295 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
++ IG G +G V+R + G+ VA+K E E +RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHE 57
Query: 230 NIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
NI+ ++L+ +Y E GSLF L + + + L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGL 113
Query: 286 SYLHHDC-----TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN----RTLLA 336
++LH + P I HRD+ S N+L+ +AD G+A + +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 337 GTYGYIAPELAYTMV------VTEKCDVYSFGVVALEVLMGKHPGEL----------LSS 380
GT Y+APE+ + ++ D+Y+ G+V E+ G + L
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
S S+++ K++ R + P + + + +++ + C + +R T +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-51
Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 22/288 (7%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
E E + I +G G +G V+R S K K + T++ E +L+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
RHRNI+ L+ + + +I+E++ +F + A L+ + V+ V +C AL
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEAL 115
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTYGYIA 343
+LH I H DI N++ + + + +FG AR L + R L Y A
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYA 171
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
PE+ VV+ D++S G + +L G +P L+ ++ + +NI + +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
D + L + KSR T + + + ++ + +
Sbjct: 230 ISIEAMDFVD------RLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-51
Identities = 63/294 (21%), Positives = 113/294 (38%), Gaps = 45/294 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFGNEARLL 223
E+ +G+G +G V A VA+K L E+ +E +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 94
Query: 224 SQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------------------- 262
+Q+ H NIV L G C ++LI+EY G L LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 263 DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322
+E+ L + + + + +L VHRD+++ NVL+ + DFG+A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 323 RLLNFDSSNRTL--LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVL-MGKHPGELLS 379
R + DS+ ++APE + + T K DV+S+G++ E+ +G +P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----- 266
Query: 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ + L+ ++I + SC + RP+
Sbjct: 267 --YPGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSFP 315
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 7e-51
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 19/297 (6%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
+ + + +GTG + V A + K+VA+K + + E S NE +L +I+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK 65
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
H NIV L ++LI + + G LF + E ++ + A+ Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKY 122
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH + + L+ + + ++DFG++++ + S T GT GY+APE+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 181
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
++ D +S GV+A +L G P + K + I + P I
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 408 RQDII-LVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHEISILELRNQ 462
+ + P+ R T Q + + +I + K H+ +++
Sbjct: 237 SDSAKDFIR----HLMEKDPEKRFTCEQALQHPWI-AGDTALDKNIHQSVSEQIKKN 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 9e-51
Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 44/295 (14%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLL 223
+ IG G +G V++AR P +VA+K L + ++ F EA L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---------------------T 262
++ + NIVKL G C K M L++EYM G L LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 263 DEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322
L A+++ + + + ++YL VHRD+++ N L+ + +ADFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 323 RLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSS 380
R + + A ++ PE + T + DV+++GVV E+
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------ 241
Query: 381 SSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLV 435
+ + ++I + + ++ + C P RP+ +
Sbjct: 242 -PYYGMAHEEVIYYVRDGNILACPENCPLELY---NLMRLCWSKLPADRPSFCSI 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 69/272 (25%), Positives = 111/272 (40%), Gaps = 24/272 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQ 225
+D + +G G +G V R + VA+K L + +++ F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
+ HRN+++LYG L M ++ E +GSL LR + L R + +
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLLAGTYGYI 342
YL +HRD+++ N+LL + + DFG+ R L + + + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
APE T + D + FGV E+ G+ P L+ S + ID RL
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 236
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
P D QDI V C +P+ RPT
Sbjct: 237 PED--CPQDIY---NVMVQCWAHKPEDRPTFV 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFGNEARLLSQI 226
D + IG G +G V +AR+ A+K++ +++ F E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 67
Query: 227 -RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWA 272
H NI+ L G C HR ++L EY G+L LR + A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 273 KRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 332
+ ++ + + YL +HRD+++ N+L+ A +ADFG++R +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 183
Query: 333 TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLI 392
T+ ++A E V T DV+S+GV+ E++ + +L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAELY 236
Query: 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ L ++ + C R +P RP+
Sbjct: 237 EKLPQGYRLEKPLNCDDEVY---DLMRQCWREKPYERPSFA 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-50
Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 25/272 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRSETEELASLESFGNEARLLS 224
+ IG G +G VY+ L + VA+K L TE+ F EA ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMG 64
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
Q H NI++L G K M +I EYME G+ E+ + V +++G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTYGY 341
+ + VHRD+++ N+L+NS L V+DFG++R+L D + +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
APE T DV+SFG+V EV+ + N +++ ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------PYWELSNHEVMKAINDGFRL 232
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
P I + C + + RP
Sbjct: 233 PTPMDCPSAIY---QLMMQCWQQERARRPKFA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-49
Identities = 64/299 (21%), Positives = 124/299 (41%), Gaps = 33/299 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLS-QIR 227
EDF + +G G +G V+ A + + A+K L + +E E R+LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 228 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
H + ++ ++ +F + EY+ G L ++ D ++ + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELA 347
LH IV+RD+ +N+LL+ + +ADFG+ + + GT YIAPE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407
D +SFGV+ E+L+G+ P ++ I + +P ++++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTM--QLVSNEFIARNKAPMQKPFHEISILELRNQEM 464
+ D+++ +P+ R + + + F EI+ EL +E+
Sbjct: 231 K-DLLV------KLFVREPEKRLGVRGDIRQHPL-----------FREINWEELERKEI 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-49
Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 26/276 (9%)
Query: 173 HIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFGNEARLLSQIRH 228
H IG G +G VY L A+K L+R + F E ++ H
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 87
Query: 229 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSY 287
N++ L G CL + ++ YM+ G L +R + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-----GLQVAKG 142
Query: 288 LHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS----SNRTLLAGTYGYIA 343
+ + VHRD+++ N +L+ + VADFG+AR + N+T ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 344 PELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403
E T T K DV+SFGV+ E++ P ++ ++ LL P P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
+ V C + + RP+ + +
Sbjct: 263 ----------LYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-48
Identities = 66/269 (24%), Positives = 106/269 (39%), Gaps = 23/269 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQ 225
E + CIG G +G V++ S VA+K ++ + E F EA + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQ 64
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
H +IVKL G +++I E +G L LD A + + AL
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTAL 121
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTYGYIAP 344
+YL VHRDI++ NVL++S + DFG++R + + + + ++AP
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
E T DV+ FGV E+LM + KN +I ++ P+
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVK-------PFQGVKNNDVIGRIENGERLPMP 231
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ ++ C P RP
Sbjct: 232 PNCPPTLY---SLMTKCWAYDPSRRPRFT 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 6e-48
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 23/281 (8%)
Query: 169 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR 227
++ + + +G GG V+ AR L + VA+K L + + F EA+ + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 228 HRNIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
H IV +Y +++ EY++ +L ++ T+ + + + V+ C
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTYG 340
AL++ H I+HRD+ N+++++ V DFG+AR + ++ T + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400
Y++PE A V + DVYS G V EVL G+ P S S ++++ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPIPPSARH 238
Query: 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFI 440
+ + ++L L P++R T + + +
Sbjct: 239 EGLSADLD-AVVL------KALAKNPENRYQTAAEMRADLV 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-47
Identities = 56/280 (20%), Positives = 115/280 (41%), Gaps = 24/280 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRS---ETEELASLESFGNEARLLSQ 225
+ + +G+G + V + R +G A K + + + S E E +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
I+H N++ L+ ++ + LI E + G LF ++E++ + A + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEF-----LKQIL 123
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
+ +++ + I H D+ N++L + DFG+A ++F + + GT +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182
Query: 342 IAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401
+APE+ + + D++S GV+ +L G P L + N+ ++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYF 240
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFI 440
+ +D I L PK R T+ + + +I
Sbjct: 241 SNTSALAKDFIR------RLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (412), Expect = 6e-47
Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+DF I +GTG +G V+ R +G+ A+K L + L +E +E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
I++++G + +F+I +Y+E G LF +LR + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
+ + I++RD+ N+LL+ + DFG A+ + L GT YIAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL-LDPRLSPPVDQKI 407
T + D +SFG++ E+L G P S++ + I +L P + V +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKP-FHEISILELRNQEM 464
+ + R E + P F E+ +L ++ +
Sbjct: 233 SR-----------LITRDLSQRLGNLQNGTEDV------KNHPWFKEVVWEKLLSRNI 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-47
Identities = 59/293 (20%), Positives = 120/293 (40%), Gaps = 25/293 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKV----VALKKLHRSETEELASLESFGNEARLLS 224
+F +G+G +G+VY+ +P G+ VA+K+L + + + + + +EA +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66
Query: 225 QIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+ + ++ +L G CL + LI + M G L E + +N +
Sbjct: 67 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKG 123
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTYGYI 342
++YL +VHRD+++ NVL+ + + DFG+A+LL + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402
A E + T + DV+S+GV E++ + ++ +L+ P
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------PYDGIPASEISSILEKGERLP 233
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEIS 455
D+ + C SRP + + EF + P + +
Sbjct: 234 QPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-45
Identities = 62/301 (20%), Positives = 113/301 (37%), Gaps = 34/301 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLL 223
E + +G G +G VY VA+K ++ + + F NEA ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-------LDWAKRVN 276
+ ++V+L G + +I E M G L LR+ A+ +K +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 277 VVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR--TL 334
+ + ++YL+ VHRD+++ N ++ + + DFG+ R + R
Sbjct: 138 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394
+++PE V T DV+SFGVV E+ + N +++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSNEQVLRF 247
Query: 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHEI 454
+ + + C + PK RP+ E I+ K M+ F E+
Sbjct: 248 VMEGGLLDKPDNCPDMLF---ELMRMCWQYNPKMRPSFL----EIISSIKEEMEPGFREV 300
Query: 455 S 455
S
Sbjct: 301 S 301
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 1e-45
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS------LESFGNEARL 222
E++ K +G G V R P+ K A+K + + ++ E+ E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 223 LSQIR-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGM 281
L ++ H NI++L FL+++ M+ G LF L E V L + +++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 282 CHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGY 341
+ LH IVHRD+ N+LL+ ++ + DFG + L+ + GT Y
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSY 175
Query: 342 IAPELAYTMVV------TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395
+APE+ + ++ D++S GV+ +L G P +++I
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSG 230
Query: 396 DPRLSPPVDQKIRQDII-LVSTVAFSCLRSQPKSRPTM-QLVSNEFIAR 442
+ + P + LVS L QP+ R T + +++ F +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----RFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 3e-44
Identities = 57/269 (21%), Positives = 98/269 (36%), Gaps = 22/269 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNE---ARLLSQ 225
DF + IG GG+G VY R +GK+ A+K L + + NE L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 226 IRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHAL 285
IV + + I + M G L L A + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 286 SYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE 345
++H+ +V+RD+ N+LL+ ++D G+A +F GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPE 175
Query: 346 -LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
L + D +S G + ++L G P + + ++ + L
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
++R ++ L+ R
Sbjct: 234 PELR-SLLE------GLLQRDVNRRLGCL 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-44
Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 39/288 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFGNEAR 221
+ + +G G +G V A VA+K L TE+ L +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 222 LLSQI-RHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAV 267
++ I +H+NI+ L G C +++I EY G+L L+ +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 268 GLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327
L V+ + + YL +HRD+++ NVL+ + +ADFG+AR ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 328 DSSNRTLLA--GTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL 385
+ ++APE + + T + DV+SFGV+ E+ +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------PYPG 240
Query: 386 DKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+L LL ++ + C + P RPT +
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 9e-44
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 26/290 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
E +H IG G YG VY+A+ G+ ALKK+ + +E + E +L +++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 230 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
NIVKLY +K + L++E+++ + + GL+ + + + + ++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH 117
Query: 290 HDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LAY 348
++HRD+ N+L+N E E +ADFG+AR T T Y AP+ L
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHP-------------GELLSSSSWSLDKNIKLIDLL 395
+ + D++S G + E++ G +L + + N+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 396 DPRLSPPVDQKIRQDIILVSTVAF----SCLRSQPKSRPTM-QLVSNEFI 440
DP + + + L+ P R T Q + + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-44
Identities = 65/302 (21%), Positives = 123/302 (40%), Gaps = 32/302 (10%)
Query: 170 EDFHI-KYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQI- 226
+D+ + +G G G V + + + ALK L E L +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRAS 62
Query: 227 RHRNIVKLYGFC----LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC 282
+ +IV++ RKC+ ++ E ++ G LF ++ D + ++K +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIG 121
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELE---AFVADFGVARLLNFDSSNRTLLAGTY 339
A+ YLH I HRD+ N+L S+ + DFG A+ +S T T
Sbjct: 122 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTP 177
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP--GELLSSSSWSLDKNIKLIDLLDP 397
Y+APE+ + CD++S GV+ +L G P + S + I++ P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKPFHEISI 456
+ + +I + L+++P R T+ + +++ +I ++ Q P H +
Sbjct: 238 NPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
Query: 457 LE 458
L+
Sbjct: 292 LK 293
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 26/297 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
DF +G G +G V R +G+ A+K L + + E+R+L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+ L + + EY G LF L + + + AL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSAL--- 118
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
+ + +V+RDI N++L+ + + DFG+ + D + GT Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
D + GVV E++ G+ P + ++ +LI + + R + + +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFELILMEEIRFPRTLSPEAK 233
Query: 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKP-FHEISILELRNQEM 464
++ L+ PK R + + M+ F I+ ++ +++
Sbjct: 234 -SLLA------GLLKKDPKQRLGGGPSDAKEV------MEHRFFLSINWQDVVQKKL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-43
Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 36/290 (12%)
Query: 171 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR---SETEELASLESFGNEARLLSQI 226
+ + +G+GG+GSVY + VA+K + + S+ EL + E LL ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 227 R--HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
+++L + LI E E T+ L + + A
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEA 122
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTYGYIA 343
+ + H+ ++HRDI N+L++ + E + DFG LL + T GT Y
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 177
Query: 344 PE-LAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL-LDPRLSP 401
PE + Y V+S G++ +++ G P + D+ I + R+S
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--------FEHDEEIIRGQVFFRQRVSS 229
Query: 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
Q +I CL +P RPT ++ ++ ++ P +
Sbjct: 230 EC-----QHLIR------WCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 26/298 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
E+F IG G YG VY+AR +G+VVALKK+ R +TE + E LL ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
NIVKL ++L++E++ + + + L K + L L
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPE-LA 347
+ ++HRD+ N+L+N+E +ADFG+AR T T Y APE L
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 348 YTMVVTEKCDVYSFGVVALEVLMGKHP-------------GELLSSSSWSLDKNIKLIDL 394
+ D++S G + E++ + L + + + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 395 LDPRLSPPVDQKIRQDIILVSTVAFS----CLRSQPKSRPTM-QLVSNEFIARNKAPM 447
P Q + + + S L P R + +++ F P+
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-42
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHR 229
+ IG G +G VY+A+L SG++VA+KK+ + + E +++ ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73
Query: 230 NIVKLYGFCLH------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
NIV+L F + L+ +Y+ L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTYGYI 342
+L+Y+H I HRDI N+LL+ + + DFG A+ L N + + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402
+ T DV+S G V E+L+G+ + D + + + L P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI--------FPGDSGVDQLVEIIKVLGTP 242
Query: 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFI 440
++IR+ + F +++ P ++ E I
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-41
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 27/294 (9%)
Query: 178 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS--LESFGNEARLLSQIRHRNIVKL 234
+G G + +VY+AR + ++VA+KK+ E + E +LL ++ H NI+ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 235 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTP 294
H+ + L++++ME ++ + + K M L L +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAY-----MLMTLQGLEYLHQH 119
Query: 295 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTM-VVT 353
I+HRD+ NN+LL+ +ADFG+A+ + T T Y APEL + +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 354 EKCDVYSFGVVALEVLMGKHP--------------GELLSSSSWSLDKNIKLIDLLDPRL 399
D+++ G + E+L+ L + + L D + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 400 SPPVDQKIRQDIILVSTVAF--SCLRSQPKSRPTM-QLVSNEFIARNKAPMQKP 450
P + + P +R T Q + ++ + P
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-41
Identities = 64/314 (20%), Positives = 118/314 (37%), Gaps = 30/314 (9%)
Query: 165 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ + + IG G YG V A + VA+KK+ E + + E ++L
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY--CQRTLREIKIL 60
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
+ RH NI+ + + Y+ + L + L + +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTYG 340
L Y+H ++HRD+ +N+LLN+ + + DFG+AR+ + D + T
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 341 YIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHP-------------GELLSSSSWSLD 386
Y APE+ T+ D++S G + E+L + +L S S
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 387 KNIKLIDLLDPRLSPPVDQKIRQDIIL--VSTVAF----SCLRSQPKSRPTM-QLVSNEF 439
I + + LS P K+ + + + A L P R + Q +++ +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 440 IARNKAPMQKPFHE 453
+ + P +P E
Sbjct: 298 LEQYYDPSDEPIAE 311
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 7e-41
Identities = 44/295 (14%), Positives = 97/295 (32%), Gaps = 30/295 (10%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ + IG+G +G +Y + +G+ VA+K E+++ ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63
Query: 231 IVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
+ +C ++ E + + + + M + Y+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120
Query: 290 HDCTPPIVHRDISSNNVLLNSE---LEAFVADFGVARLLNFDSSN-------RTLLAGTY 339
+HRD+ +N L+ ++ DFG+A+ ++ L GT
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 340 GYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRL 399
Y + + + + D+ S G V + +G P + K K + + ++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP----WQGLKAATKRQKYERISEKKM 233
Query: 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF---IARNKAPMQKPF 451
S P++ + +T C + +P + F R F
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 37/287 (12%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFGNEARLL 223
+ + +G G +G V A + + VA+K L T + +E ++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 224 SQIRHR-NIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRT-------------DEEAVG 268
I H N+V L G C + +I E+ + G+L LR+ D
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328
L + + + +L +HRD+++ N+LL+ + + DFG+AR + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 329 SSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD 386
+ ++APE + V T + DV+SFGV+ E+
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 387 KNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433
+ +K + R ++ Q C +P RPT
Sbjct: 248 RRLK--EGTRMRAPDYTTPEMYQ-------TMLDCWHGEPSQRPTFS 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 29/297 (9%)
Query: 168 ATEDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFG--NEARLL 223
A + + IG G YG V++AR G+ VALK++ EE L + R L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 224 SQIRHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV---LRTDEEAVGLDWAKRVNVVKG 280
H N+V+L+ C + + + G+ +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYG 340
+ L +LH +VHRD+ N+L+ S + +ADFG+AR+ +F + ++ T
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLW 180
Query: 341 YIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400
Y APE+ D++S G + E+ K SS L K + +I L
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEEDW 239
Query: 401 PPVDQKIRQDIILVSTVAFS----------------CLRSQPKSRPTM-QLVSNEFI 440
P RQ S CL P R + +S+ +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-39
Identities = 54/293 (18%), Positives = 115/293 (39%), Gaps = 28/293 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + IG G YG+V++A+ + ++VALK++ + +E S E LL +++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+NIV+L+ K + L++E+ + + V + L L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
+ ++HRD+ N+L+N E +A+FG+AR + T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 349 -TMVVTEKCDVYSFGVVALEVLMGKHP--------------GELLSSSSWSLDKNIKLID 393
+ + D++S G + E+ P LL + + ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 394 LLDPRLSPPVDQKIRQDIILVSTVAFS----CLRSQPKSRPTM-QLVSNEFIA 441
P P + + ++ L+ P R + + + + + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 8e-39
Identities = 54/262 (20%), Positives = 98/262 (37%), Gaps = 22/262 (8%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ F +GTG +G V + SG A+K L + + +L +E NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 229 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYL 288
+VKL ++++ EY+ G +F LR + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 289 HHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAY 348
H +++RD+ N+L++ + V DFG A+ L GT +APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 349 TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408
+ + D ++ GV+ E+ G P + + + I R ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 409 QDIILVSTVAFSCLRSQPKSRP 430
+ + L+ R
Sbjct: 267 DLLR-------NLLQVDLTKRF 281
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (350), Expect = 2e-38
Identities = 46/297 (15%), Positives = 93/297 (31%), Gaps = 32/297 (10%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ + IG G +G ++ L + + VA+K R +E R +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61
Query: 231 -IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLH 289
I +Y F L+ + + + + K M + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIH 118
Query: 290 HDCTPPIVHRDISSNNVLLNSELE-----AFVADFGVARLLNFDSSN-------RTLLAG 337
+V+RDI +N L+ +V DFG+ + + + L+G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 338 TYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDP 397
T Y++ + + D+ + G V + L G P + L ++ K + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGEK 231
Query: 398 RLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF---IARNKAPMQKPF 451
+ S P+ + + P + F + R + F
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-38
Identities = 64/312 (20%), Positives = 115/312 (36%), Gaps = 42/312 (13%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ IG G +G V++AR +G+ VALKK+ +E + E ++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKH 68
Query: 229 RNIVKLYGFCLHRK--------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKG 280
N+V L C + ++L++++ E + + L KRV
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV----- 122
Query: 281 MCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS----NRTLLA 336
M L+ L++ I+HRD+ + NVL+ + +ADFG+AR + + T
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 337 GTYGYIAPE-LAYTMVVTEKCDVYSFGVVALEVLMGKHPGE----------------LLS 379
T Y PE L D++ G + E+ + ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 380 SSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAF----SCLRSQPKSRPTM-QL 434
W N +L + L+ K R + A L P R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 435 VSNEFIARNKAP 446
++++F + P
Sbjct: 303 LNHDFFWSDPMP 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 68/305 (22%), Positives = 123/305 (40%), Gaps = 30/305 (9%)
Query: 170 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSE-TEELASLESFGNEARLLS 224
E+F + +GTG YG V+ R +GK+ A+K L ++ ++ + E E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 225 QIRHR-NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCH 283
IR +V L+ + LI +Y+ G LF L + V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGE 137
Query: 284 ALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTYGYI 342
+ L H I++RDI N+LL+S + DFG++ + ++ GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 343 APELAYTMV--VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400
AP++ + D +S GV+ E+L G P + + S + + I +P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPPYP 256
Query: 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKP-FHEISILEL 459
+ + D+I L PK R + I + F +I+ +L
Sbjct: 257 QEMSALAK-DLIQ------RLLMKDPKKRLGCGPRDADEI------KEHLFFQKINWDDL 303
Query: 460 RNQEM 464
+++
Sbjct: 304 AAKKV 308
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 64/318 (20%), Positives = 111/318 (34%), Gaps = 36/318 (11%)
Query: 161 TFQDMIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLES 215
Q++ + + Y +G+G YG+V A +G VA+KKL+R EL +
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKR 63
Query: 216 FGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE-YMEMGSLFCVLRTDEEAVGLDWAKR 274
E RLL +RH N++ L + + + Y+ M + L + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 275 VNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
+V M L Y+H HRD+ N+ +N + E + DFG+AR DS
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGY 178
Query: 335 LAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDL 394
+ + + M T+ D++S G + E++ GK S K I +
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQLKEIMKVTG 236
Query: 395 LDPRLSPPVDQKIRQDIILVSTVAF---------------------SCLRSQPKSRPTM- 432
P Q + L + R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 433 QLVSNEFIARNKAPMQKP 450
+ +++ + +P
Sbjct: 297 EALAHPYFESLHDTEDEP 314
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 7e-33
Identities = 43/227 (18%), Positives = 91/227 (40%), Gaps = 25/227 (11%)
Query: 154 WNYDG-RITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA 211
W+Y+ + + + +D+ + +G G Y V+ A + + + V +K L + ++
Sbjct: 22 WDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-- 75
Query: 212 SLESFGNEARLLSQIR-HRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG 268
E ++L +R NI+ L + L++E++ + +T
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------ 125
Query: 269 LDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNF 327
L + + AL Y H I+HRD+ +NV+++ E + + D+G+A +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHP 374
+A Y L + D++S G + ++ K P
Sbjct: 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 61/307 (19%), Positives = 115/307 (37%), Gaps = 30/307 (9%)
Query: 167 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQ 225
E E + +G+G YGSV A +G VA+KKL R + + + E RLL
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73
Query: 226 IRHRNIVKLYGFCLHRKCMFLI-YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHA 284
++H N++ L + + Y+ + L + L ++ +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 285 LSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYIAP 344
L Y+H HRD+ +N+ +N + E + DFG+AR + D +A +
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPE 188
Query: 345 ELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404
+ M + D++S G + E+L G+ + L ++L+ L +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 405 QKIRQDIIL----------------VSTVAF----SCLRSQPKSRPTM-QLVSNEFIARN 443
+ ++ I + +A L R T Q +++ + A+
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 444 KAPMQKP 450
P +P
Sbjct: 308 HDPDDEP 314
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-32
Identities = 66/335 (19%), Positives = 121/335 (36%), Gaps = 51/335 (15%)
Query: 170 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH 228
+ + IG+G G V A + VA+KKL R + + E L+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 229 RNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMC 282
+NI+ L +K + +L+ E M+ + D + ++ M
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129
Query: 283 HALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTYGYI 342
+ +LH I+HRD+ +N+++ S+ + DFG+AR S T T Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185
Query: 343 APELAYTMVVTEKCDVYSFGVVALEVLMGKHP-------------------------GEL 377
APE+ M E D++S G + E++ K +L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 378 LSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAF-----SCLRSQPKSRPTM 432
+ ++ K L P+L P + + L P R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 433 -QLVSNEFI--ARNKAPMQKPFHEISILELRNQEM 464
+ + +I + A ++ P +I +L +E
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 340
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 5e-26
Identities = 49/288 (17%), Positives = 108/288 (37%), Gaps = 28/288 (9%)
Query: 172 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRN 230
+ + +G G + +V+ A+ + + VA+K + + E+ +E +LL ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 70
Query: 231 IVKLYGFCLHR---------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 275
K + + +++E + L + + + + L + K++
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 276 NVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRT- 333
K + L Y+H C I+H DI NVL+ + +A L N +
Sbjct: 131 --SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 334 -LLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN-IKL 391
T Y +PE+ D++S + E++ G E S++ D + I
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEF 439
I L L + + + ++ S+ K P +++ ++
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 1e-19
Identities = 29/164 (17%), Positives = 56/164 (34%), Gaps = 17/164 (10%)
Query: 178 IGTGGYGSVYRARLPSGKVVALKKLHRSETE-------ELASLESFGNEARLLSQIRHRN 230
+G G +V+ +K T F A ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 231 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHH 290
+ KL G + + +Y + ++ L +E + V+ + ++ +H
Sbjct: 68 LQKLQGLAVPK-----VYAWEG-NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 291 DCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 334
IVH D+S NVL+ SE ++ DF + + + L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 7e-10
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 1/69 (1%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
L L+L NN + G++P + +L+ L+ LN+S N++ G+I Q G + R D +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYA 299
Query: 61 MNNLSGSIP 69
N P
Sbjct: 300 NNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 4e-09
Identities = 17/69 (24%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N L L L N +S P ++ L +L L ++N ++ +S L + I+ +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 61 MNNLSGSIP 69
N +S P
Sbjct: 360 HNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+ +KL+ L NN +S S + L +N+L+ HN I+ L+ L + RI + L+
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLND 382
Query: 62 N 62
Sbjct: 383 Q 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 9/68 (13%), Positives = 24/68 (35%), Gaps = 4/68 (5%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
++ LG ++ ++ L ++ L I + + + + ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 62 NNLSGSIP 69
N L+ P
Sbjct: 76 NQLTDITP 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 1e-07
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 13/91 (14%)
Query: 1 MNCSKLRVLELGNNLLSG----SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPR--- 53
S LRVL L + +S S+ + + L L+LS+N + + QL E R
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 54 --IDTVDLSMNNLSGSIPESVRKV----PHL 78
++ + L S + + ++ + P L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 12/72 (16%), Positives = 26/72 (36%), Gaps = 5/72 (6%)
Query: 6 LRVLELGNNLLSGSIPSEI-NKLQELNYLNLSHNSINGKILSQLGEI----PRIDTVDLS 60
++ L++ LS + +E+ LQ+ + L + + P + ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 61 MNNLSGSIPESV 72
N L V
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 7e-05
Identities = 13/107 (12%), Positives = 33/107 (30%), Gaps = 4/107 (3%)
Query: 2 NCSKLRVLELGNNLLSG----SIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTV 57
+ +V+ L + L+ I S + L LNL N + + + + + +
Sbjct: 25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 84
Query: 58 DLSMNNLSGSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKI 104
+ +L ++ + S+N ++
Sbjct: 85 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL 131
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 1/96 (1%)
Query: 6 LRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65
+L+L NN ++ + L+ L+ L L +N I+ + +++ + LS N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 66 GSIPESVRKVPHLYVYGKNFDVEIPNTSENSPPPHH 101
+PE + K +N ++ + N
Sbjct: 93 -ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 6e-06
Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 3/80 (3%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
N + R L+L + I + L + + ++ S N I L + R+ T+ ++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 72
Query: 62 NNLSGSIPESVRKVPHLYVY 81
N + + +P L
Sbjct: 73 NRICRIGEGLDQALPDLTEL 92
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 11/75 (14%), Positives = 30/75 (40%), Gaps = 2/75 (2%)
Query: 5 KLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQ-LGEIPRIDTVDLSMNN 63
+ + + + + + + +++LS++ I L L + ++ + L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 64 LSGSIPESVRKVPHL 78
LS I ++ K +L
Sbjct: 83 LSDPIVNTLAKNSNL 97
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 1/97 (1%)
Query: 13 NNLLSGSIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES 71
+ +L E +L L +L+LS I + L +LGEIP + T+ + G++
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL 244
Query: 72 VRKVPHLYVYGKNFDVEIPNTSENSPPPHHKKIATRL 108
+PHL + +F T N I RL
Sbjct: 245 KEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRL 281
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 8e-04
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 13 NNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV 72
N S I S + L LN+S+N K++ PR++ + S N+L+ +PE
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLA-EVPELP 323
Query: 73 RKVPHLYVYGKNFDVEIPNTSEN 95
+ + L+V N E P+ E+
Sbjct: 324 QNLKQLHVEY-NPLREFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.003
Identities = 15/62 (24%), Positives = 26/62 (41%), Gaps = 10/62 (16%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSM 61
+L L N L+ +P L++ L++ +N L + +IP DL M
Sbjct: 302 LPPRLERLIASFNHLA-EVPELPQNLKQ---LHVEYNP-----LREFPDIPE-SVEDLRM 351
Query: 62 NN 63
N+
Sbjct: 352 NS 353
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 24/94 (25%)
Query: 7 RVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKI--LSQLGEIPRID--------- 55
RVL L + L+ + + +L + +L+LSHN + L+ L + +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 56 ----------TVDLSMNNL-SGSIPESVRKVPHL 78
+ L N L + + + P L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 4/59 (6%)
Query: 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLS 60
N SKL L+ +N +S P + L L ++L +N I+ +S L + V L+
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.002
Identities = 10/58 (17%), Positives = 24/58 (41%), Gaps = 7/58 (12%)
Query: 1 MNCSKLRVLELGNNLLSGSIPSEI-----NKLQELNYLNLSHNSIN--GKILSQLGEI 51
+ L+ L L N + + K+ +L +L L+ N + ++ ++ E+
Sbjct: 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.33 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.3 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.28 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.26 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.23 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.13 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.04 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.98 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.85 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.85 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.84 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.78 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.73 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.71 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.65 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.63 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.58 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.54 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.47 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.24 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.23 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.96 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.9 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.59 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.53 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.52 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.64 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=404.73 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=198.4
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|++.+.||+|+||+||+|++.+++.||||+++..... .++|.+|++++++++|||||+++|+|..++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 578889999999999999999988999999999865433 3679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++.... ..+++..++.++.|||.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999987643 34889999999999999999999 7799999999999999999999999999998765432
Q ss_pred C-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 S-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. ......||+.|+|||++.+..++.++|||||||++|||+| |++|+........ ... +.....+..+...+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~-~~~---i~~~~~~~~p~~~~--- 228 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VED---ISTGFRLYKPRLAS--- 228 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-HHH---HHHTCCCCCCTTSC---
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-HHH---HHhcCCCCCccccC---
Confidence 2 2233568999999999999999999999999999999999 4556554322111 111 11111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
+ .+.+++.+||+.||++||||++|+++|+++.
T Consensus 229 -~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 229 -T---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -H---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1 2678999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=409.72 Aligned_cols=262 Identities=25% Similarity=0.427 Sum_probs=202.8
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|.+.+.||+|+||+||+|++++ .||||+++...... ...+.|.+|++++++++|||||+++|++.++ ..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEecc-EEEEEE
Confidence 4678999999999999999998753 59999997654332 3467899999999999999999999998654 579999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++..... .+++.+++.++.|||+||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999975433 4899999999999999999999 779999999999999999999999999999876432
Q ss_pred C--CCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 S--SNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
. .......||+.|||||++.. ..++.++|||||||++|||+||+.||.............. .....+.... .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~-~ 234 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--RGYLSPDLSK-V 234 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--HTSCCCCGGG-S
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh--cCCCCCcchh-c
Confidence 2 22344679999999999864 3589999999999999999999999986543222111100 0111111110 0
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.... ...+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 235 ~~~~---~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 235 RSNC---PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1111 12267899999999999999999999999876543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-55 Score=411.84 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=196.7
Q ss_pred hCccccceeeeeCCceEEEEEcC-CC---CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SG---KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||+||+|++. ++ ..||||++...... ...+.|.+|++++++++|||||+++|+|..++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45666789999999999999864 23 35899998765443 24568999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++..... .+++.+++.++.|||+||+||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999998876433 4899999999999999999999 779999999999999999999999999999876
Q ss_pred cCCCCCc-----eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCC
Q 012219 326 NFDSSNR-----TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRL 399 (468)
Q Consensus 326 ~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.......... .+.....+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~----~i~~~~~~~~ 254 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AIEQDYRLPP 254 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTTCCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCC
Confidence 5332211 12357899999999999999999999999999999998 899997654321111 0111111111
Q ss_pred CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 400 SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 400 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
....+ ..+.+++.+||+.||++||||++|++.|+++.+.
T Consensus 255 ~~~~~-------~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 255 PMDCP-------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CTTCC-------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred Cccch-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111 2267899999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=399.29 Aligned_cols=248 Identities=31% Similarity=0.489 Sum_probs=207.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+++.||+|++......+....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999976 468999999998665555455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999997643 3899999999999999999999 77999999999999999999999999999976542
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||+........ ... ...+..++...+
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i----~~~~~~~p~~~s---- 228 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRI----SRVEFTFPDFVT---- 228 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHH----HTTCCCCCTTSC----
T ss_pred -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-HHH----HcCCCCCCccCC----
Confidence 3345568999999999999999999999999999999999999999754322111 100 001112222222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
+ .+.+++.+||+.||++|||++|+++
T Consensus 229 ~---~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 229 E---GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp H---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2 2667899999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=399.39 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=201.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|.. .+|+.||||++......+ ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 5799999999999999999975 579999999997654332 3457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999997543 4899999999999999999999 779999999999999999999999999999876433
Q ss_pred C--CCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 S--SNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
. ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.............. ..........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------~~~~~~~~~~ 230 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------EKKTYLNPWK 230 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH------TTCTTSTTGG
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh------cCCCCCCccc
Confidence 2 22345679999999999988776 5789999999999999999999975443222111110 0000111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+.. .+.+++.+||+.||++|||++|++++
T Consensus 231 ~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 231 KIDS---APLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112 25678999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=395.92 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=209.8
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|++.+.||+|+||+||+|++++++.||||+++..... .++|.+|++++++++||||++++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 578999999999999999999988999999999875543 3679999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|..++..... .+++..+++++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999999765443 3889999999999999999999 7799999999999999999999999999998765433
Q ss_pred C-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 330 S-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 330 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. ......||+.|+|||++....++.++|||||||++|||+| |+.||+......... .+.+...+..+...+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~----~i~~~~~~~~p~~~~--- 227 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLRLYRPHLAS--- 227 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHHTTCCCCCCTTCC---
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH----HHHhCCCCCCccccc---
Confidence 2 2334568999999999999999999999999999999998 899998665332211 111111111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+.+++.+||+.||++|||+++++++|..
T Consensus 228 ----~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 228 ----EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 136789999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=403.55 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=203.1
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|+||+||+|.+++++.||||+++..... .+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4679999999999999999999988899999999765432 3679999999999999999999998865 4578999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ...+++.+++.++.||++||.||| +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999876543 234899999999999999999999 779999999999999999999999999999887533
Q ss_pred CC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 SS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||+||..|+........... .+.....+..+...+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~~~~~~~~p~~~~--- 236 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERGYRMVRPDNCP--- 236 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTTCCCCCCTTCC---
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---HHHhcCCCCCcccCh---
Confidence 22 22335688999999999999999999999999999999996555432222111111 111111111222121
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
+ .+.+++.+||+.||++||||++|++.|+.
T Consensus 237 -~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 -E---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -H---HHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2 26779999999999999999999987764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=407.91 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=209.0
Q ss_pred HHhhCccccceeeeeCCceEEEEEcC-CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 167 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 167 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
...++|++.+.||+|+||+||+|.+. +++.||||+++.+.. ..++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 33568999999999999999999764 688999999976543 2467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++..... ..+++..++.++.|||.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999975432 35899999999999999999999 679999999999999999999999999999876
Q ss_pred cCCCCCc-eeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 326 NFDSSNR-TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 326 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
....... ....|++.|+|||++.+..++.++|||||||++|||++|..|+......... .+.+.........
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-------~~~i~~~~~~~~~ 238 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDYRMERP 238 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHTTCCCCCC
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH-------HHHHhcCCCCCCC
Confidence 5433222 2245788999999999999999999999999999999977665432221111 1111111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
....+ .+.+++.+||+.||++||||++|++.|+.+.+
T Consensus 239 ~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11112 26789999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=401.40 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=193.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee--CCEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH--RKCMFL 246 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 246 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++......+ ...+.|.+|++++++++|||||++++++.+ .+..++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6799999999999999999975 578999999997765432 345778999999999999999999999865 456899
Q ss_pred EEEeccCCChhhhhhcCc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNVVKGMCHALSYLHHDC--TPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986532 2345899999999999999999999531 2359999999999999999999999999999
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.+...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.....+.+....
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~ 238 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKFRRIPYRY 238 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCCCCCTTS
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH----HHHcCCCCCCCccc
Confidence 87655555556789999999999999999999999999999999999999997544321110 01111111122222
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+ + .+.+++.+||+.||++|||++|++++
T Consensus 239 s----~---~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 239 S----D---ELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C----H---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----H---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 2 2 26678999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=398.35 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999975 57999999999755432 3467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999987653 3899999999999999999999 779999999999999999999999999999987665
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
........||+.|+|||++.+..++.++|||||||++|||+||+.||........... ......+.+. ....+.
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~~~~--~~~~~s 243 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGTPELQ--NPEKLS 243 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHHCSCCCS--SGGGSC
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH----HHhCCCCCCC--CcccCC
Confidence 5556667899999999999999999999999999999999999999975432211110 0000011111 111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH-HHHhc
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSN-EFIAR 442 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~-~l~~~ 442 (468)
+ .+.+++.+||+.||++|||++|+++ .|.+.
T Consensus 244 ~---~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 244 A---IFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp H---HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred H---HHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 2 2667999999999999999999985 44443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=395.37 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=203.1
Q ss_pred hCccccce-eeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYC-IGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|.+.+. ||+|+||+||+|.++ ++..||||+++..... ...+.|.+|++++++++|||||+++|+|..+ ..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 45666774 999999999999653 3557999999765433 3457899999999999999999999999754 578
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... ..+++.+++.++.|||.||+||| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999986543 24899999999999999999999 779999999999999999999999999999887
Q ss_pred cCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... ......||+.|+|||++....++.++|||||||++|||+| |+.||.......... .+.....+..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~~~~~~p~ 235 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGKRMECPP 235 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTCCCCCCT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCCC
Confidence 54322 2223468899999999999999999999999999999998 999998654321111 011111112222
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+ . .+.+++.+||+.||++|||+.+|.+.|+..
T Consensus 236 ~~~----~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 236 ECP----P---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TCC----H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222 2 267899999999999999999999887643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=395.80 Aligned_cols=259 Identities=27% Similarity=0.371 Sum_probs=199.3
Q ss_pred hCccccceeeeeCCceEEEEEcCCC-----CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
+.|++.+.||+|+||+||+|.++++ ..||||+++...... ..+.|.+|++++++++|||||+++|+|.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 5688899999999999999976432 469999997654432 346799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+.+|++.+.+..... .+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999998875433 4899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC---CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSS---NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+........... .+.+...+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---~i~~~~~~~~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---AINDGFRLPTPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHTTCCCCCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH---HHhccCCCCCch
Confidence 643322 22234689999999999999999999999999999999996665443222111111 111111111221
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
..+ ..+.+++.+||+.||++||||.+|++.|.++.+.
T Consensus 237 ~~~-------~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 237 DCP-------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TCB-------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hhH-------HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 2267899999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=397.45 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=202.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|++.+.||+|+||+||+|+. .+++.||||++...... ..+.|.+|++++++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4688999999999999999975 57899999999765433 3467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999876532 34899999999999999999999 779999999999999999999999999999765432
Q ss_pred CCCceecccccccccccccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 329 SSNRTLLAGTYGYIAPELAY-----TMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
........||+.|+|||++. ...++.++|||||||++|||+||+.||........... +...-.+.+..
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~-- 237 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK----IAKSEPPTLAQ-- 237 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHHSCCCCCSS--
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH----HHcCCCCCCCc--
Confidence 22333467999999999884 45688999999999999999999999976543221111 00000111111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.....+ .+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~s~---~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 PSRWSS---NFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112 26679999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=393.09 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=194.7
Q ss_pred ceeeeeCCceEEEEEcC---CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEecc
Q 012219 176 YCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYME 252 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 252 (468)
+.||+|+||+||+|.+. .++.||||+++..... ....+.|.+|++++++++|||||+++|+|..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999753 3568999999754432 23457899999999999999999999999654 5789999999
Q ss_pred CCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC-
Q 012219 253 MGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN- 331 (468)
Q Consensus 253 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 331 (468)
+|+|.++++... .+++.+++.++.|||.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999998654 3899999999999999999999 779999999999999999999999999999876543322
Q ss_pred --ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 332 --RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 332 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.......... .+.....+..+...+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~----~i~~~~~~~~p~~~~---- 236 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGERMGCPAGCP---- 236 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTCCCCCCTTCC----
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH----HHHcCCCCCCCcccC----
Confidence 223468999999999999999999999999999999998 899998654321110 000101111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
. .+.+++.+||+.||++|||+++|.+.|+.
T Consensus 237 ~---~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 237 R---EMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp H---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred H---HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2 26789999999999999999999877764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=396.31 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=204.4
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999975 579999999998655444455678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987644 3899999999999999999999 779999999999999999999999999999887533
Q ss_pred CC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 329 SS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 329 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ...... ....++...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~----~~~~~p~~~s-- 234 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKIIK----LEYDFPEKFF-- 234 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHT----TCCCCCTTCC--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-HHHHHc----CCCCCCccCC--
Confidence 22 23345799999999999999999999999999999999999999975432111 111000 0111222222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
+ .+.+++.+||+.||++|||++|+.+
T Consensus 235 --~---~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 235 --P---KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --H---HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --H---HHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 2667999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=385.13 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=195.6
Q ss_pred ccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee----CCEEEE
Q 012219 172 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH----RKCMFL 246 (468)
Q Consensus 172 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 246 (468)
|.+.+.||+|+||+||+|.. .+++.||+|++....... ...+.|.+|++++++++|||||++++++.. ....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 35667899999999999975 468899999997654332 345679999999999999999999999865 456899
Q ss_pred EEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeC-CCCCeEEeeccccc
Q 012219 247 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPP--IVHRDISSNNVLLN-SELEAFVADFGVAR 323 (468)
Q Consensus 247 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~~~ 323 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999997643 3899999999999999999999 555 99999999999997 47899999999998
Q ss_pred cccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCcc
Q 012219 324 LLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPV 403 (468)
Q Consensus 324 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... ........||+.|+|||++.+ .++.++|||||||++|||+||+.||............ +..... ....
T Consensus 164 ~~~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~---i~~~~~---~~~~ 234 (270)
T d1t4ha_ 164 LKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVK---PASF 234 (270)
T ss_dssp GCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCC---CGGG
T ss_pred ecc--CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH---HHcCCC---Cccc
Confidence 643 233456689999999998865 5999999999999999999999999754332211111 000000 1111
Q ss_pred chhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 404 DQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 404 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...... .+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 DKVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccCCH---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111111 26679999999999999999999853
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=396.31 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=202.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|+..+.||+|+||+||+|+. .+++.||||++...........+.|.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999974 578999999998766554456678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|||++|+|..++.... .+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999977665433 4899999999999999999999 77999999999999999999999999999986542
Q ss_pred CCCceeccccccccccccccC---CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 329 SSNRTLLAGTYGYIAPELAYT---MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.......... .......+.....
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~--- 237 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSG--- 237 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCT---
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCCC---
Confidence 234579999999999864 468999999999999999999999997543221111 0111111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+ .+.+++.+||+.||++|||+++++++
T Consensus 238 ~~s~---~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 238 HWSE---YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TSCH---HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCH---HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111 26679999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=401.15 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=204.0
Q ss_pred hhCccccceeeeeCCceEEEEEcCC------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|++.+.||+|+||+||+|++.. ...||||++...... .....|.+|+.++.++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3679999999999999999997532 236999998755433 2346788999999998 899999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEE--------------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDI 301 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 301 (468)
+..++||||+++|+|.++++.... ...+++..++.++.||+.||+||| +.+|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence 999999999999999999976432 234899999999999999999999 779999999
Q ss_pred CCCceeeCCCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcc
Q 012219 302 SSNNVLLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELL 378 (468)
Q Consensus 302 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~ 378 (468)
||+||+++.++.+||+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765443322 23467999999999999999999999999999999998 89999765
Q ss_pred cccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 379 SSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
......... ......+..+...+ + .+.+++.+||+.||++|||++||+++|..
T Consensus 271 ~~~~~~~~~---~~~~~~~~~p~~~~----~---~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDANFYKL---IQNGFKMDQPFYAT----E---EIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSHHHHHH---HHTTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHH---HhcCCCCCCCCcCC----H---HHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 432211110 00111111111111 2 26789999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=400.60 Aligned_cols=201 Identities=28% Similarity=0.366 Sum_probs=176.9
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++..... ...+.+.+|++++++++|||||+++++|.+++..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999975 57899999999765432 2346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999997643 38999999999999999999994 24899999999999999999999999999987643
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcc
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELL 378 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~ 378 (468)
. .....+||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2 233468999999999999999999999999999999999999999654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-52 Score=393.13 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=188.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
+.|++.+.||+|+||+||+|+. .+++.||||++....... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999975 478999999998655432 2356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEeeccccccc
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN---SELEAFVADFGVARLL 325 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~ 325 (468)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997643 3899999999999999999999 77999999999999994 5789999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ..... +.....+...
T Consensus 161 ~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-~i~~~----~~~~~~~~~~ 234 (307)
T d1a06a_ 161 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-QILKA----EYEFDSPYWD 234 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHTT----CCCCCTTTTT
T ss_pred cCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH-HHhcc----CCCCCCcccc
Confidence 432 33345679999999999999999999999999999999999999997543221110 00000 0111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+ .+.+++.+||+.||++|||++|++++
T Consensus 235 ~~s~---~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 DISD---SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TSCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 26679999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=390.90 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=200.7
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
.++|++.+.||+|+||.||+|++++++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3579999999999999999999988889999999765432 3679999999999999999999999965 4578999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|..++..... ..++|.+++.++.||+.||+||| +.+|+||||||+|||++.++++||+|||+++.....
T Consensus 91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999988875432 34899999999999999999999 679999999999999999999999999999876432
Q ss_pred C-CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 329 S-SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 329 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
. .......||+.|+|||++....++.++|||||||++|||+||..|+............ +.....+......+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i~~~~~~~~~~~~~--- 240 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECP--- 240 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTTCCCCCCTTSC---
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HHhcCCCCCCcccC---
Confidence 2 2333457899999999999999999999999999999999976665433222111111 11111111222222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
+ .+.+++.+||+.||++||||++|++.|+..-.
T Consensus 241 -~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 241 -E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -H---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 2 26789999999999999999999998887543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=383.45 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=197.1
Q ss_pred hhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 247 (468)
.++|++.+.||+|+||.||+|++ .|+.||||+++.+.. .+.|.+|++++++++||||++++|+|.+ .+..++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 35788899999999999999998 478899999976543 3678999999999999999999999965 4568999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++..... ..+++..+++++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999975432 24899999999999999999999 77999999999999999999999999999987542
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
......++..|+|||++.+..++.++|||||||++|||+| |++||........... +.....+......+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~~~~~~~~~~~~~-- 226 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEKGYKMDAPDGCP-- 226 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HTTTCCCCCCTTCC--
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCCCCCCCccCC--
Confidence 2333468899999999999999999999999999999998 7888876543222111 11111222222222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
. .+.+++.+||+.||++||||.+++++|+++
T Consensus 227 --~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 227 --P---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H---HHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 266899999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=391.26 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=210.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|+. .+|+.||||++++.........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999975 579999999998765544455678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999988644 3889999999999999999999 789999999999999999999999999999877655
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||........... .. .-...++...+.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--i~---~~~~~~p~~~s~--- 230 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--IL---MEEIRFPRTLSP--- 230 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH---HCCCCCCTTSCH---
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH--Hh---cCCCCCCccCCH---
Confidence 5555667899999999999999999999999999999999999999975443211110 00 011122222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRPT-----MQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~~ 438 (468)
.+.+++.+||+.||++||+ +++++++
T Consensus 231 ----~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 231 ----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 2567899999999999995 7888763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=386.99 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=204.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhh---hhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE---LASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.|.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999975 579999999997544321 123578999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEeeccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL----EAFVADFGV 321 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~ 321 (468)
+||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999997643 4899999999999999999999 77999999999999998876 499999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ... .. .......
T Consensus 164 a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i---~~-~~~~~~~ 237 (293)
T d1jksa_ 164 AHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANV---SA-VNYEFED 237 (293)
T ss_dssp CEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH---HT-TCCCCCH
T ss_pred hhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-HHH---Hh-cCCCCCc
Confidence 9876533 2334457899999999999999999999999999999999999999754322111 000 00 0111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ....+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 238 EYFSN---TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhcCC---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11011 11236689999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-51 Score=390.69 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=209.9
Q ss_pred HHHHHhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 164 DMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
+++...++|++.+.||+|+||+||+|+.. +++.||||+++..... ...+.|.+|++++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceee
Confidence 33344678999999999999999999753 4578999999765443 245789999999999999999999999
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPI 296 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 296 (468)
|...+..+++|||+++|+|.+++.... ....+++..++.++.|++.||+||| +.+|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 999999999999999999999986422 1234889999999999999999999 7899
Q ss_pred EecCCCCCceeeCCCCCeEEeeccccccccCCC--CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCC-C
Q 012219 297 VHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK-H 373 (468)
Q Consensus 297 vH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~-~ 373 (468)
+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998764322 2233457889999999999999999999999999999999985 5
Q ss_pred CCCcccccchhhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 374 PGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 374 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
||........... +.+...+..+...+ . .+.+++.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~~e~~~~----v~~~~~~~~p~~~~----~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYY----VRDGNILACPENCP----L---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHH----HHTTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHH----HHcCCCCCCCccch----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7765433211110 11111111121121 2 2678999999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-51 Score=392.37 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=206.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35899999999999999999975 57899999999766543 346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~~~~~ 325 (468)
|||+++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.+
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999986533 24899999999999999999999 789999999999999964 578999999999887
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...... .+.........
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~----~~~~~~~~~~~ 250 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKS----CDWNMDDSAFS 250 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----TCCCSCCGGGG
T ss_pred ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHh----CCCCCCccccc
Confidence 533 344556899999999999999999999999999999999999999975432211 111000 01111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+.+ .+.+++.+||+.||++|||++|++++
T Consensus 251 ~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GISE---DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 26678999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-50 Score=390.61 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=205.6
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|.. .+|+.||||+++.....+ .+.+.+|++++++++|||||++++++.+++..++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999975 579999999998765432 357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEeecccccccc
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLN--SELEAFVADFGVARLLN 326 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~ 326 (468)
||+++|+|.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999998876543 34899999999999999999999 77999999999999998 67899999999998875
Q ss_pred CCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchh
Q 012219 327 FDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQK 406 (468)
Q Consensus 327 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (468)
.. .......||+.|+|||++.+..++.++||||+||++|||+||+.||......... ..... .+..........
T Consensus 181 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~~----~~~~~~~~~~~~ 254 (352)
T d1koba_ 181 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKR----CDWEFDEDAFSS 254 (352)
T ss_dssp TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHH----CCCCCCSSTTTT
T ss_pred CC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----CCCCCCcccccC
Confidence 43 3445567999999999999999999999999999999999999999754332111 10000 011111111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 407 IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 407 ~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+.. .+.+++.+||+.||++|||++|++++
T Consensus 255 ~s~---~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 VSP---EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 26679999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=384.58 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=194.7
Q ss_pred hCccccceeeeeCCceEEEEEcC--CC--CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP--SG--KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||.||+|++. ++ ..||||++...........+.|.+|++++++++||||++++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 57999999999999999999752 23 36899999876555555667899999999999999999999999764 568
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|++.+++..... .+++..++.++.|||.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998875432 3899999999999999999999 779999999999999999999999999999987
Q ss_pred cCCCCC---ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 326 NFDSSN---RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 326 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||........... .. .....+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~-i~--~~~~~~~~~~ 238 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-ID--KEGERLPRPE 238 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HH--TSCCCCCCCT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH-HH--hCCCCCCCcc
Confidence 543322 223457889999999999999999999999999999998 8999975543221110 00 0001111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
..+ . .+.+++.+||+.||++||||++|.+.|++.
T Consensus 239 ~~~----~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DCP----Q---DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122 1 267899999999999999999999988763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-50 Score=384.92 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=206.6
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999975 579999999998665554456778999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||++||+|..++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999998876543 788888999999999999999 88999999999999999999999999999987643
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||......... .. +.. ......+..+.
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~---i~~-~~~~~p~~~s~--- 226 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EK---ILN-AELRFPPFFNE--- 226 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH---HHH-CCCCCCTTSCH---
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-HH---HHc-CCCCCCCCCCH---
Confidence 233467999999999999999999999999999999999999999754322111 10 000 01112222222
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRP-----TMQLVSNE 438 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~~ 438 (468)
.+.+++.+||+.||++|| |+++++++
T Consensus 227 ----~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 227 ----DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 156789999999999996 89998854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=382.63 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=203.1
Q ss_pred cceeeeeCCceEEEEEcCCC----CEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-CCEEEEEEE
Q 012219 175 KYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH-RKCMFLIYE 249 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 249 (468)
.++||+|+||+||+|++.++ ..||||+++..... ...++|.+|++++++++||||++++|+|.+ +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 56899999999999986432 25899999754332 345789999999999999999999999876 468999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+++|+|.+++..... ..++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999876443 3778899999999999999999 7899999999999999999999999999998764332
Q ss_pred C----CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 330 S----NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 330 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||............ +.....+..+...+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~---i~~g~~~~~p~~~~- 260 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCP- 260 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH---HHTTCCCCCCTTCC-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCCCCcccCc-
Confidence 2 122346899999999999999999999999999999999988776543221111110 00001111111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCCCCCCCccc
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKAPMQKPFHE 453 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~~~~~~~~~ 453 (468)
+ .+.+++.+||+.||++||||.||++.|+++......+.+.+
T Consensus 261 ---~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~ 302 (311)
T d1r0pa_ 261 ---D---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302 (311)
T ss_dssp ---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred ---H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchh
Confidence 1 26789999999999999999999999998876544444433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-50 Score=379.21 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=202.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 244 (468)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.....+....+.|.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5799999999999999999974 579999999998766554455678999999999999999999999987643 47
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++...+ .+++.+++.++.||+.||+||| +.+|+||||||+|||++.++..+++|||.++.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 99999999999999887644 3899999999999999999999 77999999999999999999999999999876
Q ss_pred ccCCC---CCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDS---SNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ..............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVREDPIPPSARHE 239 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHCCCCCGGGTSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH-HHhcCCCCCchhcc
Confidence 54322 233445799999999999999999999999999999999999999975432211111 00000000001111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhc
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRP-TMQLVSNEFIAR 442 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~v~~~l~~~ 442 (468)
..+ + .+.+++.+||+.||++|| |++++.+.|.+.
T Consensus 240 ~~s----~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 240 GLS----A---DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SCC----H---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCC----H---HHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111 1 266799999999999999 899999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=379.26 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=195.0
Q ss_pred hhCccccceeeeeCCceEEEEEcCC----CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.++|++.+.||+|+||.||+|.+.. +..||||+++..... ...+.|.+|++++++++|||||+++|++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 3679999999999999999997642 356899988654433 345789999999999999999999999964 568
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876543 34899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCC-CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCCc
Q 012219 325 LNFDSS-NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSPP 402 (468)
Q Consensus 325 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |++||........... +.....+...+.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGERLPMPPN 233 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTCCCCCCTT
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCCCCC
Confidence 653322 2334568999999999999999999999999999999998 8999876543221111 011111112222
Q ss_pred cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 403 VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 403 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.+ + .+.+++.+||+.||++|||+++|++.|.++
T Consensus 234 ~~----~---~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 234 CP----P---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 2 267799999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=387.55 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=199.3
Q ss_pred hCccccceeeeeCCceEEEEEcC-CCC----EEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 244 (468)
.+|++.+.||+|+||+||+|.+. +|+ .||+|+++..... ...+.|.+|++++++++|||||+++|+|.++. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 46999999999999999999753 444 5899988754332 34578999999999999999999999998765 6
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
++++||+.+|+|.+++.... ..+++..++.++.|||.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 77889999999999887643 34899999999999999999999 77999999999999999999999999999998
Q ss_pred ccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccchhhhcccccccccCCCCCC
Q 012219 325 LNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSWSLDKNIKLIDLLDPRLSP 401 (468)
Q Consensus 325 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+.......... +.....+..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~----i~~~~~~~~p~ 236 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----LEKGERLPQPP 236 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH----HHHTCCCCCCT
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCCCCCCCc
Confidence 7543332 223468999999999999999999999999999999999 8999876543221110 00111111111
Q ss_pred ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 402 PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 402 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
..+ . .+.+++.+||+.||++|||+.+++++|..+.
T Consensus 237 ~~~----~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 237 ICT----I---DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp TBC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC----H---HHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 121 1 2677999999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=378.98 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=198.4
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 245 (468)
++|.+.+.||+|+||.||+|++ +|+.||||+++...... ..+..|+..+.+++|||||+++|+|.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4678889999999999999987 68899999997543221 12234555566789999999999998643 689
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeeCCCCCeEEeecc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHD-----CTPPIVHRDISSNNVLLNSELEAFVADFG 320 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 320 (468)
+||||+++|+|.++++.. .++|.++++++.|+|.||+|||+. .+++|+||||||+|||++.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999764 389999999999999999999952 13699999999999999999999999999
Q ss_pred ccccccCCCC----CceeccccccccccccccCC------CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc--
Q 012219 321 VARLLNFDSS----NRTLLAGTYGYIAPELAYTM------VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN-- 388 (468)
Q Consensus 321 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~-- 388 (468)
+++....... ......||+.|+|||++... .++.++|||||||++|||+||..|+.............
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987754322 22345799999999998754 36779999999999999999998875432211110000
Q ss_pred -----c-ccccccCCCCCCccchh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcC
Q 012219 389 -----I-KLIDLLDPRLSPPVDQK--IRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARN 443 (468)
Q Consensus 389 -----~-~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~ 443 (468)
. ......+..+.+..... ..+....+.+++.+||+.||++|||+.||++.|.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0 00011122222221111 1133445888999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=383.28 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=206.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHh-hccCCceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLS-QIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||+||+|+. .+++.||||+++..........+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999975 578999999998655444445566777777765 68999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccC
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 327 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 327 (468)
|||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997644 3889999999999999999999 77999999999999999999999999999987765
Q ss_pred CCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhH
Q 012219 328 DSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKI 407 (468)
Q Consensus 328 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (468)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||......... .. .. .-.+..+...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-~~-i~---~~~~~~p~~~s--- 227 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HS-IR---MDNPFYPRWLE--- 227 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-HH---HCCCCCCTTSC---
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-HH-HH---cCCCCCCccCC---
Confidence 556666678999999999999999999999999999999999999999754322111 10 00 01122222222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 012219 408 RQDIILVSTVAFSCLRSQPKSRPTMQ-LVSN 437 (468)
Q Consensus 408 ~~~~~~l~~l~~~cl~~dP~~RPs~~-~v~~ 437 (468)
. .+.+++.+||+.||++|||+. ++++
T Consensus 228 -~---~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 228 -K---EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -H---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -H---HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2 266799999999999999995 6753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-49 Score=371.67 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=204.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchh------hhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE------ELASLESFGNEARLLSQIR-HRNIVKLYGFCLHR 241 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 241 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... .....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999975 57899999999765322 1223456889999999997 99999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997543 4899999999999999999999 77999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccC------CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhccccccccc
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYT------MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLL 395 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||......... ..... .
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-~~i~~--~-- 230 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMIMS--G-- 230 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH--T--
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-HHHHh--C--
Confidence 98876433 3445679999999998853 35788999999999999999999999865432111 00000 0
Q ss_pred CCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 396 DPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+.....++ .+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~s~---~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFGSPEWDDYSD---TVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCCTTTGGGSCH---HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCH---HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111111111112 26779999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=380.24 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred HhhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee
Q 012219 168 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH 240 (468)
Q Consensus 168 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 240 (468)
..++|++.+.||+|+||.||+|.+. +++.||||+++..... ...+.+.+|...+.++ +|+||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3468999999999999999999742 3568999999755433 2346788888888877 68999999999876
Q ss_pred C-CEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 241 R-KCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 241 ~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
. ...++||||+++|+|.++++.... ...+++.+++.++.||+.||+||| +.+|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccce
Confidence 4 468999999999999999975432 234889999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhC-CCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMG-KHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg-~~p~~~~~~~~~ 383 (468)
|++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+|| ..||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987643322 23345799999999999999999999999999999999996 567765443222
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.... +.+...+......+ . .+.+++.+||+.||++|||++|++++|+++
T Consensus 246 ~~~~---~~~~~~~~~~~~~~----~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 FCRR---LKEGTRMRAPDYTT----P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHH---HHHTCCCCCCTTCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---HhcCCCCCCCccCC----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1110 01111122222122 1 267899999999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-50 Score=384.64 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=206.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+++++.++|||||++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999975 579999999998665555556678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.+|+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997654 3899999999999999999999 779999999999999999999999999999876532
Q ss_pred CCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccchhHH
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQKIR 408 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (468)
.....||+.|||||++.+..++.++|||||||++|||+||+.||........ ... +.. -.+......+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~---i~~-~~~~~p~~~s~--- 263 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEK---IVS-GKVRFPSHFSS--- 263 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH---HHH-CCCCCCTTCCH---
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-HHH---Hhc-CCCCCCccCCH---
Confidence 3346799999999999999999999999999999999999999975432111 110 000 01111222221
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 012219 409 QDIILVSTVAFSCLRSQPKSRP-----TMQLVSN 437 (468)
Q Consensus 409 ~~~~~l~~l~~~cl~~dP~~RP-----s~~~v~~ 437 (468)
.+.+++.+||+.||++|+ |++++++
T Consensus 264 ----~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 264 ----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 266799999999999994 8999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-49 Score=384.39 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=198.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHH---HHHHhhccCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNE---ARLLSQIRHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||.||+|+. .+|+.||||++.............+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999975 5799999999975544333333344444 66777788999999999999999999
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 325 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 325 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997643 3789999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccc
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVD 404 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (468)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||............ ..............+
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTMAVELPDSFS 233 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH--HHSSSCCCCCCSSSC
T ss_pred CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcccCCCCCCCCCC
Confidence 533 2344579999999999875 56899999999999999999999999754332111100 000001111222222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 405 QKIRQDIILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 405 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
. .+.+++.+||+.||++||| ++++++
T Consensus 234 ~-------~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 234 P-------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp H-------HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred H-------HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1 2667999999999999999 688874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=380.52 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=202.6
Q ss_pred hCccccceeeeeCCceEEEEEcCC-CC--EEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeCCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPS-GK--VVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHRKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 245 (468)
++|++.+.||+|+||+||+|.+.+ |. .||||+++..... ...+.|.+|++++.++ +|||||+++|+|.+.+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 578999999999999999997643 43 4788887654333 2346799999999999 7999999999999999999
Q ss_pred EEEEeccCCChhhhhhcC-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 012219 246 LIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL 312 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~ 312 (468)
+||||+++|+|.++++.. .....+++.+++.++.|||.||.||| +.+|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence 999999999999999754 23356899999999999999999999 77999999999999999999
Q ss_pred CeEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCC-CCCCcccccchhhhccccc
Q 012219 313 EAFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK-HPGELLSSSSWSLDKNIKL 391 (468)
Q Consensus 313 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~ 391 (468)
.+||+|||+++..... .......||..|+|||.+....++.++|||||||++|||++|. +||.......... .+
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~----~i 239 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL 239 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HG
T ss_pred ceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH----HH
Confidence 9999999999865422 2223456899999999999999999999999999999999965 5676443221110 11
Q ss_pred ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCCC
Q 012219 392 IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNKA 445 (468)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~~ 445 (468)
.+...+......+ + .+.+++.+||+.||++||||++|++.|.++.+.
T Consensus 240 ~~~~~~~~~~~~~----~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 PQGYRLEKPLNCD----D---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGTCCCCCCTTBC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcCCCCCCccCC----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111122222222 2 267799999999999999999999998876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=378.01 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=203.7
Q ss_pred hhCccccceeeeeCCceEEEEEcC--------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEe
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCL 239 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 239 (468)
.++|.+.+.||+|+||.||+|+.. ++..||||+++..... .....+.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 367999999999999999999742 2347999999865543 2456788999999888 8999999999999
Q ss_pred eCCEEEEEEEeccCCChhhhhhcCcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 240 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 240 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
+++..++||||+++|+|.+++..... ...+++.+++.++.||+.||.||| +.+|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 99999999999999999999975431 235899999999999999999999 78999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCC--CceeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
|++.++.+||+|||+++....... ......|++.|+|||++.++.++.++|||||||++|||+| |++||........
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999987754332 2233568999999999999999999999999999999998 7888875443211
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
. . .+.....+..+.... + .+.+++.+||+.||++|||+.||++.|+++
T Consensus 247 ~-~---~i~~~~~~~~p~~~~----~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 F-K---LLKEGHRMDKPSNCT----N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H-H---HHHTTCCCCCCSSCC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-H---HHHcCCCCCCCccch----H---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 0 111111122222222 2 267899999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=378.34 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=196.5
Q ss_pred hhCccccc-eeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEee----C
Q 012219 169 TEDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLH----R 241 (468)
Q Consensus 169 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~ 241 (468)
.++|.+.. .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 35788765 699999999999975 67999999999643 3456899887655 89999999999865 4
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEee
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVAD 318 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D 318 (468)
...++|||||+||+|.+++.... ...+++.++..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence 56899999999999999997643 235899999999999999999999 789999999999999986 46799999
Q ss_pred ccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCC
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPR 398 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
||+|+..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ...........
T Consensus 158 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~~i~~~~~~ 235 (335)
T d2ozaa1 158 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRMGQYE 235 (335)
T ss_dssp CTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSS
T ss_pred cceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-HHHHHhcCCCC
Confidence 9999876543 334456799999999999999999999999999999999999999975432111000 00000001111
Q ss_pred CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 399 LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 399 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+..+....+ ...+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FPNPEWSEV---SEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCTTHHHHS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccC---CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111111 2237789999999999999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=377.03 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=203.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEE
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 247 (468)
.++|.+.+.||+|+||+||+|.. .+++.||||+++..... ...+.+|++++++++|||||++++++.+++..++|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999975 57889999999876543 24678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC--CCeEEeeccccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE--LEAFVADFGVARLL 325 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~~~~~ 325 (468)
||||++|+|.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999997643 24899999999999999999999 7799999999999999854 58999999999876
Q ss_pred cCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCCCccch
Q 012219 326 NFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLSPPVDQ 405 (468)
Q Consensus 326 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (468)
.. ........+++.|+|||...+..++.++||||+||++|||++|+.||......... ..... ....+......
T Consensus 155 ~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-~~i~~----~~~~~~~~~~~ 228 (321)
T d1tkia_ 155 KP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-ENIMN----AEYTFDEEAFK 228 (321)
T ss_dssp CT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHH----TCCCCCHHHHT
T ss_pred cc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----CCCCCChhhcc
Confidence 43 23344567899999999999999999999999999999999999999754322111 00000 00011110000
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 406 KIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 406 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
.+. ..+.+++.+||..||++|||++|++++
T Consensus 229 ~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EIS---IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 126689999999999999999999963
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=373.03 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=199.1
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5799999999999999999975 67999999999765432 223567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
||+.++ +.+++.... ...+++.++..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 81 e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 999765 444443322 234899999999999999999999 779999999999999999999999999999887655
Q ss_pred CCCceeccccccccccccccCCC-CCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------c---ccccccc--
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------K---NIKLIDL-- 394 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------~---~~~~~~~-- 394 (468)
........||+.|+|||++.... ++.++||||+||++|+|++|+.||........... . .......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 55556678999999999877655 57899999999999999999999975432110000 0 0000000
Q ss_pred cCCCC----CCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 395 LDPRL----SPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 395 ~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ..............+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 000000000011236789999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=376.03 Aligned_cols=261 Identities=22% Similarity=0.259 Sum_probs=194.7
Q ss_pred cceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh--hhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEEec
Q 012219 175 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL--ASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYEYM 251 (468)
Q Consensus 175 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 251 (468)
.+.||+|+||+||+|+. .+|+.||||+++....... ...+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999986 4689999999976543221 12346889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCCCC
Q 012219 252 EMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 331 (468)
Q Consensus 252 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 331 (468)
.++++....... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988777665433 33888899999999999999999 789999999999999999999999999999887655555
Q ss_pred ceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------cccccccccC
Q 012219 332 RTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------KNIKLIDLLD 396 (468)
Q Consensus 332 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------~~~~~~~~~~ 396 (468)
.....||+.|+|||++... .++.++|||||||++|||+||+.||........... ..........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5566899999999988654 679999999999999999999999965332111000 0000000000
Q ss_pred -CCCCC-ccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 397 -PRLSP-PVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 397 -~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
..... +...........+.+++.+||+.||++|||++|++++ |++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 00000 0000000001237789999999999999999999864 554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=375.85 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=207.2
Q ss_pred hhCccccceeeeeCCceEEEEEc------CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc-cCCceeeEEEEEeeC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFGNEARLLSQI-RHRNIVKLYGFCLHR 241 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 241 (468)
.++|++.+.||+|+||.||+|++ .+++.||||+++..... .....|.+|+.+++++ +|||||+++|+|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 46899999999999999999974 35678999999865543 2346799999999999 699999999999999
Q ss_pred CEEEEEEEeccCCChhhhhhcCc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDE---------------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNV 306 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NI 306 (468)
+..++||||+++|+|.++++... ....+++..+..++.||+.||+||| +.+++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 99999999999999999997543 2235889999999999999999999 77999999999999
Q ss_pred eeCCCCCeEEeeccccccccCCCCCc--eeccccccccccccccCCCCCccchhhHHHHHHHHHHh-CCCCCCcccccch
Q 012219 307 LLNSELEAFVADFGVARLLNFDSSNR--TLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLM-GKHPGELLSSSSW 383 (468)
Q Consensus 307 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~t-g~~p~~~~~~~~~ 383 (468)
+++.++.+|++|||.++......... ....||+.|+|||++.+..++.++|||||||++|||+| |++|+........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998775433222 23578999999999999999999999999999999999 5566654333211
Q ss_pred hhhcccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 384 SLDKNIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
.... ......+......+ + .+.+++.+||+.||++||||++|++.|+++
T Consensus 257 ~~~~---i~~~~~~~~~~~~~----~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FYKM---IKEGFRMLSPEHAP----A---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH---HHHTCCCCCCTTSC----H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---HhcCCCCCCccccc----H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1100 00111111111111 2 267899999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=377.63 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=208.1
Q ss_pred hhCccccceeeeeCCceEEEEEcC------CCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 242 (468)
.++|.+.+.||+|+||+||+|.+. +++.||||+++..... .....|.+|++++++++||||++++|+|....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 468899999999999999999753 3578999999765433 34567999999999999999999999999999
Q ss_pred EEEEEEEeccCCChhhhhhcCc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDE-------EAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAF 315 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 315 (468)
..++||||+++|+|.+++.... ....+++..+..++.|+|+||.||| +.+|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999886432 2234789999999999999999999 77999999999999999999999
Q ss_pred EeeccccccccCCCCC--ceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCC-CCCCcccccchhhhcccccc
Q 012219 316 VADFGVARLLNFDSSN--RTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGK-HPGELLSSSSWSLDKNIKLI 392 (468)
Q Consensus 316 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++........ .....||+.|+|||.+.+..++.++|||||||++|||+||. .||........... +.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~ 249 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VM 249 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH
Confidence 9999999876433221 22346899999999999999999999999999999999984 77765433221110 00
Q ss_pred cccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhcCC
Q 012219 393 DLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIARNK 444 (468)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~~~ 444 (468)
+...+......+ ..+.+++.+||+.||++||||++|++.|++...
T Consensus 250 ~~~~~~~p~~~~-------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKPDNCP-------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCcccch-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000111111111 127789999999999999999999999987644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.2e-49 Score=369.32 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=198.8
Q ss_pred hCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIYE 249 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 249 (468)
++|++.+.||+|+||+||+|+.++|+.||||+++.....+ ...+.+.+|+.++++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 5799999999999999999998899999999997765432 345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCCC
Q 012219 250 YMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 329 (468)
Q Consensus 250 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 329 (468)
|+.++.+..+.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99887776665543 34899999999999999999999 7799999999999999999999999999998876555
Q ss_pred CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh-----------cc---cccccc
Q 012219 330 SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-----------KN---IKLIDL 394 (468)
Q Consensus 330 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-----------~~---~~~~~~ 394 (468)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||........... .. ......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 555556789999999998754 578999999999999999999999975432110000 00 000000
Q ss_pred ---cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 395 ---LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 395 ---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
.......+...........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000000112668999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=365.24 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=195.0
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhh---hhHHHHHHHHHHHhhcc--CCceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFGNEARLLSQIR--HRNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 243 (468)
++|.+.+.||+|+||+||+|+. .+|+.||||++........ ...+.+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999975 5799999999975432211 11234668999999996 8999999999999999
Q ss_pred EEEEEEeccC-CChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEeeccc
Q 012219 244 MFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSE-LEAFVADFGV 321 (468)
Q Consensus 244 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~ 321 (468)
.++||||+.+ +++.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777776543 3899999999999999999999 7899999999999999855 7999999999
Q ss_pred cccccCCCCCceeccccccccccccccCCCC-CccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYTMVV-TEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...... ... ...+.
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---~~~--------~~~~~ 224 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IRG--------QVFFR 224 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHC--------CCCCS
T ss_pred ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH---hhc--------ccCCC
Confidence 987542 33445679999999999987665 56789999999999999999999753210 000 01111
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
...+. .+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~s~-------~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 QRVSS-------ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCH-------HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 12221 26679999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=363.04 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=193.0
Q ss_pred hhCccccceeeeeCCceEEEEEc-CC-CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhc---cCCceeeEEEEEee---
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PS-GKVVALKKLHRSETEELASLESFGNEARLLSQI---RHRNIVKLYGFCLH--- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~--- 240 (468)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++.....+. ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999975 34 66799999975443221 123455777777665 79999999999853
Q ss_pred --CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEee
Q 012219 241 --RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVAD 318 (468)
Q Consensus 241 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 318 (468)
....++++||+.++++........ ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999877765544332 34889999999999999999999 77999999999999999999999999
Q ss_pred ccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh------------
Q 012219 319 FGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD------------ 386 (468)
Q Consensus 319 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~------------ 386 (468)
||+++.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||...........
T Consensus 160 fg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 999976542 2334456799999999999999999999999999999999999999975432110000
Q ss_pred --ccccc-ccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 387 --KNIKL-IDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 387 --~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..... ......................+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000000000000000001125678999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=359.61 Aligned_cols=260 Identities=21% Similarity=0.232 Sum_probs=192.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC----EE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----CM 244 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 244 (468)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+++|++++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 5799999999999999999964 68999999999754432 34567889999999999999999999997643 23
Q ss_pred EEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 245 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 245 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
+++++|+.+|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4455667799999999653 3899999999999999999999 77999999999999999999999999999987
Q ss_pred ccCCCC---CceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc-------------
Q 012219 325 LNFDSS---NRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK------------- 387 (468)
Q Consensus 325 ~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~------------- 387 (468)
...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 643222 2344579999999999854 56789999999999999999999999754321000000
Q ss_pred ------ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 388 ------NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 388 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
..............+...........+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000111100000001136789999999999999999999954
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=352.25 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=194.8
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee-------
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------- 240 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 240 (468)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+ ...+.+.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 36899999999999999999975 579999999987654432 344678899999999999999999998865
Q ss_pred -CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeec
Q 012219 241 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADF 319 (468)
Q Consensus 241 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 319 (468)
....++||||+.++.+....... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence 34579999999887766554432 23888999999999999999999 779999999999999999999999999
Q ss_pred cccccccCCC----CCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhc---c---
Q 012219 320 GVARLLNFDS----SNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDK---N--- 388 (468)
Q Consensus 320 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---~--- 388 (468)
|+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||............ .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998764322 122335699999999998755 6899999999999999999999999754321110000 0
Q ss_pred ----------cccccccCC--CCCCccchhHHH--HHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 389 ----------IKLIDLLDP--RLSPPVDQKIRQ--DIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 389 ----------~~~~~~~~~--~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
......... ............ ....+.+++.+||+.||++|||++|++++ |++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 000000000 000000000000 01235679999999999999999999866 554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=349.99 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=203.5
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCCEEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRKCMFLIY 248 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 248 (468)
++|++.+.||+|+||+||+|+. .+++.||||+++..... ....+.+.+|+.+++.++||||+++++++.+....++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5799999999999999999975 67899999999765432 234678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccccccCC
Q 012219 249 EYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 328 (468)
Q Consensus 249 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 328 (468)
|++.++++..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++.....
T Consensus 81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888876543 3789999999999999999999 779999999999999999999999999999987665
Q ss_pred CCCceeccccccccccccccCCC-CCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcc---------------cccc
Q 012219 329 SSNRTLLAGTYGYIAPELAYTMV-VTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKN---------------IKLI 392 (468)
Q Consensus 329 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~---------------~~~~ 392 (468)
........++..|+|||++.... ++.++||||+||++|||++|+.||............. ....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 55555667888999999887664 6899999999999999999999974322211100000 0000
Q ss_pred cccCC-C--CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 393 DLLDP-R--LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 393 ~~~~~-~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
+.... . ...............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0 0000000000001126678999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=359.31 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=190.5
Q ss_pred CccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC------CE
Q 012219 171 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR------KC 243 (468)
Q Consensus 171 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 243 (468)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++||||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 588889999999999999976 5799999999976542 233799999999999999999998643 34
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeecccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVA 322 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~ 322 (468)
.++||||++++.+....+.......+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 7899999987655444433333445999999999999999999999 88999999999999999875 8999999999
Q ss_pred ccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--------------- 386 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--------------- 386 (468)
+...... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...........
T Consensus 171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 8765332 3344579999999998765 5789999999999999999999999965432110000
Q ss_pred cccccccccCCCCCC-c----cchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 387 KNIKLIDLLDPRLSP-P----VDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~-~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
......+..-+.... + ...... ..+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTP---PEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 0 000111 126678999999999999999999953
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=349.67 Aligned_cols=254 Identities=16% Similarity=0.216 Sum_probs=190.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCcee-eEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIV-KLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv 247 (468)
++|++.+.||+|+||.||+|+. .+|+.||||++...... +.+..|+++++.++|+|++ .+.++..+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4699999999999999999975 57899999998765432 3577899999999877655 555566778889999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEeecccccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARL 324 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg~~~~ 324 (468)
|||+ ++++...+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. +..+||+|||+|+.
T Consensus 82 me~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9999 456766665433 34899999999999999999999 789999999999998753 56799999999988
Q ss_pred ccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--ccccc-ccc
Q 012219 325 LNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--KNIKL-IDL 394 (468)
Q Consensus 325 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--~~~~~-~~~ 394 (468)
+..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 753222 22345799999999999999999999999999999999999999975433211110 00000 000
Q ss_pred cCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 012219 395 LDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIA 441 (468)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~ 441 (468)
..+......+ ..+.+++..||+.+|++||+++++.+.|+.
T Consensus 236 ~~~~~~~~~p-------~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 236 PIEVLCKGYP-------SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CHHHHTTTSC-------HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ChhHhccCCC-------HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0000111111 226778999999999999999888766654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=356.18 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=190.6
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeCC-----
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHRK----- 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 242 (468)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.....+ ...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 36799999999999999999975 579999999997654332 34567889999999999999999999997654
Q ss_pred -EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccc
Q 012219 243 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGV 321 (468)
Q Consensus 243 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 321 (468)
..++||||+ +++|....+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence 479999999 56777776532 3899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCCceeccccccccccccccC-CCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh--------------
Q 012219 322 ARLLNFDSSNRTLLAGTYGYIAPELAYT-MVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD-------------- 386 (468)
Q Consensus 322 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~-------------- 386 (468)
++.... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 987643 2345679999999999876 4578999999999999999999999975432110000
Q ss_pred c-----ccccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 387 K-----NIKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 387 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
. .......................-..+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000000000000001125679999999999999999999965
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-45 Score=343.81 Aligned_cols=255 Identities=17% Similarity=0.198 Sum_probs=199.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-CceeeEEEEEeeCCEEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-RNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 247 (468)
++|.+.+.||+|+||+||+|+. .+|+.||||++...... +.+.+|++.++.++| +|++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 5799999999999999999975 57899999998654322 346688899999975 8999999999999999999
Q ss_pred EEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----CCCeEEeecccc
Q 012219 248 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNS-----ELEAFVADFGVA 322 (468)
Q Consensus 248 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfg~~ 322 (468)
|||+ +++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|
T Consensus 80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999 6899998876443 4899999999999999999999 889999999999999974 578999999999
Q ss_pred ccccCCCC-------CceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh--hccccccc
Q 012219 323 RLLNFDSS-------NRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL--DKNIKLID 393 (468)
Q Consensus 323 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~ 393 (468)
+....... ......||+.|||||++.+..++.++|||||||++|||+||+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 87643211 2234579999999999999999999999999999999999999997544321111 00000000
Q ss_pred ccC-CCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 012219 394 LLD-PRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNEFIAR 442 (468)
Q Consensus 394 ~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~l~~~ 442 (468)
... +.+....+ ..+.+++..|+..+|++||+++.+.+.|.+.
T Consensus 234 ~~~~~~l~~~~p-------~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLRELCAGFP-------EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHHHHTTTSC-------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChHHhcCCCC-------HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 000 00011111 2267788999999999999998887777654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=351.53 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=198.1
Q ss_pred hCccccceeeeeCCceEEEEEc----CCCCEEEEEEecCcchh-hhhhHHHHHHHHHHHhhccC-CceeeEEEEEeeCCE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFGNEARLLSQIRH-RNIVKLYGFCLHRKC 243 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 243 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999964 25889999998754321 11223567799999999977 899999999999999
Q ss_pred EEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 244 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 244 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.++++||+.+|+|.+++..... +.......++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999976543 678889999999999999999 7799999999999999999999999999998
Q ss_pred cccCC-CCCceeccccccccccccccCC--CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhhcccccccccCCCCC
Q 012219 324 LLNFD-SSNRTLLAGTYGYIAPELAYTM--VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLDKNIKLIDLLDPRLS 400 (468)
Q Consensus 324 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.+... ........|++.|+|||.+.+. .++.++|||||||++|||+||+.||...........-... .....+...
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~ 256 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYP 256 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-HHHCCCCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cccCCCCCc
Confidence 76432 2233446799999999998754 4788999999999999999999999754432111110000 000111122
Q ss_pred CccchhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 012219 401 PPVDQKIRQDIILVSTVAFSCLRSQPKSRPT-----MQLVSN 437 (468)
Q Consensus 401 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~v~~ 437 (468)
...+. .+.+++.+||+.||++||| ++|+++
T Consensus 257 ~~~s~-------~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 QEMSA-------LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TTSCH-------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccCCH-------HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 21221 2667899999999999994 788886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=344.97 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=192.9
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEee--CCEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLH--RKCMF 245 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~ 245 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++++.++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 6899999999999999999975 579999999997644 246789999999995 9999999999874 35689
Q ss_pred EEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEeecccccc
Q 012219 246 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARL 324 (468)
Q Consensus 246 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~ 324 (468)
+||||+.+++|..+.+ .+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.
T Consensus 109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 9999999999977643 3899999999999999999999 78999999999999998765 589999999987
Q ss_pred ccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhh------------------
Q 012219 325 LNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL------------------ 385 (468)
Q Consensus 325 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~------------------ 385 (468)
.... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........
T Consensus 180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred ccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 6533 334456789999999998765 57999999999999999999999986543211000
Q ss_pred ---hcccccccccCCC--------CCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 012219 386 ---DKNIKLIDLLDPR--------LSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSN 437 (468)
Q Consensus 386 ---~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~ 437 (468)
............. .......... ..+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVS---PEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 0000001111 12668999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=348.55 Aligned_cols=258 Identities=22% Similarity=0.249 Sum_probs=187.8
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEee------CC
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLH------RK 242 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 242 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 5799999999999999999975 47999999999865433 2345678899999999999999999999864 36
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..++||||+.++.+. .+. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhh
Confidence 789999999765544 442 23889999999999999999999 779999999999999999999999999998
Q ss_pred ccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhh-----------------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSL----------------- 385 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~----------------- 385 (468)
+.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 167 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 87643 333445578999999999999999999999999999999999999996432110000
Q ss_pred --------hcc-----cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 012219 386 --------DKN-----IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE 438 (468)
Q Consensus 386 --------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~ 438 (468)
... .........................+.+++.+||..||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000011111111112223347789999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=346.74 Aligned_cols=262 Identities=22% Similarity=0.236 Sum_probs=193.3
Q ss_pred hhCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCceeeEEEEEeeC-----C
Q 012219 169 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNIVKLYGFCLHR-----K 242 (468)
Q Consensus 169 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 242 (468)
+++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|++++++++|||+|++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46799999999999999999974 679999999998654332 3456788999999999999999999998643 3
Q ss_pred EEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEeecccc
Q 012219 243 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVADFGVA 322 (468)
Q Consensus 243 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 322 (468)
..+++++|+.+|+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence 346677888899999998643 3899999999999999999999 779999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccccccccccCC-CCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---cc----------
Q 012219 323 RLLNFDSSNRTLLAGTYGYIAPELAYTM-VVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD---KN---------- 388 (468)
Q Consensus 323 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~---~~---------- 388 (468)
.... .......|++.|+|||...+. .++.++||||+||++|+|++|+.||........... ..
T Consensus 169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 7643 223345789999999987665 568899999999999999999999964332100000 00
Q ss_pred ------cccccccCCCCCCccchhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHh
Q 012219 389 ------IKLIDLLDPRLSPPVDQKIRQDIILVSTVAFSCLRSQPKSRPTMQLVSNE-FIA 441 (468)
Q Consensus 389 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~v~~~-l~~ 441 (468)
.........................+.+++.+||+.||++|||++|++++ |+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 00000000000000000000011226689999999999999999999963 444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-39 Score=312.70 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=187.3
Q ss_pred hCccccceeeeeCCceEEEEEc-CCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-----------CCceeeEEEE
Q 012219 170 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-----------HRNIVKLYGF 237 (468)
Q Consensus 170 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~ 237 (468)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3599999999999999999975 57999999999865432 356778888888775 5789999988
Q ss_pred Eee--CCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--
Q 012219 238 CLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELE-- 313 (468)
Q Consensus 238 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-- 313 (468)
+.. ....+++++++..+..............+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 764 45567777776655544333333334458889999999999999999995 369999999999999987654
Q ss_pred ----eEEeeccccccccCCCCCceeccccccccccccccCCCCCccchhhHHHHHHHHHHhCCCCCCcccccchhhh---
Q 012219 314 ----AFVADFGVARLLNFDSSNRTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALEVLMGKHPGELLSSSSWSLD--- 386 (468)
Q Consensus 314 ----~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~--- 386 (468)
++++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...........
T Consensus 167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999976542 23445799999999999999999999999999999999999999864322110000
Q ss_pred -----------------cccccccccC-----CCCCC----ccc-------hhHHHHHHHHHHHHHhcccCCCCCCCCHH
Q 012219 387 -----------------KNIKLIDLLD-----PRLSP----PVD-------QKIRQDIILVSTVAFSCLRSQPKSRPTMQ 433 (468)
Q Consensus 387 -----------------~~~~~~~~~~-----~~~~~----~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 433 (468)
.........+ ..... ... .........+.+++.+||..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000000 00000 000 00112334578899999999999999999
Q ss_pred HHHHH
Q 012219 434 LVSNE 438 (468)
Q Consensus 434 ~v~~~ 438 (468)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2e-24 Score=188.90 Aligned_cols=166 Identities=17% Similarity=0.189 Sum_probs=119.9
Q ss_pred cccceeeeeCCceEEEEEcCCCCEEEEEEecCcchh---------------hhhhHHHHHHHHHHHhhccCCceeeEEEE
Q 012219 173 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE---------------ELASLESFGNEARLLSQIRHRNIVKLYGF 237 (468)
Q Consensus 173 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 237 (468)
.+.+.||+|+||+||+|...+|+.||||+++..... .......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457889999999999999889999999987642211 01122345678889999999999988866
Q ss_pred EeeCCEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEe
Q 012219 238 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDCTPPIVHRDISSNNVLLNSELEAFVA 317 (468)
Q Consensus 238 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 317 (468)
.. .+++|||++++.+.. ++......++.|++.++.||| ..+|+||||||+|||+++++ ++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEE
Confidence 42 279999998765432 233345678999999999999 77999999999999999765 8899
Q ss_pred eccccccccCCCCCceeccccccccccc-----cccCCCCCccchhhHHHHH
Q 012219 318 DFGVARLLNFDSSNRTLLAGTYGYIAPE-----LAYTMVVTEKCDVYSFGVV 364 (468)
Q Consensus 318 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~Dv~s~Gvi 364 (468)
|||.|.....+... .|.... ......|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99999765422111 111110 0123567889999996543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.33 E-value=1.1e-12 Score=104.48 Aligned_cols=82 Identities=21% Similarity=0.340 Sum_probs=58.4
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--c---CCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--S---VRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~---~~~l~ 76 (468)
++++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+.++++|+.|++++|+++ .+|. . +.++.
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~ 93 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLV 93 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCC
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCC
Confidence 4667788888888887 67777777888888888888887 445 4777888888888888877 4442 2 34455
Q ss_pred ceecccccccc
Q 012219 77 HLYVYGKNFDV 87 (468)
Q Consensus 77 ~l~~~~n~l~~ 87 (468)
.|++++|+++.
T Consensus 94 ~L~l~~N~i~~ 104 (124)
T d1dcea3 94 LLNLQGNSLCQ 104 (124)
T ss_dssp EEECTTSGGGG
T ss_pred EEECCCCcCCc
Confidence 66777777654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.30 E-value=1.7e-12 Score=112.17 Aligned_cols=95 Identities=18% Similarity=0.238 Sum_probs=78.5
Q ss_pred CCCcEEEccCCcccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCcccee
Q 012219 4 SKLRVLELGNNLLSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLY 79 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~ 79 (468)
+++++|+|++|+|++.++ ..|+++++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..|..| .+|..|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 478999999999987664 568999999999999999998888899999999999999999995444444 4556688
Q ss_pred cccccccccCCCCCCCCCC
Q 012219 80 VYGKNFDVEIPNTSENSPP 98 (468)
Q Consensus 80 ~~~n~l~~~~p~~~~~~~~ 98 (468)
+++|.+....|..+...+.
T Consensus 109 L~~N~l~~i~~~~f~~l~~ 127 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNS 127 (192)
T ss_dssp CCSSCCCEECTTSSTTCTT
T ss_pred cCCccccccCHHHhcCCcc
Confidence 9999999887777665443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.28 E-value=1.5e-12 Score=121.64 Aligned_cols=84 Identities=21% Similarity=0.331 Sum_probs=74.2
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
++++|+.|++++|+++|.+| .++.+++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|. .+.+|..+.
T Consensus 219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~ 297 (313)
T d1ogqa_ 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297 (313)
T ss_dssp TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGG
T ss_pred cccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHH
Confidence 57889999999999997655 799999999999999999999999999999999999999999999997 345666677
Q ss_pred ccccccc
Q 012219 80 VYGKNFD 86 (468)
Q Consensus 80 ~~~n~l~ 86 (468)
+.+|+..
T Consensus 298 l~~N~~l 304 (313)
T d1ogqa_ 298 YANNKCL 304 (313)
T ss_dssp TCSSSEE
T ss_pred hCCCccc
Confidence 8888743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.26 E-value=1.3e-12 Score=122.09 Aligned_cols=93 Identities=23% Similarity=0.415 Sum_probs=71.9
Q ss_pred CCcEEEccCCcccc--cCCcccccCCCCCEeeccC-ccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 5 KLRVLELGNNLLSG--SIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 5 ~l~~l~l~~N~l~g--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
+++.|+|++|+++| .+|+++++|++|++|+|++ |+|+|.+|.+|++|++|++|+|++|+++|..|..+ ..+..+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57888888888887 5788888888888888886 78888888888888888888888888887666544 345556
Q ss_pred ecccccccccCCCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSENSP 97 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~~~ 97 (468)
+++.|.+...+|......+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp ECCSSEEESCCCGGGGGCT
T ss_pred ccccccccccCchhhccCc
Confidence 7777777777776554433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.23 E-value=9.6e-12 Score=107.28 Aligned_cols=87 Identities=23% Similarity=0.314 Sum_probs=73.0
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l 78 (468)
++++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..| .++..|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 57899999999999998888889999999999999999997777789999999999999999995444444 456667
Q ss_pred eccccccccc
Q 012219 79 YVYGKNFDVE 88 (468)
Q Consensus 79 ~~~~n~l~~~ 88 (468)
++++|.+.+.
T Consensus 132 ~L~~N~~~~~ 141 (192)
T d1w8aa_ 132 NLASNPFNCN 141 (192)
T ss_dssp ECTTCCBCCS
T ss_pred cccccccccc
Confidence 8888887654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.22 E-value=7.7e-12 Score=99.46 Aligned_cols=77 Identities=21% Similarity=0.370 Sum_probs=68.3
Q ss_pred cEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceeccccc
Q 012219 7 RVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYVYGKN 84 (468)
Q Consensus 7 ~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~n~ 84 (468)
++|+|++|+|+ .+| .++++++|++|+|++|+|+ .+|+.++.+++|+.|++++|+++ .+|. .+.++..|++++|.
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGGGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCccccccccCeEECCCCc
Confidence 58999999999 777 5999999999999999999 78989999999999999999999 5774 45667778899998
Q ss_pred ccc
Q 012219 85 FDV 87 (468)
Q Consensus 85 l~~ 87 (468)
+..
T Consensus 77 i~~ 79 (124)
T d1dcea3 77 LQQ 79 (124)
T ss_dssp CCS
T ss_pred cCC
Confidence 865
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=2.1e-11 Score=101.06 Aligned_cols=84 Identities=21% Similarity=0.315 Sum_probs=66.5
Q ss_pred CCCCCcEEEccCCc-ccccCC-cccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc-C--CCcc
Q 012219 2 NCSKLRVLELGNNL-LSGSIP-SEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES-V--RKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~-l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~--~~l~ 76 (468)
.+++|+.|+|++|+ |+ .|+ +.|.++++|+.|+|++|+|++.-|..|.++++|++|+|++|+|+ .+|.. + .++.
T Consensus 29 ~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~ 106 (156)
T d2ifga3 29 GAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ 106 (156)
T ss_dssp SCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCC
T ss_pred CccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcccccc
Confidence 46788999997664 87 554 56888999999999999999666777999999999999999998 67763 2 2456
Q ss_pred ceecccccccc
Q 012219 77 HLYVYGKNFDV 87 (468)
Q Consensus 77 ~l~~~~n~l~~ 87 (468)
.|++++|.+..
T Consensus 107 ~L~L~~Np~~C 117 (156)
T d2ifga3 107 ELVLSGNPLHC 117 (156)
T ss_dssp EEECCSSCCCC
T ss_pred ccccCCCcccC
Confidence 78888888764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=3.8e-11 Score=100.18 Aligned_cols=82 Identities=20% Similarity=0.272 Sum_probs=71.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC----cCCCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~ 77 (468)
++.+|++|+|++|+|+ .||..+..+++|+.|+||+|+|+ .++ .|..|++|++|++++|+++ .+|. .+.++..
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTE 91 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCcccccccccccc
Confidence 5678999999999999 88887889999999999999999 664 6899999999999999999 5665 3567888
Q ss_pred eecccccccc
Q 012219 78 LYVYGKNFDV 87 (468)
Q Consensus 78 l~~~~n~l~~ 87 (468)
|++.+|.+..
T Consensus 92 L~L~~N~i~~ 101 (162)
T d1a9na_ 92 LILTNNSLVE 101 (162)
T ss_dssp EECCSCCCCC
T ss_pred ceeccccccc
Confidence 9999998764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=7.5e-11 Score=98.36 Aligned_cols=83 Identities=14% Similarity=0.221 Sum_probs=69.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-----cCCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-----SVRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-----~~~~l~ 76 (468)
++++|+.|+|++|+|+ .++ .|..+++|++|+|++|++++..+..+..+++|+.|+|++|+++ .+++ .+.+|.
T Consensus 39 ~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~ 115 (162)
T d1a9na_ 39 TLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT 115 (162)
T ss_dssp GTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC
T ss_pred ccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccc
Confidence 4789999999999999 775 5999999999999999999544445678999999999999998 5553 345677
Q ss_pred ceecccccccc
Q 012219 77 HLYVYGKNFDV 87 (468)
Q Consensus 77 ~l~~~~n~l~~ 87 (468)
.|++.+|+++.
T Consensus 116 ~L~l~~N~i~~ 126 (162)
T d1a9na_ 116 YLCILRNPVTN 126 (162)
T ss_dssp EEECCSSGGGG
T ss_pred hhhcCCCcccc
Confidence 78899988754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=2.4e-10 Score=104.74 Aligned_cols=93 Identities=20% Similarity=0.266 Sum_probs=70.4
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
.+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..+. ++..|
T Consensus 127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 456788888888888854456688888888888888888876677788888888888888888876676654 45567
Q ss_pred ecccccccccCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSE 94 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~ 94 (468)
++++|.+....+..+.
T Consensus 207 ~l~~N~i~~~~~~~~~ 222 (284)
T d1ozna_ 207 YLFANNLSALPTEALA 222 (284)
T ss_dssp ECCSSCCSCCCHHHHT
T ss_pred cccccccccccccccc
Confidence 7888888766554443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.96 E-value=6.1e-10 Score=100.95 Aligned_cols=83 Identities=24% Similarity=0.347 Sum_probs=39.7
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcC---CCccceec
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPHLYV 80 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~ 80 (468)
.+|+.|++++|.+++..|..+..+++|+.|++++|+|++..|..|..+++|+.|+|++|+|+ .+|.++ .+++.|++
T Consensus 124 ~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L 202 (266)
T d1p9ag_ 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202 (266)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEEC
T ss_pred cccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEe
Confidence 34444445555554222333444555555555555555444444555555555555555555 455433 22333445
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
++|++.+
T Consensus 203 ~~Np~~C 209 (266)
T d1p9ag_ 203 HGNPWLC 209 (266)
T ss_dssp CSCCBCC
T ss_pred cCCCCCC
Confidence 5555443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.85 E-value=2.1e-09 Score=99.34 Aligned_cols=85 Identities=24% Similarity=0.335 Sum_probs=62.8
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Ccccee
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHLY 79 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~ 79 (468)
+++|+.|+|++|.+++..|..|.+++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .+|.++. +|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 467778888888887777777777888888888888887666777777888888888888887 6776544 445567
Q ss_pred ccccccccc
Q 012219 80 VYGKNFDVE 88 (468)
Q Consensus 80 ~~~n~l~~~ 88 (468)
+++|++...
T Consensus 249 Ls~N~i~~i 257 (305)
T d1xkua_ 249 LHNNNISAI 257 (305)
T ss_dssp CCSSCCCCC
T ss_pred CCCCccCcc
Confidence 777776643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=4e-09 Score=87.02 Aligned_cols=92 Identities=10% Similarity=0.054 Sum_probs=74.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCcc-ccccccccccCCCCCceecccCcccccccCCcC---CCccc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNS-INGKILSQLGEIPRIDTVDLSMNNLSGSIPESV---RKVPH 77 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~ 77 (468)
.+...+.+++++|+++ .+|..+..+++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|++.-|..| .+++.
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 4566788999999999 889999999999999998764 885556679999999999999999994334444 56777
Q ss_pred eecccccccccCCCCCC
Q 012219 78 LYVYGKNFDVEIPNTSE 94 (468)
Q Consensus 78 l~~~~n~l~~~~p~~~~ 94 (468)
|++++|.+....+..+.
T Consensus 85 L~Ls~N~l~~l~~~~~~ 101 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQ 101 (156)
T ss_dssp EECCSSCCSCCCSTTTC
T ss_pred eeccCCCCcccChhhhc
Confidence 89999999865554443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=1.8e-09 Score=98.78 Aligned_cols=96 Identities=18% Similarity=0.201 Sum_probs=74.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCC---Cccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVR---KVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l 78 (468)
++++|+.|+|++|.+.+..+..+..+.+|+.+++++|+|++..+..|.++++|+.|++++|++++..|..+. ++..+
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 578899999999998866666788888999999999999866667788889999999999999854454444 45567
Q ss_pred ecccccccccCCCCCCCCC
Q 012219 79 YVYGKNFDVEIPNTSENSP 97 (468)
Q Consensus 79 ~~~~n~l~~~~p~~~~~~~ 97 (468)
.+++|.+....|..+...+
T Consensus 183 ~l~~N~l~~i~~~~f~~l~ 201 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLG 201 (284)
T ss_dssp ECCSSCCCEECTTTTTTCT
T ss_pred hhhhccccccChhHhhhhh
Confidence 7888888877776665543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.78 E-value=6.7e-09 Score=95.84 Aligned_cols=83 Identities=22% Similarity=0.253 Sum_probs=61.5
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc----------
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---------- 71 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---------- 71 (468)
+++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .+|.+|.++++|+.|+|++|+|+ .++..
T Consensus 193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~ 270 (305)
T d1xkua_ 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTK 270 (305)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTT
T ss_pred ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcc
Confidence 4667788888888888666777888888888888888887 67778888888888888888887 56531
Q ss_pred CCCccceeccccccc
Q 012219 72 VRKVPHLYVYGKNFD 86 (468)
Q Consensus 72 ~~~l~~l~~~~n~l~ 86 (468)
..++..|.+.+|.+.
T Consensus 271 ~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 271 KASYSGVSLFSNPVQ 285 (305)
T ss_dssp SCCCSEEECCSSSSC
T ss_pred cCCCCEEECCCCcCc
Confidence 234556677777764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=1.5e-08 Score=91.56 Aligned_cols=86 Identities=23% Similarity=0.360 Sum_probs=58.7
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCc---CCCccce
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l 78 (468)
++++|+.|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+.++++|+.|++++|.+.+..+.. +.++..|
T Consensus 53 ~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L 129 (266)
T d1p9ag_ 53 PYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (266)
T ss_dssp TCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred cccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccc
Confidence 5777888888888887 565 3567888888888888887 45667777888888888887777433322 3344556
Q ss_pred ecccccccccCC
Q 012219 79 YVYGKNFDVEIP 90 (468)
Q Consensus 79 ~~~~n~l~~~~p 90 (468)
.+.+|.+....+
T Consensus 130 ~l~~n~l~~l~~ 141 (266)
T d1p9ag_ 130 YLKGNELKTLPP 141 (266)
T ss_dssp ECTTSCCCCCCT
T ss_pred cccccccceecc
Confidence 666666654433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.71 E-value=3e-10 Score=98.04 Aligned_cols=82 Identities=20% Similarity=0.293 Sum_probs=63.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
+|++|+.|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .++. .+.+++.|+
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLY 121 (198)
T ss_dssp HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHHHHHHHHSSEEE
T ss_pred cccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccccccccccccccc
Confidence 4778889999999988 676 5888889999999999888 67766666678888888888888 4543 345667778
Q ss_pred cccccccc
Q 012219 80 VYGKNFDV 87 (468)
Q Consensus 80 ~~~n~l~~ 87 (468)
+++|.+..
T Consensus 122 L~~N~i~~ 129 (198)
T d1m9la_ 122 MSNNKITN 129 (198)
T ss_dssp ESEEECCC
T ss_pred cccchhcc
Confidence 88887653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.65 E-value=1.2e-08 Score=97.08 Aligned_cols=77 Identities=21% Similarity=0.336 Sum_probs=47.5
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccC-CcCCCccceecc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIP-ESVRKVPHLYVY 81 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~ 81 (468)
+++++.|+|++|++++ ++ .+..+++|+.|+|++|+|+ .+| .|++|++|+.|++++|++++..| ..+.+|+.|+++
T Consensus 306 ~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~ 381 (384)
T d2omza2 306 LKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLN 381 (384)
T ss_dssp CTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECC
T ss_pred hcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCC
Confidence 4566777777777764 33 3666777777777777776 344 46677777777777777774333 233445555665
Q ss_pred cc
Q 012219 82 GK 83 (468)
Q Consensus 82 ~n 83 (468)
+|
T Consensus 382 ~N 383 (384)
T d2omza2 382 DQ 383 (384)
T ss_dssp CE
T ss_pred CC
Confidence 54
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.63 E-value=3.9e-10 Score=97.27 Aligned_cols=85 Identities=22% Similarity=0.320 Sum_probs=71.3
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC-----cCCCcc
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE-----SVRKVP 76 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-----~~~~l~ 76 (468)
+|++|+.|+|++|+|+ .+|+.+..+.+|++|++++|+++ .++ .+.++++|+.|+|++|+++ .++. .+.+|+
T Consensus 68 ~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~ 143 (198)
T d1m9la_ 68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLE 143 (198)
T ss_dssp HHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCS
T ss_pred CCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhc-cccccccccCCCccc
Confidence 4789999999999998 88877777889999999999999 454 5889999999999999998 4542 566778
Q ss_pred ceecccccccccCC
Q 012219 77 HLYVYGKNFDVEIP 90 (468)
Q Consensus 77 ~l~~~~n~l~~~~p 90 (468)
.|++++|++....+
T Consensus 144 ~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 144 DLLLAGNPLYNDYK 157 (198)
T ss_dssp EEEECSSHHHHHHC
T ss_pred eeecCCCccccCcc
Confidence 89999998766433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.60 E-value=3.3e-08 Score=84.96 Aligned_cols=80 Identities=15% Similarity=0.281 Sum_probs=51.9
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~ 80 (468)
+.+|+.|++++|+++ .++ .+..+++|++|+|++|++++..| +++|++|+.|++++|.+. .+|. .+..+..|++
T Consensus 39 l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~l~~l~~L~~L~l 113 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTL 113 (199)
T ss_dssp HTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGGGTTCTTCSEEEC
T ss_pred hcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccccccccccccccc
Confidence 456777777777777 554 46777777777777777774332 777777777777777776 4442 3344555566
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
+++....
T Consensus 114 ~~~~~~~ 120 (199)
T d2omxa2 114 FNNQITD 120 (199)
T ss_dssp CSSCCCC
T ss_pred ccccccc
Confidence 6555443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.6e-07 Score=84.12 Aligned_cols=150 Identities=11% Similarity=0.067 Sum_probs=99.4
Q ss_pred HHHHHHhhCccccceeeeeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeC
Q 012219 163 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHR 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 241 (468)
.++....+.|...+..+.++.+.||+... +++.+++|+........ ...+.+|...+..+. +--+.+++.++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 34556666776655544445578999875 55667788876543322 224567888877664 33456778888888
Q ss_pred CEEEEEEEeccCCChhhhhhcCcccCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 012219 242 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNVVKGMCHALSYLHHDC----------------------------- 292 (468)
Q Consensus 242 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------- 292 (468)
+..++||++++|.++.+...... ....++.+++..+..||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 89999999999988765442211 11224445555555555321
Q ss_pred ---------------------------CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 293 ---------------------------TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 293 ---------------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
...++|+|+.|.||++++++.+-|.||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22389999999999999877677999987753
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.58 E-value=3.2e-08 Score=86.96 Aligned_cols=59 Identities=29% Similarity=0.470 Sum_probs=32.1
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccc
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+++|+.|++++|.+++ ++ .++++++|+.|+|++|++++ +| .++++++|+.|+|++|+++
T Consensus 150 ~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC
T ss_pred cccccccccccccccc-ch-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCC
Confidence 3455556666665552 22 25555566666666666553 33 2555556666666666655
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=5.1e-08 Score=83.76 Aligned_cols=82 Identities=18% Similarity=0.314 Sum_probs=67.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccC-CcCCCccceec
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIP-ESVRKVPHLYV 80 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~ 80 (468)
.|++|++|+|++|+|++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+....+ ..+.++..|++
T Consensus 60 ~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l 135 (199)
T d2omxa2 60 YLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 135 (199)
T ss_dssp GCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred cCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhh
Confidence 57899999999999994 554 999999999999999998 555 48999999999999999985322 25667788889
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
++|.+..
T Consensus 136 ~~n~l~~ 142 (199)
T d2omxa2 136 SSNTISD 142 (199)
T ss_dssp CSSCCCC
T ss_pred hhhhhcc
Confidence 9888754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.54 E-value=6e-08 Score=84.05 Aligned_cols=79 Identities=16% Similarity=0.246 Sum_probs=60.3
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~ 80 (468)
|.+|+.|++++|+++ .++ .+..+++|++|+|++|+|++ ++ .+++|++|+.|++++|+++ .+|. .+.++..|++
T Consensus 45 L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~~l~~l~~L~~L~l 119 (210)
T d1h6ta2 45 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSL 119 (210)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGGGGTTCTTCCEEEC
T ss_pred hcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-cccccccccccccccc
Confidence 457888999999988 555 47888899999999999885 44 3688889999999999988 4663 3455666777
Q ss_pred cccccc
Q 012219 81 YGKNFD 86 (468)
Q Consensus 81 ~~n~l~ 86 (468)
.+|.+.
T Consensus 120 ~~~~~~ 125 (210)
T d1h6ta2 120 EHNGIS 125 (210)
T ss_dssp TTSCCC
T ss_pred cccccc
Confidence 777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=4.7e-08 Score=84.77 Aligned_cols=81 Identities=21% Similarity=0.380 Sum_probs=64.9
Q ss_pred CCCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCcccee
Q 012219 2 NCSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLY 79 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~ 79 (468)
+|++|+.|+|++|+|++ ++ .+++|++|++|++++|+|+ .+| .+.++++|+.|++++|.++ .++. .+..+..++
T Consensus 66 ~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 66 YLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLY 140 (210)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEE
T ss_pred hCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccc
Confidence 57899999999999994 55 4788999999999999999 566 5899999999999999987 4543 344556677
Q ss_pred cccccccc
Q 012219 80 VYGKNFDV 87 (468)
Q Consensus 80 ~~~n~l~~ 87 (468)
+.+|.+..
T Consensus 141 ~~~n~l~~ 148 (210)
T d1h6ta2 141 LGNNKITD 148 (210)
T ss_dssp CCSSCCCC
T ss_pred cccccccc
Confidence 77777654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.47 E-value=8.9e-08 Score=90.78 Aligned_cols=81 Identities=16% Similarity=0.301 Sum_probs=67.3
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~ 80 (468)
+.+|+.|++++|+++ .+ +.+..|++|++|+|++|+|++ +| .|++|++|+.|++++|++++ ++. .+.+|+.|++
T Consensus 43 l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~-i~~l~~l~~L~~L~~ 117 (384)
T d2omza2 43 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTL 117 (384)
T ss_dssp HTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEEC
T ss_pred hCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccc-ccccccccccccccc
Confidence 568999999999998 66 478999999999999999995 45 39999999999999999995 443 5566777888
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
+++.+...
T Consensus 118 ~~~~~~~~ 125 (384)
T d2omza2 118 FNNQITDI 125 (384)
T ss_dssp CSSCCCCC
T ss_pred cccccccc
Confidence 87776654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.38 E-value=2e-07 Score=86.97 Aligned_cols=55 Identities=25% Similarity=0.359 Sum_probs=31.9
Q ss_pred CCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceeccccccc
Q 012219 27 LQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYGKNFD 86 (468)
Q Consensus 27 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~l~ 86 (468)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|..+.+|+.|++++|++.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR 337 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCC
Confidence 345666666666666 55532 345556666666666 56655555666666666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=4.4e-08 Score=81.11 Aligned_cols=65 Identities=28% Similarity=0.272 Sum_probs=41.8
Q ss_pred CCCCcEEEccCCcccccCC---cccccCCCCCEeeccCccccccccc-cccCCCCCceecccCcccccccC
Q 012219 3 CSKLRVLELGNNLLSGSIP---SEINKLQELNYLNLSHNSINGKILS-QLGEIPRIDTVDLSMNNLSGSIP 69 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p---~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p 69 (468)
+++|++|+|++|+|+ .++ ..+..+++|+.|+|++|+++ .+++ ......+|+.|++++|.+++...
T Consensus 64 ~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 64 IPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred CCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 567777777777777 332 34666777777777777777 3332 33344467777777777764433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.26 E-value=7.2e-07 Score=83.09 Aligned_cols=75 Identities=24% Similarity=0.236 Sum_probs=62.8
Q ss_pred CCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCCcCCCccceecccc
Q 012219 4 SKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYVYGK 83 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n 83 (468)
.+|+.|||++|+|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.-...++.|++++|
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp~~L~~L~L~~n 108 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLPPLLEYLGVSNN 108 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhcccccccccccc
Confidence 36899999999998 79964 468999999999999 888764 47889999999998 77765567888999998
Q ss_pred cccc
Q 012219 84 NFDV 87 (468)
Q Consensus 84 ~l~~ 87 (468)
.+..
T Consensus 109 ~l~~ 112 (353)
T d1jl5a_ 109 QLEK 112 (353)
T ss_dssp CCSS
T ss_pred cccc
Confidence 8764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=1.6e-06 Score=77.10 Aligned_cols=74 Identities=15% Similarity=0.109 Sum_probs=53.4
Q ss_pred eeeeCC-ceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC--CceeeEEEEEeeCCEEEEEEEeccCC
Q 012219 178 IGTGGY-GSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH--RNIVKLYGFCLHRKCMFLIYEYMEMG 254 (468)
Q Consensus 178 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 254 (468)
+..|.. +.||+....++..+++|.-...... .+..|.+.++.+.. -.+.++++++.+++..++||++++|.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 445553 6789999888888999987654432 34567777776643 33566788888888899999999886
Q ss_pred Chh
Q 012219 255 SLF 257 (468)
Q Consensus 255 sL~ 257 (468)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.24 E-value=6.2e-07 Score=78.43 Aligned_cols=80 Identities=19% Similarity=0.243 Sum_probs=65.2
Q ss_pred CCCCcEEEccCCcccccCCcccccCCCCCEeeccCccccccccccccCCCCCceecccCcccccccCC--cCCCccceec
Q 012219 3 CSKLRVLELGNNLLSGSIPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMNNLSGSIPE--SVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~ 80 (468)
|.+|+.|++++|+|+ .++ .+..|++|++|+|++|++++..| +..+++|+.+++++|.++ .++. .+.++..+.+
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l 114 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDL 114 (227)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEEC
T ss_pred cCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cccccccccccccccc
Confidence 568999999999999 675 69999999999999999996544 899999999999999998 6663 4455666677
Q ss_pred ccccccc
Q 012219 81 YGKNFDV 87 (468)
Q Consensus 81 ~~n~l~~ 87 (468)
.++....
T Consensus 115 ~~~~~~~ 121 (227)
T d1h6ua2 115 TSTQITD 121 (227)
T ss_dssp TTSCCCC
T ss_pred ccccccc
Confidence 6665443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=7.8e-07 Score=78.47 Aligned_cols=82 Identities=17% Similarity=0.265 Sum_probs=56.3
Q ss_pred CCcEEEccCCcccccCCc-ccccCCCCCEeeccCccccccccc-cccCCCCCceeccc-CcccccccCCc---CCCccce
Q 012219 5 KLRVLELGNNLLSGSIPS-EINKLQELNYLNLSHNSINGKILS-QLGEIPRIDTVDLS-MNNLSGSIPES---VRKVPHL 78 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~-~N~l~g~~p~~---~~~l~~l 78 (468)
+++.|+|++|+|+ .+|. .|.++++|++|+|++|.+.+.+|. .|.++++++.++++ .|++....|.. +.+++.+
T Consensus 30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 6788888888887 4544 577888888888888887765544 47778888888765 36666444443 3456666
Q ss_pred ecccccccc
Q 012219 79 YVYGKNFDV 87 (468)
Q Consensus 79 ~~~~n~l~~ 87 (468)
++.+|.+..
T Consensus 109 ~l~~~~l~~ 117 (242)
T d1xwdc1 109 LISNTGIKH 117 (242)
T ss_dssp EEESCCCCS
T ss_pred ccchhhhcc
Confidence 777776643
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=7.8e-08 Score=79.58 Aligned_cols=65 Identities=28% Similarity=0.326 Sum_probs=51.8
Q ss_pred ccccCCCCCEeeccCcccccc--ccccccCCCCCceecccCcccccccCC----cCCCccceeccccccccc
Q 012219 23 EINKLQELNYLNLSHNSINGK--ILSQLGEIPRIDTVDLSMNNLSGSIPE----SVRKVPHLYVYGKNFDVE 88 (468)
Q Consensus 23 ~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~~~n~l~~~ 88 (468)
.+..+++|++|+||+|+|+.. ++..+..|++|+.|+|++|+++ .+++ ...++..|++.+|+++..
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcC
Confidence 345689999999999999953 3456788999999999999999 6665 334567788999988653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=4.4e-06 Score=75.56 Aligned_cols=86 Identities=28% Similarity=0.397 Sum_probs=49.6
Q ss_pred CCCCcEEEccCC-cccccCCcccccCCCCCEeeccC-ccccccccccccCCCCCceecccCcccccccCCcCCCccceec
Q 012219 3 CSKLRVLELGNN-LLSGSIPSEINKLQELNYLNLSH-NSINGKILSQLGEIPRIDTVDLSMNNLSGSIPESVRKVPHLYV 80 (468)
Q Consensus 3 l~~l~~l~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~ 80 (468)
+++|+.|+|++| .+++..+..++++++|++|+|++ +.+++.....++++++|+.|+++++--.+.++.-...++.|.+
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i 253 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSEE
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccccc
Confidence 566777777664 46666666667777777777776 3566555566667777777777665111122221233455555
Q ss_pred cccccccc
Q 012219 81 YGKNFDVE 88 (468)
Q Consensus 81 ~~n~l~~~ 88 (468)
..+.++..
T Consensus 254 ~~~~ls~~ 261 (284)
T d2astb2 254 NCSHFTTI 261 (284)
T ss_dssp SCCCSCCT
T ss_pred cCccCCCC
Confidence 55555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=6.8e-06 Score=72.18 Aligned_cols=72 Identities=17% Similarity=0.196 Sum_probs=54.6
Q ss_pred CCcEEEccCCcccccCCcccccCCCCCEe-eccCccccccccc-cccCCCCCceecccCcccccccCC-cCCCcccee
Q 012219 5 KLRVLELGNNLLSGSIPSEINKLQELNYL-NLSHNSINGKILS-QLGEIPRIDTVDLSMNNLSGSIPE-SVRKVPHLY 79 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~p~~~~~l~~L~~L-~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~ 79 (468)
.++.|++++|+++ .++....+.++++.+ ++++|+|+ .+|. .|.++++|+.|+|++|+|+ .+|. .+.+++.|.
T Consensus 154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR 228 (242)
T ss_dssp SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred cceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccc
Confidence 6778899999998 666666666666555 56888888 5554 5888999999999999998 6665 567777664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=9e-06 Score=73.40 Aligned_cols=81 Identities=16% Similarity=0.224 Sum_probs=62.2
Q ss_pred CCCCCcEEEccCCccccc-CCcccccCCCCCEeeccCccccccccccccCCCCCceecccCc-ccccc----cCCcCCCc
Q 012219 2 NCSKLRVLELGNNLLSGS-IPSEINKLQELNYLNLSHNSINGKILSQLGEIPRIDTVDLSMN-NLSGS----IPESVRKV 75 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N-~l~g~----~p~~~~~l 75 (468)
...+|+.|||++|.+++. ++.-+.++++|++|+|++|.+++..+..++.+++|+.|+|+++ .++.. +-....+|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 355789999999988754 3455788999999999999999888888999999999999984 56521 12345667
Q ss_pred cceeccc
Q 012219 76 PHLYVYG 82 (468)
Q Consensus 76 ~~l~~~~ 82 (468)
+.|++++
T Consensus 124 ~~L~ls~ 130 (284)
T d2astb2 124 DELNLSW 130 (284)
T ss_dssp CEEECCC
T ss_pred ccccccc
Confidence 7777765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.55 E-value=1.4e-05 Score=76.86 Aligned_cols=83 Identities=16% Similarity=0.163 Sum_probs=41.2
Q ss_pred CCCcEEEccCCcccccCCcc----cccCCCCCEeeccCcccccc----cccccc-CCCCCceecccCccccc----ccCC
Q 012219 4 SKLRVLELGNNLLSGSIPSE----INKLQELNYLNLSHNSINGK----ILSQLG-EIPRIDTVDLSMNNLSG----SIPE 70 (468)
Q Consensus 4 ~~l~~l~l~~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~l~l~~N~l~g----~~p~ 70 (468)
+.|+.+++++|.++..-... +....+|++|+|++|+|++. ++..+. ..+.|+.|+|++|+|+. .+++
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 34666666666665332222 23344566666666666532 333332 34556666666666652 1222
Q ss_pred c---CCCccceeccccccc
Q 012219 71 S---VRKVPHLYVYGKNFD 86 (468)
Q Consensus 71 ~---~~~l~~l~~~~n~l~ 86 (468)
. ..+|+.|++++|+++
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHCCCCCEEECCSSSCC
T ss_pred HHhcCCCCCEEECCCCcCC
Confidence 2 234555666666553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=8.2e-05 Score=70.16 Aligned_cols=78 Identities=13% Similarity=0.114 Sum_probs=46.7
Q ss_pred ceeeeeCCceEEEEEcCC-CCEEEEEEecCcch--hh--hhhHHHHHHHHHHHhhcc-C--CceeeEEEEEeeCCEEEEE
Q 012219 176 YCIGTGGYGSVYRARLPS-GKVVALKKLHRSET--EE--LASLESFGNEARLLSQIR-H--RNIVKLYGFCLHRKCMFLI 247 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 247 (468)
+.||.|....||++...+ ++.++||.-..... .+ .........|.+.+..+. + ..+.+++.+.. ...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEEE
Confidence 458999999999998654 67889986432110 00 011223446777776653 2 34556666543 345789
Q ss_pred EEeccCCC
Q 012219 248 YEYMEMGS 255 (468)
Q Consensus 248 ~e~~~~gs 255 (468)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.41 E-value=1.5e-05 Score=76.47 Aligned_cols=61 Identities=21% Similarity=0.293 Sum_probs=32.8
Q ss_pred CCcEEEccCCcccccC-CcccccCCCCCEeeccCccccc----cccccccCCCCCceecccCcccc
Q 012219 5 KLRVLELGNNLLSGSI-PSEINKLQELNYLNLSHNSING----KILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 5 ~l~~l~l~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+|+.|||+.|++++.. ..-+..+++|++|+|++|.|+- .++..+..+++|+.|||++|+++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 4556666666665321 2234445566666666666551 23444555666666666666553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.38 E-value=2.7e-05 Score=72.15 Aligned_cols=84 Identities=17% Similarity=0.195 Sum_probs=54.8
Q ss_pred CCCCcEEEccCCccccc-----CCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcccccc----c-
Q 012219 3 CSKLRVLELGNNLLSGS-----IPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSGS----I- 68 (468)
Q Consensus 3 l~~l~~l~l~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~----~- 68 (468)
++.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|++++. +
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 46778888888887631 334466777888888888887632 445567778888888888877642 1
Q ss_pred ---CC-cCCCccceeccccccc
Q 012219 69 ---PE-SVRKVPHLYVYGKNFD 86 (468)
Q Consensus 69 ---p~-~~~~l~~l~~~~n~l~ 86 (468)
+. ....+..|++++|++.
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCB
T ss_pred HHhhhccCCCCCEEECCCCcCC
Confidence 11 1234666777777654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.29 E-value=3.8e-05 Score=71.18 Aligned_cols=86 Identities=19% Similarity=0.229 Sum_probs=64.4
Q ss_pred CCCCCcEEEccCCcccc----cCCcccccCCCCCEeeccCcccccc-----ccccccCCCCCceecccCcccccc----c
Q 012219 2 NCSKLRVLELGNNLLSG----SIPSEINKLQELNYLNLSHNSINGK-----ILSQLGEIPRIDTVDLSMNNLSGS----I 68 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~l~l~~N~l~g~----~ 68 (468)
+.+.|+.|++++|+++. .+...+..+..|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 35689999999998862 2334566789999999999998742 345578899999999999998632 2
Q ss_pred CC---cCCCccceecccccccc
Q 012219 69 PE---SVRKVPHLYVYGKNFDV 87 (468)
Q Consensus 69 p~---~~~~l~~l~~~~n~l~~ 87 (468)
.. ...+|+.|++++|.+..
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccccccchhhhhhcCccCc
Confidence 22 34567788898888754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.00057 Score=62.41 Aligned_cols=136 Identities=13% Similarity=0.134 Sum_probs=76.4
Q ss_pred CceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccCCce--eeEEE-----EEeeCCEEEEEEEeccCCC
Q 012219 183 YGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRHRNI--VKLYG-----FCLHRKCMFLIYEYMEMGS 255 (468)
Q Consensus 183 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gs 255 (468)
--.||+++..+|+.+++|+....... .+++..|.+.+..|....+ +..+. ........+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 45899999999999999998754322 3456678887777642221 11111 1234566788999998654
Q ss_pred hhh----hh----------hc----C--cccCCCCHH----------------------HHHHHHHHHHHHHHHH-HhcC
Q 012219 256 LFC----VL----------RT----D--EEAVGLDWA----------------------KRVNVVKGMCHALSYL-HHDC 292 (468)
Q Consensus 256 L~~----~l----------~~----~--~~~~~l~~~----------------------~~~~i~~~ia~~l~~L-H~~~ 292 (468)
+.. .+ +. . ......++. .....+..+...+.-. ....
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 311 00 10 0 000111111 1112222222222211 1222
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEeecccccc
Q 012219 293 TPPIVHRDISSNNVLLNSELEAFVADFGVARL 324 (468)
Q Consensus 293 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 324 (468)
..+++|+|+.+.|||++++ ..+.||+.++.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4579999999999999754 45789998854
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.00 E-value=0.00089 Score=60.68 Aligned_cols=158 Identities=12% Similarity=0.050 Sum_probs=82.8
Q ss_pred cCHHHHHHHhhCccccceee-----eeCCceEEEEEcCCCCEEEEEEecCcchhhhhhHHHHHHHHHHHhhccC-----C
Q 012219 160 ITFQDMIEATEDFHIKYCIG-----TGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFGNEARLLSQIRH-----R 229 (468)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~ 229 (468)
++-+++.....+|.+.+... .|---+.|+.+..+|+ +++|+....... ++...|++++..+.. |
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence 46678888888898765443 4555778999876665 888988643211 233346666666542 2
Q ss_pred ceeeEE-E--EEeeCCEEEEEEEeccCCChhhh--------------hhc----C--cccCCCC----------------
Q 012219 230 NIVKLY-G--FCLHRKCMFLIYEYMEMGSLFCV--------------LRT----D--EEAVGLD---------------- 270 (468)
Q Consensus 230 niv~l~-~--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~----~--~~~~~l~---------------- 270 (468)
..+... | +.........++.+..+...... ++. . .......
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 222110 0 11223456667777665433110 000 0 0000000
Q ss_pred --HHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceeeCCCCCeEEeeccccc
Q 012219 271 --WAKRVNVVKGMCHALSYLH-HDCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 323 (468)
Q Consensus 271 --~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 323 (468)
.......+..+...+.-.+ .....|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011111222222222222 1225689999999999999998877899999874
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.85 E-value=0.00016 Score=59.23 Aligned_cols=84 Identities=11% Similarity=0.228 Sum_probs=59.2
Q ss_pred CCCCCcEEEccCC-ccccc----CCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcccccc----c
Q 012219 2 NCSKLRVLELGNN-LLSGS----IPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSGS----I 68 (468)
Q Consensus 2 ~l~~l~~l~l~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~----~ 68 (468)
+.++|+.|+|+++ .++.. +-..+...+.|+.|+|++|.++.. +...+...+.|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 5689999999974 46532 233566778999999999999743 334566778999999999999742 1
Q ss_pred CCcC---CCccceecccccc
Q 012219 69 PESV---RKVPHLYVYGKNF 85 (468)
Q Consensus 69 p~~~---~~l~~l~~~~n~l 85 (468)
-..+ .+++.|++++|..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHhCCcCCEEECCCCcC
Confidence 1122 3466777776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.53 E-value=0.0039 Score=58.25 Aligned_cols=72 Identities=22% Similarity=0.223 Sum_probs=47.6
Q ss_pred ceeeeeCCceEEEEEcCC--------CCEEEEEEecCcchhhhhhHHHHHHHHHHHhhcc-CCceeeEEEEEeeCCEEEE
Q 012219 176 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFGNEARLLSQIR-HRNIVKLYGFCLHRKCMFL 246 (468)
Q Consensus 176 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 246 (468)
+.|+.|-.-.+|++...+ .+.|.+++.-.... .....+|..+++.+. +.-..++++++.. .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 568888889999998654 35677776653221 123447888888775 3333467777753 57
Q ss_pred EEEeccCCCh
Q 012219 247 IYEYMEMGSL 256 (468)
Q Consensus 247 v~e~~~~gsL 256 (468)
|+||++|.++
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.52 E-value=0.0007 Score=55.19 Aligned_cols=64 Identities=20% Similarity=0.191 Sum_probs=50.7
Q ss_pred CCCCCcEEEccCCcccccCC----cccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCcccc
Q 012219 2 NCSKLRVLELGNNLLSGSIP----SEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLS 65 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 65 (468)
+.++|+.|+|++|.+...-. ..+...+.|+.|+|++|.|+.. +-..+...++|+.|+|++|.+.
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 45789999999999974322 3455679999999999999854 3345778899999999999776
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.36 E-value=0.0071 Score=48.75 Aligned_cols=65 Identities=14% Similarity=0.169 Sum_probs=47.6
Q ss_pred CCCCCcEEEccC-Cccccc----CCcccccCCCCCEeeccCcccccc----ccccccCCCCCceecccCccccc
Q 012219 2 NCSKLRVLELGN-NLLSGS----IPSEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTVDLSMNNLSG 66 (468)
Q Consensus 2 ~l~~l~~l~l~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g 66 (468)
+.++|+.|+|++ |.++.. +-..+...+.|+.|+|++|.++.. +-..+...++|+.|++++|.++.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 568899999997 556522 223445688999999999998744 23345677899999999998863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.64 E-value=0.016 Score=46.57 Aligned_cols=64 Identities=14% Similarity=0.195 Sum_probs=48.4
Q ss_pred CCCCCcEEEccCCcccccCC----cccccCCCCCEeeccCcccccc----ccccccCCCCCcee--cccCcccc
Q 012219 2 NCSKLRVLELGNNLLSGSIP----SEINKLQELNYLNLSHNSINGK----ILSQLGEIPRIDTV--DLSMNNLS 65 (468)
Q Consensus 2 ~l~~l~~l~l~~N~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l--~l~~N~l~ 65 (468)
+.++|+.|+|++|.++..-- ..+...++|+.|++++|.++.. +-..+...++|+.+ ++++|.+.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 46789999999999874422 3456679999999999999744 34567788999875 45677774
|